Protein Group,Protein ID,Accession,Significance,-10lgP,Intensity iTRAQ4-114,Intensity iTRAQ4-115,Intensity iTRAQ4-116,Intensity iTRAQ4-117,Ratio iTRAQ4-114,Ratio iTRAQ4-115,Ratio iTRAQ4-116,Ratio iTRAQ4-117,Intensity SMC_FLT1(iTRAQ4-114),Intensity SMC_FLT2(iTRAQ4-115),Intensity SMC_mockF1(iTRAQ4-116),Intensity SMC_mockF2(iTRAQ4-117),Ratio SMC_FLT1(iTRAQ4-114),Ratio SMC_FLT2(iTRAQ4-115),Ratio SMC_mockF1(iTRAQ4-116),Ratio SMC_mockF2(iTRAQ4-117),Coverage (%),#Peptides,#Unique,PTM,Avg. Mass,Description
2,36,sp|Q15149|PLEC_HUMAN,7.35,417.21,2.236E7,2.284E7,2.741E7,2.722E7,1.00,1.02,1.23,1.22,2.236E7,2.284E7,2.741E7,2.722E7,1.00,1.02,1.23,1.22,3,425,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),531796,Plectin OS=Homo sapiens OX=9606 GN=PLEC PE=1 SV=3
4,33,sp|Q15149-3|PLEC_HUMAN,1.54,416.53,1.575E7,1.529E7,2.524E7,2.29E7,1.00,0.97,1.60,1.45,1.575E7,1.529E7,2.524E7,2.29E7,1.00,0.97,1.60,1.45,0,414,1,iTRAQ 4plex (K  N-term),518037,Isoform 3 of Plectin OS=Homo sapiens OX=9606 GN=PLEC
5,31,sp|Q15149-4|PLEC_HUMAN,22.99,415.13,1.629E7,1.608E7,2.541E7,2.449E7,1.00,0.99,1.56,1.50,1.629E7,1.608E7,2.541E7,2.449E7,1.00,0.99,1.56,1.50,0,414,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),516204,Isoform 4 of Plectin OS=Homo sapiens OX=9606 GN=PLEC
1,3,sp|P35579|MYH9_HUMAN,8.63,404.61,2.288E10,2.174E10,2.068E10,2.542E10,1.00,0.95,0.90,1.11,2.288E10,2.174E10,2.068E10,2.542E10,1.00,0.95,0.90,1.11,59,390,316,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ); Phosphorylation (STY),226530,Myosin-9 OS=Homo sapiens OX=9606 GN=MYH9 PE=1 SV=4
6,37,H0YDN1|H0YDN1_HUMAN,30.80,395.97,5.987E5,6.578E5,1.037E6,9.63E5,1.00,1.10,1.73,1.61,5.987E5,6.578E5,1.037E6,9.63E5,1.00,1.10,1.73,1.61,1,298,3,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),388036,Plectin OS=Homo sapiens OX=9606 GN=PLEC PE=1 SV=9
21,5314,D6RGG3|D6RGG3_HUMAN,3.71,375.59,7.688E8,8.016E8,8.588E8,8.105E8,1.00,1.04,1.12,1.05,7.688E8,8.016E8,8.588E8,8.105E8,1.00,1.04,1.12,1.05,59,200,200,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),333203,Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=1
19,714,A0A2R8Y4T1|A0A2R8Y4T1_HUMAN,46.59,367.27,5.446E8,5.639E8,9.809E8,9.396E8,1.00,1.04,1.80,1.73,5.446E8,5.639E8,9.809E8,9.396E8,1.00,1.04,1.80,1.73,67,137,133,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),199549,Tensin-1 OS=Homo sapiens OX=9606 GN=TNS1 PE=1 SV=1
14,1365,sp|P21333-2|FLNA_HUMAN,16.09,362.94,1.05E9,1.07E9,1.434E9,1.384E9,1.00,1.02,1.37,1.32,1.05E9,1.07E9,1.434E9,1.384E9,1.00,1.02,1.37,1.32,55,190,162,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),280016,Isoform 2 of Filamin-A OS=Homo sapiens OX=9606 GN=FLNA
41,859,sp|Q9Y520-4|PRC2C_HUMAN,58.14,343.84,1.21E8,1.239E8,2.355E8,2.276E8,1.00,1.02,1.95,1.88,1.21E8,1.239E8,2.355E8,2.276E8,1.00,1.02,1.95,1.88,52,137,123,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),308606,Isoform 4 of Protein PRRC2C OS=Homo sapiens OX=9606 GN=PRRC2C
56,24,sp|O15027-5|SC16A_HUMAN,8.43,339.81,1.302E6,1.34E6,2.484E6,1.81E6,1.00,1.03,1.91,1.39,1.302E6,1.34E6,2.484E6,1.81E6,1.00,1.03,1.91,1.39,2,99,2,iTRAQ 4plex (K  N-term),254126,Isoform 5 of Protein transport protein Sec16A OS=Homo sapiens OX=9606 GN=SEC16A
62,23,sp|O15027|SC16A_HUMAN,1.03,338.21,3.85E4,2.942E4,3.513E4,4.257E4,1.00,0.76,0.91,1.11,3.85E4,2.942E4,3.513E4,4.257E4,1.00,0.76,0.91,1.11,2,98,1,iTRAQ 4plex (K  N-term),251891,Protein transport protein Sec16A OS=Homo sapiens OX=9606 GN=SEC16A PE=1 SV=4
24,839,sp|Q14315|FLNC_HUMAN,41.90,334.63,3.868E8,3.967E8,6.73E8,6.451E8,1.00,1.03,1.74,1.67,3.868E8,3.967E8,6.73E8,6.451E8,1.00,1.03,1.74,1.67,43,147,120,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ); Phosphorylation (STY),291020,Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3
58,3292,sp|Q14157|UBP2L_HUMAN,2.29,334.29,1.898E5,2.026E5,2.602E5,2.561E5,1.00,1.07,1.37,1.35,1.898E5,2.026E5,2.602E5,2.561E5,1.00,1.07,1.37,1.35,2,65,2,iTRAQ 4plex (K  N-term),114534,Ubiquitin-associated protein 2-like OS=Homo sapiens OX=9606 GN=UBAP2L PE=1 SV=2
60,3296,sp|Q14157-5|UBP2L_HUMAN,4.04,333.31,9.985E3,1.195E4,3.227E4,3.094E4,1.00,1.20,3.23,3.10,9.985E3,1.195E4,3.227E4,3.094E4,1.00,1.20,3.23,3.10,1,64,1,iTRAQ 4plex (K  N-term),116640,Isoform 5 of Ubiquitin-associated protein 2-like OS=Homo sapiens OX=9606 GN=UBAP2L
28,982,sp|P15924|DESP_HUMAN,9.50,331.36,5.74E8,5.862E8,7.155E8,6.879E8,1.00,1.02,1.25,1.20,5.74E8,5.862E8,7.155E8,6.879E8,1.00,1.02,1.25,1.20,50,172,170,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),331774,Desmoplakin OS=Homo sapiens OX=9606 GN=DSP PE=1 SV=3
69,3256,sp|Q14157-4|UBP2L_HUMAN,3.64,328.92,8.432E5,8.971E5,2.429E6,2.302E6,1.00,1.06,2.88,2.73,8.432E5,8.971E5,2.429E6,2.302E6,1.00,1.06,2.88,2.73,1,58,1,iTRAQ 4plex (K  N-term),103168,Isoform 4 of Ubiquitin-associated protein 2-like OS=Homo sapiens OX=9606 GN=UBAP2L
93,1288,sp|Q9C0C2|TB182_HUMAN,57.04,327.23,5.28E7,5.447E7,1.021E8,1.007E8,1.00,1.03,1.93,1.91,5.28E7,5.447E7,1.021E8,1.007E8,1.00,1.03,1.93,1.91,51,81,62,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),181795,182 kDa tankyrase-1-binding protein OS=Homo sapiens OX=9606 GN=TNKS1BP1 PE=1 SV=4
17,272,sp|P35580|MYH10_HUMAN,0.63,326.63,1.588E6,1.585E6,1.829E6,1.99E6,1.00,1.00,1.15,1.25,1.588E6,1.585E6,1.829E6,1.99E6,1.00,1.00,1.15,1.25,1,156,1,iTRAQ 4plex (K  N-term),228997,Myosin-10 OS=Homo sapiens OX=9606 GN=MYH10 PE=1 SV=3
18,273,sp|P35580-5|MYH10_HUMAN,1.64,326.40,3.6E4,3.795E4,6.309E4,5.587E4,1.00,1.05,1.75,1.55,3.6E4,3.795E4,6.309E4,5.587E4,1.00,1.05,1.75,1.55,0,156,1,iTRAQ 4plex (K  N-term),230028,Isoform 5 of Myosin-10 OS=Homo sapiens OX=9606 GN=MYH10
27,511,sp|P11940|PABP1_HUMAN,27.44,325.94,9.703E7,1.014E8,1.496E8,1.396E8,1.00,1.05,1.54,1.44,9.703E7,1.014E8,1.496E8,1.396E8,1.00,1.05,1.54,1.44,28,94,37,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),70671,Polyadenylate-binding protein 1 OS=Homo sapiens OX=9606 GN=PABPC1 PE=1 SV=2
35,1284,sp|O75369-2|FLNB_HUMAN,13.35,323.62,2.551E8,2.559E8,3.363E8,3.313E8,1.00,1.00,1.32,1.30,2.551E8,2.559E8,3.363E8,3.313E8,1.00,1.00,1.32,1.30,53,143,114,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),275666,Isoform 2 of Filamin-B OS=Homo sapiens OX=9606 GN=FLNB
40,2289,sp|Q00610|CLH1_HUMAN,2.61,318.72,4.917E8,4.938E8,4.686E8,4.543E8,1.00,1.00,0.95,0.92,4.917E8,4.938E8,4.686E8,4.543E8,1.00,1.00,0.95,0.92,41,104,87,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),191613,Clathrin heavy chain 1 OS=Homo sapiens OX=9606 GN=CLTC PE=1 SV=5
67,27,sp|P98160|PGBM_HUMAN,8.13,316.08,2.01E8,2.047E8,2.45E8,2.412E8,1.00,1.02,1.22,1.20,2.01E8,2.047E8,2.45E8,2.412E8,1.00,1.02,1.22,1.20,32,122,117,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),468835,Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4
112,2622,G3V1L9|G3V1L9_HUMAN,96.72,315.02,1.008E6,1.09E6,2.956E6,2.682E6,1.00,1.08,2.93,2.66,1.008E6,1.09E6,2.956E6,2.682E6,1.00,1.08,2.93,2.66,4,86,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),197458,Tight junction protein 1 (Zona occludens 1)  isoform CRA_a OS=Homo sapiens OX=9606 GN=TJP1 PE=1 SV=1
158,476,sp|Q03001|DYST_HUMAN,21.64,312.33,1.105E7,1.115E7,1.773E7,1.832E7,1.00,1.01,1.61,1.66,1.105E7,1.115E7,1.773E7,1.832E7,1.00,1.01,1.61,1.66,4,119,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),860679,Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4
114,2669,G5E9E7|G5E9E7_HUMAN,2.42,311.33,2.876E5,2.949E5,6.086E5,6.118E5,1.00,1.03,2.12,2.13,2.876E5,2.949E5,6.086E5,6.118E5,1.00,1.03,2.12,2.13,1,83,1,iTRAQ 4plex (K  N-term),189674,Tight junction protein 1 (Zona occludens 1)  isoform CRA_e OS=Homo sapiens OX=9606 GN=TJP1 PE=1 SV=1
74,1961,sp|P12111|CO6A3_HUMAN,43.37,311.12,4.983E6,5.198E6,8.766E6,8.338E6,1.00,1.04,1.76,1.67,4.983E6,5.198E6,8.766E6,8.338E6,1.00,1.04,1.76,1.67,2,128,7,iTRAQ 4plex (K  N-term),343668,Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5
63,882,sp|O94979-8|SC31A_HUMAN,32.80,309.91,2.057E5,2.151E5,3.985E5,3.677E5,1.00,1.05,1.94,1.79,2.057E5,2.151E5,3.985E5,3.677E5,1.00,1.05,1.94,1.79,2,82,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),134499,Isoform 8 of Protein transport protein Sec31A OS=Homo sapiens OX=9606 GN=SEC31A
117,2790,sp|Q9UDY2|ZO2_HUMAN,111.17,309.26,7.778E7,7.785E7,2.009E8,2.007E8,1.00,1.00,2.58,2.58,7.778E7,7.785E7,2.009E8,2.007E8,1.00,1.00,2.58,2.58,58,68,65,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),133958,Tight junction protein ZO-2 OS=Homo sapiens OX=9606 GN=TJP2 PE=1 SV=2
57,884,D6REX3|D6REX3_HUMAN,4.87,308.02,4.052E5,4.151E5,7.004E5,6.257E5,1.00,1.02,1.73,1.54,4.052E5,4.151E5,7.004E5,6.257E5,1.00,1.02,1.73,1.54,2,82,2,iTRAQ 4plex (K  N-term),136226,Protein transport protein Sec31A OS=Homo sapiens OX=9606 GN=SEC31A PE=1 SV=1
7,9,sp|P60709|ACTB_HUMAN,8.02,307.36,2.966E8,2.881E8,2.784E8,3.386E8,1.00,0.97,0.94,1.14,2.966E8,2.881E8,2.784E8,3.386E8,1.00,0.97,0.94,1.14,6,91,7,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),41737,Actin  cytoplasmic 1 OS=Homo sapiens OX=9606 GN=ACTB PE=1 SV=1
111,280,sp|P27708|PYR1_HUMAN,3.62,302.31,2.32E8,2.344E8,2.211E8,2.103E8,1.00,1.01,0.95,0.91,2.32E8,2.344E8,2.211E8,2.103E8,1.00,1.01,0.95,0.91,37,83,83,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),242981,CAD protein OS=Homo sapiens OX=9606 GN=CAD PE=1 SV=3
71,44,sp|Q8WWM7|ATX2L_HUMAN,10.04,301.22,2.387E6,2.575E6,5.454E6,5.539E6,1.00,1.08,2.29,2.32,2.387E6,2.575E6,5.454E6,5.539E6,1.00,1.08,2.29,2.32,2,63,2,iTRAQ 4plex (K  N-term),113374,Ataxin-2-like protein OS=Homo sapiens OX=9606 GN=ATXN2L PE=1 SV=2
183,470,F6QMI7|F6QMI7_HUMAN,1.29,299.86,4.642E5,4.716E5,7.2E5,7.008E5,1.00,1.02,1.55,1.51,4.642E5,4.716E5,7.2E5,7.008E5,1.00,1.02,1.55,1.51,0,100,1,iTRAQ 4plex (K  N-term),633674,Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=2
76,39,sp|Q8WWM7-4|ATX2L_HUMAN,1.94,298.42,4.636E5,4.713E5,8.688E5,8.299E5,1.00,1.02,1.87,1.79,4.636E5,4.713E5,8.688E5,8.299E5,1.00,1.02,1.87,1.79,2,61,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),110326,Isoform 4 of Ataxin-2-like protein OS=Homo sapiens OX=9606 GN=ATXN2L
77,46,H3BUF6|H3BUF6_HUMAN,3.99,297.43,7.533E5,7.76E5,1.184E6,1.18E6,1.00,1.03,1.57,1.57,7.533E5,7.76E5,1.184E6,1.18E6,1.00,1.03,1.57,1.57,3,60,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),112714,Ataxin-2-like protein OS=Homo sapiens OX=9606 GN=ATXN2L PE=1 SV=1
81,823,sp|Q96N67|DOCK7_HUMAN,0.84,296.41,8.775E5,8.519E5,9.191E5,9.646E5,1.00,0.97,1.05,1.10,8.775E5,8.519E5,9.191E5,9.646E5,1.00,0.97,1.05,1.10,1,100,2,iTRAQ 4plex (K  N-term),242558,Dedicator of cytokinesis protein 7 OS=Homo sapiens OX=9606 GN=DOCK7 PE=1 SV=4
79,482,sp|Q96N67-2|DOCK7_HUMAN,2.24,295.97,3.865E5,3.416E5,5.974E5,6.977E5,1.00,0.88,1.55,1.81,3.865E5,3.416E5,5.974E5,6.977E5,1.00,0.88,1.55,1.81,0,99,1,iTRAQ 4plex (K  N-term),241410,Isoform 2 of Dedicator of cytokinesis protein 7 OS=Homo sapiens OX=9606 GN=DOCK7
122,163,sp|Q6PKG0|LARP1_HUMAN,58.59,294.76,1.183E8,1.211E8,2.311E8,2.239E8,1.00,1.02,1.95,1.89,1.183E8,1.211E8,2.311E8,2.239E8,1.00,1.02,1.95,1.89,56,63,59,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),123510,La-related protein 1 OS=Homo sapiens OX=9606 GN=LARP1 PE=1 SV=2
99,605,sp|P46939|UTRO_HUMAN,50.11,292.97,1.069E8,1.076E8,1.974E8,1.931E8,1.00,1.01,1.85,1.81,1.069E8,1.076E8,1.974E8,1.931E8,1.00,1.01,1.85,1.81,33,111,105,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),394467,Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2
138,8553,sp|P49750|YLPM1_HUMAN,19.14,291.73,5.968E7,5.977E7,8.448E7,8.216E7,1.00,1.00,1.42,1.38,5.968E7,5.977E7,8.448E7,8.216E7,1.00,1.00,1.42,1.38,38,72,71,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),241643,YLP motif-containing protein 1 OS=Homo sapiens OX=9606 GN=YLPM1 PE=1 SV=4
20,1811,sp|P08670|VIME_HUMAN,11.11,291.25,1.769E9,1.705E9,1.709E9,2.178E9,1.00,0.96,0.97,1.23,1.769E9,1.705E9,1.709E9,2.178E9,1.00,0.96,0.97,1.23,74,74,63,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),53652,Vimentin OS=Homo sapiens OX=9606 GN=VIM PE=1 SV=4
100,415,sp|Q8WX93-3|PALLD_HUMAN,16.23,291.09,3.206E6,2.888E6,4.582E6,4.481E6,1.00,0.90,1.43,1.40,3.206E6,2.888E6,4.582E6,4.481E6,1.00,0.90,1.43,1.40,9,61,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),108631,Isoform 3 of Palladin OS=Homo sapiens OX=9606 GN=PALLD
65,4521,sp|P09651-2|ROA1_HUMAN,200.00,290.39,3.551E6,4.259E6,1.329E7,1.207E7,1.00,1.20,3.74,3.40,3.551E6,4.259E6,1.329E7,1.207E7,1.00,1.20,3.74,3.40,14,49,1,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),34196,Isoform A1-A of Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens OX=9606 GN=HNRNPA1
118,5935,sp|Q92945|FUBP2_HUMAN,200.00,290.00,9.436E7,9.774E7,3.036E8,2.966E8,1.00,1.04,3.22,3.14,9.436E7,9.774E7,3.036E8,2.966E8,1.00,1.04,3.22,3.14,60,45,41,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),73115,Far upstream element-binding protein 2 OS=Homo sapiens OX=9606 GN=KHSRP PE=1 SV=4
80,3407,A0A1X7SBZ2|A0A1X7SBZ2_HUMAN,84.91,286.26,1.72E8,1.806E8,3.908E8,3.781E8,1.00,1.05,2.27,2.20,1.72E8,1.806E8,3.908E8,3.781E8,1.00,1.05,2.27,2.20,47,59,44,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),80255,Probable ATP-dependent RNA helicase DDX17 OS=Homo sapiens OX=9606 GN=DDX17 PE=1 SV=1
78,1113,sp|Q92626|PXDN_HUMAN,12.93,285.64,3.514E8,3.628E8,4.606E8,4.412E8,1.00,1.03,1.31,1.26,3.514E8,3.628E8,4.606E8,4.412E8,1.00,1.03,1.31,1.26,46,78,75,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),165274,Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2
96,3122,sp|Q14444|CAPR1_HUMAN,49.40,284.97,3.539E8,3.619E8,6.502E8,6.166E8,1.00,1.02,1.84,1.74,3.539E8,3.619E8,6.502E8,6.166E8,1.00,1.02,1.84,1.74,59,49,49,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),78366,Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2
143,3015,sp|Q09666|AHNK_HUMAN,26.29,284.91,8.043E7,7.642E7,1.167E8,1.18E8,1.00,0.95,1.45,1.47,8.043E7,7.642E7,1.167E8,1.18E8,1.00,0.95,1.45,1.47,26,113,113,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),629114,Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2
132,168,sp|P48634|PRC2A_HUMAN,63.81,284.37,5.195E7,5.257E7,1.048E8,1.016E8,1.00,1.01,2.02,1.96,5.195E7,5.257E7,1.048E8,1.016E8,1.00,1.01,2.02,1.96,37,71,65,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),228861,Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3
107,1330,sp|Q8WX93-4|PALLD_HUMAN,0.77,283.98,4.238E4,4.243E4,3.617E4,3.191E4,1.00,1.00,0.85,0.75,4.238E4,4.243E4,3.617E4,3.191E4,1.00,1.00,0.85,0.75,2,54,1,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term),73322,Isoform 4 of Palladin OS=Homo sapiens OX=9606 GN=PALLD
82,3252,sp|P17844|DDX5_HUMAN,88.36,283.35,2.349E8,2.488E8,5.433E8,5.19E8,1.00,1.06,2.31,2.21,2.349E8,2.488E8,5.433E8,5.19E8,1.00,1.06,2.31,2.21,55,61,45,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),69148,Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1
181,748,sp|Q5JSZ5|PRC2B_HUMAN,36.58,282.12,3.602E7,3.591E7,5.994E7,5.649E7,1.00,1.00,1.66,1.57,3.602E7,3.591E7,5.994E7,5.649E7,1.00,1.00,1.66,1.57,31,69,55,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),242964,Protein PRRC2B OS=Homo sapiens OX=9606 GN=PRRC2B PE=1 SV=2
280,1935,sp|Q14671-2|PUM1_HUMAN,2.25,281.49,1.618E5,1.507E5,3.065E5,2.93E5,1.00,0.93,1.89,1.81,1.618E5,1.507E5,3.065E5,2.93E5,1.00,0.93,1.89,1.81,1,41,1,iTRAQ 4plex (K  N-term),124420,Isoform 2 of Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1
277,1781,sp|Q14671|PUM1_HUMAN,3.05,281.24,4.397E5,4.608E5,1.09E6,1.086E6,1.00,1.05,2.48,2.47,4.397E5,4.608E5,1.09E6,1.086E6,1.00,1.05,2.48,2.47,1,41,1,iTRAQ 4plex (K  N-term),126473,Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3
127,5197,sp|O60716-5|CTND1_HUMAN,76.47,280.34,1.799E6,1.88E6,6.596E6,6.337E6,1.00,1.05,3.67,3.52,1.799E6,1.88E6,6.596E6,6.337E6,1.00,1.05,3.67,3.52,3,51,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),104156,Isoform 1A of Catenin delta-1 OS=Homo sapiens OX=9606 GN=CTNND1
156,215,sp|Q5SW79|CE170_HUMAN,1.87,280.09,2.07E4,2.353E4,3.843E4,3.285E4,1.00,1.14,1.86,1.59,2.07E4,2.353E4,3.843E4,3.285E4,1.00,1.14,1.86,1.59,1,67,1,iTRAQ 4plex (K  N-term),175292,Centrosomal protein of 170 kDa OS=Homo sapiens OX=9606 GN=CEP170 PE=1 SV=1
12,2495,sp|P62736|ACTA_HUMAN,16.51,279.77,2.526E6,1.684E6,2.727E6,2.869E6,1.00,0.67,1.08,1.14,2.526E6,1.684E6,2.727E6,2.869E6,1.00,0.67,1.08,1.14,3,64,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),42009,Actin  aortic smooth muscle OS=Homo sapiens OX=9606 GN=ACTA2 PE=1 SV=1
9,1,gi|121038|sp|P01869.2|IGH1M_MOUSE,200.00,279.18,8.59E9,8.799E9,2.983E9,2.665E9,1.00,1.02,0.35,0.31,8.59E9,8.799E9,2.983E9,2.665E9,1.00,1.02,0.35,0.31,59,64,60,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),43387,RecName: Full=Ig gamma-1 chain C region  membrane-bound form
157,211,sp|Q5SW79-3|CE170_HUMAN,7.62,278.88,5.211E5,5.51E5,1.046E6,1.079E6,1.00,1.06,2.01,2.07,5.211E5,5.51E5,1.046E6,1.079E6,1.00,1.06,2.01,2.07,2,65,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),164538,Isoform 3 of Centrosomal protein of 170 kDa OS=Homo sapiens OX=9606 GN=CEP170
206,1571,sp|O75533|SF3B1_HUMAN,40.91,277.37,5.136E7,5.171E7,8.871E7,8.485E7,1.00,1.01,1.73,1.65,5.136E7,5.171E7,8.871E7,8.485E7,1.00,1.01,1.73,1.65,49,52,52,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),145830,Splicing factor 3B subunit 1 OS=Homo sapiens OX=9606 GN=SF3B1 PE=1 SV=3
135,5194,sp|O60716-8|CTND1_HUMAN,2.31,276.86,1.643E4,2.151E4,3.48E4,3.386E4,1.00,1.31,2.12,2.06,1.643E4,2.151E4,3.48E4,3.386E4,1.00,1.31,2.12,2.06,1,48,1,iTRAQ 4plex (K  N-term),101765,Isoform 1 of Catenin delta-1 OS=Homo sapiens OX=9606 GN=CTNND1
133,376,sp|Q14764|MVP_HUMAN,23.37,276.55,2.367E8,2.299E8,1.598E8,1.645E8,1.00,0.97,0.68,0.70,2.367E8,2.299E8,1.598E8,1.645E8,1.00,0.97,0.68,0.70,54,51,51,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),99327,Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4
121,230,sp|O00159-3|MYO1C_HUMAN,10.68,275.29,2.252E8,2.186E8,2.405E8,2.775E8,1.00,0.97,1.07,1.23,2.252E8,2.186E8,2.405E8,2.775E8,1.00,0.97,1.07,1.23,47,65,62,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),119628,Isoform 3 of Unconventional myosin-Ic OS=Homo sapiens OX=9606 GN=MYO1C
172,214,H0Y2V6|H0Y2V6_HUMAN,1.45,274.78,1.344E5,1.158E5,1.904E5,1.909E5,1.00,0.86,1.42,1.42,1.344E5,1.158E5,1.904E5,1.909E5,1.00,0.86,1.42,1.42,1,61,1,iTRAQ 4plex (K  N-term),172091,Centrosomal protein of 170 kDa (Fragment) OS=Homo sapiens OX=9606 GN=CEP170 PE=1 SV=1
126,1541,sp|Q6Y7W6|GGYF2_HUMAN,65.53,273.86,1.073E8,1.105E8,2.187E8,2.099E8,1.00,1.03,2.04,1.96,1.073E8,1.105E8,2.187E8,2.099E8,1.00,1.03,2.04,1.96,42,65,61,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),150070,GRB10-interacting GYF protein 2 OS=Homo sapiens OX=9606 GN=GIGYF2 PE=1 SV=1
187,1930,sp|O95425-4|SVIL_HUMAN,1.97,273.33,7.393E5,6.997E5,8.31E5,8.9E5,1.00,0.95,1.12,1.20,7.393E5,6.997E5,8.31E5,8.9E5,1.00,0.95,1.12,1.20,1,62,2,iTRAQ 4plex (K  N-term),244520,Isoform SV4 of Supervillin OS=Homo sapiens OX=9606 GN=SVIL
106,4920,A0A2R8Y5A6|A0A2R8Y5A6_HUMAN,3.53,273.05,1.181E6,1.299E6,1.824E6,1.722E6,1.00,1.10,1.54,1.46,1.181E6,1.299E6,1.824E6,1.722E6,1.00,1.10,1.54,1.46,1,52,2,iTRAQ 4plex (K  N-term),126009,Ataxin-2 OS=Homo sapiens OX=9606 GN=ATXN2 PE=1 SV=1
104,1869,sp|Q99700|ATX2_HUMAN,3.14,272.83,1.958E6,1.987E6,2.378E6,2.326E6,1.00,1.02,1.21,1.19,1.958E6,1.987E6,2.378E6,2.326E6,1.00,1.02,1.21,1.19,1,52,2,iTRAQ 4plex (K  N-term); Oxidation (M),140283,Ataxin-2 OS=Homo sapiens OX=9606 GN=ATXN2 PE=1 SV=2
94,369,sp|Q14152|EIF3A_HUMAN,126.85,272.74,1.551E8,1.629E8,4.294E8,4.143E8,1.00,1.05,2.77,2.67,1.551E8,1.629E8,4.294E8,4.143E8,1.00,1.05,2.77,2.67,44,80,79,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),166569,Eukaryotic translation initiation factor 3 subunit A OS=Homo sapiens OX=9606 GN=EIF3A PE=1 SV=1
188,1931,sp|O95425-3|SVIL_HUMAN,0.70,272.02,5.578E5,5.687E5,5.931E5,7.184E5,1.00,1.02,1.06,1.29,5.578E5,5.687E5,5.931E5,7.184E5,1.00,1.02,1.06,1.29,1,61,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),244677,Isoform SV3 of Supervillin OS=Homo sapiens OX=9606 GN=SVIL
70,1124,sp|Q13310-2|PABP4_HUMAN,35.39,272.01,1.81E8,1.897E8,2.993E8,2.852E8,1.00,1.05,1.65,1.58,1.81E8,1.897E8,2.993E8,2.852E8,1.00,1.05,1.65,1.58,47,68,36,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),69579,Isoform 2 of Polyadenylate-binding protein 4 OS=Homo sapiens OX=9606 GN=PABPC4
68,4524,sp|P09651|ROA1_HUMAN,104.68,270.00,3.154E5,4.194E5,8.638E5,8.268E5,1.00,1.33,2.74,2.62,3.154E5,4.194E5,8.638E5,8.268E5,1.00,1.33,2.74,2.62,21,50,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),38747,Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens OX=9606 GN=HNRNPA1 PE=1 SV=5
163,8222,sp|Q96AE4|FUBP1_HUMAN,45.23,268.50,2.568E6,2.461E6,4.758E6,4.739E6,1.00,0.96,1.85,1.85,2.568E6,2.461E6,4.758E6,4.739E6,1.00,0.96,1.85,1.85,7,35,5,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),67560,Far upstream element-binding protein 1 OS=Homo sapiens OX=9606 GN=FUBP1 PE=1 SV=3
42,3383,sp|P23246|SFPQ_HUMAN,37.62,268.26,4.646E8,4.894E8,7.82E8,7.484E8,1.00,1.05,1.68,1.61,4.646E8,4.894E8,7.82E8,7.484E8,1.00,1.05,1.68,1.61,49,47,46,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),76150,Splicing factor  proline- and glutamine-rich OS=Homo sapiens OX=9606 GN=SFPQ PE=1 SV=2
148,2262,sp|Q08211|DHX9_HUMAN,105.90,268.10,7.924E7,8.142E7,1.997E8,1.884E8,1.00,1.03,2.52,2.38,7.924E7,8.142E7,1.997E8,1.884E8,1.00,1.03,2.52,2.38,40,48,48,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),140958,ATP-dependent RNA helicase A OS=Homo sapiens OX=9606 GN=DHX9 PE=1 SV=4
145,16417,sp|Q9NZJ4|SACS_HUMAN,28.33,267.56,6.65E7,6.858E7,1.11E8,1.075E8,1.00,1.03,1.67,1.62,6.65E7,6.858E7,1.11E8,1.075E8,1.00,1.03,1.67,1.62,23,101,100,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),521131,Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2
101,1868,sp|P51659|DHB4_HUMAN,21.17,266.91,2.91E8,3.033E8,4.213E8,3.985E8,1.00,1.04,1.45,1.37,2.91E8,3.033E8,4.213E8,3.985E8,1.00,1.04,1.45,1.37,58,55,54,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),79686,Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3
83,3442,sp|Q15436|SC23A_HUMAN,54.12,266.88,2.548E8,2.568E8,4.834E8,4.596E8,1.00,1.01,1.90,1.80,2.548E8,2.568E8,4.834E8,4.596E8,1.00,1.01,1.90,1.80,52,58,46,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),86161,Protein transport protein Sec23A OS=Homo sapiens OX=9606 GN=SEC23A PE=1 SV=2
219,8340,C9J0Q5|C9J0Q5_HUMAN,200.00,265.93,2.793E7,2.93E7,1.722E8,1.624E8,1.00,1.05,6.17,5.81,2.793E7,2.93E7,1.722E8,1.624E8,1.00,1.05,6.17,5.81,28,63,57,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),272821,Nuclear receptor corepressor 2 OS=Homo sapiens OX=9606 GN=NCOR2 PE=1 SV=2
23,2116,I3L4N8|I3L4N8_HUMAN,0.47,265.67,1.196E5,1.151E5,1.054E5,1.256E5,1.00,0.96,0.88,1.05,1.196E5,1.151E5,1.054E5,1.256E5,1.00,0.96,0.88,1.05,10,55,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),26878,Actin  cytoplasmic 2 (Fragment) OS=Homo sapiens OX=9606 GN=ACTG1 PE=1 SV=8
205,1084,sp|P46821|MAP1B_HUMAN,21.83,265.65,3.734E7,3.749E7,5.27E7,5.443E7,1.00,1.00,1.41,1.46,3.734E7,3.749E7,5.27E7,5.443E7,1.00,1.00,1.41,1.46,31,63,61,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),270632,Microtubule-associated protein 1B OS=Homo sapiens OX=9606 GN=MAP1B PE=1 SV=2
147,4960,sp|P27816|MAP4_HUMAN,29.39,264.71,2.742E7,2.734E7,4.187E7,4.291E7,1.00,1.00,1.53,1.57,2.742E7,2.734E7,4.187E7,4.291E7,1.00,1.00,1.53,1.57,21,58,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),121005,Microtubule-associated protein 4 OS=Homo sapiens OX=9606 GN=MAP4 PE=1 SV=3
102,1067,sp|Q9P2E9|RRBP1_HUMAN,20.21,264.01,9.617E7,9.452E7,1.28E8,1.354E8,1.00,0.98,1.33,1.41,9.617E7,9.452E7,1.28E8,1.354E8,1.00,0.98,1.33,1.41,49,89,87,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),152456,Ribosome-binding protein 1 OS=Homo sapiens OX=9606 GN=RRBP1 PE=1 SV=5
97,8511,sp|P22626|ROA2_HUMAN,200.00,263.79,1.711E8,1.836E8,6.158E8,5.787E8,1.00,1.07,3.60,3.38,1.711E8,1.836E8,6.158E8,5.787E8,1.00,1.07,3.60,3.38,65,36,29,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),37430,Heterogeneous nuclear ribonucleoproteins A2/B1 OS=Homo sapiens OX=9606 GN=HNRNPA2B1 PE=1 SV=2
173,8223,sp|Q96AE4-2|FUBP1_HUMAN,78.39,263.06,1.663E6,1.656E6,4.145E6,4.122E6,1.00,1.00,2.49,2.48,1.663E6,1.656E6,4.145E6,4.122E6,1.00,1.00,2.49,2.48,3,32,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),68605,Isoform 2 of Far upstream element-binding protein 1 OS=Homo sapiens OX=9606 GN=FUBP1
88,1486,sp|P11021|BIP_HUMAN,49.90,262.75,2.584E8,2.525E8,4.655E8,4.646E8,1.00,0.98,1.80,1.80,2.584E8,2.525E8,4.655E8,4.646E8,1.00,0.98,1.80,1.80,67,55,50,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),72333,Endoplasmic reticulum chaperone BiP OS=Homo sapiens OX=9606 GN=HSPA5 PE=1 SV=2
166,1606,sp|Q9H0D6|XRN2_HUMAN,48.72,261.31,6.922E7,7.099E7,1.266E8,1.206E8,1.00,1.03,1.83,1.74,6.922E7,7.099E7,1.266E8,1.206E8,1.00,1.03,1.83,1.74,41,50,50,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),108583,5'-3' exoribonuclease 2 OS=Homo sapiens OX=9606 GN=XRN2 PE=1 SV=1
109,4013,sp|Q9Y6Y8|S23IP_HUMAN,107.55,260.74,1.523E8,1.618E8,3.869E8,3.78E8,1.00,1.06,2.54,2.48,1.523E8,1.618E8,3.869E8,3.78E8,1.00,1.06,2.54,2.48,40,56,48,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),111076,SEC23-interacting protein OS=Homo sapiens OX=9606 GN=SEC23IP PE=1 SV=1
90,5339,sp|P11142|HSP7C_HUMAN,48.72,260.47,1.25E8,1.283E8,2.286E8,2.269E8,1.00,1.03,1.83,1.81,1.25E8,1.283E8,2.286E8,2.269E8,1.00,1.03,1.83,1.81,43,49,27,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),70898,Heat shock cognate 71 kDa protein OS=Homo sapiens OX=9606 GN=HSPA8 PE=1 SV=1
144,1379,sp|Q92900-2|RENT1_HUMAN,29.96,260.29,1.026E8,1.073E8,1.618E8,1.57E8,1.00,1.05,1.58,1.53,1.026E8,1.073E8,1.618E8,1.57E8,1.00,1.05,1.58,1.53,53,57,57,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),123036,Isoform 2 of Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1
119,5,sp|P53992|SC24C_HUMAN,41.21,259.82,1.815E8,1.86E8,3.142E8,3.077E8,1.00,1.02,1.73,1.70,1.815E8,1.86E8,3.142E8,3.077E8,1.00,1.02,1.73,1.70,50,48,47,iTRAQ 4plex (K  N-term); Deamidation (NQ),118325,Protein transport protein Sec24C OS=Homo sapiens OX=9606 GN=SEC24C PE=1 SV=3
120,2043,sp|Q14247|SRC8_HUMAN,111.54,259.57,1.598E8,1.63E8,4.135E8,4.053E8,1.00,1.02,2.59,2.54,1.598E8,1.63E8,4.135E8,4.053E8,1.00,1.02,2.59,2.54,59,39,39,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),61586,Src substrate cortactin OS=Homo sapiens OX=9606 GN=CTTN PE=1 SV=2
150,11599,sp|Q96I24|FUBP3_HUMAN,117.13,259.44,6.624E7,6.916E7,1.758E8,1.741E8,1.00,1.04,2.65,2.63,6.624E7,6.916E7,1.758E8,1.741E8,1.00,1.04,2.65,2.63,65,37,30,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),61640,Far upstream element-binding protein 3 OS=Homo sapiens OX=9606 GN=FUBP3 PE=1 SV=2
179,339,sp|Q9UQ35|SRRM2_HUMAN,19.64,259.16,3.594E7,3.502E7,4.923E7,4.986E7,1.00,0.97,1.37,1.39,3.594E7,3.502E7,4.923E7,4.986E7,1.00,0.97,1.37,1.39,28,65,65,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),299616,Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2
113,158,sp|Q00839|HNRPU_HUMAN,71.81,259.03,5.859E5,6.509E5,2.161E6,2.148E6,1.00,1.11,3.69,3.67,5.859E5,6.509E5,2.161E6,2.148E6,1.00,1.11,3.69,3.67,4,50,5,iTRAQ 4plex (K  N-term),90585,Heterogeneous nuclear ribonucleoprotein U OS=Homo sapiens OX=9606 GN=HNRNPU PE=1 SV=6
304,4875,sp|Q9UPQ9-1|TNR6B_HUMAN,17.59,257.80,1.903E7,1.886E7,2.623E7,2.571E7,1.00,0.99,1.38,1.35,1.903E7,1.886E7,2.623E7,2.571E7,1.00,0.99,1.38,1.35,39,47,46,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),182814,Isoform 2 of Trinucleotide repeat-containing gene 6B protein OS=Homo sapiens OX=9606 GN=TNRC6B
251,790,E9PMS6|E9PMS6_HUMAN,1.74,257.50,4.668E5,4.613E5,7.755E5,8.216E5,1.00,0.99,1.66,1.76,4.668E5,4.613E5,7.755E5,8.216E5,1.00,0.99,1.66,1.76,1,46,1,iTRAQ 4plex (K  N-term),145423,LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=1
98,9535,sp|P67809|YBOX1_HUMAN,30.57,257.44,2.279E7,2.402E7,3.615E7,3.506E7,1.00,1.05,1.59,1.54,2.279E7,2.402E7,3.615E7,3.506E7,1.00,1.05,1.59,1.54,59,26,19,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ); Phosphorylation (STY),35924,Nuclease-sensitive element-binding protein 1 OS=Homo sapiens OX=9606 GN=YBX1 PE=1 SV=3
311,917,sp|O75376|NCOR1_HUMAN,57.87,257.16,2.142E7,2.147E7,4.164E7,4.079E7,1.00,1.00,1.94,1.90,2.142E7,2.147E7,4.164E7,4.079E7,1.00,1.00,1.94,1.90,25,55,49,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),270207,Nuclear receptor corepressor 1 OS=Homo sapiens OX=9606 GN=NCOR1 PE=1 SV=2
50,503,A0A2R8YFS5|A0A2R8YFS5_HUMAN,31.12,257.05,9.407E7,9.994E7,1.499E8,1.471E8,1.00,1.06,1.59,1.56,9.407E7,9.994E7,1.499E8,1.471E8,1.00,1.06,1.59,1.56,25,59,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),73156,ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=1
149,32063,sp|P02461|CO3A1_HUMAN,1.62,256.70,1.49E8,1.548E8,1.464E8,1.466E8,1.00,1.04,0.98,0.98,1.49E8,1.548E8,1.464E8,1.466E8,1.00,1.04,0.98,0.98,37,45,45,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),138564,Collagen alpha-1(III) chain OS=Homo sapiens OX=9606 GN=COL3A1 PE=1 SV=4
116,157,sp|Q00839-2|HNRPU_HUMAN,16.00,256.65,4.951E5,5.184E5,1.323E6,1.555E6,1.00,1.05,2.67,3.14,4.951E5,5.184E5,1.323E6,1.555E6,1.00,1.05,2.67,3.14,2,47,2,iTRAQ 4plex (K  N-term),88980,Isoform 2 of Heterogeneous nuclear ribonucleoprotein U OS=Homo sapiens OX=9606 GN=HNRNPU
195,5932,sp|Q16643-3|DREB_HUMAN,13.07,256.42,6.317E7,5.84E7,6.359E7,7.67E7,1.00,0.92,1.01,1.21,6.317E7,5.84E7,6.359E7,7.67E7,1.00,0.92,1.01,1.21,46,34,34,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),76300,Isoform 3 of Drebrin OS=Homo sapiens OX=9606 GN=DBN1
54,4481,sp|Q15233|NONO_HUMAN,47.51,256.25,3.796E8,3.983E8,6.883E8,6.556E8,1.00,1.05,1.81,1.73,3.796E8,3.983E8,6.883E8,6.556E8,1.00,1.05,1.81,1.73,60,44,41,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),54232,Non-POU domain-containing octamer-binding protein OS=Homo sapiens OX=9606 GN=NONO PE=1 SV=4
129,1031,sp|P07996|TSP1_HUMAN,19.37,256.19,2.674E8,2.761E8,3.796E8,3.682E8,1.00,1.03,1.42,1.38,2.674E8,2.761E8,3.796E8,3.682E8,1.00,1.03,1.42,1.38,35,50,43,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),129383,Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2
226,50,sp|P48681|NEST_HUMAN,14.15,254.98,4.069E7,3.951E7,4.589E7,5.265E7,1.00,0.97,1.13,1.29,4.069E7,3.951E7,4.589E7,5.265E7,1.00,0.97,1.13,1.29,48,59,59,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),177438,Nestin OS=Homo sapiens OX=9606 GN=NES PE=1 SV=2
31,6111,sp|P31943|HNRH1_HUMAN,11.74,254.28,4.322E5,4.241E5,7.288E5,5.832E5,1.00,0.98,1.69,1.35,4.322E5,4.241E5,7.288E5,5.832E5,1.00,0.98,1.69,1.35,9,38,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),49229,Heterogeneous nuclear ribonucleoprotein H OS=Homo sapiens OX=9606 GN=HNRNPH1 PE=1 SV=4
238,147,H3BQK9|H3BQK9_HUMAN,19.03,254.20,2.165E7,2.182E7,3.197E7,3.224E7,1.00,1.01,1.48,1.49,2.165E7,2.182E7,3.197E7,3.224E7,1.00,1.01,1.48,1.49,10,84,64,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),861093,Microtubule-actin cross-linking factor 1  isoforms 1/2/3/5 OS=Homo sapiens OX=9606 GN=MACF1 PE=1 SV=1
72,8146,sp|Q92499|DDX1_HUMAN,22.65,253.83,6.413E8,6.668E8,9.429E8,9.038E8,1.00,1.04,1.47,1.41,6.413E8,6.668E8,9.429E8,9.038E8,1.00,1.04,1.47,1.41,60,55,55,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),82432,ATP-dependent RNA helicase DDX1 OS=Homo sapiens OX=9606 GN=DDX1 PE=1 SV=2
175,3125,sp|O95486|SC24A_HUMAN,73.04,253.48,8.052E7,8.197E7,1.715E8,1.654E8,1.00,1.02,2.13,2.05,8.052E7,8.197E7,1.715E8,1.654E8,1.00,1.02,2.13,2.05,41,46,40,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),119749,Protein transport protein Sec24A OS=Homo sapiens OX=9606 GN=SEC24A PE=1 SV=2
66,445,sp|O15523|DDX3Y_HUMAN,34.04,252.82,2.659E7,2.816E7,4.864E7,4.751E7,1.00,1.06,1.83,1.79,2.659E7,2.816E7,4.864E7,4.751E7,1.00,1.06,1.83,1.79,18,53,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),73154,ATP-dependent RNA helicase DDX3Y OS=Homo sapiens OX=9606 GN=DDX3Y PE=1 SV=2
225,1333,sp|A5YKK6|CNOT1_HUMAN,87.93,251.93,3.489E7,3.567E7,8.052E7,7.861E7,1.00,1.02,2.31,2.25,3.489E7,3.567E7,8.052E7,7.861E7,1.00,1.02,2.31,2.25,25,53,53,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),266937,CCR4-NOT transcription complex subunit 1 OS=Homo sapiens OX=9606 GN=CNOT1 PE=1 SV=2
89,6169,sp|Q13283|G3BP1_HUMAN,59.25,251.47,2.198E8,2.283E8,4.31E8,4.231E8,1.00,1.04,1.96,1.93,2.198E8,2.283E8,4.31E8,4.231E8,1.00,1.04,1.96,1.93,56,35,27,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),52164,Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1
103,13095,sp|Q9Y3I0|RTCB_HUMAN,23.30,251.40,3.917E8,4.104E8,5.797E8,5.495E8,1.00,1.05,1.48,1.40,3.917E8,4.104E8,5.797E8,5.495E8,1.00,1.05,1.48,1.40,57,38,38,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),55210,tRNA-splicing ligase RtcB homolog OS=Homo sapiens OX=9606 GN=RTCB PE=1 SV=1
207,2129,sp|Q05682-5|CALD1_HUMAN,26.00,250.83,6.738E7,6.695E7,9.173E7,1.018E8,1.00,0.99,1.36,1.51,6.738E7,6.695E7,9.173E7,1.018E8,1.00,0.99,1.36,1.51,56,40,38,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),61213,Isoform 5 of Caldesmon OS=Homo sapiens OX=9606 GN=CALD1
33,6112,G8JLB6|G8JLB6_HUMAN,1.25,250.61,1.472E5,1.46E5,2.252E5,2.227E5,1.00,0.99,1.53,1.51,1.472E5,1.46E5,2.252E5,2.227E5,1.00,0.99,1.53,1.51,5,34,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),51230,Heterogeneous nuclear ribonucleoprotein H OS=Homo sapiens OX=9606 GN=HNRNPH1 PE=1 SV=1
169,2019,sp|P52272-2|HNRPM_HUMAN,52.84,250.31,2.655E7,2.635E7,4.923E7,4.956E7,1.00,0.99,1.85,1.87,2.655E7,2.635E7,4.923E7,4.956E7,1.00,0.99,1.85,1.87,23,40,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),73621,Isoform 2 of Heterogeneous nuclear ribonucleoprotein M OS=Homo sapiens OX=9606 GN=HNRNPM
130,1769,E9PDF6|E9PDF6_HUMAN,9.44,249.57,3.101E8,2.978E8,3.155E8,3.708E8,1.00,0.96,1.02,1.20,3.101E8,2.978E8,3.155E8,3.708E8,1.00,0.96,1.02,1.20,40,64,58,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),128481,Unconventional myosin-Ib OS=Homo sapiens OX=9606 GN=MYO1B PE=1 SV=1
134,3044,sp|P21980|TGM2_HUMAN,6.58,249.48,3.294E8,3.404E8,3.905E8,3.885E8,1.00,1.03,1.19,1.18,3.294E8,3.404E8,3.905E8,3.885E8,1.00,1.03,1.19,1.18,49,43,43,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),77329,Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens OX=9606 GN=TGM2 PE=1 SV=2
139,7575,sp|Q9NZB2|F120A_HUMAN,33.82,249.32,1.145E8,1.181E8,1.868E8,1.815E8,1.00,1.03,1.63,1.58,1.145E8,1.181E8,1.868E8,1.815E8,1.00,1.03,1.63,1.58,48,49,47,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),121888,Constitutive coactivator of PPAR-gamma-like protein 1 OS=Homo sapiens OX=9606 GN=FAM120A PE=1 SV=2
8,2,gi|125146|sp|P01837.1|IGKC_MOUSE,50.15,248.82,4.252E9,4.164E9,7.689E9,7.404E9,1.00,0.98,1.81,1.74,4.252E9,4.164E9,7.689E9,7.404E9,1.00,0.98,1.81,1.74,96,52,51,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),11778,RecName: Full=Ig kappa chain C region
281,1834,sp|P51114|FXR1_HUMAN,10.07,247.93,6.416E5,6.784E5,7.961E5,8.068E5,1.00,1.06,1.24,1.26,6.416E5,6.784E5,7.961E5,8.068E5,1.00,1.06,1.24,1.26,8,28,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),69721,Fragile X mental retardation syndrome-related protein 1 OS=Homo sapiens OX=9606 GN=FXR1 PE=1 SV=3
152,15152,sp|Q92734-2|TFG_HUMAN,8.02,247.23,2.365E8,2.417E8,2.877E8,2.779E8,1.00,1.02,1.22,1.18,2.365E8,2.417E8,2.877E8,2.779E8,1.00,1.02,1.22,1.18,52,27,27,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ); Phosphorylation (STY),43020,Isoform 2 of Protein TFG OS=Homo sapiens OX=9606 GN=TFG
283,2083,sp|P35658-2|NU214_HUMAN,3.03,247.06,3.702E5,3.494E5,5.176E5,5.147E5,1.00,0.94,1.40,1.39,3.702E5,3.494E5,5.176E5,5.147E5,1.00,0.94,1.40,1.39,1,48,2,iTRAQ 4plex (K  N-term),212569,Isoform 2 of Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214
196,449,sp|Q9UM54-6|MYO6_HUMAN,15.19,247.01,6.33E7,6.178E7,7.747E7,8.604E7,1.00,0.98,1.22,1.36,6.33E7,6.178E7,7.747E7,8.604E7,1.00,0.98,1.22,1.36,39,53,52,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),148658,Isoform 6 of Unconventional myosin-VI OS=Homo sapiens OX=9606 GN=MYO6
296,1859,sp|Q13813|SPTN1_HUMAN,12.67,246.89,2.878E7,2.72E7,3.498E7,3.69E7,1.00,0.94,1.22,1.28,2.878E7,2.72E7,3.498E7,3.69E7,1.00,0.94,1.22,1.28,27,57,57,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),284538,Spectrin alpha chain  non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=3
202,335,sp|Q9UHB6-4|LIMA1_HUMAN,1.10,245.56,8.893E4,7.252E4,7.972E4,1.065E5,1.00,0.82,0.90,1.20,8.893E4,7.252E4,7.972E4,1.065E5,1.00,0.82,0.90,1.20,2,38,1,iTRAQ 4plex (K  N-term),85224,Isoform 4 of LIM domain and actin-binding protein 1 OS=Homo sapiens OX=9606 GN=LIMA1
199,7328,sp|O60506|HNRPQ_HUMAN,50.41,245.49,1.053E6,1.145E6,2.037E6,2.078E6,1.00,1.09,1.94,1.97,1.053E6,1.145E6,2.037E6,2.078E6,1.00,1.09,1.94,1.97,7,29,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),69603,Heterogeneous nuclear ribonucleoprotein Q OS=Homo sapiens OX=9606 GN=SYNCRIP PE=1 SV=2
141,19280,sp|Q7Z417|NUFP2_HUMAN,27.98,245.38,9.58E7,9.979E7,1.484E8,1.445E8,1.00,1.04,1.55,1.51,9.58E7,9.979E7,1.484E8,1.445E8,1.00,1.04,1.55,1.51,62,37,37,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),76121,Nuclear fragile X mental retardation-interacting protein 2 OS=Homo sapiens OX=9606 GN=NUFIP2 PE=1 SV=1
203,334,sp|Q9UHB6|LIMA1_HUMAN,1.32,244.95,8.092E4,8.446E4,1.277E5,1.237E5,1.00,1.04,1.58,1.53,8.092E4,8.446E4,1.277E5,1.237E5,1.00,1.04,1.58,1.53,1,38,1,iTRAQ 4plex (K  N-term),85226,LIM domain and actin-binding protein 1 OS=Homo sapiens OX=9606 GN=LIMA1 PE=1 SV=1
161,1663,A0A0U1RQK7|A0A0U1RQK7_HUMAN,22.94,244.80,1.318E6,1.315E6,2.575E6,2.519E6,1.00,1.00,1.95,1.91,1.318E6,1.315E6,2.575E6,2.519E6,1.00,1.00,1.95,1.91,2,62,3,iTRAQ 4plex (K  N-term),195272,Eukaryotic translation initiation factor 4 gamma 3 OS=Homo sapiens OX=9606 GN=EIF4G3 PE=1 SV=1
177,3482,H0YAB3|H0YAB3_HUMAN,3.34,244.10,7.494E5,3.848E5,1.039E6,9.097E5,1.00,0.51,1.39,1.21,7.494E5,3.848E5,1.039E6,9.097E5,1.00,0.51,1.39,1.21,2,35,1,iTRAQ 4plex (K  N-term),48991,Protein transport protein Sec31A (Fragment) OS=Homo sapiens OX=9606 GN=SEC31A PE=1 SV=1
180,13942,sp|Q9Y5X1|SNX9_HUMAN,80.53,243.96,9.219E7,9.39E7,2.046E8,1.973E8,1.00,1.02,2.22,2.14,9.219E7,9.39E7,2.046E8,1.973E8,1.00,1.02,2.22,2.14,55,37,37,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),66592,Sorting nexin-9 OS=Homo sapiens OX=9606 GN=SNX9 PE=1 SV=1
201,7229,sp|Q9NR12|PDLI7_HUMAN,200.00,243.62,6.458E7,6.703E7,2.119E8,2.058E8,1.00,1.04,3.28,3.19,6.458E7,6.703E7,2.119E8,2.058E8,1.00,1.04,3.28,3.19,58,28,28,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),49845,PDZ and LIM domain protein 7 OS=Homo sapiens OX=9606 GN=PDLIM7 PE=1 SV=1
229,2067,sp|P24928|RPB1_HUMAN,81.36,243.47,3.676E7,3.822E7,8.195E7,7.926E7,1.00,1.04,2.23,2.16,3.676E7,3.822E7,8.195E7,7.926E7,1.00,1.04,2.23,2.16,31,54,54,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),217174,DNA-directed RNA polymerase II subunit RPB1 OS=Homo sapiens OX=9606 GN=POLR2A PE=1 SV=2
254,5145,sp|Q00341|VIGLN_HUMAN,47.24,242.49,4.715E7,4.69E7,8.486E7,8.382E7,1.00,0.99,1.80,1.78,4.715E7,4.69E7,8.486E7,8.382E7,1.00,0.99,1.80,1.78,42,47,45,iTRAQ 4plex (K  N-term); Deamidation (NQ),141455,Vigilin OS=Homo sapiens OX=9606 GN=HDLBP PE=1 SV=2
314,351,sp|Q15678|PTN14_HUMAN,100.81,242.46,2.377E7,2.42E7,5.849E7,5.539E7,1.00,1.02,2.46,2.33,2.377E7,2.42E7,5.849E7,5.539E7,1.00,1.02,2.46,2.33,31,34,34,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),135261,Tyrosine-protein phosphatase non-receptor type 14 OS=Homo sapiens OX=9606 GN=PTPN14 PE=1 SV=2
167,2417,A0A0A0MSA7|A0A0A0MSA7_HUMAN,1.76,242.42,1.368E5,1.352E5,2.431E5,2.364E5,1.00,0.99,1.78,1.73,1.368E5,1.352E5,2.431E5,2.364E5,1.00,0.99,1.78,1.73,1,60,1,iTRAQ 4plex (K  N-term),180497,Eukaryotic translation initiation factor 4 gamma 3 OS=Homo sapiens OX=9606 GN=EIF4G3 PE=1 SV=1
287,6071,E9PS17|E9PS17_HUMAN,108.73,242.05,4.624E7,4.834E7,1.181E8,1.14E8,1.00,1.05,2.55,2.46,4.624E7,4.834E7,1.181E8,1.14E8,1.00,1.05,2.55,2.46,44,33,33,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),85719,N-terminal kinase-like protein OS=Homo sapiens OX=9606 GN=SCYL1 PE=1 SV=1
262,5868,D3DQV9|D3DQV9_HUMAN,0.79,241.94,4.339E5,3.72E5,4.954E5,4.806E5,1.00,0.86,1.14,1.11,4.339E5,3.72E5,4.954E5,4.806E5,1.00,0.86,1.14,1.11,1,35,1,iTRAQ 4plex (K  N-term),102330,Eukaryotic translation initiation factor 4 gamma 2 (Fragment) OS=Homo sapiens OX=9606 GN=EIF4G2 PE=1 SV=1
22,1655,sp|P35749-4|MYH11_HUMAN,5.81,241.91,2.917E6,2.531E6,3.084E6,3.462E6,1.00,0.87,1.06,1.19,2.917E6,2.531E6,3.084E6,3.462E6,1.00,0.87,1.06,1.19,3,65,5,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),223575,Isoform 4 of Myosin-11 OS=Homo sapiens OX=9606 GN=MYH11
151,4777,sp|P38646|GRP75_HUMAN,33.31,241.85,7.291E7,7.42E7,1.184E8,1.155E8,1.00,1.02,1.62,1.58,7.291E7,7.42E7,1.184E8,1.155E8,1.00,1.02,1.62,1.58,51,45,42,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),73681,Stress-70 protein  mitochondrial OS=Homo sapiens OX=9606 GN=HSPA9 PE=1 SV=2
136,847,sp|Q07065|CKAP4_HUMAN,28.27,241.80,1.824E8,1.836E8,2.761E8,2.834E8,1.00,1.01,1.51,1.55,1.824E8,1.836E8,2.761E8,2.834E8,1.00,1.01,1.51,1.55,63,41,40,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),66023,Cytoskeleton-associated protein 4 OS=Homo sapiens OX=9606 GN=CKAP4 PE=1 SV=2
184,38707,sp|P02452|CO1A1_HUMAN,12.87,240.82,7.162E7,7.124E7,9.132E7,9.33E7,1.00,0.99,1.28,1.30,7.162E7,7.124E7,9.132E7,9.33E7,1.00,0.99,1.28,1.30,36,45,43,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),138942,Collagen alpha-1(I) chain OS=Homo sapiens OX=9606 GN=COL1A1 PE=1 SV=5
185,25,sp|P55884|EIF3B_HUMAN,117.81,239.97,6.54E7,6.752E7,1.741E8,1.663E8,1.00,1.03,2.66,2.54,6.54E7,6.752E7,1.741E8,1.663E8,1.00,1.03,2.66,2.54,32,39,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),92482,Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3
310,166,sp|Q01082|SPTB2_HUMAN,16.43,238.66,2.291E7,2.182E7,2.976E7,3.113E7,1.00,0.95,1.30,1.36,2.291E7,2.182E7,2.976E7,3.113E7,1.00,0.95,1.30,1.36,28,55,53,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),274608,Spectrin beta chain  non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTBN1 PE=1 SV=2
222,2995,sp|Q86V48|LUZP1_HUMAN,48.92,238.44,3.51E7,3.555E7,6.989E7,7.002E7,1.00,1.01,1.99,1.99,3.51E7,3.555E7,6.989E7,7.002E7,1.00,1.01,1.99,1.99,52,53,53,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),120275,Leucine zipper protein 1 OS=Homo sapiens OX=9606 GN=LUZP1 PE=1 SV=2
227,1361,X6RLX0|X6RLX0_HUMAN,130.00,238.41,3.411E7,3.478E7,9.568E7,9.359E7,1.00,1.02,2.81,2.74,3.411E7,3.478E7,9.568E7,9.359E7,1.00,1.02,2.81,2.74,41,50,50,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),128475,ELKS/Rab6-interacting/CAST family member 1 OS=Homo sapiens OX=9606 GN=ERC1 PE=1 SV=1
223,3540,sp|P26196|DDX6_HUMAN,40.66,238.17,6.102E7,6.211E7,1.052E8,9.974E7,1.00,1.02,1.72,1.63,6.102E7,6.211E7,1.052E8,9.974E7,1.00,1.02,1.72,1.63,51,28,27,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),54417,Probable ATP-dependent RNA helicase DDX6 OS=Homo sapiens OX=9606 GN=DDX6 PE=1 SV=2
244,8060,sp|Q15637-6|SF01_HUMAN,2.76,237.94,6.191E5,6.131E5,1.429E6,1.427E6,1.00,0.99,2.31,2.31,6.191E5,6.131E5,1.429E6,1.427E6,1.00,0.99,2.31,2.31,2,24,1,iTRAQ 4plex (K  N-term),61889,Isoform 6 of Splicing factor 1 OS=Homo sapiens OX=9606 GN=SF1
329,1588,sp|Q9P2Q2|FRM4A_HUMAN,113.24,237.88,1.734E7,1.768E7,4.522E7,4.358E7,1.00,1.02,2.61,2.51,1.734E7,1.768E7,4.522E7,4.358E7,1.00,1.02,2.61,2.51,31,36,28,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),115458,FERM domain-containing protein 4A OS=Homo sapiens OX=9606 GN=FRMD4A PE=1 SV=3
282,959,sp|Q8WXF1|PSPC1_HUMAN,46.70,237.75,5.183E7,5.352E7,9.343E7,9.219E7,1.00,1.03,1.80,1.78,5.183E7,5.352E7,9.343E7,9.219E7,1.00,1.03,1.80,1.78,55,30,28,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),58744,Paraspeckle component 1 OS=Homo sapiens OX=9606 GN=PSPC1 PE=1 SV=1
193,59,sp|Q02809|PLOD1_HUMAN,16.69,237.65,1.111E8,1.081E8,1.487E8,1.438E8,1.00,0.97,1.34,1.29,1.111E8,1.081E8,1.487E8,1.438E8,1.00,0.97,1.34,1.29,51,44,41,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),83550,Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens OX=9606 GN=PLOD1 PE=1 SV=2
142,7180,sp|Q9UN86-2|G3BP2_HUMAN,27.21,237.18,7.4E6,7.631E6,1.203E7,1.209E7,1.00,1.03,1.63,1.63,7.4E6,7.631E6,1.203E7,1.209E7,1.00,1.03,1.63,1.63,4,34,1,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),50817,Isoform B of Ras GTPase-activating protein-binding protein 2 OS=Homo sapiens OX=9606 GN=G3BP2
153,7183,sp|Q9UN86|G3BP2_HUMAN,14.94,237.16,7.208E6,7.131E6,1.131E7,1.108E7,1.00,0.99,1.57,1.54,7.208E6,7.131E6,1.131E7,1.108E7,1.00,0.99,1.57,1.54,7,36,3,iTRAQ 4plex (K  N-term),54121,Ras GTPase-activating protein-binding protein 2 OS=Homo sapiens OX=9606 GN=G3BP2 PE=1 SV=2
288,7353,sp|O15371-3|EIF3D_HUMAN,105.73,236.09,4.735E7,4.572E7,1.152E8,1.099E8,1.00,0.97,2.43,2.32,4.735E7,4.572E7,1.152E8,1.099E8,1.00,0.97,2.43,2.32,45,33,33,iTRAQ 4plex (K  N-term); Deamidation (NQ),62040,Isoform 3 of Eukaryotic translation initiation factor 3 subunit D OS=Homo sapiens OX=9606 GN=EIF3D
247,7886,sp|Q15637-5|SF01_HUMAN,2.66,235.85,2.594E5,2.435E5,3.57E5,3.31E5,1.00,0.94,1.38,1.28,2.594E5,2.435E5,3.57E5,3.31E5,1.00,0.94,1.38,1.28,4,24,2,iTRAQ 4plex (K  N-term),71752,Isoform 5 of Splicing factor 1 OS=Homo sapiens OX=9606 GN=SF1
374,971,sp|Q15424-4|SAFB1_HUMAN,24.07,235.82,2.237E7,2.377E7,3.406E7,3.354E7,1.00,1.06,1.52,1.50,2.237E7,2.377E7,3.406E7,3.354E7,1.00,1.06,1.52,1.50,19,26,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),102768,Isoform 4 of Scaffold attachment factor B1 OS=Homo sapiens OX=9606 GN=SAFB
210,7317,sp|O60506-3|HNRPQ_HUMAN,1.63,235.79,2.288E6,2.393E6,3.527E6,3.921E6,1.00,1.05,1.54,1.71,2.288E6,2.393E6,3.527E6,3.921E6,1.00,1.05,1.54,1.71,2,26,1,iTRAQ 4plex (K  N-term),62656,Isoform 3 of Heterogeneous nuclear ribonucleoprotein Q OS=Homo sapiens OX=9606 GN=SYNCRIP
86,3258,sp|P61978-3|HNRPK_HUMAN,92.43,235.58,2.557E8,2.668E8,6.038E8,5.847E8,1.00,1.04,2.36,2.29,2.557E8,2.668E8,6.038E8,5.847E8,1.00,1.04,2.36,2.29,70,37,37,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),48562,Isoform 3 of Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens OX=9606 GN=HNRNPK
160,19326,sp|P16989|YBOX3_HUMAN,36.06,235.40,7.951E6,8.236E6,1.321E7,1.313E7,1.00,1.04,1.66,1.65,7.951E6,8.236E6,1.321E7,1.313E7,1.00,1.04,1.66,1.65,12,24,3,iTRAQ 4plex (K  N-term); Oxidation (M),40090,Y-box-binding protein 3 OS=Homo sapiens OX=9606 GN=YBX3 PE=1 SV=4
249,1434,sp|P11047|LAMC1_HUMAN,7.34,235.37,4.511E7,4.486E7,5.393E7,5.287E7,1.00,0.99,1.20,1.17,4.511E7,4.486E7,5.393E7,5.287E7,1.00,0.99,1.20,1.17,25,39,38,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),177602,Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3
200,2700,sp|Q92804|RBP56_HUMAN,4.29,235.02,1.728E5,1.977E5,2.677E5,2.167E5,1.00,1.14,1.55,1.25,1.728E5,1.977E5,2.677E5,2.167E5,1.00,1.14,1.55,1.25,4,20,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),61830,TATA-binding protein-associated factor 2N OS=Homo sapiens OX=9606 GN=TAF15 PE=1 SV=1
306,640,sp|Q9HCD6-2|TANC2_HUMAN,29.15,234.97,3.276E7,3.218E7,5.045E7,4.964E7,1.00,0.98,1.54,1.52,3.276E7,3.218E7,5.045E7,4.964E7,1.00,0.98,1.54,1.52,27,47,45,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),220744,Isoform 2 of Protein TANC2 OS=Homo sapiens OX=9606 GN=TANC2
215,3074,sp|O95782-2|AP2A1_HUMAN,35.36,234.79,4.841E7,4.782E7,7.764E7,7.903E7,1.00,0.99,1.60,1.63,4.841E7,4.782E7,7.764E7,7.903E7,1.00,0.99,1.60,1.63,30,36,27,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),105361,Isoform B of AP-2 complex subunit alpha-1 OS=Homo sapiens OX=9606 GN=AP2A1
237,17118,sp|P52907|CAZA1_HUMAN,17.05,234.62,3.295E7,3.283E7,4.148E7,4.537E7,1.00,1.00,1.26,1.38,3.295E7,3.283E7,4.148E7,4.537E7,1.00,1.00,1.26,1.38,45,17,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),32923,F-actin-capping protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=CAPZA1 PE=1 SV=3
284,4336,sp|Q14161|GIT2_HUMAN,98.19,234.46,3.218E7,3.258E7,7.818E7,7.7E7,1.00,1.01,2.43,2.39,3.218E7,3.258E7,7.818E7,7.7E7,1.00,1.01,2.43,2.39,48,31,28,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),84543,ARF GTPase-activating protein GIT2 OS=Homo sapiens OX=9606 GN=GIT2 PE=1 SV=2
378,6055,sp|O95248-5|MTMR5_HUMAN,48.47,233.93,1.729E7,1.78E7,3.155E7,3.115E7,1.00,1.03,1.83,1.80,1.729E7,1.78E7,3.155E7,3.115E7,1.00,1.03,1.83,1.80,25,38,35,iTRAQ 4plex (K  N-term); Deamidation (NQ),211047,Isoform 5 of Myotubularin-related protein 5 OS=Homo sapiens OX=9606 GN=SBF1
125,7247,sp|P55795|HNRH2_HUMAN,58.24,233.86,3.486E7,3.715E7,6.792E7,6.672E7,1.00,1.07,1.95,1.91,3.486E7,3.715E7,6.792E7,6.672E7,1.00,1.07,1.95,1.91,39,30,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),49264,Heterogeneous nuclear ribonucleoprotein H2 OS=Homo sapiens OX=9606 GN=HNRNPH2 PE=1 SV=1
383,38709,sp|Q08397|LOXL1_HUMAN,23.77,233.81,2.43E7,2.438E7,3.614E7,3.464E7,1.00,1.00,1.49,1.43,2.43E7,2.438E7,3.614E7,3.464E7,1.00,1.00,1.49,1.43,62,31,31,iTRAQ 4plex (K  N-term); Deamidation (NQ),63110,Lysyl oxidase homolog 1 OS=Homo sapiens OX=9606 GN=LOXL1 PE=1 SV=2
257,4906,sp|Q13435|SF3B2_HUMAN,35.08,233.70,5.306E7,5.381E7,8.724E7,8.747E7,1.00,1.01,1.64,1.65,5.306E7,5.381E7,8.724E7,8.747E7,1.00,1.01,1.64,1.65,44,37,37,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),100228,Splicing factor 3B subunit 2 OS=Homo sapiens OX=9606 GN=SF3B2 PE=1 SV=2
61,18,A0A2R8YEA7|A0A2R8YEA7_HUMAN,1.14,233.56,2.989E5,2.696E5,3.748E5,4.032E5,1.00,0.90,1.25,1.35,2.989E5,2.696E5,3.748E5,4.032E5,1.00,0.90,1.25,1.35,4,28,1,iTRAQ 4plex (K  N-term),17471,Actin  cytoplasmic 1 (Fragment) OS=Homo sapiens OX=9606 GN=ACTB PE=1 SV=1
340,19291,sp|O14974-5|MYPT1_HUMAN,25.56,233.41,3.518E7,3.491E7,4.685E7,5.285E7,1.00,0.99,1.33,1.50,3.518E7,3.491E7,4.685E7,5.285E7,1.00,0.99,1.33,1.50,34,38,38,iTRAQ 4plex (K  N-term); Deamidation (NQ),105641,Isoform 5 of Protein phosphatase 1 regulatory subunit 12A OS=Homo sapiens OX=9606 GN=PPP1R12A
316,5552,sp|Q93052|LPP_HUMAN,200.00,233.00,2.646E7,2.807E7,8.683E7,8.204E7,1.00,1.06,3.28,3.10,2.646E7,2.807E7,8.683E7,8.204E7,1.00,1.06,3.28,3.10,50,23,23,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),65746,Lipoma-preferred partner OS=Homo sapiens OX=9606 GN=LPP PE=1 SV=1
422,2209,sp|Q92793|CBP_HUMAN,18.75,232.68,7.441E6,7.55E6,1.049E7,1.022E7,1.00,1.01,1.41,1.37,7.441E6,7.55E6,1.049E7,1.022E7,1.00,1.01,1.41,1.37,19,31,23,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),265348,CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3
176,6605,sp|Q12906-7|ILF3_HUMAN,3.26,232.48,2.335E6,2.375E6,3.552E6,3.561E6,1.00,1.02,1.52,1.52,2.335E6,2.375E6,3.552E6,3.561E6,1.00,1.02,1.52,1.52,5,36,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),95808,Isoform 7 of Interleukin enhancer-binding factor 3 OS=Homo sapiens OX=9606 GN=ILF3
248,237,sp|O14578-4|CTRO_HUMAN,29.08,232.06,3.858E7,3.889E7,6.431E7,6.303E7,1.00,1.01,1.67,1.63,3.858E7,3.889E7,6.431E7,6.303E7,1.00,1.01,1.67,1.63,30,65,64,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),236605,Isoform 4 of Citron Rho-interacting kinase OS=Homo sapiens OX=9606 GN=CIT
186,6828,sp|Q12906|ILF3_HUMAN,1.97,232.03,1.123E5,1.133E5,2.13E5,1.834E5,1.00,1.01,1.90,1.63,1.123E5,1.133E5,2.13E5,1.834E5,1.00,1.01,1.90,1.63,4,35,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),95339,Interleukin enhancer-binding factor 3 OS=Homo sapiens OX=9606 GN=ILF3 PE=1 SV=3
209,11644,sp|P26599-3|PTBP1_HUMAN,1.36,231.74,3.967E5,4.158E5,6.302E5,5.989E5,1.00,1.05,1.59,1.51,3.967E5,4.158E5,6.302E5,5.989E5,1.00,1.05,1.59,1.51,2,41,1,iTRAQ 4plex (K  N-term),59633,Isoform 3 of Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1
178,6074,sp|O00469-2|PLOD2_HUMAN,5.97,231.64,1.226E8,1.231E8,1.436E8,1.383E8,1.00,1.00,1.17,1.13,1.226E8,1.231E8,1.436E8,1.383E8,1.00,1.00,1.17,1.13,40,39,37,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),87098,Isoform 2 of Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 OS=Homo sapiens OX=9606 GN=PLOD2
411,1854,sp|P98175-2|RBM10_HUMAN,39.96,231.62,1.736E7,1.775E7,2.976E7,2.872E7,1.00,1.02,1.71,1.65,1.736E7,1.775E7,2.976E7,2.872E7,1.00,1.02,1.71,1.65,35,29,27,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),103433,Isoform 2 of RNA-binding protein 10 OS=Homo sapiens OX=9606 GN=RBM10
471,4361,sp|Q8NDV7-5|TNR6A_HUMAN,10.55,231.12,3.453E6,3.395E6,4.301E6,4.19E6,1.00,0.98,1.25,1.21,3.453E6,3.395E6,4.301E6,4.19E6,1.00,0.98,1.25,1.21,11,32,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),206361,Isoform 5 of Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens OX=9606 GN=TNRC6A
212,8886,A0A0U1RRM4|A0A0U1RRM4_HUMAN,0.86,231.05,7.457E4,9.419E4,9.802E4,1.02E5,1.00,1.26,1.31,1.37,7.457E4,9.419E4,9.802E4,1.02E5,1.00,1.26,1.31,1.37,2,41,1,iTRAQ 4plex (K  N-term),62464,Polypyrimidine tract-binding protein 1 OS=Homo sapiens OX=9606 GN=PTBP1 PE=1 SV=1
541,2625,sp|O14497|ARI1A_HUMAN,14.82,230.85,1.01E7,1.024E7,1.357E7,1.293E7,1.00,1.01,1.34,1.28,1.01E7,1.024E7,1.357E7,1.293E7,1.00,1.01,1.34,1.28,20,30,28,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),242042,AT-rich interactive domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ARID1A PE=1 SV=3
214,11613,sp|Q8NC51-2|PAIRB_HUMAN,40.20,230.45,1.885E6,2.053E6,3.225E6,3.237E6,1.00,1.09,1.71,1.72,1.885E6,2.053E6,3.225E6,3.237E6,1.00,1.09,1.71,1.72,16,26,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),44257,Isoform 2 of Plasminogen activator inhibitor 1 RNA-binding protein OS=Homo sapiens OX=9606 GN=SERBP1
220,7113,sp|P14866|HNRPL_HUMAN,50.75,230.36,5.735E6,6.338E6,9.716E6,1.064E7,1.00,1.11,1.69,1.85,5.735E6,6.338E6,9.716E6,1.064E7,1.00,1.11,1.69,1.85,12,25,5,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),64133,Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2
234,3150,sp|Q96PK6|RBM14_HUMAN,25.19,230.25,6.183E7,6.533E7,9.327E7,8.822E7,1.00,1.06,1.51,1.43,6.183E7,6.533E7,9.327E7,8.822E7,1.00,1.06,1.51,1.43,42,34,29,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),69492,RNA-binding protein 14 OS=Homo sapiens OX=9606 GN=RBM14 PE=1 SV=2
351,261,H0YM23|H0YM23_HUMAN,95.78,230.13,9.396E6,9.574E6,2.282E7,2.208E7,1.00,1.02,2.43,2.35,9.396E6,9.574E6,2.282E7,2.208E7,1.00,1.02,2.43,2.35,14,40,27,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),263371,Ankyrin repeat domain-containing protein 17 (Fragment) OS=Homo sapiens OX=9606 GN=ANKRD17 PE=1 SV=1
278,179,sp|P42694|HELZ_HUMAN,22.42,230.12,3.001E7,3.049E7,4.59E7,4.386E7,1.00,1.02,1.53,1.46,3.001E7,3.049E7,4.59E7,4.386E7,1.00,1.02,1.53,1.46,28,47,47,iTRAQ 4plex (K  N-term); Deamidation (NQ),218968,Probable helicase with zinc finger domain OS=Homo sapiens OX=9606 GN=HELZ PE=1 SV=2
221,4006,sp|Q9Y6M1|IF2B2_HUMAN,26.54,229.98,7.244E7,7.755E7,1.107E8,1.092E8,1.00,1.07,1.53,1.51,7.244E7,7.755E7,1.107E8,1.092E8,1.00,1.07,1.53,1.51,45,33,28,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),66121,Insulin-like growth factor 2 mRNA-binding protein 2 OS=Homo sapiens OX=9606 GN=IGF2BP2 PE=1 SV=2
394,293,sp|Q93074-3|MED12_HUMAN,1.97,229.33,3.729E6,3.965E6,4.154E6,4.174E6,1.00,1.06,1.11,1.12,3.729E6,3.965E6,4.154E6,4.174E6,1.00,1.06,1.11,1.12,3,35,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),242950,Isoform 3 of Mediator of RNA polymerase II transcription subunit 12 OS=Homo sapiens OX=9606 GN=MED12
334,21377,sp|P03956|MMP1_HUMAN,46.26,229.23,3.859E7,3.937E7,6.934E7,6.781E7,1.00,1.02,1.80,1.76,3.859E7,3.937E7,6.934E7,6.781E7,1.00,1.02,1.80,1.76,62,29,29,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),54007,Interstitial collagenase OS=Homo sapiens OX=9606 GN=MMP1 PE=1 SV=3
191,1095,sp|Q99613-2|EIF3C_HUMAN,128.26,229.16,7.807E7,8.293E7,2.174E8,2.099E8,1.00,1.06,2.78,2.69,7.807E7,8.293E7,2.174E8,2.099E8,1.00,1.06,2.78,2.69,39,37,36,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),104101,Isoform 2 of Eukaryotic translation initiation factor 3 subunit C OS=Homo sapiens OX=9606 GN=EIF3C
450,1689,sp|O43896|KIF1C_HUMAN,65.77,229.15,1.304E7,1.322E7,2.661E7,2.59E7,1.00,1.01,2.04,1.99,1.304E7,1.322E7,2.661E7,2.59E7,1.00,1.01,2.04,1.99,28,29,21,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),122947,Kinesin-like protein KIF1C OS=Homo sapiens OX=9606 GN=KIF1C PE=1 SV=3
198,19410,sp|Q7Z739|YTHD3_HUMAN,77.58,228.75,1.608E7,1.603E7,3.502E7,3.413E7,1.00,1.00,2.18,2.12,1.608E7,1.603E7,3.502E7,3.413E7,1.00,1.00,2.18,2.12,47,30,21,iTRAQ 4plex (K  N-term); Deamidation (NQ),63861,YTH domain-containing family protein 3 OS=Homo sapiens OX=9606 GN=YTHDF3 PE=1 SV=1
330,1983,sp|P51114-2|FXR1_HUMAN,11.16,228.68,6.316E5,6.549E5,8.943E5,9.049E5,1.00,1.04,1.42,1.43,6.316E5,6.549E5,8.943E5,9.049E5,1.00,1.04,1.42,1.43,5,26,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),60792,Isoform 2 of Fragile X mental retardation syndrome-related protein 1 OS=Homo sapiens OX=9606 GN=FXR1
204,2699,sp|Q92804-2|RBP56_HUMAN,8.89,228.15,0,1.175E4,0,0,-,256.00,-,-,0,1.175E4,0,0,-,256.00,-,-,9,19,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),61558,Isoform Short of TATA-binding protein-associated factor 2N OS=Homo sapiens OX=9606 GN=TAF15
46,5284,sp|P19105|ML12A_HUMAN,2.60,227.97,1.085E5,7.221E4,6.548E4,4.817E4,1.00,0.67,0.60,0.44,1.085E5,7.221E4,6.548E4,4.817E4,1.00,0.67,0.60,0.44,12,32,1,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),19794,Myosin regulatory light chain 12A OS=Homo sapiens OX=9606 GN=MYL12A PE=1 SV=2
218,4448,sp|O95487-2|SC24B_HUMAN,39.53,227.12,4.019E7,4.042E7,6.868E7,6.726E7,1.00,1.01,1.71,1.67,4.019E7,4.042E7,6.868E7,6.726E7,1.00,1.01,1.71,1.67,26,35,29,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),133629,Isoform 2 of Protein transport protein Sec24B OS=Homo sapiens OX=9606 GN=SEC24B
285,8097,sp|Q5T6F2|UBAP2_HUMAN,55.01,227.02,3.362E7,3.456E7,6.415E7,6.207E7,1.00,1.03,1.91,1.85,3.362E7,3.456E7,6.415E7,6.207E7,1.00,1.03,1.91,1.85,30,26,26,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),117115,Ubiquitin-associated protein 2 OS=Homo sapiens OX=9606 GN=UBAP2 PE=1 SV=1
366,2152,sp|P49790|NU153_HUMAN,23.08,226.97,4.327E7,4.259E7,6.24E7,6.291E7,1.00,0.98,1.44,1.45,4.327E7,4.259E7,6.24E7,6.291E7,1.00,0.98,1.44,1.45,28,35,35,iTRAQ 4plex (K  N-term); Deamidation (NQ),153938,Nuclear pore complex protein Nup153 OS=Homo sapiens OX=9606 GN=NUP153 PE=1 SV=2
48,5285,sp|O14950|ML12B_HUMAN,0.93,226.94,1.662E5,1.42E5,1.987E5,1.743E5,1.00,0.85,1.20,1.05,1.662E5,1.42E5,1.987E5,1.743E5,1.00,0.85,1.20,1.05,6,32,1,iTRAQ 4plex (K  N-term),19779,Myosin regulatory light chain 12B OS=Homo sapiens OX=9606 GN=MYL12B PE=1 SV=2
350,283,sp|Q86UU1-2|PHLB1_HUMAN,92.83,226.90,2.501E7,2.495E7,5.903E7,5.825E7,1.00,1.00,2.36,2.33,2.501E7,2.495E7,5.903E7,5.825E7,1.00,1.00,2.36,2.33,32,40,38,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),144739,Isoform 2 of Pleckstrin homology-like domain family B member 1 OS=Homo sapiens OX=9606 GN=PHLDB1
405,3818,sp|Q71RC2|LARP4_HUMAN,68.56,226.87,1.244E7,1.286E7,2.581E7,2.542E7,1.00,1.03,2.08,2.04,1.244E7,1.286E7,2.581E7,2.542E7,1.00,1.03,2.08,2.04,41,23,19,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),80596,La-related protein 4 OS=Homo sapiens OX=9606 GN=LARP4 PE=1 SV=3
246,268,sp|P58107|EPIPL_HUMAN,6.82,226.40,9.481E6,9.64E6,1.144E7,1.152E7,1.00,1.02,1.21,1.22,9.481E6,9.64E6,1.144E7,1.152E7,1.00,1.02,1.21,1.22,7,38,27,iTRAQ 4plex (K  N-term); Deamidation (NQ),555666,Epiplakin OS=Homo sapiens OX=9606 GN=EPPK1 PE=1 SV=3
162,19349,sp|P16989-2|YBOX3_HUMAN,3.39,226.18,2.285E6,2.329E6,3.416E6,3.319E6,1.00,1.02,1.49,1.45,2.285E6,2.329E6,3.416E6,3.319E6,1.00,1.02,1.49,1.45,3,22,1,iTRAQ 4plex (K  N-term); Oxidation (M),31947,Isoform 2 of Y-box-binding protein 3 OS=Homo sapiens OX=9606 GN=YBX3
137,4166,sp|P51991|ROA3_HUMAN,34.59,225.87,4.246E6,4.47E6,8.351E6,8.192E6,1.00,1.05,1.97,1.93,4.246E6,4.47E6,8.351E6,8.192E6,1.00,1.05,1.97,1.93,8,29,3,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),39595,Heterogeneous nuclear ribonucleoprotein A3 OS=Homo sapiens OX=9606 GN=HNRNPA3 PE=1 SV=2
75,18513,sp|P24844|MYL9_HUMAN,6.18,225.86,3.284E8,3.183E8,3.081E8,3.625E8,1.00,0.97,0.94,1.10,3.284E8,3.183E8,3.081E8,3.625E8,1.00,0.97,0.94,1.10,30,28,7,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),19827,Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4
232,4474,sp|P27816-5|MAP4_HUMAN,1.48,225.11,1.559E5,1.517E5,2.296E5,2.508E5,1.00,0.97,1.47,1.61,1.559E5,1.517E5,2.296E5,2.508E5,1.00,0.97,1.47,1.61,2,37,1,iTRAQ 4plex (K  N-term),85252,Isoform 5 of Microtubule-associated protein 4 OS=Homo sapiens OX=9606 GN=MAP4
216,6705,sp|P31942|HNRH3_HUMAN,18.34,225.10,6.703E7,6.964E7,9.403E7,9.098E7,1.00,1.04,1.40,1.36,6.703E7,6.964E7,9.403E7,9.098E7,1.00,1.04,1.40,1.36,66,21,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),36926,Heterogeneous nuclear ribonucleoprotein H3 OS=Homo sapiens OX=9606 GN=HNRNPH3 PE=1 SV=2
387,357,A0A0U1RQF0|A0A0U1RQF0_HUMAN,1.94,224.97,3.689E7,3.604E7,3.866E7,3.782E7,1.00,0.98,1.05,1.03,3.689E7,3.604E7,3.866E7,3.782E7,1.00,0.98,1.05,1.03,18,41,41,iTRAQ 4plex (K  N-term); Deamidation (NQ),273196,Fatty acid synthase OS=Homo sapiens OX=9606 GN=FASN PE=1 SV=1
256,10610,sp|Q9P0K7|RAI14_HUMAN,20.13,224.58,5.181E7,5.064E7,6.577E7,7.249E7,1.00,0.98,1.27,1.40,5.181E7,5.064E7,6.577E7,7.249E7,1.00,0.98,1.27,1.40,43,43,42,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),110041,Ankycorbin OS=Homo sapiens OX=9606 GN=RAI14 PE=1 SV=2
347,1076,sp|P53814-6|SMTN_HUMAN,12.24,224.57,2.635E7,2.602E7,3.054E7,3.379E7,1.00,0.99,1.16,1.28,2.635E7,2.602E7,3.054E7,3.379E7,1.00,0.99,1.16,1.28,29,33,24,iTRAQ 4plex (K  N-term); Deamidation (NQ),101810,Isoform B3 of Smoothelin OS=Homo sapiens OX=9606 GN=SMTN
155,2087,sp|Q9BUJ2-2|HNRL1_HUMAN,48.05,224.40,1.02E8,1.046E8,1.857E8,1.794E8,1.00,1.02,1.82,1.76,1.02E8,1.046E8,1.857E8,1.794E8,1.00,1.02,1.82,1.76,38,36,36,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),90292,Isoform 2 of Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens OX=9606 GN=HNRNPUL1
154,1545,sp|Q8IXB1|DJC10_HUMAN,27.15,224.06,1.26E8,1.247E8,1.917E8,1.809E8,1.00,0.99,1.52,1.44,1.26E8,1.247E8,1.917E8,1.809E8,1.00,0.99,1.52,1.44,31,38,37,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),91080,DnaJ homolog subfamily C member 10 OS=Homo sapiens OX=9606 GN=DNAJC10 PE=1 SV=2
691,11028,sp|Q00577|PURA_HUMAN,29.15,223.81,1.211E7,1.274E7,1.897E7,1.835E7,1.00,1.05,1.57,1.51,1.211E7,1.274E7,1.897E7,1.835E7,1.00,1.05,1.57,1.51,61,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),34911,Transcriptional activator protein Pur-alpha OS=Homo sapiens OX=9606 GN=PURA PE=1 SV=2
485,2150,sp|Q86XP3|DDX42_HUMAN,200.00,223.56,1.186E7,1.21E7,4.082E7,4.016E7,1.00,1.02,3.44,3.39,1.186E7,1.21E7,4.082E7,4.016E7,1.00,1.02,3.44,3.39,41,29,29,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),102975,ATP-dependent RNA helicase DDX42 OS=Homo sapiens OX=9606 GN=DDX42 PE=1 SV=1
270,819,sp|Q15393|SF3B3_HUMAN,46.36,223.27,4.717E7,4.908E7,8.482E7,8.307E7,1.00,1.04,1.80,1.76,4.717E7,4.908E7,8.482E7,8.307E7,1.00,1.04,1.80,1.76,32,37,37,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),135577,Splicing factor 3B subunit 3 OS=Homo sapiens OX=9606 GN=SF3B3 PE=1 SV=4
87,2062,sp|Q9H361|PABP3_HUMAN,4.44,223.14,7.121E5,8.386E5,1.198E6,1.242E6,1.00,1.18,1.68,1.74,7.121E5,8.386E5,1.198E6,1.242E6,1.00,1.18,1.68,1.74,7,39,2,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),70031,Polyadenylate-binding protein 3 OS=Homo sapiens OX=9606 GN=PABPC3 PE=1 SV=2
328,10339,sp|Q86SQ0|PHLB2_HUMAN,9.73,222.87,1.096E6,1.083E6,2.713E6,2.617E6,1.00,0.99,2.47,2.39,1.096E6,1.083E6,2.713E6,2.617E6,1.00,0.99,2.47,2.39,1,37,2,iTRAQ 4plex (K  N-term),142158,Pleckstrin homology-like domain family B member 2 OS=Homo sapiens OX=9606 GN=PHLDB2 PE=1 SV=2
445,318,Q7Z3Z5|Q7Z3Z5_HUMAN,1.22,222.60,1.024E4,7.538E3,1.161E4,7.88E3,1.00,0.74,1.13,0.77,1.024E4,7.538E3,1.161E4,7.88E3,1.00,0.74,1.13,0.77,2,30,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),226321,Mediator of RNA polymerase II transcription subunit 12 OS=Homo sapiens OX=9606 GN=MED12 PE=1 SV=1
194,5751,A0A2R8YG42|A0A2R8YG42_HUMAN,126.52,222.33,4.242E7,4.377E7,1.173E8,1.136E8,1.00,1.03,2.76,2.68,4.242E7,4.377E7,1.173E8,1.136E8,1.00,1.03,2.76,2.68,37,39,31,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),97153,Rho guanine nucleotide exchange factor 7 OS=Homo sapiens OX=9606 GN=ARHGEF7 PE=1 SV=1
274,3610,sp|O75821|EIF3G_HUMAN,134.38,222.21,5.098E7,5.297E7,1.457E8,1.363E8,1.00,1.04,2.86,2.67,5.098E7,5.297E7,1.457E8,1.363E8,1.00,1.04,2.86,2.67,62,25,24,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),35611,Eukaryotic translation initiation factor 3 subunit G OS=Homo sapiens OX=9606 GN=EIF3G PE=1 SV=2
461,38708,sp|Q12797|ASPH_HUMAN,31.84,222.09,2.712E7,2.773E7,4.235E7,4.35E7,1.00,1.02,1.56,1.60,2.712E7,2.773E7,4.235E7,4.35E7,1.00,1.02,1.56,1.60,38,25,25,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),85863,Aspartyl/asparaginyl beta-hydroxylase OS=Homo sapiens OX=9606 GN=ASPH PE=1 SV=3
435,826,sp|Q6WCQ1|MPRIP_HUMAN,11.49,222.09,1.882E7,1.837E7,2.083E7,2.431E7,1.00,0.98,1.11,1.29,1.882E7,1.837E7,2.083E7,2.431E7,1.00,0.98,1.11,1.29,40,35,34,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),116533,Myosin phosphatase Rho-interacting protein OS=Homo sapiens OX=9606 GN=MPRIP PE=1 SV=3
360,900,sp|Q9BZF9|UACA_HUMAN,31.93,221.83,2.497E7,2.502E7,4.391E7,4.396E7,1.00,1.00,1.76,1.76,2.497E7,2.502E7,4.391E7,4.396E7,1.00,1.00,1.76,1.76,32,49,49,iTRAQ 4plex (K  N-term); Deamidation (NQ),162504,Uveal autoantigen with coiled-coil domains and ankyrin repeats OS=Homo sapiens OX=9606 GN=UACA PE=1 SV=2
336,3878,sp|Q86SQ0-3|PHLB2_HUMAN,3.12,221.75,2.898E5,3.697E5,6.811E5,7.404E5,1.00,1.28,2.35,2.55,2.898E5,3.697E5,6.811E5,7.404E5,1.00,1.28,2.35,2.55,1,36,1,iTRAQ 4plex (K  N-term),139973,Isoform 3 of Pleckstrin homology-like domain family B member 2 OS=Homo sapiens OX=9606 GN=PHLDB2
416,5007,sp|Q9Y5S2|MRCKB_HUMAN,28.64,221.27,7.173E6,6.942E6,1.024E7,1.105E7,1.00,0.97,1.43,1.54,7.173E6,6.942E6,1.024E7,1.105E7,1.00,0.97,1.43,1.54,12,34,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),194314,Serine/threonine-protein kinase MRCK beta OS=Homo sapiens OX=9606 GN=CDC42BPB PE=1 SV=2
263,1227,sp|O15042-2|SR140_HUMAN,42.67,221.19,5.878E7,6.054E7,1.029E8,1.002E8,1.00,1.03,1.75,1.71,5.878E7,6.054E7,1.029E8,1.002E8,1.00,1.03,1.75,1.71,30,34,34,iTRAQ 4plex (K  N-term); Deamidation (NQ),118235,Isoform 2 of U2 snRNP-associated SURP motif-containing protein OS=Homo sapiens OX=9606 GN=U2SURP
323,1211,sp|Q8IZH2-2|XRN1_HUMAN,85.38,221.03,2.174E7,2.178E7,5.178E7,4.951E7,1.00,1.00,2.38,2.28,2.174E7,2.178E7,5.178E7,4.951E7,1.00,1.00,2.38,2.28,25,41,40,iTRAQ 4plex (K  N-term); Deamidation (NQ),192842,Isoform 2 of 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1
146,4536,sp|P51991-2|ROA3_HUMAN,1.23,221.02,9.299E5,7.88E5,9.348E5,9.431E5,1.00,0.85,1.01,1.01,9.299E5,7.88E5,9.348E5,9.431E5,1.00,0.85,1.01,1.01,4,28,2,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term),37029,Isoform 2 of Heterogeneous nuclear ribonucleoprotein A3 OS=Homo sapiens OX=9606 GN=HNRNPA3
264,3904,sp|Q7KZF4|SND1_HUMAN,26.53,220.69,4.613E7,4.697E7,6.988E7,7.071E7,1.00,1.02,1.51,1.53,4.613E7,4.697E7,6.988E7,7.071E7,1.00,1.02,1.51,1.53,43,34,34,iTRAQ 4plex (K  N-term); Deamidation (NQ),101997,Staphylococcal nuclease domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SND1 PE=1 SV=1
452,379,sp|Q8IWZ3|ANKH1_HUMAN,76.27,220.17,4.643E6,4.804E6,1.163E7,1.112E7,1.00,1.03,2.51,2.40,4.643E6,4.804E6,1.163E7,1.112E7,1.00,1.03,2.51,2.40,5,32,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),269455,Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1
355,1312,sp|Q12965|MYO1E_HUMAN,54.32,220.07,2.464E7,2.54E7,5.268E7,5.299E7,1.00,1.03,2.14,2.15,2.464E7,2.54E7,5.268E7,5.299E7,1.00,1.03,2.14,2.15,31,37,31,iTRAQ 4plex (K  N-term); Deamidation (NQ),127062,Unconventional myosin-Ie OS=Homo sapiens OX=9606 GN=MYO1E PE=1 SV=2
168,19284,sp|P19338|NUCL_HUMAN,20.44,220.05,2.142E8,2.127E8,2.75E8,3.055E8,1.00,0.99,1.28,1.43,2.142E8,2.127E8,2.75E8,3.055E8,1.00,0.99,1.28,1.43,43,44,43,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),76615,Nucleolin OS=Homo sapiens OX=9606 GN=NCL PE=1 SV=3
298,4359,sp|Q9Y608-4|LRRF2_HUMAN,11.64,219.89,4.196E7,4.022E7,4.171E7,5.177E7,1.00,0.96,0.99,1.23,4.196E7,4.022E7,4.171E7,5.177E7,1.00,0.96,0.99,1.23,41,24,17,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),48294,Isoform 4 of Leucine-rich repeat flightless-interacting protein 2 OS=Homo sapiens OX=9606 GN=LRRFIP2
268,2288,E7EX17|E7EX17_HUMAN,200.00,219.60,2.373E7,2.696E7,7.987E7,7.593E7,1.00,1.14,3.37,3.20,2.373E7,2.696E7,7.987E7,7.593E7,1.00,1.14,3.37,3.20,48,31,31,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),69698,Eukaryotic translation initiation factor 4B OS=Homo sapiens OX=9606 GN=EIF4B PE=1 SV=1
258,4119,A0A087X253|A0A087X253_HUMAN,25.86,219.55,3.984E7,3.832E7,5.977E7,6.086E7,1.00,0.96,1.50,1.53,3.984E7,3.832E7,5.977E7,6.086E7,1.00,0.96,1.50,1.53,24,36,22,iTRAQ 4plex (K  N-term); Deamidation (NQ),101333,AP complex subunit beta OS=Homo sapiens OX=9606 GN=AP2B1 PE=1 SV=1
190,4532,sp|Q9Y262|EIF3L_HUMAN,135.23,219.48,8.479E7,8.988E7,2.431E8,2.33E8,1.00,1.06,2.87,2.75,8.479E7,8.988E7,2.431E8,2.33E8,1.00,1.06,2.87,2.75,47,32,32,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),66727,Eukaryotic translation initiation factor 3 subunit L OS=Homo sapiens OX=9606 GN=EIF3L PE=1 SV=1
260,11884,sp|O94855|SC24D_HUMAN,117.52,219.04,6.334E7,5.982E7,1.59E8,1.544E8,1.00,0.94,2.51,2.44,6.334E7,5.982E7,1.59E8,1.544E8,1.00,0.94,2.51,2.44,29,33,32,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),113010,Protein transport protein Sec24D OS=Homo sapiens OX=9606 GN=SEC24D PE=1 SV=2
451,3162,C9J2Y9|C9J2Y9_HUMAN,74.00,218.20,1.9E7,1.925E7,4.067E7,3.944E7,1.00,1.01,2.14,2.08,1.9E7,1.925E7,4.067E7,3.944E7,1.00,1.01,2.14,2.08,24,25,25,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),133057,DNA-directed RNA polymerase subunit beta OS=Homo sapiens OX=9606 GN=POLR2B PE=1 SV=2
279,2630,sp|P08123|CO1A2_HUMAN,12.00,218.19,2.879E7,2.851E7,3.704E7,3.713E7,1.00,0.99,1.29,1.29,2.879E7,2.851E7,3.704E7,3.713E7,1.00,0.99,1.29,1.29,33,35,34,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),129314,Collagen alpha-2(I) chain OS=Homo sapiens OX=9606 GN=COL1A2 PE=1 SV=7
519,633,sp|Q96RT1-7|ERBIN_HUMAN,65.55,218.12,9.765E6,9.489E6,2.021E7,1.955E7,1.00,0.97,2.07,2.00,9.765E6,9.489E6,2.021E7,1.955E7,1.00,0.97,2.07,2.00,30,33,32,iTRAQ 4plex (K  N-term); Deamidation (NQ),146086,Isoform 7 of Erbin OS=Homo sapiens OX=9606 GN=ERBIN
259,5713,sp|P07437|TBB5_HUMAN,110.04,218.09,5.396E6,5.718E6,1.336E7,1.387E7,1.00,1.06,2.48,2.57,5.396E6,5.718E6,1.336E7,1.387E7,1.00,1.06,2.48,2.57,12,25,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),49671,Tubulin beta chain OS=Homo sapiens OX=9606 GN=TUBB PE=1 SV=2
265,2642,M0QZM1|M0QZM1_HUMAN,2.22,217.96,1.323E6,1.326E6,2.593E6,2.658E6,1.00,1.00,1.96,2.01,1.323E6,1.326E6,2.593E6,2.658E6,1.00,1.00,1.96,2.01,4,27,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),40052,Heterogeneous nuclear ribonucleoprotein M (Fragment) OS=Homo sapiens OX=9606 GN=HNRNPM PE=1 SV=1
318,1918,sp|Q5GLZ8-2|HERC4_HUMAN,143.52,217.67,9.463E7,8.794E7,3.366E7,3.191E7,1.00,0.93,0.36,0.34,9.463E7,8.794E7,3.366E7,3.191E7,1.00,0.93,0.36,0.34,30,29,29,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),117697,Isoform 2 of Probable E3 ubiquitin-protein ligase HERC4 OS=Homo sapiens OX=9606 GN=HERC4
434,2392,sp|O60292|SI1L3_HUMAN,44.76,217.49,1.639E7,1.662E7,2.913E7,2.895E7,1.00,1.01,1.78,1.77,1.639E7,1.662E7,2.913E7,2.895E7,1.00,1.01,1.78,1.77,20,33,28,iTRAQ 4plex (K  N-term); Deamidation (NQ),194608,Signal-induced proliferation-associated 1-like protein 3 OS=Homo sapiens OX=9606 GN=SIPA1L3 PE=1 SV=3
286,2154,sp|P55268|LAMB2_HUMAN,9.22,217.25,3.707E7,3.779E7,4.647E7,4.515E7,1.00,1.02,1.25,1.22,3.707E7,3.779E7,4.647E7,4.515E7,1.00,1.02,1.25,1.22,21,36,36,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),195980,Laminin subunit beta-2 OS=Homo sapiens OX=9606 GN=LAMB2 PE=1 SV=2
469,4353,sp|Q9BTC0|DIDO1_HUMAN,51.06,217.25,1.122E7,1.14E7,2.085E7,2.007E7,1.00,1.02,1.86,1.79,1.122E7,1.14E7,2.085E7,2.007E7,1.00,1.02,1.86,1.79,20,35,34,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),243870,Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5
470,38717,sp|O60841|IF2P_HUMAN,20.84,217.22,1.702E7,1.707E7,2.551E7,2.594E7,1.00,1.00,1.50,1.52,1.702E7,1.707E7,2.551E7,2.594E7,1.00,1.00,1.50,1.52,32,34,32,iTRAQ 4plex (K  N-term); Deamidation (NQ),138827,Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4
364,285,sp|P78332|RBM6_HUMAN,30.15,216.92,1.983E7,1.963E7,3.104E7,3.067E7,1.00,0.99,1.57,1.55,1.983E7,1.963E7,3.104E7,3.067E7,1.00,0.99,1.57,1.55,34,35,35,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),128644,RNA-binding protein 6 OS=Homo sapiens OX=9606 GN=RBM6 PE=1 SV=5
365,394,A0A2R8Y7S2|A0A2R8Y7S2_HUMAN,18.93,216.72,1.513E7,1.564E7,2.26E7,2.12E7,1.00,1.03,1.49,1.40,1.513E7,1.564E7,2.26E7,2.12E7,1.00,1.03,1.49,1.40,20,38,27,iTRAQ 4plex (K  N-term); Deamidation (NQ),184850,Transcription activator BRG1 OS=Homo sapiens OX=9606 GN=SMARCA4 PE=1 SV=1
297,20728,E7ESP9|E7ESP9_HUMAN,17.04,216.28,2.442E7,2.324E7,2.656E7,3.211E7,1.00,0.95,1.09,1.31,2.442E7,2.324E7,2.656E7,3.211E7,1.00,0.95,1.09,1.31,35,33,30,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),98381,Neurofilament medium polypeptide OS=Homo sapiens OX=9606 GN=NEFM PE=1 SV=1
409,19506,sp|O75534|CSDE1_HUMAN,50.68,216.06,2.686E7,2.804E7,4.977E7,4.643E7,1.00,1.04,1.85,1.73,2.686E7,2.804E7,4.977E7,4.643E7,1.00,1.04,1.85,1.73,39,31,31,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),88885,Cold shock domain-containing protein E1 OS=Homo sapiens OX=9606 GN=CSDE1 PE=1 SV=2
473,2650,sp|Q15648|MED1_HUMAN,16.68,215.76,2.01E7,2.07E7,2.851E7,2.667E7,1.00,1.03,1.42,1.33,2.01E7,2.07E7,2.851E7,2.667E7,1.00,1.03,1.42,1.33,24,30,30,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),168477,Mediator of RNA polymerase II transcription subunit 1 OS=Homo sapiens OX=9606 GN=MED1 PE=1 SV=4
26,4812,B7Z6Z4|B7Z6Z4_HUMAN,10.92,215.15,1.282E6,1.68E6,9.672E5,9.238E5,1.00,1.31,0.75,0.72,1.282E6,1.68E6,9.672E5,9.238E5,1.00,1.31,0.75,0.72,22,35,3,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),26707,cDNA FLJ56329  highly similar to Myosin light polypeptide 6 OS=Homo sapiens OX=9606 GN=MYL6 PE=1 SV=1
312,1530,sp|P60842|IF4A1_HUMAN,138.21,215.10,1.99E7,1.92E7,5.848E7,5.286E7,1.00,0.96,2.94,2.66,1.99E7,1.92E7,5.848E7,5.286E7,1.00,0.96,2.94,2.66,24,27,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),46154,Eukaryotic initiation factor 4A-I OS=Homo sapiens OX=9606 GN=EIF4A1 PE=1 SV=1
313,4378,sp|P04264|K2C1_HUMAN,200.00,214.87,6.228E7,1.808E7,2.418E7,1.9E7,1.00,0.29,0.39,0.31,6.228E7,1.808E7,2.418E7,1.9E7,1.00,0.29,0.39,0.31,38,27,21,iTRAQ 4plex (K  N-term); Oxidation (M),66039,Keratin  type II cytoskeletal 1 OS=Homo sapiens OX=9606 GN=KRT1 PE=1 SV=6
25,7440,J3KND3|J3KND3_HUMAN,4.29,214.68,1.163E6,1.311E6,1.273E6,1.509E6,1.00,1.13,1.09,1.30,1.163E6,1.311E6,1.273E6,1.509E6,1.00,1.13,1.09,1.30,27,34,2,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),17058,Myosin light polypeptide 6 OS=Homo sapiens OX=9606 GN=MYL6 PE=1 SV=1
73,88,sp|P67936-2|TPM4_HUMAN,10.88,214.61,1.276E7,1.222E7,1.555E7,1.688E7,1.00,0.96,1.22,1.32,1.276E7,1.222E7,1.555E7,1.688E7,1.00,0.96,1.22,1.32,18,38,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),32723,Isoform 2 of Tropomyosin alpha-4 chain OS=Homo sapiens OX=9606 GN=TPM4
579,492,sp|Q14151|SAFB2_HUMAN,18.82,214.40,1.02E7,1.046E7,1.636E7,1.579E7,1.00,1.02,1.60,1.55,1.02E7,1.046E7,1.636E7,1.579E7,1.00,1.02,1.60,1.55,14,19,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),107474,Scaffold attachment factor B2 OS=Homo sapiens OX=9606 GN=SAFB2 PE=1 SV=1
291,7426,A0A3B3ITJ4|A0A3B3ITJ4_HUMAN,3.90,214.14,9.342E5,9.845E5,1.457E6,1.326E6,1.00,1.05,1.56,1.42,9.342E5,9.845E5,1.457E6,1.326E6,1.00,1.05,1.56,1.42,4,22,2,iTRAQ 4plex (K  N-term),59219,Heterogeneous nuclear ribonucleoprotein L (Fragment) OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=1
357,15528,sp|Q9NXV6|CARF_HUMAN,43.96,213.71,1.337E7,1.372E7,2.363E7,2.242E7,1.00,1.03,1.77,1.68,1.337E7,1.372E7,2.363E7,2.242E7,1.00,1.03,1.77,1.68,56,22,22,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),61125,CDKN2A-interacting protein OS=Homo sapiens OX=9606 GN=CDKN2AIP PE=1 SV=3
230,3692,sp|Q9NVI7-2|ATD3A_HUMAN,27.44,213.71,1.162E7,1.241E7,1.869E7,1.797E7,1.00,1.07,1.61,1.55,1.162E7,1.241E7,1.869E7,1.797E7,1.00,1.07,1.61,1.55,16,30,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),66218,Isoform 2 of ATPase family AAA domain-containing protein 3A OS=Homo sapiens OX=9606 GN=ATAD3A
320,547,sp|P02545|LMNA_HUMAN,38.11,213.52,2.795E7,2.536E7,4.193E7,4.563E7,1.00,0.91,1.50,1.63,2.795E7,2.536E7,4.193E7,4.563E7,1.00,0.91,1.50,1.63,51,37,35,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),74140,Prelamin-A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1
766,21215,sp|Q13459-2|MYO9B_HUMAN,28.98,213.48,4.928E6,4.874E6,7.593E6,7.62E6,1.00,0.99,1.54,1.55,4.928E6,4.874E6,7.593E6,7.62E6,1.00,0.99,1.54,1.55,12,22,20,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),229141,Isoform Short of Unconventional myosin-IXb OS=Homo sapiens OX=9606 GN=MYO9B
430,3079,C9J6P4|C9J6P4_HUMAN,25.79,213.14,1.687E5,2.124E5,2.993E5,3.213E5,1.00,1.26,1.77,1.90,1.687E5,2.124E5,2.993E5,3.213E5,1.00,1.26,1.77,1.90,6,26,3,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),114085,Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens OX=9606 GN=ZC3HAV1 PE=1 SV=1
615,1798,sp|Q09472|EP300_HUMAN,16.42,213.10,5.363E6,5.292E6,7.354E6,7.043E6,1.00,0.99,1.37,1.31,5.363E6,5.292E6,7.354E6,7.043E6,1.00,0.99,1.37,1.31,12,25,16,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),264158,Histone acetyltransferase p300 OS=Homo sapiens OX=9606 GN=EP300 PE=1 SV=2
619,3089,sp|Q8NFD5|ARI1B_HUMAN,19.94,212.05,6.249E6,6.266E6,8.926E6,8.729E6,1.00,1.00,1.43,1.40,6.249E6,6.266E6,8.926E6,8.729E6,1.00,1.00,1.43,1.40,14,24,21,iTRAQ 4plex (K  N-term); Deamidation (NQ),236121,AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=2
319,1898,sp|Q9Y2W1|TR150_HUMAN,29.88,211.89,3.586E7,3.546E7,5.589E7,5.582E7,1.00,0.99,1.56,1.56,3.586E7,3.546E7,5.589E7,5.582E7,1.00,0.99,1.56,1.56,32,29,29,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),108666,Thyroid hormone receptor-associated protein 3 OS=Homo sapiens OX=9606 GN=THRAP3 PE=1 SV=2
460,1302,sp|Q7L2E3-2|DHX30_HUMAN,9.49,211.79,3.095E7,3.156E7,3.961E7,3.89E7,1.00,1.02,1.28,1.26,3.095E7,3.156E7,3.961E7,3.89E7,1.00,1.02,1.28,1.26,32,37,37,iTRAQ 4plex (K  N-term); Deamidation (NQ),136115,Isoform 2 of ATP-dependent RNA helicase DHX30 OS=Homo sapiens OX=9606 GN=DHX30
245,11680,sp|P60228|EIF3E_HUMAN,88.32,211.75,7.316E7,7.618E7,1.865E8,1.775E8,1.00,1.04,2.55,2.43,7.316E7,7.618E7,1.865E8,1.775E8,1.00,1.04,2.55,2.43,45,26,26,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),52221,Eukaryotic translation initiation factor 3 subunit E OS=Homo sapiens OX=9606 GN=EIF3E PE=1 SV=1
189,3340,sp|O00425|IF2B3_HUMAN,20.37,211.50,7.789E7,8.054E7,1.118E8,1.093E8,1.00,1.03,1.44,1.40,7.789E7,8.054E7,1.118E8,1.093E8,1.00,1.03,1.44,1.40,39,28,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),63705,Insulin-like growth factor 2 mRNA-binding protein 3 OS=Homo sapiens OX=9606 GN=IGF2BP3 PE=1 SV=2
404,25813,sp|P20908|CO5A1_HUMAN,3.43,210.80,1.384E6,1.324E6,1.854E6,1.987E6,1.00,0.96,1.34,1.44,1.384E6,1.324E6,1.854E6,1.987E6,1.00,0.96,1.34,1.44,1,26,2,iTRAQ 4plex (K  N-term),183559,Collagen alpha-1(V) chain OS=Homo sapiens OX=9606 GN=COL5A1 PE=1 SV=3
397,796,sp|Q9Y4I1-2|MYO5A_HUMAN,15.49,210.35,2.121E7,2.074E7,2.601E7,2.949E7,1.00,0.98,1.23,1.39,2.121E7,2.074E7,2.601E7,2.949E7,1.00,0.98,1.23,1.39,21,36,35,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),212271,Isoform 2 of Unconventional myosin-Va OS=Homo sapiens OX=9606 GN=MYO5A
217,7110,sp|P07355|ANXA2_HUMAN,22.15,210.25,1.005E8,1.001E8,1.464E8,1.453E8,1.00,1.00,1.46,1.45,1.005E8,1.001E8,1.464E8,1.453E8,1.00,1.00,1.46,1.45,53,28,28,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),38604,Annexin A2 OS=Homo sapiens OX=9606 GN=ANXA2 PE=1 SV=2
269,5358,sp|Q14694|UBP10_HUMAN,41.06,210.11,7.662E7,7.915E7,1.325E8,1.286E8,1.00,1.03,1.73,1.68,7.662E7,7.915E7,1.325E8,1.286E8,1.00,1.03,1.73,1.68,40,28,28,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),87134,Ubiquitin carboxyl-terminal hydrolase 10 OS=Homo sapiens OX=9606 GN=USP10 PE=1 SV=2
521,38712,sp|P35568|IRS1_HUMAN,42.21,210.04,1.468E7,1.509E7,2.588E7,2.512E7,1.00,1.03,1.76,1.71,1.468E7,1.509E7,2.588E7,2.512E7,1.00,1.03,1.76,1.71,26,27,27,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),131591,Insulin receptor substrate 1 OS=Homo sapiens OX=9606 GN=IRS1 PE=1 SV=1
543,4477,sp|Q2M2I8|AAK1_HUMAN,98.58,209.73,7.099E6,7.057E6,1.745E7,1.735E7,1.00,0.99,2.46,2.44,7.099E6,7.057E6,1.745E7,1.735E7,1.00,0.99,2.46,2.44,25,21,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),103885,AP2-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=AAK1 PE=1 SV=3
481,686,sp|Q9H2U1|DHX36_HUMAN,32.17,209.46,1.632E7,1.602E7,2.789E7,2.725E7,1.00,0.98,1.71,1.67,1.632E7,1.602E7,2.789E7,2.725E7,1.00,0.98,1.71,1.67,35,32,30,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),114760,ATP-dependent DNA/RNA helicase DHX36 OS=Homo sapiens OX=9606 GN=DHX36 PE=1 SV=2
423,25812,sp|P20908-2|CO5A1_HUMAN,1.56,209.34,3.618E5,3.699E5,3.823E5,4.553E5,1.00,1.02,1.06,1.26,3.618E5,3.699E5,3.823E5,4.553E5,1.00,1.02,1.06,1.26,2,26,2,iTRAQ 4plex (K  N-term),183652,Isoform 2 of Collagen alpha-1(V) chain OS=Homo sapiens OX=9606 GN=COL5A1
407,6737,sp|Q8IWX8|CHERP_HUMAN,31.25,209.02,3.402E7,3.566E7,5.429E7,5.339E7,1.00,1.05,1.60,1.57,3.402E7,3.566E7,5.429E7,5.339E7,1.00,1.05,1.60,1.57,27,22,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),103702,Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3
34,2251,sp|A5A3E0|POTEF_HUMAN,0.83,208.92,1.334E6,1.494E6,1.497E6,1.791E6,1.00,1.12,1.12,1.34,1.334E6,1.494E6,1.497E6,1.791E6,1.00,1.12,1.12,1.34,2,41,1,iTRAQ 4plex (K  N-term),121444,POTE ankyrin domain family member F OS=Homo sapiens OX=9606 GN=POTEF PE=1 SV=2
228,7406,sp|Q9NYL9|TMOD3_HUMAN,9.25,208.86,1.101E8,1.041E8,1.093E8,1.293E8,1.00,0.95,0.99,1.17,1.101E8,1.041E8,1.093E8,1.293E8,1.00,0.95,0.99,1.17,54,24,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),39595,Tropomodulin-3 OS=Homo sapiens OX=9606 GN=TMOD3 PE=1 SV=1
590,4989,sp|Q13573|SNW1_HUMAN,103.03,208.65,8.216E6,8.384E6,2.043E7,1.928E7,1.00,1.02,2.49,2.35,8.216E6,8.384E6,2.043E7,1.928E7,1.00,1.02,2.49,2.35,48,20,20,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),61495,SNW domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SNW1 PE=1 SV=1
385,303,sp|Q86UU0-4|BCL9L_HUMAN,34.18,208.65,1.817E7,1.862E7,3.039E7,2.998E7,1.00,1.02,1.67,1.65,1.817E7,1.862E7,3.039E7,2.998E7,1.00,1.02,1.67,1.65,29,24,24,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),152547,Isoform 4 of B-cell CLL/lymphoma 9-like protein OS=Homo sapiens OX=9606 GN=BCL9L
567,1717,sp|Q9P270|SLAI2_HUMAN,71.90,208.29,2.317E6,2.341E6,6.269E6,6.218E6,1.00,1.01,2.71,2.68,2.317E6,2.341E6,6.269E6,6.218E6,1.00,1.01,2.71,2.68,20,19,8,iTRAQ 4plex (K  N-term),62543,SLAIN motif-containing protein 2 OS=Homo sapiens OX=9606 GN=SLAIN2 PE=1 SV=2
602,15958,H0Y4E8|H0Y4E8_HUMAN,76.66,208.14,8.987E6,9.099E6,1.967E7,1.903E7,1.00,1.01,2.19,2.12,8.987E6,9.099E6,1.967E7,1.903E7,1.00,1.01,2.19,2.12,25,25,25,iTRAQ 4plex (K  N-term); Deamidation (NQ),150103,Serine/threonine-protein kinase SIK3 (Fragment) OS=Homo sapiens OX=9606 GN=SIK3 PE=1 SV=1
398,3670,sp|O94832|MYO1D_HUMAN,14.61,207.86,5.821E7,5.529E7,6.602E7,7.412E7,1.00,0.95,1.13,1.27,5.821E7,5.529E7,6.602E7,7.412E7,1.00,0.95,1.13,1.27,28,29,27,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),116202,Unconventional myosin-Id OS=Homo sapiens OX=9606 GN=MYO1D PE=1 SV=2
255,4992,sp|P36578|RL4_HUMAN,13.85,207.46,1.129E8,1.118E8,1.385E8,1.483E8,1.00,0.99,1.23,1.31,1.129E8,1.118E8,1.385E8,1.483E8,1.00,0.99,1.23,1.31,48,30,30,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),47697,60S ribosomal protein L4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5
354,1132,sp|Q71U36-2|TBA1A_HUMAN,39.30,207.21,6.9E7,6.897E7,1.176E8,1.138E8,1.00,1.00,1.70,1.65,6.9E7,6.897E7,1.176E8,1.138E8,1.00,1.00,1.70,1.65,44,20,20,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),46297,Isoform 2 of Tubulin alpha-1A chain OS=Homo sapiens OX=9606 GN=TUBA1A
429,5021,sp|P12814|ACTN1_HUMAN,20.02,207.21,1.578E7,1.505E7,2.048E7,2.317E7,1.00,0.95,1.30,1.47,1.578E7,1.505E7,2.048E7,2.317E7,1.00,0.95,1.30,1.47,24,28,20,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),103058,Alpha-actinin-1 OS=Homo sapiens OX=9606 GN=ACTN1 PE=1 SV=2
492,1224,sp|Q93008-1|USP9X_HUMAN,57.45,207.03,6.556E6,6.738E6,1.271E7,1.212E7,1.00,1.03,1.94,1.85,6.556E6,6.738E6,1.271E7,1.212E7,1.00,1.03,1.94,1.85,6,26,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),290461,Isoform 2 of Probable ubiquitin carboxyl-terminal hydrolase FAF-X OS=Homo sapiens OX=9606 GN=USP9X
476,4979,sp|Q6P3W7|SCYL2_HUMAN,80.20,206.93,2.675E7,2.378E7,5.456E7,5.274E7,1.00,0.89,2.04,1.97,2.675E7,2.378E7,5.456E7,5.274E7,1.00,0.89,2.04,1.97,35,26,26,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),103709,SCY1-like protein 2 OS=Homo sapiens OX=9606 GN=SCYL2 PE=1 SV=1
337,1624,sp|Q01804|OTUD4_HUMAN,55.91,206.76,2.34E7,2.396E7,5.229E7,5.215E7,1.00,1.02,2.23,2.23,2.34E7,2.396E7,5.229E7,5.215E7,1.00,1.02,2.23,2.23,29,29,29,iTRAQ 4plex (K  N-term); Deamidation (NQ),124045,OTU domain-containing protein 4 OS=Homo sapiens OX=9606 GN=OTUD4 PE=1 SV=4
417,608,sp|Q13045|FLII_HUMAN,16.63,206.56,4.072E7,3.854E7,4.867E7,5.312E7,1.00,0.95,1.20,1.30,4.072E7,3.854E7,4.867E7,5.312E7,1.00,0.95,1.20,1.30,24,28,27,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),144751,Protein flightless-1 homolog OS=Homo sapiens OX=9606 GN=FLII PE=1 SV=2
325,3706,A0A2R8YFH5|A0A2R8YFH5_HUMAN,47.25,206.50,1.518E7,1.599E7,2.924E7,2.748E7,1.00,1.05,1.93,1.81,1.518E7,1.599E7,2.924E7,2.748E7,1.00,1.05,1.93,1.81,27,30,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),84473,Protein transport protein SEC23 OS=Homo sapiens OX=9606 GN=SEC23B PE=1 SV=1
578,518,sp|O75165|DJC13_HUMAN,15.71,206.35,1.809E7,1.844E7,2.603E7,2.534E7,1.00,1.02,1.44,1.40,1.809E7,1.844E7,2.603E7,2.534E7,1.00,1.02,1.44,1.40,16,31,31,iTRAQ 4plex (K  N-term); Deamidation (NQ),254412,DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5
327,1893,sp|Q15084-2|PDIA6_HUMAN,75.88,206.22,5.191E7,4.683E7,1.013E8,9.567E7,1.00,0.90,1.95,1.84,5.191E7,4.683E7,1.013E8,9.567E7,1.00,0.90,1.95,1.84,45,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),53901,Isoform 2 of Protein disulfide-isomerase A6 OS=Homo sapiens OX=9606 GN=PDIA6
436,3083,sp|Q7Z2W4|ZCCHV_HUMAN,1.78,206.17,7.574E5,7.419E5,1.322E6,1.307E6,1.00,0.98,1.74,1.73,7.574E5,7.419E5,1.322E6,1.307E6,1.00,0.98,1.74,1.73,2,24,1,iTRAQ 4plex (K  N-term),101431,Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens OX=9606 GN=ZC3HAV1 PE=1 SV=3
631,1664,sp|P78347-2|GTF2I_HUMAN,40.56,206.11,8.584E6,8.693E6,1.478E7,1.467E7,1.00,1.01,1.72,1.71,8.584E6,8.693E6,1.478E7,1.467E7,1.00,1.01,1.72,1.71,25,21,20,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),107970,Isoform 2 of General transcription factor II-I OS=Homo sapiens OX=9606 GN=GTF2I
253,1065,sp|O43143|DHX15_HUMAN,30.66,205.94,4.062E7,4.261E7,6.705E7,6.234E7,1.00,1.05,1.65,1.53,4.062E7,4.261E7,6.705E7,6.234E7,1.00,1.05,1.65,1.53,32,31,30,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),90933,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 OS=Homo sapiens OX=9606 GN=DHX15 PE=1 SV=2
261,7559,sp|Q86X55-1|CARM1_HUMAN,60.07,205.46,1.344E8,1.365E8,2.649E8,2.437E8,1.00,1.02,1.97,1.81,1.344E8,1.365E8,2.649E8,2.437E8,1.00,1.02,1.97,1.81,47,32,32,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),63460,Isoform 1 of Histone-arginine methyltransferase CARM1 OS=Homo sapiens OX=9606 GN=CARM1
651,4717,sp|Q9C0J8|WDR33_HUMAN,18.69,205.28,7.258E6,7.469E6,1.077E7,1.05E7,1.00,1.03,1.48,1.45,7.258E6,7.469E6,1.077E7,1.05E7,1.00,1.03,1.48,1.45,26,21,21,iTRAQ 4plex (K  N-term); Deamidation (NQ),145891,pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens OX=9606 GN=WDR33 PE=1 SV=2
477,9537,A0A0D9SF63|A0A0D9SF63_HUMAN,96.36,204.91,9.194E6,9.612E6,2.214E7,2.1E7,1.00,1.05,2.41,2.28,9.194E6,9.612E6,2.214E7,2.1E7,1.00,1.05,2.41,2.28,29,17,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),51556,F-box-like/WD repeat-containing protein TBL1XR1 OS=Homo sapiens OX=9606 GN=TBL1XR1 PE=1 SV=1
528,2231,sp|P98082|DAB2_HUMAN,46.64,204.91,1.309E7,1.275E7,2.181E7,2.296E7,1.00,0.97,1.67,1.75,1.309E7,1.275E7,2.181E7,2.296E7,1.00,0.97,1.67,1.75,38,21,21,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),82448,Disabled homolog 2 OS=Homo sapiens OX=9606 GN=DAB2 PE=1 SV=3
305,5349,A0A0R4J2E8|A0A0R4J2E8_HUMAN,28.95,204.68,2.994E7,3.088E7,5.076E7,4.904E7,1.00,1.03,1.70,1.64,2.994E7,3.088E7,5.076E7,4.904E7,1.00,1.03,1.70,1.64,40,30,29,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),94623,Matrin-3 OS=Homo sapiens OX=9606 GN=MATR3 PE=1 SV=1
295,3537,sp|Q9NZI8|IF2B1_HUMAN,24.51,204.30,3.548E7,3.733E7,5.317E7,5.077E7,1.00,1.05,1.50,1.43,3.548E7,3.733E7,5.317E7,5.077E7,1.00,1.05,1.50,1.43,40,26,23,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),63481,Insulin-like growth factor 2 mRNA-binding protein 1 OS=Homo sapiens OX=9606 GN=IGF2BP1 PE=1 SV=2
373,4618,sp|O95817|BAG3_HUMAN,94.88,204.28,1.39E7,1.408E7,3.849E7,3.803E7,1.00,1.01,2.77,2.74,1.39E7,1.408E7,3.849E7,3.803E7,1.00,1.01,2.77,2.74,58,29,29,iTRAQ 4plex (K  N-term); Deamidation (NQ),61595,BAG family molecular chaperone regulator 3 OS=Homo sapiens OX=9606 GN=BAG3 PE=1 SV=3
784,5172,sp|Q9HCD5|NCOA5_HUMAN,39.18,204.17,9.29E6,9.504E6,1.583E7,1.516E7,1.00,1.02,1.70,1.63,9.29E6,9.504E6,1.583E7,1.516E7,1.00,1.02,1.70,1.63,34,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),65536,Nuclear receptor coactivator 5 OS=Homo sapiens OX=9606 GN=NCOA5 PE=1 SV=2
379,5523,sp|Q9HCE1|MOV10_HUMAN,19.71,204.15,3.849E7,3.745E7,5.335E7,5.179E7,1.00,0.97,1.39,1.35,3.849E7,3.745E7,5.335E7,5.179E7,1.00,0.97,1.39,1.35,29,28,28,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),113671,Helicase MOV-10 OS=Homo sapiens OX=9606 GN=MOV10 PE=1 SV=2
432,4773,sp|P51116|FXR2_HUMAN,9.78,204.15,1.783E7,1.834E7,2.232E7,2.141E7,1.00,1.03,1.25,1.20,1.783E7,1.834E7,2.232E7,2.141E7,1.00,1.03,1.25,1.20,33,19,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),74223,Fragile X mental retardation syndrome-related protein 2 OS=Homo sapiens OX=9606 GN=FXR2 PE=1 SV=2
462,19431,sp|P13010|XRCC5_HUMAN,43.75,204.11,2.698E7,2.702E7,4.76E7,4.627E7,1.00,1.00,1.76,1.71,2.698E7,2.702E7,4.76E7,4.627E7,1.00,1.00,1.76,1.71,39,27,27,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),82705,X-ray repair cross-complementing protein 5 OS=Homo sapiens OX=9606 GN=XRCC5 PE=1 SV=3
591,19297,sp|O75175|CNOT3_HUMAN,83.22,204.09,1.093E7,1.108E7,2.462E7,2.443E7,1.00,1.01,2.25,2.23,1.093E7,1.108E7,2.462E7,2.443E7,1.00,1.01,2.25,2.23,43,21,21,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),81872,CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1
386,14568,sp|P12956|XRCC6_HUMAN,23.75,204.04,5.202E7,5.278E7,7.593E7,7.735E7,1.00,1.01,1.46,1.49,5.202E7,5.278E7,7.593E7,7.735E7,1.00,1.01,1.46,1.49,40,26,24,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),69843,X-ray repair cross-complementing protein 6 OS=Homo sapiens OX=9606 GN=XRCC6 PE=1 SV=2
608,2200,sp|Q96RN5|MED15_HUMAN,14.13,203.92,1.284E7,1.33E7,1.71E7,1.705E7,1.00,1.04,1.33,1.33,1.284E7,1.33E7,1.71E7,1.705E7,1.00,1.04,1.33,1.33,34,18,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),86753,Mediator of RNA polymerase II transcription subunit 15 OS=Homo sapiens OX=9606 GN=MED15 PE=1 SV=2
584,2706,sp|P27694|RFA1_HUMAN,129.14,203.91,9.052E6,9.151E6,2.53E7,2.41E7,1.00,1.01,2.80,2.66,9.052E6,9.151E6,2.53E7,2.41E7,1.00,1.01,2.80,2.66,45,23,23,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),68138,Replication protein A 70 kDa DNA-binding subunit OS=Homo sapiens OX=9606 GN=RPA1 PE=1 SV=2
532,5221,sp|O43707|ACTN4_HUMAN,16.62,203.90,1.611E7,1.477E7,1.87E7,2.183E7,1.00,0.92,1.16,1.35,1.611E7,1.477E7,1.87E7,2.183E7,1.00,0.92,1.16,1.35,24,28,19,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),104854,Alpha-actinin-4 OS=Homo sapiens OX=9606 GN=ACTN4 PE=1 SV=2
550,5837,sp|P08238|HS90B_HUMAN,13.69,203.87,5.751E6,5.586E6,6.98E6,7.398E6,1.00,0.97,1.21,1.29,5.751E6,5.586E6,6.98E6,7.398E6,1.00,0.97,1.21,1.29,17,21,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),83264,Heat shock protein HSP 90-beta OS=Homo sapiens OX=9606 GN=HSP90AB1 PE=1 SV=4
459,11276,sp|Q76M96|CCD80_HUMAN,9.46,203.22,3.331E7,3.377E7,4.732E7,4.586E7,1.00,1.01,1.42,1.38,3.331E7,3.377E7,4.732E7,4.586E7,1.00,1.01,1.42,1.38,30,27,27,iTRAQ 4plex (K  N-term); Deamidation (NQ),108174,Coiled-coil domain-containing protein 80 OS=Homo sapiens OX=9606 GN=CCDC80 PE=1 SV=1
348,207,sp|Q96HP0|DOCK6_HUMAN,24.03,203.00,1.357E7,1.352E7,2.324E7,2.283E7,1.00,1.00,1.71,1.68,1.357E7,1.352E7,2.324E7,2.283E7,1.00,1.00,1.71,1.68,15,36,26,iTRAQ 4plex (K  N-term); Deamidation (NQ),229556,Dedicator of cytokinesis protein 6 OS=Homo sapiens OX=9606 GN=DOCK6 PE=1 SV=3
546,6229,sp|Q96HC4|PDLI5_HUMAN,86.98,202.53,1.109E7,1.131E7,2.547E7,2.479E7,1.00,1.02,2.30,2.24,1.109E7,1.131E7,2.547E7,2.479E7,1.00,1.02,2.30,2.24,39,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),63945,PDZ and LIM domain protein 5 OS=Homo sapiens OX=9606 GN=PDLIM5 PE=1 SV=5
424,2082,sp|Q6NYC8|PPR18_HUMAN,83.94,202.21,1.8E7,1.81E7,3.859E7,4.068E7,1.00,1.01,2.14,2.26,1.8E7,1.81E7,3.859E7,4.068E7,1.00,1.01,2.14,2.26,46,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),67943,Phostensin OS=Homo sapiens OX=9606 GN=PPP1R18 PE=1 SV=1
511,5132,sp|Q9Y5V3|MAGD1_HUMAN,119.46,202.19,1.013E7,1.062E7,2.716E7,2.649E7,1.00,1.05,2.68,2.62,1.013E7,1.062E7,2.716E7,2.649E7,1.00,1.05,2.68,2.62,31,19,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),86161,Melanoma-associated antigen D1 OS=Homo sapiens OX=9606 GN=MAGED1 PE=1 SV=3
453,3884,sp|Q9BZH6|WDR11_HUMAN,9.82,202.18,2.691E7,2.739E7,3.69E7,3.626E7,1.00,1.02,1.37,1.35,2.691E7,2.739E7,3.69E7,3.626E7,1.00,1.02,1.37,1.35,23,27,27,iTRAQ 4plex (K  N-term); Deamidation (NQ),136685,WD repeat-containing protein 11 OS=Homo sapiens OX=9606 GN=WDR11 PE=1 SV=1
380,1897,sp|Q8WUM4|PDC6I_HUMAN,54.67,202.11,2.714E7,2.602E7,5.447E7,5.364E7,1.00,0.96,2.01,1.98,2.714E7,2.602E7,5.447E7,5.364E7,1.00,0.96,2.01,1.98,36,31,30,iTRAQ 4plex (K  N-term); Deamidation (NQ),96023,Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1
273,13135,sp|P68371|TBB4B_HUMAN,2.09,202.01,1.102E6,1.155E6,2.132E6,1.999E6,1.00,1.05,1.93,1.81,1.102E6,1.155E6,2.132E6,1.999E6,1.00,1.05,1.93,1.81,3,26,1,iTRAQ 4plex (K  N-term),49831,Tubulin beta-4B chain OS=Homo sapiens OX=9606 GN=TUBB4B PE=1 SV=1
514,1053,sp|Q92974-3|ARHG2_HUMAN,29.21,201.75,1.704E7,1.673E7,2.76E7,2.728E7,1.00,0.98,1.62,1.60,1.704E7,1.673E7,2.76E7,2.728E7,1.00,0.98,1.62,1.60,31,26,26,iTRAQ 4plex (K  N-term); Deamidation (NQ),108242,Isoform 3 of Rho guanine nucleotide exchange factor 2 OS=Homo sapiens OX=9606 GN=ARHGEF2
762,19993,sp|Q9Y4G8|RPGF2_HUMAN,83.19,201.61,4.988E6,5.176E6,1.342E7,1.308E7,1.00,1.04,2.69,2.62,4.988E6,5.176E6,1.342E7,1.308E7,1.00,1.04,2.69,2.62,14,22,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),167416,Rap guanine nucleotide exchange factor 2 OS=Homo sapiens OX=9606 GN=RAPGEF2 PE=1 SV=1
449,5545,sp|Q9BUF5|TBB6_HUMAN,57.85,201.51,1.449E6,1.578E6,2.817E6,2.708E6,1.00,1.09,1.94,1.87,1.449E6,1.578E6,2.817E6,2.708E6,1.00,1.09,1.94,1.87,15,20,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),49857,Tubulin beta-6 chain OS=Homo sapiens OX=9606 GN=TUBB6 PE=1 SV=1
393,6907,sp|O43390|HNRPR_HUMAN,36.66,201.27,2.022E7,2.104E7,3.578E7,3.551E7,1.00,1.04,1.77,1.76,2.022E7,2.104E7,3.578E7,3.551E7,1.00,1.04,1.77,1.76,30,21,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),70943,Heterogeneous nuclear ribonucleoprotein R OS=Homo sapiens OX=9606 GN=HNRNPR PE=1 SV=1
231,11606,sp|Q8NC51-4|PAIRB_HUMAN,5.29,201.22,1.102E5,1.152E5,1.968E5,1.694E5,1.00,1.05,1.79,1.54,1.102E5,1.152E5,1.968E5,1.694E5,1.00,1.05,1.79,1.54,11,21,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),42427,Isoform 4 of Plasminogen activator inhibitor 1 RNA-binding protein OS=Homo sapiens OX=9606 GN=SERBP1
420,14185,sp|O43148|MCES_HUMAN,60.29,201.05,2.163E7,2.262E7,4.27E7,4.046E7,1.00,1.05,1.97,1.87,2.163E7,2.262E7,4.27E7,4.046E7,1.00,1.05,1.97,1.87,46,21,21,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),54844,mRNA cap guanine-N7 methyltransferase OS=Homo sapiens OX=9606 GN=RNMT PE=1 SV=1
392,19462,sp|Q53EP0|FND3B_HUMAN,66.78,201.02,2.371E7,2.444E7,5.347E7,5.127E7,1.00,1.03,2.26,2.16,2.371E7,2.444E7,5.347E7,5.127E7,1.00,1.03,2.26,2.16,27,29,29,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),132888,Fibronectin type III domain-containing protein 3B OS=Homo sapiens OX=9606 GN=FNDC3B PE=1 SV=2
639,20081,sp|Q658Y4|F91A1_HUMAN,67.03,199.97,1.992E7,2.123E7,4.096E7,3.889E7,1.00,1.07,2.06,1.95,1.992E7,2.123E7,4.096E7,3.889E7,1.00,1.07,2.06,1.95,29,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),93909,Protein FAM91A1 OS=Homo sapiens OX=9606 GN=FAM91A1 PE=1 SV=3
577,24276,sp|Q8NE71|ABCF1_HUMAN,14.79,199.96,6.4E6,6.371E6,8.782E6,9.102E6,1.00,1.00,1.37,1.42,6.4E6,6.371E6,8.782E6,9.102E6,1.00,1.00,1.37,1.42,13,22,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),95926,ATP-binding cassette sub-family F member 1 OS=Homo sapiens OX=9606 GN=ABCF1 PE=1 SV=2
534,2810,sp|Q92922|SMRC1_HUMAN,16.04,199.75,1.33E7,1.387E7,1.933E7,1.913E7,1.00,1.04,1.45,1.44,1.33E7,1.387E7,1.933E7,1.913E7,1.00,1.04,1.45,1.44,21,30,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),122867,SWI/SNF complex subunit SMARCC1 OS=Homo sapiens OX=9606 GN=SMARCC1 PE=1 SV=3
276,9012,sp|P07237|PDIA1_HUMAN,21.49,199.46,6.973E7,6.613E7,9.967E7,9.957E7,1.00,0.95,1.43,1.43,6.973E7,6.613E7,9.967E7,9.957E7,1.00,0.95,1.43,1.43,58,30,30,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),57116,Protein disulfide-isomerase OS=Homo sapiens OX=9606 GN=P4HB PE=1 SV=3
463,38736,sp|Q16891-2|MIC60_HUMAN,12.54,199.45,2.251E7,2.236E7,2.808E7,3.073E7,1.00,0.99,1.25,1.36,2.251E7,2.236E7,2.808E7,3.073E7,1.00,0.99,1.25,1.36,39,32,32,iTRAQ 4plex (K  N-term); Deamidation (NQ),82625,Isoform 2 of MICOS complex subunit MIC60 OS=Homo sapiens OX=9606 GN=IMMT
252,10264,sp|P35637-2|FUS_HUMAN,11.39,199.35,9.606E7,1.027E8,1.232E8,1.209E8,1.00,1.07,1.28,1.26,9.606E7,1.027E8,1.232E8,1.209E8,1.00,1.07,1.28,1.26,26,14,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),53355,Isoform Short of RNA-binding protein FUS OS=Homo sapiens OX=9606 GN=FUS
627,3887,sp|A6NHR9-2|SMHD1_HUMAN,31.30,199.07,8.39E6,8.552E6,1.493E7,1.487E7,1.00,1.02,1.78,1.77,8.39E6,8.552E6,1.493E7,1.487E7,1.00,1.02,1.78,1.77,16,26,26,iTRAQ 4plex (K  N-term); Deamidation (NQ),215744,Isoform 2 of Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SMCHD1
568,1924,E9PDP5|E9PDP5_HUMAN,3.00,199.06,3.039E5,2.838E5,7.035E5,6.855E5,1.00,0.93,2.31,2.26,3.039E5,2.838E5,7.035E5,6.855E5,1.00,0.93,2.31,2.26,1,22,1,iTRAQ 4plex (K  N-term),166743,Ankyrin repeat and KH domain-containing protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1
533,1417,sp|O00443|P3C2A_HUMAN,27.60,198.72,1.537E7,1.476E7,2.422E7,2.465E7,1.00,0.96,1.58,1.60,1.537E7,1.476E7,2.422E7,2.465E7,1.00,0.96,1.58,1.60,20,29,28,iTRAQ 4plex (K  N-term); Deamidation (NQ),190678,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha OS=Homo sapiens OX=9606 GN=PIK3C2A PE=1 SV=2
609,4827,sp|Q7Z5H3-2|RHG22_HUMAN,88.27,198.66,8.652E6,8.718E6,2E7,1.932E7,1.00,1.01,2.31,2.23,8.652E6,8.718E6,2E7,1.932E7,1.00,1.01,2.31,2.23,31,21,21,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),78497,Isoform 2 of Rho GTPase-activating protein 22 OS=Homo sapiens OX=9606 GN=ARHGAP22
324,26854,sp|P28300|LYOX_HUMAN,54.72,198.52,2.456E7,2.54E7,4.678E7,4.442E7,1.00,1.03,1.90,1.81,2.456E7,2.54E7,4.678E7,4.442E7,1.00,1.03,1.90,1.81,47,20,20,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),46944,Protein-lysine 6-oxidase OS=Homo sapiens OX=9606 GN=LOX PE=1 SV=2
455,1280,sp|Q9UKV8|AGO2_HUMAN,11.59,198.39,2.337E7,2.435E7,3.075E7,2.927E7,1.00,1.04,1.32,1.25,2.337E7,2.435E7,3.075E7,2.927E7,1.00,1.04,1.32,1.25,26,23,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),97208,Protein argonaute-2 OS=Homo sapiens OX=9606 GN=AGO2 PE=1 SV=3
267,4194,gi|1351907|sp|P02769.4|ALBU_BOVIN,5.87,197.93,1.127E8,1.149E8,8.342E7,7.875E7,1.00,1.02,0.74,0.70,1.127E8,1.149E8,8.342E7,7.875E7,1.00,1.02,0.74,0.70,28,26,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),69294,Serum albumin - Bos taurus (Bovine).
369,1249,A0A2R8Y5C4|A0A2R8Y5C4_HUMAN,1.34,197.88,3.217E6,3.097E6,4.881E6,4.846E6,1.00,0.96,1.52,1.51,3.217E6,3.097E6,4.881E6,4.846E6,1.00,0.96,1.52,1.51,3,20,1,iTRAQ 4plex (K  N-term),30925,182 kDa tankyrase-1-binding protein (Fragment) OS=Homo sapiens OX=9606 GN=TNKS1BP1 PE=1 SV=1
523,5162,sp|Q9H9G7|AGO3_HUMAN,12.60,197.69,1.203E7,1.211E7,1.687E7,1.584E7,1.00,1.01,1.40,1.32,1.203E7,1.211E7,1.687E7,1.584E7,1.00,1.01,1.40,1.32,19,24,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),97360,Protein argonaute-3 OS=Homo sapiens OX=9606 GN=AGO3 PE=1 SV=2
250,8327,sp|O15372|EIF3H_HUMAN,137.19,197.64,5.586E7,5.843E7,1.615E8,1.519E8,1.00,1.05,2.89,2.72,5.586E7,5.843E7,1.615E8,1.519E8,1.00,1.05,2.89,2.72,57,24,24,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),39930,Eukaryotic translation initiation factor 3 subunit H OS=Homo sapiens OX=9606 GN=EIF3H PE=1 SV=1
412,1937,sp|Q14240|IF4A2_HUMAN,98.54,197.63,9.569E6,9.033E6,2.702E7,2.491E7,1.00,0.94,2.82,2.60,9.569E6,9.033E6,2.702E7,2.491E7,1.00,0.94,2.82,2.60,16,21,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),46402,Eukaryotic initiation factor 4A-II OS=Homo sapiens OX=9606 GN=EIF4A2 PE=1 SV=2
512,3748,sp|Q8TAQ2-2|SMRC2_HUMAN,8.65,197.60,9.26E6,9.416E6,1.199E7,1.166E7,1.00,1.02,1.30,1.26,9.26E6,9.416E6,1.199E7,1.166E7,1.00,1.02,1.30,1.26,18,25,17,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),124841,Isoform 2 of SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2
370,11456,sp|P08621|RU17_HUMAN,20.85,197.47,3.879E7,3.442E7,4.965E7,4.834E7,1.00,0.89,1.28,1.25,3.879E7,3.442E7,4.965E7,4.834E7,1.00,0.89,1.28,1.25,46,18,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),51557,U1 small nuclear ribonucleoprotein 70 kDa OS=Homo sapiens OX=9606 GN=SNRNP70 PE=1 SV=2
59,6309,sp|Q9BYX7|ACTBM_HUMAN,2.07,196.82,1.543E6,1.426E6,2.007E6,1.452E6,1.00,0.92,1.30,0.94,1.543E6,1.426E6,2.007E6,1.452E6,1.00,0.92,1.30,0.94,10,32,2,iTRAQ 4plex (K  N-term); Oxidation (M); Phosphorylation (STY),42016,Putative beta-actin-like protein 3 OS=Homo sapiens OX=9606 GN=POTEKP PE=5 SV=1
239,5088,sp|P0DMV8|HS71A_HUMAN,23.96,196.78,5.07E6,4.797E6,8.336E6,8.239E6,1.00,0.95,1.64,1.62,5.07E6,4.797E6,8.336E6,8.239E6,1.00,0.95,1.64,1.62,13,26,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),70052,Heat shock 70 kDa protein 1A OS=Homo sapiens OX=9606 GN=HSPA1A PE=1 SV=1
596,1662,sp|Q69YQ0-2|CYTSA_HUMAN,18.49,196.62,1.031E7,9.943E6,1.267E7,1.464E7,1.00,0.96,1.23,1.42,1.031E7,9.943E6,1.267E7,1.464E7,1.00,0.96,1.23,1.42,25,25,25,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),120182,Isoform 2 of Cytospin-A OS=Homo sapiens OX=9606 GN=SPECC1L
682,2134,sp|P56945-5|BCAR1_HUMAN,68.32,196.62,7.517E6,7.667E6,1.697E7,1.666E7,1.00,1.02,2.26,2.22,7.517E6,7.667E6,1.697E7,1.666E7,1.00,1.02,2.26,2.22,30,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),93137,Isoform 5 of Breast cancer anti-estrogen resistance protein 1 OS=Homo sapiens OX=9606 GN=BCAR1
844,1752,sp|Q5TC82|RC3H1_HUMAN,41.19,196.52,5.68E6,5.795E6,9.83E6,9.507E6,1.00,1.02,1.73,1.67,5.68E6,5.795E6,9.83E6,9.507E6,1.00,1.02,1.73,1.67,17,15,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),125736,Roquin-1 OS=Homo sapiens OX=9606 GN=RC3H1 PE=1 SV=1
808,10683,sp|P0CG12|CTF8A_HUMAN,200.00,196.21,5.332E6,5.521E6,1.865E7,1.871E7,1.00,1.04,3.50,3.51,5.332E6,5.521E6,1.865E7,1.871E7,1.00,1.04,3.50,3.51,39,15,15,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),51391,Chromosome transmission fidelity protein 8 homolog isoform 2 OS=Homo sapiens OX=9606 GN=CHTF8 PE=1 SV=1
583,19289,sp|Q14847|LASP1_HUMAN,123.89,195.80,1.151E7,1.18E7,3.145E7,3.062E7,1.00,1.03,2.73,2.66,1.151E7,1.18E7,3.145E7,3.062E7,1.00,1.03,2.73,2.66,57,15,15,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),29717,LIM and SH3 domain protein 1 OS=Homo sapiens OX=9606 GN=LASP1 PE=1 SV=2
307,8853,E7EMB3|E7EMB3_HUMAN,11.14,195.30,2.089E8,1.956E8,1.993E8,2.499E8,1.00,0.94,0.95,1.20,2.089E8,1.956E8,1.993E8,2.499E8,1.00,0.94,0.95,1.20,55,15,15,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),21689,Calmodulin-2 OS=Homo sapiens OX=9606 GN=CALM2 PE=1 SV=1
363,11969,D6R938|D6R938_HUMAN,36.31,195.26,2.733E7,2.87E7,4.584E7,4.477E7,1.00,1.05,1.68,1.64,2.733E7,2.87E7,4.584E7,4.477E7,1.00,1.05,1.68,1.64,27,21,13,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),56298,Calcium/calmodulin-dependent protein kinase (CaM kinase) II delta  isoform CRA_e OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=1
653,8246,H7C269|H7C269_HUMAN,0.77,194.63,8.309E4,8.244E4,1.042E5,1.091E5,1.00,0.99,1.25,1.31,8.309E4,8.244E4,1.042E5,1.091E5,1.00,0.99,1.25,1.31,1,21,1,iTRAQ 4plex (K  N-term),98630,Trinucleotide repeat-containing gene 6A protein (Fragment) OS=Homo sapiens OX=9606 GN=TNRC6A PE=1 SV=1
37,196,sp|Q7Z406|MYH14_HUMAN,3.18,194.56,1.734E6,1.677E6,1.868E6,2.029E6,1.00,0.97,1.08,1.17,1.734E6,1.677E6,1.868E6,2.029E6,1.00,0.97,1.08,1.17,2,35,3,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),227868,Myosin-14 OS=Homo sapiens OX=9606 GN=MYH14 PE=1 SV=2
707,17474,sp|Q14112-2|NID2_HUMAN,7.98,193.87,1.424E7,1.361E7,1.694E7,1.692E7,1.00,0.96,1.19,1.19,1.424E7,1.361E7,1.694E7,1.692E7,1.00,0.96,1.19,1.19,19,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),140866,Isoform 2 of Nidogen-2 OS=Homo sapiens OX=9606 GN=NID2
192,4346,sp|Q8NCA5-2|FA98A_HUMAN,13.72,193.82,6.946E7,7.119E7,9.32E7,8.42E7,1.00,1.02,1.34,1.21,6.946E7,7.119E7,9.32E7,8.42E7,1.00,1.02,1.34,1.21,30,22,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),55272,Isoform 2 of Protein FAM98A OS=Homo sapiens OX=9606 GN=FAM98A
509,8330,sp|Q8N3C0|ASCC3_HUMAN,16.25,193.70,2.323E7,2.325E7,3.601E7,3.605E7,1.00,1.00,1.55,1.55,2.323E7,2.325E7,3.601E7,3.605E7,1.00,1.00,1.55,1.55,15,36,36,iTRAQ 4plex (K  N-term),251458,Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens OX=9606 GN=ASCC3 PE=1 SV=3
655,581,H0Y3K4|H0Y3K4_HUMAN,5.83,193.47,5.516E5,6.039E5,9.295E5,9.258E5,1.00,1.09,1.69,1.68,5.516E5,6.039E5,9.295E5,9.258E5,1.00,1.09,1.69,1.68,2,18,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),100364,RNA-binding protein 33 (Fragment) OS=Homo sapiens OX=9606 GN=RBM33 PE=1 SV=1
510,4546,sp|Q9NTZ6|RBM12_HUMAN,79.89,193.45,1.233E7,1.244E7,3.144E7,3.035E7,1.00,1.01,2.55,2.46,1.233E7,1.244E7,3.144E7,3.035E7,1.00,1.01,2.55,2.46,28,21,21,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),97396,RNA-binding protein 12 OS=Homo sapiens OX=9606 GN=RBM12 PE=1 SV=1
636,7866,sp|O75962-4|TRIO_HUMAN,38.77,193.23,6.488E6,6.274E6,1.181E7,1.152E7,1.00,0.97,1.82,1.78,6.488E6,6.274E6,1.181E7,1.152E7,1.00,0.97,1.82,1.78,11,30,30,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),341599,Isoform 4 of Triple functional domain protein OS=Homo sapiens OX=9606 GN=TRIO
454,2431,sp|Q15459|SF3A1_HUMAN,32.25,193.16,2.036E7,2.018E7,3.317E7,3.256E7,1.00,0.99,1.63,1.60,2.036E7,2.018E7,3.317E7,3.256E7,1.00,0.99,1.63,1.60,28,22,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),88886,Splicing factor 3A subunit 1 OS=Homo sapiens OX=9606 GN=SF3A1 PE=1 SV=1
361,19864,sp|Q9BYJ9|YTHD1_HUMAN,63.86,192.98,7.721E6,7.559E6,1.525E7,1.497E7,1.00,0.98,1.98,1.94,7.721E6,7.559E6,1.525E7,1.497E7,1.00,0.98,1.98,1.94,25,17,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),60874,YTH domain-containing family protein 1 OS=Homo sapiens OX=9606 GN=YTHDF1 PE=1 SV=1
749,3217,sp|Q5JRA6|TGO1_HUMAN,40.87,192.86,5.025E6,5.063E6,9.965E6,9.591E6,1.00,1.01,1.98,1.91,5.025E6,5.063E6,9.965E6,9.591E6,1.00,1.01,1.98,1.91,15,22,22,iTRAQ 4plex (K  N-term); Deamidation (NQ),213700,Transport and Golgi organization protein 1 homolog OS=Homo sapiens OX=9606 GN=MIA3 PE=1 SV=1
301,12309,sp|P39023|RL3_HUMAN,14.44,192.73,7.932E7,7.875E7,1.015E8,1.129E8,1.00,0.99,1.28,1.42,7.932E7,7.875E7,1.015E8,1.129E8,1.00,0.99,1.28,1.42,17,20,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),46109,60S ribosomal protein L3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2
518,1293,sp|Q9Y4F5-2|C170B_HUMAN,40.46,192.67,6.789E6,6.759E6,1.291E7,1.258E7,1.00,1.00,1.90,1.85,6.789E6,6.759E6,1.291E7,1.258E7,1.00,1.00,1.90,1.85,19,27,25,iTRAQ 4plex (K  N-term); Deamidation (NQ),167713,Isoform 2 of Centrosomal protein of 170 kDa protein B OS=Homo sapiens OX=9606 GN=CEP170B
684,18860,sp|Q9NZN8|CNOT2_HUMAN,3.04,192.66,2.076E5,2.544E5,5.161E5,4.834E5,1.00,1.23,2.49,2.33,2.076E5,2.544E5,5.161E5,4.834E5,1.00,1.23,2.49,2.33,2,15,1,iTRAQ 4plex (K  N-term),59738,CCR4-NOT transcription complex subunit 2 OS=Homo sapiens OX=9606 GN=CNOT2 PE=1 SV=1
465,674,sp|O60313|OPA1_HUMAN,8.08,192.53,2.471E7,2.515E7,3.152E7,3.111E7,1.00,1.02,1.28,1.26,2.471E7,2.515E7,3.152E7,3.111E7,1.00,1.02,1.28,1.26,30,30,30,iTRAQ 4plex (K  N-term); Deamidation (NQ),111630,Dynamin-like 120 kDa protein  mitochondrial OS=Homo sapiens OX=9606 GN=OPA1 PE=1 SV=3
381,5052,sp|Q13425|SNTB2_HUMAN,58.36,192.45,3.633E7,3.754E7,7.084E7,6.776E7,1.00,1.03,1.95,1.87,3.633E7,3.754E7,7.084E7,6.776E7,1.00,1.03,1.95,1.87,39,20,18,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),57950,Beta-2-syntrophin OS=Homo sapiens OX=9606 GN=SNTB2 PE=1 SV=1
566,4054,sp|Q86W92-4|LIPB1_HUMAN,42.44,192.32,7.202E6,7.243E6,1.361E7,1.39E7,1.00,1.01,1.89,1.93,7.202E6,7.243E6,1.361E7,1.39E7,1.00,1.01,1.89,1.93,28,24,24,iTRAQ 4plex (K  N-term); Deamidation (NQ),110297,Isoform 4 of Liprin-beta-1 OS=Homo sapiens OX=9606 GN=PPFIBP1
437,3159,sp|P33176|KINH_HUMAN,26.16,192.25,7.802E6,7.868E6,1.283E7,1.281E7,1.00,1.01,1.64,1.64,7.802E6,7.868E6,1.283E7,1.281E7,1.00,1.01,1.64,1.64,26,23,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),109685,Kinesin-1 heavy chain OS=Homo sapiens OX=9606 GN=KIF5B PE=1 SV=1
813,4924,sp|Q9UBC2|EP15R_HUMAN,52.78,192.23,4.109E6,4.093E6,8.485E6,8.11E6,1.00,1.00,2.06,1.97,4.109E6,4.093E6,8.485E6,8.11E6,1.00,1.00,2.06,1.97,31,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),94255,Epidermal growth factor receptor substrate 15-like 1 OS=Homo sapiens OX=9606 GN=EPS15L1 PE=1 SV=1
29,102,sp|Q562R1|ACTBL_HUMAN,4.73,192.11,1.524E7,1.578E7,1.58E7,1.935E7,1.00,1.04,1.04,1.27,1.524E7,1.578E7,1.58E7,1.935E7,1.00,1.04,1.04,1.27,19,37,6,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),42003,Beta-actin-like protein 2 OS=Homo sapiens OX=9606 GN=ACTBL2 PE=1 SV=2
593,1370,sp|Q00537-2|CDK17_HUMAN,87.42,192.08,1.772E7,1.793E7,4.078E7,4.049E7,1.00,1.01,2.30,2.29,1.772E7,1.793E7,4.078E7,4.049E7,1.00,1.01,2.30,2.29,36,18,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),59531,Isoform 2 of Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17
750,1614,sp|P39060-2|COIA1_HUMAN,15.97,192.01,1.632E7,1.665E7,2.225E7,2.135E7,1.00,1.02,1.36,1.31,1.632E7,1.665E7,2.225E7,2.135E7,1.00,1.02,1.36,1.31,16,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),135761,Isoform 3 of Collagen alpha-1(XVIII) chain OS=Homo sapiens OX=9606 GN=COL18A1
575,173,sp|Q9Y490|TLN1_HUMAN,16.08,191.97,8.507E6,8.049E6,1.212E7,1.239E7,1.00,0.95,1.42,1.46,8.507E6,8.049E6,1.212E7,1.239E7,1.00,0.95,1.42,1.46,13,34,30,iTRAQ 4plex (K  N-term); Deamidation (NQ),269765,Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3
621,350,sp|Q96EV2|RBM33_HUMAN,9.41,191.75,1.305E6,1.372E6,1.838E6,1.788E6,1.00,1.05,1.41,1.37,1.305E6,1.372E6,1.838E6,1.788E6,1.00,1.05,1.41,1.37,7,20,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),129986,RNA-binding protein 33 OS=Homo sapiens OX=9606 GN=RBM33 PE=1 SV=3
696,1238,sp|O95793-2|STAU1_HUMAN,29.00,191.68,1.025E7,1.035E7,1.588E7,1.604E7,1.00,1.01,1.55,1.56,1.025E7,1.035E7,1.588E7,1.604E7,1.00,1.01,1.55,1.56,33,15,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),54934,Isoform Short of Double-stranded RNA-binding protein Staufen homolog 1 OS=Homo sapiens OX=9606 GN=STAU1
480,2874,sp|Q9NYF8-2|BCLF1_HUMAN,14.80,191.59,1.508E7,1.481E7,2.101E7,2.121E7,1.00,0.98,1.39,1.41,1.508E7,1.481E7,2.101E7,2.121E7,1.00,0.98,1.39,1.41,27,23,23,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),105948,Isoform 2 of Bcl-2-associated transcription factor 1 OS=Homo sapiens OX=9606 GN=BCLAF1
771,10663,B4DGM3|B4DGM3_HUMAN,13.72,191.56,8.415E6,8.827E6,1.115E7,1.097E7,1.00,1.05,1.32,1.30,8.415E6,8.827E6,1.115E7,1.097E7,1.00,1.05,1.32,1.30,46,15,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),44770,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 OS=Homo sapiens OX=9606 GN=SMARCE1 PE=1 SV=1
715,38721,sp|Q12929|EPS8_HUMAN,70.00,191.13,5.675E6,5.82E6,1.449E7,1.398E7,1.00,1.03,2.55,2.46,5.675E6,5.82E6,1.449E7,1.398E7,1.00,1.03,2.55,2.46,30,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),91882,Epidermal growth factor receptor kinase substrate 8 OS=Homo sapiens OX=9606 GN=EPS8 PE=1 SV=1
640,1604,sp|P14618|KPYM_HUMAN,17.06,191.13,1.878E7,1.824E7,2.508E7,2.521E7,1.00,0.97,1.34,1.34,1.878E7,1.824E7,2.508E7,2.521E7,1.00,0.97,1.34,1.34,37,18,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),57937,Pyruvate kinase PKM OS=Homo sapiens OX=9606 GN=PKM PE=1 SV=4
547,9719,sp|Q9UPN6|SCAF8_HUMAN,28.44,191.07,7.777E6,7.805E6,1.412E7,1.372E7,1.00,1.00,1.82,1.76,7.777E6,7.805E6,1.412E7,1.372E7,1.00,1.00,1.82,1.76,18,23,19,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),140519,Protein SCAF8 OS=Homo sapiens OX=9606 GN=SCAF8 PE=1 SV=1
428,7867,sp|Q9BXP5-5|SRRT_HUMAN,64.37,190.56,1.765E7,1.71E7,3.758E7,3.668E7,1.00,0.97,2.13,2.08,1.765E7,1.71E7,3.758E7,3.668E7,1.00,0.97,2.13,2.08,27,25,25,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),96223,Isoform 5 of Serrate RNA effector molecule homolog OS=Homo sapiens OX=9606 GN=SRRT
663,4726,sp|Q8NEY1-2|NAV1_HUMAN,34.97,190.52,5.577E6,5.648E6,1.09E7,1.05E7,1.00,1.01,1.95,1.88,5.577E6,5.648E6,1.09E7,1.05E7,1.00,1.01,1.95,1.88,15,22,22,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),201509,Isoform 2 of Neuron navigator 1 OS=Homo sapiens OX=9606 GN=NAV1
299,821,sp|Q5T9A4|ATD3B_HUMAN,4.20,190.42,1.63E6,1.742E6,2.472E6,2.431E6,1.00,1.07,1.52,1.49,1.63E6,1.742E6,2.472E6,2.431E6,1.00,1.07,1.52,1.49,4,25,2,iTRAQ 4plex (K  N-term),72573,ATPase family AAA domain-containing protein 3B OS=Homo sapiens OX=9606 GN=ATAD3B PE=1 SV=1
597,38725,sp|Q9NUQ6|SPS2L_HUMAN,20.49,190.41,2.398E6,2.317E6,3.784E6,3.71E6,1.00,0.97,1.58,1.55,2.398E6,2.317E6,3.784E6,3.71E6,1.00,0.97,1.58,1.55,6,18,3,iTRAQ 4plex (K  N-term),61729,SPATS2-like protein OS=Homo sapiens OX=9606 GN=SPATS2L PE=1 SV=2
338,10070,sp|Q13885|TBB2A_HUMAN,1.74,190.39,9.32E5,9.154E5,1.618E6,1.569E6,1.00,0.98,1.74,1.68,9.32E5,9.154E5,1.618E6,1.569E6,1.00,0.98,1.74,1.68,3,21,1,iTRAQ 4plex (K  N-term),49907,Tubulin beta-2A chain OS=Homo sapiens OX=9606 GN=TUBB2A PE=1 SV=1
702,8135,sp|Q8WUF5|IASPP_HUMAN,128.24,190.19,6.062E6,6.128E6,1.769E7,1.752E7,1.00,1.01,2.92,2.89,6.062E6,6.128E6,1.769E7,1.752E7,1.00,1.01,2.92,2.89,28,18,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),89091,RelA-associated inhibitor OS=Homo sapiens OX=9606 GN=PPP1R13L PE=1 SV=4
589,5119,sp|Q9UL18|AGO1_HUMAN,13.53,190.09,4.99E6,5.176E6,7.421E6,7.126E6,1.00,1.04,1.49,1.43,4.99E6,5.176E6,7.421E6,7.126E6,1.00,1.04,1.49,1.43,15,21,10,iTRAQ 4plex (K  N-term),97214,Protein argonaute-1 OS=Homo sapiens OX=9606 GN=AGO1 PE=1 SV=3
233,13308,sp|Q02878|RL6_HUMAN,20.66,189.77,1.282E8,1.279E8,1.724E8,1.842E8,1.00,1.00,1.35,1.44,1.282E8,1.279E8,1.724E8,1.842E8,1.00,1.00,1.35,1.44,49,20,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),32728,60S ribosomal protein L6 OS=Homo sapiens OX=9606 GN=RPL6 PE=1 SV=3
466,107,C9JZG1|C9JZG1_HUMAN,3.17,189.76,3.699E4,4.04E4,9.213E4,9.635E4,1.00,1.09,2.49,2.60,3.699E4,4.04E4,9.213E4,9.635E4,1.00,1.09,2.49,2.60,19,18,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),33382,Eukaryotic translation initiation factor 3 subunit B (Fragment) OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=1
665,38747,sp|Q3KQU3-4|MA7D1_HUMAN,14.14,189.75,7.492E6,7.591E6,9.64E6,9.982E6,1.00,1.01,1.29,1.33,7.492E6,7.591E6,9.64E6,9.982E6,1.00,1.01,1.29,1.33,30,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),89467,Isoform 4 of MAP7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MAP7D1
713,29614,J3QSU6|J3QSU6_HUMAN,21.86,189.74,8.957E6,8.909E6,1.269E7,1.389E7,1.00,0.99,1.42,1.55,8.957E6,8.909E6,1.269E7,1.389E7,1.00,0.99,1.42,1.55,15,22,22,iTRAQ 4plex (K  N-term); Deamidation (NQ),220851,Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=1
362,19295,sp|O14979-2|HNRDL_HUMAN,56.19,189.62,6.077E7,6.225E7,1.169E8,1.114E8,1.00,1.02,1.92,1.83,6.077E7,6.225E7,1.169E8,1.114E8,1.00,1.02,1.92,1.83,42,16,14,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),33589,Isoform 2 of Heterogeneous nuclear ribonucleoprotein D-like OS=Homo sapiens OX=9606 GN=HNRNPDL
343,19697,sp|P29558-2|RBMS1_HUMAN,5.03,189.36,4.38E5,4.414E5,7.502E5,7.029E5,1.00,1.01,1.71,1.60,4.38E5,4.414E5,7.502E5,7.029E5,1.00,1.01,1.71,1.60,6,13,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),44137,Isoform 2 of RNA-binding motif  single-stranded-interacting protein 1 OS=Homo sapiens OX=9606 GN=RBMS1
685,18859,F8VV52|F8VV52_HUMAN,3.86,189.26,6.033E4,6.594E4,1.64E5,1.869E5,1.00,1.09,2.72,3.10,6.033E4,6.594E4,1.64E5,1.869E5,1.00,1.09,2.72,3.10,3,15,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),58621,CCR4-NOT transcription complex subunit 2 (Fragment) OS=Homo sapiens OX=9606 GN=CNOT2 PE=1 SV=1
634,5927,sp|Q14195-2|DPYL3_HUMAN,42.82,189.09,1.059E7,1.057E7,2.069E7,2.019E7,1.00,1.00,1.95,1.91,1.059E7,1.057E7,2.069E7,2.019E7,1.00,1.00,1.95,1.91,27,19,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),73911,Isoform LCRMP-4 of Dihydropyrimidinase-related protein 3 OS=Homo sapiens OX=9606 GN=DPYSL3
438,6386,sp|Q9NYJ8|TAB2_HUMAN,26.29,188.72,1.086E7,1.105E7,1.739E7,1.649E7,1.00,1.02,1.60,1.52,1.086E7,1.105E7,1.739E7,1.649E7,1.00,1.02,1.60,1.52,34,20,20,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),76494,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 OS=Homo sapiens OX=9606 GN=TAB2 PE=1 SV=1
763,1519,sp|O75427|LRCH4_HUMAN,48.22,188.51,7.903E6,6.978E6,1.272E7,1.192E7,1.00,0.88,1.61,1.51,7.903E6,6.978E6,1.272E7,1.192E7,1.00,0.88,1.61,1.51,32,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),73450,Leucine-rich repeat and calponin homology domain-containing protein 4 OS=Homo sapiens OX=9606 GN=LRCH4 PE=1 SV=2
197,17679,sp|P52597|HNRPF_HUMAN,36.32,188.44,2.585E7,2.72E7,4.325E7,4.201E7,1.00,1.05,1.67,1.62,2.585E7,2.72E7,4.325E7,4.201E7,1.00,1.05,1.67,1.62,30,18,10,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),45672,Heterogeneous nuclear ribonucleoprotein F OS=Homo sapiens OX=9606 GN=HNRNPF PE=1 SV=3
581,2398,sp|O75382-4|TRIM3_HUMAN,34.01,188.37,1.592E7,1.51E7,2.692E7,2.618E7,1.00,0.95,1.69,1.64,1.592E7,1.51E7,2.692E7,2.618E7,1.00,0.95,1.69,1.64,32,21,21,iTRAQ 4plex (K  N-term); Deamidation (NQ),67726,Isoform 4 of Tripartite motif-containing protein 3 OS=Homo sapiens OX=9606 GN=TRIM3
661,907,sp|Q9NXC5|MIO_HUMAN,29.67,188.19,1.948E7,2.038E7,3.18E7,3.13E7,1.00,1.05,1.63,1.61,1.948E7,2.038E7,3.18E7,3.13E7,1.00,1.05,1.63,1.61,27,21,21,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),98584,GATOR complex protein MIOS OS=Homo sapiens OX=9606 GN=MIOS PE=1 SV=2
555,2953,sp|Q86XZ4|SPAS2_HUMAN,35.68,188.18,1.238E7,1.227E7,2.171E7,2.208E7,1.00,0.99,1.75,1.78,1.238E7,1.227E7,2.171E7,2.208E7,1.00,0.99,1.75,1.78,46,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),59545,Spermatogenesis-associated serine-rich protein 2 OS=Homo sapiens OX=9606 GN=SPATS2 PE=1 SV=1
595,1092,sp|Q02388|CO7A1_HUMAN,12.03,188.09,1.043E7,1.051E7,1.433E7,1.397E7,1.00,1.01,1.37,1.34,1.043E7,1.051E7,1.433E7,1.397E7,1.00,1.01,1.37,1.34,11,27,27,iTRAQ 4plex (K  N-term); Deamidation (NQ),295216,Collagen alpha-1(VII) chain OS=Homo sapiens OX=9606 GN=COL7A1 PE=1 SV=2
610,16879,sp|P07814|SYEP_HUMAN,9.94,188.07,9.457E6,9.444E6,1.248E7,1.25E7,1.00,1.00,1.32,1.32,9.457E6,9.444E6,1.248E7,1.25E7,1.00,1.00,1.32,1.32,19,23,23,iTRAQ 4plex (K  N-term); Deamidation (NQ),170590,Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS PE=1 SV=5
548,38724,sp|Q15582|BGH3_HUMAN,24.42,188.03,2.279E7,2.316E7,3.41E7,3.411E7,1.00,1.02,1.50,1.50,2.279E7,2.316E7,3.41E7,3.411E7,1.00,1.02,1.50,1.50,30,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),74681,Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens OX=9606 GN=TGFBI PE=1 SV=1
748,14449,sp|Q15750|TAB1_HUMAN,72.06,188.00,1.208E7,1.231E7,2.559E7,2.501E7,1.00,1.02,2.12,2.07,1.208E7,1.231E7,2.559E7,2.501E7,1.00,1.02,2.12,2.07,43,15,15,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),54644,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Homo sapiens OX=9606 GN=TAB1 PE=1 SV=1
294,11663,sp|P18124|RL7_HUMAN,16.51,187.99,1.204E8,1.193E8,1.529E8,1.638E8,1.00,0.99,1.27,1.36,1.204E8,1.193E8,1.529E8,1.638E8,1.00,0.99,1.27,1.36,50,22,22,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),29226,60S ribosomal protein L7 OS=Homo sapiens OX=9606 GN=RPL7 PE=1 SV=1
637,3213,sp|O75694|NU155_HUMAN,11.92,187.61,1.13E7,1.157E7,1.548E7,1.512E7,1.00,1.02,1.37,1.34,1.13E7,1.157E7,1.548E7,1.512E7,1.00,1.02,1.37,1.34,17,20,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),155199,Nuclear pore complex protein Nup155 OS=Homo sapiens OX=9606 GN=NUP155 PE=1 SV=1
468,6482,sp|P05997|CO5A2_HUMAN,16.99,187.41,2.078E7,2.052E7,2.714E7,2.852E7,1.00,0.99,1.31,1.37,2.078E7,2.052E7,2.714E7,2.852E7,1.00,0.99,1.31,1.37,16,21,19,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),144910,Collagen alpha-2(V) chain OS=Homo sapiens OX=9606 GN=COL5A2 PE=1 SV=3
240,10921,sp|Q5VTE0|EF1A3_HUMAN,44.86,187.37,1.4E8,1.403E8,2.487E8,2.49E8,1.00,1.00,1.78,1.78,1.4E8,1.403E8,2.487E8,2.49E8,1.00,1.00,1.78,1.78,39,21,21,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),50185,Putative elongation factor 1-alpha-like 3 OS=Homo sapiens OX=9606 GN=EEF1A1P5 PE=5 SV=1
680,6013,sp|P49792|RBP2_HUMAN,46.39,187.26,9.798E6,9.905E6,2.164E7,2.121E7,1.00,1.01,2.21,2.16,9.798E6,9.905E6,2.164E7,2.121E7,1.00,1.01,2.21,2.16,9,27,26,iTRAQ 4plex (K  N-term); Deamidation (NQ),358201,E3 SUMO-protein ligase RanBP2 OS=Homo sapiens OX=9606 GN=RANBP2 PE=1 SV=2
426,8791,sp|Q8N684-3|CPSF7_HUMAN,121.06,187.20,2.41E7,2.513E7,6.505E7,6.277E7,1.00,1.04,2.70,2.60,2.41E7,2.513E7,6.505E7,6.277E7,1.00,1.04,2.70,2.60,32,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),56375,Isoform 3 of Cleavage and polyadenylation specificity factor subunit 7 OS=Homo sapiens OX=9606 GN=CPSF7
544,20530,sp|P42704|LPPRC_HUMAN,30.41,187.06,1.112E7,1.112E7,1.969E7,1.915E7,1.00,1.00,1.77,1.72,1.112E7,1.112E7,1.969E7,1.915E7,1.00,1.00,1.77,1.72,19,25,25,iTRAQ 4plex (K  N-term); Deamidation (NQ),157904,Leucine-rich PPR motif-containing protein  mitochondrial OS=Homo sapiens OX=9606 GN=LRPPRC PE=1 SV=3
516,23440,sp|P20042|IF2B_HUMAN,16.97,187.00,2.318E7,1.874E7,2.587E7,2.676E7,1.00,0.81,1.12,1.15,2.318E7,1.874E7,2.587E7,2.676E7,1.00,0.81,1.12,1.15,52,18,18,iTRAQ 4plex (K  N-term); Acetylation (Protein N-term); Deamidation (NQ); Phosphorylation (STY),38388,Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2
699,666,sp|O00267-2|SPT5H_HUMAN,55.78,186.57,6.092E6,6.173E6,1.452E7,1.385E7,1.00,1.01,2.38,2.27,6.092E6,6.173E6,1.452E7,1.385E7,1.00,1.01,2.38,2.27,28,22,22,iTRAQ 4plex (K  N-term); Deamidation (NQ),120499,Isoform 2 of Transcription elongation factor SPT5 OS=Homo sapiens OX=9606 GN=SUPT5H
497,4810,sp|P10809|CH60_HUMAN,19.88,186.52,2.531E7,2.559E7,3.612E7,3.517E7,1.00,1.01,1.43,1.39,2.531E7,2.559E7,3.612E7,3.517E7,1.00,1.01,1.43,1.39,36,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),61055,60 kDa heat shock protein  mitochondrial OS=Homo sapiens OX=9606 GN=HSPD1 PE=1 SV=2
433,918,sp|Q96II8|LRCH3_HUMAN,25.27,186.46,1.61E7,1.604E7,2.632E7,2.544E7,1.00,1.00,1.63,1.58,1.61E7,1.604E7,2.632E7,2.544E7,1.00,1.00,1.63,1.58,25,21,20,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),86083,Leucine-rich repeat and calponin homology domain-containing protein 3 OS=Homo sapiens OX=9606 GN=LRCH3 PE=1 SV=2
358,19698,sp|P29558|RBMS1_HUMAN,2.34,186.38,1.577E5,1.788E5,3.331E5,3.07E5,1.00,1.13,2.11,1.95,1.577E5,1.788E5,3.331E5,3.07E5,1.00,1.13,2.11,1.95,6,13,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),44505,RNA-binding motif  single-stranded-interacting protein 1 OS=Homo sapiens OX=9606 GN=RBMS1 PE=1 SV=3
408,1679,sp|Q01844-6|EWS_HUMAN,16.72,186.37,4.012E7,4.28E7,5.522E7,5.236E7,1.00,1.07,1.38,1.30,4.012E7,4.28E7,5.522E7,5.236E7,1.00,1.07,1.38,1.30,22,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),62508,Isoform 6 of RNA-binding protein EWS OS=Homo sapiens OX=9606 GN=EWSR1
241,5862,sp|Q99961|SH3G1_HUMAN,200.00,186.23,3.002E8,2.896E8,5.972E7,5.17E7,1.00,0.96,0.20,0.17,3.002E8,2.896E8,5.972E7,5.17E7,1.00,0.96,0.20,0.17,43,23,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),41490,Endophilin-A2 OS=Homo sapiens OX=9606 GN=SH3GL1 PE=1 SV=1
724,691,sp|P51531|SMCA2_HUMAN,21.83,186.19,3.891E6,3.983E6,6.382E6,6.055E6,1.00,1.02,1.64,1.56,3.891E6,3.983E6,6.382E6,6.055E6,1.00,1.02,1.64,1.56,6,18,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),181278,Probable global transcription activator SNF2L2 OS=Homo sapiens OX=9606 GN=SMARCA2 PE=1 SV=2
542,17210,sp|O95835|LATS1_HUMAN,24.48,186.15,1.108E7,1.159E7,2.028E7,1.971E7,1.00,1.05,1.83,1.78,1.108E7,1.159E7,2.028E7,1.971E7,1.00,1.05,1.83,1.78,28,27,26,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),126870,Serine/threonine-protein kinase LATS1 OS=Homo sapiens OX=9606 GN=LATS1 PE=1 SV=1
781,11579,sp|Q86UP2|KTN1_HUMAN,16.62,186.10,6.619E6,6.611E6,9.396E6,9.356E6,1.00,1.00,1.42,1.41,6.619E6,6.611E6,9.396E6,9.356E6,1.00,1.00,1.42,1.41,18,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),156275,Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1
613,38731,sp|O94851-6|MICA2_HUMAN,36.88,185.85,1.292E7,1.262E7,2.421E7,2.359E7,1.00,0.98,1.87,1.83,1.292E7,1.262E7,2.421E7,2.359E7,1.00,0.98,1.87,1.83,21,22,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),109216,Isoform 6 of [F-actin]-monooxygenase MICAL2 OS=Homo sapiens OX=9606 GN=MICAL2
607,10473,sp|O43318-2|M3K7_HUMAN,68.02,185.51,1.062E7,1.111E7,2.386E7,2.286E7,1.00,1.05,2.25,2.15,1.062E7,1.111E7,2.386E7,2.286E7,1.00,1.05,2.25,2.15,40,19,19,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),64230,Isoform 1A of Mitogen-activated protein kinase kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP3K7
733,189,sp|O15230|LAMA5_HUMAN,7.04,185.39,8.905E6,8.886E6,1.118E7,1.093E7,1.00,1.00,1.26,1.23,8.905E6,8.886E6,1.118E7,1.093E7,1.00,1.00,1.26,1.23,6,20,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),399740,Laminin subunit alpha-5 OS=Homo sapiens OX=9606 GN=LAMA5 PE=1 SV=8
734,806,sp|Q9P2N5|RBM27_HUMAN,67.18,185.39,7.427E6,7.63E6,1.971E7,1.927E7,1.00,1.03,2.65,2.59,7.427E6,7.63E6,1.971E7,1.927E7,1.00,1.03,2.65,2.59,23,22,22,iTRAQ 4plex (K  N-term); Deamidation (NQ),118718,RNA-binding protein 27 OS=Homo sapiens OX=9606 GN=RBM27 PE=1 SV=2
513,19376,sp|Q92615|LAR4B_HUMAN,39.22,185.31,1.296E7,1.295E7,2.321E7,2.239E7,1.00,1.00,1.79,1.73,1.296E7,1.295E7,2.321E7,2.239E7,1.00,1.00,1.79,1.73,35,21,21,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),80552,La-related protein 4B OS=Homo sapiens OX=9606 GN=LARP4B PE=1 SV=3
667,1724,D6RIF6|D6RIF6_HUMAN,16.25,185.16,4.02E5,4.164E5,1.494E6,1.488E6,1.00,1.04,3.72,3.70,4.02E5,4.164E5,1.494E6,1.488E6,1.00,1.04,3.72,3.70,5,13,2,iTRAQ 4plex (K  N-term),44657,SLAIN motif-containing protein 2 OS=Homo sapiens OX=9606 GN=SLAIN2 PE=1 SV=1
783,5817,A0A1B0GTL5|A0A1B0GTL5_HUMAN,39.70,185.08,5.018E6,5.588E6,9.319E6,9.322E6,1.00,1.11,1.86,1.86,5.018E6,5.588E6,9.319E6,9.322E6,1.00,1.11,1.86,1.86,22,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),138414,Rab11 family-interacting protein 5 OS=Homo sapiens OX=9606 GN=RAB11FIP5 PE=1 SV=1
333,6377,sp|Q15717-2|ELAV1_HUMAN,17.78,185.04,7.846E7,8.182E7,1.093E8,1.08E8,1.00,1.04,1.39,1.38,7.846E7,8.182E7,1.093E8,1.08E8,1.00,1.04,1.39,1.38,47,19,19,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),38996,Isoform 2 of ELAV-like protein 1 OS=Homo sapiens OX=9606 GN=ELAVL1
617,1392,sp|Q9C0D5|TANC1_HUMAN,72.17,184.86,7.653E6,7.76E6,1.94E7,1.885E7,1.00,1.01,2.53,2.46,7.653E6,7.76E6,1.94E7,1.885E7,1.00,1.01,2.53,2.46,16,27,26,iTRAQ 4plex (K  N-term); Deamidation (NQ),202218,Protein TANC1 OS=Homo sapiens OX=9606 GN=TANC1 PE=1 SV=3
611,13945,sp|P13639|EF2_HUMAN,15.24,184.84,2.034E7,1.996E7,2.759E7,2.792E7,1.00,0.98,1.36,1.37,2.034E7,1.996E7,2.759E7,2.792E7,1.00,0.98,1.36,1.37,26,23,23,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),95338,Elongation factor 2 OS=Homo sapiens OX=9606 GN=EEF2 PE=1 SV=4
489,9073,sp|Q9Y2L9|LRCH1_HUMAN,45.84,184.74,1.05E7,9.471E6,1.883E7,1.837E7,1.00,0.90,1.79,1.75,1.05E7,9.471E6,1.883E7,1.837E7,1.00,0.90,1.79,1.75,26,15,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),80875,Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LRCH1 PE=1 SV=3
384,19327,sp|Q14103-3|HNRPD_HUMAN,40.23,184.69,1.576E6,1.713E6,3.247E6,3.297E6,1.00,1.09,2.06,2.09,1.576E6,1.713E6,3.247E6,3.297E6,1.00,1.09,2.06,2.09,10,15,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),32835,Isoform 3 of Heterogeneous nuclear ribonucleoprotein D0 OS=Homo sapiens OX=9606 GN=HNRNPD
421,11657,sp|P47755|CAZA2_HUMAN,14.53,184.57,1.692E7,1.651E7,2.047E7,2.211E7,1.00,0.98,1.21,1.31,1.692E7,1.651E7,2.047E7,2.211E7,1.00,0.98,1.21,1.31,36,11,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),32949,F-actin-capping protein subunit alpha-2 OS=Homo sapiens OX=9606 GN=CAPZA2 PE=1 SV=3
488,19421,sp|Q13492-3|PICAL_HUMAN,103.47,184.39,2.435E7,2.454E7,6.658E7,6.69E7,1.00,1.01,2.73,2.75,2.435E7,2.454E7,6.658E7,6.69E7,1.00,1.01,2.73,2.75,19,20,13,iTRAQ 4plex (K  N-term); Oxidation (M),66393,Isoform 3 of Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens OX=9606 GN=PICALM
704,7764,sp|Q9UH99-3|SUN2_HUMAN,83.34,183.74,6.884E6,6.621E6,1.492E7,1.454E7,1.00,0.96,2.17,2.11,6.884E6,6.621E6,1.492E7,1.454E7,1.00,0.96,2.17,2.11,27,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),79612,Isoform 3 of SUN domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUN2
235,19503,sp|Q07666|KHDR1_HUMAN,200.00,183.67,4.412E7,4.719E7,1.624E8,1.589E8,1.00,1.07,3.68,3.60,4.412E7,4.719E7,1.624E8,1.589E8,1.00,1.07,3.68,3.60,34,21,19,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),48227,KH domain-containing  RNA-binding  signal transduction-associated protein 1 OS=Homo sapiens OX=9606 GN=KHDRBS1 PE=1 SV=1
787,6080,sp|P46937-6|YAP1_HUMAN,58.57,183.62,5.836E6,6.095E6,1.139E7,1.093E7,1.00,1.04,1.95,1.87,5.836E6,6.095E6,1.139E7,1.093E7,1.00,1.04,1.95,1.87,43,12,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),49989,Isoform 6 of Transcriptional coactivator YAP1 OS=Homo sapiens OX=9606 GN=YAP1
300,14993,sp|Q13347|EIF3I_HUMAN,135.39,183.55,4.804E7,5.097E7,1.378E8,1.31E8,1.00,1.06,2.87,2.73,4.804E7,5.097E7,1.378E8,1.31E8,1.00,1.06,2.87,2.73,52,16,16,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),36502,Eukaryotic translation initiation factor 3 subunit I OS=Homo sapiens OX=9606 GN=EIF3I PE=1 SV=1
382,2492,sp|O00303|EIF3F_HUMAN,141.48,183.32,3.518E7,3.674E7,1.059E8,1.019E8,1.00,1.04,3.01,2.90,3.518E7,3.674E7,1.059E8,1.019E8,1.00,1.04,3.01,2.90,45,17,17,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),37564,Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens OX=9606 GN=EIF3F PE=1 SV=1
171,16465,B1AK87|B1AK87_HUMAN,14.48,183.25,2.055E8,2.021E8,2.402E8,2.704E8,1.00,0.98,1.17,1.32,2.055E8,2.021E8,2.402E8,2.704E8,1.00,0.98,1.17,1.32,48,19,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),29295,Capping protein (Actin filament) muscle Z-line  beta  isoform CRA_a OS=Homo sapiens OX=9606 GN=CAPZB PE=1 SV=1
767,6796,sp|O75420|GGYF1_HUMAN,46.60,183.15,6.404E6,6.142E6,1.145E7,1.217E7,1.00,0.96,1.79,1.90,6.404E6,6.142E6,1.145E7,1.217E7,1.00,0.96,1.79,1.90,23,17,16,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),114601,GRB10-interacting GYF protein 1 OS=Homo sapiens OX=9606 GN=GIGYF1 PE=1 SV=2
208,10130,sp|P61247|RS3A_HUMAN,31.08,182.94,2.402E8,2.443E8,3.672E8,3.827E8,1.00,1.02,1.53,1.59,2.402E8,2.443E8,3.672E8,3.827E8,1.00,1.02,1.53,1.59,56,19,19,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),29945,40S ribosomal protein S3a OS=Homo sapiens OX=9606 GN=RPS3A PE=1 SV=2
456,19558,sp|Q15434|RBMS2_HUMAN,47.54,182.93,8.108E6,8.122E6,1.47E7,1.436E7,1.00,1.00,1.81,1.77,8.108E6,8.122E6,1.47E7,1.436E7,1.00,1.00,1.81,1.77,30,13,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),43959,RNA-binding motif  single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1
580,1705,A0A1C7CYX9|A0A1C7CYX9_HUMAN,42.82,182.46,8.005E6,8.046E6,1.563E7,1.539E7,1.00,1.01,1.95,1.92,8.005E6,8.046E6,1.563E7,1.539E7,1.00,1.01,1.95,1.92,25,17,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),73503,Dihydropyrimidinase-related protein 2 OS=Homo sapiens OX=9606 GN=DPYSL2 PE=1 SV=1
878,17919,sp|P52594-2|AGFG1_HUMAN,200.00,182.38,3.416E6,3.597E6,1.26E7,1.231E7,1.00,1.05,3.69,3.60,3.416E6,3.597E6,1.26E7,1.231E7,1.00,1.05,3.69,3.60,32,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),54182,Isoform 2 of Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1
505,38729,sp|Q08380|LG3BP_HUMAN,5.40,182.05,2.828E7,2.865E7,3.352E7,3.201E7,1.00,1.01,1.19,1.13,2.828E7,2.865E7,3.352E7,3.201E7,1.00,1.01,1.19,1.13,30,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),65331,Galectin-3-binding protein OS=Homo sapiens OX=9606 GN=LGALS3BP PE=1 SV=1
703,2714,sp|Q96QC0|PP1RA_HUMAN,34.07,182.04,7.541E6,7.492E6,1.391E7,1.357E7,1.00,0.99,1.84,1.80,7.541E6,7.492E6,1.391E7,1.357E7,1.00,0.99,1.84,1.80,21,19,18,iTRAQ 4plex (K  N-term),99058,Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Homo sapiens OX=9606 GN=PPP1R10 PE=1 SV=1
564,5966,M0R2P6|M0R2P6_HUMAN,3.32,181.81,1.064E7,1.058E7,1.202E7,1.16E7,1.00,0.99,1.13,1.09,1.064E7,1.058E7,1.202E7,1.16E7,1.00,0.99,1.13,1.09,21,16,12,iTRAQ 4plex (K  N-term),73708,SH3KBP1 binding protein 1  isoform CRA_c OS=Homo sapiens OX=9606 GN=SHKBP1 PE=1 SV=1
643,17368,sp|P35611-2|ADDA_HUMAN,15.66,181.49,1.38E7,1.352E7,1.88E7,1.935E7,1.00,0.98,1.36,1.40,1.38E7,1.352E7,1.88E7,1.935E7,1.00,0.98,1.36,1.40,33,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),69985,Isoform 2 of Alpha-adducin OS=Homo sapiens OX=9606 GN=ADD1
888,4659,A0A0A0MSU2|A0A0A0MSU2_HUMAN,29.71,181.36,4.206E6,4.328E6,7.205E6,7.013E6,1.00,1.03,1.71,1.67,4.206E6,4.328E6,7.205E6,7.013E6,1.00,1.03,1.71,1.67,22,17,17,iTRAQ 4plex (K  N-term); Phosphorylation (STY),111830,ELM2 and SANT domain-containing protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=ELMSAN1 PE=1 SV=6
341,2008,sp|Q9ULV4-3|COR1C_HUMAN,9.38,181.24,6.122E7,5.684E7,6.254E7,7.455E7,1.00,0.93,1.02,1.22,6.122E7,5.684E7,6.254E7,7.455E7,1.00,0.93,1.02,1.22,26,23,22,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),58948,Isoform 3 of Coronin-1C OS=Homo sapiens OX=9606 GN=CORO1C
693,2012,sp|Q96CW5|GCP3_HUMAN,51.31,181.15,9.677E6,9.996E6,2.139E7,2.076E7,1.00,1.03,2.21,2.14,9.677E6,9.996E6,2.139E7,2.076E7,1.00,1.03,2.21,2.14,23,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),103571,Gamma-tubulin complex component 3 OS=Homo sapiens OX=9606 GN=TUBGCP3 PE=1 SV=2
721,38751,sp|Q9BY44-3|EIF2A_HUMAN,28.44,180.94,1.272E7,1.308E7,2.108E7,2.067E7,1.00,1.03,1.66,1.63,1.272E7,1.308E7,2.108E7,2.067E7,1.00,1.03,1.66,1.63,33,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),62289,Isoform 3 of Eukaryotic translation initiation factor 2A OS=Homo sapiens OX=9606 GN=EIF2A
604,19369,sp|Q8IX12-2|CCAR1_HUMAN,87.53,180.92,1.717E7,1.784E7,4.314E7,3.952E7,1.00,1.04,2.51,2.30,1.717E7,1.784E7,4.314E7,3.952E7,1.00,1.04,2.51,2.30,20,21,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),131043,Isoform 2 of Cell division cycle and apoptosis regulator protein 1 OS=Homo sapiens OX=9606 GN=CCAR1
934,22251,sp|Q8IXQ6-2|PARP9_HUMAN,36.80,180.75,6.743E6,6.664E6,1.114E7,1.079E7,1.00,0.99,1.65,1.60,6.743E6,6.664E6,1.114E7,1.079E7,1.00,0.99,1.65,1.60,20,14,14,iTRAQ 4plex (K  N-term),92272,Isoform 2 of Protein mono-ADP-ribosyltransferase PARP9 OS=Homo sapiens OX=9606 GN=PARP9
708,2574,sp|P35908|K22E_HUMAN,37.03,180.64,1.135E7,5.134E6,7.024E6,6.814E6,1.00,0.45,0.62,0.60,1.135E7,5.134E6,7.024E6,6.814E6,1.00,0.45,0.62,0.60,29,20,15,iTRAQ 4plex (K  N-term),65433,Keratin  type II cytoskeletal 2 epidermal OS=Homo sapiens OX=9606 GN=KRT2 PE=1 SV=2
652,38730,sp|Q9NUQ6-2|SPS2L_HUMAN,2.40,180.63,9.63E5,1.014E6,1.993E6,2.042E6,1.00,1.05,2.07,2.12,9.63E5,1.014E6,1.993E6,2.042E6,1.00,1.05,2.07,2.12,2,16,1,iTRAQ 4plex (K  N-term),54178,Isoform 2 of SPATS2-like protein OS=Homo sapiens OX=9606 GN=SPATS2L
628,3142,sp|O60244|MED14_HUMAN,12.78,180.63,1.643E7,1.603E7,2.272E7,2.199E7,1.00,0.98,1.38,1.34,1.643E7,1.603E7,2.272E7,2.199E7,1.00,0.98,1.38,1.34,21,23,23,iTRAQ 4plex (K  N-term); Deamidation (NQ),160606,Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2
402,19321,sp|O43809|CPSF5_HUMAN,105.05,180.36,3.413E7,3.532E7,1.016E8,9.64E7,1.00,1.03,2.98,2.82,3.413E7,3.532E7,1.016E8,9.64E7,1.00,1.03,2.98,2.82,60,23,22,iTRAQ 4plex (K  N-term); Deamidation (NQ),26227,Cleavage and polyadenylation specificity factor subunit 5 OS=Homo sapiens OX=9606 GN=NUDT21 PE=1 SV=1
603,19466,sp|P26368-2|U2AF2_HUMAN,28.48,180.20,1.361E7,1.384E7,2.118E7,2.023E7,1.00,1.02,1.56,1.49,1.361E7,1.384E7,2.118E7,2.023E7,1.00,1.02,1.56,1.49,46,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),53121,Isoform 2 of Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2
302,3863,sp|P34931|HS71L_HUMAN,2.51,180.19,5.694E4,7.388E4,1.271E5,1.245E5,1.00,1.30,2.23,2.19,5.694E4,7.388E4,1.271E5,1.245E5,1.00,1.30,2.23,2.19,2,19,1,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),70375,Heat shock 70 kDa protein 1-like OS=Homo sapiens OX=9606 GN=HSPA1L PE=1 SV=2
616,2941,sp|Q14204|DYHC1_HUMAN,15.90,180.03,1.003E7,9.933E6,1.582E7,1.573E7,1.00,0.99,1.58,1.57,1.003E7,9.933E6,1.582E7,1.573E7,1.00,0.99,1.58,1.57,7,31,31,iTRAQ 4plex (K  N-term); Deamidation (NQ),532412,Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens OX=9606 GN=DYNC1H1 PE=1 SV=5
598,6693,sp|Q9NUL3-2|STAU2_HUMAN,11.97,179.93,1.11E7,1.131E7,1.552E7,1.553E7,1.00,1.02,1.40,1.40,1.11E7,1.131E7,1.552E7,1.553E7,1.00,1.02,1.40,1.40,36,19,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),58970,Isoform 2 of Double-stranded RNA-binding protein Staufen homolog 2 OS=Homo sapiens OX=9606 GN=STAU2
506,19388,F5GY05|F5GY05_HUMAN,60.94,179.89,1.215E7,1.237E7,2.665E7,2.543E7,1.00,1.02,2.19,2.09,1.215E7,1.237E7,2.665E7,2.543E7,1.00,1.02,2.19,2.09,22,18,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),106117,Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens OX=9606 GN=FAM120B PE=1 SV=1
1127,591,sp|O15014|ZN609_HUMAN,48.65,179.49,2.125E6,1.993E6,3.682E6,3.694E6,1.00,0.94,1.73,1.74,2.125E6,1.993E6,3.682E6,3.694E6,1.00,0.94,1.73,1.74,15,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),151191,Zinc finger protein 609 OS=Homo sapiens OX=9606 GN=ZNF609 PE=1 SV=2
520,13872,A0A087X0S5|A0A087X0S5_HUMAN,6.72,179.42,2.521E7,2.507E7,3.065E7,3.069E7,1.00,0.99,1.22,1.22,2.521E7,2.507E7,3.065E7,3.069E7,1.00,0.99,1.22,1.22,19,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),108339,Collagen alpha-1(VI) chain OS=Homo sapiens OX=9606 GN=COL6A1 PE=1 SV=1
573,7465,sp|P20073-2|ANXA7_HUMAN,200.00,179.40,1.764E7,1.85E7,5.849E7,5.688E7,1.00,1.05,3.32,3.23,1.764E7,1.85E7,5.849E7,5.688E7,1.00,1.05,3.32,3.23,28,14,14,iTRAQ 4plex (K  N-term); Oxidation (M),50316,Isoform 2 of Annexin A7 OS=Homo sapiens OX=9606 GN=ANXA7
213,4282,sp|P54652|HSP72_HUMAN,1.08,179.35,1.428E5,1.402E5,1.991E5,2.059E5,1.00,0.98,1.39,1.44,1.428E5,1.402E5,1.991E5,2.059E5,1.00,0.98,1.39,1.44,2,19,1,iTRAQ 4plex (K  N-term); Oxidation (M),70021,Heat shock-related 70 kDa protein 2 OS=Homo sapiens OX=9606 GN=HSPA2 PE=1 SV=1
738,1597,sp|Q9NYU2-2|UGGG1_HUMAN,26.04,179.22,8.221E6,8.106E6,1.235E7,1.175E7,1.00,0.99,1.50,1.43,8.221E6,8.106E6,1.235E7,1.175E7,1.00,0.99,1.50,1.43,15,19,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),174976,Isoform 2 of UDP-glucose:glycoprotein glucosyltransferase 1 OS=Homo sapiens OX=9606 GN=UGGT1
406,3662,sp|P53675-2|CLH2_HUMAN,2.21,178.99,1.063E5,1.032E5,1.294E5,1.475E5,1.00,0.97,1.22,1.39,1.063E5,1.032E5,1.294E5,1.475E5,1.00,0.97,1.22,1.39,2,19,2,Carbamidomethylation; iTRAQ 4plex (K  N-term); Phosphorylation (STY),180295,Isoform 2 of Clathrin heavy chain 2 OS=Homo sapiens OX=9606 GN=CLTCL1
650,2236,sp|Q9H792|PEAK1_HUMAN,10.29,178.88,7.649E6,7.584E6,1.053E7,1.054E7,1.00,0.99,1.38,1.38,7.649E6,7.584E6,1.053E7,1.054E7,1.00,0.99,1.38,1.38,15,23,23,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),193105,Inactive tyrosine-protein kinase PEAK1 OS=Homo sapiens OX=9606 GN=PEAK1 PE=1 SV=4
674,23999,sp|O15460-2|P4HA2_HUMAN,25.11,178.71,1.746E7,1.615E7,2.418E7,2.443E7,1.00,0.93,1.39,1.40,1.746E7,1.615E7,2.418E7,2.443E7,1.00,0.93,1.39,1.40,32,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),60633,Isoform IIa of Prolyl 4-hydroxylase subunit alpha-2 OS=Homo sapiens OX=9606 GN=P4HA2
910,3985,sp|Q96Q15|SMG1_HUMAN,48.66,178.62,3.038E6,3.044E6,5.552E6,5.494E6,1.00,1.00,1.83,1.81,3.038E6,3.044E6,5.552E6,5.494E6,1.00,1.00,1.83,1.81,6,17,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),410501,Serine/threonine-protein kinase SMG1 OS=Homo sapiens OX=9606 GN=SMG1 PE=1 SV=3
864,38768,sp|Q8IZL2|MAML2_HUMAN,25.66,178.31,3.623E6,3.676E6,5.61E6,5.384E6,1.00,1.01,1.55,1.49,3.623E6,3.676E6,5.61E6,5.384E6,1.00,1.01,1.55,1.49,19,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),125196,Mastermind-like protein 2 OS=Homo sapiens OX=9606 GN=MAML2 PE=1 SV=2
746,4655,sp|Q8WVV9-5|HNRLL_HUMAN,16.67,178.25,7.291E6,7.561E6,1.122E7,1.09E7,1.00,1.04,1.54,1.49,7.291E6,7.561E6,1.122E7,1.09E7,1.00,1.04,1.54,1.49,38,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),56467,Isoform 5 of Heterogeneous nuclear ribonucleoprotein L-like OS=Homo sapiens OX=9606 GN=HNRNPLL
882,1817,sp|Q9Y2D5-5|AKAP2_HUMAN,22.78,178.02,3.468E6,3.389E6,4.91E6,5.066E6,1.00,0.98,1.42,1.46,3.468E6,3.389E6,4.91E6,5.066E6,1.00,0.98,1.42,1.46,25,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),104107,Isoform 2 of A-kinase anchor protein 2 OS=Homo sapiens OX=9606 GN=AKAP2
592,19305,sp|O43684-2|BUB3_HUMAN,89.87,177.91,1.995E7,2.109E7,4.651E7,4.536E7,1.00,1.06,2.33,2.27,1.995E7,2.109E7,4.651E7,4.536E7,1.00,1.06,2.33,2.27,48,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),36955,Isoform 2 of Mitotic checkpoint protein BUB3 OS=Homo sapiens OX=9606 GN=BUB3
570,19820,G3V0J0|G3V0J0_HUMAN,0.70,177.60,1.88E5,1.935E5,2.419E5,2.268E5,1.00,1.03,1.29,1.21,1.88E5,1.935E5,2.419E5,2.268E5,1.00,1.03,1.29,1.21,3,17,1,iTRAQ 4plex (K  N-term),66786,Fragile X mental retardation 1  isoform CRA_e OS=Homo sapiens OX=9606 GN=FMR1 PE=1 SV=1
446,13347,sp|Q13148|TADBP_HUMAN,200.00,177.56,1.665E7,1.748E7,5.77E7,5.587E7,1.00,1.05,3.47,3.36,1.665E7,1.748E7,5.77E7,5.587E7,1.00,1.05,3.47,3.36,34,12,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),44740,TAR DNA-binding protein 43 OS=Homo sapiens OX=9606 GN=TARDBP PE=1 SV=1
443,19330,sp|Q14103-4|HNRPD_HUMAN,2.43,177.53,8.569E5,9.503E5,1.79E6,1.824E6,1.00,1.11,2.09,2.13,8.569E5,9.503E5,1.79E6,1.824E6,1.00,1.11,2.09,2.13,4,14,1,iTRAQ 4plex (K  N-term),30672,Isoform 4 of Heterogeneous nuclear ribonucleoprotein D0 OS=Homo sapiens OX=9606 GN=HNRNPD
491,18552,sp|P09012|SNRPA_HUMAN,12.93,177.30,3.451E7,3.174E7,4.16E7,4.131E7,1.00,0.92,1.21,1.20,3.451E7,3.174E7,4.16E7,4.131E7,1.00,0.92,1.21,1.20,34,11,9,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),31280,U1 small nuclear ribonucleoprotein A OS=Homo sapiens OX=9606 GN=SNRPA PE=1 SV=3
346,4695,sp|Q52LJ0-2|FA98B_HUMAN,42.81,177.03,2.636E7,2.618E7,4.882E7,4.629E7,1.00,0.99,1.85,1.76,2.636E7,2.618E7,4.882E7,4.629E7,1.00,0.99,1.85,1.76,26,16,9,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),45547,Isoform 2 of Protein FAM98B OS=Homo sapiens OX=9606 GN=FAM98B
654,7993,sp|P25205|MCM3_HUMAN,43.36,176.90,3.717E6,3.796E6,7.325E6,7.256E6,1.00,1.02,1.97,1.95,3.717E6,3.796E6,7.325E6,7.256E6,1.00,1.02,1.97,1.95,30,18,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),90981,DNA replication licensing factor MCM3 OS=Homo sapiens OX=9606 GN=MCM3 PE=1 SV=3
535,38745,sp|Q86UE4|LYRIC_HUMAN,20.26,176.85,1.487E7,1.516E7,2.179E7,2.267E7,1.00,1.02,1.47,1.52,1.487E7,1.516E7,2.179E7,2.267E7,1.00,1.02,1.47,1.52,33,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),63837,Protein LYRIC OS=Homo sapiens OX=9606 GN=MTDH PE=1 SV=2
800,38750,sp|P46940|IQGA1_HUMAN,8.94,176.60,8.128E6,7.883E6,1.031E7,1.072E7,1.00,0.97,1.27,1.32,8.128E6,7.883E6,1.031E7,1.072E7,1.00,0.97,1.27,1.32,14,22,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),189251,Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1
625,412,A0A0C4DGN6|A0A0C4DGN6_HUMAN,76.76,176.44,9.591E6,9.992E6,2.331E7,2.246E7,1.00,1.04,2.43,2.34,9.591E6,9.992E6,2.331E7,2.246E7,1.00,1.04,2.43,2.34,26,18,15,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),83132,ARF GTPase-activating protein GIT1 OS=Homo sapiens OX=9606 GN=GIT1 PE=1 SV=1
431,2017,sp|Q96I25|SPF45_HUMAN,22.63,176.36,3.099E7,3.176E7,4.776E7,4.592E7,1.00,1.02,1.54,1.48,3.099E7,3.176E7,4.776E7,4.592E7,1.00,1.02,1.54,1.48,49,18,16,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),44962,Splicing factor 45 OS=Homo sapiens OX=9606 GN=RBM17 PE=1 SV=1
372,19415,sp|P38159|RBMX_HUMAN,35.11,176.31,6.736E6,7.047E6,1.504E7,1.472E7,1.00,1.05,2.23,2.19,6.736E6,7.047E6,1.504E7,1.472E7,1.00,1.05,2.23,2.19,14,20,7,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),42332,RNA-binding motif protein  X chromosome OS=Homo sapiens OX=9606 GN=RBMX PE=1 SV=3
659,19296,sp|P05388|RLA0_HUMAN,49.45,176.11,4.477E7,2.908E7,4.532E7,5.345E7,1.00,0.65,1.01,1.19,4.477E7,2.908E7,4.532E7,5.345E7,1.00,0.65,1.01,1.19,52,15,15,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),34274,60S acidic ribosomal protein P0 OS=Homo sapiens OX=9606 GN=RPLP0 PE=1 SV=1
822,5072,sp|Q10570|CPSF1_HUMAN,20.34,176.08,8.728E6,8.933E6,1.358E7,1.316E7,1.00,1.02,1.56,1.51,8.728E6,8.933E6,1.358E7,1.316E7,1.00,1.02,1.56,1.51,13,19,18,iTRAQ 4plex (K  N-term),160883,Cleavage and polyadenylation specificity factor subunit 1 OS=Homo sapiens OX=9606 GN=CPSF1 PE=1 SV=2
687,4852,sp|Q13418|ILK_HUMAN,31.90,176.06,1.797E7,1.816E7,3.116E7,3.143E7,1.00,1.01,1.73,1.75,1.797E7,1.816E7,3.116E7,3.143E7,1.00,1.01,1.73,1.75,44,20,20,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),51419,Integrin-linked protein kinase OS=Homo sapiens OX=9606 GN=ILK PE=1 SV=2
1055,20435,sp|Q9NZC9|SMAL1_HUMAN,74.33,175.85,4.507E6,4.435E6,9.514E6,9.34E6,1.00,0.98,2.11,2.07,4.507E6,4.435E6,9.514E6,9.34E6,1.00,0.98,2.11,2.07,14,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),105938,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens OX=9606 GN=SMARCAL1 PE=1 SV=1
484,3487,sp|Q10567-4|AP1B1_HUMAN,4.83,175.84,1.68E6,1.581E6,2.611E6,2.682E6,1.00,0.94,1.55,1.60,1.68E6,1.581E6,2.611E6,2.682E6,1.00,0.94,1.55,1.60,3,16,2,iTRAQ 4plex (K  N-term),101348,Isoform 4 of AP-1 complex subunit beta-1 OS=Homo sapiens OX=9606 GN=AP1B1
182,19309,sp|P62701|RS4X_HUMAN,25.44,175.51,8.364E7,8.614E7,1.211E8,1.265E8,1.00,1.03,1.45,1.51,8.364E7,8.614E7,1.211E8,1.265E8,1.00,1.03,1.45,1.51,27,19,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),29598,40S ribosomal protein S4  X isoform OS=Homo sapiens OX=9606 GN=RPS4X PE=1 SV=2
586,6471,sp|Q9Y597|KCTD3_HUMAN,2.52,175.37,1.368E7,1.306E7,1.464E7,1.411E7,1.00,0.96,1.07,1.03,1.368E7,1.306E7,1.464E7,1.411E7,1.00,0.96,1.07,1.03,19,18,14,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),88984,BTB/POZ domain-containing protein KCTD3 OS=Homo sapiens OX=9606 GN=KCTD3 PE=1 SV=2
620,1043,sp|Q2M1P5|KIF7_HUMAN,21.95,175.22,8.674E6,8.812E6,1.458E7,1.426E7,1.00,1.02,1.68,1.64,8.674E6,8.812E6,1.458E7,1.426E7,1.00,1.02,1.68,1.64,20,23,23,iTRAQ 4plex (K  N-term); Deamidation (NQ),150587,Kinesin-like protein KIF7 OS=Homo sapiens OX=9606 GN=KIF7 PE=1 SV=2
562,19825,sp|Q06787-9|FMR1_HUMAN,2.78,175.05,9.43E5,8.89E5,1.299E6,1.124E6,1.00,0.94,1.38,1.19,9.43E5,8.89E5,1.299E6,1.124E6,1.00,0.94,1.38,1.19,3,18,2,iTRAQ 4plex (K  N-term),68966,Isoform 9 of Synaptic functional regulator FMR1 OS=Homo sapiens OX=9606 GN=FMR1
854,1552,sp|Q9H0L4|CSTFT_HUMAN,56.71,174.82,1.782E6,1.779E6,3.375E6,3.487E6,1.00,1.00,1.89,1.96,1.782E6,1.779E6,3.375E6,3.487E6,1.00,1.00,1.89,1.96,17,12,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),64436,Cleavage stimulation factor subunit 2 tau variant OS=Homo sapiens OX=9606 GN=CSTF2T PE=1 SV=1
464,3688,sp|P13645|K1C10_HUMAN,200.00,174.54,3.965E7,8.249E6,1.067E7,9.026E6,1.00,0.21,0.27,0.23,3.965E7,8.249E6,1.067E7,9.026E6,1.00,0.21,0.27,0.23,23,18,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),58827,Keratin  type I cytoskeletal 10 OS=Homo sapiens OX=9606 GN=KRT10 PE=1 SV=6
764,1188,sp|Q12874|SF3A3_HUMAN,44.10,174.51,1.2E7,1.218E7,2.123E7,2.098E7,1.00,1.01,1.77,1.75,1.2E7,1.218E7,2.123E7,2.098E7,1.00,1.01,1.77,1.75,27,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),58849,Splicing factor 3A subunit 3 OS=Homo sapiens OX=9606 GN=SF3A3 PE=1 SV=1
846,2225,sp|P33992|MCM5_HUMAN,34.67,174.44,7.2E6,7.232E6,1.313E7,1.273E7,1.00,1.00,1.82,1.77,7.2E6,7.232E6,1.313E7,1.273E7,1.00,1.00,1.82,1.77,25,17,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),82286,DNA replication licensing factor MCM5 OS=Homo sapiens OX=9606 GN=MCM5 PE=1 SV=5
918,15337,sp|Q8N163|CCAR2_HUMAN,45.81,174.36,3.729E6,3.715E6,7.318E6,7.13E6,1.00,1.00,1.96,1.91,3.729E6,3.715E6,7.318E6,7.13E6,1.00,1.00,1.96,1.91,21,13,12,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),102902,Cell cycle and apoptosis regulator protein 2 OS=Homo sapiens OX=9606 GN=CCAR2 PE=1 SV=2
418,1269,sp|Q15366|PCBP2_HUMAN,24.91,174.22,1.494E6,1.574E6,2.911E6,2.864E6,1.00,1.05,1.95,1.92,1.494E6,1.574E6,2.911E6,2.864E6,1.00,1.05,1.95,1.92,6,14,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),38580,Poly(rC)-binding protein 2 OS=Homo sapiens OX=9606 GN=PCBP2 PE=1 SV=1
946,38782,sp|Q9UMS6-5|SYNP2_HUMAN,109.63,174.05,4.039E6,3.899E6,9.999E6,9.882E6,1.00,0.97,2.48,2.45,4.039E6,3.899E6,9.999E6,9.882E6,1.00,0.97,2.48,2.45,35,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),74762,Isoform 5 of Synaptopodin-2 OS=Homo sapiens OX=9606 GN=SYNPO2
668,5550,sp|Q14008-2|CKAP5_HUMAN,21.16,174.03,1.05E7,1.023E7,1.836E7,1.823E7,1.00,0.97,1.75,1.74,1.05E7,1.023E7,1.836E7,1.823E7,1.00,0.97,1.75,1.74,13,24,24,iTRAQ 4plex (K  N-term); Deamidation (NQ),218524,Isoform 2 of Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5
1010,5139,C9JRJ5|C9JRJ5_HUMAN,49.16,173.76,4.675E6,4.581E6,9.197E6,8.878E6,1.00,0.98,1.97,1.90,4.675E6,4.581E6,9.197E6,8.878E6,1.00,0.98,1.97,1.90,33,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),65535,LIM domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LIMD1 PE=1 SV=1
725,17797,sp|Q06210-2|GFPT1_HUMAN,24.44,173.61,8.028E6,8.108E6,1.38E7,1.373E7,1.00,1.01,1.72,1.71,8.028E6,8.108E6,1.38E7,1.373E7,1.00,1.01,1.72,1.71,24,18,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),76759,Isoform 2 of Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens OX=9606 GN=GFPT1
164,101,sp|Q4VXU2|PAP1L_HUMAN,1.51,173.59,2.342E5,2.684E5,3.924E5,3.325E5,1.00,1.15,1.68,1.42,2.342E5,2.684E5,3.924E5,3.325E5,1.00,1.15,1.68,1.42,2,19,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),68392,Polyadenylate-binding protein 1-like OS=Homo sapiens OX=9606 GN=PABPC1L PE=2 SV=1
700,11173,sp|P09874|PARP1_HUMAN,15.17,173.50,9.653E6,9.515E6,1.368E7,1.401E7,1.00,0.99,1.42,1.45,9.653E6,9.515E6,1.368E7,1.401E7,1.00,0.99,1.42,1.45,18,16,16,iTRAQ 4plex (K  N-term),113084,Poly [ADP-ribose] polymerase 1 OS=Homo sapiens OX=9606 GN=PARP1 PE=1 SV=4
642,1618,sp|P07942|LAMB1_HUMAN,2.79,173.38,1.248E7,1.209E7,1.362E7,1.334E7,1.00,0.97,1.09,1.07,1.248E7,1.209E7,1.362E7,1.334E7,1.00,0.97,1.09,1.07,11,20,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),198037,Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2
572,8019,sp|Q6NZI2|CAVN1_HUMAN,11.95,173.26,1.603E7,1.624E7,2.07E7,2.129E7,1.00,1.01,1.29,1.33,1.603E7,1.624E7,2.07E7,2.129E7,1.00,1.01,1.29,1.33,44,12,12,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ); Phosphorylation (STY),43476,Caveolae-associated protein 1 OS=Homo sapiens OX=9606 GN=CAVIN1 PE=1 SV=1
472,3627,sp|P52294|IMA5_HUMAN,29.00,173.07,1.116E7,1.102E7,1.837E7,1.782E7,1.00,0.99,1.65,1.60,1.116E7,1.102E7,1.837E7,1.782E7,1.00,0.99,1.65,1.60,16,17,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),60222,Importin subunit alpha-5 OS=Homo sapiens OX=9606 GN=KPNA1 PE=1 SV=3
622,1449,sp|P53396-2|ACLY_HUMAN,7.28,172.89,1.501E7,1.383E7,1.799E7,1.784E7,1.00,0.92,1.20,1.19,1.501E7,1.383E7,1.799E7,1.784E7,1.00,0.92,1.20,1.19,22,25,25,iTRAQ 4plex (K  N-term); Deamidation (NQ),119772,Isoform 2 of ATP-citrate synthase OS=Homo sapiens OX=9606 GN=ACLY
629,38754,sp|P12110|CO6A2_HUMAN,11.71,172.68,2.379E7,2.391E7,3.223E7,3.229E7,1.00,1.01,1.36,1.36,2.379E7,2.391E7,3.223E7,3.229E7,1.00,1.01,1.36,1.36,18,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),108579,Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4
525,20201,sp|Q9Y5A9|YTHD2_HUMAN,85.32,172.64,4.974E6,5.066E6,1.221E7,1.186E7,1.00,1.02,2.45,2.38,4.974E6,5.066E6,1.221E7,1.186E7,1.00,1.02,2.45,2.38,25,14,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),62334,YTH domain-containing family protein 2 OS=Homo sapiens OX=9606 GN=YTHDF2 PE=1 SV=2
600,11230,K7EQ02|K7EQ02_HUMAN,49.31,172.62,1.193E7,1.248E7,2.19E7,2.138E7,1.00,1.05,1.84,1.79,1.193E7,1.248E7,2.19E7,2.138E7,1.00,1.05,1.84,1.79,54,10,10,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ); Phosphorylation (STY),35020,DAZ-associated protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=DAZAP1 PE=1 SV=2
718,4493,sp|P35527|K1C9_HUMAN,25.65,172.49,4.855E6,4.601E6,6.995E6,5.514E6,1.00,0.95,1.44,1.14,4.855E6,4.601E6,6.995E6,5.514E6,1.00,0.95,1.44,1.14,30,14,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),62064,Keratin  type I cytoskeletal 9 OS=Homo sapiens OX=9606 GN=KRT9 PE=1 SV=3
780,3001,sp|O14686-3|KMT2D_HUMAN,13.23,172.48,4.116E6,4.125E6,5.913E6,5.798E6,1.00,1.00,1.44,1.41,4.116E6,4.125E6,5.913E6,5.798E6,1.00,1.00,1.44,1.41,6,23,22,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),593686,Isoform 3 of Histone-lysine N-methyltransferase 2D OS=Homo sapiens OX=9606 GN=KMT2D
442,11307,sp|P61158|ARP3_HUMAN,13.61,172.45,2.983E7,2.782E7,3.296E7,3.757E7,1.00,0.93,1.10,1.26,2.983E7,2.782E7,3.296E7,3.757E7,1.00,0.93,1.10,1.26,36,15,15,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),47371,Actin-related protein 3 OS=Homo sapiens OX=9606 GN=ACTR3 PE=1 SV=3
448,5260,A0A087WY71|A0A087WY71_HUMAN,26.27,172.45,3.672E7,3.583E7,5.619E7,5.866E7,1.00,0.98,1.53,1.60,3.672E7,3.583E7,5.619E7,5.866E7,1.00,0.98,1.53,1.60,38,18,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),49527,AP-2 complex subunit mu OS=Homo sapiens OX=9606 GN=AP2M1 PE=1 SV=1
496,19889,sp|Q12905|ILF2_HUMAN,32.78,171.93,2.753E7,2.935E7,4.69E7,4.516E7,1.00,1.07,1.70,1.64,2.753E7,2.935E7,4.69E7,4.516E7,1.00,1.07,1.70,1.64,46,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),43062,Interleukin enhancer-binding factor 2 OS=Homo sapiens OX=9606 GN=ILF2 PE=1 SV=2
754,38760,A0A3B3IT15|A0A3B3IT15_HUMAN,10.35,171.73,1.294E7,1.243E7,1.724E7,1.712E7,1.00,0.96,1.33,1.32,1.294E7,1.243E7,1.724E7,1.712E7,1.00,0.96,1.33,1.32,17,19,19,iTRAQ 4plex (K  N-term),136020,Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=1
236,9170,sp|Q9Y224|RTRAF_HUMAN,18.69,171.55,1.855E8,1.868E8,2.613E8,2.525E8,1.00,1.01,1.41,1.36,1.855E8,1.868E8,2.613E8,2.525E8,1.00,1.01,1.41,1.36,57,18,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),28068,RNA transcription  translation and transport factor protein OS=Homo sapiens OX=9606 GN=RTRAF PE=1 SV=1
501,1420,sp|Q8IYB3-2|SRRM1_HUMAN,15.13,171.22,6.461E6,6.474E6,9.468E6,9.775E6,1.00,1.00,1.47,1.51,6.461E6,6.474E6,9.468E6,9.775E6,1.00,1.00,1.47,1.51,27,21,21,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),102126,Isoform 2 of Serine/arginine repetitive matrix protein 1 OS=Homo sapiens OX=9606 GN=SRRM1
675,5243,sp|Q6UN15|FIP1_HUMAN,22.72,171.20,9.833E5,1.019E6,1.59E6,1.584E6,1.00,1.04,1.62,1.61,9.833E5,1.019E6,1.59E6,1.584E6,1.00,1.04,1.62,1.61,11,13,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),66526,Pre-mRNA 3'-end-processing factor FIP1 OS=Homo sapiens OX=9606 GN=FIP1L1 PE=1 SV=1
821,22203,sp|Q6R327|RICTR_HUMAN,35.10,171.19,6.182E6,6.209E6,1.219E7,1.174E7,1.00,1.00,1.97,1.90,6.182E6,6.209E6,1.219E7,1.174E7,1.00,1.00,1.97,1.90,12,18,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),192216,Rapamycin-insensitive companion of mTOR OS=Homo sapiens OX=9606 GN=RICTOR PE=1 SV=1
669,13058,sp|Q7Z478|DHX29_HUMAN,20.09,171.01,2.888E7,2.755E7,1.539E7,1.507E7,1.00,0.95,0.53,0.52,2.888E7,2.755E7,1.539E7,1.507E7,1.00,0.95,0.53,0.52,16,20,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),155235,ATP-dependent RNA helicase DHX29 OS=Homo sapiens OX=9606 GN=DHX29 PE=1 SV=2
745,757,sp|Q9BSJ2|GCP2_HUMAN,48.48,170.89,1.437E7,1.487E7,3.166E7,3.057E7,1.00,1.03,2.20,2.13,1.437E7,1.487E7,3.166E7,3.057E7,1.00,1.03,2.20,2.13,22,18,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),102534,Gamma-tubulin complex component 2 OS=Homo sapiens OX=9606 GN=TUBGCP2 PE=1 SV=2
478,11785,sp|P09496-2|CLCA_HUMAN,6.35,170.88,1.026E8,1.015E8,8.692E7,8.933E7,1.00,0.99,0.85,0.87,1.026E8,1.015E8,8.692E7,8.933E7,1.00,0.99,0.85,0.87,52,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),23662,Isoform Non-brain of Clathrin light chain A OS=Homo sapiens OX=9606 GN=CLTA
482,838,sp|Q9H2D6-3|TARA_HUMAN,16.84,170.72,1.848E7,1.886E7,3.054E7,3.037E7,1.00,1.02,1.65,1.64,1.848E7,1.886E7,3.054E7,3.037E7,1.00,1.02,1.65,1.64,12,30,28,iTRAQ 4plex (K  N-term); Deamidation (NQ),243068,Isoform 4 of TRIO and F-actin-binding protein OS=Homo sapiens OX=9606 GN=TRIOBP
698,1951,sp|O43166-3|SI1L1_HUMAN,15.38,170.64,6.457E6,6.603E6,9.817E6,1.002E7,1.00,1.02,1.52,1.55,6.457E6,6.603E6,9.817E6,1.002E7,1.00,1.02,1.52,1.55,15,24,23,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),197407,Isoform 3 of Signal-induced proliferation-associated 1-like protein 1 OS=Homo sapiens OX=9606 GN=SIPA1L1
563,2454,sp|Q8NBJ5|GT251_HUMAN,11.53,170.52,4.366E7,4.14E7,5.606E7,5.526E7,1.00,0.95,1.28,1.27,4.366E7,4.14E7,5.606E7,5.526E7,1.00,0.95,1.28,1.27,29,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),71636,Procollagen galactosyltransferase 1 OS=Homo sapiens OX=9606 GN=COLGALT1 PE=1 SV=1
618,20293,sp|Q8N4C8|MINK1_HUMAN,22.41,170.51,1.839E6,1.828E6,3.482E6,3.421E6,1.00,0.99,1.89,1.86,1.839E6,1.828E6,3.482E6,3.421E6,1.00,0.99,1.89,1.86,9,21,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),149821,Misshapen-like kinase 1 OS=Homo sapiens OX=9606 GN=MINK1 PE=1 SV=2
495,19842,A0A2R8Y6J3|A0A2R8Y6J3_HUMAN,11.35,170.43,4.107E7,4.219E7,5.182E7,5.537E7,1.00,1.03,1.26,1.35,4.107E7,4.219E7,5.182E7,5.537E7,1.00,1.03,1.26,1.35,53,17,17,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),27045,60S ribosomal protein L5 (Fragment) OS=Homo sapiens OX=9606 GN=RPL5 PE=1 SV=1
672,19433,G3V4W0|G3V4W0_HUMAN,22.50,170.42,2.347E7,1.904E7,2.794E7,2.686E7,1.00,0.81,1.19,1.14,2.347E7,1.904E7,2.794E7,2.686E7,1.00,0.81,1.19,1.14,47,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),28916,Heterogeneous nuclear ribonucleoproteins C1/C2 (Fragment) OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=1
841,316,sp|Q13085|ACACA_HUMAN,8.06,170.37,8.246E6,7.777E6,1.01E7,9.778E6,1.00,0.94,1.23,1.19,8.246E6,7.777E6,1.01E7,9.778E6,1.00,0.94,1.23,1.19,8,17,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),265551,Acetyl-CoA carboxylase 1 OS=Homo sapiens OX=9606 GN=ACACA PE=1 SV=2
565,49,sp|Q8TB72|PUM2_HUMAN,2.80,170.36,6.641E4,7.983E4,1.512E5,1.569E5,1.00,1.20,2.28,2.36,6.641E4,7.983E4,1.512E5,1.569E5,1.00,1.20,2.28,2.36,2,18,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),114216,Pumilio homolog 2 OS=Homo sapiens OX=9606 GN=PUM2 PE=1 SV=2
498,8685,sp|P83111|LACTB_HUMAN,9.09,170.15,3.505E7,3.459E7,3.845E7,4.544E7,1.00,0.99,1.10,1.30,3.505E7,3.459E7,3.845E7,4.544E7,1.00,0.99,1.10,1.30,27,17,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),60694,Serine beta-lactamase-like protein LACTB  mitochondrial OS=Homo sapiens OX=9606 GN=LACTB PE=1 SV=2
474,12345,sp|O94973|AP2A2_HUMAN,7.81,169.92,7.924E6,7.513E6,9.592E6,9.969E6,1.00,0.95,1.21,1.26,7.924E6,7.513E6,9.592E6,9.969E6,1.00,0.95,1.21,1.26,15,20,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),103960,AP-2 complex subunit alpha-2 OS=Homo sapiens OX=9606 GN=AP2A2 PE=1 SV=2
549,38775,sp|Q9UQ80|PA2G4_HUMAN,15.94,169.92,2.357E7,2.395E7,3.187E7,3.301E7,1.00,1.02,1.35,1.40,2.357E7,2.395E7,3.187E7,3.301E7,1.00,1.02,1.35,1.40,37,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),43787,Proliferation-associated protein 2G4 OS=Homo sapiens OX=9606 GN=PA2G4 PE=1 SV=3
587,38758,sp|Q16666-2|IF16_HUMAN,15.01,169.73,1.253E7,1.258E7,1.835E7,1.844E7,1.00,1.00,1.46,1.47,1.253E7,1.258E7,1.835E7,1.844E7,1.00,1.00,1.46,1.47,29,18,18,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),82096,Isoform 2 of Gamma-interferon-inducible protein 16 OS=Homo sapiens OX=9606 GN=IFI16
558,48,sp|Q8TB72-3|PUM2_HUMAN,2.55,169.51,1.748E5,1.694E5,3.711E5,3.745E5,1.00,0.97,2.12,2.14,1.748E5,1.694E5,3.711E5,3.745E5,1.00,0.97,2.12,2.14,1,18,1,iTRAQ 4plex (K  N-term),114003,Isoform 3 of Pumilio homolog 2 OS=Homo sapiens OX=9606 GN=PUM2
585,326,A0A0A0MQS9|A0A0A0MQS9_HUMAN,5.86,169.10,2.102E7,2.027E7,2.357E7,2.526E7,1.00,0.96,1.12,1.20,2.102E7,2.027E7,2.357E7,2.526E7,1.00,0.96,1.12,1.20,12,25,24,iTRAQ 4plex (K  N-term); Deamidation (NQ),202567,Laminin subunit alpha-4 OS=Homo sapiens OX=9606 GN=LAMA4 PE=1 SV=1
410,12443,sp|P62424|RL7A_HUMAN,20.96,169.10,9.891E7,9.396E7,1.217E8,1.357E8,1.00,0.95,1.23,1.37,9.891E7,9.396E7,1.217E8,1.357E8,1.00,0.95,1.23,1.37,33,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),29996,60S ribosomal protein L7a OS=Homo sapiens OX=9606 GN=RPL7A PE=1 SV=2
671,10122,A0A096LP25|A0A096LP25_HUMAN,45.33,169.09,1.02E6,9.913E5,2.307E6,2.214E6,1.00,0.97,2.26,2.17,1.02E6,9.913E5,2.307E6,2.214E6,1.00,0.97,2.26,2.17,9,12,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),54448,AP2-associated protein kinase 1 (Fragment) OS=Homo sapiens OX=9606 GN=AAK1 PE=1 SV=1
884,2381,sp|Q9UHV7|MED13_HUMAN,10.59,169.02,6.79E6,6.839E6,9.165E6,9.197E6,1.00,1.01,1.35,1.35,6.79E6,6.839E6,9.165E6,9.197E6,1.00,1.01,1.35,1.35,9,15,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),239295,Mediator of RNA polymerase II transcription subunit 13 OS=Homo sapiens OX=9606 GN=MED13 PE=1 SV=3
768,14976,sp|Q9UEY8-2|ADDG_HUMAN,16.86,168.93,7.684E6,7.636E6,1.069E7,1.08E7,1.00,0.99,1.39,1.41,7.684E6,7.636E6,1.069E7,1.08E7,1.00,0.99,1.39,1.41,27,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),75671,Isoform 1 of Gamma-adducin OS=Homo sapiens OX=9606 GN=ADD3
712,19840,sp|Q92878|RAD50_HUMAN,15.94,168.61,7.222E6,6.635E6,1.026E7,1.009E7,1.00,0.92,1.42,1.40,7.222E6,6.635E6,1.026E7,1.009E7,1.00,0.92,1.42,1.40,17,23,22,iTRAQ 4plex (K  N-term); Deamidation (NQ),153892,DNA repair protein RAD50 OS=Homo sapiens OX=9606 GN=RAD50 PE=1 SV=1
883,19821,sp|O75592-2|MYCB2_HUMAN,7.29,168.40,5.544E6,5.488E6,7.329E6,7.31E6,1.00,0.99,1.32,1.32,5.544E6,5.488E6,7.329E6,7.31E6,1.00,0.99,1.32,1.32,5,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),513266,Isoform 2 of E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2
867,6493,sp|Q5VUJ6-2|LRCH2_HUMAN,24.80,168.36,6.993E6,7.103E6,1.125E7,1.107E7,1.00,1.02,1.61,1.58,6.993E6,7.103E6,1.125E7,1.107E7,1.00,1.02,1.61,1.58,19,13,12,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),82810,Isoform 2 of Leucine-rich repeat and calponin homology domain-containing protein 2 OS=Homo sapiens OX=9606 GN=LRCH2
801,6508,sp|Q4L180-3|FIL1L_HUMAN,40.50,168.21,5.372E6,5.147E6,8.738E6,8.86E6,1.00,0.96,1.63,1.65,5.372E6,5.147E6,8.738E6,8.86E6,1.00,0.96,1.63,1.65,21,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),102232,Isoform 3 of Filamin A-interacting protein 1-like OS=Homo sapiens OX=9606 GN=FILIP1L
810,10382,sp|P17812|PYRG1_HUMAN,5.52,168.17,1.224E7,1.273E7,1.452E7,1.41E7,1.00,1.04,1.19,1.15,1.224E7,1.273E7,1.452E7,1.41E7,1.00,1.04,1.19,1.15,30,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),66690,CTP synthase 1 OS=Homo sapiens OX=9606 GN=CTPS1 PE=1 SV=2
272,7120,sp|Q13151|ROA0_HUMAN,134.28,168.02,1.879E7,1.986E7,5.462E7,5.29E7,1.00,1.06,2.91,2.82,1.879E7,1.986E7,5.462E7,5.29E7,1.00,1.06,2.91,2.82,43,13,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),30841,Heterogeneous nuclear ribonucleoprotein A0 OS=Homo sapiens OX=9606 GN=HNRNPA0 PE=1 SV=1
812,21125,sp|P17302|CXA1_HUMAN,24.95,167.97,8.674E6,8.771E6,1.292E7,1.305E7,1.00,1.01,1.49,1.50,8.674E6,8.771E6,1.292E7,1.305E7,1.00,1.01,1.49,1.50,29,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),43008,Gap junction alpha-1 protein OS=Homo sapiens OX=9606 GN=GJA1 PE=1 SV=2
635,13431,sp|Q7L2H7|EIF3M_HUMAN,82.82,167.89,1.234E7,1.27E7,2.909E7,2.871E7,1.00,1.03,2.36,2.33,1.234E7,1.27E7,2.909E7,2.871E7,1.00,1.03,2.36,2.33,39,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),42503,Eukaryotic translation initiation factor 3 subunit M OS=Homo sapiens OX=9606 GN=EIF3M PE=1 SV=1
916,6747,sp|P01024|CO3_HUMAN,15.40,167.66,8.036E6,8.164E6,1.217E7,1.181E7,1.00,1.02,1.51,1.47,8.036E6,8.164E6,1.217E7,1.181E7,1.00,1.02,1.51,1.47,10,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),187147,Complement C3 OS=Homo sapiens OX=9606 GN=C3 PE=1 SV=2
955,19389,sp|Q14257|RCN2_HUMAN,24.81,167.63,3.426E6,3.581E6,5.415E6,5.444E6,1.00,1.05,1.58,1.59,3.426E6,3.581E6,5.415E6,5.444E6,1.00,1.05,1.58,1.59,39,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),36876,Reticulocalbin-2 OS=Homo sapiens OX=9606 GN=RCN2 PE=1 SV=1
695,627,sp|Q9Y2A7|NCKP1_HUMAN,19.84,167.42,1.217E7,1.169E7,2.061E7,2.06E7,1.00,0.96,1.69,1.69,1.217E7,1.169E7,2.061E7,2.06E7,1.00,0.96,1.69,1.69,18,20,20,iTRAQ 4plex (K  N-term); Deamidation (NQ),128790,Nck-associated protein 1 OS=Homo sapiens OX=9606 GN=NCKAP1 PE=1 SV=1
941,24800,sp|Q99569|PKP4_HUMAN,36.80,167.32,6.078E6,6.059E6,1.086E7,1.083E7,1.00,1.00,1.79,1.78,6.078E6,6.059E6,1.086E7,1.083E7,1.00,1.00,1.79,1.78,16,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),131868,Plakophilin-4 OS=Homo sapiens OX=9606 GN=PKP4 PE=1 SV=2
224,5683,sp|P23396|RS3_HUMAN,41.04,166.95,1.558E8,1.609E8,2.709E8,2.623E8,1.00,1.03,1.74,1.68,1.558E8,1.609E8,2.709E8,2.623E8,1.00,1.03,1.74,1.68,66,17,17,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),26688,40S ribosomal protein S3 OS=Homo sapiens OX=9606 GN=RPS3 PE=1 SV=2
415,12351,sp|P62277|RS13_HUMAN,32.07,166.72,1.214E8,1.253E8,1.979E8,1.957E8,1.00,1.03,1.63,1.61,1.214E8,1.253E8,1.979E8,1.957E8,1.00,1.03,1.63,1.61,62,16,16,iTRAQ 4plex (K  N-term),17222,40S ribosomal protein S13 OS=Homo sapiens OX=9606 GN=RPS13 PE=1 SV=2
688,13,sp|P50402|EMD_HUMAN,39.40,166.70,1.211E7,1.048E7,1.887E7,1.887E7,1.00,0.87,1.56,1.56,1.211E7,1.048E7,1.887E7,1.887E7,1.00,0.87,1.56,1.56,51,12,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),28994,Emerin OS=Homo sapiens OX=9606 GN=EMD PE=1 SV=1
344,7437,sp|P15880|RS2_HUMAN,32.60,166.65,1.594E8,1.654E8,2.573E8,2.48E8,1.00,1.04,1.61,1.56,1.594E8,1.654E8,2.573E8,2.48E8,1.00,1.04,1.61,1.56,39,15,15,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),31324,40S ribosomal protein S2 OS=Homo sapiens OX=9606 GN=RPS2 PE=1 SV=2
388,1268,sp|Q15366-5|PCBP2_HUMAN,6.67,166.64,1.801E6,1.84E6,2.728E6,2.76E6,1.00,1.02,1.51,1.53,1.801E6,1.84E6,2.728E6,2.76E6,1.00,1.02,1.51,1.53,7,13,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),35347,Isoform 5 of Poly(rC)-binding protein 2 OS=Homo sapiens OX=9606 GN=PCBP2
658,2005,sp|O94875-3|SRBS2_HUMAN,75.51,166.59,6.921E6,7.314E6,1.87E7,1.876E7,1.00,1.06,2.70,2.71,6.921E6,7.314E6,1.87E7,1.876E7,1.00,1.06,2.70,2.71,25,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),71899,Isoform 3 of Sorbin and SH3 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SORBS2
785,7694,sp|P41252|SYIC_HUMAN,8.31,166.13,7.112E6,7.208E6,9.304E6,9.102E6,1.00,1.01,1.31,1.28,7.112E6,7.208E6,9.304E6,9.102E6,1.00,1.01,1.31,1.28,14,17,16,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),144498,Isoleucine--tRNA ligase  cytoplasmic OS=Homo sapiens OX=9606 GN=IARS PE=1 SV=2
638,664,sp|P02533|K1C14_HUMAN,129.10,166.08,2.381E6,5.744E5,7.548E5,7.16E5,1.00,0.24,0.32,0.30,2.381E6,5.744E5,7.548E5,7.16E5,1.00,0.24,0.32,0.30,10,15,3,iTRAQ 4plex (K  N-term),51562,Keratin  type I cytoskeletal 14 OS=Homo sapiens OX=9606 GN=KRT14 PE=1 SV=4
676,14208,sp|P05198|IF2A_HUMAN,16.02,165.78,1.629E7,1.617E7,2.277E7,2.322E7,1.00,0.99,1.40,1.43,1.629E7,1.617E7,2.277E7,2.322E7,1.00,0.99,1.40,1.43,42,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),36112,Eukaryotic translation initiation factor 2 subunit 1 OS=Homo sapiens OX=9606 GN=EIF2S1 PE=1 SV=3
982,4710,sp|Q15032|R3HD1_HUMAN,21.38,165.72,5.039E6,5.163E6,7.772E6,7.415E6,1.00,1.02,1.54,1.47,5.039E6,5.163E6,7.772E6,7.415E6,1.00,1.02,1.54,1.47,15,14,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),120696,R3H domain-containing protein 1 OS=Homo sapiens OX=9606 GN=R3HDM1 PE=1 SV=3
425,4552,sp|Q16630|CPSF6_HUMAN,56.94,165.67,2.083E7,2.23E7,4.895E7,4.716E7,1.00,1.07,2.35,2.26,2.083E7,2.23E7,4.895E7,4.716E7,1.00,1.07,2.35,2.26,25,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),59210,Cleavage and polyadenylation specificity factor subunit 6 OS=Homo sapiens OX=9606 GN=CPSF6 PE=1 SV=2
732,3467,sp|O15021-2|MAST4_HUMAN,29.56,165.64,3.185E6,3.013E6,5.728E6,5.705E6,1.00,0.95,1.80,1.79,3.185E6,3.013E6,5.728E6,5.705E6,1.00,0.95,1.80,1.79,8,21,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),264759,Isoform 2 of Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens OX=9606 GN=MAST4
647,20878,sp|Q99816|TS101_HUMAN,92.75,165.45,8.975E6,8.872E6,2.347E7,2.284E7,1.00,0.99,2.62,2.55,8.975E6,8.872E6,2.347E7,2.284E7,1.00,0.99,2.62,2.55,39,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),43944,Tumor susceptibility gene 101 protein OS=Homo sapiens OX=9606 GN=TSG101 PE=1 SV=2
697,12354,sp|O94929-3|ABLM3_HUMAN,21.45,165.27,1.61E7,1.673E7,2.68E7,2.652E7,1.00,1.04,1.66,1.65,1.61E7,1.673E7,2.68E7,2.652E7,1.00,1.04,1.66,1.65,29,17,17,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),67073,Isoform 3 of Actin-binding LIM protein 3 OS=Homo sapiens OX=9606 GN=ABLIM3
683,12262,H7C422|H7C422_HUMAN,2.37,165.24,2.603E6,2.529E6,5.04E6,5.32E6,1.00,0.97,1.94,2.04,2.603E6,2.529E6,5.04E6,5.32E6,1.00,0.97,1.94,2.04,4,11,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),34968,60S ribosomal protein L3 (Fragment) OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=1
526,19346,sp|Q99729-3|ROAA_HUMAN,1.51,165.18,4.238E5,4.5E5,6.993E5,6.316E5,1.00,1.06,1.65,1.49,4.238E5,4.5E5,6.993E5,6.316E5,1.00,1.06,1.65,1.49,6,13,1,iTRAQ 4plex (K  N-term),30588,Isoform 3 of Heterogeneous nuclear ribonucleoprotein A/B OS=Homo sapiens OX=9606 GN=HNRNPAB
356,10182,sp|P35555|FBN1_HUMAN,59.03,165.08,4.366E7,4.086E7,1.024E8,9.742E7,1.00,0.94,2.35,2.23,4.366E7,4.086E7,1.024E8,9.742E7,1.00,0.94,2.35,2.23,6,20,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),312237,Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=3
419,11161,sp|Q07955|SRSF1_HUMAN,14.25,164.90,4.719E7,4.817E7,6.34E7,6.387E7,1.00,1.02,1.34,1.35,4.719E7,4.817E7,6.34E7,6.387E7,1.00,1.02,1.34,1.35,49,13,13,iTRAQ 4plex (K  N-term); Phosphorylation (STY),27745,Serine/arginine-rich splicing factor 1 OS=Homo sapiens OX=9606 GN=SRSF1 PE=1 SV=2
885,880,sp|P47897-2|SYQ_HUMAN,5.64,164.75,4.582E6,4.535E6,5.623E6,5.647E6,1.00,0.99,1.23,1.23,4.582E6,4.535E6,5.623E6,5.647E6,1.00,0.99,1.23,1.23,22,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),86579,Isoform 2 of Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS
728,20098,sp|P13674-3|P4HA1_HUMAN,15.54,164.68,1.391E7,1.33E7,2.002E7,2.006E7,1.00,0.96,1.44,1.44,1.391E7,1.33E7,2.002E7,2.006E7,1.00,0.96,1.44,1.44,29,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),58958,Isoform 3 of Prolyl 4-hydroxylase subunit alpha-1 OS=Homo sapiens OX=9606 GN=P4HA1
877,14145,sp|P06733|ENOA_HUMAN,6.00,164.66,9.281E6,9.068E6,1.079E7,1.088E7,1.00,0.98,1.16,1.17,9.281E6,9.068E6,1.079E7,1.088E7,1.00,0.98,1.16,1.17,36,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),47169,Alpha-enolase OS=Homo sapiens OX=9606 GN=ENO1 PE=1 SV=2
701,19525,sp|O75400-3|PR40A_HUMAN,16.01,164.57,1.041E7,1.033E7,1.616E7,1.481E7,1.00,0.99,1.55,1.42,1.041E7,1.033E7,1.616E7,1.481E7,1.00,0.99,1.55,1.42,21,17,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),106907,Isoform 3 of Pre-mRNA-processing factor 40 homolog A OS=Homo sapiens OX=9606 GN=PRPF40A
559,10432,sp|P19474|RO52_HUMAN,6.20,164.55,3.147E7,2.569E7,2.702E7,2.662E7,1.00,0.82,0.86,0.85,3.147E7,2.569E7,2.702E7,2.662E7,1.00,0.82,0.86,0.85,33,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),54170,E3 ubiquitin-protein ligase TRIM21 OS=Homo sapiens OX=9606 GN=TRIM21 PE=1 SV=1
751,3353,sp|Q63ZY3-3|KANK2_HUMAN,27.72,164.30,8.768E6,8.306E6,1.522E7,1.527E7,1.00,0.95,1.74,1.74,8.768E6,8.306E6,1.522E7,1.527E7,1.00,0.95,1.74,1.74,24,19,16,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),90044,Isoform 3 of KN motif and ankyrin repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=KANK2
353,15629,A0A2R8Y811|A0A2R8Y811_HUMAN,25.10,164.29,5.344E7,5.376E7,8.021E7,8.054E7,1.00,1.01,1.50,1.51,5.344E7,5.376E7,8.021E7,8.054E7,1.00,1.01,1.50,1.51,51,11,11,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),16160,40S ribosomal protein S14 (Fragment) OS=Homo sapiens OX=9606 GN=RPS14 PE=1 SV=1
828,908,sp|P55072|TERA_HUMAN,11.72,164.26,6.213E6,5.082E6,7.239E6,7.349E6,1.00,0.82,1.17,1.18,6.213E6,5.082E6,7.239E6,7.349E6,1.00,0.82,1.17,1.18,25,17,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),89322,Transitional endoplasmic reticulum ATPase OS=Homo sapiens OX=9606 GN=VCP PE=1 SV=4
716,2631,H3BQQ2|H3BQQ2_HUMAN,37.51,163.94,8.058E6,8.236E6,1.602E7,1.575E7,1.00,1.02,1.99,1.96,8.058E6,8.236E6,1.602E7,1.575E7,1.00,1.02,1.99,1.96,23,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),93288,E3 ubiquitin-protein ligase ZNF598 OS=Homo sapiens OX=9606 GN=ZNF598 PE=1 SV=1
483,19404,sp|P62829|RL23_HUMAN,28.95,163.89,4.68E7,4.858E7,7.159E7,7.315E7,1.00,1.04,1.53,1.56,4.68E7,4.858E7,7.159E7,7.315E7,1.00,1.04,1.53,1.56,60,10,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),14865,60S ribosomal protein L23 OS=Homo sapiens OX=9606 GN=RPL23 PE=1 SV=1
775,19339,sp|Q9Y3F4|STRAP_HUMAN,31.37,163.84,1.065E7,1.075E7,1.803E7,1.78E7,1.00,1.01,1.69,1.67,1.065E7,1.075E7,1.803E7,1.78E7,1.00,1.01,1.69,1.67,38,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),38438,Serine-threonine kinase receptor-associated protein OS=Homo sapiens OX=9606 GN=STRAP PE=1 SV=1
662,14455,sp|P50479|PDLI4_HUMAN,101.64,163.73,1.252E7,1.2E7,2.983E7,3.006E7,1.00,0.96,2.38,2.40,1.252E7,1.2E7,2.983E7,3.006E7,1.00,0.96,2.38,2.40,41,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),35398,PDZ and LIM domain protein 4 OS=Homo sapiens OX=9606 GN=PDLIM4 PE=1 SV=2
752,22223,sp|Q7KZI7-16|MARK2_HUMAN,17.68,163.49,2.7E6,2.615E6,4.453E6,4.386E6,1.00,0.97,1.65,1.62,2.7E6,2.615E6,4.453E6,4.386E6,1.00,0.97,1.65,1.62,22,19,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),81209,Isoform 16 of Serine/threonine-protein kinase MARK2 OS=Homo sapiens OX=9606 GN=MARK2
630,4138,Q5VW30|Q5VW30_HUMAN,38.72,163.39,5.872E6,5.896E6,1.153E7,1.112E7,1.00,1.00,1.96,1.89,5.872E6,5.896E6,1.153E7,1.112E7,1.00,1.00,1.96,1.89,31,13,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),62617,Nuclear factor 1 OS=Homo sapiens OX=9606 GN=NFIB PE=1 SV=1
739,38831,sp|P35442|TSP2_HUMAN,17.40,163.34,3.916E6,3.976E6,6.245E6,6.379E6,1.00,1.02,1.59,1.63,3.916E6,3.976E6,6.245E6,6.379E6,1.00,1.02,1.59,1.63,6,13,6,iTRAQ 4plex (K  N-term),129991,Thrombospondin-2 OS=Homo sapiens OX=9606 GN=THBS2 PE=1 SV=2
1006,6146,sp|P17987|TCPA_HUMAN,6.46,163.29,5.238E6,4.786E6,5.962E6,5.973E6,1.00,0.91,1.14,1.14,5.238E6,4.786E6,5.962E6,5.973E6,1.00,0.91,1.14,1.14,31,15,13,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),60344,T-complex protein 1 subunit alpha OS=Homo sapiens OX=9606 GN=TCP1 PE=1 SV=1
689,4927,sp|Q14677|EPN4_HUMAN,43.11,163.08,1.234E7,1.049E7,2.159E7,2.151E7,1.00,0.85,1.75,1.74,1.234E7,1.049E7,2.159E7,2.151E7,1.00,0.85,1.75,1.74,24,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),68259,Clathrin interactor 1 OS=Homo sapiens OX=9606 GN=CLINT1 PE=1 SV=1
719,10995,sp|P50454|SERPH_HUMAN,8.97,163.04,1.615E7,1.458E7,1.974E7,1.944E7,1.00,0.90,1.22,1.20,1.615E7,1.458E7,1.974E7,1.944E7,1.00,0.90,1.22,1.20,40,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),46441,Serpin H1 OS=Homo sapiens OX=9606 GN=SERPINH1 PE=1 SV=2
958,10372,J3KMX2|J3KMX2_HUMAN,8.99,162.71,4.897E6,5.17E6,6.527E6,6.46E6,1.00,1.06,1.33,1.32,4.897E6,5.17E6,6.527E6,6.46E6,1.00,1.06,1.33,1.32,29,13,10,iTRAQ 4plex (K  N-term),52238,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 OS=Homo sapiens OX=9606 GN=SMARCD2 PE=1 SV=1
335,20457,sp|P46778|RL21_HUMAN,18.52,162.66,6.856E7,6.752E7,8.752E7,9.491E7,1.00,0.98,1.28,1.38,6.856E7,6.752E7,8.752E7,9.491E7,1.00,0.98,1.28,1.38,57,19,19,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),18565,60S ribosomal protein L21 OS=Homo sapiens OX=9606 GN=RPL21 PE=1 SV=2
292,18567,sp|P62249|RS16_HUMAN,18.48,162.45,1.588E8,1.639E8,2.294E8,2.291E8,1.00,1.03,1.44,1.44,1.588E8,1.639E8,2.294E8,2.291E8,1.00,1.03,1.44,1.44,66,18,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),16445,40S ribosomal protein S16 OS=Homo sapiens OX=9606 GN=RPS16 PE=1 SV=2
774,10096,A0A096LNZ0|A0A096LNZ0_HUMAN,8.12,162.29,9.897E4,9.693E4,2.003E5,1.756E5,1.00,0.98,2.02,1.77,9.897E4,9.693E4,2.003E5,1.756E5,1.00,0.98,2.02,1.77,10,9,1,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),36316,AP2-associated protein kinase 1 (Fragment) OS=Homo sapiens OX=9606 GN=AAK1 PE=1 SV=6
837,5811,sp|P23258|TBG1_HUMAN,42.10,162.23,1.311E7,1.368E7,2.447E7,2.447E7,1.00,1.04,1.87,1.87,1.311E7,1.368E7,2.447E7,2.447E7,1.00,1.04,1.87,1.87,39,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),51170,Tubulin gamma-1 chain OS=Homo sapiens OX=9606 GN=TUBG1 PE=1 SV=2
856,1708,sp|P30153|2AAA_HUMAN,45.46,162.19,1.083E7,1.056E7,1.98E7,1.928E7,1.00,0.98,1.83,1.78,1.083E7,1.056E7,1.98E7,1.928E7,1.00,0.98,1.83,1.78,22,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),65309,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform OS=Homo sapiens OX=9606 GN=PPP2R1A PE=1 SV=4
736,6048,sp|Q96J02-2|ITCH_HUMAN,35.16,162.04,6.644E6,6.734E6,1.284E7,1.225E7,1.00,1.01,1.93,1.84,6.644E6,6.734E6,1.284E7,1.225E7,1.00,1.01,1.93,1.84,18,18,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),98676,Isoform 2 of E3 ubiquitin-protein ligase Itchy homolog OS=Homo sapiens OX=9606 GN=ITCH
571,800,sp|O60568|PLOD3_HUMAN,6.08,161.66,2.837E7,2.84E7,3.472E7,3.413E7,1.00,1.00,1.22,1.20,2.837E7,2.84E7,3.472E7,3.413E7,1.00,1.00,1.22,1.20,21,17,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),84785,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 OS=Homo sapiens OX=9606 GN=PLOD3 PE=1 SV=1
494,19700,sp|P62906|RL10A_HUMAN,14.21,161.65,8.091E7,8.089E7,9.886E7,1.079E8,1.00,1.00,1.22,1.33,8.091E7,8.089E7,9.886E7,1.079E8,1.00,1.00,1.22,1.33,35,10,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),24831,60S ribosomal protein L10a OS=Homo sapiens OX=9606 GN=RPL10A PE=1 SV=2
898,706,sp|P05783|K1C18_HUMAN,14.53,161.49,3.788E6,3.775E6,5.08E6,5.212E6,1.00,1.00,1.34,1.38,3.788E6,3.775E6,5.08E6,5.212E6,1.00,1.00,1.34,1.38,31,13,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),48058,Keratin  type I cytoskeletal 18 OS=Homo sapiens OX=9606 GN=KRT18 PE=1 SV=2
717,20189,sp|O95104|SFR15_HUMAN,16.21,161.36,6.259E6,6.495E6,9.424E6,9.249E6,1.00,1.04,1.51,1.48,6.259E6,6.495E6,9.424E6,9.249E6,1.00,1.04,1.51,1.48,15,14,11,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),125869,Splicing factor  arginine/serine-rich 15 OS=Homo sapiens OX=9606 GN=SCAF4 PE=1 SV=3
930,4903,sp|P42167|LAP2B_HUMAN,21.33,161.36,2.73E6,2.692E6,5.135E6,5.293E6,1.00,0.99,1.88,1.94,2.73E6,2.692E6,5.135E6,5.293E6,1.00,0.99,1.88,1.94,12,10,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),50670,Lamina-associated polypeptide 2  isoforms beta/gamma OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2
914,4663,sp|Q9P2E3|ZNFX1_HUMAN,21.55,161.36,3.885E6,3.892E6,6.654E6,6.382E6,1.00,1.00,1.71,1.64,3.885E6,3.892E6,6.654E6,6.382E6,1.00,1.00,1.71,1.64,9,15,15,iTRAQ 4plex (K  N-term),220225,NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=2 SV=2
574,19374,D6RBZ0|D6RBZ0_HUMAN,1.53,161.06,1.33E5,1.528E5,2.231E5,1.778E5,1.00,1.15,1.68,1.34,1.33E5,1.528E5,2.231E5,1.778E5,1.00,1.15,1.68,1.34,6,13,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),35682,Heterogeneous nuclear ribonucleoprotein A/B OS=Homo sapiens OX=9606 GN=HNRNPAB PE=1 SV=1
1004,17881,sp|P14625|ENPL_HUMAN,6.55,160.90,8.476E6,8.385E6,1.061E7,1.055E7,1.00,0.99,1.25,1.24,8.476E6,8.385E6,1.061E7,1.055E7,1.00,0.99,1.25,1.24,16,15,13,iTRAQ 4plex (K  N-term),92469,Endoplasmin OS=Homo sapiens OX=9606 GN=HSP90B1 PE=1 SV=1
1056,38769,sp|Q6ZRV2|FA83H_HUMAN,12.91,160.62,2.548E6,2.554E6,3.842E6,3.761E6,1.00,1.00,1.51,1.48,2.548E6,2.554E6,3.842E6,3.761E6,1.00,1.00,1.51,1.48,15,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),127122,Protein FAM83H OS=Homo sapiens OX=9606 GN=FAM83H PE=1 SV=3
657,19468,sp|P05387|RLA2_HUMAN,41.76,160.61,4.555E7,2.931E7,4.135E7,5.492E7,1.00,0.64,0.91,1.21,4.555E7,2.931E7,4.135E7,5.492E7,1.00,0.64,0.91,1.21,77,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),11665,60S acidic ribosomal protein P2 OS=Homo sapiens OX=9606 GN=RPLP2 PE=1 SV=1
582,5885,H7BXY5|H7BXY5_HUMAN,16.55,160.59,2.215E7,2.056E7,2.408E7,3E7,1.00,0.93,1.09,1.35,2.215E7,2.056E7,2.408E7,3E7,1.00,0.93,1.09,1.35,31,20,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),68934,Nexilin (Fragment) OS=Homo sapiens OX=9606 GN=NEXN PE=1 SV=1
974,13184,sp|Q9NVC6|MED17_HUMAN,13.13,160.54,8.699E6,8.905E6,1.228E7,1.237E7,1.00,1.02,1.41,1.42,8.699E6,8.905E6,1.228E7,1.237E7,1.00,1.02,1.41,1.42,22,14,14,iTRAQ 4plex (K  N-term),72890,Mediator of RNA polymerase II transcription subunit 17 OS=Homo sapiens OX=9606 GN=MED17 PE=1 SV=2
969,6782,sp|Q9UHX1-4|PUF60_HUMAN,23.09,160.47,5.111E6,5.448E6,7.879E6,7.607E6,1.00,1.07,1.54,1.49,5.111E6,5.448E6,7.879E6,7.607E6,1.00,1.07,1.54,1.49,30,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),54025,Isoform 4 of Poly(U)-binding-splicing factor PUF60 OS=Homo sapiens OX=9606 GN=PUF60
317,7,sp|A0A075B6S2|KVD29_HUMAN,2.93,160.26,1.495E6,1.443E6,3.47E6,3.338E6,1.00,0.97,2.32,2.23,1.495E6,1.443E6,3.47E6,3.338E6,1.00,0.97,2.32,2.23,9,12,1,iTRAQ 4plex (K  N-term),13143,Immunoglobulin kappa variable 2D-29 OS=Homo sapiens OX=9606 GN=IGKV2D-29 PE=3 SV=1
705,4267,sp|O60504|VINEX_HUMAN,45.66,160.10,1.222E7,1.297E7,2.543E7,2.515E7,1.00,1.06,2.08,2.06,1.222E7,1.297E7,2.543E7,2.515E7,1.00,1.06,2.08,2.06,20,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),75341,Vinexin OS=Homo sapiens OX=9606 GN=SORBS3 PE=1 SV=2
502,6091,sp|Q63HR2-6|TNS2_HUMAN,34.84,160.10,3.853E6,4.092E6,7.558E6,7.036E6,1.00,1.06,1.96,1.83,3.853E6,4.092E6,7.558E6,7.036E6,1.00,1.06,1.96,1.83,12,14,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),152452,Isoform 6 of Tensin-2 OS=Homo sapiens OX=9606 GN=TNS2
400,19485,sp|P16403|H12_HUMAN,11.12,160.04,2.658E6,2.493E6,3.624E6,3.906E6,1.00,0.94,1.36,1.47,2.658E6,2.493E6,3.624E6,3.906E6,1.00,0.94,1.36,1.47,19,15,5,iTRAQ 4plex (K  N-term),21365,Histone H1.2 OS=Homo sapiens OX=9606 GN=HIST1H1C PE=1 SV=2
531,9245,sp|Q9Y4K0|LOXL2_HUMAN,18.39,159.70,1.848E7,1.914E7,2.843E7,2.649E7,1.00,1.04,1.54,1.43,1.848E7,1.914E7,2.843E7,2.649E7,1.00,1.04,1.54,1.43,16,14,11,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),86725,Lysyl oxidase homolog 2 OS=Homo sapiens OX=9606 GN=LOXL2 PE=1 SV=1
569,20649,sp|P61313|RL15_HUMAN,13.42,159.68,4.292E7,4.262E7,5.273E7,5.834E7,1.00,0.99,1.23,1.36,4.292E7,4.262E7,5.273E7,5.834E7,1.00,0.99,1.23,1.36,55,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),24146,60S ribosomal protein L15 OS=Homo sapiens OX=9606 GN=RPL15 PE=1 SV=2
396,19342,sp|P06748|NPM_HUMAN,28.64,159.26,7.431E7,5.856E7,8.293E7,9.578E7,1.00,0.79,1.12,1.29,7.431E7,5.856E7,8.293E7,9.578E7,1.00,0.79,1.12,1.29,37,15,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),32575,Nucleophosmin OS=Homo sapiens OX=9606 GN=NPM1 PE=1 SV=2
720,15647,sp|P50552|VASP_HUMAN,92.62,159.20,5.153E6,5.185E6,1.471E7,1.438E7,1.00,1.01,2.85,2.79,5.153E6,5.185E6,1.471E7,1.438E7,1.00,1.01,2.85,2.79,34,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),39830,Vasodilator-stimulated phosphoprotein OS=Homo sapiens OX=9606 GN=VASP PE=1 SV=3
857,24107,Q5STZ8|Q5STZ8_HUMAN,3.53,159.14,6.261E4,6.427E4,1.055E5,1.043E5,1.00,1.03,1.68,1.67,6.261E4,6.427E4,1.055E5,1.043E5,1.00,1.03,1.68,1.67,4,12,2,iTRAQ 4plex (K  N-term),38319,ATP-binding cassette sub-family F member 1 (Fragment) OS=Homo sapiens OX=9606 GN=ABCF1 PE=1 SV=9
1032,24724,A0A087WZ13|A0A087WZ13_HUMAN,65.12,159.06,3.668E6,3.653E6,9.271E6,9.115E6,1.00,1.00,2.53,2.48,3.668E6,3.653E6,9.271E6,9.115E6,1.00,1.00,2.53,2.48,24,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),77844,Ribonucleoprotein PTB-binding 1 OS=Homo sapiens OX=9606 GN=RAVER1 PE=1 SV=1
633,19344,sp|P21291|CSRP1_HUMAN,100.06,159.03,1.89E7,1.937E7,4.633E7,4.365E7,1.00,1.03,2.45,2.31,1.89E7,1.937E7,4.633E7,4.365E7,1.00,1.03,2.45,2.31,47,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),20567,Cysteine and glycine-rich protein 1 OS=Homo sapiens OX=9606 GN=CSRP1 PE=1 SV=3
804,23062,H0YLY0|H0YLY0_HUMAN,2.58,158.99,3.872E4,2.203E4,4.948E4,3.592E4,1.00,0.57,1.28,0.93,3.872E4,2.203E4,4.948E4,3.592E4,1.00,0.57,1.28,0.93,5,16,1,iTRAQ 4plex (K  N-term),74522,Serine/threonine-protein kinase MRCK beta (Fragment) OS=Homo sapiens OX=9606 GN=CDC42BPB PE=1 SV=8
893,21765,sp|Q8NFW8|NEUA_HUMAN,50.12,158.97,7.464E6,7.709E6,1.378E7,1.327E7,1.00,1.03,1.85,1.78,7.464E6,7.709E6,1.378E7,1.327E7,1.00,1.03,1.85,1.78,25,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),48379,N-acylneuraminate cytidylyltransferase OS=Homo sapiens OX=9606 GN=CMAS PE=1 SV=2
517,15089,sp|Q15052|ARHG6_HUMAN,36.86,158.90,4.398E6,4.562E6,1.112E7,1.062E7,1.00,1.04,2.53,2.42,4.398E6,4.562E6,1.112E7,1.062E7,1.00,1.04,2.53,2.42,10,15,7,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),87499,Rho guanine nucleotide exchange factor 6 OS=Homo sapiens OX=9606 GN=ARHGEF6 PE=1 SV=2
322,19567,sp|P62750|RL23A_HUMAN,25.70,158.86,1.451E8,1.47E8,2.254E8,2.284E8,1.00,1.01,1.55,1.57,1.451E8,1.47E8,2.254E8,2.284E8,1.00,1.01,1.55,1.57,51,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),17695,60S ribosomal protein L23a OS=Homo sapiens OX=9606 GN=RPL23A PE=1 SV=1
588,13639,F8W8I6|F8W8I6_HUMAN,1.15,158.83,1.013E5,9.814E4,1.474E5,1.397E5,1.00,0.97,1.45,1.38,1.013E5,9.814E4,1.474E5,1.397E5,1.00,0.97,1.45,1.38,3,14,1,iTRAQ 4plex (K  N-term),42835,Nucleolysin TIA-1 isoform p40 OS=Homo sapiens OX=9606 GN=TIA1 PE=1 SV=1
866,38772,sp|P78559|MAP1A_HUMAN,12.79,158.80,4.155E6,4.006E6,5.96E6,6.097E6,1.00,0.96,1.43,1.47,4.155E6,4.006E6,5.96E6,6.097E6,1.00,0.96,1.43,1.47,8,17,15,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),305484,Microtubule-associated protein 1A OS=Homo sapiens OX=9606 GN=MAP1A PE=1 SV=6
1228,12477,sp|Q8IUX7|AEBP1_HUMAN,26.64,158.75,3.098E6,3.073E6,4.701E6,4.689E6,1.00,0.99,1.52,1.51,3.098E6,3.073E6,4.701E6,4.689E6,1.00,0.99,1.52,1.51,10,10,10,iTRAQ 4plex (K  N-term),130929,Adipocyte enhancer-binding protein 1 OS=Homo sapiens OX=9606 GN=AEBP1 PE=1 SV=1
735,7570,sp|Q9HAU4|SMUF2_HUMAN,24.34,158.67,8.904E6,9.08E6,1.665E7,1.597E7,1.00,1.02,1.87,1.79,8.904E6,9.08E6,1.665E7,1.597E7,1.00,1.02,1.87,1.79,23,19,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),86196,E3 ubiquitin-protein ligase SMURF2 OS=Homo sapiens OX=9606 GN=SMURF2 PE=1 SV=1
952,19333,sp|P13797|PLST_HUMAN,9.52,158.56,8.516E6,8.09E6,1.142E7,1.119E7,1.00,0.95,1.34,1.31,8.516E6,8.09E6,1.142E7,1.119E7,1.00,0.95,1.34,1.31,27,15,15,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term),70811,Plastin-3 OS=Homo sapiens OX=9606 GN=PLS3 PE=1 SV=4
677,1728,sp|P63104|1433Z_HUMAN,40.45,158.32,5.406E6,5.01E6,9.997E6,1.015E7,1.00,0.93,1.85,1.88,5.406E6,5.01E6,9.997E6,1.015E7,1.00,0.93,1.85,1.88,44,13,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),27745,14-3-3 protein zeta/delta OS=Homo sapiens OX=9606 GN=YWHAZ PE=1 SV=1
803,8296,sp|P49756|RBM25_HUMAN,39.00,158.31,7.951E6,7.791E6,1.415E7,1.401E7,1.00,0.98,1.78,1.76,7.951E6,7.791E6,1.415E7,1.401E7,1.00,0.98,1.78,1.76,16,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),100186,RNA-binding protein 25 OS=Homo sapiens OX=9606 GN=RBM25 PE=1 SV=3
789,11782,sp|Q15417|CNN3_HUMAN,58.57,158.31,4.661E6,4.827E6,1.041E7,1.101E7,1.00,1.04,2.23,2.36,4.661E6,4.827E6,1.041E7,1.101E7,1.00,1.04,2.23,2.36,36,11,8,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),36414,Calponin-3 OS=Homo sapiens OX=9606 GN=CNN3 PE=1 SV=1
690,3570,sp|P30101|PDIA3_HUMAN,15.51,158.19,1.349E7,1.372E7,2.047E7,2.018E7,1.00,1.02,1.52,1.50,1.349E7,1.372E7,2.047E7,2.018E7,1.00,1.02,1.52,1.50,32,15,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),56782,Protein disulfide-isomerase A3 OS=Homo sapiens OX=9606 GN=PDIA3 PE=1 SV=4
890,9599,sp|Q01813|PFKAP_HUMAN,20.31,158.17,7.411E6,7.337E6,1.191E7,1.172E7,1.00,0.99,1.61,1.58,7.411E6,7.337E6,1.191E7,1.172E7,1.00,0.99,1.61,1.58,15,12,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),85596,ATP-dependent 6-phosphofructokinase  platelet type OS=Homo sapiens OX=9606 GN=PFKP PE=1 SV=2
843,7897,A0A1W2PNZ9|A0A1W2PNZ9_HUMAN,44.40,158.17,4.493E6,4.6E6,1.134E7,1.115E7,1.00,1.02,2.52,2.48,4.493E6,4.6E6,1.134E7,1.115E7,1.00,1.02,2.52,2.48,9,18,18,iTRAQ 4plex (K  N-term); Deamidation (NQ),263137,Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens OX=9606 GN=JMJD1C PE=1 SV=1
714,17954,sp|Q7L7X3|TAOK1_HUMAN,27.01,158.17,4.12E6,4.119E6,8.033E6,7.983E6,1.00,1.00,1.95,1.94,4.12E6,4.119E6,8.033E6,7.983E6,1.00,1.00,1.95,1.94,17,21,16,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),116070,Serine/threonine-protein kinase TAO1 OS=Homo sapiens OX=9606 GN=TAOK1 PE=1 SV=1
726,24357,sp|P41091|IF2G_HUMAN,25.10,158.05,1.855E7,1.799E7,2.835E7,2.93E7,1.00,0.97,1.53,1.58,1.855E7,1.799E7,2.835E7,2.93E7,1.00,0.97,1.53,1.58,26,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),51110,Eukaryotic translation initiation factor 2 subunit 3 OS=Homo sapiens OX=9606 GN=EIF2S3 PE=1 SV=3
832,2157,A0A2R8YFW3|A0A2R8YFW3_HUMAN,2.91,157.99,1.417E6,1.432E6,1.614E6,1.611E6,1.00,1.01,1.14,1.14,1.417E6,1.432E6,1.614E6,1.611E6,1.00,1.01,1.14,1.14,18,10,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),56994,F-box-like/WD repeat-containing protein TBL1X OS=Homo sapiens OX=9606 GN=TBL1X PE=1 SV=1
829,442,sp|O94913|PCF11_HUMAN,56.96,157.93,9.565E6,9.707E6,1.95E7,1.925E7,1.00,1.01,2.04,2.01,9.565E6,9.707E6,1.95E7,1.925E7,1.00,1.01,2.04,2.01,13,16,15,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),173050,Pre-mRNA cleavage complex 2 protein Pcf11 OS=Homo sapiens OX=9606 GN=PCF11 PE=1 SV=3
757,6219,sp|P38919|IF4A3_HUMAN,17.25,157.92,3.75E6,3.901E6,6.414E6,5.875E6,1.00,1.04,1.71,1.57,3.75E6,3.901E6,6.414E6,5.875E6,1.00,1.04,1.71,1.57,24,14,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),46871,Eukaryotic initiation factor 4A-III OS=Homo sapiens OX=9606 GN=EIF4A3 PE=1 SV=4
211,16207,sp|P55735|SEC13_HUMAN,64.57,157.72,5.131E7,5.174E7,1.148E8,1.062E8,1.00,1.01,2.24,2.07,5.131E7,5.174E7,1.148E8,1.062E8,1.00,1.01,2.24,2.07,42,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),35541,Protein SEC13 homolog OS=Homo sapiens OX=9606 GN=SEC13 PE=1 SV=3
845,6584,sp|Q9P2I0|CPSF2_HUMAN,32.15,157.46,1.015E7,1.034E7,1.633E7,1.574E7,1.00,1.02,1.61,1.55,1.015E7,1.034E7,1.633E7,1.574E7,1.00,1.02,1.61,1.55,16,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),88487,Cleavage and polyadenylation specificity factor subunit 2 OS=Homo sapiens OX=9606 GN=CPSF2 PE=1 SV=2
601,19748,sp|Q6XE24-3|RBMS3_HUMAN,45.05,157.44,5.739E6,5.943E6,1.06E7,1.053E7,1.00,1.04,1.85,1.84,5.739E6,5.943E6,1.06E7,1.053E7,1.00,1.04,1.85,1.84,20,9,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),45744,Isoform 3 of RNA-binding motif  single-stranded-interacting protein 3 OS=Homo sapiens OX=9606 GN=RBMS3
965,29818,sp|O00468-6|AGRIN_HUMAN,9.76,157.37,7.221E6,7.598E6,9.496E6,9.432E6,1.00,1.05,1.32,1.31,7.221E6,7.598E6,9.496E6,9.432E6,1.00,1.05,1.32,1.31,7,11,11,iTRAQ 4plex (K  N-term),214844,Isoform 6 of Agrin OS=Homo sapiens OX=9606 GN=AGRN
1129,12714,sp|Q15654|TRIP6_HUMAN,69.40,157.25,3.251E6,2.83E6,6.402E6,6.439E6,1.00,0.87,1.97,1.98,3.251E6,2.83E6,6.402E6,6.439E6,1.00,0.87,1.97,1.98,30,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),50288,Thyroid receptor-interacting protein 6 OS=Homo sapiens OX=9606 GN=TRIP6 PE=1 SV=3
740,7459,sp|P61160|ARP2_HUMAN,23.66,157.20,2.287E7,2.143E7,3.038E7,3.435E7,1.00,0.94,1.33,1.50,2.287E7,2.143E7,3.038E7,3.435E7,1.00,0.94,1.33,1.50,31,10,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),44761,Actin-related protein 2 OS=Homo sapiens OX=9606 GN=ACTR2 PE=1 SV=1
782,17518,E3W994|E3W994_HUMAN,18.02,157.18,4.796E6,4.849E6,8.133E6,7.803E6,1.00,1.01,1.70,1.63,4.796E6,4.849E6,8.133E6,7.803E6,1.00,1.01,1.70,1.63,18,20,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),138864,CLIP-associating protein 2 OS=Homo sapiens OX=9606 GN=CLASP2 PE=1 SV=2
1014,19786,sp|Q6P2C8|MED27_HUMAN,9.66,157.16,4.903E6,5.013E6,6.456E6,6.397E6,1.00,1.02,1.32,1.30,4.903E6,5.013E6,6.456E6,6.397E6,1.00,1.02,1.32,1.30,34,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),35432,Mediator of RNA polymerase II transcription subunit 27 OS=Homo sapiens OX=9606 GN=MED27 PE=1 SV=1
504,19815,sp|Q96E39|RMXL1_HUMAN,1.33,156.96,4.121E4,4.085E4,6.517E4,5.463E4,1.00,0.99,1.58,1.33,4.121E4,4.085E4,6.517E4,5.463E4,1.00,0.99,1.58,1.33,4,13,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),42142,RNA binding motif protein  X-linked-like-1 OS=Homo sapiens OX=9606 GN=RBMXL1 PE=1 SV=1
1017,7027,sp|Q96QR8|PURB_HUMAN,17.04,156.85,9.129E6,9.13E6,1.261E7,1.255E7,1.00,1.00,1.38,1.37,9.129E6,9.13E6,1.261E7,1.255E7,1.00,1.00,1.38,1.37,38,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),33241,Transcriptional activator protein Pur-beta OS=Homo sapiens OX=9606 GN=PURB PE=1 SV=3
911,344,E9PLY5|E9PLY5_HUMAN,1.18,156.78,1.718E5,1.937E5,2.479E5,2.581E5,1.00,1.13,1.44,1.50,1.718E5,1.937E5,2.479E5,2.581E5,1.00,1.13,1.44,1.50,1,17,1,iTRAQ 4plex (K  N-term),159923,Microtubule-actin cross-linking factor 1  isoforms 1/2/3/5 (Fragment) OS=Homo sapiens OX=9606 GN=MACF1 PE=1 SV=1
1028,1140,sp|Q9ULK4-4|MED23_HUMAN,11.65,156.72,5.368E6,5.369E6,6.843E6,7E6,1.00,1.00,1.27,1.30,5.368E6,5.369E6,6.843E6,7E6,1.00,1.00,1.27,1.30,11,12,12,Carbamidomethylation; iTRAQ 4plex (K  N-term); Phosphorylation (STY),155552,Isoform 4 of Mediator of RNA polymerase II transcription subunit 23 OS=Homo sapiens OX=9606 GN=MED23
875,16527,sp|P14868|SYDC_HUMAN,12.61,156.71,1.015E7,1.046E7,1.481E7,1.477E7,1.00,1.03,1.46,1.46,1.015E7,1.046E7,1.481E7,1.477E7,1.00,1.03,1.46,1.46,31,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),57136,Aspartate--tRNA ligase  cytoplasmic OS=Homo sapiens OX=9606 GN=DARS PE=1 SV=2
537,3637,B9A044|B9A044_HUMAN,35.77,156.59,1.515E7,1.471E7,2.812E7,2.66E7,1.00,0.97,1.86,1.76,1.515E7,1.471E7,2.812E7,2.66E7,1.00,0.97,1.86,1.76,57,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),26816,Eukaryotic translation initiation factor 4E type 2 OS=Homo sapiens OX=9606 GN=EIF4E2 PE=1 SV=1
744,2173,sp|Q13049|TRI32_HUMAN,8.20,156.55,1.39E7,1.352E7,1.798E7,1.742E7,1.00,0.97,1.29,1.25,1.39E7,1.352E7,1.798E7,1.742E7,1.00,0.97,1.29,1.25,21,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),71989,E3 ubiquitin-protein ligase TRIM32 OS=Homo sapiens OX=9606 GN=TRIM32 PE=1 SV=2
1060,4246,H0Y412|H0Y412_HUMAN,1.20,156.39,6.06E5,6.184E5,9.136E5,8.936E5,1.00,1.02,1.51,1.47,6.06E5,6.184E5,9.136E5,8.936E5,1.00,1.02,1.51,1.47,3,10,1,iTRAQ 4plex (K  N-term),63316,Protein PRRC2B (Fragment) OS=Homo sapiens OX=9606 GN=PRRC2B PE=1 SV=1
1024,7196,sp|Q09161|NCBP1_HUMAN,37.54,156.35,5.781E6,5.915E6,9.723E6,9.407E6,1.00,1.02,1.68,1.63,5.781E6,5.915E6,9.723E6,9.407E6,1.00,1.02,1.68,1.63,12,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),91839,Nuclear cap-binding protein subunit 1 OS=Homo sapiens OX=9606 GN=NCBP1 PE=1 SV=1
681,536,sp|Q9Y6Q9-2|NCOA3_HUMAN,24.33,156.32,8.204E6,8.507E6,2.311E7,2.136E7,1.00,1.04,2.82,2.60,8.204E6,8.507E6,2.311E7,2.136E7,1.00,1.04,2.82,2.60,13,15,14,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),153796,Isoform 2 of Nuclear receptor coactivator 3 OS=Homo sapiens OX=9606 GN=NCOA3
507,19483,sp|P16401|H15_HUMAN,23.75,156.23,3.153E7,3.161E7,4.9E7,5.013E7,1.00,1.00,1.55,1.59,3.153E7,3.161E7,4.9E7,5.013E7,1.00,1.00,1.55,1.59,34,14,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),22580,Histone H1.5 OS=Homo sapiens OX=9606 GN=HIST1H1B PE=1 SV=3
1149,20450,sp|Q99704|DOK1_HUMAN,32.25,155.89,3.478E6,3.702E6,5.83E6,5.617E6,1.00,1.06,1.68,1.62,3.478E6,3.702E6,5.83E6,5.617E6,1.00,1.06,1.68,1.62,25,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),52392,Docking protein 1 OS=Homo sapiens OX=9606 GN=DOK1 PE=1 SV=1
953,19027,sp|P40939|ECHA_HUMAN,8.47,155.81,9.071E6,9.253E6,1.163E7,1.199E7,1.00,1.02,1.28,1.32,9.071E6,9.253E6,1.163E7,1.199E7,1.00,1.02,1.28,1.32,19,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),83000,Trifunctional enzyme subunit alpha  mitochondrial OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2
839,1154,sp|O75815|BCAR3_HUMAN,44.87,155.71,6.205E6,6.28E6,1.407E7,1.381E7,1.00,1.01,2.27,2.23,6.205E6,6.28E6,1.407E7,1.381E7,1.00,1.01,2.27,2.23,19,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),92566,Breast cancer anti-estrogen resistance protein 3 OS=Homo sapiens OX=9606 GN=BCAR3 PE=1 SV=1
376,19504,sp|P10412|H14_HUMAN,10.23,155.67,2.577E6,2.665E6,4.207E6,4.323E6,1.00,1.03,1.63,1.68,2.577E6,2.665E6,4.207E6,4.323E6,1.00,1.03,1.63,1.68,12,14,4,iTRAQ 4plex (K  N-term),21865,Histone H1.4 OS=Homo sapiens OX=9606 GN=HIST1H1E PE=1 SV=2
1147,4097,sp|Q14974|IMB1_HUMAN,13.17,155.30,6.807E6,6.215E6,9.033E6,8.369E6,1.00,0.91,1.33,1.23,6.807E6,6.215E6,9.033E6,8.369E6,1.00,0.91,1.33,1.23,14,11,11,iTRAQ 4plex (K  N-term),97170,Importin subunit beta-1 OS=Homo sapiens OX=9606 GN=KPNB1 PE=1 SV=2
737,6889,sp|O15143|ARC1B_HUMAN,16.66,155.25,5.454E6,5.19E6,7.187E6,7.863E6,1.00,0.95,1.32,1.44,5.454E6,5.19E6,7.187E6,7.863E6,1.00,0.95,1.32,1.44,5,12,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),40950,Actin-related protein 2/3 complex subunit 1B OS=Homo sapiens OX=9606 GN=ARPC1B PE=1 SV=3
792,19441,sp|Q9UDY4|DNJB4_HUMAN,35.68,155.15,6.133E6,6.284E6,1.254E7,1.221E7,1.00,1.02,2.05,1.99,6.133E6,6.284E6,1.254E7,1.221E7,1.00,1.02,2.05,1.99,44,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),37807,DnaJ homolog subfamily B member 4 OS=Homo sapiens OX=9606 GN=DNAJB4 PE=1 SV=1
467,7809,F8W7C6|F8W7C6_HUMAN,17.16,155.11,3.413E7,3.359E7,4.535E7,4.739E7,1.00,0.98,1.33,1.39,3.413E7,3.359E7,4.535E7,4.739E7,1.00,0.98,1.33,1.39,44,11,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),18565,60S ribosomal protein L10 OS=Homo sapiens OX=9606 GN=RPL10 PE=1 SV=2
666,631,sp|Q9UKK3|PARP4_HUMAN,2.53,154.99,9.877E6,9.737E6,1.111E7,1.074E7,1.00,0.99,1.13,1.09,9.877E6,9.737E6,1.111E7,1.074E7,1.00,0.99,1.13,1.09,13,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),192593,Protein mono-ADP-ribosyltransferase PARP4 OS=Homo sapiens OX=9606 GN=PARP4 PE=1 SV=3
850,19347,sp|P52943|CRIP2_HUMAN,75.79,154.68,1.52E7,1.644E7,3.286E7,3.161E7,1.00,1.08,2.16,2.08,1.52E7,1.644E7,3.286E7,3.161E7,1.00,1.08,2.16,2.08,51,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),22493,Cysteine-rich protein 2 OS=Homo sapiens OX=9606 GN=CRIP2 PE=1 SV=1
947,13153,sp|Q8N8S7-3|ENAH_HUMAN,45.98,154.66,2.543E6,2.566E6,5.989E6,5.913E6,1.00,1.01,2.36,2.33,2.543E6,2.566E6,5.989E6,5.913E6,1.00,1.01,2.36,2.33,28,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),60349,Isoform 3 of Protein enabled homolog OS=Homo sapiens OX=9606 GN=ENAH
772,4397,sp|Q12996|CSTF3_HUMAN,59.26,154.63,9.451E6,9.897E6,2.043E7,1.925E7,1.00,1.05,2.16,2.04,9.451E6,9.897E6,2.043E7,1.925E7,1.00,1.05,2.16,2.04,19,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),82922,Cleavage stimulation factor subunit 3 OS=Homo sapiens OX=9606 GN=CSTF3 PE=1 SV=1
805,6979,sp|Q05397-7|FAK1_HUMAN,40.59,154.58,1.057E7,1.072E7,2.157E7,2.078E7,1.00,1.01,2.04,1.97,1.057E7,1.072E7,2.157E7,2.078E7,1.00,1.01,2.04,1.97,13,13,12,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),114253,Isoform 7 of Focal adhesion kinase 1 OS=Homo sapiens OX=9606 GN=PTK2
959,11178,sp|Q15464|SHB_HUMAN,33.67,154.38,2.975E6,3.087E6,6.134E6,6.05E6,1.00,1.04,2.06,2.03,2.975E6,3.087E6,6.134E6,6.05E6,1.00,1.04,2.06,2.03,30,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),55042,SH2 domain-containing adapter protein B OS=Homo sapiens OX=9606 GN=SHB PE=1 SV=2
1002,6850,A0A0A0MTR7|A0A0A0MTR7_HUMAN,24.06,154.37,2.029E6,2.051E6,3.027E6,2.988E6,1.00,1.01,1.49,1.47,2.029E6,2.051E6,3.027E6,2.988E6,1.00,1.01,1.49,1.47,2,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),591416,E3 ubiquitin-protein ligase RNF213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=1
755,6019,sp|Q99567|NUP88_HUMAN,55.30,154.16,9.506E6,9.917E6,2.301E7,2.245E7,1.00,1.04,2.42,2.36,9.506E6,9.917E6,2.301E7,2.245E7,1.00,1.04,2.42,2.36,23,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),83542,Nuclear pore complex protein Nup88 OS=Homo sapiens OX=9606 GN=NUP88 PE=1 SV=2
814,38781,sp|P11387|TOP1_HUMAN,12.01,153.96,1.327E7,1.306E7,1.803E7,1.867E7,1.00,0.98,1.36,1.41,1.327E7,1.306E7,1.803E7,1.867E7,1.00,0.98,1.36,1.41,18,14,14,iTRAQ 4plex (K  N-term),90726,DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2
271,19626,sp|P39019|RS19_HUMAN,18.71,153.80,1.168E8,1.177E8,1.776E8,1.831E8,1.00,1.01,1.52,1.57,1.168E8,1.177E8,1.776E8,1.831E8,1.00,1.01,1.52,1.57,71,18,18,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),16060,40S ribosomal protein S19 OS=Homo sapiens OX=9606 GN=RPS19 PE=1 SV=2
777,10396,sp|P62136|PP1A_HUMAN,39.85,153.48,1.388E7,1.361E7,2.644E7,2.707E7,1.00,0.98,1.91,1.95,1.388E7,1.361E7,2.644E7,2.707E7,1.00,0.98,1.91,1.95,15,11,5,iTRAQ 4plex (K  N-term),37512,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit OS=Homo sapiens OX=9606 GN=PPP1CA PE=1 SV=1
791,4306,sp|P04843|RPN1_HUMAN,17.14,153.46,8.058E6,7.986E6,1.339E7,1.313E7,1.00,0.99,1.66,1.63,8.058E6,7.986E6,1.339E7,1.313E7,1.00,0.99,1.66,1.63,29,17,17,iTRAQ 4plex (K  N-term),68569,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Homo sapiens OX=9606 GN=RPN1 PE=1 SV=1
367,8291,sp|Q01085-2|TIAR_HUMAN,65.25,153.35,4.158E7,4.224E7,1.085E8,1.041E8,1.00,1.02,2.61,2.50,4.158E7,4.224E7,1.085E8,1.041E8,1.00,1.02,2.61,2.50,26,14,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),43449,Isoform 2 of Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1
632,19232,sp|O15144|ARPC2_HUMAN,9.85,153.32,2.823E7,2.52E7,2.938E7,3.365E7,1.00,0.89,1.04,1.19,2.823E7,2.52E7,2.938E7,3.365E7,1.00,0.89,1.04,1.19,37,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),34333,Actin-related protein 2/3 complex subunit 2 OS=Homo sapiens OX=9606 GN=ARPC2 PE=1 SV=1
759,38813,E5RJM0|E5RJM0_HUMAN,5.05,153.22,3.175E6,2.959E6,3.728E6,3.695E6,1.00,0.93,1.17,1.16,3.175E6,2.959E6,3.728E6,3.695E6,1.00,0.93,1.17,1.16,10,13,5,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),69769,Cytoplasmic polyadenylation element-binding protein 4 OS=Homo sapiens OX=9606 GN=CPEB4 PE=1 SV=1
943,19319,A0A087WVF7|A0A087WVF7_HUMAN,31.72,153.17,4.253E6,4.146E6,8.194E6,7.962E6,1.00,0.97,1.93,1.87,4.253E6,4.146E6,8.194E6,7.962E6,1.00,0.97,1.93,1.87,11,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),191597,Intersectin-2 OS=Homo sapiens OX=9606 GN=ITSN2 PE=1 SV=1
776,2592,sp|O75448-2|MED24_HUMAN,14.18,153.09,1.14E7,1.086E7,1.632E7,1.485E7,1.00,0.95,1.43,1.30,1.14E7,1.086E7,1.632E7,1.485E7,1.00,0.95,1.43,1.30,17,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),108938,Isoform 2 of Mediator of RNA polymerase II transcription subunit 24 OS=Homo sapiens OX=9606 GN=MED24
315,128,J3QR09|J3QR09_HUMAN,23.19,153.07,6.431E7,6.5E7,9.133E7,9.509E7,1.00,1.01,1.42,1.48,6.431E7,6.5E7,9.133E7,9.509E7,1.00,1.01,1.42,1.48,36,11,11,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),23135,Ribosomal protein L19 OS=Homo sapiens OX=9606 GN=RPL19 PE=1 SV=1
977,14618,sp|P13667|PDIA4_HUMAN,16.25,152.92,6.168E6,5.903E6,9.145E6,8.826E6,1.00,0.96,1.48,1.43,6.168E6,5.903E6,9.145E6,8.826E6,1.00,0.96,1.48,1.43,19,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),72933,Protein disulfide-isomerase A4 OS=Homo sapiens OX=9606 GN=PDIA4 PE=1 SV=2
793,6380,sp|P09661|RU2A_HUMAN,16.72,152.83,1.228E7,1.233E7,1.845E7,1.76E7,1.00,1.00,1.50,1.43,1.228E7,1.233E7,1.845E7,1.76E7,1.00,1.00,1.50,1.43,36,11,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),28416,U2 small nuclear ribonucleoprotein A' OS=Homo sapiens OX=9606 GN=SNRPA1 PE=1 SV=2
660,81,sp|P13647|K2C5_HUMAN,70.93,152.43,7.849E6,2.451E6,3.612E6,3.614E6,1.00,0.31,0.46,0.46,7.849E6,2.451E6,3.612E6,3.614E6,1.00,0.31,0.46,0.46,21,18,12,iTRAQ 4plex (K  N-term),62378,Keratin  type II cytoskeletal 5 OS=Homo sapiens OX=9606 GN=KRT5 PE=1 SV=3
769,4297,sp|P07900|HS90A_HUMAN,3.68,152.25,3.27E5,2.968E5,4.521E5,4.806E5,1.00,0.91,1.38,1.47,3.27E5,2.968E5,4.521E5,4.806E5,1.00,0.91,1.38,1.47,3,14,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),84660,Heat shock protein HSP 90-alpha OS=Homo sapiens OX=9606 GN=HSP90AA1 PE=1 SV=5
826,38801,sp|P46063|RECQ1_HUMAN,12.20,152.13,7.55E6,7.34E6,1.016E7,1.05E7,1.00,0.97,1.35,1.39,7.55E6,7.34E6,1.016E7,1.05E7,1.00,0.97,1.35,1.39,20,13,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),73457,ATP-dependent DNA helicase Q1 OS=Homo sapiens OX=9606 GN=RECQL PE=1 SV=3
849,1720,sp|Q8TDM6|DLG5_HUMAN,21.92,152.13,3.647E6,3.507E6,6.219E6,6.087E6,1.00,0.96,1.71,1.67,3.647E6,3.507E6,6.219E6,6.087E6,1.00,0.96,1.71,1.67,8,17,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),213866,Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4
770,8380,sp|Q9C035|TRIM5_HUMAN,20.50,152.10,3.325E7,3.532E7,1.316E7,1.276E7,1.00,1.06,0.40,0.38,3.325E7,3.532E7,1.316E7,1.276E7,1.00,1.06,0.40,0.38,32,16,16,iTRAQ 4plex (K  N-term); Deamidation (NQ),56338,Tripartite motif-containing protein 5 OS=Homo sapiens OX=9606 GN=TRIM5 PE=1 SV=1
811,2089,sp|Q9H9A5-2|CNO10_HUMAN,41.91,152.08,4.135E6,4.347E6,8.533E6,8.197E6,1.00,1.05,2.06,1.98,4.135E6,4.347E6,8.533E6,8.197E6,1.00,1.05,2.06,1.98,19,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),82181,Isoform 2 of CCR4-NOT transcription complex subunit 10 OS=Homo sapiens OX=9606 GN=CNOT10
561,19302,sp|Q15365|PCBP1_HUMAN,18.16,152.02,1.001E7,1.013E7,1.613E7,1.53E7,1.00,1.01,1.61,1.53,1.001E7,1.013E7,1.613E7,1.53E7,1.00,1.01,1.61,1.53,21,10,6,iTRAQ 4plex (K  N-term),37498,Poly(rC)-binding protein 1 OS=Homo sapiens OX=9606 GN=PCBP1 PE=1 SV=2
756,1324,sp|Q8IXT5|RB12B_HUMAN,16.92,151.83,6.749E6,6.708E6,1.059E7,1.055E7,1.00,0.99,1.57,1.56,6.749E6,6.708E6,1.059E7,1.055E7,1.00,0.99,1.57,1.56,18,19,19,iTRAQ 4plex (K  N-term); Deamidation (NQ),118103,RNA-binding protein 12B OS=Homo sapiens OX=9606 GN=RBM12B PE=1 SV=2
1007,4414,sp|P42166|LAP2A_HUMAN,6.22,151.77,5.818E5,5.529E5,1.01E6,1.066E6,1.00,0.95,1.74,1.83,5.818E5,5.529E5,1.01E6,1.066E6,1.00,0.95,1.74,1.83,3,8,2,iTRAQ 4plex (K  N-term),75492,Lamina-associated polypeptide 2  isoform alpha OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2
427,11567,H3BNC9|H3BNC9_HUMAN,34.96,151.75,3.505E7,3.431E7,5.396E7,5.652E7,1.00,0.98,1.54,1.61,3.505E7,3.431E7,5.396E7,5.652E7,1.00,0.98,1.54,1.61,11,9,9,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),64533,Uncharacterized protein OS=Homo sapiens OX=9606 PE=3 SV=2
499,19564,Q5JR95|Q5JR95_HUMAN,22.97,151.68,1.008E8,1.047E8,1.407E8,1.496E8,1.00,1.04,1.40,1.48,1.008E8,1.047E8,1.407E8,1.496E8,1.00,1.04,1.40,1.48,43,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),21880,40S ribosomal protein S8 OS=Homo sapiens OX=9606 GN=RPS8 PE=1 SV=1
983,38800,sp|Q9NYL2|M3K20_HUMAN,73.70,151.64,3.297E6,3.343E6,9.728E6,9.661E6,1.00,1.01,2.95,2.93,3.297E6,3.343E6,9.728E6,9.661E6,1.00,1.01,2.95,2.93,16,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),91155,Mitogen-activated protein kinase kinase kinase 20 OS=Homo sapiens OX=9606 GN=MAP3K20 PE=1 SV=3
556,19364,sp|P05141|ADT2_HUMAN,36.44,151.62,5.398E6,5.796E6,1.113E7,1.061E7,1.00,1.07,2.06,1.97,5.398E6,5.796E6,1.113E7,1.061E7,1.00,1.07,2.06,1.97,11,16,3,iTRAQ 4plex (K  N-term),32852,ADP/ATP translocase 2 OS=Homo sapiens OX=9606 GN=SLC25A5 PE=1 SV=7
331,9682,sp|P46783|RS10_HUMAN,36.54,151.54,3.872E7,3.898E7,6.806E7,6.827E7,1.00,1.01,1.76,1.76,3.872E7,3.898E7,6.806E7,6.827E7,1.00,1.01,1.76,1.76,54,14,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),18898,40S ribosomal protein S10 OS=Homo sapiens OX=9606 GN=RPS10 PE=1 SV=1
972,22284,sp|Q15007|FL2D_HUMAN,24.80,151.54,4.243E6,4.371E6,7.35E6,7.202E6,1.00,1.03,1.73,1.70,4.243E6,4.371E6,7.35E6,7.202E6,1.00,1.03,1.73,1.70,38,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),44244,Pre-mRNA-splicing regulator WTAP OS=Homo sapiens OX=9606 GN=WTAP PE=1 SV=2
345,3948,sp|P62917|RL8_HUMAN,14.53,151.45,7.415E7,7.451E7,9.284E7,1.005E8,1.00,1.00,1.25,1.36,7.415E7,7.451E7,9.284E7,1.005E8,1.00,1.00,1.25,1.36,53,17,17,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),28025,60S ribosomal protein L8 OS=Homo sapiens OX=9606 GN=RPL8 PE=1 SV=2
944,3300,A0A2R8YD40|A0A2R8YD40_HUMAN,37.49,151.28,4.292E6,3.736E6,7.944E6,7.794E6,1.00,0.87,1.85,1.82,4.292E6,3.736E6,7.944E6,7.794E6,1.00,0.87,1.85,1.82,11,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),170594,Chromodomain-helicase-DNA-binding protein 4 (Fragment) OS=Homo sapiens OX=9606 GN=CHD4 PE=1 SV=1
391,19509,A0A087WXM6|A0A087WXM6_HUMAN,20.20,151.08,6.573E7,6.779E7,9.561E7,9.849E7,1.00,1.03,1.45,1.50,6.573E7,6.779E7,9.561E7,9.849E7,1.00,1.03,1.45,1.50,45,12,11,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),19586,60S ribosomal protein L17 (Fragment) OS=Homo sapiens OX=9606 GN=RPL17 PE=3 SV=1
403,19323,sp|Q06830|PRDX1_HUMAN,30.46,151.07,4.811E7,4.847E7,8.411E7,8.149E7,1.00,1.01,1.75,1.69,4.811E7,4.847E7,8.411E7,8.149E7,1.00,1.01,1.75,1.69,37,13,9,iTRAQ 4plex (K  N-term); Oxidation (M),22110,Peroxiredoxin-1 OS=Homo sapiens OX=9606 GN=PRDX1 PE=1 SV=1
862,19981,sp|Q8IXW5-2|RPAP2_HUMAN,72.37,150.98,6.829E6,6.828E6,1.484E7,1.426E7,1.00,1.00,2.17,2.09,6.829E6,6.828E6,1.484E7,1.426E7,1.00,1.00,2.17,2.09,21,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),66474,Isoform 2 of Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 OS=Homo sapiens OX=9606 GN=RPAP2
773,38811,sp|Q13724|MOGS_HUMAN,24.01,150.85,1.485E7,1.315E7,2.13E7,2.153E7,1.00,0.89,1.43,1.45,1.485E7,1.315E7,2.13E7,2.153E7,1.00,0.89,1.43,1.45,15,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),91918,Mannosyl-oligosaccharide glucosidase OS=Homo sapiens OX=9606 GN=MOGS PE=1 SV=5
1091,770,sp|Q92738|US6NL_HUMAN,25.43,150.84,2.628E6,2.637E6,4.477E6,4.419E6,1.00,1.00,1.70,1.68,2.628E6,2.637E6,4.477E6,4.419E6,1.00,1.00,1.70,1.68,21,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),94104,USP6 N-terminal-like protein OS=Homo sapiens OX=9606 GN=USP6NL PE=1 SV=3
1130,1642,B1AKL4|B1AKL4_HUMAN,70.41,150.83,1.589E6,1.669E6,3.92E6,3.716E6,1.00,1.05,2.47,2.34,1.589E6,1.669E6,3.92E6,3.716E6,1.00,1.05,2.47,2.34,15,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),105550,Eukaryotic translation initiation factor 4E transporter OS=Homo sapiens OX=9606 GN=EIF4ENIF1 PE=1 SV=1
876,38790,sp|Q9H694|BICC1_HUMAN,21.63,150.62,4.944E6,4.931E6,9.369E6,9.246E6,1.00,1.00,1.90,1.87,4.944E6,4.931E6,9.369E6,9.246E6,1.00,1.00,1.90,1.87,20,17,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),104844,Protein bicaudal C homolog 1 OS=Homo sapiens OX=9606 GN=BICC1 PE=1 SV=2
892,38806,sp|Q8IVH8|M4K3_HUMAN,20.82,150.48,4.804E6,4.834E6,8.102E6,7.863E6,1.00,1.01,1.69,1.64,4.804E6,4.834E6,8.102E6,7.863E6,1.00,1.01,1.69,1.64,12,12,9,iTRAQ 4plex (K  N-term),101316,Mitogen-activated protein kinase kinase kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP4K3 PE=1 SV=1
1123,6423,sp|O00512|BCL9_HUMAN,24.46,150.41,3.331E6,3.467E6,5.932E6,5.651E6,1.00,1.04,1.78,1.70,3.331E6,3.467E6,5.932E6,5.651E6,1.00,1.04,1.78,1.70,12,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),149289,B-cell CLL/lymphoma 9 protein OS=Homo sapiens OX=9606 GN=BCL9 PE=1 SV=4
539,17305,M0R0F0|M0R0F0_HUMAN,29.87,150.35,2.547E7,2.6E7,4.035E7,4.029E7,1.00,1.02,1.58,1.58,2.547E7,2.6E7,4.035E7,4.029E7,1.00,1.02,1.58,1.58,42,11,11,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),22391,40S ribosomal protein S5 (Fragment) OS=Homo sapiens OX=9606 GN=RPS5 PE=1 SV=1
1094,19745,sp|Q9HAU0-2|PKHA5_HUMAN,33.38,150.18,2.471E6,2.517E6,4.776E6,4.834E6,1.00,1.02,1.93,1.96,2.471E6,2.517E6,4.776E6,4.834E6,1.00,1.02,1.93,1.96,11,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),134323,Isoform 2 of Pleckstrin homology domain-containing family A member 5 OS=Homo sapiens OX=9606 GN=PLEKHA5
842,3961,sp|Q14498-2|RBM39_HUMAN,19.59,150.10,5.682E6,5.922E6,8.884E6,9.107E6,1.00,1.04,1.56,1.60,5.682E6,5.922E6,8.884E6,9.107E6,1.00,1.04,1.56,1.60,23,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),58657,Isoform 2 of RNA-binding protein 39 OS=Homo sapiens OX=9606 GN=RBM39
975,16585,sp|P50990-2|TCPQ_HUMAN,7.14,150.07,7.572E6,7.319E6,9.532E6,9.768E6,1.00,0.97,1.26,1.29,7.572E6,7.319E6,9.532E6,9.768E6,1.00,0.97,1.26,1.29,29,15,15,iTRAQ 4plex (K  N-term),57645,Isoform 2 of T-complex protein 1 subunit theta OS=Homo sapiens OX=9606 GN=CCT8
871,2215,sp|P0CAP2|GRL1A_HUMAN,37.46,149.94,5.17E6,5.243E6,9.569E6,9.3E6,1.00,1.01,1.85,1.80,5.17E6,5.243E6,9.569E6,9.3E6,1.00,1.01,1.85,1.80,30,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),41740,DNA-directed RNA polymerase II subunit GRINL1A OS=Homo sapiens OX=9606 GN=POLR2M PE=1 SV=1
679,19709,sp|P04406|G3P_HUMAN,17.33,149.80,2.02E7,1.879E7,2.575E7,2.826E7,1.00,0.93,1.27,1.40,2.02E7,1.879E7,2.575E7,2.826E7,1.00,0.93,1.27,1.40,37,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),36053,Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens OX=9606 GN=GAPDH PE=1 SV=3
1053,21419,sp|P18206-2|VINC_HUMAN,112.87,149.75,4.666E6,4.49E6,1.119E7,1.169E7,1.00,0.96,2.40,2.51,4.666E6,4.49E6,1.119E7,1.169E7,1.00,0.96,2.40,2.51,11,10,10,Carbamidomethylation; iTRAQ 4plex (K  N-term),116722,Isoform 1 of Vinculin OS=Homo sapiens OX=9606 GN=VCL
1174,38816,sp|P10070|GLI2_HUMAN,49.42,149.66,2.257E6,2.31E6,5.317E6,5.241E6,1.00,1.02,2.36,2.32,2.257E6,2.31E6,5.317E6,5.241E6,1.00,1.02,2.36,2.32,11,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),167783,Zinc finger protein GLI2 OS=Homo sapiens OX=9606 GN=GLI2 PE=1 SV=4
991,20472,sp|O15379|HDAC3_HUMAN,51.79,149.64,5.399E6,5.3E6,1.114E7,1.055E7,1.00,0.98,2.06,1.95,5.399E6,5.3E6,1.114E7,1.055E7,1.00,0.98,2.06,1.95,24,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),48848,Histone deacetylase 3 OS=Homo sapiens OX=9606 GN=HDAC3 PE=1 SV=2
1016,38817,A0A087WU80|A0A087WU80_HUMAN,35.72,149.64,9.011E6,9.376E6,1.756E7,1.653E7,1.00,1.04,1.95,1.83,9.011E6,9.376E6,1.756E7,1.653E7,1.00,1.04,1.95,1.83,19,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),84939,Tumor necrosis factor alpha-induced protein 3 OS=Homo sapiens OX=9606 GN=TNFAIP3 PE=1 SV=1
359,12,sp|A0A0A0MRZ7|KVD26_HUMAN,29.62,149.40,6.026E5,6.379E5,4.337E6,3.555E6,1.00,1.06,7.20,5.90,6.026E5,6.379E5,4.337E6,3.555E6,1.00,1.06,7.20,5.90,8,10,2,iTRAQ 4plex (K  N-term),13297,Immunoglobulin kappa variable 2D-26 OS=Homo sapiens OX=9606 GN=IGKV2D-26 PE=3 SV=1
796,7169,sp|Q6UN15-3|FIP1_HUMAN,1.29,149.32,3.731E5,3.573E5,5.572E5,5.472E5,1.00,0.96,1.49,1.47,3.731E5,3.573E5,5.572E5,5.472E5,1.00,0.96,1.49,1.47,1,9,1,iTRAQ 4plex (K  N-term),58376,Isoform 3 of Pre-mRNA 3'-end-processing factor FIP1 OS=Homo sapiens OX=9606 GN=FIP1L1
656,19963,sp|O75822|EIF3J_HUMAN,118.80,149.29,9.719E6,1.021E7,2.945E7,2.871E7,1.00,1.05,3.03,2.95,9.719E6,1.021E7,2.945E7,2.871E7,1.00,1.05,3.03,2.95,37,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),29062,Eukaryotic translation initiation factor 3 subunit J OS=Homo sapiens OX=9606 GN=EIF3J PE=1 SV=2
935,10716,sp|P48729|KC1A_HUMAN,16.66,149.24,3.495E5,5.113E5,6.289E5,6.326E5,1.00,1.46,1.80,1.81,3.495E5,5.113E5,6.289E5,6.326E5,1.00,1.46,1.80,1.81,6,13,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),38915,Casein kinase I isoform alpha OS=Homo sapiens OX=9606 GN=CSNK1A1 PE=1 SV=2
1110,13384,sp|Q16698-2|DECR_HUMAN,32.17,149.21,5.406E6,4.641E6,7.313E6,7.788E6,1.00,0.86,1.35,1.44,5.406E6,4.641E6,7.313E6,7.788E6,1.00,0.86,1.35,1.44,34,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),34994,Isoform 2 of 2 4-dienoyl-CoA reductase  mitochondrial OS=Homo sapiens OX=9606 GN=DECR1
971,24751,sp|Q86WG5|MTMRD_HUMAN,23.56,149.07,2.814E6,2.796E6,5.2E6,5.129E6,1.00,0.99,1.85,1.82,2.814E6,2.796E6,5.2E6,5.129E6,1.00,0.99,1.85,1.82,8,14,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),208463,Myotubularin-related protein 13 OS=Homo sapiens OX=9606 GN=SBF2 PE=1 SV=1
840,6527,sp|P50995-2|ANX11_HUMAN,55.94,148.97,6.659E6,6.287E6,1.679E7,1.628E7,1.00,0.94,2.52,2.44,6.659E6,6.287E6,1.679E7,1.628E7,1.00,0.94,2.52,2.44,30,14,14,iTRAQ 4plex (K  N-term),51242,Isoform 2 of Annexin A11 OS=Homo sapiens OX=9606 GN=ANXA11
1131,6341,sp|Q9UPN9-2|TRI33_HUMAN,2.66,148.96,2.166E5,1.922E5,4.35E5,4.359E5,1.00,0.89,2.01,2.01,2.166E5,1.922E5,4.35E5,4.359E5,1.00,0.89,2.01,2.01,1,10,1,iTRAQ 4plex (K  N-term),120541,Isoform Beta of E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens OX=9606 GN=TRIM33
1093,31733,sp|Q6P1N0|C2D1A_HUMAN,39.08,148.95,3.126E6,3.076E6,5.707E6,5.573E6,1.00,0.98,1.83,1.78,3.126E6,3.076E6,5.707E6,5.573E6,1.00,0.98,1.83,1.78,14,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),104062,Coiled-coil and C2 domain-containing protein 1A OS=Homo sapiens OX=9606 GN=CC2D1A PE=1 SV=1
1033,13313,sp|Q9H7E2-3|TDRD3_HUMAN,4.02,148.80,1.052E7,1.082E7,8.701E6,8.637E6,1.00,1.03,0.83,0.82,1.052E7,1.082E7,8.701E6,8.637E6,1.00,1.03,0.83,0.82,22,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),83103,Isoform 3 of Tudor domain-containing protein 3 OS=Homo sapiens OX=9606 GN=TDRD3
861,20210,A0A087WWK8|A0A087WWK8_HUMAN,29.93,148.79,4.72E6,4.614E6,9.124E6,8.998E6,1.00,0.98,1.93,1.91,4.72E6,4.614E6,9.124E6,8.998E6,1.00,0.98,1.93,1.91,11,15,12,iTRAQ 4plex (K  N-term); Phosphorylation (STY),124477,IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1
545,19533,A0A2R8Y424|A0A2R8Y424_HUMAN,1.54,148.75,1.912E5,2.053E5,2.97E5,3.218E5,1.00,1.07,1.55,1.68,1.912E5,2.053E5,2.97E5,3.218E5,1.00,1.07,1.55,1.68,9,11,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),16973,Protein PRRC2C (Fragment) OS=Homo sapiens OX=9606 GN=PRRC2C PE=1 SV=1
694,4309,sp|Q8ND56-3|LS14A_HUMAN,75.13,148.69,7.786E6,8.346E6,2.254E7,2.149E7,1.00,1.07,2.90,2.76,7.786E6,8.346E6,2.254E7,2.149E7,1.00,1.07,2.90,2.76,27,13,12,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),46411,Isoform 3 of Protein LSM14 homolog A OS=Homo sapiens OX=9606 GN=LSM14A
936,19481,sp|P05121|PAI1_HUMAN,13.77,148.61,8.75E6,8.905E6,1.152E7,1.22E7,1.00,1.02,1.32,1.39,8.75E6,8.905E6,1.152E7,1.22E7,1.00,1.02,1.32,1.39,27,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),45060,Plasminogen activator inhibitor 1 OS=Homo sapiens OX=9606 GN=SERPINE1 PE=1 SV=1
851,24653,sp|Q7Z5Q1-5|CPEB2_HUMAN,17.87,148.37,1.295E6,1.291E6,2.159E6,2.157E6,1.00,1.00,1.67,1.67,1.295E6,1.291E6,2.159E6,2.157E6,1.00,1.00,1.67,1.67,9,11,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),61726,Isoform 4 of Cytoplasmic polyadenylation element-binding protein 2 OS=Homo sapiens OX=9606 GN=CPEB2
1171,6342,sp|Q9UPN9|TRI33_HUMAN,2.70,148.29,2.929E5,3.308E5,6.707E5,5.988E5,1.00,1.13,2.29,2.04,2.929E5,3.308E5,6.707E5,5.988E5,1.00,1.13,2.29,2.04,1,10,1,iTRAQ 4plex (K  N-term),122533,E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens OX=9606 GN=TRIM33 PE=1 SV=3
891,38843,sp|P21589|5NTD_HUMAN,17.78,148.26,5.579E6,5.695E6,7.837E6,8.771E6,1.00,1.02,1.40,1.57,5.579E6,5.695E6,7.837E6,8.771E6,1.00,1.02,1.40,1.57,20,12,12,iTRAQ 4plex (K  N-term),63368,5'-nucleotidase OS=Homo sapiens OX=9606 GN=NT5E PE=1 SV=1
1165,38871,sp|A7KAX9|RHG32_HUMAN,24.34,148.14,1.713E6,1.768E6,2.946E6,2.793E6,1.00,1.03,1.72,1.63,1.713E6,1.768E6,2.946E6,2.793E6,1.00,1.03,1.72,1.63,7,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),230527,Rho GTPase-activating protein 32 OS=Homo sapiens OX=9606 GN=ARHGAP32 PE=1 SV=1
1178,19618,sp|Q15046-2|SYK_HUMAN,2.42,148.14,6.954E6,6.976E6,7.353E6,7.519E6,1.00,1.00,1.06,1.08,6.954E6,6.976E6,7.353E6,7.519E6,1.00,1.00,1.06,1.08,18,9,9,iTRAQ 4plex (K  N-term),71497,Isoform Mitochondrial of Lysine--tRNA ligase OS=Homo sapiens OX=9606 GN=KARS
1066,21018,sp|Q9H6T3-2|RPAP3_HUMAN,37.41,148.13,3.655E6,3.74E6,7.777E6,7.713E6,1.00,1.02,2.13,2.11,3.655E6,3.74E6,7.777E6,7.713E6,1.00,1.02,2.13,2.11,21,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),71866,Isoform 2 of RNA polymerase II-associated protein 3 OS=Homo sapiens OX=9606 GN=RPAP3
1102,5433,sp|O43670-2|ZN207_HUMAN,101.48,148.08,4.35E6,4.172E6,1.036E7,1.002E7,1.00,0.96,2.38,2.30,4.35E6,4.172E6,1.036E7,1.002E7,1.00,0.96,2.38,2.30,14,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),49692,Isoform 2 of BUB3-interacting and GLEBS motif-containing protein ZNF207 OS=Homo sapiens OX=9606 GN=ZNF207
530,19834,sp|P61353|RL27_HUMAN,12.75,147.78,6.577E7,6.568E7,8.43E7,8.95E7,1.00,1.00,1.28,1.36,6.577E7,6.568E7,8.43E7,8.95E7,1.00,1.00,1.28,1.36,51,11,11,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),15798,60S ribosomal protein L27 OS=Homo sapiens OX=9606 GN=RPL27 PE=1 SV=2
926,16274,sp|Q93009|UBP7_HUMAN,22.91,147.78,5.05E6,4.87E6,8.509E6,8.524E6,1.00,0.96,1.68,1.69,5.05E6,4.87E6,8.509E6,8.524E6,1.00,0.96,1.68,1.69,14,16,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),128302,Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=2
1201,19659,sp|Q96IZ0|PAWR_HUMAN,16.03,147.70,5.239E6,5.269E6,6.646E6,7.58E6,1.00,1.01,1.27,1.45,5.239E6,5.269E6,6.646E6,7.58E6,1.00,1.01,1.27,1.45,38,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),36568,PRKC apoptosis WT1 regulator protein OS=Homo sapiens OX=9606 GN=PAWR PE=1 SV=1
905,16927,sp|P19387|RPB3_HUMAN,85.11,147.64,5.538E6,5.728E6,1.306E7,1.244E7,1.00,1.03,2.36,2.25,5.538E6,5.728E6,1.306E7,1.244E7,1.00,1.03,2.36,2.25,37,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),31441,DNA-directed RNA polymerase II subunit RPB3 OS=Homo sapiens OX=9606 GN=POLR2C PE=1 SV=2
1111,3168,sp|Q96GM5-2|SMRD1_HUMAN,11.64,147.60,1.875E6,1.919E6,2.707E6,2.644E6,1.00,1.02,1.44,1.41,1.875E6,1.919E6,2.707E6,2.644E6,1.00,1.02,1.44,1.41,17,10,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),53299,Isoform 2 of SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 OS=Homo sapiens OX=9606 GN=SMARCD1
948,19967,D6RD66|D6RD66_HUMAN,29.99,147.50,1.531E7,1.267E7,1.917E7,2.19E7,1.00,0.83,1.25,1.43,1.531E7,1.267E7,1.917E7,2.19E7,1.00,0.83,1.25,1.43,47,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),26797,WD repeat-containing protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=WDR1 PE=1 SV=1
908,8494,sp|O95429-2|BAG4_HUMAN,12.00,147.43,2.771E6,2.79E6,4.097E6,3.959E6,1.00,1.01,1.48,1.43,2.771E6,2.79E6,4.097E6,3.959E6,1.00,1.01,1.48,1.43,43,10,9,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),45410,Isoform 2 of BAG family molecular chaperone regulator 4 OS=Homo sapiens OX=9606 GN=BAG4
1071,4950,sp|Q92785|REQU_HUMAN,9.76,147.42,7.135E6,7.409E6,9.487E6,9.11E6,1.00,1.04,1.33,1.28,7.135E6,7.409E6,9.487E6,9.11E6,1.00,1.04,1.33,1.28,25,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),44156,Zinc finger protein ubi-d4 OS=Homo sapiens OX=9606 GN=DPF2 PE=1 SV=2
1042,16751,sp|P55265-5|DSRAD_HUMAN,39.35,147.36,3.661E6,3.666E6,6.247E6,6.136E6,1.00,1.00,1.71,1.68,3.661E6,3.666E6,6.247E6,6.136E6,1.00,1.00,1.71,1.68,15,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),103642,Isoform 5 of Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR
1124,38821,sp|Q92614-2|MY18A_HUMAN,14.98,147.25,2.557E6,2.486E6,3.427E6,3.678E6,1.00,0.97,1.34,1.44,2.557E6,2.486E6,3.427E6,3.678E6,1.00,0.97,1.34,1.44,7,12,11,iTRAQ 4plex (K  N-term),196436,Isoform 2 of Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A
1169,38859,sp|Q9HAU5|RENT2_HUMAN,24.16,147.18,5.099E6,5.226E6,7.89E6,7.919E6,1.00,1.02,1.55,1.55,5.099E6,5.226E6,7.89E6,7.919E6,1.00,1.02,1.55,1.55,8,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),147810,Regulator of nonsense transcripts 2 OS=Homo sapiens OX=9606 GN=UPF2 PE=1 SV=1
612,9318,I3L4Q0|I3L4Q0_HUMAN,21.09,147.01,4.19E7,4.283E7,6.435E7,6.155E7,1.00,1.02,1.54,1.47,4.19E7,4.283E7,6.435E7,6.155E7,1.00,1.02,1.54,1.47,76,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),12951,HCG1818442  isoform CRA_a OS=Homo sapiens OX=9606 GN=MCRIP1 PE=1 SV=1
753,24301,sp|P51911|CNN1_HUMAN,200.00,147.01,7.323E6,7.376E6,2.411E7,2.382E7,1.00,1.01,3.29,3.25,7.323E6,7.376E6,2.411E7,2.382E7,1.00,1.01,3.29,3.25,26,8,7,iTRAQ 4plex (K  N-term); Oxidation (M),33170,Calponin-1 OS=Homo sapiens OX=9606 GN=CNN1 PE=1 SV=2
788,2025,A0A3B3ISF0|A0A3B3ISF0_HUMAN,11.82,146.85,3.926E5,3.946E5,6.741E5,6.663E5,1.00,1.01,1.72,1.70,3.926E5,3.946E5,6.741E5,6.663E5,1.00,1.01,1.72,1.70,4,16,4,iTRAQ 4plex (K  N-term),126207,La-related protein 1B OS=Homo sapiens OX=9606 GN=LARP1B PE=1 SV=1
447,19672,sp|P16402|H13_HUMAN,9.32,146.83,1.312E6,1.348E6,2.058E6,2.127E6,1.00,1.03,1.57,1.62,1.312E6,1.348E6,2.058E6,2.127E6,1.00,1.03,1.57,1.62,11,11,3,iTRAQ 4plex (K  N-term),22350,Histone H1.3 OS=Homo sapiens OX=9606 GN=HIST1H1D PE=1 SV=2
309,14221,sp|P62753|RS6_HUMAN,21.65,146.79,9.652E7,9.897E7,1.414E8,1.484E8,1.00,1.03,1.47,1.54,9.652E7,9.897E7,1.414E8,1.484E8,1.00,1.03,1.47,1.54,33,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),28681,40S ribosomal protein S6 OS=Homo sapiens OX=9606 GN=RPS6 PE=1 SV=1
457,18180,sp|P26373|RL13_HUMAN,16.18,146.76,1.167E8,1.171E8,1.49E8,1.64E8,1.00,1.00,1.28,1.40,1.167E8,1.171E8,1.49E8,1.64E8,1.00,1.00,1.28,1.40,47,12,12,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),24261,60S ribosomal protein L13 OS=Homo sapiens OX=9606 GN=RPL13 PE=1 SV=4
1069,20526,sp|Q9NP61|ARFG3_HUMAN,28.33,146.39,1.867E6,1.997E6,3.838E6,3.754E6,1.00,1.07,2.06,2.01,1.867E6,1.997E6,3.838E6,3.754E6,1.00,1.07,2.06,2.01,17,13,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),56928,ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens OX=9606 GN=ARFGAP3 PE=1 SV=1
990,10709,sp|P48729-3|KC1A_HUMAN,2.94,146.32,1.2E5,1.369E5,1.741E5,1.813E5,1.00,1.14,1.45,1.51,1.2E5,1.369E5,1.741E5,1.813E5,1.00,1.14,1.45,1.51,6,13,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),37567,Isoform 3 of Casein kinase I isoform alpha OS=Homo sapiens OX=9606 GN=CSNK1A1
1166,38837,sp|Q9UHF7|TRPS1_HUMAN,29.04,146.17,1.583E6,1.543E6,2.927E6,2.981E6,1.00,0.97,1.85,1.88,1.583E6,1.543E6,2.927E6,2.981E6,1.00,0.97,1.85,1.88,10,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),141521,Zinc finger transcription factor Trps1 OS=Homo sapiens OX=9606 GN=TRPS1 PE=1 SV=2
624,21587,sp|Q14011|CIRBP_HUMAN,6.97,146.16,1.018E6,1.152E6,1.973E6,1.965E6,1.00,1.13,1.94,1.93,1.018E6,1.152E6,1.973E6,1.965E6,1.00,1.13,1.94,1.93,12,7,2,iTRAQ 4plex (K  N-term),18648,Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1
479,19761,F8WB05|F8WB05_HUMAN,3.66,146.08,1.37E6,1.415E6,2.11E6,1.978E6,1.00,1.03,1.54,1.44,1.37E6,1.415E6,2.11E6,1.978E6,1.00,1.03,1.54,1.44,6,13,2,iTRAQ 4plex (K  N-term),45809,Ataxin-2 (Fragment) OS=Homo sapiens OX=9606 GN=ATXN2 PE=1 SV=2
1160,19518,sp|O15234|CASC3_HUMAN,31.79,146.07,2.213E6,2.116E6,3.981E6,3.862E6,1.00,0.96,1.80,1.75,2.213E6,2.116E6,3.981E6,3.862E6,1.00,0.96,1.80,1.75,18,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),76278,Protein CASC3 OS=Homo sapiens OX=9606 GN=CASC3 PE=1 SV=2
925,3745,sp|P33240-2|CSTF2_HUMAN,22.12,146.00,1.48E6,1.429E6,2.833E6,2.77E6,1.00,0.97,1.91,1.87,1.48E6,1.429E6,2.833E6,2.77E6,1.00,0.97,1.91,1.87,11,11,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),59251,Isoform 2 of Cleavage stimulation factor subunit 2 OS=Homo sapiens OX=9606 GN=CSTF2
1095,11120,sp|Q71F56|MD13L_HUMAN,10.74,145.91,1.869E6,1.874E6,2.518E6,2.58E6,1.00,1.00,1.35,1.38,1.869E6,1.874E6,2.518E6,2.58E6,1.00,1.00,1.35,1.38,6,12,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),242599,Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens OX=9606 GN=MED13L PE=1 SV=1
765,23383,B4DNJ1|B4DNJ1_HUMAN,59.30,145.76,1.201E7,1.182E7,2.404E7,2.383E7,1.00,0.98,2.00,1.98,1.201E7,1.182E7,2.404E7,2.383E7,1.00,0.98,2.00,1.98,21,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),49080,Tissue-type plasminogen activator OS=Homo sapiens OX=9606 GN=PLAT PE=1 SV=1
900,13652,H7C4S4|H7C4S4_HUMAN,2.89,145.55,1.133E4,5.54E3,1.297E4,1.375E4,1.00,0.49,1.15,1.21,1.133E4,5.54E3,1.297E4,1.375E4,1.00,0.49,1.15,1.21,12,7,1,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),27548,Fragile X mental retardation syndrome-related protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=FXR1 PE=1 SV=8
1026,2356,sp|Q9Y6C2|EMIL1_HUMAN,17.68,145.49,4.524E6,4.529E6,6.927E6,7.121E6,1.00,1.00,1.53,1.57,4.524E6,4.529E6,6.927E6,7.121E6,1.00,1.00,1.53,1.57,15,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),106695,EMILIN-1 OS=Homo sapiens OX=9606 GN=EMILIN1 PE=1 SV=3
1126,3474,sp|Q5SYE7|NHSL1_HUMAN,29.95,145.32,2.311E6,2.324E6,4.342E6,4.352E6,1.00,1.01,1.88,1.88,2.311E6,2.324E6,4.342E6,4.352E6,1.00,1.01,1.88,1.88,9,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),170667,NHS-like protein 1 OS=Homo sapiens OX=9606 GN=NHSL1 PE=1 SV=2
414,13939,C9JEH7|C9JEH7_HUMAN,0.97,145.20,2.292E6,2.31E6,3.089E6,3.232E6,1.00,1.01,1.35,1.41,2.292E6,2.31E6,3.089E6,3.232E6,1.00,1.01,1.35,1.41,3,14,1,iTRAQ 4plex (K  N-term),29384,40S ribosomal protein S4  Y isoform 1 (Fragment) OS=Homo sapiens OX=9606 GN=RPS4Y1 PE=1 SV=1
1175,38818,sp|O00203-3|AP3B1_HUMAN,25.60,145.05,5.861E6,5.869E6,1.044E7,1.061E7,1.00,1.00,1.78,1.81,5.861E6,5.869E6,1.044E7,1.061E7,1.00,1.00,1.78,1.81,13,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),116195,Isoform 2 of AP-3 complex subunit beta-1 OS=Homo sapiens OX=9606 GN=AP3B1
1082,38841,sp|Q9UGR2|Z3H7B_HUMAN,16.30,145.05,4.825E6,4.763E6,7.252E6,7.176E6,1.00,0.99,1.50,1.49,4.825E6,4.763E6,7.252E6,7.176E6,1.00,0.99,1.50,1.49,12,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),109858,Zinc finger CCCH domain-containing protein 7B OS=Homo sapiens OX=9606 GN=ZC3H7B PE=1 SV=2
1342,20766,sp|Q9BUT9|MCRI2_HUMAN,15.66,144.70,1.159E6,1.206E6,1.633E6,1.679E6,1.00,1.04,1.41,1.45,1.159E6,1.206E6,1.633E6,1.679E6,1.00,1.04,1.41,1.45,56,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),17828,MAPK regulated corepressor interacting protein 2 OS=Homo sapiens OX=9606 GN=MCRIP2 PE=1 SV=2
1104,21390,B5MCU0|B5MCU0_HUMAN,19.39,144.65,4.716E6,4.989E6,7.573E6,7.363E6,1.00,1.06,1.61,1.56,4.716E6,4.989E6,7.573E6,7.363E6,1.00,1.06,1.61,1.56,12,11,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),108866,R3H domain-containing protein 2 OS=Homo sapiens OX=9606 GN=R3HDM2 PE=1 SV=1
887,19340,sp|Q9NQW6-2|ANLN_HUMAN,27.38,144.59,3.301E6,3.515E6,6.335E6,6.249E6,1.00,1.06,1.92,1.89,3.301E6,3.515E6,6.335E6,6.249E6,1.00,1.06,1.92,1.89,13,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),120016,Isoform 2 of Anillin OS=Homo sapiens OX=9606 GN=ANLN
524,19811,F8W727|F8W727_HUMAN,12.56,144.59,3.951E7,3.886E7,5.032E7,5.366E7,1.00,0.98,1.27,1.36,3.951E7,3.886E7,5.032E7,5.366E7,1.00,0.98,1.27,1.36,42,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),17962,60S ribosomal protein L32 OS=Homo sapiens OX=9606 GN=RPL32 PE=1 SV=1
868,5282,sp|Q9Y4E8|UBP15_HUMAN,22.77,144.48,9.002E6,8.905E6,1.705E7,1.688E7,1.00,0.99,1.89,1.88,9.002E6,8.905E6,1.705E7,1.688E7,1.00,0.99,1.89,1.88,14,17,15,iTRAQ 4plex (K  N-term),112419,Ubiquitin carboxyl-terminal hydrolase 15 OS=Homo sapiens OX=9606 GN=USP15 PE=1 SV=3
978,8241,sp|P62140|PP1B_HUMAN,17.60,144.44,7.405E6,7.536E6,1.166E7,1.174E7,1.00,1.02,1.57,1.59,7.405E6,7.536E6,1.166E7,1.174E7,1.00,1.02,1.57,1.59,12,9,3,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),37187,Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Homo sapiens OX=9606 GN=PPP1CB PE=1 SV=3
824,12950,sp|O60333-3|KIF1B_HUMAN,19.83,144.34,2.137E6,2.051E6,3.904E6,4.049E6,1.00,0.96,1.83,1.90,2.137E6,2.051E6,3.904E6,4.049E6,1.00,0.96,1.83,1.90,6,15,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),130363,Isoform 3 of Kinesin-like protein KIF1B OS=Homo sapiens OX=9606 GN=KIF1B
664,212,sp|P08779|K1C16_HUMAN,34.58,144.19,1.739E6,6.382E5,1.014E6,8.962E5,1.00,0.37,0.58,0.52,1.739E6,6.382E5,1.014E6,8.962E5,1.00,0.37,0.58,0.52,16,15,6,iTRAQ 4plex (K  N-term),51268,Keratin  type I cytoskeletal 16 OS=Homo sapiens OX=9606 GN=KRT16 PE=1 SV=4
984,6346,sp|A6ND36|FA83G_HUMAN,31.13,144.11,4.147E6,4.243E6,8.047E6,7.763E6,1.00,1.02,1.94,1.87,4.147E6,4.243E6,8.047E6,7.763E6,1.00,1.02,1.94,1.87,21,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),90835,Protein FAM83G OS=Homo sapiens OX=9606 GN=FAM83G PE=1 SV=2
1034,19430,sp|Q9UKX7|NUP50_HUMAN,10.77,144.09,3.788E6,3.768E6,5.306E6,5.211E6,1.00,0.99,1.40,1.38,3.788E6,3.768E6,5.306E6,5.211E6,1.00,0.99,1.40,1.38,32,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),50144,Nuclear pore complex protein Nup50 OS=Homo sapiens OX=9606 GN=NUP50 PE=1 SV=2
831,5039,sp|Q7L576|CYFP1_HUMAN,21.32,143.71,7.134E6,7.169E6,1.26E7,1.226E7,1.00,1.00,1.77,1.72,7.134E6,7.169E6,1.26E7,1.226E7,1.00,1.00,1.77,1.72,12,14,14,iTRAQ 4plex (K  N-term),145182,Cytoplasmic FMR1-interacting protein 1 OS=Homo sapiens OX=9606 GN=CYFIP1 PE=1 SV=1
988,19605,sp|Q07866-3|KLC1_HUMAN,18.36,143.63,4.175E6,4.179E6,7.304E6,6.851E6,1.00,1.00,1.75,1.64,4.175E6,4.179E6,7.304E6,6.851E6,1.00,1.00,1.75,1.64,24,15,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),64320,Isoform G of Kinesin light chain 1 OS=Homo sapiens OX=9606 GN=KLC1
1011,4055,sp|Q9Y3M8|STA13_HUMAN,22.46,143.52,2.878E6,2.979E6,5.1E6,4.965E6,1.00,1.03,1.77,1.73,2.878E6,2.979E6,5.1E6,4.965E6,1.00,1.03,1.77,1.73,11,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),124967,StAR-related lipid transfer protein 13 OS=Homo sapiens OX=9606 GN=STARD13 PE=1 SV=2
1103,7536,sp|Q99081|HTF4_HUMAN,27.69,143.51,1.022E6,9.796E5,1.749E6,1.69E6,1.00,0.96,1.71,1.65,1.022E6,9.796E5,1.749E6,1.69E6,1.00,0.96,1.71,1.65,19,8,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),72965,Transcription factor 12 OS=Homo sapiens OX=9606 GN=TCF12 PE=1 SV=1
709,19595,sp|P32969|RL9_HUMAN,19.83,143.48,4.896E7,4.402E7,6.563E7,6.567E7,1.00,0.90,1.34,1.34,4.896E7,4.402E7,6.563E7,6.567E7,1.00,0.90,1.34,1.34,49,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),21863,60S ribosomal protein L9 OS=Homo sapiens OX=9606 GN=RPL9 PE=1 SV=1
1177,21092,sp|Q15596|NCOA2_HUMAN,11.09,143.48,2.34E6,2.372E6,3.466E6,3.464E6,1.00,1.01,1.48,1.48,2.34E6,2.372E6,3.466E6,3.464E6,1.00,1.01,1.48,1.48,9,10,9,iTRAQ 4plex (K  N-term),159156,Nuclear receptor coactivator 2 OS=Homo sapiens OX=9606 GN=NCOA2 PE=1 SV=2
855,4455,sp|Q92600|CNOT9_HUMAN,41.02,143.25,6.433E6,6.199E6,1.38E7,1.273E7,1.00,0.96,2.15,1.98,6.433E6,6.199E6,1.38E7,1.273E7,1.00,0.96,2.15,1.98,39,12,12,iTRAQ 4plex (K  N-term); Oxidation (M),33631,CCR4-NOT transcription complex subunit 9 OS=Homo sapiens OX=9606 GN=CNOT9 PE=1 SV=1
1335,14966,sp|O43251-6|RFOX2_HUMAN,39.14,143.24,2.358E6,2.324E6,4.62E6,4.586E6,1.00,0.99,1.96,1.94,2.358E6,2.324E6,4.62E6,4.586E6,1.00,0.99,1.96,1.94,24,8,7,iTRAQ 4plex (K  N-term),47215,Isoform 6 of RNA binding protein fox-1 homolog 2 OS=Homo sapiens OX=9606 GN=RBFOX2
794,7274,sp|P62258|1433E_HUMAN,32.71,143.07,6.956E6,6.425E6,1.257E7,1.235E7,1.00,0.92,1.81,1.77,6.956E6,6.425E6,1.257E7,1.235E7,1.00,0.92,1.81,1.77,38,11,8,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),29174,14-3-3 protein epsilon OS=Homo sapiens OX=9606 GN=YWHAE PE=1 SV=1
816,9803,A0A087WYS1|A0A087WYS1_HUMAN,12.97,142.97,1.645E7,1.415E7,1.151E7,1.135E7,1.00,0.86,0.70,0.69,1.645E7,1.415E7,1.151E7,1.135E7,1.00,0.86,0.70,0.69,27,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),56967,UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens OX=9606 GN=UGP2 PE=1 SV=1
1260,2603,sp|Q05048|CSTF1_HUMAN,53.51,142.85,4.227E6,4.413E6,9.572E6,9.177E6,1.00,1.04,2.26,2.17,4.227E6,4.413E6,9.572E6,9.177E6,1.00,1.04,2.26,2.17,23,7,7,iTRAQ 4plex (K  N-term),48358,Cleavage stimulation factor subunit 1 OS=Homo sapiens OX=9606 GN=CSTF1 PE=1 SV=1
895,31204,sp|P29536-2|LMOD1_HUMAN,8.49,142.81,6.118E6,5.893E6,7.715E6,8.227E6,1.00,0.96,1.26,1.34,6.118E6,5.893E6,7.715E6,8.227E6,1.00,0.96,1.26,1.34,25,15,15,iTRAQ 4plex (K  N-term),63784,Isoform 2 of Leiomodin-1 OS=Homo sapiens OX=9606 GN=LMOD1
921,3977,sp|Q5T5P2|SKT_HUMAN,30.04,142.79,3.885E6,3.757E6,8.037E6,7.872E6,1.00,0.97,2.07,2.03,3.885E6,3.757E6,8.037E6,7.872E6,1.00,0.97,2.07,2.03,9,16,15,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),214114,Sickle tail protein homolog OS=Homo sapiens OX=9606 GN=KIAA1217 PE=1 SV=2
1008,38844,sp|O94808|GFPT2_HUMAN,13.25,142.74,3.639E6,3.653E6,5.911E6,5.984E6,1.00,1.00,1.62,1.64,3.639E6,3.653E6,5.911E6,5.984E6,1.00,1.00,1.62,1.64,13,12,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),76931,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 OS=Homo sapiens OX=9606 GN=GFPT2 PE=1 SV=3
967,13286,sp|P08572|CO4A2_HUMAN,6.73,142.68,8.197E6,8.124E6,9.971E6,9.708E6,1.00,0.99,1.22,1.18,8.197E6,8.124E6,9.971E6,9.708E6,1.00,0.99,1.22,1.18,8,9,9,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),167553,Collagen alpha-2(IV) chain OS=Homo sapiens OX=9606 GN=COL4A2 PE=1 SV=4
848,16840,sp|P49757-3|NUMB_HUMAN,28.11,142.64,4.055E6,4.113E6,7.546E6,7.744E6,1.00,1.01,1.86,1.91,4.055E6,4.113E6,7.546E6,7.744E6,1.00,1.01,1.86,1.91,15,11,8,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),69431,Isoform 3 of Protein numb homolog OS=Homo sapiens OX=9606 GN=NUMB
985,13386,sp|Q6NZY4|ZCHC8_HUMAN,29.91,142.48,3.045E6,3.146E6,6.084E6,5.976E6,1.00,1.03,2.00,1.96,3.045E6,3.146E6,6.084E6,5.976E6,1.00,1.03,2.00,1.96,20,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),78577,Zinc finger CCHC domain-containing protein 8 OS=Homo sapiens OX=9606 GN=ZCCHC8 PE=1 SV=2
1058,8766,A0A2R8Y6I6|A0A2R8Y6I6_HUMAN,21.86,142.44,3.707E6,3.842E6,5.93E6,6.237E6,1.00,1.04,1.60,1.68,3.707E6,3.842E6,5.93E6,6.237E6,1.00,1.04,1.60,1.68,16,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),81599,Dual-specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens OX=9606 GN=DYRK1A PE=1 SV=1
1075,1464,sp|P11413|G6PD_HUMAN,15.69,142.42,5.102E6,4.942E6,7.581E6,7.689E6,1.00,0.97,1.49,1.51,5.102E6,4.942E6,7.581E6,7.689E6,1.00,0.97,1.49,1.51,24,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),59257,Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens OX=9606 GN=G6PD PE=1 SV=4
1059,7249,sp|P34932|HSP74_HUMAN,7.66,142.35,3.384E6,3.219E6,4.271E6,4.315E6,1.00,0.95,1.26,1.28,3.384E6,3.219E6,4.271E6,4.315E6,1.00,0.95,1.26,1.28,15,11,11,iTRAQ 4plex (K  N-term),94331,Heat shock 70 kDa protein 4 OS=Homo sapiens OX=9606 GN=HSPA4 PE=1 SV=4
968,20931,sp|Q8IY63-2|AMOL1_HUMAN,4.52,142.21,1.783E7,1.687E7,1.738E7,2.013E7,1.00,0.95,0.97,1.13,1.783E7,1.687E7,1.738E7,2.013E7,1.00,0.95,0.97,1.13,15,12,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),101179,Isoform 2 of Angiomotin-like protein 1 OS=Homo sapiens OX=9606 GN=AMOTL1
976,1222,sp|Q7Z460-4|CLAP1_HUMAN,21.46,142.14,3.227E6,3.144E6,5.593E6,5.528E6,1.00,0.97,1.73,1.71,3.227E6,3.144E6,5.593E6,5.528E6,1.00,0.97,1.73,1.71,12,16,15,iTRAQ 4plex (K  N-term),163061,Isoform 4 of CLIP-associating protein 1 OS=Homo sapiens OX=9606 GN=CLASP1
1143,17266,sp|Q14686|NCOA6_HUMAN,13.14,142.08,3.29E6,3.355E6,4.797E6,4.6E6,1.00,1.02,1.46,1.40,3.29E6,3.355E6,4.797E6,4.6E6,1.00,1.02,1.46,1.40,8,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),219144,Nuclear receptor coactivator 6 OS=Homo sapiens OX=9606 GN=NCOA6 PE=1 SV=3
1067,8548,sp|O96019|ACL6A_HUMAN,7.63,142.03,9.836E6,1.006E7,1.261E7,1.25E7,1.00,1.02,1.28,1.27,9.836E6,1.006E7,1.261E7,1.25E7,1.00,1.02,1.28,1.27,23,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),47461,Actin-like protein 6A OS=Homo sapiens OX=9606 GN=ACTL6A PE=1 SV=1
1025,17423,sp|P52948-6|NUP98_HUMAN,23.43,142.01,4.819E6,4.847E6,8.361E6,8.484E6,1.00,1.01,1.74,1.76,4.819E6,4.847E6,8.361E6,8.484E6,1.00,1.01,1.74,1.76,9,11,11,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),186267,Isoform 6 of Nuclear pore complex protein Nup98-Nup96 OS=Homo sapiens OX=9606 GN=NUP98
1196,6373,sp|Q96EE3|SEH1_HUMAN,34.19,141.92,4.137E6,4.51E6,7.954E6,7.413E6,1.00,1.09,1.92,1.79,4.137E6,4.51E6,7.954E6,7.413E6,1.00,1.09,1.92,1.79,28,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),39649,Nucleoporin SEH1 OS=Homo sapiens OX=9606 GN=SEH1L PE=1 SV=3
626,16160,sp|P62316|SMD2_HUMAN,19.79,141.85,2.914E7,2.703E7,3.952E7,3.793E7,1.00,0.93,1.36,1.30,2.914E7,2.703E7,3.952E7,3.793E7,1.00,0.93,1.36,1.30,45,9,9,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),13527,Small nuclear ribonucleoprotein Sm D2 OS=Homo sapiens OX=9606 GN=SNRPD2 PE=1 SV=1
889,19325,sp|P42285|MTREX_HUMAN,35.73,141.84,7.982E6,8.052E6,1.676E7,1.637E7,1.00,1.01,2.10,2.05,7.982E6,8.052E6,1.676E7,1.637E7,1.00,1.01,2.10,2.05,12,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),117805,Exosome RNA helicase MTR4 OS=Homo sapiens OX=9606 GN=MTREX PE=1 SV=3
439,17138,A0A024R4M0|A0A024R4M0_HUMAN,12.41,141.84,1.24E8,1.26E8,1.831E8,1.787E8,1.00,1.02,1.48,1.44,1.24E8,1.26E8,1.831E8,1.787E8,1.00,1.02,1.48,1.44,57,17,17,iTRAQ 4plex (K  N-term); Deamidation (NQ),22591,40S ribosomal protein S9 OS=Homo sapiens OX=9606 GN=RPS9 PE=1 SV=1
1331,39041,sp|P27540-3|ARNT_HUMAN,97.20,141.84,1.094E6,1.054E6,3.134E6,2.974E6,1.00,0.96,2.87,2.72,1.094E6,1.054E6,3.134E6,2.974E6,1.00,0.96,2.87,2.72,17,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),85296,Isoform 3 of Aryl hydrocarbon receptor nuclear translocator OS=Homo sapiens OX=9606 GN=ARNT
966,1356,sp|Q8N3V7-2|SYNPO_HUMAN,15.96,141.64,4.168E6,4.172E6,6.767E6,6.826E6,1.00,1.00,1.62,1.64,4.168E6,4.172E6,6.767E6,6.826E6,1.00,1.00,1.62,1.64,20,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),96397,Isoform 2 of Synaptopodin OS=Homo sapiens OX=9606 GN=SYNPO
368,113,sp|P01615|KVD28_HUMAN,63.91,141.52,1.192E8,1.24E8,1.066E7,7.416E6,1.00,1.04,0.09,0.06,1.192E8,1.24E8,1.066E7,7.416E6,1.00,1.04,0.09,0.06,14,11,3,iTRAQ 4plex (K  N-term),12957,Immunoglobulin kappa variable 2D-28 OS=Homo sapiens OX=9606 GN=IGKV2D-28 PE=1 SV=2
1285,5104,A0A2Q2TH77|A0A2Q2TH77_HUMAN,4.30,141.40,2.805E6,2.837E6,3.366E6,3.282E6,1.00,1.01,1.20,1.17,2.805E6,2.837E6,3.366E6,3.282E6,1.00,1.01,1.20,1.17,13,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),111659,Golgin subfamily A member 2 OS=Homo sapiens OX=9606 GN=GOLGA2 PE=1 SV=1
923,15940,sp|Q86U42-2|PABP2_HUMAN,18.23,141.31,1.092E7,1.106E7,1.698E7,1.62E7,1.00,1.01,1.55,1.48,1.092E7,1.106E7,1.698E7,1.62E7,1.00,1.01,1.55,1.48,37,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),31497,Isoform 2 of Polyadenylate-binding protein 2 OS=Homo sapiens OX=9606 GN=PABPN1
847,15881,sp|Q15650|TRIP4_HUMAN,11.82,141.18,6.587E6,6.654E6,1.008E7,1.006E7,1.00,1.01,1.53,1.53,6.587E6,6.654E6,1.008E7,1.006E7,1.00,1.01,1.53,1.53,33,15,15,iTRAQ 4plex (K  N-term); Deamidation (NQ),66146,Activating signal cointegrator 1 OS=Homo sapiens OX=9606 GN=TRIP4 PE=1 SV=4
1399,3426,sp|Q9Y613|FHOD1_HUMAN,32.29,141.17,8.891E5,8.887E5,1.369E6,1.46E6,1.00,1.00,1.54,1.64,8.891E5,8.887E5,1.369E6,1.46E6,1.00,1.00,1.54,1.64,8,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),126551,FH1/FH2 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHOD1 PE=1 SV=3
852,10703,sp|O15511|ARPC5_HUMAN,17.46,141.15,1.938E7,1.825E7,2.165E7,2.533E7,1.00,0.94,1.12,1.31,1.938E7,1.825E7,2.165E7,2.533E7,1.00,0.94,1.12,1.31,50,8,7,iTRAQ 4plex (K  N-term),16320,Actin-related protein 2/3 complex subunit 5 OS=Homo sapiens OX=9606 GN=ARPC5 PE=1 SV=3
1382,1070,sp|Q9NNW5|WDR6_HUMAN,22.05,141.08,2.213E6,2.229E6,3.79E6,3.612E6,1.00,1.01,1.71,1.63,2.213E6,2.229E6,3.79E6,3.612E6,1.00,1.01,1.71,1.63,10,9,9,iTRAQ 4plex (K  N-term),121724,WD repeat-containing protein 6 OS=Homo sapiens OX=9606 GN=WDR6 PE=1 SV=1
500,7197,sp|P62244|RS15A_HUMAN,24.16,140.96,1.287E8,1.326E8,1.965E8,1.944E8,1.00,1.03,1.53,1.51,1.287E8,1.326E8,1.965E8,1.944E8,1.00,1.03,1.53,1.51,55,10,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),14840,40S ribosomal protein S15a OS=Homo sapiens OX=9606 GN=RPS15A PE=1 SV=2
1204,21719,sp|Q92567-2|F168A_HUMAN,61.49,140.96,4.188E6,4.052E6,9.108E6,8.288E6,1.00,0.97,2.17,1.98,4.188E6,4.052E6,9.108E6,8.288E6,1.00,0.97,2.17,1.98,39,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),25061,Isoform 2 of Protein FAM168A OS=Homo sapiens OX=9606 GN=FAM168A
1182,14411,sp|Q96PC5-8|MIA2_HUMAN,46.59,140.74,1.219E6,1.202E6,2.385E6,2.364E6,1.00,0.99,1.96,1.94,1.219E6,1.202E6,2.385E6,2.364E6,1.00,0.99,1.96,1.94,14,8,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),86532,Isoform 7 of Melanoma inhibitory activity protein 2 OS=Homo sapiens OX=9606 GN=MIA2
1170,3093,A0A087WZG4|A0A087WZG4_HUMAN,27.81,140.67,2.112E6,2.234E6,3.701E6,3.772E6,1.00,1.06,1.75,1.79,2.112E6,2.234E6,3.701E6,3.772E6,1.00,1.06,1.75,1.79,9,9,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),126222,Rho guanine nucleotide exchange factor 18 (Fragment) OS=Homo sapiens OX=9606 GN=ARHGEF18 PE=4 SV=2
722,1592,sp|P26038|MOES_HUMAN,13.72,140.57,5.938E6,5.633E6,8.842E6,9.206E6,1.00,0.95,1.49,1.55,5.938E6,5.633E6,8.842E6,9.206E6,1.00,0.95,1.49,1.55,17,18,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),67820,Moesin OS=Homo sapiens OX=9606 GN=MSN PE=1 SV=3
790,7494,H0Y4R1|H0Y4R1_HUMAN,8.83,140.54,8.422E6,8.308E6,1.129E7,1.127E7,1.00,0.99,1.34,1.34,8.422E6,8.308E6,1.129E7,1.127E7,1.00,0.99,1.34,1.34,20,11,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),51077,Inosine-5'-monophosphate dehydrogenase 2 (Fragment) OS=Homo sapiens OX=9606 GN=IMPDH2 PE=1 SV=1
1250,2187,sp|P52292|IMA1_HUMAN,26.92,140.46,3.535E6,3.583E6,6.037E6,5.837E6,1.00,1.01,1.71,1.65,3.535E6,3.583E6,6.037E6,5.837E6,1.00,1.01,1.71,1.65,23,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),57862,Importin subunit alpha-1 OS=Homo sapiens OX=9606 GN=KPNA2 PE=1 SV=1
1083,17205,sp|Q9H857-2|NT5D2_HUMAN,49.65,140.42,4.542E6,4.292E6,9.028E6,8.43E6,1.00,0.94,1.99,1.86,4.542E6,4.292E6,9.028E6,8.43E6,1.00,0.94,1.99,1.86,17,9,9,iTRAQ 4plex (K  N-term),64145,Isoform 2 of 5'-nucleotidase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NT5DC2
1307,4645,sp|Q9UHD2|TBK1_HUMAN,15.82,140.16,2.438E6,2.594E6,3.821E6,3.737E6,1.00,1.06,1.57,1.53,2.438E6,2.594E6,3.821E6,3.737E6,1.00,1.06,1.57,1.53,16,10,10,iTRAQ 4plex (K  N-term),83642,Serine/threonine-protein kinase TBK1 OS=Homo sapiens OX=9606 GN=TBK1 PE=1 SV=1
1230,1556,sp|Q92585|MAML1_HUMAN,11.95,139.83,2.32E6,2.293E6,3.212E6,3.359E6,1.00,0.99,1.38,1.45,2.32E6,2.293E6,3.212E6,3.359E6,1.00,0.99,1.38,1.45,12,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),108054,Mastermind-like protein 1 OS=Homo sapiens OX=9606 GN=MAML1 PE=1 SV=3
527,15743,sp|Q3MHD2|LSM12_HUMAN,20.11,139.74,5.08E7,5.265E7,7.617E7,7.272E7,1.00,1.04,1.50,1.43,5.08E7,5.265E7,7.617E7,7.272E7,1.00,1.04,1.50,1.43,39,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),21701,Protein LSM12 homolog OS=Homo sapiens OX=9606 GN=LSM12 PE=1 SV=2
992,14668,sp|P23284|PPIB_HUMAN,6.76,139.39,2.415E7,1.955E7,2.282E7,2.51E7,1.00,0.81,0.94,1.04,2.415E7,1.955E7,2.282E7,2.51E7,1.00,0.81,0.94,1.04,44,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),23743,Peptidyl-prolyl cis-trans isomerase B OS=Homo sapiens OX=9606 GN=PPIB PE=1 SV=2
919,7312,sp|P08651-2|NFIC_HUMAN,25.81,139.26,3.557E6,3.585E6,6.586E6,6.587E6,1.00,1.01,1.85,1.85,3.557E6,3.585E6,6.586E6,6.587E6,1.00,1.01,1.85,1.85,15,10,7,iTRAQ 4plex (K  N-term),54682,Isoform 1 of Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC
1573,7006,sp|Q58A45|PAN3_HUMAN,26.09,139.17,1.07E6,1.084E6,1.947E6,1.9E6,1.00,1.01,1.82,1.77,1.07E6,1.084E6,1.947E6,1.9E6,1.00,1.01,1.82,1.77,13,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),95613,PAN2-PAN3 deadenylation complex subunit PAN3 OS=Homo sapiens OX=9606 GN=PAN3 PE=1 SV=3
1003,18019,sp|Q9ULJ6|ZMIZ1_HUMAN,19.36,139.14,4.266E6,4.199E6,6.567E6,6.281E6,1.00,0.98,1.54,1.47,4.266E6,4.199E6,6.567E6,6.281E6,1.00,0.98,1.54,1.47,8,9,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),115483,Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3
830,17348,sp|O43294-2|TGFI1_HUMAN,81.35,139.10,5.793E6,5.811E6,1.378E7,1.334E7,1.00,1.00,2.38,2.30,5.793E6,5.811E6,1.378E7,1.334E7,1.00,1.00,2.38,2.30,19,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),47941,Isoform 2 of Transforming growth factor beta-1-induced transcript 1 protein OS=Homo sapiens OX=9606 GN=TGFB1I1
818,38851,sp|Q70UQ0-4|IKIP_HUMAN,17.47,138.99,5.448E6,5.627E6,8.773E6,9.126E6,1.00,1.03,1.61,1.67,5.448E6,5.627E6,8.773E6,9.126E6,1.00,1.03,1.61,1.67,20,12,9,iTRAQ 4plex (K  N-term),43084,Isoform 4 of Inhibitor of nuclear factor kappa-B kinase-interacting protein OS=Homo sapiens OX=9606 GN=IKBIP
1155,38926,sp|Q2NL82|TSR1_HUMAN,16.04,138.95,2.809E6,2.801E6,4.15E6,4.215E6,1.00,1.00,1.48,1.50,2.809E6,2.801E6,4.15E6,4.215E6,1.00,1.00,1.48,1.50,13,9,9,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),91810,Pre-rRNA-processing protein TSR1 homolog OS=Homo sapiens OX=9606 GN=TSR1 PE=1 SV=1
902,3651,sp|Q8IYM9|TRI22_HUMAN,48.39,138.72,6.289E6,6.443E6,1.389E7,1.381E7,1.00,1.02,2.21,2.20,6.289E6,6.443E6,1.389E7,1.381E7,1.00,1.02,2.21,2.20,19,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),56947,E3 ubiquitin-protein ligase TRIM22 OS=Homo sapiens OX=9606 GN=TRIM22 PE=1 SV=1
1054,1253,sp|Q86US8|EST1A_HUMAN,22.36,138.62,3.597E6,3.722E6,6.691E6,6.476E6,1.00,1.03,1.86,1.80,3.597E6,3.722E6,6.691E6,6.476E6,1.00,1.03,1.86,1.80,8,10,10,iTRAQ 4plex (K  N-term),160461,Telomerase-binding protein EST1A OS=Homo sapiens OX=9606 GN=SMG6 PE=1 SV=2
874,13151,sp|Q9UG63|ABCF2_HUMAN,19.11,138.48,7.086E6,6.923E6,1.151E7,1.139E7,1.00,0.98,1.62,1.61,7.086E6,6.923E6,1.151E7,1.139E7,1.00,0.98,1.62,1.61,18,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),71290,ATP-binding cassette sub-family F member 2 OS=Homo sapiens OX=9606 GN=ABCF2 PE=1 SV=2
1323,30438,sp|O95985-3|TOP3B_HUMAN,24.15,138.19,2.836E6,2.893E6,4.987E6,5.042E6,1.00,1.02,1.76,1.78,2.836E6,2.893E6,4.987E6,5.042E6,1.00,1.02,1.76,1.78,14,9,8,iTRAQ 4plex (K  N-term),79839,Isoform 3 of DNA topoisomerase 3-beta-1 OS=Homo sapiens OX=9606 GN=TOP3B
913,3154,sp|Q9Y4B5|MTCL1_HUMAN,13.61,138.16,3.274E6,3.38E6,5.276E6,5.404E6,1.00,1.03,1.61,1.65,3.274E6,3.38E6,5.276E6,5.404E6,1.00,1.03,1.61,1.65,10,17,17,iTRAQ 4plex (K  N-term),209525,Microtubule cross-linking factor 1 OS=Homo sapiens OX=9606 GN=MTCL1 PE=1 SV=5
1012,38809,sp|Q8TEQ6|GEMI5_HUMAN,9.91,138.15,3.885E6,3.82E6,5.62E6,5.498E6,1.00,0.98,1.45,1.42,3.885E6,3.82E6,5.62E6,5.498E6,1.00,0.98,1.45,1.42,11,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),168589,Gem-associated protein 5 OS=Homo sapiens OX=9606 GN=GEMIN5 PE=1 SV=3
1209,6029,sp|P49411|EFTU_HUMAN,23.62,138.15,4.949E6,4.897E6,8.597E6,8.49E6,1.00,0.99,1.74,1.72,4.949E6,4.897E6,8.597E6,8.49E6,1.00,0.99,1.74,1.72,23,9,9,iTRAQ 4plex (K  N-term),49542,Elongation factor Tu  mitochondrial OS=Homo sapiens OX=9606 GN=TUFM PE=1 SV=2
646,20012,sp|P62847-2|RS24_HUMAN,35.01,138.12,3.708E7,3.66E7,6.071E7,6.048E7,1.00,0.99,1.64,1.63,3.708E7,3.66E7,6.071E7,6.048E7,1.00,0.99,1.64,1.63,39,8,8,iTRAQ 4plex (K  N-term); Oxidation (M),15069,Isoform 2 of 40S ribosomal protein S24 OS=Homo sapiens OX=9606 GN=RPS24
1048,22737,A0A0J9YYA7|A0A0J9YYA7_HUMAN,2.15,138.11,1.137E6,1.123E6,2.241E6,2.231E6,1.00,0.99,1.97,1.96,1.137E6,1.123E6,2.241E6,2.231E6,1.00,0.99,1.97,1.96,3,7,1,iTRAQ 4plex (K  N-term),24911,FERM domain-containing protein 4A (Fragment) OS=Homo sapiens OX=9606 GN=FRMD4A PE=1 SV=1
869,6798,sp|Q659C4-2|LAR1B_HUMAN,1.48,137.90,2.46E5,2.292E5,3.788E5,3.708E5,1.00,0.93,1.54,1.51,2.46E5,2.292E5,3.788E5,3.708E5,1.00,0.93,1.54,1.51,1,13,1,iTRAQ 4plex (K  N-term),98592,Isoform 2 of La-related protein 1B OS=Homo sapiens OX=9606 GN=LARP1B
349,132,E9PKG0|E9PKG0_HUMAN,0.54,137.83,5.605E5,5.696E5,5.784E5,6.835E5,1.00,1.02,1.03,1.22,5.605E5,5.696E5,5.784E5,6.835E5,1.00,1.02,1.03,1.22,7,9,1,iTRAQ 4plex (K  N-term),22520,Plectin (Fragment) OS=Homo sapiens OX=9606 GN=PLEC PE=1 SV=1
806,18982,B4DDF4|B4DDF4_HUMAN,83.47,137.75,7.877E6,7.747E6,2.192E7,2.182E7,1.00,0.98,2.78,2.77,7.877E6,7.747E6,2.192E7,2.182E7,1.00,0.98,2.78,2.77,25,8,6,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),32617,Calponin OS=Homo sapiens OX=9606 GN=CNN2 PE=1 SV=1
901,38840,sp|Q6NUQ4-2|TM214_HUMAN,23.80,137.49,9.088E6,9.292E6,1.574E7,1.589E7,1.00,1.02,1.73,1.75,9.088E6,9.292E6,1.574E7,1.589E7,1.00,1.02,1.73,1.75,16,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),72040,Isoform 2 of Transmembrane protein 214 OS=Homo sapiens OX=9606 GN=TMEM214
1092,12832,sp|Q13136-2|LIPA1_HUMAN,18.77,137.40,2.539E6,2.434E6,4.146E6,4.202E6,1.00,0.96,1.63,1.65,2.539E6,2.434E6,4.146E6,4.202E6,1.00,0.96,1.63,1.65,10,11,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),133970,Isoform 2 of Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1
1039,4085,sp|Q9H6S0|YTDC2_HUMAN,12.65,137.27,3.923E6,4.205E6,6.61E6,6.505E6,1.00,1.07,1.68,1.66,3.923E6,4.205E6,6.61E6,6.505E6,1.00,1.07,1.68,1.66,8,13,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),160248,3'-5' RNA helicase YTHDC2 OS=Homo sapiens OX=9606 GN=YTHDC2 PE=1 SV=2
1279,10030,sp|Q13356|PPIL2_HUMAN,41.36,137.25,1.021E6,9.374E5,1.927E6,1.794E6,1.00,0.92,1.89,1.76,1.021E6,9.374E5,1.927E6,1.794E6,1.00,0.92,1.89,1.76,21,8,8,iTRAQ 4plex (K  N-term),58824,RING-type E3 ubiquitin-protein ligase PPIL2 OS=Homo sapiens OX=9606 GN=PPIL2 PE=1 SV=1
458,4274,sp|P05787|K2C8_HUMAN,22.35,137.17,2.501E6,2.491E6,4.787E6,4.885E6,1.00,1.00,1.91,1.95,2.501E6,2.491E6,4.787E6,4.885E6,1.00,1.00,1.91,1.95,16,14,8,iTRAQ 4plex (K  N-term),53704,Keratin  type II cytoskeletal 8 OS=Homo sapiens OX=9606 GN=KRT8 PE=1 SV=7
490,20901,sp|P62081|RS7_HUMAN,13.25,137.12,1.167E8,1.205E8,1.626E8,1.646E8,1.00,1.03,1.39,1.41,1.167E8,1.205E8,1.626E8,1.646E8,1.00,1.03,1.39,1.41,71,14,14,iTRAQ 4plex (K  N-term); Oxidation (M); Acetylation (Protein N-term); Deamidation (NQ),22127,40S ribosomal protein S7 OS=Homo sapiens OX=9606 GN=RPS7 PE=1 SV=1
1122,14192,sp|P78527-2|PRKDC_HUMAN,13.84,136.95,2.645E6,2.629E6,4.135E6,4.013E6,1.00,0.99,1.56,1.52,2.645E6,2.629E6,4.135E6,4.013E6,1.00,0.99,1.56,1.52,3,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),465505,Isoform 2 of DNA-dependent protein kinase catalytic subunit OS=Homo sapiens OX=9606 GN=PRKDC
942,9375,sp|Q86V81|THOC4_HUMAN,16.99,136.93,7.403E6,6.983E6,1.071E7,1.05E7,1.00,0.94,1.45,1.42,7.403E6,6.983E6,1.071E7,1.05E7,1.00,0.94,1.45,1.42,31,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),26888,THO complex subunit 4 OS=Homo sapiens OX=9606 GN=ALYREF PE=1 SV=3
614,19399,sp|P12236|ADT3_HUMAN,1.82,136.89,2.853E5,2.969E5,5.171E5,4.982E5,1.00,1.04,1.81,1.75,2.853E5,2.969E5,5.171E5,4.982E5,1.00,1.04,1.81,1.75,4,14,1,iTRAQ 4plex (K  N-term),32866,ADP/ATP translocase 3 OS=Homo sapiens OX=9606 GN=SLC25A6 PE=1 SV=4
760,4043,sp|P48668|K2C6C_HUMAN,10.08,136.77,1.218E6,5.243E5,5.983E5,5.045E5,1.00,0.43,0.49,0.41,1.218E6,5.243E5,5.983E5,5.045E5,1.00,0.43,0.49,0.41,5,12,2,iTRAQ 4plex (K  N-term),60025,Keratin  type II cytoskeletal 6C OS=Homo sapiens OX=9606 GN=KRT6C PE=1 SV=3
950,20235,A0A0C4DGH3|A0A0C4DGH3_HUMAN,11.93,136.71,4.748E6,4.568E6,6.561E6,6.561E6,1.00,0.96,1.38,1.38,4.748E6,4.568E6,6.561E6,6.561E6,1.00,0.96,1.38,1.38,11,8,5,iTRAQ 4plex (K  N-term),60813,Numb-like protein OS=Homo sapiens OX=9606 GN=NUMBL PE=1 SV=1
441,114,sp|P06310|KV230_HUMAN,0.80,136.61,1.274E5,1.085E5,1.404E5,1.457E5,1.00,0.85,1.10,1.14,1.274E5,1.085E5,1.404E5,1.457E5,1.00,0.85,1.10,1.14,6,9,1,iTRAQ 4plex (K  N-term),13185,Immunoglobulin kappa variable 2-30 OS=Homo sapiens OX=9606 GN=IGKV2-30 PE=3 SV=2
979,1932,sp|Q7Z6B7|SRGP1_HUMAN,14.31,136.57,3.79E6,3.91E6,6.197E6,6.143E6,1.00,1.03,1.63,1.62,3.79E6,3.91E6,6.197E6,6.143E6,1.00,1.03,1.63,1.62,10,12,11,iTRAQ 4plex (K  N-term),124264,SLIT-ROBO Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=SRGAP1 PE=1 SV=1
540,19924,sp|P17096|HMGA1_HUMAN,13.96,136.53,4.429E6,4.22E6,5.679E6,6.063E6,1.00,0.95,1.28,1.37,4.429E6,4.22E6,5.679E6,6.063E6,1.00,0.95,1.28,1.37,15,9,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),11676,High mobility group protein HMG-I/HMG-Y OS=Homo sapiens OX=9606 GN=HMGA1 PE=1 SV=3
1148,10504,sp|Q9Y230|RUVB2_HUMAN,21.13,136.49,2.745E6,2.755E6,5.065E6,5.048E6,1.00,1.00,1.85,1.84,2.745E6,2.755E6,5.065E6,5.048E6,1.00,1.00,1.85,1.84,26,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),51157,RuvB-like 2 OS=Homo sapiens OX=9606 GN=RUVBL2 PE=1 SV=3
1084,10448,sp|Q9BVC5|ASHWN_HUMAN,18.21,136.22,4.741E6,4.841E6,8.097E6,7.88E6,1.00,1.02,1.71,1.66,4.741E6,4.841E6,8.097E6,7.88E6,1.00,1.02,1.71,1.66,47,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),25858,Ashwin OS=Homo sapiens OX=9606 GN=C2orf49 PE=1 SV=1
1248,3349,sp|Q9Y2X0-2|MED16_HUMAN,8.33,136.20,5.094E6,5.225E6,6.697E6,6.297E6,1.00,1.03,1.31,1.24,5.094E6,5.225E6,6.697E6,6.297E6,1.00,1.03,1.31,1.24,16,9,9,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),93029,Isoform 2 of Mediator of RNA polymerase II transcription subunit 16 OS=Homo sapiens OX=9606 GN=MED16
275,2115,sp|P14649|MYL6B_HUMAN,2.43,136.07,5.654E6,4.974E6,5.014E6,5.512E6,1.00,0.88,0.89,0.97,5.654E6,4.974E6,5.014E6,5.512E6,1.00,0.88,0.89,0.97,20,11,4,iTRAQ 4plex (K  N-term),22764,Myosin light chain 6B OS=Homo sapiens OX=9606 GN=MYL6B PE=1 SV=1
986,20437,sp|Q14258|TRI25_HUMAN,10.23,136.05,5.153E6,5.199E6,7.131E6,7.105E6,1.00,1.01,1.38,1.38,5.153E6,5.199E6,7.131E6,7.105E6,1.00,1.01,1.38,1.38,14,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),70974,E3 ubiquitin/ISG15 ligase TRIM25 OS=Homo sapiens OX=9606 GN=TRIM25 PE=1 SV=2
838,141,A0A3B3IT11|A0A3B3IT11_HUMAN,1.53,135.95,8.849E4,8.713E4,1.463E5,1.265E5,1.00,0.98,1.65,1.43,8.849E4,8.713E4,1.463E5,1.265E5,1.00,0.98,1.65,1.43,9,6,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),31619,Basement membrane-specific heparan sulfate proteoglycan core protein (Fragment) OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=1
1128,3546,sp|Q5T5U3|RHG21_HUMAN,22.05,135.86,1.144E6,1.085E6,2.133E6,2.125E6,1.00,0.95,1.86,1.86,1.144E6,1.085E6,2.133E6,2.125E6,1.00,0.95,1.86,1.86,8,12,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),217329,Rho GTPase-activating protein 21 OS=Homo sapiens OX=9606 GN=ARHGAP21 PE=1 SV=1
963,19432,sp|P04792|HSPB1_HUMAN,22.11,135.66,8.76E6,8.074E6,1.215E7,1.245E7,1.00,0.92,1.39,1.42,8.76E6,8.074E6,1.215E7,1.245E7,1.00,0.92,1.39,1.42,35,7,7,iTRAQ 4plex (K  N-term); Phosphorylation (STY),22783,Heat shock protein beta-1 OS=Homo sapiens OX=9606 GN=HSPB1 PE=1 SV=2
912,11833,Q5T985|Q5T985_HUMAN,116.48,135.62,4.154E7,4.363E7,1.039E7,9.878E6,1.00,1.05,0.25,0.24,4.154E7,4.363E7,1.039E7,9.878E6,1.00,1.05,0.25,0.24,8,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),105216,Inter-alpha-trypsin inhibitor heavy chain H2 OS=Homo sapiens OX=9606 GN=ITIH2 PE=1 SV=1
673,19460,E9PK25|E9PK25_HUMAN,18.18,135.61,1.194E7,9.443E6,1.31E7,1.487E7,1.00,0.79,1.10,1.25,1.194E7,9.443E6,1.31E7,1.487E7,1.00,0.79,1.10,1.25,25,10,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),22728,Cofilin-1 OS=Homo sapiens OX=9606 GN=CFL1 PE=1 SV=1
1242,9823,sp|Q9NQC7-2|CYLD_HUMAN,20.28,135.58,2.578E6,2.614E6,4.758E6,4.681E6,1.00,1.01,1.85,1.82,2.578E6,2.614E6,4.758E6,4.681E6,1.00,1.01,1.85,1.82,12,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),107044,Isoform 2 of Ubiquitin carboxyl-terminal hydrolase CYLD OS=Homo sapiens OX=9606 GN=CYLD
486,19780,sp|P62899|RL31_HUMAN,15.96,135.55,4.479E7,4.752E7,6.791E7,6.671E7,1.00,1.06,1.52,1.49,4.479E7,4.752E7,6.791E7,6.671E7,1.00,1.06,1.52,1.49,54,10,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),14463,60S ribosomal protein L31 OS=Homo sapiens OX=9606 GN=RPL31 PE=1 SV=1
825,1509,sp|Q9BZL4|PP12C_HUMAN,13.69,135.46,4.451E6,4.149E6,6.661E6,6.791E6,1.00,0.93,1.50,1.53,4.451E6,4.149E6,6.661E6,6.791E6,1.00,0.93,1.50,1.53,17,13,13,iTRAQ 4plex (K  N-term),84881,Protein phosphatase 1 regulatory subunit 12C OS=Homo sapiens OX=9606 GN=PPP1R12C PE=1 SV=1
1020,6203,sp|Q9NPJ6|MED4_HUMAN,10.20,135.44,5.3E6,5.389E6,7.339E6,7.039E6,1.00,1.02,1.38,1.33,5.3E6,5.389E6,7.339E6,7.039E6,1.00,1.02,1.38,1.33,40,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),29745,Mediator of RNA polymerase II transcription subunit 4 OS=Homo sapiens OX=9606 GN=MED4 PE=1 SV=1
1035,38846,sp|Q6PJI9|WDR59_HUMAN,17.30,135.27,4.949E6,5.121E6,8.001E6,7.839E6,1.00,1.03,1.62,1.58,4.949E6,5.121E6,8.001E6,7.839E6,1.00,1.03,1.62,1.58,15,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),109793,GATOR complex protein WDR59 OS=Homo sapiens OX=9606 GN=WDR59 PE=1 SV=2
795,38826,sp|Q12792|TWF1_HUMAN,8.22,135.24,8.828E6,8.339E6,9.804E6,1.114E7,1.00,0.94,1.11,1.26,8.828E6,8.339E6,9.804E6,1.114E7,1.00,0.94,1.11,1.26,35,12,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),40283,Twinfilin-1 OS=Homo sapiens OX=9606 GN=TWF1 PE=1 SV=3
1043,20934,sp|P54136|SYRC_HUMAN,5.34,134.95,6.618E6,6.548E6,8.131E6,7.912E6,1.00,0.99,1.23,1.20,6.618E6,6.548E6,8.131E6,7.912E6,1.00,0.99,1.23,1.20,15,10,10,iTRAQ 4plex (K  N-term),75379,Arginine--tRNA ligase  cytoplasmic OS=Homo sapiens OX=9606 GN=RARS PE=1 SV=2
903,14425,sp|Q9Y285|SYFA_HUMAN,19.95,134.74,4.155E6,4.154E6,7.215E6,7.132E6,1.00,1.00,1.74,1.72,4.155E6,4.154E6,7.215E6,7.132E6,1.00,1.00,1.74,1.72,18,8,8,iTRAQ 4plex (K  N-term),57564,Phenylalanine--tRNA ligase alpha subunit OS=Homo sapiens OX=9606 GN=FARSA PE=1 SV=3
1052,7036,sp|Q5VT25-3|MRCKA_HUMAN,12.77,134.72,1.458E6,1.484E6,2.323E6,2.339E6,1.00,1.02,1.59,1.60,1.458E6,1.484E6,2.323E6,2.339E6,1.00,1.02,1.59,1.60,5,11,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),186112,Isoform 3 of Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens OX=9606 GN=CDC42BPA
1068,14718,sp|P40227|TCPZ_HUMAN,4.56,134.70,6.469E6,5.86E6,7.001E6,7.051E6,1.00,0.91,1.08,1.09,6.469E6,5.86E6,7.001E6,7.051E6,1.00,0.91,1.08,1.09,19,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),58024,T-complex protein 1 subunit zeta OS=Homo sapiens OX=9606 GN=CCT6A PE=1 SV=3
1112,38887,sp|P30419|NMT1_HUMAN,18.19,134.50,1.863E6,1.828E6,2.838E6,2.893E6,1.00,0.98,1.52,1.55,1.863E6,1.828E6,2.838E6,2.893E6,1.00,0.98,1.52,1.55,20,9,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),56806,Glycylpeptide N-tetradecanoyltransferase 1 OS=Homo sapiens OX=9606 GN=NMT1 PE=1 SV=2
1157,19592,sp|Q9H074-3|PAIP1_HUMAN,40.79,134.42,2.502E6,2.295E6,4.065E6,3.92E6,1.00,0.92,1.62,1.57,2.502E6,2.295E6,4.065E6,3.92E6,1.00,0.92,1.62,1.57,19,9,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),42007,Isoform 3 of Polyadenylate-binding protein-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAIP1
326,6749,sp|P62269|RS18_HUMAN,20.49,134.33,1.003E8,1.031E8,1.522E8,1.543E8,1.00,1.03,1.52,1.54,1.003E8,1.031E8,1.522E8,1.543E8,1.00,1.03,1.52,1.54,54,13,13,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),17719,40S ribosomal protein S18 OS=Homo sapiens OX=9606 GN=RPS18 PE=1 SV=3
928,20629,H0YEF7|H0YEF7_HUMAN,3.56,134.18,6.633E5,6.689E5,1.841E6,1.785E6,1.00,1.01,2.77,2.69,6.633E5,6.689E5,1.841E6,1.785E6,1.00,1.01,2.77,2.69,9,8,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),31477,Phosphatidylinositol-binding clathrin assembly protein (Fragment) OS=Homo sapiens OX=9606 GN=PICALM PE=1 SV=1
1300,21445,sp|Q16825|PTN21_HUMAN,23.87,134.11,2.702E6,2.762E6,5.459E6,5.31E6,1.00,1.02,2.02,1.97,2.702E6,2.762E6,5.459E6,5.31E6,1.00,1.02,2.02,1.97,10,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),133281,Tyrosine-protein phosphatase non-receptor type 21 OS=Homo sapiens OX=9606 GN=PTPN21 PE=1 SV=2
932,9643,D6RG15|D6RG15_HUMAN,29.58,133.91,4.935E6,4.694E6,7.723E6,8.201E6,1.00,0.95,1.56,1.66,4.935E6,4.694E6,7.723E6,8.201E6,1.00,0.95,1.56,1.66,25,6,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),28883,Twinfilin-2 OS=Homo sapiens OX=9606 GN=TWF2 PE=1 SV=1
1414,38980,sp|P08240|SRPRA_HUMAN,25.24,133.74,5.559E6,3.637E6,6.315E6,6.208E6,1.00,0.65,1.14,1.12,5.559E6,3.637E6,6.315E6,6.208E6,1.00,0.65,1.14,1.12,15,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),69811,Signal recognition particle receptor subunit alpha OS=Homo sapiens OX=9606 GN=SRPRA PE=1 SV=2
1371,1666,sp|P82933|RT09_HUMAN,20.62,133.57,3.315E6,3.05E6,4.649E6,4.574E6,1.00,0.92,1.40,1.38,3.315E6,3.05E6,4.649E6,4.574E6,1.00,0.92,1.40,1.38,21,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),45835,28S ribosomal protein S9  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS9 PE=1 SV=2
1288,38968,sp|Q13895|BYST_HUMAN,16.42,133.44,1.804E6,1.694E6,2.729E6,2.759E6,1.00,0.94,1.51,1.53,1.804E6,1.694E6,2.729E6,2.759E6,1.00,0.94,1.51,1.53,22,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),49601,Bystin OS=Homo sapiens OX=9606 GN=BYSL PE=1 SV=3
996,26980,sp|Q13188|STK3_HUMAN,15.86,133.41,1.621E6,1.579E6,2.881E6,2.812E6,1.00,0.97,1.78,1.73,1.621E6,1.579E6,2.881E6,2.812E6,1.00,0.97,1.78,1.73,11,10,5,iTRAQ 4plex (K  N-term),56301,Serine/threonine-protein kinase 3 OS=Homo sapiens OX=9606 GN=STK3 PE=1 SV=2
1099,13624,sp|Q16204|CCDC6_HUMAN,27.37,133.30,1.944E6,1.902E6,3.957E6,3.927E6,1.00,0.98,2.04,2.02,1.944E6,1.902E6,3.957E6,3.927E6,1.00,0.98,2.04,2.02,23,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),53291,Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2
1249,38915,sp|Q9H4W6-2|COE3_HUMAN,17.31,133.24,6.512E5,6.094E5,1.037E6,1.008E6,1.00,0.94,1.59,1.55,6.512E5,6.094E5,1.037E6,1.008E6,1.00,0.94,1.59,1.55,8,8,3,iTRAQ 4plex (K  N-term),60415,Isoform Short of Transcription factor COE3 OS=Homo sapiens OX=9606 GN=EBF3
819,20596,H7C4C4|H7C4C4_HUMAN,5.78,133.19,7.475E5,8.293E5,1.53E6,1.192E6,1.00,1.11,2.05,1.59,7.475E5,8.293E5,1.53E6,1.192E6,1.00,1.11,2.05,1.59,16,8,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),18313,SEC23-interacting protein (Fragment) OS=Homo sapiens OX=9606 GN=SEC23IP PE=1 SV=1
865,1192,sp|O00507|USP9Y_HUMAN,4.54,133.17,1.448E4,2.198E4,6.027E3,6.148E3,1.00,1.52,0.42,0.42,1.448E4,2.198E4,6.027E3,6.148E3,1.00,1.52,0.42,0.42,2,14,1,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),291075,Probable ubiquitin carboxyl-terminal hydrolase FAF-Y OS=Homo sapiens OX=9606 GN=USP9Y PE=2 SV=2
413,20005,sp|P61254|RL26_HUMAN,17.61,133.12,1.186E8,1.231E8,1.74E8,1.764E8,1.00,1.04,1.47,1.49,1.186E8,1.231E8,1.74E8,1.764E8,1.00,1.04,1.47,1.49,47,10,10,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),17258,60S ribosomal protein L26 OS=Homo sapiens OX=9606 GN=RPL26 PE=1 SV=1
1057,20860,sp|P27448-6|MARK3_HUMAN,8.86,132.98,2.215E6,2.178E6,3.309E6,3.27E6,1.00,0.98,1.49,1.48,2.215E6,2.178E6,3.309E6,3.27E6,1.00,0.98,1.49,1.48,15,12,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),79875,Isoform 5 of MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3
1234,38941,sp|Q8WU90|ZC3HF_HUMAN,11.17,132.91,4.518E6,4.488E6,6.018E6,6.09E6,1.00,0.99,1.33,1.35,4.518E6,4.488E6,6.018E6,6.09E6,1.00,0.99,1.33,1.35,26,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),48603,Zinc finger CCCH domain-containing protein 15 OS=Homo sapiens OX=9606 GN=ZC3H15 PE=1 SV=1
1116,9232,sp|Q16270|IBP7_HUMAN,19.66,132.90,1.109E7,1.124E7,1.713E7,1.699E7,1.00,1.01,1.54,1.53,1.109E7,1.124E7,1.713E7,1.699E7,1.00,1.01,1.54,1.53,22,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),29130,Insulin-like growth factor-binding protein 7 OS=Homo sapiens OX=9606 GN=IGFBP7 PE=1 SV=1
1152,13301,E9PKG1|E9PKG1_HUMAN,33.21,132.82,7.22E6,7.286E6,1.432E7,1.289E7,1.00,1.01,1.98,1.79,7.22E6,7.286E6,1.432E7,1.289E7,1.00,1.01,1.98,1.79,22,8,8,iTRAQ 4plex (K  N-term),37709,Protein arginine N-methyltransferase 1 OS=Homo sapiens OX=9606 GN=PRMT1 PE=1 SV=1
1237,20912,sp|Q8N1G4|LRC47_HUMAN,13.46,132.82,3.902E6,3.896E6,5.871E6,6.087E6,1.00,1.00,1.50,1.56,3.902E6,3.896E6,5.871E6,6.087E6,1.00,1.00,1.50,1.56,23,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),63473,Leucine-rich repeat-containing protein 47 OS=Homo sapiens OX=9606 GN=LRRC47 PE=1 SV=1
742,21583,K7ELT6|K7ELT6_HUMAN,3.38,132.73,1.42E5,1.468E5,3.909E5,3.919E5,1.00,1.03,2.75,2.76,1.42E5,1.468E5,3.909E5,3.919E5,1.00,1.03,2.75,2.76,5,6,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),15327,Cold-inducible RNA-binding protein OS=Homo sapiens OX=9606 GN=CIRBP PE=1 SV=1
644,20163,sp|P06730-3|IF4E_HUMAN,80.44,132.70,2.641E7,2.912E7,6.986E7,6.881E7,1.00,1.10,2.64,2.61,2.641E7,2.912E7,6.986E7,6.881E7,1.00,1.10,2.64,2.61,31,9,9,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),27260,Isoform 3 of Eukaryotic translation initiation factor 4E OS=Homo sapiens OX=9606 GN=EIF4E
440,11983,sp|P84103-2|SRSF3_HUMAN,20.69,132.55,3.695E7,3.856E7,5.802E7,5.707E7,1.00,1.04,1.57,1.54,3.695E7,3.856E7,5.802E7,5.707E7,1.00,1.04,1.57,1.54,40,9,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),14203,Isoform 2 of Serine/arginine-rich splicing factor 3 OS=Homo sapiens OX=9606 GN=SRSF3
1101,38884,sp|Q96CT7|CC124_HUMAN,11.98,132.54,4.094E6,4.027E6,5.659E6,5.916E6,1.00,0.98,1.38,1.44,4.094E6,4.027E6,5.659E6,5.916E6,1.00,0.98,1.38,1.44,39,11,11,iTRAQ 4plex (K  N-term),25835,Coiled-coil domain-containing protein 124 OS=Homo sapiens OX=9606 GN=CCDC124 PE=1 SV=1
1064,19968,sp|Q9NZM1-6|MYOF_HUMAN,12.23,132.45,2.543E6,2.625E6,4.115E6,3.99E6,1.00,1.03,1.62,1.57,2.543E6,2.625E6,4.115E6,3.99E6,1.00,1.03,1.62,1.57,9,14,14,iTRAQ 4plex (K  N-term); Deamidation (NQ),233474,Isoform 6 of Myoferlin OS=Homo sapiens OX=9606 GN=MYOF
1046,38847,sp|P19525|E2AK2_HUMAN,8.22,132.21,6.113E6,5.984E6,8.072E6,8.381E6,1.00,0.98,1.32,1.37,6.113E6,5.984E6,8.072E6,8.381E6,1.00,0.98,1.32,1.37,24,10,10,iTRAQ 4plex (K  N-term); Oxidation (M),62094,Interferon-induced  double-stranded RNA-activated protein kinase OS=Homo sapiens OX=9606 GN=EIF2AK2 PE=1 SV=2
1440,21471,sp|P49959-2|MRE11_HUMAN,62.71,132.02,2.326E6,1.161E6,1.957E6,1.887E6,1.00,0.50,0.84,0.81,2.326E6,1.161E6,1.957E6,1.887E6,1.00,0.50,0.84,0.81,14,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),77642,Isoform 2 of Double-strand break repair protein MRE11 OS=Homo sapiens OX=9606 GN=MRE11
879,19451,sp|P05455|LA_HUMAN,13.70,131.85,5.111E6,5.2E6,8.351E6,7.97E6,1.00,1.02,1.63,1.56,5.111E6,5.2E6,8.351E6,7.97E6,1.00,1.02,1.63,1.56,28,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),46837,Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2
1232,14169,sp|Q08AD1-2|CAMP2_HUMAN,20.61,131.74,2.874E6,2.907E6,5.147E6,5.149E6,1.00,1.01,1.79,1.79,2.874E6,2.907E6,5.147E6,5.149E6,1.00,1.01,1.79,1.79,9,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),165057,Isoform 2 of Calmodulin-regulated spectrin-associated protein 2 OS=Homo sapiens OX=9606 GN=CAMSAP2
1292,22249,sp|O43290|SNUT1_HUMAN,15.96,131.67,2.163E6,2.013E6,3.057E6,3.026E6,1.00,0.93,1.41,1.40,2.163E6,2.013E6,3.057E6,3.026E6,1.00,0.93,1.41,1.40,12,7,7,iTRAQ 4plex (K  N-term),90255,U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1
894,19162,sp|P08579|RU2B_HUMAN,28.96,131.46,4.272E6,4.326E6,8.092E6,7.907E6,1.00,1.01,1.89,1.85,4.272E6,4.326E6,8.092E6,7.907E6,1.00,1.01,1.89,1.85,39,10,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),25486,U2 small nuclear ribonucleoprotein B'' OS=Homo sapiens OX=9606 GN=SNRPB2 PE=1 SV=1
1119,38875,sp|Q14554|PDIA5_HUMAN,11.15,131.46,4.778E6,3.944E6,5.575E6,5.949E6,1.00,0.83,1.17,1.25,4.778E6,3.944E6,5.575E6,5.949E6,1.00,0.83,1.17,1.25,21,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),59594,Protein disulfide-isomerase A5 OS=Homo sapiens OX=9606 GN=PDIA5 PE=1 SV=1
686,5309,sp|P61981|1433G_HUMAN,23.32,131.35,2.419E6,2.359E6,4.348E6,4.378E6,1.00,0.97,1.80,1.81,2.419E6,2.359E6,4.348E6,4.378E6,1.00,0.97,1.80,1.81,28,10,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),28303,14-3-3 protein gamma OS=Homo sapiens OX=9606 GN=YWHAG PE=1 SV=2
1238,3070,sp|Q6P2H3-4|CEP85_HUMAN,39.02,131.26,1.619E6,1.647E6,3.557E6,3.469E6,1.00,1.02,2.20,2.14,1.619E6,1.647E6,3.557E6,3.469E6,1.00,1.02,2.20,2.14,15,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),80302,Isoform 4 of Centrosomal protein of 85 kDa OS=Homo sapiens OX=9606 GN=CEP85
1293,23523,sp|P21399|ACOC_HUMAN,8.65,131.02,2.199E6,2.147E6,2.989E6,2.95E6,1.00,0.98,1.36,1.34,2.199E6,2.147E6,2.989E6,2.95E6,1.00,0.98,1.36,1.34,11,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),98399,Cytoplasmic aconitate hydratase OS=Homo sapiens OX=9606 GN=ACO1 PE=1 SV=3
1090,9308,sp|Q14669|TRIPC_HUMAN,7.20,131.01,2.915E6,2.989E6,4.021E6,4.061E6,1.00,1.03,1.38,1.39,2.915E6,2.989E6,4.021E6,4.061E6,1.00,1.03,1.38,1.39,7,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),220432,E3 ubiquitin-protein ligase TRIP12 OS=Homo sapiens OX=9606 GN=TRIP12 PE=1 SV=1
1334,22244,sp|Q69YN4-3|VIR_HUMAN,30.21,130.99,2.204E6,2.239E6,3.979E6,3.932E6,1.00,1.02,1.81,1.78,2.204E6,2.239E6,3.979E6,3.932E6,1.00,1.02,1.81,1.78,6,9,9,iTRAQ 4plex (K  N-term); Phosphorylation (STY),201055,Isoform 3 of Protein virilizer homolog OS=Homo sapiens OX=9606 GN=VIRMA
741,13642,sp|Q96AG4|LRC59_HUMAN,8.93,130.98,2.903E7,2.884E7,3.809E7,3.982E7,1.00,0.99,1.31,1.37,2.903E7,2.884E7,3.809E7,3.982E7,1.00,0.99,1.31,1.37,37,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),34930,Leucine-rich repeat-containing protein 59 OS=Homo sapiens OX=9606 GN=LRRC59 PE=1 SV=1
1219,2648,sp|Q8TDB6|DTX3L_HUMAN,18.75,130.80,5.789E6,5.916E6,9.822E6,9.395E6,1.00,1.02,1.70,1.62,5.789E6,5.916E6,9.822E6,9.395E6,1.00,1.02,1.70,1.62,14,9,9,iTRAQ 4plex (K  N-term); Phosphorylation (STY),83554,E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1
993,18109,C9J9K3|C9J9K3_HUMAN,13.20,130.75,1.084E7,1.039E7,1.462E7,1.451E7,1.00,0.96,1.35,1.34,1.084E7,1.039E7,1.462E7,1.451E7,1.00,0.96,1.35,1.34,31,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),29405,40S ribosomal protein SA (Fragment) OS=Homo sapiens OX=9606 GN=RPSA PE=1 SV=8
1195,2367,sp|Q9NSY1|BMP2K_HUMAN,8.57,130.57,3.803E6,3.852E6,5.461E6,5.396E6,1.00,1.01,1.44,1.42,3.803E6,3.852E6,5.461E6,5.396E6,1.00,1.01,1.44,1.42,9,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),129171,BMP-2-inducible protein kinase OS=Homo sapiens OX=9606 GN=BMP2K PE=1 SV=2
1065,20482,sp|P62995|TRA2B_HUMAN,36.78,130.54,1.906E7,2.107E7,3.286E7,2.914E7,1.00,1.11,1.72,1.53,1.906E7,2.107E7,3.286E7,2.914E7,1.00,1.11,1.72,1.53,23,7,5,iTRAQ 4plex (K  N-term); Phosphorylation (STY),33666,Transformer-2 protein homolog beta OS=Homo sapiens OX=9606 GN=TRA2B PE=1 SV=1
1190,22318,sp|Q9NX05|F120C_HUMAN,15.17,130.50,4.521E6,4.52E6,6.954E6,6.829E6,1.00,1.00,1.54,1.51,4.521E6,4.52E6,6.954E6,6.829E6,1.00,1.00,1.54,1.51,8,10,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),120588,Constitutive coactivator of PPAR-gamma-like protein 2 OS=Homo sapiens OX=9606 GN=FAM120C PE=1 SV=3
1227,4608,sp|Q14966-3|ZN638_HUMAN,24.03,130.44,3.015E6,2.977E6,5.747E6,5.502E6,1.00,0.99,1.91,1.82,3.015E6,2.977E6,5.747E6,5.502E6,1.00,0.99,1.91,1.82,7,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),218244,Isoform 3 of Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638
1137,7837,sp|Q86VM9|ZCH18_HUMAN,17.44,130.35,1.636E6,1.625E6,2.9E6,2.795E6,1.00,0.99,1.77,1.71,1.636E6,1.625E6,2.9E6,2.795E6,1.00,0.99,1.77,1.71,14,12,12,iTRAQ 4plex (K  N-term),106379,Zinc finger CCCH domain-containing protein 18 OS=Homo sapiens OX=9606 GN=ZC3H18 PE=1 SV=2
1553,736,sp|Q13428-4|TCOF_HUMAN,13.37,130.34,9.831E5,9.293E5,1.188E6,1.273E6,1.00,0.95,1.21,1.29,9.831E5,9.293E5,1.188E6,1.273E6,1.00,0.95,1.21,1.29,7,7,7,iTRAQ 4plex (K  N-term); Phosphorylation (STY),155928,Isoform 4 of Treacle protein OS=Homo sapiens OX=9606 GN=TCOF1
1270,22549,sp|P18085|ARF4_HUMAN,13.86,130.18,9.197E6,9.106E6,1.406E7,1.43E7,1.00,0.99,1.53,1.56,9.197E6,9.106E6,1.406E7,1.43E7,1.00,0.99,1.53,1.56,28,7,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),20511,ADP-ribosylation factor 4 OS=Homo sapiens OX=9606 GN=ARF4 PE=1 SV=3
1040,20531,sp|Q8N556-2|AFAP1_HUMAN,11.95,130.13,5.637E6,5.555E6,7.408E6,7.947E6,1.00,0.99,1.31,1.41,5.637E6,5.555E6,7.408E6,7.947E6,1.00,0.99,1.31,1.41,12,9,9,iTRAQ 4plex (K  N-term); Phosphorylation (STY),89795,Isoform 2 of Actin filament-associated protein 1 OS=Homo sapiens OX=9606 GN=AFAP1
1340,6876,sp|P49023-3|PAXI_HUMAN,20.99,130.06,2.177E6,2.22E6,3.681E6,3.695E6,1.00,1.02,1.69,1.70,2.177E6,2.22E6,3.681E6,3.695E6,1.00,1.02,1.69,1.70,18,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),66213,Isoform Gamma of Paxillin OS=Homo sapiens OX=9606 GN=PXN
1469,16050,sp|P34897-3|GLYM_HUMAN,24.63,129.96,2.652E6,2.482E6,4.102E6,4.151E6,1.00,0.94,1.55,1.57,2.652E6,2.482E6,4.102E6,4.151E6,1.00,0.94,1.55,1.57,16,7,7,iTRAQ 4plex (K  N-term),53455,Isoform 3 of Serine hydroxymethyltransferase  mitochondrial OS=Homo sapiens OX=9606 GN=SHMT2
1140,9689,sp|P04083|ANXA1_HUMAN,9.80,129.94,3.893E6,3.371E6,4.668E6,4.73E6,1.00,0.87,1.20,1.21,3.893E6,3.371E6,4.668E6,4.73E6,1.00,0.87,1.20,1.21,27,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),38714,Annexin A1 OS=Homo sapiens OX=9606 GN=ANXA1 PE=1 SV=2
1176,38866,sp|P16615|AT2A2_HUMAN,19.49,129.84,6.526E6,6.328E6,1.091E7,1.059E7,1.00,0.97,1.67,1.62,6.526E6,6.328E6,1.091E7,1.059E7,1.00,0.97,1.67,1.62,9,9,9,iTRAQ 4plex (K  N-term),114757,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens OX=9606 GN=ATP2A2 PE=1 SV=1
880,12104,sp|O95816|BAG2_HUMAN,11.25,129.70,1.462E7,1.453E7,2.032E7,2.08E7,1.00,0.99,1.39,1.42,1.462E7,1.453E7,2.032E7,2.08E7,1.00,0.99,1.39,1.42,46,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),23772,BAG family molecular chaperone regulator 2 OS=Homo sapiens OX=9606 GN=BAG2 PE=1 SV=1
1113,11771,A0A024R442|A0A024R442_HUMAN,0.98,129.50,3.351E6,3.509E6,3.482E6,3.313E6,1.00,1.05,1.04,0.99,3.351E6,3.509E6,3.482E6,3.313E6,1.00,1.05,1.04,0.99,15,8,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),51999,Aspartyl aminopeptidase  isoform CRA_b OS=Homo sapiens OX=9606 GN=DNPEP PE=1 SV=1
1277,6281,A0A1W2PR85|A0A1W2PR85_HUMAN,21.51,129.22,2.035E6,2.148E6,3.769E6,3.638E6,1.00,1.06,1.85,1.79,2.035E6,2.148E6,3.769E6,3.638E6,1.00,1.06,1.85,1.79,9,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),139281,Synaptojanin-2 OS=Homo sapiens OX=9606 GN=SYNJ2 PE=1 SV=1
1332,21121,sp|Q12986|NFX1_HUMAN,19.18,129.12,9.778E5,1.025E6,1.566E6,1.552E6,1.00,1.05,1.60,1.59,9.778E5,1.025E6,1.566E6,1.552E6,1.00,1.05,1.60,1.59,6,6,6,iTRAQ 4plex (K  N-term),124395,Transcriptional repressor NF-X1 OS=Homo sapiens OX=9606 GN=NFX1 PE=1 SV=2
648,39787,sp|O60565|GREM1_HUMAN,19.32,128.79,3.923E6,4.001E6,5.674E6,5.746E6,1.00,1.02,1.45,1.46,3.923E6,4.001E6,5.674E6,5.746E6,1.00,1.02,1.45,1.46,28,4,4,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),20697,Gremlin-1 OS=Homo sapiens OX=9606 GN=GREM1 PE=1 SV=1
1427,7053,sp|P46109|CRKL_HUMAN,34.74,128.64,4.18E6,4.061E6,7.652E6,7.855E6,1.00,0.97,1.83,1.88,4.18E6,4.061E6,7.652E6,7.855E6,1.00,0.97,1.83,1.88,33,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),33777,Crk-like protein OS=Homo sapiens OX=9606 GN=CRKL PE=1 SV=1
1150,2099,G5E9W3|G5E9W3_HUMAN,13.30,128.38,4.371E6,4.335E6,6.772E6,6.77E6,1.00,0.99,1.55,1.55,4.371E6,4.335E6,6.772E6,6.77E6,1.00,0.99,1.55,1.55,15,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),73477,Cleavage and polyadenylation specific factor 3  73kDa  isoform CRA_b OS=Homo sapiens OX=9606 GN=CPSF3 PE=1 SV=1
1120,24282,sp|Q9H0J9|PAR12_HUMAN,18.69,128.20,3.789E6,3.89E6,6.499E6,6.029E6,1.00,1.03,1.72,1.59,3.789E6,3.89E6,6.499E6,6.029E6,1.00,1.03,1.72,1.59,11,8,7,iTRAQ 4plex (K  N-term),79064,Protein mono-ADP-ribosyltransferase PARP12 OS=Homo sapiens OX=9606 GN=PARP12 PE=1 SV=1
1330,7727,sp|Q96BY6-3|DOC10_HUMAN,18.28,128.14,2.712E6,2.672E6,4.755E6,4.829E6,1.00,0.99,1.75,1.78,2.712E6,2.672E6,4.755E6,4.829E6,1.00,0.99,1.75,1.78,5,10,10,iTRAQ 4plex (K  N-term),249489,Isoform 3 of Dedicator of cytokinesis protein 10 OS=Homo sapiens OX=9606 GN=DOCK10
1062,4399,sp|P25705-2|ATPA_HUMAN,14.63,128.03,2.867E6,2.863E6,4.629E6,4.489E6,1.00,1.00,1.61,1.57,2.867E6,2.863E6,4.629E6,4.489E6,1.00,1.00,1.61,1.57,20,11,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),54494,Isoform 2 of ATP synthase subunit alpha  mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1A
896,9136,sp|O00505|IMA4_HUMAN,15.47,128.02,1.251E6,1.201E6,2.191E6,2.183E6,1.00,0.96,1.75,1.75,1.251E6,1.201E6,2.191E6,2.183E6,1.00,0.96,1.75,1.75,8,12,4,iTRAQ 4plex (K  N-term),57811,Importin subunit alpha-4 OS=Homo sapiens OX=9606 GN=KPNA3 PE=1 SV=2
1324,38987,sp|O00178|GTPB1_HUMAN,10.49,127.99,2.379E6,2.329E6,3.322E6,3.382E6,1.00,0.98,1.40,1.42,2.379E6,2.329E6,3.322E6,3.382E6,1.00,0.98,1.40,1.42,18,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),72454,GTP-binding protein 1 OS=Homo sapiens OX=9606 GN=GTPBP1 PE=1 SV=3
1275,7927,sp|Q9BYK8|HELZ2_HUMAN,8.51,127.83,1.954E6,1.861E6,2.639E6,2.517E6,1.00,0.95,1.35,1.29,1.954E6,1.861E6,2.639E6,2.517E6,1.00,0.95,1.35,1.29,5,10,10,iTRAQ 4plex (K  N-term),294649,Helicase with zinc finger domain 2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=6
1284,19719,sp|Q5VZL5-4|ZMYM4_HUMAN,26.19,127.69,2.331E6,2.248E6,4.514E6,4.279E6,1.00,0.96,1.94,1.84,2.331E6,2.248E6,4.514E6,4.279E6,1.00,0.96,1.94,1.84,8,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),169236,Isoform 4 of Zinc finger MYM-type protein 4 OS=Homo sapiens OX=9606 GN=ZMYM4
1359,6241,sp|P48730-2|KC1D_HUMAN,31.02,127.57,8.386E5,8.837E5,1.833E6,1.739E6,1.00,1.05,2.19,2.07,8.386E5,8.837E5,1.833E6,1.739E6,1.00,1.05,2.19,2.07,13,7,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),46832,Isoform 2 of Casein kinase I isoform delta OS=Homo sapiens OX=9606 GN=CSNK1D
915,5634,sp|Q32MZ4-4|LRRF1_HUMAN,2.63,127.44,4.884E5,4.403E5,5.481E5,6.105E5,1.00,0.90,1.12,1.25,4.884E5,4.403E5,5.481E5,6.105E5,1.00,0.90,1.12,1.25,5,7,2,iTRAQ 4plex (K  N-term),73061,Isoform 4 of Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens OX=9606 GN=LRRFIP1
1030,20294,sp|Q8IWR0|Z3H7A_HUMAN,8.38,127.41,2.831E6,2.819E6,4.159E6,4.037E6,1.00,1.00,1.47,1.43,2.831E6,2.819E6,4.159E6,4.037E6,1.00,1.00,1.47,1.43,14,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),110538,Zinc finger CCCH domain-containing protein 7A OS=Homo sapiens OX=9606 GN=ZC3H7A PE=1 SV=1
1229,38947,Q5H909|Q5H909_HUMAN,6.96,127.35,2.111E6,2.074E6,2.645E6,2.701E6,1.00,0.98,1.25,1.28,2.111E6,2.074E6,2.645E6,2.701E6,1.00,0.98,1.25,1.28,15,8,7,iTRAQ 4plex (K  N-term),63139,Melanoma-associated antigen D2 OS=Homo sapiens OX=9606 GN=MAGED2 PE=1 SV=2
1247,3431,sp|P11586|C1TC_HUMAN,15.19,127.12,2.033E6,2.071E6,3.354E6,3.282E6,1.00,1.02,1.65,1.61,2.033E6,2.071E6,3.354E6,3.282E6,1.00,1.02,1.65,1.61,10,10,9,iTRAQ 4plex (K  N-term),101559,C-1-tetrahydrofolate synthase  cytoplasmic OS=Homo sapiens OX=9606 GN=MTHFD1 PE=1 SV=3
1189,1622,sp|Q9NXR1-1|NDE1_HUMAN,27.28,127.05,1.314E6,1.321E6,2.835E6,2.723E6,1.00,1.01,2.16,2.07,1.314E6,1.321E6,2.835E6,2.723E6,1.00,1.01,2.16,2.07,25,9,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),38808,Isoform 2 of Nuclear distribution protein nudE homolog 1 OS=Homo sapiens OX=9606 GN=NDE1
1139,20964,sp|Q96S15-2|WDR24_HUMAN,1.04,127.00,2.107E5,2.128E5,2.808E5,3.031E5,1.00,1.01,1.33,1.44,2.107E5,2.128E5,2.808E5,3.031E5,1.00,1.01,1.33,1.44,2,8,1,iTRAQ 4plex (K  N-term),88207,Isoform 2 of GATOR complex protein WDR24 OS=Homo sapiens OX=9606 GN=WDR24
1018,23631,C9JWJ8|C9JWJ8_HUMAN,43.81,126.93,4.802E5,5.432E5,1.076E6,1.052E6,1.00,1.13,2.24,2.19,4.802E5,5.432E5,1.076E6,1.052E6,1.00,1.13,2.24,2.19,19,7,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),44655,Nuclear factor 1 OS=Homo sapiens OX=9606 GN=NFIX PE=1 SV=2
493,20807,sp|P06312|KV401_HUMAN,12.83,126.79,2.886E7,2.653E7,2.068E7,1.848E7,1.00,0.92,0.72,0.64,2.886E7,2.653E7,2.068E7,1.848E7,1.00,0.92,0.72,0.64,31,12,8,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),13380,Immunoglobulin kappa variable 4-1 OS=Homo sapiens OX=9606 GN=IGKV4-1 PE=1 SV=1
1183,38950,sp|Q99594|TEAD3_HUMAN,27.62,126.69,1.183E6,1.333E6,2.16E6,2.034E6,1.00,1.13,1.83,1.72,1.183E6,1.333E6,2.16E6,2.034E6,1.00,1.13,1.83,1.72,15,9,6,iTRAQ 4plex (K  N-term),48676,Transcriptional enhancer factor TEF-5 OS=Homo sapiens OX=9606 GN=TEAD3 PE=1 SV=2
1009,19859,sp|Q32MZ4-2|LRRF1_HUMAN,1.09,126.58,2.399E4,1.954E4,2.361E4,2.868E4,1.00,0.81,0.98,1.20,2.399E4,1.954E4,2.361E4,2.868E4,1.00,0.81,0.98,1.20,4,6,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),86404,Isoform 2 of Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens OX=9606 GN=LRRFIP1
1262,8594,sp|O43293|DAPK3_HUMAN,31.44,126.31,3.828E6,3.764E6,7.463E6,7.612E6,1.00,0.98,1.95,1.99,3.828E6,3.764E6,7.463E6,7.612E6,1.00,0.98,1.95,1.99,19,8,8,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),52536,Death-associated protein kinase 3 OS=Homo sapiens OX=9606 GN=DAPK3 PE=1 SV=1
1079,17774,sp|Q96C19|EFHD2_HUMAN,14.08,126.26,6.421E6,6.065E6,7.995E6,9.692E6,1.00,0.94,1.25,1.51,6.421E6,6.065E6,7.995E6,9.692E6,1.00,0.94,1.25,1.51,30,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),26697,EF-hand domain-containing protein D2 OS=Homo sapiens OX=9606 GN=EFHD2 PE=1 SV=1
1070,12472,sp|Q99418-2|CYH2_HUMAN,51.91,126.16,2.282E6,2.346E6,6.633E6,6.462E6,1.00,1.03,2.91,2.83,2.282E6,2.346E6,6.633E6,6.462E6,1.00,1.03,2.91,2.83,15,8,5,iTRAQ 4plex (K  N-term),46489,Isoform 2 of Cytohesin-2 OS=Homo sapiens OX=9606 GN=CYTH2
1226,308,sp|Q6XZF7|DNMBP_HUMAN,22.44,126.15,3.165E6,3.204E6,5.606E6,5.559E6,1.00,1.01,1.77,1.76,3.165E6,3.204E6,5.606E6,5.559E6,1.00,1.01,1.77,1.76,8,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),177346,Dynamin-binding protein OS=Homo sapiens OX=9606 GN=DNMBP PE=1 SV=1
863,38922,sp|Q96SB4|SRPK1_HUMAN,8.75,126.06,2.304E6,2.366E6,3.313E6,3.185E6,1.00,1.03,1.44,1.38,2.304E6,2.366E6,3.313E6,3.185E6,1.00,1.03,1.44,1.38,11,9,5,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),74325,SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2
1257,21015,sp|P50281|MMP14_HUMAN,17.30,125.99,6.867E6,7.017E6,1.12E7,1.135E7,1.00,1.02,1.63,1.65,6.867E6,7.017E6,1.12E7,1.135E7,1.00,1.02,1.63,1.65,16,9,9,iTRAQ 4plex (K  N-term),65894,Matrix metalloproteinase-14 OS=Homo sapiens OX=9606 GN=MMP14 PE=1 SV=3
1072,9725,sp|P09382|LEG1_HUMAN,24.13,125.95,1.917E7,1.694E7,2.755E7,2.746E7,1.00,0.88,1.44,1.43,1.917E7,1.694E7,2.755E7,2.746E7,1.00,0.88,1.44,1.43,39,8,8,iTRAQ 4plex (K  N-term),14716,Galectin-1 OS=Homo sapiens OX=9606 GN=LGALS1 PE=1 SV=2
1045,17676,sp|Q99417|MYCBP_HUMAN,200.00,125.94,1.002E7,9.747E6,5.15E7,4.934E7,1.00,0.97,5.14,4.92,1.002E7,9.747E6,5.15E7,4.934E7,1.00,0.97,5.14,4.92,74,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),11967,c-Myc-binding protein OS=Homo sapiens OX=9606 GN=MYCBP PE=1 SV=3
1138,12348,sp|Q12824-2|SNF5_HUMAN,17.80,125.91,8.622E6,9.272E6,1.317E7,1.217E7,1.00,1.08,1.53,1.41,8.622E6,9.272E6,1.317E7,1.217E7,1.00,1.08,1.53,1.41,17,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),43158,Isoform B of SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 OS=Homo sapiens OX=9606 GN=SMARCB1
1413,38944,sp|Q96PV6|LENG8_HUMAN,52.15,125.83,1.266E6,1.358E6,3.588E6,3.513E6,1.00,1.07,2.83,2.77,1.266E6,1.358E6,3.588E6,3.513E6,1.00,1.07,2.83,2.77,15,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),88157,Leukocyte receptor cluster member 8 OS=Homo sapiens OX=9606 GN=LENG8 PE=1 SV=3
670,13680,sp|O95758-1|PTBP3_HUMAN,16.13,125.82,8.485E5,8.736E5,1.387E6,1.333E6,1.00,1.03,1.63,1.57,8.485E5,8.736E5,1.387E6,1.333E6,1.00,1.03,1.63,1.57,14,8,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),56502,Isoform 1 of Polypyrimidine tract-binding protein 3 OS=Homo sapiens OX=9606 GN=PTBP3
1167,38878,sp|Q9UDT6-2|CLIP2_HUMAN,12.98,125.70,2.908E6,2.874E6,4.666E6,4.625E6,1.00,0.99,1.60,1.59,2.908E6,2.874E6,4.666E6,4.625E6,1.00,0.99,1.60,1.59,13,13,13,iTRAQ 4plex (K  N-term),111782,Isoform 2 of CAP-Gly domain-containing linker protein 2 OS=Homo sapiens OX=9606 GN=CLIP2
552,13448,sp|P40429|RL13A_HUMAN,11.38,125.55,8.923E7,8.72E7,1.127E8,1.219E8,1.00,0.98,1.26,1.37,8.923E7,8.72E7,1.127E8,1.219E8,1.00,0.98,1.26,1.37,34,10,10,iTRAQ 4plex (K  N-term); Oxidation (M),23577,60S ribosomal protein L13a OS=Homo sapiens OX=9606 GN=RPL13A PE=1 SV=2
1341,39181,sp|Q8NEZ2|VP37A_HUMAN,48.68,125.43,1.91E6,2.034E6,4E6,3.974E6,1.00,1.06,2.09,2.08,1.91E6,2.034E6,4E6,3.974E6,1.00,1.06,2.09,2.08,18,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),44314,Vacuolar protein sorting-associated protein 37A OS=Homo sapiens OX=9606 GN=VPS37A PE=1 SV=1
1325,19684,sp|O43852|CALU_HUMAN,14.06,125.42,3.229E6,3.248E6,5.016E6,4.851E6,1.00,1.01,1.55,1.50,3.229E6,3.248E6,5.016E6,4.851E6,1.00,1.01,1.55,1.50,30,7,7,iTRAQ 4plex (K  N-term); Phosphorylation (STY),37107,Calumenin OS=Homo sapiens OX=9606 GN=CALU PE=1 SV=2
599,2423,sp|O60684|IMA7_HUMAN,13.72,125.41,6.723E6,6.692E6,1.071E7,1.078E7,1.00,1.00,1.59,1.60,6.723E6,6.692E6,1.071E7,1.078E7,1.00,1.00,1.59,1.60,8,11,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),60030,Importin subunit alpha-7 OS=Homo sapiens OX=9606 GN=KPNA6 PE=1 SV=1
1315,11585,Q4VXZ8|Q4VXZ8_HUMAN,15.46,125.40,2.221E6,2.234E6,3.554E6,3.581E6,1.00,1.01,1.60,1.61,2.221E6,2.234E6,3.554E6,3.581E6,1.00,1.01,1.60,1.61,31,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),29484,Peroxisomal 2 4-dienoyl-CoA reductase OS=Homo sapiens OX=9606 GN=DECR2 PE=1 SV=1
954,14694,sp|Q13242|SRSF9_HUMAN,1.80,125.33,9.539E6,9.633E6,1.033E7,1.061E7,1.00,1.01,1.08,1.11,9.539E6,9.633E6,1.033E7,1.061E7,1.00,1.01,1.08,1.11,38,9,9,iTRAQ 4plex (K  N-term),25542,Serine/arginine-rich splicing factor 9 OS=Homo sapiens OX=9606 GN=SRSF9 PE=1 SV=1
853,8260,sp|Q8WUP2-2|FBLI1_HUMAN,24.70,125.32,7.172E6,7.212E6,1.367E7,1.356E7,1.00,1.01,1.91,1.89,7.172E6,7.212E6,1.367E7,1.356E7,1.00,1.01,1.91,1.89,19,8,8,iTRAQ 4plex (K  N-term); Oxidation (M),40306,Isoform 2 of Filamin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=FBLIM1
727,19079,K7ERI7|K7ERI7_HUMAN,30.62,125.23,4.494E7,4.678E7,7.513E7,7.191E7,1.00,1.04,1.67,1.60,4.494E7,4.678E7,7.513E7,7.191E7,1.00,1.04,1.67,1.60,44,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),11169,60S ribosomal protein L22 OS=Homo sapiens OX=9606 GN=RPL22 PE=1 SV=1
536,12047,sp|Q07020|RL18_HUMAN,10.15,125.05,5.705E7,5.552E7,7.014E7,7.45E7,1.00,0.97,1.23,1.31,5.705E7,5.552E7,7.014E7,7.45E7,1.00,0.97,1.23,1.31,29,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),21634,60S ribosomal protein L18 OS=Homo sapiens OX=9606 GN=RPL18 PE=1 SV=2
1231,2577,Q5T8T7|Q5T8T7_HUMAN,6.23,124.92,3.255E6,2.898E6,3.665E6,3.363E6,1.00,0.89,1.13,1.03,3.255E6,2.898E6,3.665E6,3.363E6,1.00,0.89,1.13,1.03,56,7,7,iTRAQ 4plex (K  N-term),15855,Mediator complex subunit 22 OS=Homo sapiens OX=9606 GN=MED22 PE=1 SV=1
834,19796,sp|Q99958|FOXC2_HUMAN,34.31,124.91,4.782E6,5.168E6,9.441E6,9.006E6,1.00,1.08,1.97,1.88,4.782E6,5.168E6,9.441E6,9.006E6,1.00,1.08,1.97,1.88,20,9,9,iTRAQ 4plex (K  N-term); Phosphorylation (STY),53719,Forkhead box protein C2 OS=Homo sapiens OX=9606 GN=FOXC2 PE=1 SV=1
1312,23446,sp|Q13501-2|SQSTM_HUMAN,21.85,124.85,7.566E5,7.585E5,1.096E6,1.103E6,1.00,1.00,1.45,1.46,7.566E5,7.585E5,1.096E6,1.103E6,1.00,1.00,1.45,1.46,19,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),38629,Isoform 2 of Sequestosome-1 OS=Homo sapiens OX=9606 GN=SQSTM1
503,19614,C9JNW5|C9JNW5_HUMAN,18.55,124.79,4.499E7,4.555E7,6.493E7,6.798E7,1.00,1.01,1.44,1.51,4.499E7,4.555E7,6.493E7,6.798E7,1.00,1.01,1.44,1.51,37,11,11,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),17543,60S ribosomal protein L24 OS=Homo sapiens OX=9606 GN=RPL24 PE=1 SV=1
1197,1737,sp|P35221|CTNA1_HUMAN,17.80,124.70,3.047E6,2.944E6,4.956E6,5.09E6,1.00,0.97,1.63,1.67,3.047E6,2.944E6,4.956E6,5.09E6,1.00,0.97,1.63,1.67,11,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),100071,Catenin alpha-1 OS=Homo sapiens OX=9606 GN=CTNNA1 PE=1 SV=1
1198,14973,sp|O14964|HGS_HUMAN,35.27,124.66,3.21E6,2.902E6,6.962E6,6.778E6,1.00,0.90,2.17,2.11,3.21E6,2.902E6,6.962E6,6.778E6,1.00,0.90,2.17,2.11,15,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),86192,Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Homo sapiens OX=9606 GN=HGS PE=1 SV=1
1180,3473,sp|O43823|AKAP8_HUMAN,33.25,124.63,2.661E6,2.651E6,5.079E6,4.988E6,1.00,1.00,1.91,1.87,2.661E6,2.651E6,5.079E6,4.988E6,1.00,1.00,1.91,1.87,11,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),76108,A-kinase anchor protein 8 OS=Homo sapiens OX=9606 GN=AKAP8 PE=1 SV=1
711,2411,sp|P31946-2|1433B_HUMAN,5.73,124.61,7.299E5,6.999E5,9.735E5,9.568E5,1.00,0.96,1.33,1.31,7.299E5,6.999E5,9.735E5,9.568E5,1.00,0.96,1.33,1.31,19,10,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),27850,Isoform Short of 14-3-3 protein beta/alpha OS=Homo sapiens OX=9606 GN=YWHAB
1031,5810,sp|Q32P28|P3H1_HUMAN,13.08,124.61,3.323E6,2.989E6,4.717E6,4.789E6,1.00,0.90,1.42,1.44,3.323E6,2.989E6,4.717E6,4.789E6,1.00,0.90,1.42,1.44,12,9,9,iTRAQ 4plex (K  N-term),83394,Prolyl 3-hydroxylase 1 OS=Homo sapiens OX=9606 GN=P3H1 PE=1 SV=2
1603,22440,sp|P20290-2|BTF3_HUMAN,46.19,124.61,9.532E5,9.511E5,2.021E6,2.133E6,1.00,1.00,2.12,2.24,9.532E5,9.511E5,2.021E6,2.133E6,1.00,1.00,2.12,2.24,40,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),17699,Isoform 2 of Transcription factor BTF3 OS=Homo sapiens OX=9606 GN=BTF3
1558,39070,sp|Q08J23-2|NSUN2_HUMAN,12.11,124.54,9.416E5,9.216E5,1.263E6,1.28E6,1.00,0.98,1.34,1.36,9.416E5,9.216E5,1.263E6,1.28E6,1.00,0.98,1.34,1.36,12,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),82393,Isoform 2 of tRNA (cytosine(34)-C(5))-methyltransferase OS=Homo sapiens OX=9606 GN=NSUN2
140,6150,sp|P08590|MYL3_HUMAN,1.16,124.48,1.34E6,1.273E6,1.184E6,1.413E6,1.00,0.95,0.88,1.05,1.34E6,1.273E6,1.184E6,1.413E6,1.00,0.95,0.88,1.05,7,6,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),21932,Myosin light chain 3 OS=Homo sapiens OX=9606 GN=MYL3 PE=1 SV=3
649,19110,sp|P09497-2|CLCB_HUMAN,1.80,124.29,5.069E7,4.983E7,4.641E7,4.678E7,1.00,0.98,0.92,0.92,5.069E7,4.983E7,4.641E7,4.678E7,1.00,0.98,0.92,0.92,33,10,10,iTRAQ 4plex (K  N-term); Oxidation (M),23181,Isoform Non-brain of Clathrin light chain B OS=Homo sapiens OX=9606 GN=CLTB
1135,12919,sp|P04844-2|RPN2_HUMAN,17.64,124.25,5.314E6,5.448E6,8.334E6,8.269E6,1.00,1.03,1.57,1.56,5.314E6,5.448E6,8.334E6,8.269E6,1.00,1.03,1.57,1.56,12,7,7,iTRAQ 4plex (K  N-term),67723,Isoform 2 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Homo sapiens OX=9606 GN=RPN2
817,19568,sp|P30050|RL12_HUMAN,21.92,124.06,5.203E7,4.882E7,6.686E7,7.498E7,1.00,0.94,1.28,1.44,5.203E7,4.882E7,6.686E7,7.498E7,1.00,0.94,1.28,1.44,33,8,7,iTRAQ 4plex (K  N-term),17819,60S ribosomal protein L12 OS=Homo sapiens OX=9606 GN=RPL12 PE=1 SV=1
1044,38910,sp|Q13043-2|STK4_HUMAN,11.12,123.94,5.58E5,5.306E5,8.583E5,8.905E5,1.00,0.95,1.54,1.60,5.58E5,5.306E5,8.583E5,8.905E5,1.00,0.95,1.54,1.60,7,8,3,iTRAQ 4plex (K  N-term),52335,Isoform 2 of Serine/threonine-protein kinase 4 OS=Homo sapiens OX=9606 GN=STK4
1528,39115,sp|Q12849-5|GRSF1_HUMAN,12.30,123.83,1.522E6,1.474E6,2.169E6,2.22E6,1.00,0.97,1.42,1.46,1.522E6,1.474E6,2.169E6,2.22E6,1.00,0.97,1.42,1.46,22,7,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),36613,Isoform 2 of G-rich sequence factor 1 OS=Homo sapiens OX=9606 GN=GRSF1
922,3382,sp|O00629|IMA3_HUMAN,5.76,123.82,1.313E6,1.417E6,2.304E6,2.242E6,1.00,1.08,1.75,1.71,1.313E6,1.417E6,2.304E6,2.242E6,1.00,1.08,1.75,1.71,4,10,2,iTRAQ 4plex (K  N-term),57887,Importin subunit alpha-3 OS=Homo sapiens OX=9606 GN=KPNA4 PE=1 SV=1
1199,4530,sp|P52756|RBM5_HUMAN,8.51,123.64,2.503E6,2.506E6,3.607E6,3.447E6,1.00,1.00,1.44,1.38,2.503E6,2.506E6,3.607E6,3.447E6,1.00,1.00,1.44,1.38,9,8,6,iTRAQ 4plex (K  N-term),92154,RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2
1100,38876,sp|Q70UQ0|IKIP_HUMAN,8.50,123.64,2.382E6,2.349E6,3.547E6,3.549E6,1.00,0.99,1.49,1.49,2.382E6,2.349E6,3.547E6,3.549E6,1.00,0.99,1.49,1.49,18,9,6,iTRAQ 4plex (K  N-term),39309,Inhibitor of nuclear factor kappa-B kinase-interacting protein OS=Homo sapiens OX=9606 GN=IKBIP PE=1 SV=1
1618,39434,sp|Q9HAS0|NJMU_HUMAN,63.04,123.57,2.163E6,2.07E6,4.059E6,4.157E6,1.00,0.96,1.88,1.92,2.163E6,2.07E6,4.059E6,4.157E6,1.00,0.96,1.88,1.92,17,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),44622,Protein Njmu-R1 OS=Homo sapiens OX=9606 GN=C17orf75 PE=1 SV=2
1105,20029,G3V511|G3V511_HUMAN,35.43,123.42,1.531E6,1.525E6,3.288E6,3.25E6,1.00,1.00,2.15,2.12,1.531E6,1.525E6,3.288E6,3.25E6,1.00,1.00,2.15,2.12,5,8,7,iTRAQ 4plex (K  N-term),189240,Latent-transforming growth factor beta-binding protein 2 OS=Homo sapiens OX=9606 GN=LTBP2 PE=1 SV=1
997,3277,sp|Q96F86|EDC3_HUMAN,47.14,123.08,3.857E6,3.786E6,1.098E7,1.077E7,1.00,0.98,2.85,2.79,3.857E6,3.786E6,1.098E7,1.077E7,1.00,0.98,2.85,2.79,24,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),56078,Enhancer of mRNA-decapping protein 3 OS=Homo sapiens OX=9606 GN=EDC3 PE=1 SV=1
1318,8164,F8VYE8|F8VYE8_HUMAN,1.37,122.54,1.124E6,1.108E6,1.742E6,1.757E6,1.00,0.99,1.55,1.56,1.124E6,1.108E6,1.742E6,1.757E6,1.00,0.99,1.55,1.56,3,6,1,iTRAQ 4plex (K  N-term),34950,Serine/threonine-protein phosphatase OS=Homo sapiens OX=9606 GN=PPP1CC PE=1 SV=1
1472,4533,sp|Q9BRZ2|TRI56_HUMAN,18.08,122.45,2.189E6,2.223E6,3.46E6,3.479E6,1.00,1.02,1.58,1.59,2.189E6,2.223E6,3.46E6,3.479E6,1.00,1.02,1.58,1.59,9,5,5,iTRAQ 4plex (K  N-term),81488,E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3
1283,660,sp|Q9ULL8|SHRM4_HUMAN,17.78,122.31,1.117E6,9.974E5,1.805E6,1.601E6,1.00,0.89,1.62,1.43,1.117E6,9.974E5,1.805E6,1.601E6,1.00,0.89,1.62,1.43,5,7,6,iTRAQ 4plex (K  N-term),164857,Protein Shroom4 OS=Homo sapiens OX=9606 GN=SHROOM4 PE=1 SV=3
1191,21214,sp|P50991|TCPD_HUMAN,8.54,122.30,5.008E6,4.695E6,6.736E6,6.792E6,1.00,0.94,1.35,1.36,5.008E6,4.695E6,6.736E6,6.792E6,1.00,0.94,1.35,1.36,17,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),57924,T-complex protein 1 subunit delta OS=Homo sapiens OX=9606 GN=CCT4 PE=1 SV=4
1428,13539,sp|Q96EY1-2|DNJA3_HUMAN,4.35,122.22,8.291E4,9.533E4,1.37E5,1.321E5,1.00,1.15,1.65,1.59,8.291E4,9.533E4,1.37E5,1.321E5,1.00,1.15,1.65,1.59,6,6,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),49612,Isoform 2 of DnaJ homolog subfamily A member 3  mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3
1220,38963,sp|Q9UQ03-2|COR2B_HUMAN,13.11,122.11,5.801E6,5.61E6,7.325E6,8.282E6,1.00,0.97,1.26,1.43,5.801E6,5.61E6,7.325E6,8.282E6,1.00,0.97,1.26,1.43,15,9,8,iTRAQ 4plex (K  N-term),54393,Isoform 2 of Coronin-2B OS=Homo sapiens OX=9606 GN=CORO2B
1524,17541,sp|P23526-2|SAHH_HUMAN,3.30,122.07,5.285E6,4.721E6,4.789E6,4.482E6,1.00,0.89,0.91,0.85,5.285E6,4.721E6,4.789E6,4.482E6,1.00,0.89,0.91,0.85,17,7,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),44659,Isoform 2 of Adenosylhomocysteinase OS=Homo sapiens OX=9606 GN=AHCY
1027,22402,sp|Q13884|SNTB1_HUMAN,9.87,122.05,2.541E6,2.547E6,3.74E6,3.653E6,1.00,1.00,1.47,1.44,2.541E6,2.547E6,3.74E6,3.653E6,1.00,1.00,1.47,1.44,15,10,8,iTRAQ 4plex (K  N-term),58061,Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3
833,7007,sp|Q04917|1433F_HUMAN,23.53,121.97,7.729E5,7.261E5,1.486E6,1.435E6,1.00,0.94,1.92,1.86,7.729E5,7.261E5,1.486E6,1.435E6,1.00,0.94,1.92,1.86,22,9,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),28219,14-3-3 protein eta OS=Homo sapiens OX=9606 GN=YWHAH PE=1 SV=4
1185,17288,sp|Q92896|GSLG1_HUMAN,4.72,121.83,6.796E6,6.884E6,8.317E6,8.447E6,1.00,1.01,1.22,1.24,6.796E6,6.884E6,8.317E6,8.447E6,1.00,1.01,1.22,1.24,8,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),134552,Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2
1405,38945,sp|Q5TCZ1|SPD2A_HUMAN,10.38,121.80,1.386E6,1.391E6,2.077E6,2.043E6,1.00,1.00,1.50,1.47,1.386E6,1.391E6,2.077E6,2.043E6,1.00,1.00,1.50,1.47,8,8,8,iTRAQ 4plex (K  N-term),125289,SH3 and PX domain-containing protein 2A OS=Homo sapiens OX=9606 GN=SH3PXD2A PE=1 SV=1
1085,19493,sp|P22061|PIMT_HUMAN,4.86,121.77,1.049E7,1.033E7,1.258E7,1.242E7,1.00,0.98,1.20,1.18,1.049E7,1.033E7,1.258E7,1.242E7,1.00,0.98,1.20,1.18,45,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),24636,Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Homo sapiens OX=9606 GN=PCMT1 PE=1 SV=4
1470,6157,sp|Q13322-2|GRB10_HUMAN,31.23,121.76,1.786E6,1.819E6,3.179E6,3.191E6,1.00,1.02,1.78,1.79,1.786E6,1.819E6,3.179E6,3.191E6,1.00,1.02,1.78,1.79,14,6,6,iTRAQ 4plex (K  N-term),62026,Isoform 1 of Growth factor receptor-bound protein 10 OS=Homo sapiens OX=9606 GN=GRB10
1398,18633,sp|Q8IWT6|LRC8A_HUMAN,7.81,121.70,1.236E6,1.281E6,1.76E6,1.706E6,1.00,1.04,1.42,1.38,1.236E6,1.281E6,1.76E6,1.706E6,1.00,1.04,1.42,1.38,9,8,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),94199,Volume-regulated anion channel subunit LRRC8A OS=Homo sapiens OX=9606 GN=LRRC8A PE=1 SV=1
1386,20887,sp|Q9UMS4|PRP19_HUMAN,27.42,121.66,4.22E6,4.104E6,7.283E6,7.275E6,1.00,0.97,1.73,1.72,4.22E6,4.104E6,7.283E6,7.275E6,1.00,0.97,1.73,1.72,14,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),55181,Pre-mRNA-processing factor 19 OS=Homo sapiens OX=9606 GN=PRPF19 PE=1 SV=1
998,16662,sp|P50914|RL14_HUMAN,4.58,121.45,1.29E7,1.451E7,1.463E7,1.574E7,1.00,1.12,1.13,1.22,1.29E7,1.451E7,1.463E7,1.574E7,1.00,1.12,1.13,1.22,28,8,7,iTRAQ 4plex (K  N-term),23432,60S ribosomal protein L14 OS=Homo sapiens OX=9606 GN=RPL14 PE=1 SV=4
956,4587,sp|O75494-5|SRS10_HUMAN,13.66,121.36,6.481E6,6.477E6,1.009E7,1.017E7,1.00,1.00,1.56,1.57,6.481E6,6.477E6,1.009E7,1.017E7,1.00,1.00,1.56,1.57,44,9,9,iTRAQ 4plex (K  N-term),20117,Isoform 5 of Serine/arginine-rich splicing factor 10 OS=Homo sapiens OX=9606 GN=SRSF10
1505,19401,sp|O94842-3|TOX4_HUMAN,24.01,121.35,2.809E6,2.803E6,5.298E6,5.355E6,1.00,1.00,1.89,1.91,2.809E6,2.803E6,5.298E6,5.355E6,1.00,1.00,1.89,1.91,21,7,7,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),63595,Isoform 3 of TOX high mobility group box family member 4 OS=Homo sapiens OX=9606 GN=TOX4
980,38890,sp|Q6ZUT6|CCD9B_HUMAN,28.17,121.29,4.145E6,3.974E6,8.462E6,7.837E6,1.00,0.96,2.04,1.89,4.145E6,3.974E6,8.462E6,7.837E6,1.00,0.96,2.04,1.89,16,9,9,iTRAQ 4plex (K  N-term); Oxidation (M),57325,Coiled-coil domain-containing protein 9B OS=Homo sapiens OX=9606 GN=CCDC9B PE=1 SV=1
909,16398,sp|P55084|ECHB_HUMAN,9.40,121.29,6.25E6,6.364E6,8.974E6,9.407E6,1.00,1.02,1.44,1.51,6.25E6,6.364E6,8.974E6,9.407E6,1.00,1.02,1.44,1.51,25,13,13,iTRAQ 4plex (K  N-term); Deamidation (NQ),51294,Trifunctional enzyme subunit beta  mitochondrial OS=Homo sapiens OX=9606 GN=HADHB PE=1 SV=3
1339,10318,sp|P78371-2|TCPB_HUMAN,4.82,121.22,4.525E6,3.961E6,4.807E6,5.001E6,1.00,0.88,1.06,1.11,4.525E6,3.961E6,4.807E6,5.001E6,1.00,0.88,1.06,1.11,19,8,8,iTRAQ 4plex (K  N-term),52718,Isoform 2 of T-complex protein 1 subunit beta OS=Homo sapiens OX=9606 GN=CCT2
1132,2038,sp|Q9GZM8-2|NDEL1_HUMAN,20.99,121.19,1.681E6,1.674E6,3.311E6,3.419E6,1.00,1.00,1.97,2.03,1.681E6,1.674E6,3.311E6,3.419E6,1.00,1.00,1.97,2.03,21,8,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),40616,Isoform 2 of Nuclear distribution protein nudE-like 1 OS=Homo sapiens OX=9606 GN=NDEL1
1098,38961,sp|P35659|DEK_HUMAN,12.62,121.11,6.538E6,6.452E6,9.951E6,1.001E7,1.00,0.99,1.52,1.53,6.538E6,6.452E6,9.951E6,1.001E7,1.00,0.99,1.52,1.53,20,7,7,iTRAQ 4plex (K  N-term),42674,Protein DEK OS=Homo sapiens OX=9606 GN=DEK PE=1 SV=1
1087,39097,sp|Q9P0L0|VAPA_HUMAN,14.31,121.05,5.864E6,5.604E6,8.607E6,8.707E6,1.00,0.96,1.47,1.48,5.864E6,5.604E6,8.607E6,8.707E6,1.00,0.96,1.47,1.48,27,7,6,iTRAQ 4plex (K  N-term); Oxidation (M),27893,Vesicle-associated membrane protein-associated protein A OS=Homo sapiens OX=9606 GN=VAPA PE=1 SV=3
939,22866,sp|P52926|HMGA2_HUMAN,18.87,121.00,1.468E6,1.522E6,2.297E6,2.385E6,1.00,1.04,1.57,1.62,1.468E6,1.522E6,2.297E6,2.385E6,1.00,1.04,1.57,1.62,58,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),11832,High mobility group protein HMGI-C OS=Homo sapiens OX=9606 GN=HMGA2 PE=1 SV=1
962,4742,sp|Q9NVD7|PARVA_HUMAN,19.85,120.98,4.474E6,4.566E6,7.739E6,7.601E6,1.00,1.02,1.73,1.70,4.474E6,4.566E6,7.739E6,7.601E6,1.00,1.02,1.73,1.70,16,6,5,iTRAQ 4plex (K  N-term),42244,Alpha-parvin OS=Homo sapiens OX=9606 GN=PARVA PE=1 SV=1
906,19894,sp|P62805|H4_HUMAN,15.44,120.97,1.895E7,1.685E7,2.074E7,2.544E7,1.00,0.89,1.09,1.34,1.895E7,1.685E7,2.074E7,2.544E7,1.00,0.89,1.09,1.34,51,7,7,iTRAQ 4plex (K  N-term),11367,Histone H4 OS=Homo sapiens OX=9606 GN=HIST1H4A PE=1 SV=2
557,19552,K7ERF1|K7ERF1_HUMAN,85.18,120.96,2.961E7,3.168E7,7.745E7,7.378E7,1.00,1.07,2.62,2.49,2.961E7,3.168E7,7.745E7,7.378E7,1.00,1.07,2.62,2.49,44,7,7,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),22095,Eukaryotic translation initiation factor 3 subunit K OS=Homo sapiens OX=9606 GN=EIF3K PE=1 SV=1
1192,6062,sp|Q9Y3X0|CCDC9_HUMAN,30.50,120.95,2.316E6,2.36E6,4.803E6,4.76E6,1.00,1.02,2.07,2.06,2.316E6,2.36E6,4.803E6,4.76E6,1.00,1.02,2.07,2.06,16,8,8,iTRAQ 4plex (K  N-term); Phosphorylation (STY),59703,Coiled-coil domain-containing protein 9 OS=Homo sapiens OX=9606 GN=CCDC9 PE=1 SV=1
1429,13554,sp|Q96EY1|DNJA3_HUMAN,2.69,120.93,3.409E5,3.619E5,7.54E5,7.75E5,1.00,1.06,2.21,2.27,3.409E5,3.619E5,7.54E5,7.75E5,1.00,1.06,2.21,2.27,2,6,1,iTRAQ 4plex (K  N-term),52489,DnaJ homolog subfamily A member 3  mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3 PE=1 SV=2
731,13541,sp|P27348|1433T_HUMAN,14.04,120.82,2.05E6,2.18E6,3.244E6,3.264E6,1.00,1.06,1.58,1.59,2.05E6,2.18E6,3.244E6,3.264E6,1.00,1.06,1.58,1.59,20,9,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),27764,14-3-3 protein theta OS=Homo sapiens OX=9606 GN=YWHAQ PE=1 SV=1
1172,636,sp|Q9Y2J4-3|AMOL2_HUMAN,7.82,120.51,1.473E6,1.5E6,2.018E6,2.028E6,1.00,1.02,1.37,1.38,1.473E6,1.5E6,2.018E6,2.028E6,1.00,1.02,1.37,1.38,12,8,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),85480,Isoform 3 of Angiomotin-like protein 2 OS=Homo sapiens OX=9606 GN=AMOTL2
1608,38967,sp|Q16706|MA2A1_HUMAN,7.22,120.45,2.408E6,2.509E6,3.275E6,3.162E6,1.00,1.04,1.36,1.31,2.408E6,2.509E6,3.275E6,3.162E6,1.00,1.04,1.36,1.31,7,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),131140,Alpha-mannosidase 2 OS=Homo sapiens OX=9606 GN=MAN2A1 PE=1 SV=2
1168,38931,sp|P06396-2|GELS_HUMAN,6.59,120.45,3.867E6,3.636E6,4.596E6,4.965E6,1.00,0.94,1.19,1.28,3.867E6,3.636E6,4.596E6,4.965E6,1.00,0.94,1.19,1.28,14,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),80641,Isoform 2 of Gelsolin OS=Homo sapiens OX=9606 GN=GSN
1308,6839,sp|Q86TB9|PATL1_HUMAN,12.99,120.30,3.57E6,3.429E6,5.538E6,5.295E6,1.00,0.96,1.55,1.48,3.57E6,3.429E6,5.538E6,5.295E6,1.00,0.96,1.55,1.48,16,10,9,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),86850,Protein PAT1 homolog 1 OS=Homo sapiens OX=9606 GN=PATL1 PE=1 SV=2
1173,20028,sp|P50750-2|CDK9_HUMAN,45.65,120.26,1.398E6,1.357E6,3.558E6,3.397E6,1.00,0.97,2.55,2.43,1.398E6,1.357E6,3.558E6,3.397E6,1.00,0.97,2.55,2.43,9,7,5,iTRAQ 4plex (K  N-term),53365,Isoform 2 of Cyclin-dependent kinase 9 OS=Homo sapiens OX=9606 GN=CDK9
1114,13589,sp|Q9UIV1|CNOT7_HUMAN,47.54,120.24,3.622E6,3.922E6,8.901E6,8.715E6,1.00,1.08,2.46,2.41,3.622E6,3.922E6,8.901E6,8.715E6,1.00,1.08,2.46,2.41,27,6,6,iTRAQ 4plex (K  N-term),32745,CCR4-NOT transcription complex subunit 7 OS=Homo sapiens OX=9606 GN=CNOT7 PE=1 SV=3
1272,23362,sp|O95084|PRS23_HUMAN,9.08,119.96,3.948E6,4.093E6,4.942E6,5.279E6,1.00,1.04,1.25,1.34,3.948E6,4.093E6,4.942E6,5.279E6,1.00,1.04,1.25,1.34,19,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),43001,Serine protease 23 OS=Homo sapiens OX=9606 GN=PRSS23 PE=1 SV=1
1360,39122,sp|Q92879-5|CELF1_HUMAN,6.05,119.91,1.51E6,1.518E6,2.033E6,1.924E6,1.00,1.01,1.35,1.27,1.51E6,1.518E6,2.033E6,1.924E6,1.00,1.01,1.35,1.27,14,8,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),50130,Isoform 5 of CUGBP Elav-like family member 1 OS=Homo sapiens OX=9606 GN=CELF1
1164,2654,sp|Q5T200|ZC3HD_HUMAN,9.15,119.81,2.9E6,3.015E6,4.201E6,4.134E6,1.00,1.04,1.45,1.43,2.9E6,3.015E6,4.201E6,4.134E6,1.00,1.04,1.45,1.43,6,9,9,iTRAQ 4plex (K  N-term),196635,Zinc finger CCCH domain-containing protein 13 OS=Homo sapiens OX=9606 GN=ZC3H13 PE=1 SV=1
1239,21981,sp|Q13595|TRA2A_HUMAN,16.57,119.80,1.574E6,1.605E6,2.652E6,2.594E6,1.00,1.02,1.68,1.65,1.574E6,1.605E6,2.652E6,2.594E6,1.00,1.02,1.68,1.65,24,8,6,iTRAQ 4plex (K  N-term),32689,Transformer-2 protein homolog alpha OS=Homo sapiens OX=9606 GN=TRA2A PE=1 SV=1
1348,19278,H0Y2Y8|H0Y2Y8_HUMAN,26.45,119.75,2.478E6,2.543E6,5.05E6,5.013E6,1.00,1.03,2.04,2.02,2.478E6,2.543E6,5.05E6,5.013E6,1.00,1.03,2.04,2.02,14,7,7,iTRAQ 4plex (K  N-term),57643,Zyxin (Fragment) OS=Homo sapiens OX=9606 GN=ZYX PE=1 SV=1
1029,22353,sp|O14647|CHD2_HUMAN,21.99,119.75,2.244E6,2.279E6,4.877E6,4.777E6,1.00,1.02,2.17,2.13,2.244E6,2.279E6,4.877E6,4.777E6,1.00,1.02,2.17,2.13,7,13,12,iTRAQ 4plex (K  N-term); Deamidation (NQ),211342,Chromodomain-helicase-DNA-binding protein 2 OS=Homo sapiens OX=9606 GN=CHD2 PE=1 SV=2
1254,8149,sp|P63151|2ABA_HUMAN,34.93,119.69,4.954E6,4.87E6,8.83E6,8.788E6,1.00,0.98,1.78,1.77,4.954E6,4.87E6,8.83E6,8.788E6,1.00,0.98,1.78,1.77,19,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),51692,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform OS=Homo sapiens OX=9606 GN=PPP2R2A PE=1 SV=1
747,14757,sp|P01023|A2MG_HUMAN,1.27,119.50,8.718E6,8.982E6,9.812E6,9.576E6,1.00,1.03,1.13,1.10,8.718E6,8.982E6,9.812E6,9.576E6,1.00,1.03,1.13,1.10,4,10,8,iTRAQ 4plex (K  N-term),163290,Alpha-2-macroglobulin OS=Homo sapiens OX=9606 GN=A2M PE=1 SV=3
1080,19002,sp|Q96RF0-2|SNX18_HUMAN,28.67,119.42,2.882E6,3.016E6,5.759E6,5.719E6,1.00,1.05,2.00,1.98,2.882E6,3.016E6,5.759E6,5.719E6,1.00,1.05,2.00,1.98,18,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),69007,Isoform 2 of Sorting nexin-18 OS=Homo sapiens OX=9606 GN=SNX18
1211,13340,sp|Q9Y295|DRG1_HUMAN,12.03,119.41,4.253E6,4.226E6,6.466E6,6.546E6,1.00,0.99,1.52,1.54,4.253E6,4.226E6,6.466E6,6.546E6,1.00,0.99,1.52,1.54,23,7,7,iTRAQ 4plex (K  N-term),40542,Developmentally-regulated GTP-binding protein 1 OS=Homo sapiens OX=9606 GN=DRG1 PE=1 SV=1
1097,6875,sp|Q02880-2|TOP2B_HUMAN,11.66,119.40,1.717E6,1.803E6,2.896E6,2.915E6,1.00,1.05,1.69,1.70,1.717E6,1.803E6,2.896E6,2.915E6,1.00,1.05,1.69,1.70,8,12,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),182661,Isoform Beta-1 of DNA topoisomerase 2-beta OS=Homo sapiens OX=9606 GN=TOP2B
1125,38879,sp|Q96PE2|ARHGH_HUMAN,23.36,119.34,1.102E6,1.157E6,2.282E6,2.215E6,1.00,1.05,2.07,2.01,1.102E6,1.157E6,2.282E6,2.215E6,1.00,1.05,2.07,2.01,8,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),221671,Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1
981,19808,sp|O00160|MYO1F_HUMAN,2.67,119.31,1.373E5,1.463E5,3.078E5,3.155E5,1.00,1.07,2.24,2.30,1.373E5,1.463E5,3.078E5,3.155E5,1.00,1.07,2.24,2.30,1,7,1,iTRAQ 4plex (K  N-term),124844,Unconventional myosin-If OS=Homo sapiens OX=9606 GN=MYO1F PE=1 SV=3
1599,24367,H0YAJ8|H0YAJ8_HUMAN,3.25,119.20,1.583E5,1.65E5,3.954E5,4.17E5,1.00,1.04,2.50,2.63,1.583E5,1.65E5,3.954E5,4.17E5,1.00,1.04,2.50,2.63,7,5,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),34667,Rap guanine nucleotide exchange factor 2 (Fragment) OS=Homo sapiens OX=9606 GN=RAPGEF2 PE=1 SV=1
1417,39108,E9PF19|E9PF19_HUMAN,12.76,119.18,3.635E6,3.654E6,5.184E6,5.407E6,1.00,1.01,1.43,1.49,3.635E6,3.654E6,5.184E6,5.407E6,1.00,1.01,1.43,1.49,14,6,5,iTRAQ 4plex (K  N-term),45935,Transducin beta-like protein 2 OS=Homo sapiens OX=9606 GN=TBL2 PE=1 SV=1
1233,38937,sp|Q9UJV9|DDX41_HUMAN,12.94,119.16,4.066E6,4.085E6,5.973E6,6.097E6,1.00,1.00,1.47,1.50,4.066E6,4.085E6,5.973E6,6.097E6,1.00,1.00,1.47,1.50,13,9,9,iTRAQ 4plex (K  N-term),69838,Probable ATP-dependent RNA helicase DDX41 OS=Homo sapiens OX=9606 GN=DDX41 PE=1 SV=2
1610,19378,sp|P78406|RAE1L_HUMAN,41.30,118.97,2.242E6,2.302E6,4.621E6,4.606E6,1.00,1.03,2.06,2.05,2.242E6,2.302E6,4.621E6,4.606E6,1.00,1.03,2.06,2.05,18,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),40968,mRNA export factor OS=Homo sapiens OX=9606 GN=RAE1 PE=1 SV=1
931,19865,sp|Q13247-3|SRSF6_HUMAN,10.36,118.76,9.817E6,9.859E6,1.379E7,1.454E7,1.00,1.00,1.41,1.48,9.817E6,9.859E6,1.379E7,1.454E7,1.00,1.00,1.41,1.48,12,9,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),38419,Isoform SRP55-3 of Serine/arginine-rich splicing factor 6 OS=Homo sapiens OX=9606 GN=SRSF6
1423,64,sp|Q96HQ2|C2AIL_HUMAN,27.88,118.69,3.703E6,3.734E6,6.392E6,6.599E6,1.00,1.01,1.73,1.78,3.703E6,3.734E6,6.392E6,6.599E6,1.00,1.01,1.73,1.78,31,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),13196,CDKN2AIP N-terminal-like protein OS=Homo sapiens OX=9606 GN=CDKN2AIPNL PE=1 SV=1
1411,13842,sp|Q86U70-2|LDB1_HUMAN,11.89,118.68,2.875E6,2.891E6,3.715E6,3.709E6,1.00,1.01,1.29,1.29,2.875E6,2.891E6,3.715E6,3.709E6,1.00,1.01,1.29,1.29,21,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),42809,Isoform 3 of LIM domain-binding protein 1 OS=Homo sapiens OX=9606 GN=LDB1
1023,21481,Q5QPL9|Q5QPL9_HUMAN,13.29,118.66,4.353E6,4.494E6,6.862E6,6.674E6,1.00,1.03,1.58,1.53,4.353E6,4.494E6,6.862E6,6.674E6,1.00,1.03,1.58,1.53,36,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),24665,RNA-binding protein Raly (Fragment) OS=Homo sapiens OX=9606 GN=RALY PE=1 SV=1
1457,12222,sp|Q9Y265|RUVB1_HUMAN,18.47,118.51,1.445E6,1.469E6,2.563E6,2.519E6,1.00,1.02,1.77,1.74,1.445E6,1.469E6,2.563E6,2.519E6,1.00,1.02,1.77,1.74,19,7,7,iTRAQ 4plex (K  N-term),50228,RuvB-like 1 OS=Homo sapiens OX=9606 GN=RUVBL1 PE=1 SV=1
1258,38895,sp|Q92540-2|SMG7_HUMAN,33.28,118.48,2.758E6,2.596E6,6.147E6,5.921E6,1.00,0.94,2.23,2.15,2.758E6,2.596E6,6.147E6,5.921E6,1.00,0.94,2.23,2.15,8,9,9,iTRAQ 4plex (K  N-term),122020,Isoform 2 of Protein SMG7 OS=Homo sapiens OX=9606 GN=SMG7
1243,2435,sp|Q9UQB8-3|BAIP2_HUMAN,19.61,118.30,2.745E6,2.686E6,5.422E6,5.427E6,1.00,0.98,1.98,1.98,2.745E6,2.686E6,5.422E6,5.427E6,1.00,0.98,1.98,1.98,28,11,11,iTRAQ 4plex (K  N-term); Deamidation (NQ),56626,Isoform 3 of Brain-specific angiogenesis inhibitor 1-associated protein 2 OS=Homo sapiens OX=9606 GN=BAIAP2
554,19985,sp|P42766|RL35_HUMAN,11.99,118.25,8.253E7,8.348E7,1.142E8,1.166E8,1.00,1.01,1.38,1.41,8.253E7,8.348E7,1.142E8,1.166E8,1.00,1.01,1.38,1.41,46,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),14551,60S ribosomal protein L35 OS=Homo sapiens OX=9606 GN=RPL35 PE=1 SV=2
1202,2949,sp|O15231-7|ZN185_HUMAN,10.21,118.24,2.859E6,2.838E6,1.89E6,2.018E6,1.00,0.99,0.66,0.71,2.859E6,2.838E6,1.89E6,2.018E6,1.00,0.99,0.66,0.71,15,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),70380,Isoform 7 of Zinc finger protein 185 OS=Homo sapiens OX=9606 GN=ZNF185
1096,9677,sp|Q8IVL0-2|NAV3_HUMAN,20.59,118.14,1.294E6,1.348E6,2.748E6,2.661E6,1.00,1.04,2.12,2.06,1.294E6,1.348E6,2.748E6,2.661E6,1.00,1.04,2.12,2.06,5,12,12,iTRAQ 4plex (K  N-term),253020,Isoform 2 of Neuron navigator 3 OS=Homo sapiens OX=9606 GN=NAV3
1236,20966,A0A3B3ISA1|A0A3B3ISA1_HUMAN,0.91,118.12,1.704E5,1.557E5,2.167E5,2.032E5,1.00,0.91,1.27,1.19,1.704E5,1.557E5,2.167E5,2.032E5,1.00,0.91,1.27,1.19,1,8,1,Carbamidomethylation; iTRAQ 4plex (K  N-term),96305,GATOR complex protein WDR24 OS=Homo sapiens OX=9606 GN=WDR24 PE=1 SV=1
1357,6790,sp|Q9UPT8|ZC3H4_HUMAN,10.60,118.10,8.536E5,8.546E5,1.261E6,1.26E6,1.00,1.00,1.48,1.48,8.536E5,8.546E5,1.261E6,1.26E6,1.00,1.00,1.48,1.48,10,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),140256,Zinc finger CCCH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=ZC3H4 PE=1 SV=3
1394,19486,sp|O60341|KDM1A_HUMAN,10.99,118.02,2.523E6,2.447E6,3.655E6,3.69E6,1.00,0.97,1.45,1.46,2.523E6,2.447E6,3.655E6,3.69E6,1.00,0.97,1.45,1.46,11,8,8,iTRAQ 4plex (K  N-term),92903,Lysine-specific histone demethylase 1A OS=Homo sapiens OX=9606 GN=KDM1A PE=1 SV=2
1282,38893,sp|Q9Y485|DMXL1_HUMAN,17.92,117.98,1.446E6,1.452E6,2.738E6,2.644E6,1.00,1.00,1.89,1.83,1.446E6,1.452E6,2.738E6,2.644E6,1.00,1.00,1.89,1.83,3,8,8,iTRAQ 4plex (K  N-term),337839,DmX-like protein 1 OS=Homo sapiens OX=9606 GN=DMXL1 PE=1 SV=3
1200,6475,sp|Q8WUI4-7|HDAC7_HUMAN,23.97,117.93,1.564E6,1.378E6,2.945E6,2.902E6,1.00,0.88,1.88,1.86,1.564E6,1.378E6,2.945E6,2.902E6,1.00,0.88,1.88,1.86,11,9,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),102906,Isoform 7 of Histone deacetylase 7 OS=Homo sapiens OX=9606 GN=HDAC7
1294,8738,sp|Q9BQ39|DDX50_HUMAN,12.71,117.74,1.975E6,1.984E6,3.306E6,3.208E6,1.00,1.00,1.67,1.62,1.975E6,1.984E6,3.306E6,3.208E6,1.00,1.00,1.67,1.62,9,9,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),82565,ATP-dependent RNA helicase DDX50 OS=Homo sapiens OX=9606 GN=DDX50 PE=1 SV=1
1370,8686,sp|Q9P2B4|CT2NL_HUMAN,41.07,117.65,2.18E6,2.074E6,4.919E6,4.915E6,1.00,0.95,2.26,2.26,2.18E6,2.074E6,4.919E6,4.915E6,1.00,0.95,2.26,2.26,17,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),70158,CTTNBP2 N-terminal-like protein OS=Homo sapiens OX=9606 GN=CTTNBP2NL PE=1 SV=2
1393,21218,sp|O43242|PSMD3_HUMAN,11.92,117.45,1.625E6,1.551E6,2.39E6,2.517E6,1.00,0.95,1.47,1.55,1.625E6,1.551E6,2.39E6,2.517E6,1.00,0.95,1.47,1.55,17,9,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),60978,26S proteasome non-ATPase regulatory subunit 3 OS=Homo sapiens OX=9606 GN=PSMD3 PE=1 SV=2
1401,4743,A0A2R8Y804|A0A2R8Y804_HUMAN,26.27,117.32,1.499E6,1.452E6,3E6,2.834E6,1.00,0.97,2.00,1.89,1.499E6,1.452E6,3E6,2.834E6,1.00,0.97,2.00,1.89,11,7,7,iTRAQ 4plex (K  N-term),77207,Catenin beta-1 OS=Homo sapiens OX=9606 GN=CTNNB1 PE=1 SV=1
1241,20968,sp|Q92997-2|DVL3_HUMAN,26.72,117.20,1.437E6,1.462E6,2.673E6,2.663E6,1.00,1.02,1.86,1.85,1.437E6,1.462E6,2.673E6,2.663E6,1.00,1.02,1.86,1.85,6,6,3,iTRAQ 4plex (K  N-term),76256,Isoform 2 of Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens OX=9606 GN=DVL3
1781,39356,sp|Q9Y512|SAM50_HUMAN,17.62,117.06,2.723E6,2.8E6,3.815E6,4.148E6,1.00,1.03,1.40,1.52,2.723E6,2.8E6,3.815E6,4.148E6,1.00,1.03,1.40,1.52,14,4,4,iTRAQ 4plex (K  N-term),51976,Sorting and assembly machinery component 50 homolog OS=Homo sapiens OX=9606 GN=SAMM50 PE=1 SV=3
339,5678,sp|P62979|RS27A_HUMAN,7.83,117.06,5.854E7,5.5E7,6.81E7,6.928E7,1.00,0.94,1.16,1.18,5.854E7,5.5E7,6.81E7,6.928E7,1.00,0.94,1.16,1.18,38,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),17965,Ubiquitin-40S ribosomal protein S27a OS=Homo sapiens OX=9606 GN=RPS27A PE=1 SV=2
1347,17537,sp|P08603|CFAH_HUMAN,23.17,117.01,1.881E6,1.952E6,3.662E6,3.555E6,1.00,1.04,1.95,1.89,1.881E6,1.952E6,3.662E6,3.555E6,1.00,1.04,1.95,1.89,7,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),139096,Complement factor H OS=Homo sapiens OX=9606 GN=CFH PE=1 SV=4
1047,19406,sp|P62993|GRB2_HUMAN,20.06,116.98,5.615E6,5.467E6,9.894E6,9.803E6,1.00,0.97,1.76,1.75,5.615E6,5.467E6,9.894E6,9.803E6,1.00,0.97,1.76,1.75,33,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),25206,Growth factor receptor-bound protein 2 OS=Homo sapiens OX=9606 GN=GRB2 PE=1 SV=1
1326,5615,sp|O15294-3|OGT1_HUMAN,15.37,116.94,3.437E6,3.24E6,5.287E6,5.3E6,1.00,0.94,1.54,1.54,3.437E6,3.24E6,5.287E6,5.3E6,1.00,0.94,1.54,1.54,9,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),115706,Isoform 1 of UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Homo sapiens OX=9606 GN=OGT
1426,7709,sp|Q9NSD9-2|SYFB_HUMAN,14.79,116.94,2.278E6,2.172E6,3.693E6,3.618E6,1.00,0.95,1.62,1.59,2.278E6,2.172E6,3.693E6,3.618E6,1.00,0.95,1.62,1.59,14,7,7,iTRAQ 4plex (K  N-term),54861,Isoform 2 of Phenylalanine--tRNA ligase beta subunit OS=Homo sapiens OX=9606 GN=FARSB
1179,7407,sp|Q6P158|DHX57_HUMAN,20.18,116.85,2.287E6,2.298E6,3.925E6,3.974E6,1.00,1.00,1.72,1.74,2.287E6,2.298E6,3.925E6,3.974E6,1.00,1.00,1.72,1.74,6,7,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),155604,Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens OX=9606 GN=DHX57 PE=1 SV=2
1404,4568,sp|Q96P47|AGAP3_HUMAN,34.97,116.84,1.293E6,1.34E6,2.943E6,2.87E6,1.00,1.04,2.28,2.22,1.293E6,1.34E6,2.943E6,2.87E6,1.00,1.04,2.28,2.22,5,7,4,iTRAQ 4plex (K  N-term),95044,Arf-GAP with GTPase  ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=AGAP3 PE=1 SV=2
1527,15296,sp|P98170|XIAP_HUMAN,16.96,116.80,1.26E6,1.267E6,2.046E6,1.936E6,1.00,1.01,1.62,1.54,1.26E6,1.267E6,2.046E6,1.936E6,1.00,1.01,1.62,1.54,14,6,6,iTRAQ 4plex (K  N-term),56685,E3 ubiquitin-protein ligase XIAP OS=Homo sapiens OX=9606 GN=XIAP PE=1 SV=2
1156,21818,sp|O60832|DKC1_HUMAN,16.85,116.70,1.738E6,1.76E6,3.107E6,3.114E6,1.00,1.01,1.79,1.79,1.738E6,1.76E6,3.107E6,3.114E6,1.00,1.01,1.79,1.79,20,9,9,iTRAQ 4plex (K  N-term),57674,H/ACA ribonucleoprotein complex subunit DKC1 OS=Homo sapiens OX=9606 GN=DKC1 PE=1 SV=3
1019,19778,sp|Q9Y383-3|LC7L2_HUMAN,9.22,116.69,3.172E6,3.251E6,4.269E6,4.503E6,1.00,1.02,1.35,1.42,3.172E6,3.251E6,4.269E6,4.503E6,1.00,1.02,1.35,1.42,12,8,5,iTRAQ 4plex (K  N-term),46229,Isoform 3 of Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2
1333,13653,sp|Q6P2Q9|PRP8_HUMAN,17.77,116.68,1.49E6,1.488E6,2.457E6,2.469E6,1.00,1.00,1.65,1.66,1.49E6,1.488E6,2.457E6,2.469E6,1.00,1.00,1.65,1.66,3,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),273599,Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2
1314,29873,sp|Q9Y4F1|FARP1_HUMAN,10.08,116.68,2.733E6,2.716E6,4.153E6,4.217E6,1.00,0.99,1.52,1.54,2.733E6,2.716E6,4.153E6,4.217E6,1.00,0.99,1.52,1.54,10,10,10,iTRAQ 4plex (K  N-term); Deamidation (NQ),118633,FERM  ARHGEF and pleckstrin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FARP1 PE=1 SV=1
1225,3912,sp|Q07954|LRP1_HUMAN,8.36,116.57,2.263E6,2.306E6,3.263E6,3.184E6,1.00,1.02,1.44,1.41,2.263E6,2.306E6,3.263E6,3.184E6,1.00,1.02,1.44,1.41,2,8,8,iTRAQ 4plex (K  N-term),504610,Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2
1221,19562,sp|P17931|LEG3_HUMAN,68.20,116.54,6.037E6,5.541E6,1.531E7,1.496E7,1.00,0.92,2.54,2.48,6.037E6,5.541E6,1.531E7,1.496E7,1.00,0.92,2.54,2.48,24,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),26152,Galectin-3 OS=Homo sapiens OX=9606 GN=LGALS3 PE=1 SV=5
1701,20337,sp|O75340-2|PDCD6_HUMAN,37.29,116.41,1.369E6,1.391E6,2.923E6,2.805E6,1.00,1.02,2.14,2.05,1.369E6,1.391E6,2.923E6,2.805E6,1.00,1.02,2.14,2.05,37,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),21664,Isoform 2 of Programmed cell death protein 6 OS=Homo sapiens OX=9606 GN=PDCD6
1346,38905,sp|O00139-2|KIF2A_HUMAN,11.47,116.30,2.369E6,2.476E6,3.727E6,3.783E6,1.00,1.05,1.57,1.60,2.369E6,2.476E6,3.727E6,3.783E6,1.00,1.05,1.57,1.60,17,8,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),75043,Isoform 2 of Kinesin-like protein KIF2A OS=Homo sapiens OX=9606 GN=KIF2A
1452,249,sp|Q9ULL5-3|PRR12_HUMAN,16.88,116.24,8.426E5,8.08E5,1.363E6,1.448E6,1.00,0.96,1.62,1.72,8.426E5,8.08E5,1.363E6,1.448E6,1.00,0.96,1.62,1.72,7,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),211042,Isoform 3 of Proline-rich protein 12 OS=Homo sapiens OX=9606 GN=PRR12
1453,39051,sp|Q14644|RASA3_HUMAN,11.34,116.10,2.177E6,2.186E6,3.164E6,3.127E6,1.00,1.00,1.45,1.44,2.177E6,2.186E6,3.164E6,3.127E6,1.00,1.00,1.45,1.44,9,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),95699,Ras GTPase-activating protein 3 OS=Homo sapiens OX=9606 GN=RASA3 PE=1 SV=3
1433,9018,sp|Q07021|C1QBP_HUMAN,28.92,116.07,1.579E6,1.687E6,3.31E6,3.246E6,1.00,1.07,2.10,2.06,1.579E6,1.687E6,3.31E6,3.246E6,1.00,1.07,2.10,2.06,22,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),31362,Complement component 1 Q subcomponent-binding protein  mitochondrial OS=Homo sapiens OX=9606 GN=C1QBP PE=1 SV=1
1214,20505,sp|Q13404|UB2V1_HUMAN,19.50,116.03,1.326E7,9.851E6,8.974E6,8.729E6,1.00,0.74,0.68,0.66,1.326E7,9.851E6,8.974E6,8.729E6,1.00,0.74,0.68,0.66,43,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),16495,Ubiquitin-conjugating enzyme E2 variant 1 OS=Homo sapiens OX=9606 GN=UBE2V1 PE=1 SV=2
1403,21080,sp|O75970-5|MPDZ_HUMAN,15.76,115.97,1.349E6,1.285E6,2.085E6,2.209E6,1.00,0.95,1.55,1.64,1.349E6,1.285E6,2.085E6,2.209E6,1.00,0.95,1.55,1.64,5,8,8,iTRAQ 4plex (K  N-term),214802,Isoform 4 of Multiple PDZ domain protein OS=Homo sapiens OX=9606 GN=MPDZ
1395,975,sp|Q8WWN8|ARAP3_HUMAN,29.49,115.95,1.902E6,1.363E6,2.963E6,2.915E6,1.00,0.72,1.56,1.53,1.902E6,1.363E6,2.963E6,2.915E6,1.00,0.72,1.56,1.53,5,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),169843,Arf-GAP with Rho-GAP domain  ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ARAP3 PE=1 SV=1
1518,12146,sp|P43307|SSRA_HUMAN,19.76,115.86,3.16E6,3.384E6,4.671E6,4.535E6,1.00,1.07,1.48,1.44,3.16E6,3.384E6,4.671E6,4.535E6,1.00,1.07,1.48,1.44,21,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),32235,Translocon-associated protein subunit alpha OS=Homo sapiens OX=9606 GN=SSR1 PE=1 SV=3
779,4058,sp|Q9BPX5|ARP5L_HUMAN,10.40,115.75,3.96E6,3.527E6,4.654E6,5.323E6,1.00,0.89,1.18,1.34,3.96E6,3.527E6,4.654E6,5.323E6,1.00,0.89,1.18,1.34,59,9,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),16941,Actin-related protein 2/3 complex subunit 5-like protein OS=Homo sapiens OX=9606 GN=ARPC5L PE=1 SV=1
1286,11881,sp|Q52LW3|RHG29_HUMAN,20.96,115.65,1.92E6,1.892E6,3.613E6,3.634E6,1.00,0.99,1.88,1.89,1.92E6,1.892E6,3.613E6,3.634E6,1.00,0.99,1.88,1.89,6,8,7,iTRAQ 4plex (K  N-term),142063,Rho GTPase-activating protein 29 OS=Homo sapiens OX=9606 GN=ARHGAP29 PE=1 SV=2
1181,7541,A0A0C4DGA6|A0A0C4DGA6_HUMAN,13.67,115.64,2.397E6,2.528E6,4.239E6,4.217E6,1.00,1.05,1.77,1.76,2.397E6,2.528E6,4.239E6,4.217E6,1.00,1.05,1.77,1.76,10,11,11,iTRAQ 4plex (K  N-term),113857,Helicase-like transcription factor OS=Homo sapiens OX=9606 GN=HLTF PE=1 SV=1
1186,11875,sp|P61962|DCAF7_HUMAN,20.84,115.55,3.405E6,3.408E6,6.109E6,5.981E6,1.00,1.00,1.79,1.76,3.405E6,3.408E6,6.109E6,5.981E6,1.00,1.00,1.79,1.76,24,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),38926,DDB1- and CUL4-associated factor 7 OS=Homo sapiens OX=9606 GN=DCAF7 PE=1 SV=1
960,19785,sp|Q15404|RSU1_HUMAN,20.48,115.55,4.328E6,4.421E6,7.768E6,7.724E6,1.00,1.02,1.79,1.78,4.328E6,4.421E6,7.768E6,7.724E6,1.00,1.02,1.79,1.78,26,7,7,iTRAQ 4plex (K  N-term),31540,Ras suppressor protein 1 OS=Homo sapiens OX=9606 GN=RSU1 PE=1 SV=3
1514,39264,sp|Q12904|AIMP1_HUMAN,3.66,115.27,3.717E6,3.801E6,4.27E6,4.269E6,1.00,1.02,1.15,1.15,3.717E6,3.801E6,4.27E6,4.269E6,1.00,1.02,1.15,1.15,17,5,5,iTRAQ 4plex (K  N-term),34353,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens OX=9606 GN=AIMP1 PE=1 SV=2
1415,21406,sp|Q32P44|EMAL3_HUMAN,17.98,115.26,1.773E6,1.839E6,2.99E6,3.077E6,1.00,1.04,1.69,1.74,1.773E6,1.839E6,2.99E6,3.077E6,1.00,1.04,1.69,1.74,10,7,7,iTRAQ 4plex (K  N-term),95197,Echinoderm microtubule-associated protein-like 3 OS=Homo sapiens OX=9606 GN=EML3 PE=1 SV=1
1588,20634,sp|O94763-3|RMP_HUMAN,17.70,115.12,2.373E6,2.347E6,4.03E6,4.099E6,1.00,0.99,1.70,1.73,2.373E6,2.347E6,4.03E6,4.099E6,1.00,0.99,1.70,1.73,13,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),56978,Isoform 3 of Unconventional prefoldin RPB5 interactor 1 OS=Homo sapiens OX=9606 GN=URI1
1144,20484,sp|Q9NZN4|EHD2_HUMAN,9.20,115.01,4.722E6,4.744E6,6.624E6,6.854E6,1.00,1.00,1.40,1.45,4.722E6,4.744E6,6.624E6,6.854E6,1.00,1.00,1.40,1.45,12,9,7,iTRAQ 4plex (K  N-term),61162,EH domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EHD2 PE=1 SV=2
1287,18877,sp|Q99590-2|SCAFB_HUMAN,92.44,114.91,2.502E6,2.525E6,1.174E7,1.149E7,1.00,1.01,4.69,4.59,2.502E6,2.525E6,1.174E7,1.149E7,1.00,1.01,4.69,4.59,7,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),128875,Isoform 2 of Protein SCAF11 OS=Homo sapiens OX=9606 GN=SCAF11
1526,446,sp|Q6UUV7-3|CRTC3_HUMAN,29.31,114.82,2.445E6,2.596E6,5.084E6,4.948E6,1.00,1.06,2.08,2.02,2.445E6,2.596E6,5.084E6,4.948E6,1.00,1.06,2.08,2.02,17,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),66830,Isoform 3 of CREB-regulated transcription coactivator 3 OS=Homo sapiens OX=9606 GN=CRTC3
1436,21210,sp|P42224|STAT1_HUMAN,9.07,114.61,3.041E6,3.017E6,4.349E6,4.423E6,1.00,0.99,1.43,1.45,3.041E6,3.017E6,4.349E6,4.423E6,1.00,0.99,1.43,1.45,12,8,8,iTRAQ 4plex (K  N-term),87335,Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens OX=9606 GN=STAT1 PE=1 SV=2
1151,39002,sp|Q9Y6N5|SQOR_HUMAN,14.59,114.32,4.942E6,5.047E6,8.077E6,8.076E6,1.00,1.02,1.63,1.63,4.942E6,5.047E6,8.077E6,8.076E6,1.00,1.02,1.63,1.63,20,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),49961,Sulfide:quinone oxidoreductase  mitochondrial OS=Homo sapiens OX=9606 GN=SQOR PE=1 SV=1
1889,31170,sp|Q8TDJ6|DMXL2_HUMAN,14.77,114.31,4.858E5,5.066E5,7.688E5,7.497E5,1.00,1.04,1.58,1.54,4.858E5,5.066E5,7.688E5,7.497E5,1.00,1.04,1.58,1.54,3,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),339642,DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2
1595,6452,sp|Q96EY7|PTCD3_HUMAN,19.92,114.27,1.349E6,1.339E6,2.528E6,2.559E6,1.00,0.99,1.87,1.90,1.349E6,1.339E6,2.528E6,2.559E6,1.00,0.99,1.87,1.90,6,6,4,iTRAQ 4plex (K  N-term),78550,Pentatricopeptide repeat domain-containing protein 3  mitochondrial OS=Homo sapiens OX=9606 GN=PTCD3 PE=1 SV=3
1154,3528,sp|Q8NF50-4|DOCK8_HUMAN,3.79,114.26,1.541E6,1.653E6,6.75E5,5.489E5,1.00,1.07,0.44,0.36,1.541E6,1.653E6,6.75E5,5.489E5,1.00,1.07,0.44,0.36,1,5,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),227475,Isoform 4 of Dedicator of cytokinesis protein 8 OS=Homo sapiens OX=9606 GN=DOCK8
1317,20072,sp|O94916-2|NFAT5_HUMAN,23.33,113.90,1.154E6,1.257E6,2.365E6,2.261E6,1.00,1.09,2.05,1.96,1.154E6,1.257E6,2.365E6,2.261E6,1.00,1.09,2.05,1.96,5,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),157982,Isoform A of Nuclear factor of activated T-cells 5 OS=Homo sapiens OX=9606 GN=NFAT5
1271,22378,E9PGM4|E9PGM4_HUMAN,4.32,113.81,3.066E6,2.876E6,3.538E6,3.369E6,1.00,0.94,1.15,1.10,3.066E6,2.876E6,3.538E6,3.369E6,1.00,0.94,1.15,1.10,11,7,7,iTRAQ 4plex (K  N-term),75960,1 4-alpha-glucan-branching enzyme OS=Homo sapiens OX=9606 GN=GBE1 PE=1 SV=1
1153,5398,B1AKN6|B1AKN6_HUMAN,5.52,113.78,2.963E5,3.015E5,5.201E5,5.17E5,1.00,1.02,1.75,1.74,2.963E5,3.015E5,5.201E5,5.17E5,1.00,1.02,1.75,1.74,12,6,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),42305,Nuclear factor 1 OS=Homo sapiens OX=9606 GN=NFIA PE=1 SV=1
1482,21364,H0Y6A0|H0Y6A0_HUMAN,2.64,113.67,4.299E4,3.931E4,9.069E4,8.921E4,1.00,0.91,2.11,2.08,4.299E4,3.931E4,9.069E4,8.921E4,1.00,0.91,2.11,2.08,5,7,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),30075,ADP-ribosylation factor GTPase-activating protein 3 (Fragment) OS=Homo sapiens OX=9606 GN=ARFGAP3 PE=1 SV=1
1041,19474,sp|Q15428|SF3A2_HUMAN,18.74,113.62,3.979E6,4.161E6,6.757E6,6.628E6,1.00,1.05,1.70,1.67,3.979E6,4.161E6,6.757E6,6.628E6,1.00,1.05,1.70,1.67,14,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),49256,Splicing factor 3A subunit 2 OS=Homo sapiens OX=9606 GN=SF3A2 PE=1 SV=2
1481,6614,sp|Q92747|ARC1A_HUMAN,0.94,113.58,1.343E6,1.267E6,1.602E6,1.764E6,1.00,0.94,1.19,1.31,1.343E6,1.267E6,1.602E6,1.764E6,1.00,0.94,1.19,1.31,3,7,1,iTRAQ 4plex (K  N-term),41569,Actin-related protein 2/3 complex subunit 1A OS=Homo sapiens OX=9606 GN=ARPC1A PE=2 SV=2
1635,39512,J3QQY7|J3QQY7_HUMAN,43.73,113.53,1.346E6,1.369E6,2.488E6,2.372E6,1.00,1.02,1.85,1.76,1.346E6,1.369E6,2.488E6,2.372E6,1.00,1.02,1.85,1.76,43,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),12003,Protein TANC2 (Fragment) OS=Homo sapiens OX=9606 GN=TANC2 PE=1 SV=1
1136,1368,sp|Q04695|K1C17_HUMAN,2.18,113.49,1.081E5,5.363E4,7.595E4,6.454E4,1.00,0.50,0.70,0.60,1.081E5,5.363E4,7.595E4,6.454E4,1.00,0.50,0.70,0.60,3,7,1,iTRAQ 4plex (K  N-term),48106,Keratin  type I cytoskeletal 17 OS=Homo sapiens OX=9606 GN=KRT17 PE=1 SV=2
904,22119,sp|Q9Y281|COF2_HUMAN,14.38,113.33,2.355E6,1.841E6,2.362E6,2.959E6,1.00,0.78,1.00,1.26,2.355E6,1.841E6,2.362E6,2.959E6,1.00,0.78,1.00,1.26,22,6,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),18737,Cofilin-2 OS=Homo sapiens OX=9606 GN=CFL2 PE=1 SV=1
594,20232,sp|P17096-2|HMGA1_HUMAN,1.37,113.31,1.457E5,1.288E5,2.066E5,1.857E5,1.00,0.88,1.42,1.27,1.457E5,1.288E5,2.066E5,1.857E5,1.00,0.88,1.42,1.27,15,8,1,iTRAQ 4plex (K  N-term),10679,Isoform HMG-Y of High mobility group protein HMG-I/HMG-Y OS=Homo sapiens OX=9606 GN=HMGA1
1217,20120,sp|P05386|RLA1_HUMAN,24.66,113.27,3.532E6,2.021E6,3.101E6,3.598E6,1.00,0.57,0.88,1.02,3.532E6,2.021E6,3.101E6,3.598E6,1.00,0.57,0.88,1.02,33,5,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),11514,60S acidic ribosomal protein P1 OS=Homo sapiens OX=9606 GN=RPLP1 PE=1 SV=1
1483,2300,sp|Q8IVL6|P3H3_HUMAN,17.74,113.19,1.281E6,1.195E6,2.045E6,2.059E6,1.00,0.93,1.60,1.61,1.281E6,1.195E6,2.045E6,2.059E6,1.00,0.93,1.60,1.61,12,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),81837,Prolyl 3-hydroxylase 3 OS=Homo sapiens OX=9606 GN=P3H3 PE=1 SV=1
1210,11203,A0A0D9SEM4|A0A0D9SEM4_HUMAN,3.11,113.04,1.377E6,1.272E6,1.533E6,1.51E6,1.00,0.92,1.11,1.10,1.377E6,1.272E6,1.533E6,1.51E6,1.00,0.92,1.11,1.10,11,8,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),43647,Serine/arginine-rich-splicing factor 4 (Fragment) OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=1
1677,39343,sp|Q13155|AIMP2_HUMAN,10.71,113.02,1.918E6,2.044E6,2.572E6,2.528E6,1.00,1.07,1.34,1.32,1.918E6,2.044E6,2.572E6,2.528E6,1.00,1.07,1.34,1.32,17,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),35349,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Homo sapiens OX=9606 GN=AIMP2 PE=1 SV=2
1281,21742,H7C1M5|H7C1M5_HUMAN,13.71,112.98,4.91E6,4.708E6,7.445E6,7.647E6,1.00,0.96,1.52,1.56,4.91E6,4.708E6,7.445E6,7.647E6,1.00,0.96,1.52,1.56,30,8,8,iTRAQ 4plex (K  N-term),31783,Deoxynucleotidyltransferase terminal-interacting protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=DNTTIP1 PE=1 SV=1
1384,9580,sp|Q13464|ROCK1_HUMAN,11.19,112.95,6.07E5,6.154E5,9.574E5,9.671E5,1.00,1.01,1.58,1.59,6.07E5,6.154E5,9.574E5,9.671E5,1.00,1.01,1.58,1.59,4,8,5,iTRAQ 4plex (K  N-term),158174,Rho-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=ROCK1 PE=1 SV=1
1289,2948,sp|Q8IZ83-3|A16A1_HUMAN,5.11,112.95,3.684E6,3.932E6,3.246E6,3.08E6,1.00,1.07,0.88,0.84,3.684E6,3.932E6,3.246E6,3.08E6,1.00,1.07,0.88,0.84,11,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),79918,Isoform 3 of Aldehyde dehydrogenase family 16 member A1 OS=Homo sapiens OX=9606 GN=ALDH16A1
1728,21886,sp|O95639|CPSF4_HUMAN,37.00,112.93,2.159E6,2.119E6,4.015E6,3.768E6,1.00,0.98,1.86,1.75,2.159E6,2.119E6,4.015E6,3.768E6,1.00,0.98,1.86,1.75,22,4,4,iTRAQ 4plex (K  N-term),30255,Cleavage and polyadenylation specificity factor subunit 4 OS=Homo sapiens OX=9606 GN=CPSF4 PE=1 SV=1
487,19716,M0QZC5|M0QZC5_HUMAN,15.86,112.86,1.53E8,1.516E8,2.303E8,2.363E8,1.00,0.99,1.51,1.54,1.53E8,1.516E8,2.303E8,2.363E8,1.00,0.99,1.51,1.54,45,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),13997,40S ribosomal protein S11 OS=Homo sapiens OX=9606 GN=RPS11 PE=1 SV=1
1246,12942,R4GMV1|R4GMV1_HUMAN,3.78,112.71,2.512E6,2.395E6,2.897E6,2.942E6,1.00,0.95,1.15,1.17,2.512E6,2.395E6,2.897E6,2.942E6,1.00,0.95,1.15,1.17,18,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),38710,E3 ubiquitin-protein ligase TRIM11 OS=Homo sapiens OX=9606 GN=TRIM11 PE=1 SV=1
1159,23777,C9J4Z3|C9J4Z3_HUMAN,58.86,112.53,4.374E6,4.594E6,1.103E7,1.115E7,1.00,1.05,2.52,2.55,4.374E6,4.594E6,1.103E7,1.115E7,1.00,1.05,2.52,2.55,40,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),7624,60S ribosomal protein L37a OS=Homo sapiens OX=9606 GN=RPL37A PE=1 SV=1
1587,21149,sp|Q6AWC2|WWC2_HUMAN,24.38,112.50,7.805E5,8.72E5,1.425E6,1.415E6,1.00,1.12,1.83,1.81,7.805E5,8.72E5,1.425E6,1.415E6,1.00,1.12,1.83,1.81,7,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),133891,Protein WWC2 OS=Homo sapiens OX=9606 GN=WWC2 PE=1 SV=2
1309,38942,sp|Q96Q05-3|TPPC9_HUMAN,6.05,112.42,4.135E6,4.171E6,5.499E6,5.509E6,1.00,1.01,1.33,1.33,4.135E6,4.171E6,5.499E6,5.509E6,1.00,1.01,1.33,1.33,9,9,9,iTRAQ 4plex (K  N-term); Deamidation (NQ),127607,Isoform 3 of Trafficking protein particle complex subunit 9 OS=Homo sapiens OX=9606 GN=TRAPPC9
1510,39186,sp|Q96EY5|MB12A_HUMAN,35.05,112.39,3.041E6,2.963E6,5.979E6,6.103E6,1.00,0.97,1.97,2.01,3.041E6,2.963E6,5.979E6,6.103E6,1.00,0.97,1.97,2.01,23,5,5,iTRAQ 4plex (K  N-term),28783,Multivesicular body subunit 12A OS=Homo sapiens OX=9606 GN=MVB12A PE=1 SV=1
886,1466,sp|P11532-4|DMD_HUMAN,1.47,112.39,4.543E4,3.9E4,6.097E4,6.472E4,1.00,0.86,1.34,1.42,4.543E4,3.9E4,6.097E4,6.472E4,1.00,0.86,1.34,1.42,0,10,1,iTRAQ 4plex (K  N-term),425642,Isoform 3 of Dystrophin OS=Homo sapiens OX=9606 GN=DMD
475,7066,sp|Q68CZ2-2|TENS3_HUMAN,9.09,112.35,6.575E5,6.154E5,1.064E6,1.099E6,1.00,0.94,1.62,1.67,6.575E5,6.154E5,1.064E6,1.099E6,1.00,0.94,1.62,1.67,3,7,3,iTRAQ 4plex (K  N-term),129066,Isoform 2 of Tensin-3 OS=Homo sapiens OX=9606 GN=TNS3
1240,24527,sp|Q9NR30|DDX21_HUMAN,13.82,112.29,1.741E6,1.656E6,2.704E6,2.877E6,1.00,0.95,1.55,1.65,1.741E6,1.656E6,2.704E6,2.877E6,1.00,0.95,1.55,1.65,7,8,5,iTRAQ 4plex (K  N-term),87344,Nucleolar RNA helicase 2 OS=Homo sapiens OX=9606 GN=DDX21 PE=1 SV=5
1535,19755,sp|Q16527|CSRP2_HUMAN,31.15,112.17,1.395E6,1.41E6,2.905E6,2.857E6,1.00,1.01,2.08,2.05,1.395E6,1.41E6,2.905E6,2.857E6,1.00,1.01,2.08,2.05,37,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),20954,Cysteine and glycine-rich protein 2 OS=Homo sapiens OX=9606 GN=CSRP2 PE=1 SV=3
1310,10826,sp|Q9Y305|ACOT9_HUMAN,21.17,112.14,2.518E6,2.554E6,4.486E6,4.512E6,1.00,1.01,1.78,1.79,2.518E6,2.554E6,4.486E6,4.512E6,1.00,1.01,1.78,1.79,14,7,7,iTRAQ 4plex (K  N-term),49902,Acyl-coenzyme A thioesterase 9  mitochondrial OS=Homo sapiens OX=9606 GN=ACOT9 PE=1 SV=2
1455,21227,sp|P53618|COPB_HUMAN,16.33,112.12,1.844E6,1.729E6,2.731E6,2.69E6,1.00,0.94,1.48,1.46,1.844E6,1.729E6,2.731E6,2.69E6,1.00,0.94,1.48,1.46,7,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),107142,Coatomer subunit beta OS=Homo sapiens OX=9606 GN=COPB1 PE=1 SV=3
1479,16847,sp|Q9H0M0-3|WWP1_HUMAN,9.28,112.07,6.653E5,6.553E5,9.781E5,1.004E6,1.00,0.98,1.47,1.51,6.653E5,6.553E5,9.781E5,1.004E6,1.00,0.98,1.47,1.51,6,7,4,iTRAQ 4plex (K  N-term),91548,Isoform 3 of NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Homo sapiens OX=9606 GN=WWP1
1264,39019,sp|Q13219|PAPP1_HUMAN,10.26,111.92,2.08E6,2.066E6,3.179E6,3.145E6,1.00,0.99,1.53,1.51,2.08E6,2.066E6,3.179E6,3.145E6,1.00,0.99,1.53,1.51,5,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),180972,Pappalysin-1 OS=Homo sapiens OX=9606 GN=PAPPA PE=1 SV=3
1295,39000,sp|Q99985|SEM3C_HUMAN,8.98,111.87,4.469E6,4.616E6,6.583E6,6.551E6,1.00,1.03,1.47,1.47,4.469E6,4.616E6,6.583E6,6.551E6,1.00,1.03,1.47,1.47,11,8,8,Carbamidomethylation; iTRAQ 4plex (K  N-term),85207,Semaphorin-3C OS=Homo sapiens OX=9606 GN=SEMA3C PE=2 SV=2
1184,517,sp|P54259|ATN1_HUMAN,17.24,111.77,2.389E6,2.436E6,4.267E6,4.369E6,1.00,1.02,1.79,1.83,2.389E6,2.436E6,4.267E6,4.369E6,1.00,1.02,1.79,1.83,7,8,8,iTRAQ 4plex (K  N-term); Phosphorylation (STY),125414,Atrophin-1 OS=Homo sapiens OX=9606 GN=ATN1 PE=1 SV=3
1338,38909,sp|Q9HBD1-4|RC3H2_HUMAN,18.13,111.64,1.344E6,1.322E6,2.633E6,2.538E6,1.00,0.98,1.96,1.89,1.344E6,1.322E6,2.633E6,2.538E6,1.00,0.98,1.96,1.89,6,9,6,iTRAQ 4plex (K  N-term),117917,Isoform 4 of Roquin-2 OS=Homo sapiens OX=9606 GN=RC3H2
1597,11428,A0A0C4DG07|A0A0C4DG07_HUMAN,34.75,111.61,6.677E5,6.852E5,1.342E6,1.272E6,1.00,1.03,2.01,1.91,6.677E5,6.852E5,1.342E6,1.272E6,1.00,1.03,2.01,1.91,16,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),75969,Nibrin OS=Homo sapiens OX=9606 GN=NBN PE=1 SV=1
881,6896,E9PLL6|E9PLL6_HUMAN,15.36,111.51,5.358E7,5.253E7,7.114E7,7.579E7,1.00,0.98,1.33,1.41,5.358E7,5.253E7,7.114E7,7.579E7,1.00,0.98,1.33,1.41,31,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),12201,60S ribosomal protein L27a OS=Homo sapiens OX=9606 GN=RPL27A PE=1 SV=1
798,19673,sp|P10599|THIO_HUMAN,15.80,111.37,1.286E7,1.235E7,1.895E7,1.794E7,1.00,0.96,1.47,1.40,1.286E7,1.235E7,1.895E7,1.794E7,1.00,0.96,1.47,1.40,43,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),11737,Thioredoxin OS=Homo sapiens OX=9606 GN=TXN PE=1 SV=3
1492,39094,F5H8F7|F5H8F7_HUMAN,13.86,111.36,1.605E6,1.645E6,2.479E6,2.464E6,1.00,1.03,1.55,1.54,1.605E6,1.645E6,2.479E6,2.464E6,1.00,1.03,1.55,1.54,13,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),55325,Set1/Ash2 histone methyltransferase complex subunit ASH2 OS=Homo sapiens OX=9606 GN=ASH2L PE=1 SV=1
1530,20800,A0A2R8Y5A0|A0A2R8Y5A0_HUMAN,39.28,111.31,3.449E6,3.317E6,7.374E6,7.165E6,1.00,0.96,2.14,2.08,3.449E6,3.317E6,7.374E6,7.165E6,1.00,0.96,2.14,2.08,23,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),40718,Casein kinase II subunit alpha OS=Homo sapiens OX=9606 GN=CSNK2A1 PE=1 SV=1
797,20274,sp|O00622|CYR61_HUMAN,17.62,111.26,1.833E7,1.862E7,2.849E7,2.897E7,1.00,1.02,1.55,1.58,1.833E7,1.862E7,2.849E7,2.897E7,1.00,1.02,1.55,1.58,15,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),42027,Protein CYR61 OS=Homo sapiens OX=9606 GN=CYR61 PE=1 SV=1
729,19736,sp|Q03135|CAV1_HUMAN,5.05,111.24,1.807E7,2.02E7,1.691E7,1.721E7,1.00,1.12,0.94,0.95,1.807E7,2.02E7,1.691E7,1.721E7,1.00,1.12,0.94,0.95,29,6,6,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),20472,Caveolin-1 OS=Homo sapiens OX=9606 GN=CAV1 PE=1 SV=4
1480,38989,sp|P35606-2|COPB2_HUMAN,11.33,111.22,1.247E6,1.19E6,1.897E6,1.924E6,1.00,0.95,1.52,1.54,1.247E6,1.19E6,1.897E6,1.924E6,1.00,0.95,1.52,1.54,11,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),99046,Isoform 2 of Coatomer subunit beta' OS=Homo sapiens OX=9606 GN=COPB2
1445,8660,E7ERH2|E7ERH2_HUMAN,3.25,111.14,1.605E6,1.603E6,2.088E6,2.375E6,1.00,1.00,1.30,1.48,1.605E6,1.603E6,2.088E6,2.375E6,1.00,1.00,1.30,1.48,14,5,2,iTRAQ 4plex (K  N-term),16034,S-phase kinase-associated protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=SKP1 PE=1 SV=1
1679,2531,V9GYJ9|V9GYJ9_HUMAN,25.64,111.02,1.674E6,1.715E6,3.057E6,3.146E6,1.00,1.02,1.83,1.88,1.674E6,1.715E6,3.057E6,3.146E6,1.00,1.02,1.83,1.88,21,4,4,iTRAQ 4plex (K  N-term),30401,28S ribosomal protein S29  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=DAP3 PE=1 SV=8
1373,39227,sp|Q53H96-2|P5CR3_HUMAN,15.02,111.00,3.262E6,3.303E6,5.199E6,5.13E6,1.00,1.01,1.59,1.57,3.262E6,3.303E6,5.199E6,5.13E6,1.00,1.01,1.59,1.57,24,5,5,iTRAQ 4plex (K  N-term),26440,Isoform 2 of Pyrroline-5-carboxylate reductase 3 OS=Homo sapiens OX=9606 GN=PYCR3
1511,7873,sp|Q9UK59|DBR1_HUMAN,51.09,110.85,2.219E6,2.184E6,5.609E6,5.435E6,1.00,0.98,2.53,2.45,2.219E6,2.184E6,5.609E6,5.435E6,1.00,0.98,2.53,2.45,11,5,5,iTRAQ 4plex (K  N-term),61555,Lariat debranching enzyme OS=Homo sapiens OX=9606 GN=DBR1 PE=1 SV=2
1466,39198,sp|Q15063-3|POSTN_HUMAN,11.80,110.75,1.192E6,1.236E6,1.807E6,1.857E6,1.00,1.04,1.52,1.56,1.192E6,1.236E6,1.807E6,1.857E6,1.00,1.04,1.52,1.56,9,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),87254,Isoform 3 of Periostin OS=Homo sapiens OX=9606 GN=POSTN
1631,39231,sp|Q5U5Q3|MEX3C_HUMAN,10.23,110.55,3.158E5,3.825E5,5.184E5,4.32E5,1.00,1.21,1.64,1.37,3.158E5,3.825E5,5.184E5,4.32E5,1.00,1.21,1.64,1.37,6,5,3,iTRAQ 4plex (K  N-term),69366,RNA-binding E3 ubiquitin-protein ligase MEX3C OS=Homo sapiens OX=9606 GN=MEX3C PE=1 SV=3
1628,17454,sp|Q96JJ3-3|ELMO2_HUMAN,23.32,110.52,1.781E6,1.765E6,3.228E6,3.18E6,1.00,0.99,1.81,1.79,1.781E6,1.765E6,3.228E6,3.18E6,1.00,0.99,1.81,1.79,13,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),72798,Isoform 2 of Engulfment and cell motility protein 2 OS=Homo sapiens OX=9606 GN=ELMO2
1449,9769,sp|Q96JY6-5|PDLI2_HUMAN,16.14,110.51,1.256E6,1.22E6,1.998E6,1.976E6,1.00,0.97,1.59,1.57,1.256E6,1.22E6,1.998E6,1.976E6,1.00,0.97,1.59,1.57,13,6,6,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),62746,Isoform 5 of PDZ and LIM domain protein 2 OS=Homo sapiens OX=9606 GN=PDLIM2
1263,24377,E7EPK1|E7EPK1_HUMAN,15.01,110.50,2.118E6,2.128E6,3.544E6,3.524E6,1.00,1.00,1.67,1.66,2.118E6,2.128E6,3.544E6,3.524E6,1.00,1.00,1.67,1.66,14,7,6,iTRAQ 4plex (K  N-term),50695,Septin-7 OS=Homo sapiens OX=9606 GN=SEPT7 PE=1 SV=2
1611,39189,sp|Q70E73|RAPH1_HUMAN,9.86,110.35,1.071E6,1.071E6,1.549E6,1.53E6,1.00,1.00,1.45,1.43,1.071E6,1.071E6,1.549E6,1.53E6,1.00,1.00,1.45,1.43,6,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),135256,Ras-associated and pleckstrin homology domains-containing protein 1 OS=Homo sapiens OX=9606 GN=RAPH1 PE=1 SV=3
1390,21283,sp|O75643|U520_HUMAN,13.18,110.15,1.768E6,1.816E6,2.814E6,2.811E6,1.00,1.03,1.59,1.59,1.768E6,1.816E6,2.814E6,2.811E6,1.00,1.03,1.59,1.59,4,7,7,iTRAQ 4plex (K  N-term),244505,U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2
1996,20747,K7EIN2|K7EIN2_HUMAN,14.31,110.10,1.022E6,1.167E6,1.594E6,1.521E6,1.00,1.14,1.56,1.49,1.022E6,1.167E6,1.594E6,1.521E6,1.00,1.14,1.56,1.49,21,4,3,iTRAQ 4plex (K  N-term),21928,Tudor-interacting repair regulator protein (Fragment) OS=Homo sapiens OX=9606 GN=NUDT16L1 PE=1 SV=1
1438,39045,sp|Q00653-4|NFKB2_HUMAN,7.02,110.09,3.514E6,3.485E6,4.755E6,4.687E6,1.00,0.99,1.35,1.33,3.514E6,3.485E6,4.755E6,4.687E6,1.00,0.99,1.35,1.33,9,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),96678,Isoform 4 of Nuclear factor NF-kappa-B p100 subunit OS=Homo sapiens OX=9606 GN=NFKB2
927,5568,sp|P11532-9|DMD_HUMAN,1.81,109.92,9.545E4,9.763E4,1.745E5,1.522E5,1.00,1.02,1.83,1.59,9.545E4,9.763E4,1.745E5,1.522E5,1.00,1.02,1.83,1.59,3,9,1,iTRAQ 4plex (K  N-term),59769,Isoform 9 of Dystrophin OS=Homo sapiens OX=9606 GN=DMD
1235,18787,sp|Q96G25|MED8_HUMAN,6.52,109.83,3.318E6,3.43E6,4.207E6,4.086E6,1.00,1.03,1.27,1.23,3.318E6,3.43E6,4.207E6,4.086E6,1.00,1.03,1.27,1.23,37,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),29080,Mediator of RNA polymerase II transcription subunit 8 OS=Homo sapiens OX=9606 GN=MED8 PE=1 SV=2
1336,2004,sp|P14543-2|NID1_HUMAN,4.47,109.82,2.314E6,2.366E6,2.835E6,2.776E6,1.00,1.02,1.23,1.20,2.314E6,2.366E6,2.835E6,2.776E6,1.00,1.02,1.23,1.20,8,7,7,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),122017,Isoform 2 of Nidogen-1 OS=Homo sapiens OX=9606 GN=NID1
1660,39147,sp|Q96AQ6-2|PBIP1_HUMAN,9.83,109.82,9.438E5,9.447E5,1.329E6,1.243E6,1.00,1.00,1.41,1.32,9.438E5,9.447E5,1.329E6,1.243E6,1.00,1.00,1.41,1.32,12,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),77684,Isoform 2 of Pre-B-cell leukemia transcription factor-interacting protein 1 OS=Homo sapiens OX=9606 GN=PBXIP1
1274,2644,sp|Q3V6T2-4|GRDN_HUMAN,15.97,109.76,1.621E6,1.64E6,3.037E6,2.975E6,1.00,1.01,1.87,1.84,1.621E6,1.64E6,3.037E6,2.975E6,1.00,1.01,1.87,1.84,6,9,9,iTRAQ 4plex (K  N-term),212532,Isoform 4 of Girdin OS=Homo sapiens OX=9606 GN=CCDC88A
1193,21292,sp|Q9ULX6-2|AKP8L_HUMAN,13.22,109.66,3.994E6,4.14E6,6.667E6,6.553E6,1.00,1.04,1.67,1.64,3.994E6,4.14E6,6.667E6,6.553E6,1.00,1.04,1.67,1.64,15,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),65221,Isoform 2 of A-kinase anchor protein 8-like OS=Homo sapiens OX=9606 GN=AKAP8L
1516,12334,sp|P61964|WDR5_HUMAN,12.30,109.64,3.921E6,4.037E6,5.731E6,5.586E6,1.00,1.03,1.46,1.42,3.921E6,4.037E6,5.731E6,5.586E6,1.00,1.03,1.46,1.42,20,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),36589,WD repeat-containing protein 5 OS=Homo sapiens OX=9606 GN=WDR5 PE=1 SV=1
1361,24095,sp|O00299|CLIC1_HUMAN,9.55,109.58,1.55E6,1.445E6,2.007E6,2.072E6,1.00,0.93,1.30,1.34,1.55E6,1.445E6,2.007E6,2.072E6,1.00,0.93,1.30,1.34,32,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),26923,Chloride intracellular channel protein 1 OS=Homo sapiens OX=9606 GN=CLIC1 PE=1 SV=4
1630,39145,sp|P39656-3|OST48_HUMAN,17.17,109.53,2.807E6,2.819E6,4.552E6,4.441E6,1.00,1.00,1.62,1.58,2.807E6,2.819E6,4.552E6,4.441E6,1.00,1.00,1.62,1.58,14,6,6,iTRAQ 4plex (K  N-term),49020,Isoform 3 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens OX=9606 GN=DDOST
743,12052,sp|P62888|RL30_HUMAN,8.20,109.49,2.382E7,2.332E7,3.033E7,3.145E7,1.00,0.98,1.27,1.32,2.382E7,2.332E7,3.033E7,3.145E7,1.00,0.98,1.27,1.32,37,6,6,iTRAQ 4plex (K  N-term); Oxidation (M),12784,60S ribosomal protein L30 OS=Homo sapiens OX=9606 GN=RPL30 PE=1 SV=2
1259,10808,sp|P28482|MK01_HUMAN,25.70,109.48,4.214E6,4.264E6,8.89E6,8.82E6,1.00,1.01,2.11,2.09,4.214E6,4.264E6,8.89E6,8.82E6,1.00,1.01,2.11,2.09,18,8,6,iTRAQ 4plex (K  N-term),41390,Mitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3
165,21206,gi|121088|sp|P01870.1|IGHG_RABIT,7.23,109.45,7.31E5,7.195E5,1.252E6,1.138E6,1.00,0.98,1.71,1.56,7.31E5,7.195E5,1.252E6,1.138E6,1.00,0.98,1.71,1.56,10,8,3,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),35404,RecName: Full=Ig gamma chain C region
938,6528,sp|P32119|PRDX2_HUMAN,12.57,109.36,1.038E7,1.055E7,1.627E7,1.589E7,1.00,1.02,1.57,1.53,1.038E7,1.055E7,1.627E7,1.589E7,1.00,1.02,1.57,1.53,21,7,5,iTRAQ 4plex (K  N-term),21892,Peroxiredoxin-2 OS=Homo sapiens OX=9606 GN=PRDX2 PE=1 SV=5
778,7600,J3QT27|J3QT27_HUMAN,1.57,109.34,4.046E4,4.403E4,6.935E4,6.622E4,1.00,1.09,1.71,1.64,4.046E4,4.403E4,6.935E4,6.622E4,1.00,1.09,1.71,1.64,3,5,1,iTRAQ 4plex (K  N-term),34386,Poly(rC)-binding protein 3 (Fragment) OS=Homo sapiens OX=9606 GN=PCBP3 PE=1 SV=1
1757,39236,sp|Q9Y450|HBS1L_HUMAN,16.79,109.33,1.028E6,1.015E6,1.647E6,1.591E6,1.00,0.99,1.60,1.55,1.028E6,1.015E6,1.647E6,1.591E6,1.00,0.99,1.60,1.55,12,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),75473,HBS1-like protein OS=Homo sapiens OX=9606 GN=HBS1L PE=1 SV=1
1419,4721,sp|Q9UGJ1-2|GCP4_HUMAN,14.55,109.23,2.032E6,1.961E6,3.122E6,3.135E6,1.00,0.97,1.54,1.54,2.032E6,1.961E6,3.122E6,3.135E6,1.00,0.97,1.54,1.54,10,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),76018,Isoform 2 of Gamma-tubulin complex component 4 OS=Homo sapiens OX=9606 GN=TUBGCP4
1076,12831,sp|Q9UKU9|ANGL2_HUMAN,4.61,109.17,7.006E6,6.985E6,8.314E6,8.911E6,1.00,1.00,1.19,1.27,7.006E6,6.985E6,8.314E6,8.911E6,1.00,1.00,1.19,1.27,20,9,9,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ),57105,Angiopoietin-related protein 2 OS=Homo sapiens OX=9606 GN=ANGPTL2 PE=1 SV=1
1343,18062,sp|P15884-9|ITF2_HUMAN,18.30,109.04,4.84E5,4.829E5,8.46E5,7.964E5,1.00,1.00,1.75,1.65,4.84E5,4.829E5,8.46E5,7.964E5,1.00,1.00,1.75,1.65,11,6,5,iTRAQ 4plex (K  N-term),57425,Isoform D- of Transcription factor 4 OS=Homo sapiens OX=9606 GN=TCF4
1352,20075,sp|Q01968-2|OCRL_HUMAN,22.28,109.04,2.151E6,2.314E6,4.313E6,4.595E6,1.00,1.08,2.01,2.14,2.151E6,2.314E6,4.313E6,4.595E6,1.00,1.08,2.01,2.14,8,7,7,iTRAQ 4plex (K  N-term),103227,Isoform B of Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens OX=9606 GN=OCRL
1450,21422,sp|Q96KR1|ZFR_HUMAN,16.93,108.94,7.738E5,7.521E5,1.344E6,1.293E6,1.00,0.97,1.74,1.67,7.738E5,7.521E5,1.344E6,1.293E6,1.00,0.97,1.74,1.67,6,6,5,iTRAQ 4plex (K  N-term),117012,Zinc finger RNA-binding protein OS=Homo sapiens OX=9606 GN=ZFR PE=1 SV=2
897,20038,gi|548502304|ref|XP_005691794.1|,7.88,108.84,3.139E7,3.305E7,9.518E7,8.951E7,1.00,1.05,3.03,2.85,3.139E7,3.305E7,9.518E7,8.951E7,1.00,1.05,3.03,2.85,29,6,5,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ),24542,PREDICTED: immunoglobulin lambda-like polypeptide 1-like isoform X1 [Capra hircus]
1747,3696,sp|Q86YV5|PRAG1_HUMAN,23.69,108.84,1.091E6,1.046E6,1.9E6,1.813E6,1.00,0.96,1.74,1.66,1.091E6,1.046E6,1.9E6,1.813E6,1.00,0.96,1.74,1.66,5,4,4,iTRAQ 4plex (K  N-term),149623,Inactive tyrosine-protein kinase PRAG1 OS=Homo sapiens OX=9606 GN=PRAG1 PE=1 SV=4
1764,21103,sp|Q6ZW49|PAXI1_HUMAN,16.05,108.78,1.62E6,1.734E6,2.54E6,2.394E6,1.00,1.07,1.57,1.48,1.62E6,1.734E6,2.54E6,2.394E6,1.00,1.07,1.57,1.48,6,5,5,iTRAQ 4plex (K  N-term),121341,PAX-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAXIP1 PE=1 SV=2
1540,19735,sp|Q9H814|PHAX_HUMAN,14.66,108.69,6.734E5,6.863E5,1.083E6,1.04E6,1.00,1.02,1.61,1.55,6.734E5,6.863E5,1.083E6,1.04E6,1.00,1.02,1.61,1.55,19,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),44403,Phosphorylated adapter RNA export protein OS=Homo sapiens OX=9606 GN=PHAX PE=1 SV=1
1593,21222,sp|P48444|COPD_HUMAN,5.13,108.63,2.686E6,2.579E6,3.349E6,3.357E6,1.00,0.96,1.25,1.25,2.686E6,2.579E6,3.349E6,3.357E6,1.00,0.96,1.25,1.25,15,7,7,iTRAQ 4plex (K  N-term),57210,Coatomer subunit delta OS=Homo sapiens OX=9606 GN=ARCN1 PE=1 SV=1
1015,39315,K7EQJ5|K7EQJ5_HUMAN,13.76,108.60,1.939E7,1.936E7,2.773E7,2.925E7,1.00,1.00,1.43,1.51,1.939E7,1.936E7,2.773E7,2.925E7,1.00,1.00,1.43,1.51,43,6,6,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),16571,40S ribosomal protein S15 OS=Homo sapiens OX=9606 GN=RPS15 PE=1 SV=2
1302,39022,sp|P05120|PAI2_HUMAN,5.70,108.48,1.962E6,2.026E6,2.597E6,2.51E6,1.00,1.03,1.32,1.28,1.962E6,2.026E6,2.597E6,2.51E6,1.00,1.03,1.32,1.28,19,7,7,iTRAQ 4plex (K  N-term),46596,Plasminogen activator inhibitor 2 OS=Homo sapiens OX=9606 GN=SERPINB2 PE=1 SV=2
1351,22296,sp|Q13613|MTMR1_HUMAN,17.01,108.47,3.274E6,3.556E6,4.963E6,5.362E6,1.00,1.09,1.52,1.64,3.274E6,3.556E6,4.963E6,5.362E6,1.00,1.09,1.52,1.64,10,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),74678,Myotubularin-related protein 1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4
1265,22474,A0A087WUQ6|A0A087WUQ6_HUMAN,12.92,108.43,2.827E6,2.836E6,4.39E6,4.383E6,1.00,1.00,1.55,1.55,2.827E6,2.836E6,4.39E6,4.383E6,1.00,1.00,1.55,1.55,33,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),21938,Glutathione peroxidase OS=Homo sapiens OX=9606 GN=GPX1 PE=1 SV=1
1944,8832,sp|Q96SB3|NEB2_HUMAN,9.94,108.42,6.125E5,5.993E5,7.654E5,8.481E5,1.00,0.98,1.25,1.38,6.125E5,5.993E5,7.654E5,8.481E5,1.00,0.98,1.25,1.38,7,4,4,iTRAQ 4plex (K  N-term),89192,Neurabin-2 OS=Homo sapiens OX=9606 GN=PPP1R9B PE=1 SV=2
1268,39618,sp|Q92504|S39A7_HUMAN,40.03,108.27,1.912E6,1.95E6,4.136E6,4.052E6,1.00,1.02,2.16,2.12,1.912E6,1.95E6,4.136E6,4.052E6,1.00,1.02,2.16,2.12,10,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),50118,Zinc transporter SLC39A7 OS=Homo sapiens OX=9606 GN=SLC39A7 PE=1 SV=2
1133,39044,sp|P27658|CO8A1_HUMAN,24.99,108.25,8.338E6,8.716E6,1.612E7,1.604E7,1.00,1.05,1.93,1.92,8.338E6,8.716E6,1.612E7,1.604E7,1.00,1.05,1.93,1.92,9,7,7,iTRAQ 4plex (K  N-term),73364,Collagen alpha-1(VIII) chain OS=Homo sapiens OX=9606 GN=COL8A1 PE=1 SV=2
1724,39238,sp|P48047|ATPO_HUMAN,25.41,108.11,2.531E6,2.55E6,4.57E6,4.734E6,1.00,1.01,1.81,1.87,2.531E6,2.55E6,4.57E6,4.734E6,1.00,1.01,1.81,1.87,24,5,5,iTRAQ 4plex (K  N-term),23277,ATP synthase subunit O  mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PO PE=1 SV=1
1261,20054,sp|Q8NHV4|NEDD1_HUMAN,23.56,108.03,3.03E6,2.986E6,5.771E6,5.396E6,1.00,0.99,1.90,1.78,3.03E6,2.986E6,5.771E6,5.396E6,1.00,0.99,1.90,1.78,11,8,8,iTRAQ 4plex (K  N-term),71966,Protein NEDD1 OS=Homo sapiens OX=9606 GN=NEDD1 PE=1 SV=1
1710,39447,E5RHG8|E5RHG8_HUMAN,6.07,107.93,2.898E6,2.934E6,3.638E6,3.474E6,1.00,1.01,1.26,1.20,2.898E6,2.934E6,3.638E6,3.474E6,1.00,1.01,1.26,1.20,57,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),9960,Elongin-C (Fragment) OS=Homo sapiens OX=9606 GN=ELOC PE=1 SV=1
1567,14412,sp|Q96QB1|RHG07_HUMAN,20.54,107.91,1.335E6,1.331E6,2.491E6,2.528E6,1.00,1.00,1.87,1.89,1.335E6,1.331E6,2.491E6,2.528E6,1.00,1.00,1.87,1.89,4,5,5,iTRAQ 4plex (K  N-term),170591,Rho GTPase-activating protein 7 OS=Homo sapiens OX=9606 GN=DLC1 PE=1 SV=4
1699,39110,sp|Q4G0J3|LARP7_HUMAN,44.37,107.74,1.146E6,1.175E6,2.835E6,3.124E6,1.00,1.03,2.47,2.73,1.146E6,1.175E6,2.835E6,3.124E6,1.00,1.03,2.47,2.73,12,6,6,iTRAQ 4plex (K  N-term),66899,La-related protein 7 OS=Homo sapiens OX=9606 GN=LARP7 PE=1 SV=1
1363,5780,sp|Q53ET0|CRTC2_HUMAN,25.80,107.71,1.24E6,1.346E6,2.785E6,2.783E6,1.00,1.09,2.24,2.24,1.24E6,1.346E6,2.785E6,2.783E6,1.00,1.09,2.24,2.24,15,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),73302,CREB-regulated transcription coactivator 2 OS=Homo sapiens OX=9606 GN=CRTC2 PE=1 SV=2
987,19768,sp|P15927|RFA2_HUMAN,52.15,107.70,5.674E6,4.866E6,1.145E7,1.113E7,1.00,0.86,2.02,1.96,5.674E6,4.866E6,1.145E7,1.113E7,1.00,0.86,2.02,1.96,19,4,4,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),29247,Replication protein A 32 kDa subunit OS=Homo sapiens OX=9606 GN=RPA2 PE=1 SV=1
1022,20196,C9J0J7|C9J0J7_HUMAN,31.43,107.66,6.137E6,6.312E6,1.216E7,1.117E7,1.00,1.03,1.98,1.82,6.137E6,6.312E6,1.216E7,1.117E7,1.00,1.03,1.98,1.82,57,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),9840,Profilin OS=Homo sapiens OX=9606 GN=PFN2 PE=1 SV=1
823,4171,sp|Q16629-4|SRSF7_HUMAN,11.52,107.56,1.088E7,1.143E7,1.611E7,1.586E7,1.00,1.05,1.48,1.46,1.088E7,1.143E7,1.611E7,1.586E7,1.00,1.05,1.48,1.46,16,6,4,iTRAQ 4plex (K  N-term); Phosphorylation (STY),26012,Isoform 4 of Serine/arginine-rich splicing factor 7 OS=Homo sapiens OX=9606 GN=SRSF7
1673,39165,sp|Q04721|NOTC2_HUMAN,16.04,107.53,1.285E6,1.241E6,2.039E6,1.969E6,1.00,0.97,1.59,1.53,1.285E6,1.241E6,2.039E6,1.969E6,1.00,0.97,1.59,1.53,2,6,5,iTRAQ 4plex (K  N-term); Oxidation (M),265403,Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3
1486,18708,sp|Q13547|HDAC1_HUMAN,27.07,107.48,1.264E6,1.274E6,2.553E6,2.576E6,1.00,1.01,2.02,2.04,1.264E6,1.274E6,2.553E6,2.576E6,1.00,1.01,2.02,2.04,7,5,3,iTRAQ 4plex (K  N-term),55103,Histone deacetylase 1 OS=Homo sapiens OX=9606 GN=HDAC1 PE=1 SV=1
1409,10810,sp|Q9BYD2|RM09_HUMAN,13.74,107.47,1.962E6,1.859E6,3.082E6,3.09E6,1.00,0.95,1.57,1.58,1.962E6,1.859E6,3.082E6,3.09E6,1.00,0.95,1.57,1.58,23,7,6,iTRAQ 4plex (K  N-term),30243,39S ribosomal protein L9  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL9 PE=1 SV=2
1851,3876,sp|Q8WUZ0|BCL7C_HUMAN,4.47,107.46,4.387E5,4.577E5,5.412E5,5.41E5,1.00,1.04,1.23,1.23,4.387E5,4.577E5,5.412E5,5.41E5,1.00,1.04,1.23,1.23,29,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),23468,B-cell CLL/lymphoma 7 protein family member C OS=Homo sapiens OX=9606 GN=BCL7C PE=1 SV=3
1561,39060,sp|Q9H4A3-5|WNK1_HUMAN,23.96,107.22,7.432E5,7.036E5,1.404E6,1.364E6,1.00,0.95,1.89,1.83,7.432E5,7.036E5,1.404E6,1.364E6,1.00,0.95,1.89,1.83,3,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),279535,Isoform 4 of Serine/threonine-protein kinase WNK1 OS=Homo sapiens OX=9606 GN=WNK1
1686,39054,sp|O95340|PAPS2_HUMAN,31.92,107.20,1.771E6,1.797E6,4.209E6,4.453E6,1.00,1.01,2.38,2.51,1.771E6,1.797E6,4.209E6,4.453E6,1.00,1.01,2.38,2.51,11,6,6,iTRAQ 4plex (K  N-term),69501,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 OS=Homo sapiens OX=9606 GN=PAPSS2 PE=1 SV=2
1667,39048,sp|Q8IVT5|KSR1_HUMAN,21.52,107.00,9.465E5,9.636E5,1.888E6,1.788E6,1.00,1.02,1.99,1.89,9.465E5,9.636E5,1.888E6,1.788E6,1.00,1.02,1.99,1.89,7,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),102160,Kinase suppressor of Ras 1 OS=Homo sapiens OX=9606 GN=KSR1 PE=1 SV=3
802,4051,A0A0C4DGB6|A0A0C4DGB6_HUMAN,40.19,106.90,4.013E6,4.341E6,2.77E7,2.505E7,1.00,1.08,6.90,6.24,4.013E6,4.341E6,2.77E7,2.505E7,1.00,1.08,6.90,6.24,3,5,2,iTRAQ 4plex (K  N-term),69227,Serum albumin OS=Homo sapiens OX=9606 GN=ALB PE=1 SV=1
1106,20957,sp|P48059-3|LIMS1_HUMAN,19.93,106.86,3.638E6,3.516E6,6.173E6,5.931E6,1.00,0.97,1.70,1.63,3.638E6,3.516E6,6.173E6,5.931E6,1.00,0.97,1.70,1.63,14,7,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),44390,Isoform 3 of LIM and senescent cell antigen-like-containing domain protein 1 OS=Homo sapiens OX=9606 GN=LIMS1
1441,4499,A2IDA3|A2IDA3_HUMAN,30.12,106.75,2.206E6,2.202E6,4.695E6,4.607E6,1.00,1.00,2.13,2.09,2.206E6,2.202E6,4.695E6,4.607E6,1.00,1.00,2.13,2.09,21,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),27295,DNA-3-methyladenine glycosylase (Fragment) OS=Homo sapiens OX=9606 GN=MPG PE=1 SV=1
1161,19912,C9JLU1|C9JLU1_HUMAN,30.38,106.73,2.634E6,2.862E6,5.253E6,5.092E6,1.00,1.09,1.99,1.93,2.634E6,2.862E6,5.253E6,5.092E6,1.00,1.09,1.99,1.93,39,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),16925,DNA-directed RNA polymerases I  II  and III subunit RPABC3 (Fragment) OS=Homo sapiens OX=9606 GN=POLR2H PE=1 SV=8
1301,18371,sp|Q9HAK2|COE2_HUMAN,4.12,106.71,4.315E5,4.652E5,6.837E5,7.207E5,1.00,1.08,1.58,1.67,4.315E5,4.652E5,6.837E5,7.207E5,1.00,1.08,1.58,1.67,3,7,2,iTRAQ 4plex (K  N-term),62650,Transcription factor COE2 OS=Homo sapiens OX=9606 GN=EBF2 PE=2 SV=4
1406,39018,sp|P17480|UBF1_HUMAN,10.03,106.66,2.291E6,2.206E6,2.92E6,3.356E6,1.00,0.96,1.27,1.46,2.291E6,2.206E6,2.92E6,3.356E6,1.00,0.96,1.27,1.46,11,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),89406,Nucleolar transcription factor 1 OS=Homo sapiens OX=9606 GN=UBTF PE=1 SV=1
710,11238,Q5VVC8|Q5VVC8_HUMAN,19.80,106.66,7.77E7,7.846E7,1.101E8,1.176E8,1.00,1.01,1.42,1.51,7.77E7,7.846E7,1.101E8,1.176E8,1.00,1.01,1.42,1.51,29,6,6,iTRAQ 4plex (K  N-term),19024,60S ribosomal protein L11 OS=Homo sapiens OX=9606 GN=RPL11 PE=1 SV=2
1380,7952,sp|Q14643-4|ITPR1_HUMAN,10.89,106.61,1.064E6,1.079E6,1.515E6,1.633E6,1.00,1.01,1.42,1.53,1.064E6,1.079E6,1.515E6,1.633E6,1.00,1.01,1.42,1.53,2,7,5,iTRAQ 4plex (K  N-term),306772,Isoform 4 of Inositol 1 4 5-trisphosphate receptor type 1 OS=Homo sapiens OX=9606 GN=ITPR1
522,19847,sp|P46779|RL28_HUMAN,10.34,106.58,4.931E7,4.948E7,6.529E7,7.057E7,1.00,1.00,1.32,1.43,4.931E7,4.948E7,6.529E7,7.057E7,1.00,1.00,1.32,1.43,39,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),15747,60S ribosomal protein L28 OS=Homo sapiens OX=9606 GN=RPL28 PE=1 SV=3
1437,7070,C9JP16|C9JP16_HUMAN,13.78,106.52,5.288E6,4.756E6,8.236E6,8.41E6,1.00,0.90,1.56,1.59,5.288E6,4.756E6,8.236E6,8.41E6,1.00,0.90,1.56,1.59,21,9,9,iTRAQ 4plex (K  N-term),41433,Cartilage-associated protein OS=Homo sapiens OX=9606 GN=CRTAP PE=1 SV=1
1813,39194,sp|Q96NE9-2|FRMD6_HUMAN,15.90,106.41,6.341E5,6.333E5,1.113E6,1.09E6,1.00,1.00,1.75,1.72,6.341E5,6.333E5,1.113E6,1.09E6,1.00,1.00,1.75,1.72,10,5,5,iTRAQ 4plex (K  N-term),70982,Isoform 2 of FERM domain-containing protein 6 OS=Homo sapiens OX=9606 GN=FRMD6
1531,8985,sp|Q14678|KANK1_HUMAN,25.90,106.31,5.783E5,6.086E5,1.337E6,1.314E6,1.00,1.05,2.31,2.27,5.783E5,6.086E5,1.337E6,1.314E6,1.00,1.05,2.31,2.27,4,7,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),147289,KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KANK1 PE=1 SV=3
1960,39428,sp|Q8TDX7|NEK7_HUMAN,23.38,106.24,1.577E6,1.596E6,2.791E6,2.747E6,1.00,1.01,1.77,1.74,1.577E6,1.596E6,2.791E6,2.747E6,1.00,1.01,1.77,1.74,17,4,4,iTRAQ 4plex (K  N-term),34551,Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1
1722,13069,sp|Q96AX9-10|MIB2_HUMAN,11.15,106.22,1.946E6,1.793E6,2.789E6,2.629E6,1.00,0.92,1.43,1.35,1.946E6,1.793E6,2.789E6,2.629E6,1.00,0.92,1.43,1.35,11,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),82129,Isoform 10 of E3 ubiquitin-protein ligase MIB2 OS=Homo sapiens OX=9606 GN=MIB2
1021,5653,sp|Q96HS1-2|PGAM5_HUMAN,11.60,106.11,9.199E6,9.197E6,1.324E7,1.316E7,1.00,1.00,1.44,1.43,9.199E6,9.197E6,1.324E7,1.316E7,1.00,1.00,1.44,1.43,31,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),28020,Isoform 2 of Serine/threonine-protein phosphatase PGAM5  mitochondrial OS=Homo sapiens OX=9606 GN=PGAM5
1244,20675,A0A2R8Y7M3|A0A2R8Y7M3_HUMAN,5.20,106.05,5.379E5,4.984E5,9.134E5,8.814E5,1.00,0.93,1.70,1.64,5.379E5,4.984E5,9.134E5,8.814E5,1.00,0.93,1.70,1.64,4,8,2,iTRAQ 4plex (K  N-term),62931,Radixin OS=Homo sapiens OX=9606 GN=RDX PE=1 SV=1
1846,17612,G3V1D4|G3V1D4_HUMAN,18.07,106.05,1.376E6,1.451E6,2.394E6,2.389E6,1.00,1.05,1.74,1.74,1.376E6,1.451E6,2.394E6,2.389E6,1.00,1.05,1.74,1.74,35,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),19186,Lin-7 homolog C (C. elegans)  isoform CRA_b OS=Homo sapiens OX=9606 GN=LIN7C PE=1 SV=1
1484,39132,sp|Q8ND04|SMG8_HUMAN,50.42,105.84,1.415E6,1.453E6,3.737E6,3.689E6,1.00,1.03,2.64,2.61,1.415E6,1.453E6,3.737E6,3.689E6,1.00,1.03,2.64,2.61,7,7,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),109684,Protein SMG8 OS=Homo sapiens OX=9606 GN=SMG8 PE=1 SV=1
1613,24247,sp|O60701-3|UGDH_HUMAN,19.88,105.79,8.817E5,8.871E5,1.538E6,1.474E6,1.00,1.01,1.74,1.67,8.817E5,8.871E5,1.538E6,1.474E6,1.00,1.01,1.74,1.67,16,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),44415,Isoform 3 of UDP-glucose 6-dehydrogenase OS=Homo sapiens OX=9606 GN=UGDH
1529,11872,sp|P43694|GATA4_HUMAN,26.48,105.68,4.052E5,3.811E5,8.557E5,8.495E5,1.00,0.94,2.11,2.10,4.052E5,3.811E5,8.557E5,8.495E5,1.00,0.94,2.11,2.10,39,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),44565,Transcription factor GATA-4 OS=Homo sapiens OX=9606 GN=GATA4 PE=1 SV=2
623,14534,sp|P47914|RL29_HUMAN,16.65,105.67,2.032E7,2.157E7,2.788E7,3.027E7,1.00,1.06,1.37,1.49,2.032E7,2.157E7,2.788E7,3.027E7,1.00,1.06,1.37,1.49,24,5,5,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),17752,60S ribosomal protein L29 OS=Homo sapiens OX=9606 GN=RPL29 PE=1 SV=2
1575,16938,sp|Q8NC56|LEMD2_HUMAN,16.68,105.65,1.002E6,1.026E6,1.769E6,1.91E6,1.00,1.02,1.77,1.91,1.002E6,1.026E6,1.769E6,1.91E6,1.00,1.02,1.77,1.91,15,7,7,iTRAQ 4plex (K  N-term),56975,LEM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=LEMD2 PE=1 SV=1
1655,5700,E9PF63|E9PF63_HUMAN,8.38,105.64,3.789E5,3.94E5,5.93E5,5.943E5,1.00,1.04,1.56,1.57,3.789E5,3.94E5,5.93E5,5.943E5,1.00,1.04,1.56,1.57,3,6,3,iTRAQ 4plex (K  N-term),133266,Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=1
1400,39006,E7EQL8|E7EQL8_HUMAN,14.88,105.56,1.781E6,1.81E6,3.072E6,3.007E6,1.00,1.02,1.72,1.69,1.781E6,1.81E6,3.072E6,3.007E6,1.00,1.02,1.72,1.69,6,8,8,iTRAQ 4plex (K  N-term),163907,Gamma-tubulin complex component 6 OS=Homo sapiens OX=9606 GN=TUBGCP6 PE=1 SV=1
1194,20082,A0A3B3IU46|A0A3B3IU46_HUMAN,34.48,105.54,1.082E7,1.101E7,2.13E7,2.099E7,1.00,1.02,1.97,1.94,1.082E7,1.101E7,2.13E7,2.099E7,1.00,1.02,1.97,1.94,37,4,4,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),14367,RNA guanine-7 methyltransferase-activating subunit-like (pseudogene) OS=Homo sapiens OX=9606 GN=RAMACL PE=4 SV=1
1049,21333,H7C4T5|H7C4T5_HUMAN,3.85,105.53,3.194E4,3.529E4,5.4E4,4.595E4,1.00,1.10,1.69,1.44,3.194E4,3.529E4,5.4E4,4.595E4,1.00,1.10,1.69,1.44,10,7,2,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),35829,Muscleblind-like protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=MBNL1 PE=1 SV=1
1834,22394,sp|Q93062-4|RBPMS_HUMAN,22.96,105.47,1.254E6,1.313E6,2.285E6,2.218E6,1.00,1.05,1.82,1.77,1.254E6,1.313E6,2.285E6,2.218E6,1.00,1.05,1.82,1.77,37,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),15794,Isoform D of RNA-binding protein with multiple splicing OS=Homo sapiens OX=9606 GN=RBPMS
1678,19904,sp|Q16543|CDC37_HUMAN,20.70,105.39,1.45E6,1.427E6,2.485E6,2.459E6,1.00,0.98,1.71,1.70,1.45E6,1.427E6,2.485E6,2.459E6,1.00,0.98,1.71,1.70,15,4,4,iTRAQ 4plex (K  N-term),44468,Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1
1688,8088,A0A087X0G7|A0A087X0G7_HUMAN,16.20,105.38,2.473E6,2.542E6,3.895E6,3.881E6,1.00,1.03,1.57,1.57,2.473E6,2.542E6,3.895E6,3.881E6,1.00,1.03,1.57,1.57,16,5,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),47257,NF-kappa-B essential modulator OS=Homo sapiens OX=9606 GN=IKBKG PE=1 SV=1
1215,20036,sp|Q9Y3B4|SF3B6_HUMAN,9.75,105.36,2.936E6,2.858E6,4.092E6,3.994E6,1.00,0.97,1.39,1.36,2.936E6,2.858E6,4.092E6,3.994E6,1.00,0.97,1.39,1.36,33,5,5,iTRAQ 4plex (K  N-term),14585,Splicing factor 3B subunit 6 OS=Homo sapiens OX=9606 GN=SF3B6 PE=1 SV=1
1451,21304,sp|Q6P0Q8|MAST2_HUMAN,11.37,105.34,4.188E5,4.162E5,7.62E5,7.652E5,1.00,0.99,1.82,1.83,4.188E5,4.162E5,7.62E5,7.652E5,1.00,0.99,1.82,1.83,2,8,3,iTRAQ 4plex (K  N-term),196434,Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2
1269,12817,sp|P48643|TCPE_HUMAN,4.07,105.28,4.346E6,4.186E6,5.278E6,5.378E6,1.00,0.96,1.21,1.24,4.346E6,4.186E6,5.278E6,5.378E6,1.00,0.96,1.21,1.24,13,10,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),59671,T-complex protein 1 subunit epsilon OS=Homo sapiens OX=9606 GN=CCT5 PE=1 SV=1
1311,20983,sp|Q9UJU6|DBNL_HUMAN,7.32,105.23,1.011E6,1.01E6,1.384E6,1.344E6,1.00,1.00,1.37,1.33,1.011E6,1.01E6,1.384E6,1.344E6,1.00,1.00,1.37,1.33,15,5,5,iTRAQ 4plex (K  N-term),48207,Drebrin-like protein OS=Homo sapiens OX=9606 GN=DBNL PE=1 SV=1
508,19862,sp|P18077|RL35A_HUMAN,8.73,105.20,5.608E7,5.522E7,7.585E7,7.738E7,1.00,0.98,1.35,1.38,5.608E7,5.522E7,7.585E7,7.738E7,1.00,0.98,1.35,1.38,47,9,9,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),12538,60S ribosomal protein L35a OS=Homo sapiens OX=9606 GN=RPL35A PE=1 SV=2
1639,20598,sp|Q9BWJ5|SF3B5_HUMAN,10.51,105.07,3.292E6,3.492E6,4.581E6,4.341E6,1.00,1.06,1.39,1.32,3.292E6,3.492E6,4.581E6,4.341E6,1.00,1.06,1.39,1.32,38,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),10135,Splicing factor 3B subunit 5 OS=Homo sapiens OX=9606 GN=SF3B5 PE=1 SV=1
1700,39162,sp|O95292|VAPB_HUMAN,13.03,104.83,1.268E6,1.277E6,1.985E6,2.011E6,1.00,1.01,1.57,1.59,1.268E6,1.277E6,1.985E6,2.011E6,1.00,1.01,1.57,1.59,17,5,4,iTRAQ 4plex (K  N-term),27228,Vesicle-associated membrane protein-associated protein B/C OS=Homo sapiens OX=9606 GN=VAPB PE=1 SV=3
1648,20699,sp|Q93073|SBP2L_HUMAN,19.92,104.78,1.174E6,1.175E6,2.176E6,2.155E6,1.00,1.00,1.85,1.84,1.174E6,1.175E6,2.176E6,2.155E6,1.00,1.00,1.85,1.84,7,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),121776,Selenocysteine insertion sequence-binding protein 2-like OS=Homo sapiens OX=9606 GN=SECISBP2L PE=1 SV=3
1586,39052,sp|Q86YT6|MIB1_HUMAN,16.54,104.75,1.685E6,1.567E6,2.881E6,2.674E6,1.00,0.93,1.71,1.59,1.685E6,1.567E6,2.881E6,2.674E6,1.00,0.93,1.71,1.59,7,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),110136,E3 ubiquitin-protein ligase MIB1 OS=Homo sapiens OX=9606 GN=MIB1 PE=1 SV=1
1350,17615,sp|Q9BQ04|RBM4B_HUMAN,1.61,104.68,1.387E5,1.402E5,2.396E5,2.296E5,1.00,1.01,1.73,1.66,1.387E5,1.402E5,2.396E5,2.296E5,1.00,1.01,1.73,1.66,8,7,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),40150,RNA-binding protein 4B OS=Homo sapiens OX=9606 GN=RBM4B PE=1 SV=1
1885,4352,sp|P31629|ZEP2_HUMAN,42.61,104.67,5.632E5,5.655E5,1.223E6,1.139E6,1.00,1.00,2.17,2.02,5.632E5,5.655E5,1.223E6,1.139E6,1.00,1.00,2.17,2.02,3,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),269051,Transcription factor HIVEP2 OS=Homo sapiens OX=9606 GN=HIVEP2 PE=1 SV=2
964,9024,sp|Q9Y3U8|RL36_HUMAN,7.69,104.47,3.854E7,3.81E7,4.641E7,4.976E7,1.00,0.99,1.20,1.29,3.854E7,3.81E7,4.641E7,4.976E7,1.00,0.99,1.20,1.29,21,5,5,iTRAQ 4plex (K  N-term); Oxidation (M),12254,60S ribosomal protein L36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3
1742,8631,sp|P62314|SMD1_HUMAN,11.98,104.44,3.949E6,3.569E6,4.993E6,4.991E6,1.00,0.90,1.26,1.26,3.949E6,3.569E6,4.993E6,4.991E6,1.00,0.90,1.26,1.26,29,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),13282,Small nuclear ribonucleoprotein Sm D1 OS=Homo sapiens OX=9606 GN=SNRPD1 PE=1 SV=1
1366,20744,sp|P53007|TXTP_HUMAN,21.80,104.41,2.246E6,2.246E6,4.014E6,3.999E6,1.00,1.00,1.79,1.78,2.246E6,2.246E6,4.014E6,3.999E6,1.00,1.00,1.79,1.78,16,5,5,iTRAQ 4plex (K  N-term),34013,Tricarboxylate transport protein  mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A1 PE=1 SV=2
2107,7724,sp|Q9Y2U8|MAN1_HUMAN,24.75,104.34,4.338E5,4.323E5,7.78E5,7.383E5,1.00,1.00,1.79,1.70,4.338E5,4.323E5,7.78E5,7.383E5,1.00,1.00,1.79,1.70,5,3,3,iTRAQ 4plex (K  N-term),99997,Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2
1392,39246,J3KPP4|J3KPP4_HUMAN,22.03,104.27,2.736E6,2.814E6,4.801E6,4.542E6,1.00,1.03,1.75,1.66,2.736E6,2.814E6,4.801E6,4.542E6,1.00,1.03,1.75,1.66,10,5,4,iTRAQ 4plex (K  N-term),58220,Cisplatin resistance-associated overexpressed protein  isoform CRA_b OS=Homo sapiens OX=9606 GN=LUC7L3 PE=1 SV=1
1444,39439,sp|P04899|GNAI2_HUMAN,2.58,104.19,6.547E5,6.735E5,7.253E5,7.563E5,1.00,1.03,1.11,1.16,6.547E5,6.735E5,7.253E5,7.563E5,1.00,1.03,1.11,1.16,5,4,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),40451,Guanine nucleotide-binding protein G(i) subunit alpha-2 OS=Homo sapiens OX=9606 GN=GNAI2 PE=1 SV=3
1141,19261,sp|Q14766|LTBP1_HUMAN,5.18,104.16,9.869E6,9.718E6,1.176E7,1.297E7,1.00,0.98,1.19,1.31,9.869E6,9.718E6,1.176E7,1.297E7,1.00,0.98,1.19,1.31,5,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),186795,Latent-transforming growth factor beta-binding protein 1 OS=Homo sapiens OX=9606 GN=LTBP1 PE=1 SV=4
1391,8676,sp|O15037|KHNYN_HUMAN,22.41,104.11,1.417E6,1.412E6,2.688E6,2.691E6,1.00,1.00,1.90,1.90,1.417E6,1.412E6,2.688E6,2.691E6,1.00,1.00,1.90,1.90,9,5,5,iTRAQ 4plex (K  N-term),74534,Protein KHNYN OS=Homo sapiens OX=9606 GN=KHNYN PE=1 SV=3
2000,39772,A0A0G2JI36|A0A0G2JI36_HUMAN,0.41,103.94,4.189E5,4.415E5,4.886E5,4.786E5,1.00,1.05,1.17,1.14,4.189E5,4.415E5,4.886E5,4.786E5,1.00,1.05,1.17,1.14,4,3,1,iTRAQ 4plex (K  N-term),34216,HLA class I histocompatibility antigen  A-3 alpha chain OS=Homo sapiens OX=9606 GN=HLA-A PE=1 SV=1
1753,22231,sp|Q9H7U1-3|CCSE2_HUMAN,33.15,103.88,1.05E6,1.016E6,2.044E6,1.978E6,1.00,0.97,1.95,1.88,1.05E6,1.016E6,2.044E6,1.978E6,1.00,0.97,1.95,1.88,6,4,4,iTRAQ 4plex (K  N-term),116913,Isoform 3 of Serine-rich coiled-coil domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CCSER2
1385,6976,sp|Q9NYU1|UGGG2_HUMAN,14.90,103.86,3.089E6,3.016E6,5.266E6,5.369E6,1.00,0.98,1.70,1.74,3.089E6,3.016E6,5.266E6,5.369E6,1.00,0.98,1.70,1.74,4,8,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),174734,UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens OX=9606 GN=UGGT2 PE=1 SV=4
1850,20084,sp|O75616|ERAL1_HUMAN,15.57,103.78,1.557E6,1.665E6,2.61E6,2.544E6,1.00,1.07,1.68,1.63,1.557E6,1.665E6,2.61E6,2.544E6,1.00,1.07,1.68,1.63,12,4,4,iTRAQ 4plex (K  N-term),48350,GTPase Era  mitochondrial OS=Homo sapiens OX=9606 GN=ERAL1 PE=1 SV=2
827,22803,sp|P62861|RS30_HUMAN,13.36,103.75,2.278E7,2.158E7,3.153E7,3.27E7,1.00,0.95,1.38,1.44,2.278E7,2.158E7,3.153E7,3.27E7,1.00,0.95,1.38,1.44,32,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),6648,40S ribosomal protein S30 OS=Homo sapiens OX=9606 GN=FAU PE=1 SV=1
1388,39024,sp|P20810-9|ICAL_HUMAN,12.49,103.71,8.128E5,8.139E5,1.36E6,1.369E6,1.00,1.00,1.67,1.68,8.128E5,8.139E5,1.36E6,1.369E6,1.00,1.00,1.67,1.68,11,7,7,iTRAQ 4plex (K  N-term),80265,Isoform 9 of Calpastatin OS=Homo sapiens OX=9606 GN=CAST
1652,17238,sp|Q9BY12-2|SCAPE_HUMAN,17.50,103.65,7.624E5,7.969E5,1.354E6,1.315E6,1.00,1.05,1.78,1.73,7.624E5,7.969E5,1.354E6,1.315E6,1.00,1.05,1.78,1.73,4,4,4,iTRAQ 4plex (K  N-term),142698,Isoform 2 of S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER
1493,20431,sp|P37802|TAGL2_HUMAN,13.57,103.62,2.151E6,2.072E6,3.491E6,3.434E6,1.00,0.96,1.62,1.60,2.151E6,2.072E6,3.491E6,3.434E6,1.00,0.96,1.62,1.60,28,6,5,iTRAQ 4plex (K  N-term),22391,Transgelin-2 OS=Homo sapiens OX=9606 GN=TAGLN2 PE=1 SV=3
1494,39140,A0A024RAC6|A0A024RAC6_HUMAN,8.26,103.53,1.736E6,1.755E6,2.281E6,2.467E6,1.00,1.01,1.31,1.42,1.736E6,1.755E6,2.281E6,2.467E6,1.00,1.01,1.31,1.42,10,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),87230,Elongin-A OS=Homo sapiens OX=9606 GN=ELOA PE=1 SV=1
1819,20653,sp|O14744-3|ANM5_HUMAN,22.51,103.50,1.988E6,1.992E6,3.173E6,3.095E6,1.00,1.00,1.60,1.56,1.988E6,1.992E6,3.173E6,3.095E6,1.00,1.00,1.60,1.56,8,4,4,iTRAQ 4plex (K  N-term),66311,Isoform 3 of Protein arginine N-methyltransferase 5 OS=Homo sapiens OX=9606 GN=PRMT5
1669,2271,A0A087WXD2|A0A087WXD2_HUMAN,22.47,103.41,9.553E5,9.561E5,1.938E6,1.82E6,1.00,1.00,2.03,1.91,9.553E5,9.561E5,1.938E6,1.82E6,1.00,1.00,2.03,1.91,11,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),106898,Membrane-associated guanylate kinase  WW and PDZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MAGI1 PE=1 SV=1
1349,16555,A0A087WVM4|A0A087WVM4_HUMAN,12.36,103.30,2.292E6,2.191E6,3.635E6,3.41E6,1.00,0.96,1.59,1.49,2.292E6,2.191E6,3.635E6,3.41E6,1.00,0.96,1.59,1.49,8,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),99312,Monofunctional C1-tetrahydrofolate synthase  mitochondrial OS=Homo sapiens OX=9606 GN=MTHFD1L PE=1 SV=1
1663,39348,sp|O43776|SYNC_HUMAN,8.63,103.11,1.199E6,1.409E6,1.644E6,1.632E6,1.00,1.17,1.37,1.36,1.199E6,1.409E6,1.644E6,1.632E6,1.00,1.17,1.37,1.36,12,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),62943,Asparagine--tRNA ligase  cytoplasmic OS=Homo sapiens OX=9606 GN=NARS PE=1 SV=1
1565,39331,sp|Q9H013-2|ADA19_HUMAN,45.82,103.02,8.505E5,7.864E5,1.71E6,1.627E6,1.00,0.92,2.01,1.91,8.505E5,7.864E5,1.71E6,1.627E6,1.00,0.92,2.01,1.91,6,4,4,iTRAQ 4plex (K  N-term),100848,Isoform B of Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens OX=9606 GN=ADAM19
1490,21952,A8MYV2|A8MYV2_HUMAN,17.90,102.99,9.5E5,9.893E5,1.774E6,1.801E6,1.00,1.04,1.87,1.90,9.5E5,9.893E5,1.774E6,1.801E6,1.00,1.04,1.87,1.90,14,6,3,iTRAQ 4plex (K  N-term),32447,LUC7-like (S. cerevisiae)  isoform CRA_f OS=Homo sapiens OX=9606 GN=LUC7L PE=1 SV=1
1537,20812,sp|Q9HBI1|PARVB_HUMAN,9.75,102.93,1.838E6,1.763E6,2.644E6,2.616E6,1.00,0.96,1.44,1.42,1.838E6,1.763E6,2.644E6,2.616E6,1.00,0.96,1.44,1.42,20,6,5,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),41714,Beta-parvin OS=Homo sapiens OX=9606 GN=PARVB PE=1 SV=1
1589,8872,sp|P42566|EPS15_HUMAN,9.38,102.88,8.602E5,8.3E5,1.196E6,1.249E6,1.00,0.96,1.39,1.45,8.602E5,8.3E5,1.196E6,1.249E6,1.00,0.96,1.39,1.45,8,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),98656,Epidermal growth factor receptor substrate 15 OS=Homo sapiens OX=9606 GN=EPS15 PE=1 SV=2
1407,3796,sp|Q9UL54-2|TAOK2_HUMAN,16.65,102.75,7.3E5,7.314E5,1.458E6,1.449E6,1.00,1.00,2.00,1.99,7.3E5,7.314E5,1.458E6,1.449E6,1.00,1.00,2.00,1.99,5,7,5,iTRAQ 4plex (K  N-term),119281,Isoform 2 of Serine/threonine-protein kinase TAO2 OS=Homo sapiens OX=9606 GN=TAOK2
1609,19703,sp|Q92552|RT27_HUMAN,21.40,102.74,2.44E6,2.469E6,5.105E6,4.878E6,1.00,1.01,2.09,2.00,2.44E6,2.469E6,5.105E6,4.878E6,1.00,1.01,2.09,2.00,21,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),47611,28S ribosomal protein S27  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS27 PE=1 SV=3
1491,3484,sp|Q6STE5-2|SMRD3_HUMAN,4.99,102.62,3.854E5,3.955E5,5.177E5,5.117E5,1.00,1.03,1.34,1.33,3.854E5,3.955E5,5.177E5,5.117E5,1.00,1.03,1.34,1.33,10,6,3,iTRAQ 4plex (K  N-term),53687,Isoform 2 of SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 OS=Homo sapiens OX=9606 GN=SMARCD3
1367,13672,sp|Q9NVP1|DDX18_HUMAN,16.23,102.60,1.413E6,1.196E6,1.845E6,1.933E6,1.00,0.85,1.31,1.37,1.413E6,1.196E6,1.845E6,1.933E6,1.00,0.85,1.31,1.37,7,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),75407,ATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2
1416,39040,sp|Q96A65|EXOC4_HUMAN,9.02,102.43,8.43E5,8.506E5,1.288E6,1.296E6,1.00,1.01,1.53,1.54,8.43E5,8.506E5,1.288E6,1.296E6,1.00,1.01,1.53,1.54,8,7,6,iTRAQ 4plex (K  N-term),110498,Exocyst complex component 4 OS=Homo sapiens OX=9606 GN=EXOC4 PE=1 SV=1
933,20074,sp|P62266|RS23_HUMAN,16.43,102.39,1.931E7,1.882E7,2.932E7,2.996E7,1.00,0.97,1.52,1.55,1.931E7,1.882E7,2.932E7,2.996E7,1.00,0.97,1.52,1.55,29,5,5,iTRAQ 4plex (K  N-term),15808,40S ribosomal protein S23 OS=Homo sapiens OX=9606 GN=RPS23 PE=1 SV=3
1372,21264,sp|Q99832-3|TCPH_HUMAN,10.35,102.23,4.242E6,3.81E6,5.539E6,5.626E6,1.00,0.90,1.31,1.33,4.242E6,3.81E6,5.539E6,5.626E6,1.00,0.90,1.31,1.33,11,6,6,iTRAQ 4plex (K  N-term),54804,Isoform 3 of T-complex protein 1 subunit eta OS=Homo sapiens OX=9606 GN=CCT7
1273,21122,sp|Q9NX63|MIC19_HUMAN,4.89,102.00,4.224E6,4.233E6,5.03E6,5.376E6,1.00,1.00,1.19,1.27,4.224E6,4.233E6,5.03E6,5.376E6,1.00,1.00,1.19,1.27,26,6,6,iTRAQ 4plex (K  N-term),26152,MICOS complex subunit MIC19 OS=Homo sapiens OX=9606 GN=CHCHD3 PE=1 SV=1
1383,2071,sp|Q504Q3-2|PAN2_HUMAN,9.71,101.83,2.228E6,2.187E6,3.437E6,3.384E6,1.00,0.98,1.54,1.52,2.228E6,2.187E6,3.437E6,3.384E6,1.00,0.98,1.54,1.52,5,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),135008,Isoform 2 of PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Homo sapiens OX=9606 GN=PAN2
1615,20664,sp|Q9HC44|GPBL1_HUMAN,34.06,101.61,1.629E6,1.678E6,3.605E6,3.417E6,1.00,1.03,2.21,2.10,1.629E6,1.678E6,3.605E6,3.417E6,1.00,1.03,2.21,2.10,11,4,4,iTRAQ 4plex (K  N-term),52302,Vasculin-like protein 1 OS=Homo sapiens OX=9606 GN=GPBP1L1 PE=1 SV=1
1462,11688,sp|O94906-2|PRP6_HUMAN,16.52,101.58,1.355E6,1.355E6,2.297E6,2.285E6,1.00,1.00,1.70,1.69,1.355E6,1.355E6,2.297E6,2.285E6,1.00,1.00,1.70,1.69,7,6,6,iTRAQ 4plex (K  N-term),102429,Isoform 2 of Pre-mRNA-processing factor 6 OS=Homo sapiens OX=9606 GN=PRPF6
1860,2256,sp|Q96CX2|KCD12_HUMAN,34.29,101.45,4.796E5,5.014E5,9.592E5,8.492E5,1.00,1.05,2.00,1.77,4.796E5,5.014E5,9.592E5,8.492E5,1.00,1.05,2.00,1.77,18,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),35701,BTB/POZ domain-containing protein KCTD12 OS=Homo sapiens OX=9606 GN=KCTD12 PE=1 SV=1
1766,12481,E9PIN3|E9PIN3_HUMAN,13.49,101.36,1.015E6,1.011E6,1.605E6,1.606E6,1.00,1.00,1.58,1.58,1.015E6,1.011E6,1.605E6,1.606E6,1.00,1.00,1.58,1.58,9,4,4,iTRAQ 4plex (K  N-term),68107,Nuclear RNA export factor 1 (Fragment) OS=Homo sapiens OX=9606 GN=NXF1 PE=1 SV=1
1251,39013,sp|Q96T37-4|RBM15_HUMAN,5.53,101.34,1.401E6,1.338E6,1.849E6,1.856E6,1.00,0.96,1.32,1.32,1.401E6,1.338E6,1.849E6,1.856E6,1.00,0.96,1.32,1.32,9,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),99701,Isoform 4 of RNA-binding protein 15 OS=Homo sapiens OX=9606 GN=RBM15
1681,19954,sp|Q96PU8-8|QKI_HUMAN,13.08,101.30,8.808E5,8.996E5,1.371E6,1.312E6,1.00,1.02,1.56,1.49,8.808E5,8.996E5,1.371E6,1.312E6,1.00,1.02,1.56,1.49,17,5,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),35248,Isoform 5 of Protein quaking OS=Homo sapiens OX=9606 GN=QKI
1664,21289,sp|P62191|PRS4_HUMAN,19.12,101.14,7.831E5,7.347E5,1.237E6,1.259E6,1.00,0.94,1.58,1.61,7.831E5,7.347E5,1.237E6,1.259E6,1.00,0.94,1.58,1.61,10,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),49185,26S proteasome regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMC1 PE=1 SV=1
1036,2836,sp|Q9UKA9|PTBP2_HUMAN,11.52,101.11,3.849E5,3.45E5,6.065E5,6.076E5,1.00,0.90,1.58,1.58,3.849E5,3.45E5,6.065E5,6.076E5,1.00,0.90,1.58,1.58,11,7,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),57491,Polypyrimidine tract-binding protein 2 OS=Homo sapiens OX=9606 GN=PTBP2 PE=1 SV=1
1736,22448,sp|A0JLT2|MED19_HUMAN,7.42,101.05,8.209E5,9.011E5,1.096E6,1.021E6,1.00,1.10,1.34,1.24,8.209E5,9.011E5,1.096E6,1.021E6,1.00,1.10,1.34,1.24,26,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),26273,Mediator of RNA polymerase II transcription subunit 19 OS=Homo sapiens OX=9606 GN=MED19 PE=1 SV=2
1576,26962,sp|Q9UJF2-2|NGAP_HUMAN,21.74,100.93,1.152E6,1.171E6,2.173E6,2.218E6,1.00,1.02,1.89,1.93,1.152E6,1.171E6,2.173E6,2.218E6,1.00,1.02,1.89,1.93,6,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),143899,Isoform 2 of Ras GTPase-activating protein nGAP OS=Homo sapiens OX=9606 GN=RASAL2
1684,20348,E9PHV4|E9PHV4_HUMAN,26.14,100.91,9.373E5,9.145E5,1.754E6,1.887E6,1.00,0.98,1.87,2.01,9.373E5,9.145E5,1.754E6,1.887E6,1.00,0.98,1.87,2.01,37,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),12777,DNA-directed RNA polymerase II subunit RPB4 OS=Homo sapiens OX=9606 GN=POLR2D PE=1 SV=1
1756,39203,sp|O95163|ELP1_HUMAN,10.33,100.91,8.585E5,8.628E5,1.3E6,1.338E6,1.00,1.01,1.51,1.56,8.585E5,8.628E5,1.3E6,1.338E6,1.00,1.01,1.51,1.56,7,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),150254,Elongator complex protein 1 OS=Homo sapiens OX=9606 GN=ELP1 PE=1 SV=3
1454,15814,sp|Q9Y678|COPG1_HUMAN,9.25,100.87,2.223E6,2.195E6,3.205E6,3.228E6,1.00,0.99,1.44,1.45,2.223E6,2.195E6,3.205E6,3.228E6,1.00,0.99,1.44,1.45,6,5,5,iTRAQ 4plex (K  N-term),97718,Coatomer subunit gamma-1 OS=Homo sapiens OX=9606 GN=COPG1 PE=1 SV=1
994,19798,sp|O15145|ARPC3_HUMAN,8.10,100.84,8.589E6,7.718E6,9.597E6,1.078E7,1.00,0.90,1.12,1.26,8.589E6,7.718E6,9.597E6,1.078E7,1.00,0.90,1.12,1.26,30,6,6,iTRAQ 4plex (K  N-term),20547,Actin-related protein 2/3 complex subunit 3 OS=Homo sapiens OX=9606 GN=ARPC3 PE=1 SV=3
1600,14135,sp|Q04864-2|REL_HUMAN,28.72,100.83,1.322E6,1.312E6,2.798E6,3.012E6,1.00,0.99,2.12,2.28,1.322E6,1.312E6,2.798E6,3.012E6,1.00,0.99,2.12,2.28,11,5,5,iTRAQ 4plex (K  N-term),65225,Isoform 2 of Proto-oncogene c-Rel OS=Homo sapiens OX=9606 GN=REL
170,21086,sp|P01861|IGHG4_HUMAN,51.55,100.77,1.894E7,1.819E7,6.526E6,5.56E6,1.00,0.96,0.34,0.29,1.894E7,1.819E7,6.526E6,5.56E6,1.00,0.96,0.34,0.29,10,7,2,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),35941,Immunoglobulin heavy constant gamma 4 OS=Homo sapiens OX=9606 GN=IGHG4 PE=1 SV=1
1086,20707,sp|P62807|H2B1C_HUMAN,1.42,100.76,2.495E6,2.766E6,3.455E6,4.001E6,1.00,1.11,1.38,1.60,2.495E6,2.766E6,3.455E6,4.001E6,1.00,1.11,1.38,1.60,7,8,1,iTRAQ 4plex (K  N-term),13906,Histone H2B type 1-C/E/F/G/I OS=Homo sapiens OX=9606 GN=HIST1H2BC PE=1 SV=4
1542,20873,sp|Q9BQ61|TRIR_HUMAN,13.84,100.76,1.174E6,1.164E6,2.033E6,2.011E6,1.00,0.99,1.73,1.71,1.174E6,1.164E6,2.033E6,2.011E6,1.00,0.99,1.73,1.71,36,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),18419,Telomerase RNA component interacting RNase OS=Homo sapiens OX=9606 GN=TRIR PE=1 SV=1
1205,19633,sp|Q9UKZ1|CNO11_HUMAN,30.40,100.73,1.8E6,1.927E6,4.008E6,3.999E6,1.00,1.07,2.23,2.22,1.8E6,1.927E6,4.008E6,3.999E6,1.00,1.07,2.23,2.22,13,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),55215,CCR4-NOT transcription complex subunit 11 OS=Homo sapiens OX=9606 GN=CNOT11 PE=1 SV=1
1512,6657,sp|Q96D71-2|REPS1_HUMAN,10.01,100.65,1.809E6,1.464E6,2.167E6,2.161E6,1.00,0.81,1.20,1.19,1.809E6,1.464E6,2.167E6,2.161E6,1.00,0.81,1.20,1.19,8,5,5,iTRAQ 4plex (K  N-term),76838,Isoform 2 of RalBP1-associated Eps domain-containing protein 1 OS=Homo sapiens OX=9606 GN=REPS1
1439,10425,sp|P85037|FOXK1_HUMAN,23.50,100.64,2.071E6,2.132E6,4.289E6,4.451E6,1.00,1.03,2.07,2.15,2.071E6,2.132E6,4.289E6,4.451E6,1.00,1.03,2.07,2.15,11,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),75457,Forkhead box protein K1 OS=Homo sapiens OX=9606 GN=FOXK1 PE=1 SV=1
1212,9487,sp|Q9NZR1|TMOD2_HUMAN,5.03,100.64,4.357E6,4.161E6,4.622E6,5.516E6,1.00,0.96,1.06,1.27,4.357E6,4.161E6,4.622E6,5.516E6,1.00,0.96,1.06,1.27,13,7,5,iTRAQ 4plex (K  N-term),39595,Tropomodulin-2 OS=Homo sapiens OX=9606 GN=TMOD2 PE=1 SV=1
1656,39298,H7BYN4|H7BYN4_HUMAN,18.23,100.59,5.051E5,4.916E5,8.921E5,8.65E5,1.00,0.97,1.77,1.71,5.051E5,4.916E5,8.921E5,8.65E5,1.00,0.97,1.77,1.71,4,5,3,iTRAQ 4plex (K  N-term),109130,Kinesin-like protein OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=1
1389,9981,sp|Q2KHR3-2|QSER1_HUMAN,44.98,100.58,5.105E5,4.9E5,1.625E6,1.614E6,1.00,0.96,3.18,3.16,5.105E5,4.9E5,1.625E6,1.614E6,1.00,0.96,3.18,3.16,6,7,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),168002,Isoform 2 of Glutamine and serine-rich protein 1 OS=Homo sapiens OX=9606 GN=QSER1
1536,7412,sp|Q9UBS4|DJB11_HUMAN,18.08,100.49,2.969E6,2.704E6,4.99E6,4.9E6,1.00,0.91,1.68,1.65,2.969E6,2.704E6,4.99E6,4.9E6,1.00,0.91,1.68,1.65,20,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),40514,DnaJ homolog subfamily B member 11 OS=Homo sapiens OX=9606 GN=DNAJB11 PE=1 SV=1
1582,39263,sp|Q10471|GALT2_HUMAN,22.85,100.23,1.028E6,1.057E6,2.02E6,1.876E6,1.00,1.03,1.97,1.82,1.028E6,1.057E6,2.02E6,1.876E6,1.00,1.03,1.97,1.82,11,6,6,iTRAQ 4plex (K  N-term),64733,Polypeptide N-acetylgalactosaminyltransferase 2 OS=Homo sapiens OX=9606 GN=GALNT2 PE=1 SV=1
1517,17641,sp|Q9GZV5|WWTR1_HUMAN,22.89,100.16,1.218E6,1.142E6,2.175E6,2.211E6,1.00,0.94,1.79,1.82,1.218E6,1.142E6,2.175E6,2.211E6,1.00,0.94,1.79,1.82,10,5,4,iTRAQ 4plex (K  N-term),44101,WW domain-containing transcription regulator protein 1 OS=Homo sapiens OX=9606 GN=WWTR1 PE=1 SV=1
174,20454,sp|P01859|IGHG2_HUMAN,3.31,99.86,9.855E4,1.097E5,4.01E4,4.054E4,1.00,1.11,0.41,0.41,9.855E4,1.097E5,4.01E4,4.054E4,1.00,1.11,0.41,0.41,9,7,1,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),35901,Immunoglobulin heavy constant gamma 2 OS=Homo sapiens OX=9606 GN=IGHG2 PE=1 SV=2
1077,21115,sp|P15311|EZRI_HUMAN,3.96,99.79,4.21E5,3.657E5,6.28E5,6.073E5,1.00,0.87,1.49,1.44,4.21E5,3.657E5,6.28E5,6.073E5,1.00,0.87,1.49,1.44,3,8,2,iTRAQ 4plex (K  N-term),69413,Ezrin OS=Homo sapiens OX=9606 GN=EZR PE=1 SV=4
1337,18189,sp|Q9UPQ0-10|LIMC1_HUMAN,6.80,99.79,1.773E6,1.741E6,2.226E6,2.435E6,1.00,0.98,1.26,1.37,1.773E6,1.741E6,2.226E6,2.435E6,1.00,0.98,1.26,1.37,7,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),118950,Isoform 10 of LIM and calponin homology domains-containing protein 1 OS=Homo sapiens OX=9606 GN=LIMCH1
758,20407,sp|P0CB38|PAB4L_HUMAN,1.19,99.74,3.584E5,3.68E5,5.438E5,5.409E5,1.00,1.03,1.52,1.51,3.584E5,3.68E5,5.438E5,5.409E5,1.00,1.03,1.52,1.51,2,5,1,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),41854,Polyadenylate-binding protein 4-like OS=Homo sapiens OX=9606 GN=PABPC4L PE=2 SV=1
1629,8427,sp|Q12872|SFSWA_HUMAN,15.43,99.61,2.398E6,2.621E6,4.426E6,4.189E6,1.00,1.09,1.85,1.75,2.398E6,2.621E6,4.426E6,4.189E6,1.00,1.09,1.85,1.75,9,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),104821,Splicing factor  suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3
1507,22427,sp|Q9H1I8|ASCC2_HUMAN,13.25,99.58,2.281E6,2.245E6,3.762E6,3.697E6,1.00,0.98,1.65,1.62,2.281E6,2.245E6,3.762E6,3.697E6,1.00,0.98,1.65,1.62,9,6,6,iTRAQ 4plex (K  N-term),86360,Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens OX=9606 GN=ASCC2 PE=1 SV=3
1668,19414,G8JLH9|G8JLH9_HUMAN,9.92,99.55,2.231E6,2.155E6,3.322E6,3.148E6,1.00,0.97,1.49,1.41,2.231E6,2.155E6,3.322E6,3.148E6,1.00,0.97,1.49,1.41,12,6,6,iTRAQ 4plex (K  N-term),76138,Signal transducer and activator of transcription OS=Homo sapiens OX=9606 GN=STAT3 PE=1 SV=1
1947,19675,sp|P62487|RPB7_HUMAN,40.63,99.45,4.52E5,4.273E5,9.878E5,8.901E5,1.00,0.95,2.19,1.97,4.52E5,4.273E5,9.878E5,8.901E5,1.00,0.95,2.19,1.97,27,4,4,iTRAQ 4plex (K  N-term),19294,DNA-directed RNA polymerase II subunit RPB7 OS=Homo sapiens OX=9606 GN=POLR2G PE=1 SV=1
1252,19102,sp|O60524-4|NEMF_HUMAN,7.05,99.40,5.73E6,4.676E6,6.627E6,6.566E6,1.00,0.82,1.16,1.15,5.73E6,4.676E6,6.627E6,6.566E6,1.00,0.82,1.16,1.15,8,9,9,iTRAQ 4plex (K  N-term),118025,Isoform 4 of Nuclear export mediator factor NEMF OS=Homo sapiens OX=9606 GN=NEMF
1485,39142,sp|Q6ZMP0|THSD4_HUMAN,22.93,99.35,2.528E6,2.5E6,4.71E6,4.598E6,1.00,0.99,1.86,1.82,2.528E6,2.5E6,4.71E6,4.598E6,1.00,0.99,1.86,1.82,6,6,6,iTRAQ 4plex (K  N-term),112450,Thrombospondin type-1 domain-containing protein 4 OS=Homo sapiens OX=9606 GN=THSD4 PE=2 SV=2
1779,39317,sp|P50579-3|MAP2_HUMAN,14.26,99.34,6.615E5,6.429E5,1.064E6,1.031E6,1.00,0.97,1.61,1.56,6.615E5,6.429E5,1.064E6,1.031E6,1.00,0.97,1.61,1.56,12,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),50497,Isoform 3 of Methionine aminopeptidase 2 OS=Homo sapiens OX=9606 GN=METAP2
1374,21185,sp|Q9H944|MED20_HUMAN,8.12,99.28,3.342E6,3.506E6,4.827E6,4.611E6,1.00,1.05,1.44,1.38,3.342E6,3.506E6,4.827E6,4.611E6,1.00,1.05,1.44,1.38,23,5,5,iTRAQ 4plex (K  N-term),23222,Mediator of RNA polymerase II transcription subunit 20 OS=Homo sapiens OX=9606 GN=MED20 PE=1 SV=1
1142,10278,sp|Q01130|SRSF2_HUMAN,11.07,99.20,9.227E6,9.084E6,1.22E7,1.194E7,1.00,0.98,1.32,1.29,9.227E6,9.084E6,1.22E7,1.194E7,1.00,0.98,1.32,1.29,22,5,5,iTRAQ 4plex (K  N-term),25476,Serine/arginine-rich splicing factor 2 OS=Homo sapiens OX=9606 GN=SRSF2 PE=1 SV=4
1702,1804,A0A0C4DG44|A0A0C4DG44_HUMAN,12.18,99.19,1.526E6,1.505E6,2.425E6,2.355E6,1.00,0.99,1.59,1.54,1.526E6,1.505E6,2.425E6,2.355E6,1.00,0.99,1.59,1.54,14,5,5,iTRAQ 4plex (K  N-term),45113,Serine protease HTRA2  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=HTRA2 PE=1 SV=1
1115,20705,sp|Q16778|H2B2E_HUMAN,1.54,99.13,4.863E5,4.9E5,7.234E5,8.141E5,1.00,1.01,1.49,1.67,4.863E5,4.9E5,7.234E5,8.141E5,1.00,1.01,1.49,1.67,7,8,1,iTRAQ 4plex (K  N-term),13920,Histone H2B type 2-E OS=Homo sapiens OX=9606 GN=HIST2H2BE PE=1 SV=3
1378,39939,H0YLA2|H0YLA2_HUMAN,12.85,99.12,5.001E6,4.921E6,7.025E6,7.402E6,1.00,0.98,1.40,1.48,5.001E6,4.921E6,7.025E6,7.402E6,1.00,0.98,1.40,1.48,27,4,4,iTRAQ 4plex (K  N-term),13058,Signal recognition particle 14 kDa protein OS=Homo sapiens OX=9606 GN=SRP14 PE=1 SV=1
1687,17109,sp|Q8N752|KC1AL_HUMAN,1.17,99.00,3.157E4,2.768E4,4.194E4,3.958E4,1.00,0.88,1.33,1.25,3.157E4,2.768E4,4.194E4,3.958E4,1.00,0.88,1.33,1.25,6,5,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),39086,Casein kinase I isoform alpha-like OS=Homo sapiens OX=9606 GN=CSNK1A1L PE=2 SV=2
1488,3547,sp|P49674|KC1E_HUMAN,1.07,98.99,4.172E5,3.976E5,4.751E5,4.447E5,1.00,0.95,1.14,1.07,4.172E5,3.976E5,4.751E5,4.447E5,1.00,0.95,1.14,1.07,6,5,2,iTRAQ 4plex (K  N-term),47315,Casein kinase I isoform epsilon OS=Homo sapiens OX=9606 GN=CSNK1E PE=1 SV=1
1420,23876,G3V2D5|G3V2D5_HUMAN,13.62,98.87,3.596E6,2.139E6,2.913E6,2.893E6,1.00,0.59,0.81,0.80,3.596E6,2.139E6,2.913E6,2.893E6,1.00,0.59,0.81,0.80,30,5,5,iTRAQ 4plex (K  N-term),19527,mRNA decay activator protein ZFP36L1 (Fragment) OS=Homo sapiens OX=9606 GN=ZFP36L1 PE=1 SV=1
1050,21336,Q86VM6|Q86VM6_HUMAN,1.53,98.84,3.205E5,3.851E5,5.371E5,5.008E5,1.00,1.20,1.68,1.56,3.205E5,3.851E5,5.371E5,5.008E5,1.00,1.20,1.68,1.56,8,6,1,iTRAQ 4plex (K  N-term),36551,MBNL1 protein OS=Homo sapiens OX=9606 GN=MBNL1 PE=1 SV=1
1303,39089,E5RFQ1|E5RFQ1_HUMAN,2.62,98.78,9.668E5,8.525E5,1.22E6,1.13E6,1.00,0.88,1.26,1.17,9.668E5,8.525E5,1.22E6,1.13E6,1.00,0.88,1.26,1.17,4,6,2,iTRAQ 4plex (K  N-term),57491,Transcription factor COE1 OS=Homo sapiens OX=9606 GN=EBF1 PE=1 SV=1
1566,6900,sp|Q709C8-4|VP13C_HUMAN,7.66,98.66,1.082E6,1.025E6,1.503E6,1.325E6,1.00,0.95,1.39,1.23,1.082E6,1.025E6,1.503E6,1.325E6,1.00,0.95,1.39,1.23,3,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),403087,Isoform 4 of Vacuolar protein sorting-associated protein 13C OS=Homo sapiens OX=9606 GN=VPS13C
1596,39083,sp|Q9UJS0|CMC2_HUMAN,10.95,98.50,6.598E5,6.606E5,1.066E6,1.109E6,1.00,1.00,1.62,1.68,6.598E5,6.606E5,1.066E6,1.109E6,1.00,1.00,1.62,1.68,4,6,3,iTRAQ 4plex (K  N-term),74176,Calcium-binding mitochondrial carrier protein Aralar2 OS=Homo sapiens OX=9606 GN=SLC25A13 PE=1 SV=2
1397,20394,sp|P21912|SDHB_HUMAN,9.45,98.44,2.02E6,2.063E6,2.991E6,3.012E6,1.00,1.02,1.48,1.49,2.02E6,2.063E6,2.991E6,3.012E6,1.00,1.02,1.48,1.49,23,6,6,iTRAQ 4plex (K  N-term),31630,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit  mitochondrial OS=Homo sapiens OX=9606 GN=SDHB PE=1 SV=3
1579,16736,A0A140T936|A0A140T936_HUMAN,5.27,98.41,9.416E5,9.568E5,1.238E6,1.172E6,1.00,1.02,1.32,1.25,9.416E5,9.568E5,1.238E6,1.172E6,1.00,1.02,1.32,1.25,4,4,4,iTRAQ 4plex (K  N-term),131949,Valine--tRNA ligase (Fragment) OS=Homo sapiens OX=9606 GN=VARS PE=1 SV=1
1786,19694,sp|Q9BQE9|BCL7B_HUMAN,4.90,98.39,4.333E5,4.226E5,6.978E5,6.557E5,1.00,0.98,1.61,1.51,4.333E5,4.226E5,6.978E5,6.557E5,1.00,0.98,1.61,1.51,28,3,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),22195,B-cell CLL/lymphoma 7 protein family member B OS=Homo sapiens OX=9606 GN=BCL7B PE=1 SV=1
1916,39418,F8W079|F8W079_HUMAN,16.77,98.25,1.633E6,1.626E6,2.578E6,2.675E6,1.00,1.00,1.58,1.64,1.633E6,1.626E6,2.578E6,2.675E6,1.00,1.00,1.58,1.64,20,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),30170,ATP synthase subunit beta  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=ATP5F1B PE=1 SV=1
1245,3049,sp|Q9Y4J8-14|DTNA_HUMAN,16.78,98.13,3.362E6,3.527E6,5.998E6,6.017E6,1.00,1.05,1.78,1.79,3.362E6,3.527E6,5.998E6,6.017E6,1.00,1.05,1.78,1.79,10,7,7,iTRAQ 4plex (K  N-term); Oxidation (M),78064,Isoform 14 of Dystrobrevin alpha OS=Homo sapiens OX=9606 GN=DTNA
1473,23418,sp|O75569|PRKRA_HUMAN,8.50,98.03,5.001E6,4.82E6,6.783E6,6.835E6,1.00,0.96,1.36,1.37,5.001E6,4.82E6,6.783E6,6.835E6,1.00,0.96,1.36,1.37,22,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),34404,Interferon-inducible double-stranded RNA-dependent protein kinase activator A OS=Homo sapiens OX=9606 GN=PRKRA PE=1 SV=1
1672,39076,sp|Q9P265|DIP2B_HUMAN,14.80,97.90,1.311E6,1.379E6,2.242E6,2.38E6,1.00,1.05,1.71,1.82,1.311E6,1.379E6,2.242E6,2.38E6,1.00,1.05,1.71,1.82,5,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),171491,Disco-interacting protein 2 homolog B OS=Homo sapiens OX=9606 GN=DIP2B PE=1 SV=3
1316,20954,sp|Q9H4M9|EHD1_HUMAN,4.81,97.88,2.79E6,2.532E6,3.486E6,3.549E6,1.00,0.91,1.25,1.27,2.79E6,2.532E6,3.486E6,3.549E6,1.00,0.91,1.25,1.27,14,8,4,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),60627,EH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=EHD1 PE=1 SV=2
1778,39267,sp|Q6VY07|PACS1_HUMAN,6.95,97.76,3.193E5,3.133E5,4.41E5,4.578E5,1.00,0.98,1.38,1.43,3.193E5,3.133E5,4.41E5,4.578E5,1.00,0.98,1.38,1.43,9,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),104898,Phosphofurin acidic cluster sorting protein 1 OS=Homo sapiens OX=9606 GN=PACS1 PE=1 SV=2
929,21740,sp|P62851|RS25_HUMAN,9.26,97.71,6.08E7,6.284E7,8.316E7,8.47E7,1.00,1.03,1.37,1.39,6.08E7,6.284E7,8.316E7,8.47E7,1.00,1.03,1.37,1.39,45,6,6,iTRAQ 4plex (K  N-term),13742,40S ribosomal protein S25 OS=Homo sapiens OX=9606 GN=RPS25 PE=1 SV=1
1769,39613,sp|Q9H3P7|GCP60_HUMAN,8.36,97.69,6.224E5,6.352E5,8.549E5,8.089E5,1.00,1.02,1.37,1.30,6.224E5,6.352E5,8.549E5,8.089E5,1.00,1.02,1.37,1.30,16,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),60593,Golgi resident protein GCP60 OS=Homo sapiens OX=9606 GN=ACBD3 PE=1 SV=4
1013,18121,H3BQZ7|H3BQZ7_HUMAN,12.62,97.68,4.296E6,4.164E6,6.756E6,6.978E6,1.00,0.97,1.57,1.62,4.296E6,4.164E6,6.756E6,6.978E6,1.00,0.97,1.57,1.62,7,7,6,iTRAQ 4plex (K  N-term); Oxidation (M),84692,HCG2044799 OS=Homo sapiens OX=9606 GN=HNRNPUL2-BSCL2 PE=4 SV=1
1708,39431,sp|Q15287-3|RNPS1_HUMAN,17.53,97.61,1.329E6,1.374E6,2.331E6,2.293E6,1.00,1.03,1.75,1.72,1.329E6,1.374E6,2.331E6,2.293E6,1.00,1.03,1.75,1.72,22,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),30354,Isoform 3 of RNA-binding protein with serine-rich domain 1 OS=Homo sapiens OX=9606 GN=RNPS1
1616,8458,Q5T171|Q5T171_HUMAN,8.27,97.40,1.658E6,1.617E6,2.216E6,2.146E6,1.00,0.98,1.34,1.29,1.658E6,1.617E6,2.216E6,2.146E6,1.00,0.98,1.34,1.29,14,4,4,iTRAQ 4plex (K  N-term); Phosphorylation (STY),37773,Pygopus homolog 2 (Drosophila)  isoform CRA_b OS=Homo sapiens OX=9606 GN=PYGO2 PE=1 SV=1
1975,39757,A0A1W2PR11|A0A1W2PR11_HUMAN,1.37,97.36,1.002E5,1.143E5,1.594E5,1.611E5,1.00,1.14,1.59,1.61,1.002E5,1.143E5,1.594E5,1.611E5,1.00,1.14,1.59,1.61,4,3,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),36849,HLA class I histocompatibility antigen  Cw-6 alpha chain OS=Homo sapiens OX=9606 GN=HLA-C PE=1 SV=1
692,11319,M0R3D6|M0R3D6_HUMAN,9.28,97.31,3.406E7,3.371E7,4.288E7,4.776E7,1.00,0.99,1.26,1.40,3.406E7,3.371E7,4.288E7,4.776E7,1.00,0.99,1.26,1.40,30,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),16715,60S ribosomal protein L18a (Fragment) OS=Homo sapiens OX=9606 GN=RPL18A PE=1 SV=1
1515,10414,sp|Q6Q0C0|TRAF7_HUMAN,16.12,97.27,1.405E6,1.42E6,2.414E6,2.469E6,1.00,1.01,1.72,1.76,1.405E6,1.42E6,2.414E6,2.469E6,1.00,1.01,1.72,1.76,11,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),74609,E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1
1463,39464,sp|E9PAV3|NACAM_HUMAN,18.60,97.18,2.347E6,2.383E6,4.012E6,4.09E6,1.00,1.02,1.71,1.74,2.347E6,2.383E6,4.012E6,4.09E6,1.00,1.02,1.71,1.74,2,4,4,iTRAQ 4plex (K  N-term),205419,Nascent polypeptide-associated complex subunit alpha  muscle-specific form OS=Homo sapiens OX=9606 GN=NACA PE=1 SV=1
836,39916,sp|A0A0B4J1V0|HV315_HUMAN,36.94,97.12,2.621E5,2.833E5,2.752E6,2.8E6,1.00,1.08,10.50,10.68,2.621E5,2.833E5,2.752E6,2.8E6,1.00,1.08,10.50,10.68,15,7,2,iTRAQ 4plex (K  N-term),12926,Immunoglobulin heavy variable 3-15 OS=Homo sapiens OX=9606 GN=IGHV3-15 PE=3 SV=1
1078,8931,sp|P31947-2|1433S_HUMAN,9.59,97.11,1.131E6,4.285E5,8.063E5,7.785E5,1.00,0.38,0.71,0.69,1.131E6,4.285E5,8.063E5,7.785E5,1.00,0.38,0.71,0.69,10,6,2,iTRAQ 4plex (K  N-term),24336,Isoform 2 of 14-3-3 protein sigma OS=Homo sapiens OX=9606 GN=SFN
1658,16098,sp|Q92890|UFD1_HUMAN,22.97,97.09,1.105E6,1.11E6,2.11E6,1.914E6,1.00,1.00,1.91,1.73,1.105E6,1.11E6,2.11E6,1.914E6,1.00,1.00,1.91,1.73,18,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),34500,Ubiquitin recognition factor in ER-associated degradation protein 1 OS=Homo sapiens OX=9606 GN=UFD1 PE=1 SV=3
2058,4020,sp|Q96FS4|SIPA1_HUMAN,16.16,97.05,5.443E5,5.686E5,9.062E5,9.137E5,1.00,1.04,1.66,1.68,5.443E5,5.686E5,9.062E5,9.137E5,1.00,1.04,1.66,1.68,5,3,3,iTRAQ 4plex (K  N-term),112149,Signal-induced proliferation-associated protein 1 OS=Homo sapiens OX=9606 GN=SIPA1 PE=1 SV=1
1532,19837,sp|O75937|DNJC8_HUMAN,23.42,97.05,3.32E6,3.41E6,6.676E6,6.56E6,1.00,1.03,2.01,1.98,3.32E6,3.41E6,6.676E6,6.56E6,1.00,1.03,2.01,1.98,21,6,6,iTRAQ 4plex (K  N-term),29842,DnaJ homolog subfamily C member 8 OS=Homo sapiens OX=9606 GN=DNAJC8 PE=1 SV=2
1375,8987,sp|P23142|FBLN1_HUMAN,9.06,97.03,6.172E6,5.626E6,8.429E6,8.285E6,1.00,0.91,1.37,1.34,6.172E6,5.626E6,8.429E6,8.285E6,1.00,0.91,1.37,1.34,8,6,6,iTRAQ 4plex (K  N-term),77214,Fibulin-1 OS=Homo sapiens OX=9606 GN=FBLN1 PE=1 SV=4
1418,39137,sp|Q06190|P2R3A_HUMAN,16.37,97.00,1.111E6,1.151E6,2.133E6,2.1E6,1.00,1.04,1.92,1.89,1.111E6,1.151E6,2.133E6,2.1E6,1.00,1.04,1.92,1.89,5,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),130278,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens OX=9606 GN=PPP2R3A PE=1 SV=1
1376,20239,sp|P53680|AP2S1_HUMAN,12.19,96.94,4.829E6,4.836E6,7.637E6,7.258E6,1.00,1.00,1.58,1.50,4.829E6,4.836E6,7.637E6,7.258E6,1.00,1.00,1.58,1.50,25,5,5,iTRAQ 4plex (K  N-term),17018,AP-2 complex subunit sigma OS=Homo sapiens OX=9606 GN=AP2S1 PE=1 SV=2
1304,39176,sp|Q66K74-2|MAP1S_HUMAN,32.40,96.89,7.441E6,5.201E6,9.32E6,1.146E7,1.00,0.70,1.25,1.54,7.441E6,5.201E6,9.32E6,1.146E7,1.00,0.70,1.25,1.54,5,6,5,iTRAQ 4plex (K  N-term),109788,Isoform 2 of Microtubule-associated protein 1S OS=Homo sapiens OX=9606 GN=MAP1S
1578,39201,sp|O14776-2|TCRG1_HUMAN,14.68,96.86,1.952E6,1.771E6,3.138E6,3.244E6,1.00,0.91,1.61,1.66,1.952E6,1.771E6,3.138E6,3.244E6,1.00,0.91,1.61,1.66,4,6,4,iTRAQ 4plex (K  N-term),121690,Isoform 2 of Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1
1691,12711,sp|Q9P0V3|SH3B4_HUMAN,14.09,96.81,8.208E5,8.066E5,1.271E6,1.209E6,1.00,0.98,1.55,1.47,8.208E5,8.066E5,1.271E6,1.209E6,1.00,0.98,1.55,1.47,7,5,5,iTRAQ 4plex (K  N-term),107496,SH3 domain-binding protein 4 OS=Homo sapiens OX=9606 GN=SH3BP4 PE=1 SV=1
1539,6338,sp|Q9H223|EHD4_HUMAN,13.35,96.79,1.251E6,1.273E6,2.017E6,1.999E6,1.00,1.02,1.61,1.60,1.251E6,1.273E6,2.017E6,1.999E6,1.00,1.02,1.61,1.60,10,5,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),61175,EH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=EHD4 PE=1 SV=1
1815,20261,Q5SRQ6|Q5SRQ6_HUMAN,36.66,96.78,2.883E6,2.918E6,6.485E6,6.151E6,1.00,1.01,2.25,2.13,2.883E6,2.918E6,6.485E6,6.151E6,1.00,1.01,2.25,2.13,18,4,4,iTRAQ 4plex (K  N-term),26926,Casein kinase II subunit beta OS=Homo sapiens OX=9606 GN=CSNK2B PE=1 SV=2
1063,21010,sp|Q9UPU9-3|SMAG1_HUMAN,11.03,96.78,1.879E6,1.91E6,2.862E6,2.888E6,1.00,1.02,1.52,1.54,1.879E6,1.91E6,2.862E6,2.888E6,1.00,1.02,1.52,1.54,13,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),70095,Isoform 3 of Protein Smaug homolog 1 OS=Homo sapiens OX=9606 GN=SAMD4A
1533,39143,sp|Q9H7D7-2|WDR26_HUMAN,13.60,96.56,1.391E6,1.436E6,2.503E6,2.465E6,1.00,1.03,1.80,1.77,1.391E6,1.436E6,2.503E6,2.465E6,1.00,1.03,1.80,1.77,12,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),70460,Isoform 2 of WD repeat-containing protein 26 OS=Homo sapiens OX=9606 GN=WDR26
1623,20389,sp|P62937|PPIA_HUMAN,13.47,96.55,3.869E6,3.509E6,5.15E6,5.282E6,1.00,0.91,1.33,1.37,3.869E6,3.509E6,5.15E6,5.282E6,1.00,0.91,1.33,1.37,22,4,4,iTRAQ 4plex (K  N-term),18012,Peptidyl-prolyl cis-trans isomerase A OS=Homo sapiens OX=9606 GN=PPIA PE=1 SV=2
1859,39788,sp|P29966|MARCS_HUMAN,5.58,96.52,4.64E5,4.86E5,6.077E5,5.764E5,1.00,1.05,1.31,1.24,4.64E5,4.86E5,6.077E5,5.764E5,1.00,1.05,1.31,1.24,16,3,3,iTRAQ 4plex (K  N-term),31555,Myristoylated alanine-rich C-kinase substrate OS=Homo sapiens OX=9606 GN=MARCKS PE=1 SV=4
1206,20106,sp|P37198|NUP62_HUMAN,49.44,96.50,2.496E6,2.448E6,6.312E6,6.094E6,1.00,0.98,2.53,2.44,2.496E6,2.448E6,6.312E6,6.094E6,1.00,0.98,2.53,2.44,10,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),53255,Nuclear pore glycoprotein p62 OS=Homo sapiens OX=9606 GN=NUP62 PE=1 SV=3
1146,39873,sp|A0A0J9YX35|HV64D_HUMAN,44.00,96.43,1.942E6,1.878E6,1.482E7,1.42E7,1.00,0.97,7.63,7.31,1.942E6,1.878E6,1.482E7,1.42E7,1.00,0.97,7.63,7.31,9,4,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),12823,Immunoglobulin heavy variable 3-64D OS=Homo sapiens OX=9606 GN=IGHV3-64D PE=3 SV=1
1572,23060,sp|Q5JU85-3|IQEC2_HUMAN,5.80,96.42,1.919E5,1.647E5,3.118E5,3.006E5,1.00,0.86,1.62,1.57,1.919E5,1.647E5,3.118E5,3.006E5,1.00,0.86,1.62,1.57,5,5,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),105100,Isoform 2 of IQ motif and SEC7 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=IQSEC2
1809,6141,sp|Q13751|LAMB3_HUMAN,3.65,96.31,2.985E5,3.041E5,4.345E5,4.44E5,1.00,1.02,1.46,1.49,2.985E5,3.041E5,4.345E5,4.44E5,1.00,1.02,1.46,1.49,4,3,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),129572,Laminin subunit beta-3 OS=Homo sapiens OX=9606 GN=LAMB3 PE=1 SV=1
1690,1155,F6SS63|F6SS63_HUMAN,19.89,96.31,1.134E6,1.115E6,1.98E6,1.965E6,1.00,0.98,1.75,1.73,1.134E6,1.115E6,1.98E6,1.965E6,1.00,0.98,1.75,1.73,13,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),67030,TAK1-binding protein 3  isoform CRA_c OS=Homo sapiens OX=9606 GN=TAB3 PE=1 SV=2
1707,8540,sp|P05412|JUN_HUMAN,12.43,96.28,7.467E5,7.673E5,1.238E6,1.205E6,1.00,1.03,1.66,1.61,7.467E5,7.673E5,1.238E6,1.205E6,1.00,1.03,1.66,1.61,17,4,3,iTRAQ 4plex (K  N-term),35676,Transcription factor AP-1 OS=Homo sapiens OX=9606 GN=JUN PE=1 SV=2
1203,19799,sp|P56545|CTBP2_HUMAN,17.59,96.22,5.584E6,5.475E6,1.02E7,9.977E6,1.00,0.98,1.83,1.79,5.584E6,5.475E6,1.02E7,9.977E6,1.00,0.98,1.83,1.79,15,8,8,iTRAQ 4plex (K  N-term),48945,C-terminal-binding protein 2 OS=Homo sapiens OX=9606 GN=CTBP2 PE=1 SV=1
1508,15797,sp|Q8IYB5-3|SMAP1_HUMAN,19.23,95.91,1.964E6,1.992E6,3.733E6,3.667E6,1.00,1.01,1.90,1.87,1.964E6,1.992E6,3.733E6,3.667E6,1.00,1.01,1.90,1.87,16,6,6,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),47862,Isoform 3 of Stromal membrane-associated protein 1 OS=Homo sapiens OX=9606 GN=SMAP1
1188,17856,sp|P63244|RACK1_HUMAN,31.66,95.81,5.684E6,4.912E6,1.061E7,9.371E6,1.00,0.86,1.87,1.65,5.684E6,4.912E6,1.061E7,9.371E6,1.00,0.86,1.87,1.65,12,5,4,iTRAQ 4plex (K  N-term),35077,Receptor of activated protein C kinase 1 OS=Homo sapiens OX=9606 GN=RACK1 PE=1 SV=3
1506,22256,sp|Q9Y399|RT02_HUMAN,16.69,95.80,2.616E6,2.673E6,5.124E6,4.911E6,1.00,1.02,1.96,1.88,2.616E6,2.673E6,5.124E6,4.911E6,1.00,1.02,1.96,1.88,24,8,8,iTRAQ 4plex (K  N-term),33249,28S ribosomal protein S2  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS2 PE=1 SV=1
1752,22783,sp|P40937-2|RFC5_HUMAN,11.95,95.72,2.922E6,2.951E6,4.683E6,4.741E6,1.00,1.01,1.60,1.62,2.922E6,2.951E6,4.683E6,4.741E6,1.00,1.01,1.60,1.62,11,4,3,iTRAQ 4plex (K  N-term),36105,Isoform 2 of Replication factor C subunit 5 OS=Homo sapiens OX=9606 GN=RFC5
1654,39219,sp|P21359-2|NF1_HUMAN,15.85,95.71,9.738E5,9.898E5,1.797E6,1.816E6,1.00,1.02,1.85,1.87,9.738E5,9.898E5,1.797E6,1.816E6,1.00,1.02,1.85,1.87,2,5,5,iTRAQ 4plex (K  N-term),317032,Isoform 1 of Neurofibromin OS=Homo sapiens OX=9606 GN=NF1
1831,20733,sp|O15116|LSM1_HUMAN,20.97,95.70,3.521E5,3.388E5,6.108E5,5.667E5,1.00,0.96,1.73,1.61,3.521E5,3.388E5,6.108E5,5.667E5,1.00,0.96,1.73,1.61,30,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),15179,U6 snRNA-associated Sm-like protein LSm1 OS=Homo sapiens OX=9606 GN=LSM1 PE=1 SV=1
1513,10596,sp|P49747-2|COMP_HUMAN,8.88,95.65,2.327E6,2.47E6,1.671E6,1.578E6,1.00,1.06,0.72,0.68,2.327E6,2.47E6,1.671E6,1.578E6,1.00,1.06,0.72,0.68,6,5,4,iTRAQ 4plex (K  N-term),77214,Isoform 2 of Cartilage oligomeric matrix protein OS=Homo sapiens OX=9606 GN=COMP
1711,21282,sp|Q9NVZ3-4|NECP2_HUMAN,3.05,95.57,1.712E6,1.735E6,1.998E6,1.992E6,1.00,1.01,1.17,1.16,1.712E6,1.735E6,1.998E6,1.992E6,1.00,1.01,1.17,1.16,24,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),25267,Isoform 4 of Adaptin ear-binding coat-associated protein 2 OS=Homo sapiens OX=9606 GN=NECAP2
1865,20698,sp|Q9NWA0|MED9_HUMAN,11.80,95.56,9.258E5,9.334E5,1.305E6,1.215E6,1.00,1.01,1.41,1.31,9.258E5,9.334E5,1.305E6,1.215E6,1.00,1.01,1.41,1.31,30,3,3,iTRAQ 4plex (K  N-term),16403,Mediator of RNA polymerase II transcription subunit 9 OS=Homo sapiens OX=9606 GN=MED9 PE=1 SV=1
1328,39239,H0YAP0|H0YAP0_HUMAN,9.30,95.50,1.22E6,1.218E6,1.995E6,1.975E6,1.00,1.00,1.63,1.62,1.22E6,1.218E6,1.995E6,1.975E6,1.00,1.00,1.63,1.62,28,6,6,iTRAQ 4plex (K  N-term),20884,Zinc finger C2HC domain-containing protein 1A (Fragment) OS=Homo sapiens OX=9606 GN=ZC2HC1A PE=1 SV=1
945,23105,sp|P01772|HV333_HUMAN,9.12,95.46,5.969E5,6.819E5,9.134E6,9.222E6,1.00,1.14,15.30,15.45,5.969E5,6.819E5,9.134E6,9.222E6,1.00,1.14,15.30,15.45,8,6,1,iTRAQ 4plex (K  N-term),13074,Immunoglobulin heavy variable 3-33 OS=Homo sapiens OX=9606 GN=IGHV3-33 PE=1 SV=2
1725,39283,G3XAJ6|G3XAJ6_HUMAN,11.06,95.43,6.365E5,6.732E5,1.003E6,9.412E5,1.00,1.06,1.58,1.48,6.365E5,6.732E5,1.003E6,9.412E5,1.00,1.06,1.58,1.48,13,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),58763,Raft-linking protein  isoform CRA_c OS=Homo sapiens OX=9606 GN=RFTN1 PE=1 SV=1
1253,21085,sp|Q8N1G2|CMTR1_HUMAN,8.80,95.39,4.199E6,4.165E6,6.42E6,6.378E6,1.00,0.99,1.53,1.52,4.199E6,4.165E6,6.42E6,6.378E6,1.00,0.99,1.53,1.52,9,8,8,iTRAQ 4plex (K  N-term),95321,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 OS=Homo sapiens OX=9606 GN=CMTR1 PE=1 SV=1
1213,3275,K7ERE3|K7ERE3_HUMAN,1.53,95.35,7.436E4,6.235E4,1.014E5,1.053E5,1.00,0.84,1.36,1.42,7.436E4,6.235E4,1.014E5,1.053E5,1.00,0.84,1.36,1.42,3,5,1,iTRAQ 4plex (K  N-term),45261,Keratin  type I cytoskeletal 13 OS=Homo sapiens OX=9606 GN=KRT13 PE=1 SV=1
1645,19557,A0A0D9SGJ6|A0A0D9SGJ6_HUMAN,20.46,95.29,1.436E6,1.373E6,2.728E6,2.796E6,1.00,0.96,1.90,1.95,1.436E6,1.373E6,2.728E6,2.796E6,1.00,0.96,1.90,1.95,4,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),168158,Synaptojanin-1 OS=Homo sapiens OX=9606 GN=SYNJ1 PE=1 SV=1
1598,9579,sp|P56192|SYMC_HUMAN,5.53,95.24,1.501E6,1.51E6,1.979E6,2.014E6,1.00,1.01,1.32,1.34,1.501E6,1.51E6,1.979E6,2.014E6,1.00,1.01,1.32,1.34,8,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),101116,Methionine--tRNA ligase  cytoplasmic OS=Homo sapiens OX=9606 GN=MARS PE=1 SV=2
1928,39390,sp|Q99501|GA2L1_HUMAN,11.29,95.23,8.045E5,7.526E5,1.201E6,1.2E6,1.00,0.94,1.49,1.49,8.045E5,7.526E5,1.201E6,1.2E6,1.00,0.94,1.49,1.49,9,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),72717,GAS2-like protein 1 OS=Homo sapiens OX=9606 GN=GAS2L1 PE=1 SV=2
1594,15730,sp|Q8N3X1|FNBP4_HUMAN,9.05,95.21,9.232E5,9.463E5,1.449E6,1.445E6,1.00,1.03,1.57,1.57,9.232E5,9.463E5,1.449E6,1.445E6,1.00,1.03,1.57,1.57,6,7,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),110266,Formin-binding protein 4 OS=Homo sapiens OX=9606 GN=FNBP4 PE=1 SV=3
1476,24316,sp|O14579-3|COPE_HUMAN,12.91,95.19,1.983E6,1.969E6,3.199E6,3.177E6,1.00,0.99,1.61,1.60,1.983E6,1.969E6,3.199E6,3.177E6,1.00,0.99,1.61,1.60,16,5,5,iTRAQ 4plex (K  N-term),28773,Isoform 3 of Coatomer subunit epsilon OS=Homo sapiens OX=9606 GN=COPE
1495,16131,I3L2N2|I3L2N2_HUMAN,23.98,95.14,6.927E5,7.291E5,1.645E6,1.568E6,1.00,1.05,2.38,2.26,6.927E5,7.291E5,1.645E6,1.568E6,1.00,1.05,2.38,2.26,6,5,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),78376,Segment polarity protein dishevelled homolog DVL-2 OS=Homo sapiens OX=9606 GN=DVL2 PE=1 SV=1
859,21578,sp|P63173|RL38_HUMAN,15.48,95.11,1.759E7,1.759E7,2.827E7,2.8E7,1.00,1.00,1.61,1.59,1.759E7,1.759E7,2.827E7,2.8E7,1.00,1.00,1.61,1.59,50,4,4,iTRAQ 4plex (K  N-term),8218,60S ribosomal protein L38 OS=Homo sapiens OX=9606 GN=RPL38 PE=1 SV=2
1755,21352,H0YCK7|H0YCK7_HUMAN,17.93,95.01,1.609E6,1.614E6,2.625E6,2.706E6,1.00,1.00,1.63,1.68,1.609E6,1.614E6,2.625E6,2.706E6,1.00,1.00,1.63,1.68,24,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),22955,Elongation factor 1-delta (Fragment) OS=Homo sapiens OX=9606 GN=EEF1D PE=1 SV=1
1525,39074,sp|P35232|PHB_HUMAN,17.90,94.95,1.256E6,1.292E6,2.438E6,2.561E6,1.00,1.03,1.94,2.04,1.256E6,1.292E6,2.438E6,2.561E6,1.00,1.03,1.94,2.04,28,7,7,iTRAQ 4plex (K  N-term),29804,Prohibitin OS=Homo sapiens OX=9606 GN=PHB PE=1 SV=1
957,39479,C9JYQ9|C9JYQ9_HUMAN,9.33,94.90,7.519E6,7.574E6,1.012E7,1.054E7,1.00,1.01,1.35,1.40,7.519E6,7.574E6,1.012E7,1.054E7,1.00,1.01,1.35,1.40,38,4,4,iTRAQ 4plex (K  N-term),14478,60S ribosomal protein L22-like 1 OS=Homo sapiens OX=9606 GN=RPL22L1 PE=1 SV=1
858,21305,sp|P62854|RS26_HUMAN,14.60,94.66,2.956E7,3.012E7,4.242E7,4.366E7,1.00,1.02,1.43,1.48,2.956E7,3.012E7,4.242E7,4.366E7,1.00,1.02,1.43,1.48,33,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),13015,40S ribosomal protein S26 OS=Homo sapiens OX=9606 GN=RPS26 PE=1 SV=3
1001,20301,sp|P60866|RS20_HUMAN,18.32,94.54,2.043E7,2.047E7,3.252E7,3.169E7,1.00,1.00,1.59,1.55,2.043E7,2.047E7,3.252E7,3.169E7,1.00,1.00,1.59,1.55,23,3,3,iTRAQ 4plex (K  N-term),13373,40S ribosomal protein S20 OS=Homo sapiens OX=9606 GN=RPS20 PE=1 SV=1
1290,5167,sp|P02462|CO4A1_HUMAN,4.06,94.48,5.295E6,5.17E6,6.553E6,6.095E6,1.00,0.98,1.24,1.15,5.295E6,5.17E6,6.553E6,6.095E6,1.00,0.98,1.24,1.15,4,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),160611,Collagen alpha-1(IV) chain OS=Homo sapiens OX=9606 GN=COL4A1 PE=1 SV=4
1627,3184,sp|P08047-3|SP1_HUMAN,53.76,94.44,2.827E5,2.701E5,6.289E5,6.446E5,1.00,0.96,2.22,2.28,2.827E5,2.701E5,6.289E5,6.446E5,1.00,0.96,2.22,2.28,7,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),75824,Isoform 3 of Transcription factor Sp1 OS=Homo sapiens OX=9606 GN=SP1
2108,39747,F5GYH1|F5GYH1_HUMAN,2.57,94.44,6.221E5,6.042E5,6.695E5,6.944E5,1.00,0.97,1.08,1.12,6.221E5,6.042E5,6.695E5,6.944E5,1.00,0.97,1.08,1.12,21,3,3,iTRAQ 4plex (K  N-term),25948,Adaptin ear-binding coat-associated protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=NECAP1 PE=1 SV=2
1145,20674,sp|Q9UBV8|PEF1_HUMAN,28.37,94.42,4.177E6,3.543E6,7.515E6,7.012E6,1.00,0.85,1.80,1.68,4.177E6,3.543E6,7.515E6,7.012E6,1.00,0.85,1.80,1.68,12,4,4,iTRAQ 4plex (K  N-term),30381,Peflin OS=Homo sapiens OX=9606 GN=PEF1 PE=1 SV=1
1358,2409,sp|P28290-2|ITPI2_HUMAN,7.79,94.34,1.29E6,1.238E6,1.763E6,1.884E6,1.00,0.96,1.37,1.46,1.29E6,1.238E6,1.763E6,1.884E6,1.00,0.96,1.37,1.46,9,8,8,iTRAQ 4plex (K  N-term); Deamidation (NQ),121454,Isoform 2 of Protein ITPRID2 OS=Homo sapiens OX=9606 GN=ITPRID2
1620,19566,sp|Q8WW12|PCNP_HUMAN,18.43,94.26,9.971E5,1.003E6,1.819E6,1.747E6,1.00,1.01,1.82,1.75,9.971E5,1.003E6,1.819E6,1.747E6,1.00,1.01,1.82,1.75,28,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),18925,PEST proteolytic signal-containing nuclear protein OS=Homo sapiens OX=9606 GN=PCNP PE=1 SV=2
1362,19923,B8ZZU8|B8ZZU8_HUMAN,9.64,94.18,4.946E6,5.004E6,7.521E6,7.439E6,1.00,1.01,1.52,1.50,4.946E6,5.004E6,7.521E6,7.439E6,1.00,1.01,1.52,1.50,54,6,6,iTRAQ 4plex (K  N-term),12527,Elongin-B OS=Homo sapiens OX=9606 GN=ELOB PE=1 SV=1
1798,39534,sp|P11233|RALA_HUMAN,21.28,94.13,7.065E5,7.661E5,1.282E6,1.229E6,1.00,1.08,1.81,1.74,7.065E5,7.661E5,1.282E6,1.229E6,1.00,1.08,1.81,1.74,25,4,4,iTRAQ 4plex (K  N-term),23567,Ras-related protein Ral-A OS=Homo sapiens OX=9606 GN=RALA PE=1 SV=1
809,22058,sp|P98179|RBM3_HUMAN,34.52,94.02,5.57E6,6.131E6,1.282E7,1.251E7,1.00,1.10,2.30,2.25,5.57E6,6.131E6,1.282E7,1.251E7,1.00,1.10,2.30,2.25,27,4,4,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),17170,RNA-binding protein 3 OS=Homo sapiens OX=9606 GN=RBM3 PE=1 SV=1
1037,15661,sp|Q9UK41|VPS28_HUMAN,43.53,94.01,3.735E6,3.489E6,9.233E6,9.236E6,1.00,0.93,2.47,2.47,3.735E6,3.489E6,9.233E6,9.236E6,1.00,0.93,2.47,2.47,13,4,3,iTRAQ 4plex (K  N-term); Oxidation (M),25425,Vacuolar protein sorting-associated protein 28 homolog OS=Homo sapiens OX=9606 GN=VPS28 PE=1 SV=1
2040,40021,sp|Q5VYS8-4|TUT7_HUMAN,88.00,93.98,2.741E5,3.318E5,5.096E5,9.23E5,1.00,1.21,1.86,3.37,2.741E5,3.318E5,5.096E5,9.23E5,1.00,1.21,1.86,3.37,4,3,3,iTRAQ 4plex (K  N-term),144656,Isoform 4 of Terminal uridylyltransferase 7 OS=Homo sapiens OX=9606 GN=TUT7
1912,15921,A0A0A0MRT6|A0A0A0MRT6_HUMAN,19.08,93.97,2.875E6,3.025E6,5.074E6,4.65E6,1.00,1.05,1.76,1.62,2.875E6,3.025E6,5.074E6,4.65E6,1.00,1.05,1.76,1.62,10,4,4,iTRAQ 4plex (K  N-term),51770,Abl interactor 1 OS=Homo sapiens OX=9606 GN=ABI1 PE=1 SV=1
1906,7301,sp|O14874-3|BCKD_HUMAN,21.96,93.89,1.124E6,1.177E6,1.985E6,1.943E6,1.00,1.05,1.77,1.73,1.124E6,1.177E6,1.985E6,1.943E6,1.00,1.05,1.77,1.73,13,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),41090,Isoform 3 of [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase  mitochondrial OS=Homo sapiens OX=9606 GN=BCKDK
1577,16303,sp|Q9UPQ3-2|AGAP1_HUMAN,7.85,93.87,4.046E5,4.145E5,9.042E5,8.394E5,1.00,1.02,2.23,2.07,4.046E5,4.145E5,9.042E5,8.394E5,1.00,1.02,2.23,2.07,3,5,2,iTRAQ 4plex (K  N-term),89066,Isoform 2 of Arf-GAP with GTPase  ANK repeat and PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=AGAP1
1590,39415,sp|Q9BRP8-2|PYM1_HUMAN,10.50,93.85,8.612E5,8.695E5,1.323E6,1.261E6,1.00,1.01,1.54,1.46,8.612E5,8.695E5,1.323E6,1.261E6,1.00,1.01,1.54,1.46,26,4,4,iTRAQ 4plex (K  N-term),22705,Isoform 2 of Partner of Y14 and mago OS=Homo sapiens OX=9606 GN=PYM1
1571,4072,sp|Q12923-3|PTN13_HUMAN,16.56,93.75,8.202E5,8.762E5,1.593E6,1.533E6,1.00,1.07,1.94,1.87,8.202E5,8.762E5,1.593E6,1.533E6,1.00,1.07,1.94,1.87,3,6,6,iTRAQ 4plex (K  N-term),274930,Isoform 3 of Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13
1471,39069,sp|Q5VT52-5|RPRD2_HUMAN,47.71,93.74,8.667E5,9.526E5,3.028E6,2.961E6,1.00,1.10,3.49,3.42,8.667E5,9.526E5,3.028E6,2.961E6,1.00,1.10,3.49,3.42,9,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),100272,Isoform 5 of Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RPRD2
1497,2951,sp|O14976|GAK_HUMAN,16.51,93.71,1.32E6,1.314E6,2.327E6,2.276E6,1.00,0.99,1.76,1.72,1.32E6,1.314E6,2.327E6,2.276E6,1.00,0.99,1.76,1.72,4,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),143190,Cyclin-G-associated kinase OS=Homo sapiens OX=9606 GN=GAK PE=1 SV=2
1297,39329,sp|P01780|HV307_HUMAN,7.12,93.65,1.486E4,1.701E4,7.742E4,8.959E4,1.00,1.14,5.21,6.03,1.486E4,1.701E4,7.742E4,8.959E4,1.00,1.14,5.21,6.03,6,5,1,iTRAQ 4plex (K  N-term),12943,Immunoglobulin heavy variable 3-7 OS=Homo sapiens OX=9606 GN=IGHV3-7 PE=1 SV=2
2106,39665,F5H423|F5H423_HUMAN,0.63,93.55,6.816E5,6.577E5,7.615E5,8.271E5,1.00,0.96,1.12,1.21,6.816E5,6.577E5,7.615E5,8.271E5,1.00,0.96,1.12,1.21,4,3,1,iTRAQ 4plex (K  N-term),23346,Uncharacterized protein OS=Homo sapiens OX=9606 PE=3 SV=1
1296,2724,sp|Q9ULE0|WWC3_HUMAN,10.53,93.51,1.268E6,1.269E6,2.136E6,2.156E6,1.00,1.00,1.68,1.70,1.268E6,1.269E6,2.136E6,2.156E6,1.00,1.00,1.68,1.70,8,8,7,iTRAQ 4plex (K  N-term); Deamidation (NQ),122676,Protein WWC3 OS=Homo sapiens OX=9606 GN=WWC3 PE=1 SV=3
1913,10898,sp|Q9BZF1-3|OSBL8_HUMAN,4.11,93.45,5.172E5,5.328E5,6.594E5,6.652E5,1.00,1.03,1.27,1.29,5.172E5,5.328E5,6.594E5,6.652E5,1.00,1.03,1.27,1.29,7,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),96956,Isoform 3 of Oxysterol-binding protein-related protein 8 OS=Homo sapiens OX=9606 GN=OSBPL8
1625,23210,sp|P60903|S10AA_HUMAN,41.40,93.32,4.93E6,4.951E6,9.44E6,9.954E6,1.00,1.00,1.91,2.02,4.93E6,4.951E6,9.44E6,9.954E6,1.00,1.00,1.91,2.02,39,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),11203,Protein S100-A10 OS=Homo sapiens OX=9606 GN=S100A10 PE=1 SV=2
1670,20478,sp|Q8TDW0|LRC8C_HUMAN,9.78,93.23,1.779E6,1.712E6,2.676E6,2.82E6,1.00,0.96,1.50,1.59,1.779E6,1.712E6,2.676E6,2.82E6,1.00,0.96,1.50,1.59,6,5,4,iTRAQ 4plex (K  N-term),92449,Volume-regulated anion channel subunit LRRC8C OS=Homo sapiens OX=9606 GN=LRRC8C PE=1 SV=2
1919,8898,sp|P17858|PFKAL_HUMAN,2.32,93.08,4.145E5,3.681E5,7.631E5,7.594E5,1.00,0.89,1.84,1.83,4.145E5,3.681E5,7.631E5,7.594E5,1.00,0.89,1.84,1.83,2,3,1,iTRAQ 4plex (K  N-term),85018,ATP-dependent 6-phosphofructokinase  liver type OS=Homo sapiens OX=9606 GN=PFKL PE=1 SV=6
1715,39600,A0A087WZT0|A0A087WZT0_HUMAN,18.22,93.06,1.749E6,1.649E6,2.853E6,2.802E6,1.00,0.94,1.63,1.60,1.749E6,1.649E6,2.853E6,2.802E6,1.00,0.94,1.63,1.60,10,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),72414,Protein Smaug homolog 2 OS=Homo sapiens OX=9606 GN=SAMD4B PE=1 SV=1
1601,6207,sp|Q9C0B0|UNK_HUMAN,8.51,93.04,1.59E6,1.559E6,2.441E6,2.37E6,1.00,0.98,1.54,1.49,1.59E6,1.559E6,2.441E6,2.37E6,1.00,0.98,1.54,1.49,4,5,4,iTRAQ 4plex (K  N-term),88084,RING finger protein unkempt homolog OS=Homo sapiens OX=9606 GN=UNK PE=1 SV=2
1402,39121,sp|P36542|ATPG_HUMAN,8.19,92.92,3.08E6,3.009E6,4.522E6,4.397E6,1.00,0.98,1.47,1.43,3.08E6,3.009E6,4.522E6,4.397E6,1.00,0.98,1.47,1.43,21,6,6,iTRAQ 4plex (K  N-term),32996,ATP synthase subunit gamma  mitochondrial OS=Homo sapiens OX=9606 GN=ATP5F1C PE=1 SV=1
1222,39133,sp|Q00059|TFAM_HUMAN,17.21,92.88,3.576E6,3.64E6,6.483E6,6.618E6,1.00,1.02,1.81,1.85,3.576E6,3.64E6,6.483E6,6.618E6,1.00,1.02,1.81,1.85,24,7,7,iTRAQ 4plex (K  N-term),29097,Transcription factor A  mitochondrial OS=Homo sapiens OX=9606 GN=TFAM PE=1 SV=1
1732,3892,sp|P67775|PP2AA_HUMAN,15.14,92.72,8.858E5,8.62E5,1.442E6,1.462E6,1.00,0.97,1.63,1.65,8.858E5,8.62E5,1.442E6,1.462E6,1.00,0.97,1.63,1.65,14,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),35594,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform OS=Homo sapiens OX=9606 GN=PPP2CA PE=1 SV=1
761,19795,sp|P49207|RL34_HUMAN,10.03,92.63,5.249E7,5.467E7,6.727E7,7.641E7,1.00,1.04,1.28,1.46,5.249E7,5.467E7,6.727E7,7.641E7,1.00,1.04,1.28,1.46,28,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),13293,60S ribosomal protein L34 OS=Homo sapiens OX=9606 GN=RPL34 PE=1 SV=3
1396,39100,sp|Q8IVF7-2|FMNL3_HUMAN,12.21,92.53,1.276E6,1.486E6,2.236E6,2.013E6,1.00,1.16,1.75,1.58,1.276E6,1.486E6,2.236E6,2.013E6,1.00,1.16,1.75,1.58,4,7,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),111259,Isoform 2 of Formin-like protein 3 OS=Homo sapiens OX=9606 GN=FMNL3
1456,39353,sp|Q07092-2|COGA1_HUMAN,2.64,92.25,9.567E5,9.897E5,1.144E6,1.134E6,1.00,1.03,1.20,1.18,9.567E5,9.897E5,1.144E6,1.134E6,1.00,1.03,1.20,1.18,4,5,5,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),157557,Isoform 2 of Collagen alpha-1(XVI) chain OS=Homo sapiens OX=9606 GN=COL16A1
1796,39350,sp|Q99661-2|KIF2C_HUMAN,6.91,92.22,2.908E5,3.126E5,4.092E5,4.189E5,1.00,1.07,1.41,1.44,2.908E5,3.126E5,4.092E5,4.189E5,1.00,1.07,1.41,1.44,7,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),75561,Isoform 2 of Kinesin-like protein KIF2C OS=Homo sapiens OX=9606 GN=KIF2C
375,21791,A6XGL3|A6XGL3_HUMAN,11.50,92.05,3.027E8,2.998E8,4.044E8,3.379E8,1.00,0.99,1.34,1.12,3.027E8,2.998E8,4.044E8,3.379E8,1.00,0.99,1.34,1.12,8,6,5,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),25399,Protease serine 1 OS=Homo sapiens OX=9606 GN=PRSS1 PE=1 SV=1
2062,5623,sp|Q5T4S7-3|UBR4_HUMAN,44.61,92.03,2.025E5,2.007E5,3.94E5,4.069E5,1.00,0.99,1.95,2.01,2.025E5,2.007E5,3.94E5,4.069E5,1.00,0.99,1.95,2.01,1,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),571859,Isoform 3 of E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens OX=9606 GN=UBR4
1827,23375,E9PDK2|E9PDK2_HUMAN,7.50,91.97,6.127E5,6.076E5,8.513E5,8.282E5,1.00,0.99,1.39,1.35,6.127E5,6.076E5,8.513E5,8.282E5,1.00,0.99,1.39,1.35,4,4,3,iTRAQ 4plex (K  N-term),79480,Putative E3 ubiquitin-protein ligase UNKL OS=Homo sapiens OX=9606 GN=UNKL PE=1 SV=1
1714,15900,sp|O43739-2|CYH3_HUMAN,2.89,91.90,1.025E6,9.761E5,2.351E6,2.216E6,1.00,0.95,2.29,2.16,1.025E6,9.761E5,2.351E6,2.216E6,1.00,0.95,2.29,2.16,2,4,1,iTRAQ 4plex (K  N-term),46292,Isoform 2 of Cytohesin-3 OS=Homo sapiens OX=9606 GN=CYTH3
924,16690,sp|P63162|RSMN_HUMAN,5.85,91.89,2.269E7,2.358E7,2.657E7,2.875E7,1.00,1.04,1.17,1.27,2.269E7,2.358E7,2.657E7,2.875E7,1.00,1.04,1.17,1.27,21,5,5,iTRAQ 4plex (K  N-term); Oxidation (M),24614,Small nuclear ribonucleoprotein-associated protein N OS=Homo sapiens OX=9606 GN=SNRPN PE=1 SV=1
1534,21321,sp|Q9P258|RCC2_HUMAN,10.96,91.86,1.688E6,1.602E6,2.609E6,2.506E6,1.00,0.95,1.55,1.48,1.688E6,1.602E6,2.609E6,2.506E6,1.00,0.95,1.55,1.48,10,6,6,iTRAQ 4plex (K  N-term),56085,Protein RCC2 OS=Homo sapiens OX=9606 GN=RCC2 PE=1 SV=2
1730,39486,sp|P08754|GNAI3_HUMAN,0.44,91.80,6.97E4,6.864E4,8.122E4,7.835E4,1.00,0.98,1.17,1.12,6.97E4,6.864E4,8.122E4,7.835E4,1.00,0.98,1.17,1.12,5,4,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),40532,Guanine nucleotide-binding protein G(k) subunit alpha OS=Homo sapiens OX=9606 GN=GNAI3 PE=1 SV=3
1617,21063,sp|Q13243|SRSF5_HUMAN,8.85,91.80,2.651E6,2.708E6,3.724E6,3.876E6,1.00,1.02,1.40,1.46,2.651E6,2.708E6,3.724E6,3.876E6,1.00,1.02,1.40,1.46,14,4,3,iTRAQ 4plex (K  N-term),31264,Serine/arginine-rich splicing factor 5 OS=Homo sapiens OX=9606 GN=SRSF5 PE=1 SV=1
1322,39438,sp|P84022|SMAD3_HUMAN,34.18,91.76,1.456E6,1.581E6,3.781E6,2.939E6,1.00,1.09,2.60,2.02,1.456E6,1.581E6,3.781E6,2.939E6,1.00,1.09,2.60,2.02,9,5,4,iTRAQ 4plex (K  N-term),48081,Mothers against decapentaplegic homolog 3 OS=Homo sapiens OX=9606 GN=SMAD3 PE=1 SV=1
1474,39307,A0A140TA29|A0A140TA29_HUMAN,36.34,91.60,9.31E5,9.754E5,3.898E6,3.798E6,1.00,1.05,4.19,4.08,9.31E5,9.754E5,3.898E6,3.798E6,1.00,1.05,4.19,4.08,2,6,4,iTRAQ 4plex (K  N-term),187665,Complement C4-B OS=Homo sapiens OX=9606 GN=C4B PE=1 SV=1
940,21151,sp|P42677|RS27_HUMAN,2.52,91.58,3.456E6,3.547E6,4.651E6,4.651E6,1.00,1.03,1.35,1.35,3.456E6,3.547E6,4.651E6,4.651E6,1.00,1.03,1.35,1.35,14,3,2,iTRAQ 4plex (K  N-term),9461,40S ribosomal protein S27 OS=Homo sapiens OX=9606 GN=RPS27 PE=1 SV=3
1353,39414,sp|P01584|IL1B_HUMAN,12.07,91.55,3.25E6,3.327E6,4.931E6,5.091E6,1.00,1.02,1.52,1.57,3.25E6,3.327E6,4.931E6,5.091E6,1.00,1.02,1.52,1.57,19,4,4,iTRAQ 4plex (K  N-term),30748,Interleukin-1 beta OS=Homo sapiens OX=9606 GN=IL1B PE=1 SV=2
1968,19710,sp|Q13185|CBX3_HUMAN,31.90,91.50,9.854E5,1.042E6,2.21E6,2.257E6,1.00,1.06,2.24,2.29,9.854E5,1.042E6,2.21E6,2.257E6,1.00,1.06,2.24,2.29,23,3,3,iTRAQ 4plex (K  N-term),20811,Chromobox protein homolog 3 OS=Homo sapiens OX=9606 GN=CBX3 PE=1 SV=4
1412,10621,sp|P29279|CTGF_HUMAN,24.13,91.48,1.024E7,1.009E7,1.865E7,1.83E7,1.00,0.99,1.82,1.79,1.024E7,1.009E7,1.865E7,1.83E7,1.00,0.99,1.82,1.79,12,4,4,iTRAQ 4plex (K  N-term); Oxidation (M),38091,Connective tissue growth factor OS=Homo sapiens OX=9606 GN=CTGF PE=1 SV=2
2150,39724,sp|P46734-2|MP2K3_HUMAN,13.26,91.38,6.544E5,6.193E5,9.142E5,9.67E5,1.00,0.95,1.40,1.48,6.544E5,6.193E5,9.142E5,9.67E5,1.00,0.95,1.40,1.48,12,3,3,iTRAQ 4plex (K  N-term),36173,Isoform 1 of Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP2K3
1861,15572,sp|Q9BWW4-2|SSBP3_HUMAN,2.43,91.34,5.152E5,5.412E5,5.935E5,5.297E5,1.00,1.05,1.15,1.03,5.152E5,5.412E5,5.935E5,5.297E5,1.00,1.05,1.15,1.03,21,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),37697,Isoform 2 of Single-stranded DNA-binding protein 3 OS=Homo sapiens OX=9606 GN=SSBP3
1689,22492,sp|Q13614|MTMR2_HUMAN,5.33,91.32,1.201E6,1.15E6,1.508E6,1.4E6,1.00,0.96,1.26,1.17,1.201E6,1.15E6,1.508E6,1.4E6,1.00,0.96,1.26,1.17,6,5,4,iTRAQ 4plex (K  N-term),73381,Myotubularin-related protein 2 OS=Homo sapiens OX=9606 GN=MTMR2 PE=1 SV=4
1784,39594,sp|Q92665|RT31_HUMAN,6.72,91.29,1.378E6,1.44E6,1.876E6,1.822E6,1.00,1.05,1.36,1.32,1.378E6,1.44E6,1.876E6,1.822E6,1.00,1.05,1.36,1.32,14,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),45319,28S ribosomal protein S31  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS31 PE=1 SV=3
1855,39556,sp|Q9Y3B7|RM11_HUMAN,14.07,91.11,1.151E6,1.199E6,1.834E6,1.931E6,1.00,1.04,1.59,1.68,1.151E6,1.199E6,1.834E6,1.931E6,1.00,1.04,1.59,1.68,23,4,4,iTRAQ 4plex (K  N-term),20683,39S ribosomal protein L11  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL11 PE=1 SV=1
1430,20343,G5E9V5|G5E9V5_HUMAN,21.88,91.07,1.821E6,1.995E6,3.788E6,3.493E6,1.00,1.10,2.08,1.92,1.821E6,1.995E6,3.788E6,3.493E6,1.00,1.10,2.08,1.92,13,5,5,iTRAQ 4plex (K  N-term),41209,28S ribosomal protein S22  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS22 PE=1 SV=1
1208,39982,sp|P01782|HV309_HUMAN,14.23,90.88,1.885E6,1.96E6,5.354E6,5.439E6,1.00,1.04,2.84,2.89,1.885E6,1.96E6,5.354E6,5.439E6,1.00,1.04,2.84,2.89,14,4,2,iTRAQ 4plex (K  N-term),12945,Immunoglobulin heavy variable 3-9 OS=Homo sapiens OX=9606 GN=IGHV3-9 PE=1 SV=2
1674,20329,sp|Q70EK8|UBP53_HUMAN,17.28,90.63,9.097E5,9.032E5,1.759E6,1.711E6,1.00,0.99,1.93,1.88,9.097E5,9.032E5,1.759E6,1.711E6,1.00,0.99,1.93,1.88,6,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),120806,Inactive ubiquitin carboxyl-terminal hydrolase 53 OS=Homo sapiens OX=9606 GN=USP53 PE=1 SV=2
1442,23972,sp|Q9BZR9|TRIM8_HUMAN,9.16,90.61,1.314E6,1.296E6,2.057E6,1.993E6,1.00,0.99,1.57,1.52,1.314E6,1.296E6,2.057E6,1.993E6,1.00,0.99,1.57,1.52,9,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),61489,E3 ubiquitin-protein ligase TRIM8 OS=Homo sapiens OX=9606 GN=TRIM8 PE=1 SV=2
1967,17429,sp|Q6ZN04|MEX3B_HUMAN,1.60,90.58,1.723E5,1.842E5,2.948E5,2.822E5,1.00,1.07,1.71,1.64,1.723E5,1.842E5,2.948E5,2.822E5,1.00,1.07,1.71,1.64,2,3,1,iTRAQ 4plex (K  N-term),58832,RNA-binding protein MEX3B OS=Homo sapiens OX=9606 GN=MEX3B PE=1 SV=1
1847,6421,sp|Q5T7W0-4|ZN618_HUMAN,29.29,90.54,1.041E6,1.057E6,2.631E6,2.624E6,1.00,1.01,2.53,2.52,1.041E6,1.057E6,2.631E6,2.624E6,1.00,1.01,2.53,2.52,7,5,5,iTRAQ 4plex (K  N-term),101449,Isoform 4 of Zinc finger protein 618 OS=Homo sapiens OX=9606 GN=ZNF618
1448,108,Q8WVC2|Q8WVC2_HUMAN,4.35,90.54,3.12E6,3.129E6,4.776E6,4.97E6,1.00,1.00,1.53,1.59,3.12E6,3.129E6,4.776E6,4.97E6,1.00,1.00,1.53,1.59,14,2,2,iTRAQ 4plex (K  N-term),8850,40S ribosomal protein S21 OS=Homo sapiens OX=9606 GN=RPS21 PE=1 SV=1
1421,39288,sp|Q8TF42|UBS3B_HUMAN,19.10,90.53,1.479E6,1.428E6,2.858E6,2.782E6,1.00,0.97,1.93,1.88,1.479E6,1.428E6,2.858E6,2.782E6,1.00,0.97,1.93,1.88,8,6,6,iTRAQ 4plex (K  N-term),72696,Ubiquitin-associated and SH3 domain-containing protein B OS=Homo sapiens OX=9606 GN=UBASH3B PE=1 SV=2
872,21330,A0A0G2JQJ0|A0A0G2JQJ0_HUMAN,4.53,90.52,8.584E4,7.964E4,2.849E5,2.579E5,1.00,0.93,3.32,3.00,8.584E4,7.964E4,2.849E5,2.579E5,1.00,0.93,3.32,3.00,12,7,1,iTRAQ 4plex (K  N-term),12865,Immunoglobulin kappa variable 1D-8 (Fragment) OS=Homo sapiens OX=9606 GN=IGKV1D-8 PE=1 SV=4
1162,21891,O95205|O95205_HUMAN,1.94,90.35,1.083E5,1.109E5,2.046E5,1.905E5,1.00,1.02,1.89,1.76,1.083E5,1.109E5,2.046E5,1.905E5,1.00,1.02,1.89,1.76,10,4,1,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),28141,Muscleblind-like 2 (Drosophila)  isoform CRA_b OS=Homo sapiens OX=9606 GN=MBNL2 PE=1 SV=1
1727,20173,sp|Q9NQH7-4|XPP3_HUMAN,3.90,90.21,1.18E6,1.015E6,1.283E6,1.212E6,1.00,0.86,1.09,1.03,1.18E6,1.015E6,1.283E6,1.212E6,1.00,0.86,1.09,1.03,8,5,4,iTRAQ 4plex (K  N-term),54672,Isoform 4 of Xaa-Pro aminopeptidase 3 OS=Homo sapiens OX=9606 GN=XPNPEP3
1676,19304,sp|Q6UXN9|WDR82_HUMAN,26.29,90.09,3.435E6,3.532E6,6.773E6,6.78E6,1.00,1.03,1.97,1.97,3.435E6,3.532E6,6.773E6,6.78E6,1.00,1.03,1.97,1.97,17,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),35079,WD repeat-containing protein 82 OS=Homo sapiens OX=9606 GN=WDR82 PE=1 SV=1
1976,10841,sp|Q9BY77-2|PDIP3_HUMAN,1.25,90.05,6.385E4,7.748E4,9.752E4,9.865E4,1.00,1.21,1.53,1.55,6.385E4,7.748E4,9.752E4,9.865E4,1.00,1.21,1.53,1.55,5,3,1,iTRAQ 4plex (K  N-term),42895,Isoform 2 of Polymerase delta-interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3
1765,39352,sp|O14920-4|IKKB_HUMAN,14.93,90.03,6.098E5,5.941E5,1.114E6,1.131E6,1.00,0.97,1.83,1.86,6.098E5,5.941E5,1.114E6,1.131E6,1.00,0.97,1.83,1.86,7,4,4,iTRAQ 4plex (K  N-term),79509,Isoform 4 of Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Homo sapiens OX=9606 GN=IKBKB
2111,40142,sp|P19022-2|CADH2_HUMAN,3.71,90.03,5.89E5,6.334E5,6.86E5,6.676E5,1.00,1.08,1.16,1.13,5.89E5,6.334E5,6.86E5,6.676E5,1.00,1.08,1.16,1.13,6,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),97040,Isoform 2 of Cadherin-2 OS=Homo sapiens OX=9606 GN=CDH2
1461,5883,sp|Q15154-4|PCM1_HUMAN,8.26,89.96,6.712E5,5.718E5,9.034E5,9.202E5,1.00,0.85,1.35,1.37,6.712E5,5.718E5,9.034E5,9.202E5,1.00,0.85,1.35,1.37,4,6,5,iTRAQ 4plex (K  N-term),210115,Isoform 4 of Pericentriolar material 1 protein OS=Homo sapiens OX=9606 GN=PCM1
1797,39386,sp|P28370-2|SMCA1_HUMAN,18.78,89.84,9.611E5,9.546E5,1.924E6,1.825E6,1.00,0.99,2.00,1.90,9.611E5,9.546E5,1.924E6,1.825E6,1.00,0.99,2.00,1.90,3,4,3,iTRAQ 4plex (K  N-term),121142,Isoform 2 of Probable global transcription activator SNF2L1 OS=Homo sapiens OX=9606 GN=SMARCA1
2122,4188,sp|Q9UKL0|RCOR1_HUMAN,41.08,89.41,9.615E5,8.621E5,2.14E6,1.961E6,1.00,0.90,2.23,2.04,9.615E5,8.621E5,2.14E6,1.961E6,1.00,0.90,2.23,2.04,7,3,3,iTRAQ 4plex (K  N-term),53327,REST corepressor 1 OS=Homo sapiens OX=9606 GN=RCOR1 PE=1 SV=2
1207,11398,sp|Q14192|FHL2_HUMAN,11.77,89.39,1.097E7,1.099E7,1.712E7,1.678E7,1.00,1.00,1.56,1.53,1.097E7,1.099E7,1.712E7,1.678E7,1.00,1.00,1.56,1.53,13,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),32193,Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3
1856,22273,A0A2R8YD12|A0A2R8YD12_HUMAN,3.88,89.12,2.171E6,2.166E6,2.322E6,2.611E6,1.00,1.00,1.07,1.20,2.171E6,2.166E6,2.322E6,2.611E6,1.00,1.00,1.07,1.20,17,4,4,iTRAQ 4plex (K  N-term),38125,Serpin B6 OS=Homo sapiens OX=9606 GN=SERPINB6 PE=1 SV=1
1089,21150,sp|Q71UM5|RS27L_HUMAN,3.23,89.09,5.043E6,5.661E6,7.308E6,6.947E6,1.00,1.12,1.45,1.38,5.043E6,5.661E6,7.308E6,6.947E6,1.00,1.12,1.45,1.38,14,3,2,iTRAQ 4plex (K  N-term),9477,40S ribosomal protein S27-like OS=Homo sapiens OX=9606 GN=RPS27L PE=1 SV=3
1653,39662,J3QQS1|J3QQS1_HUMAN,21.48,89.09,2.679E6,2.473E6,4.496E6,4.728E6,1.00,0.92,1.68,1.77,2.679E6,2.473E6,4.496E6,4.728E6,1.00,0.92,1.68,1.77,20,3,3,iTRAQ 4plex (K  N-term),20022,28S ribosomal protein S7  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPS7 PE=1 SV=1
1735,18387,sp|Q9BTK6|PAGR1_HUMAN,11.46,89.01,1.156E6,9.959E5,1.581E6,1.469E6,1.00,0.86,1.37,1.27,1.156E6,9.959E5,1.581E6,1.469E6,1.00,0.86,1.37,1.27,26,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),27716,PAXIP1-associated glutamate-rich protein 1 OS=Homo sapiens OX=9606 GN=PAGR1 PE=1 SV=1
2203,39907,E5RHF4|E5RHF4_HUMAN,31.35,88.94,5.643E5,5.961E5,1.307E6,1.297E6,1.00,1.06,2.32,2.30,5.643E5,5.961E5,1.307E6,1.297E6,1.00,1.06,2.32,2.30,20,3,3,iTRAQ 4plex (K  N-term),21943,39S ribosomal protein L15  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPL15 PE=1 SV=1
1614,13338,sp|Q9NUL5-3|RYDEN_HUMAN,20.31,88.74,3.111E6,3.22E6,6.018E6,5.945E6,1.00,1.04,1.93,1.91,3.111E6,3.22E6,6.018E6,5.945E6,1.00,1.04,1.93,1.91,42,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),18871,Isoform 3 of Repressor of yield of DENV protein OS=Homo sapiens OX=9606 GN=RYDEN
1464,27066,sp|Q9H2K8|TAOK3_HUMAN,0.42,88.52,2.106E6,2.045E6,2.209E6,2.164E6,1.00,0.97,1.05,1.03,2.106E6,2.045E6,2.209E6,2.164E6,1.00,0.97,1.05,1.03,2,7,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),105406,Serine/threonine-protein kinase TAO3 OS=Homo sapiens OX=9606 GN=TAOK3 PE=1 SV=2
1777,39254,F5GY37|F5GY37_HUMAN,17.87,88.38,8.726E5,9.003E5,1.8E6,1.654E6,1.00,1.03,2.06,1.90,8.726E5,9.003E5,1.8E6,1.654E6,1.00,1.03,2.06,1.90,18,5,5,iTRAQ 4plex (K  N-term),29723,Prohibitin-2 OS=Homo sapiens OX=9606 GN=PHB2 PE=1 SV=1
2281,40265,sp|O94813-3|SLIT2_HUMAN,5.75,88.37,2.189E5,2.145E5,3.411E5,3.536E5,1.00,0.98,1.56,1.62,2.189E5,2.145E5,3.411E5,3.536E5,1.00,0.98,1.56,1.62,2,2,2,iTRAQ 4plex (K  N-term),168892,Isoform 3 of Slit homolog 2 protein OS=Homo sapiens OX=9606 GN=SLIT2
1776,2604,sp|Q8WYL5|SSH1_HUMAN,4.54,88.32,7.234E5,7.218E5,8.891E5,9.612E5,1.00,1.00,1.23,1.33,7.234E5,7.218E5,8.891E5,9.612E5,1.00,1.00,1.23,1.33,8,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),115511,Protein phosphatase Slingshot homolog 1 OS=Homo sapiens OX=9606 GN=SSH1 PE=1 SV=2
1107,6846,sp|Q96QV6|H2A1A_HUMAN,4.14,88.20,6.953E5,6.892E5,9.359E5,1.102E6,1.00,0.99,1.35,1.58,6.953E5,6.892E5,9.359E5,1.102E6,1.00,0.99,1.35,1.58,20,4,2,iTRAQ 4plex (K  N-term),14233,Histone H2A type 1-A OS=Homo sapiens OX=9606 GN=HIST1H2AA PE=1 SV=3
1726,20982,sp|O75886|STAM2_HUMAN,26.50,88.14,6.322E5,6.037E5,1.403E6,1.322E6,1.00,0.95,2.22,2.09,6.322E5,6.037E5,1.403E6,1.322E6,1.00,0.95,2.22,2.09,11,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),58164,Signal transducing adapter molecule 2 OS=Homo sapiens OX=9606 GN=STAM2 PE=1 SV=1
1538,22248,sp|O43865|SAHH2_HUMAN,6.30,88.00,1.098E6,9.488E5,1.867E6,1.733E6,1.00,0.86,1.70,1.58,1.098E6,9.488E5,1.867E6,1.733E6,1.00,0.86,1.70,1.58,4,5,2,iTRAQ 4plex (K  N-term),58952,S-adenosylhomocysteine hydrolase-like protein 1 OS=Homo sapiens OX=9606 GN=AHCYL1 PE=1 SV=2
2009,144,sp|P04080|CYTB_HUMAN,7.91,88.00,1.322E6,1.32E6,1.814E6,1.74E6,1.00,1.00,1.37,1.32,1.322E6,1.32E6,1.814E6,1.74E6,1.00,1.00,1.37,1.32,32,3,3,iTRAQ 4plex (K  N-term),11140,Cystatin-B OS=Homo sapiens OX=9606 GN=CSTB PE=1 SV=2
1762,19097,sp|Q04206-2|TF65_HUMAN,7.71,87.80,4.581E5,4.6E5,6.34E5,6.046E5,1.00,1.00,1.38,1.32,4.581E5,4.6E5,6.34E5,6.046E5,1.00,1.00,1.38,1.32,7,3,3,iTRAQ 4plex (K  N-term),58807,Isoform 2 of Transcription factor p65 OS=Homo sapiens OX=9606 GN=RELA
1985,23476,sp|Q9HC07|TM165_HUMAN,2.62,87.71,1.329E6,1.229E6,9.603E5,9.567E5,1.00,0.92,0.72,0.72,1.329E6,1.229E6,9.603E5,9.567E5,1.00,0.92,0.72,0.72,13,2,2,iTRAQ 4plex (K  N-term),34906,Transmembrane protein 165 OS=Homo sapiens OX=9606 GN=TMEM165 PE=1 SV=1
1775,1732,H3BTW3|H3BTW3_HUMAN,6.68,87.60,4.246E5,4.158E5,8.374E5,8.158E5,1.00,0.98,1.97,1.92,4.246E5,4.158E5,8.374E5,8.158E5,1.00,0.98,1.97,1.92,2,5,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),273253,Chromodomain-helicase-DNA-binding protein 9 OS=Homo sapiens OX=9606 GN=CHD9 PE=1 SV=9
1723,39182,sp|P23458|JAK1_HUMAN,13.89,87.51,1.802E6,1.812E6,3.252E6,3.225E6,1.00,1.01,1.80,1.79,1.802E6,1.812E6,3.252E6,3.225E6,1.00,1.01,1.80,1.79,4,6,5,iTRAQ 4plex (K  N-term),133277,Tyrosine-protein kinase JAK1 OS=Homo sapiens OX=9606 GN=JAK1 PE=1 SV=2
1918,24063,sp|O95573|ACSL3_HUMAN,3.37,87.47,3.163E5,2.717E5,4.26E5,3.934E5,1.00,0.86,1.35,1.24,3.163E5,2.717E5,4.26E5,3.934E5,1.00,0.86,1.35,1.24,3,4,2,iTRAQ 4plex (K  N-term),80420,Long-chain-fatty-acid--CoA ligase 3 OS=Homo sapiens OX=9606 GN=ACSL3 PE=1 SV=3
1266,19866,A0A087WWX0|A0A087WWX0_HUMAN,37.31,87.46,4.541E6,4.405E6,1.004E7,1.002E7,1.00,0.97,2.21,2.21,4.541E6,4.405E6,1.004E7,1.002E7,1.00,0.97,2.21,2.21,30,4,4,iTRAQ 4plex (K  N-term); Oxidation (M),15540,DNA-directed RNA polymerases I  II  and III subunit RPABC1 (Fragment) OS=Homo sapiens OX=9606 GN=POLR2E PE=1 SV=1
1408,39153,sp|P61619|S61A1_HUMAN,13.18,87.39,2.087E6,2.031E6,3.683E6,3.593E6,1.00,0.97,1.76,1.72,2.087E6,2.031E6,3.683E6,3.593E6,1.00,0.97,1.76,1.72,12,6,6,iTRAQ 4plex (K  N-term),52265,Protein transport protein Sec61 subunit alpha isoform 1 OS=Homo sapiens OX=9606 GN=SEC61A1 PE=1 SV=2
1826,39586,sp|Q13950-2|RUNX2_HUMAN,14.79,87.39,1.32E6,1.455E6,2.176E6,1.985E6,1.00,1.10,1.65,1.50,1.32E6,1.455E6,2.176E6,1.985E6,1.00,1.10,1.65,1.50,7,4,4,iTRAQ 4plex (K  N-term),55054,Isoform 2 of Runt-related transcription factor 2 OS=Homo sapiens OX=9606 GN=RUNX2
1555,3779,sp|Q9NYV4-2|CDK12_HUMAN,3.30,87.27,1.274E5,1.275E5,1.94E5,1.917E5,1.00,1.00,1.52,1.50,1.274E5,1.275E5,1.94E5,1.917E5,1.00,1.00,1.52,1.50,2,4,2,iTRAQ 4plex (K  N-term); Phosphorylation (STY),163227,Isoform 2 of Cyclin-dependent kinase 12 OS=Homo sapiens OX=9606 GN=CDK12
1977,22662,A0A0J9YWI3|A0A0J9YWI3_HUMAN,4.74,87.27,1.657E5,1.632E5,5.931E5,5.267E5,1.00,0.98,3.58,3.18,1.657E5,1.632E5,5.931E5,5.267E5,1.00,0.98,3.58,3.18,22,3,1,iTRAQ 4plex (K  N-term),8115,FERM domain-containing protein 4A (Fragment) OS=Homo sapiens OX=9606 GN=FRMD4A PE=1 SV=1
1772,40059,sp|Q7RTP6|MICA3_HUMAN,1.31,87.20,2.43E5,2.308E5,3.407E5,3.627E5,1.00,0.95,1.40,1.49,2.43E5,2.308E5,3.407E5,3.627E5,1.00,0.95,1.40,1.49,1,4,1,iTRAQ 4plex (K  N-term),224293,[F-actin]-monooxygenase MICAL3 OS=Homo sapiens OX=9606 GN=MICAL3 PE=1 SV=2
1434,19906,sp|Q15427|SF3B4_HUMAN,16.27,87.20,2.483E6,2.653E6,4.319E6,4.342E6,1.00,1.07,1.74,1.75,2.483E6,2.653E6,4.319E6,4.342E6,1.00,1.07,1.74,1.75,12,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),44386,Splicing factor 3B subunit 4 OS=Homo sapiens OX=9606 GN=SF3B4 PE=1 SV=1
1467,19992,sp|Q92769|HDAC2_HUMAN,8.03,87.19,7.142E5,7.623E5,1.631E6,1.583E6,1.00,1.07,2.28,2.22,7.142E5,7.623E5,1.631E6,1.583E6,1.00,1.07,2.28,2.22,3,4,2,iTRAQ 4plex (K  N-term),55364,Histone deacetylase 2 OS=Homo sapiens OX=9606 GN=HDAC2 PE=1 SV=2
1619,19711,sp|O75586|MED6_HUMAN,6.93,87.15,1.915E6,1.949E6,2.646E6,2.545E6,1.00,1.02,1.38,1.33,1.915E6,1.949E6,2.646E6,2.545E6,1.00,1.02,1.38,1.33,16,4,4,iTRAQ 4plex (K  N-term),28425,Mediator of RNA polymerase II transcription subunit 6 OS=Homo sapiens OX=9606 GN=MED6 PE=1 SV=2
1767,20300,sp|O00308-2|WWP2_HUMAN,8.92,87.02,3.181E5,2.896E5,4.424E5,4.253E5,1.00,0.91,1.39,1.34,3.181E5,2.896E5,4.424E5,4.253E5,1.00,0.91,1.39,1.34,5,4,3,iTRAQ 4plex (K  N-term),86308,Isoform 2 of NEDD4-like E3 ubiquitin-protein ligase WWP2 OS=Homo sapiens OX=9606 GN=WWP2
1886,6743,sp|Q9UKJ3-2|GPTC8_HUMAN,18.66,86.92,4.291E5,3.788E5,7.223E5,6.959E5,1.00,0.88,1.68,1.62,4.291E5,3.788E5,7.223E5,6.959E5,1.00,0.88,1.68,1.62,3,4,4,iTRAQ 4plex (K  N-term),155193,Isoform 2 of G patch domain-containing protein 8 OS=Homo sapiens OX=9606 GN=GPATCH8
1556,39552,sp|P31689-2|DNJA1_HUMAN,12.01,86.90,2.202E6,2.265E6,3.458E6,3.523E6,1.00,1.03,1.57,1.60,2.202E6,2.265E6,3.458E6,3.523E6,1.00,1.03,1.57,1.60,12,4,4,iTRAQ 4plex (K  N-term),37045,Isoform 2 of DnaJ homolog subfamily A member 1 OS=Homo sapiens OX=9606 GN=DNAJA1
1914,39376,sp|Q8N3R9-2|MPP5_HUMAN,13.74,86.73,1.171E6,1.21E6,1.9E6,1.961E6,1.00,1.03,1.62,1.67,1.171E6,1.21E6,1.9E6,1.961E6,1.00,1.03,1.62,1.67,7,4,4,iTRAQ 4plex (K  N-term),73421,Isoform 2 of MAGUK p55 subfamily member 5 OS=Homo sapiens OX=9606 GN=MPP5
2199,39845,sp|P61812|TGFB2_HUMAN,21.00,86.69,5.601E5,5.998E5,1.142E6,1.122E6,1.00,1.07,2.04,2.00,5.601E5,5.998E5,1.142E6,1.122E6,1.00,1.07,2.04,2.00,8,3,3,iTRAQ 4plex (K  N-term),47748,Transforming growth factor beta-2 proprotein OS=Homo sapiens OX=9606 GN=TGFB2 PE=1 SV=1
1541,24354,B4DUR8|B4DUR8_HUMAN,0.94,86.63,4.725E6,4.469E6,4.647E6,4.7E6,1.00,0.95,0.98,0.99,4.725E6,4.469E6,4.647E6,4.7E6,1.00,0.95,0.98,0.99,11,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),55674,T-complex protein 1 subunit gamma OS=Homo sapiens OX=9606 GN=CCT3 PE=1 SV=1
1634,19982,sp|Q9BTT4|MED10_HUMAN,5.49,86.61,4.393E6,4.445E6,5.734E6,5.613E6,1.00,1.01,1.31,1.28,4.393E6,4.445E6,5.734E6,5.613E6,1.00,1.01,1.31,1.28,29,4,4,iTRAQ 4plex (K  N-term),15688,Mediator of RNA polymerase II transcription subunit 10 OS=Homo sapiens OX=9606 GN=MED10 PE=1 SV=1
1446,9435,sp|Q09028-3|RBBP4_HUMAN,22.00,86.59,2.818E6,2.38E6,4.626E6,4.461E6,1.00,0.84,1.64,1.58,2.818E6,2.38E6,4.626E6,4.461E6,1.00,0.84,1.64,1.58,9,4,4,iTRAQ 4plex (K  N-term),46158,Isoform 3 of Histone-binding protein RBBP4 OS=Homo sapiens OX=9606 GN=RBBP4
1969,10842,sp|Q9BY77|PDIP3_HUMAN,2.46,86.46,1.396E5,1.37E5,2.983E5,2.918E5,1.00,0.98,2.14,2.09,1.396E5,1.37E5,2.983E5,2.918E5,1.00,0.98,2.14,2.09,2,3,1,iTRAQ 4plex (K  N-term),46089,Polymerase delta-interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3 PE=1 SV=2
1717,19405,sp|Q15293|RCN1_HUMAN,10.36,86.42,1.19E6,1.139E6,1.75E6,1.823E6,1.00,0.96,1.47,1.53,1.19E6,1.139E6,1.75E6,1.823E6,1.00,0.96,1.47,1.53,13,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),38890,Reticulocalbin-1 OS=Homo sapiens OX=9606 GN=RCN1 PE=1 SV=1
1780,21315,K7EK35|K7EK35_HUMAN,9.42,86.39,8.612E5,8.783E5,1.342E6,1.302E6,1.00,1.02,1.56,1.51,8.612E5,8.783E5,1.342E6,1.302E6,1.00,1.02,1.56,1.51,6,4,4,iTRAQ 4plex (K  N-term),87362,Signal transducer and activator of transcription OS=Homo sapiens OX=9606 GN=STAT5A PE=1 SV=1
1830,20410,sp|Q7L2J0|MEPCE_HUMAN,30.05,86.31,1.891E5,1.799E5,4.265E5,4.621E5,1.00,0.95,2.26,2.44,1.891E5,1.799E5,4.265E5,4.621E5,1.00,0.95,2.26,2.44,6,3,3,iTRAQ 4plex (K  N-term),74355,7SK snRNA methylphosphate capping enzyme OS=Homo sapiens OX=9606 GN=MEPCE PE=1 SV=1
1621,10288,sp|Q15438-2|CYH1_HUMAN,5.87,86.31,3.703E5,3.728E5,7.845E5,7.77E5,1.00,1.01,2.12,2.10,3.703E5,3.728E5,7.845E5,7.77E5,1.00,1.01,2.12,2.10,4,5,2,iTRAQ 4plex (K  N-term),46356,Isoform 2 of Cytohesin-1 OS=Homo sapiens OX=9606 GN=CYTH1
1641,39965,Q5VZR0|Q5VZR0_HUMAN,11.92,86.27,1.558E6,1.497E6,2.287E6,2.246E6,1.00,0.96,1.47,1.44,1.558E6,1.497E6,2.287E6,2.246E6,1.00,0.96,1.47,1.44,27,3,3,iTRAQ 4plex (K  N-term),14213,Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=1
1927,21105,sp|Q93034|CUL5_HUMAN,4.97,86.25,1.439E6,1.482E6,1.918E6,1.884E6,1.00,1.03,1.33,1.31,1.439E6,1.482E6,1.918E6,1.884E6,1.00,1.03,1.33,1.31,5,4,4,iTRAQ 4plex (K  N-term),90955,Cullin-5 OS=Homo sapiens OX=9606 GN=CUL5 PE=1 SV=4
1761,39355,sp|Q8IWW6-3|RHG12_HUMAN,22.83,86.19,1.189E6,1.253E6,2.497E6,2.432E6,1.00,1.05,2.10,2.05,1.189E6,1.253E6,2.497E6,2.432E6,1.00,1.05,2.10,2.05,7,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),90403,Isoform 3 of Rho GTPase-activating protein 12 OS=Homo sapiens OX=9606 GN=ARHGAP12
1760,5050,sp|Q8TER5-4|ARH40_HUMAN,8.61,86.13,7.511E5,7.68E5,1.151E6,1.14E6,1.00,1.02,1.53,1.52,7.511E5,7.68E5,1.151E6,1.14E6,1.00,1.02,1.53,1.52,3,4,4,iTRAQ 4plex (K  N-term),159698,Isoform 4 of Rho guanine nucleotide exchange factor 40 OS=Homo sapiens OX=9606 GN=ARHGEF40
1998,20654,sp|L0R819|ASURF_HUMAN,26.54,85.94,1.504E6,1.458E6,3.23E6,3.192E6,1.00,0.97,2.15,2.12,1.504E6,1.458E6,3.23E6,3.192E6,1.00,0.97,2.15,2.12,39,4,4,iTRAQ 4plex (K  N-term),11250,ASNSD1 upstream open reading frame protein OS=Homo sapiens OX=9606 GN=ASDURF PE=1 SV=1
1814,39202,sp|Q96QV1|HHIP_HUMAN,6.57,85.74,1.736E6,1.727E6,2.441E6,2.48E6,1.00,0.99,1.41,1.43,1.736E6,1.727E6,2.441E6,2.48E6,1.00,0.99,1.41,1.43,9,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),78851,Hedgehog-interacting protein OS=Homo sapiens OX=9606 GN=HHIP PE=1 SV=3
1520,39502,sp|O60762|DPM1_HUMAN,9.79,85.73,2.555E6,2.385E6,3.646E6,3.643E6,1.00,0.93,1.43,1.43,2.555E6,2.385E6,3.646E6,3.643E6,1.00,0.93,1.43,1.43,15,4,4,iTRAQ 4plex (K  N-term),29634,Dolichol-phosphate mannosyltransferase subunit 1 OS=Homo sapiens OX=9606 GN=DPM1 PE=1 SV=1
1365,39226,sp|Q96PY5|FMNL2_HUMAN,9.15,85.70,3.878E5,3.567E5,5.984E5,5.944E5,1.00,0.92,1.54,1.53,3.878E5,3.567E5,5.984E5,5.944E5,1.00,0.92,1.54,1.53,2,6,3,iTRAQ 4plex (K  N-term),123321,Formin-like protein 2 OS=Homo sapiens OX=9606 GN=FMNL2 PE=1 SV=3
1820,39490,sp|P20337|RAB3B_HUMAN,4.29,85.70,3.981E5,4.292E5,6.613E5,6.21E5,1.00,1.08,1.66,1.56,3.981E5,4.292E5,6.613E5,6.21E5,1.00,1.08,1.66,1.56,13,4,2,iTRAQ 4plex (K  N-term),24758,Ras-related protein Rab-3B OS=Homo sapiens OX=9606 GN=RAB3B PE=1 SV=2
1945,39402,sp|Q9ULV3-5|CIZ1_HUMAN,11.84,85.65,5.851E5,6.215E5,1.006E6,9.856E5,1.00,1.06,1.72,1.68,5.851E5,6.215E5,1.006E6,9.856E5,1.00,1.06,1.72,1.68,6,4,4,iTRAQ 4plex (K  N-term),88520,Isoform 5 of Cip1-interacting zinc finger protein OS=Homo sapiens OX=9606 GN=CIZ1
1720,12501,sp|Q9NWU2|GID8_HUMAN,23.10,85.63,6.446E5,7.094E5,1.106E6,1.135E6,1.00,1.10,1.72,1.76,6.446E5,7.094E5,1.106E6,1.135E6,1.00,1.10,1.72,1.76,17,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),26749,Glucose-induced degradation protein 8 homolog OS=Homo sapiens OX=9606 GN=GID8 PE=1 SV=1
1487,39272,sp|Q9H5V8|CDCP1_HUMAN,9.38,85.62,1.808E6,1.727E6,2.611E6,2.723E6,1.00,0.96,1.44,1.51,1.808E6,1.727E6,2.611E6,2.723E6,1.00,0.96,1.44,1.51,6,5,5,iTRAQ 4plex (K  N-term),92932,CUB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CDCP1 PE=1 SV=3
1694,39850,sp|Q9GZT3-2|SLIRP_HUMAN,7.61,85.58,4.129E6,4.085E6,5.572E6,5.685E6,1.00,0.99,1.35,1.38,4.129E6,4.085E6,5.572E6,5.685E6,1.00,0.99,1.35,1.38,34,4,4,iTRAQ 4plex (K  N-term),12122,Isoform 2 of SRA stem-loop-interacting RNA-binding protein  mitochondrial OS=Homo sapiens OX=9606 GN=SLIRP
1422,39289,M0R2Q7|M0R2Q7_HUMAN,2.07,85.58,6.056E4,7.175E4,1.173E5,1.196E5,1.00,1.18,1.94,1.98,6.056E4,7.175E4,1.173E5,1.196E5,1.00,1.18,1.94,1.98,4,5,1,iTRAQ 4plex (K  N-term),20435,Signal-induced proliferation-associated 1-like protein 3 (Fragment) OS=Homo sapiens OX=9606 GN=SIPA1L3 PE=1 SV=2
1502,23422,sp|P60468|SC61B_HUMAN,18.24,85.57,3.563E6,3.653E6,6.615E6,6.378E6,1.00,1.03,1.86,1.79,3.563E6,3.653E6,6.615E6,6.378E6,1.00,1.03,1.86,1.79,34,4,4,iTRAQ 4plex (K  N-term),9974,Protein transport protein Sec61 subunit beta OS=Homo sapiens OX=9606 GN=SEC61B PE=1 SV=2
1574,2292,sp|Q5TAX3|TUT4_HUMAN,11.58,85.57,1.803E6,1.869E6,3.279E6,2.998E6,1.00,1.04,1.82,1.66,1.803E6,1.869E6,3.279E6,2.998E6,1.00,1.04,1.82,1.66,4,7,7,iTRAQ 4plex (K  N-term),185164,Terminal uridylyltransferase 4 OS=Homo sapiens OX=9606 GN=TUT4 PE=1 SV=3
2018,21436,sp|Q8TAT6|NPL4_HUMAN,40.46,85.57,1.153E6,1.171E6,2.683E6,2.54E6,1.00,1.02,2.33,2.20,1.153E6,1.171E6,2.683E6,2.54E6,1.00,1.02,2.33,2.20,5,3,3,iTRAQ 4plex (K  N-term),68120,Nuclear protein localization protein 4 homolog OS=Homo sapiens OX=9606 GN=NPLOC4 PE=1 SV=3
2094,12539,sp|P82675|RT05_HUMAN,30.15,85.48,6.33E5,6.716E5,1.219E6,1.268E6,1.00,1.06,1.93,2.00,6.33E5,6.716E5,1.219E6,1.268E6,1.00,1.06,1.93,2.00,8,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),48007,28S ribosomal protein S5  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS5 PE=1 SV=2
1680,39430,sp|A3KMH1|VWA8_HUMAN,20.00,85.45,7.425E5,6.934E5,1.416E6,1.39E6,1.00,0.93,1.91,1.87,7.425E5,6.934E5,1.416E6,1.39E6,1.00,0.93,1.91,1.87,3,6,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),214823,von Willebrand factor A domain-containing protein 8 OS=Homo sapiens OX=9606 GN=VWA8 PE=1 SV=2
2148,19446,sp|O43164-2|PJA2_HUMAN,20.10,85.42,1.503E5,1.626E5,3.285E5,3.267E5,1.00,1.08,2.19,2.17,1.503E5,1.626E5,3.285E5,3.267E5,1.00,1.08,2.19,2.17,6,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),76091,Isoform 2 of E3 ubiquitin-protein ligase Praja-2 OS=Homo sapiens OX=9606 GN=PJA2
1431,39280,sp|Q96IJ6|GMPPA_HUMAN,26.08,85.40,1.152E6,1.235E6,3.137E6,2.109E6,1.00,1.07,2.72,1.83,1.152E6,1.235E6,3.137E6,2.109E6,1.00,1.07,2.72,1.83,16,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),46291,Mannose-1-phosphate guanyltransferase alpha OS=Homo sapiens OX=9606 GN=GMPPA PE=1 SV=1
1891,16231,sp|Q15291-2|RBBP5_HUMAN,7.99,85.39,1.582E6,1.669E6,2.302E6,2.202E6,1.00,1.05,1.45,1.39,1.582E6,1.669E6,2.302E6,2.202E6,1.00,1.05,1.45,1.39,8,4,4,iTRAQ 4plex (K  N-term),55072,Isoform 2 of Retinoblastoma-binding protein 5 OS=Homo sapiens OX=9606 GN=RBBP5
1074,16887,sp|Q00325-2|MPCP_HUMAN,15.39,85.35,5.74E6,5.899E6,1.011E7,9.598E6,1.00,1.03,1.76,1.67,5.74E6,5.899E6,1.011E7,9.598E6,1.00,1.03,1.76,1.67,14,6,6,iTRAQ 4plex (K  N-term); Deamidation (NQ),39959,Isoform B of Phosphate carrier protein  mitochondrial OS=Homo sapiens OX=9606 GN=SLC25A3
1051,20180,sp|P84090|ERH_HUMAN,9.75,85.27,4.311E6,4.331E6,6.404E6,6.181E6,1.00,1.00,1.49,1.43,4.311E6,4.331E6,6.404E6,6.181E6,1.00,1.00,1.49,1.43,25,5,5,iTRAQ 4plex (K  N-term); Oxidation (M),12259,Enhancer of rudimentary homolog OS=Homo sapiens OX=9606 GN=ERH PE=1 SV=1
1564,39291,sp|O95470|SGPL1_HUMAN,11.31,85.27,1.684E6,1.592E6,2.613E6,2.53E6,1.00,0.95,1.55,1.50,1.684E6,1.592E6,2.613E6,2.53E6,1.00,0.95,1.55,1.50,9,5,5,iTRAQ 4plex (K  N-term),63524,Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3
1443,20142,sp|Q13503|MED21_HUMAN,5.76,85.13,2.808E6,2.883E6,3.672E6,3.473E6,1.00,1.03,1.31,1.24,2.808E6,2.883E6,3.672E6,3.473E6,1.00,1.03,1.31,1.24,38,5,5,iTRAQ 4plex (K  N-term),15564,Mediator of RNA polymerase II transcription subunit 21 OS=Homo sapiens OX=9606 GN=MED21 PE=1 SV=1
1432,20906,sp|P49458|SRP09_HUMAN,11.33,85.10,1.34E7,1.363E7,2.004E7,2.009E7,1.00,1.02,1.49,1.50,1.34E7,1.363E7,2.004E7,2.009E7,1.00,1.02,1.49,1.50,48,5,5,iTRAQ 4plex (K  N-term),10112,Signal recognition particle 9 kDa protein OS=Homo sapiens OX=9606 GN=SRP9 PE=1 SV=2
1038,11359,sp|P01619|KV320_HUMAN,29.43,85.10,5.77E5,6.073E5,3.97E6,3.822E6,1.00,1.05,6.88,6.62,5.77E5,6.073E5,3.97E6,3.822E6,1.00,1.05,6.88,6.62,23,6,2,iTRAQ 4plex (K  N-term),12557,Immunoglobulin kappa variable 3-20 OS=Homo sapiens OX=9606 GN=IGKV3-20 PE=1 SV=2
1866,39950,sp|Q96EY4|TMA16_HUMAN,1.65,84.99,3.994E6,4.088E6,3.764E6,3.848E6,1.00,1.02,0.94,0.96,3.994E6,4.088E6,3.764E6,3.848E6,1.00,1.02,0.94,0.96,17,3,3,iTRAQ 4plex (K  N-term),23864,Translation machinery-associated protein 16 OS=Homo sapiens OX=9606 GN=TMA16 PE=1 SV=2
1818,20363,K7ERP4|K7ERP4_HUMAN,8.27,84.93,8.04E5,8.147E5,1.247E6,1.202E6,1.00,1.01,1.55,1.50,8.04E5,8.147E5,1.247E6,1.202E6,1.00,1.01,1.55,1.50,27,4,4,iTRAQ 4plex (K  N-term),17629,Glutathione peroxidase (Fragment) OS=Homo sapiens OX=9606 GN=GPX4 PE=1 SV=1
1915,39412,sp|Q9UHB7|AFF4_HUMAN,18.88,84.92,7.151E5,7.224E5,1.496E6,1.462E6,1.00,1.01,2.09,2.04,7.151E5,7.224E5,1.496E6,1.462E6,1.00,1.01,2.09,2.04,4,4,4,iTRAQ 4plex (K  N-term),127459,AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1
1223,39313,sp|P35625|TIMP3_HUMAN,15.96,84.92,5.775E6,5.697E6,1.023E7,9.305E6,1.00,0.99,1.77,1.61,5.775E6,5.697E6,1.023E7,9.305E6,1.00,0.99,1.77,1.61,19,5,5,iTRAQ 4plex (K  N-term),24145,Metalloproteinase inhibitor 3 OS=Homo sapiens OX=9606 GN=TIMP3 PE=1 SV=2
1496,39249,sp|Q9P016-2|THYN1_HUMAN,12.88,84.83,2.675E6,2.494E6,4.377E6,4.426E6,1.00,0.93,1.64,1.65,2.675E6,2.494E6,4.377E6,4.426E6,1.00,0.93,1.64,1.65,27,5,5,iTRAQ 4plex (K  N-term),18812,Isoform 2 of Thymocyte nuclear protein 1 OS=Homo sapiens OX=9606 GN=THYN1
1329,20854,sp|Q9UJY1|HSPB8_HUMAN,22.60,84.72,3.503E6,3.55E6,7.66E6,7.744E6,1.00,1.01,2.19,2.21,3.503E6,3.55E6,7.66E6,7.744E6,1.00,1.01,2.19,2.21,23,5,5,iTRAQ 4plex (K  N-term),21604,Heat shock protein beta-8 OS=Homo sapiens OX=9606 GN=HSPB8 PE=1 SV=1
1933,21347,sp|Q9NWH9|SLTM_HUMAN,22.95,84.72,2.451E5,2.654E5,5.19E5,5.119E5,1.00,1.08,2.12,2.09,2.451E5,2.654E5,5.19E5,5.119E5,1.00,1.08,2.12,2.09,3,4,3,iTRAQ 4plex (K  N-term),117149,SAFB-like transcription modulator OS=Homo sapiens OX=9606 GN=SLTM PE=1 SV=2
2201,39881,sp|Q8TAP9|MPLKI_HUMAN,21.61,84.69,3.968E5,4.134E5,7.676E5,7.743E5,1.00,1.04,1.93,1.95,3.968E5,4.134E5,7.676E5,7.743E5,1.00,1.04,1.93,1.95,24,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),19147,M-phase-specific PLK1-interacting protein OS=Homo sapiens OX=9606 GN=MPLKIP PE=1 SV=1
2114,23642,sp|O95199-2|RCBT2_HUMAN,2.79,84.63,3.314E5,3.14E5,4.354E5,4.245E5,1.00,0.95,1.31,1.28,3.314E5,3.14E5,4.354E5,4.245E5,1.00,0.95,1.31,1.28,6,2,2,iTRAQ 4plex (K  N-term),57769,Isoform 2 of RCC1 and BTB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RCBTB2
1640,39799,sp|Q13442|HAP28_HUMAN,11.29,84.63,1.835E6,1.856E6,2.841E6,2.897E6,1.00,1.01,1.55,1.58,1.835E6,1.856E6,2.841E6,2.897E6,1.00,1.01,1.55,1.58,22,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),20630,28 kDa heat- and acid-stable phosphoprotein OS=Homo sapiens OX=9606 GN=PDAP1 PE=1 SV=1
1990,20453,B4DLN1|B4DLN1_HUMAN,42.17,84.62,2.616E6,2.687E6,6.399E6,6.511E6,1.00,1.03,2.45,2.49,2.616E6,2.687E6,6.399E6,6.511E6,1.00,1.03,2.45,2.49,5,3,3,iTRAQ 4plex (K  N-term),48099,cDNA FLJ60124  highly similar to Mitochondrial dicarboxylate carrier OS=Homo sapiens OX=9606 PE=2 SV=1
1829,24780,sp|P61586|RHOA_HUMAN,9.87,84.57,1.975E6,1.842E6,2.59E6,2.782E6,1.00,0.93,1.31,1.41,1.975E6,1.842E6,2.59E6,2.782E6,1.00,0.93,1.31,1.41,20,3,3,iTRAQ 4plex (K  N-term),21768,Transforming protein RhoA OS=Homo sapiens OX=9606 GN=RHOA PE=1 SV=1
1499,11632,sp|P05023-3|AT1A1_HUMAN,7.82,84.56,1.645E6,1.661E6,2.489E6,2.447E6,1.00,1.01,1.51,1.49,1.645E6,1.661E6,2.489E6,2.447E6,1.00,1.01,1.51,1.49,6,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),109550,Isoform 3 of Sodium/potassium-transporting ATPase subunit alpha-1 OS=Homo sapiens OX=9606 GN=ATP1A1
1498,21104,sp|P27797|CALR_HUMAN,9.45,84.55,1.585E6,1.338E6,2.056E6,2.045E6,1.00,0.84,1.30,1.29,1.585E6,1.338E6,2.056E6,2.045E6,1.00,0.84,1.30,1.29,17,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),48142,Calreticulin OS=Homo sapiens OX=9606 GN=CALR PE=1 SV=1
2004,9541,H3BU16|H3BU16_HUMAN,7.44,84.51,1.166E6,1.166E6,1.598E6,1.653E6,1.00,1.00,1.37,1.42,1.166E6,1.166E6,1.598E6,1.653E6,1.00,1.00,1.37,1.42,23,3,3,iTRAQ 4plex (K  N-term),17604,Jupiter microtubule-associated homolog 2 (Fragment) OS=Homo sapiens OX=9606 GN=JPT2 PE=1 SV=1
1321,18816,sp|Q8NF64-3|ZMIZ2_HUMAN,18.37,84.49,3.536E5,3.727E5,8.36E5,8.568E5,1.00,1.05,2.36,2.42,3.536E5,3.727E5,8.36E5,8.568E5,1.00,1.05,2.36,2.42,3,6,3,iTRAQ 4plex (K  N-term),91112,Isoform 3 of Zinc finger MIZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ZMIZ2
1929,39392,sp|P35251-2|RFC1_HUMAN,8.36,84.45,4.442E5,4.376E5,6.366E5,6.716E5,1.00,0.99,1.43,1.51,4.442E5,4.376E5,6.366E5,6.716E5,1.00,0.99,1.43,1.51,5,4,4,iTRAQ 4plex (K  N-term),128183,Isoform 2 of Replication factor C subunit 1 OS=Homo sapiens OX=9606 GN=RFC1
2149,22365,sp|P25786|PSA1_HUMAN,14.36,84.32,4.805E5,4.135E5,7.388E5,7.531E5,1.00,0.86,1.54,1.57,4.805E5,4.135E5,7.388E5,7.531E5,1.00,0.86,1.54,1.57,14,3,3,iTRAQ 4plex (K  N-term),29556,Proteasome subunit alpha type-1 OS=Homo sapiens OX=9606 GN=PSMA1 PE=1 SV=1
1863,19488,sp|Q9H7C9|AAMDC_HUMAN,4.96,84.23,1.727E6,1.7E6,2.182E6,2.16E6,1.00,0.98,1.26,1.25,1.727E6,1.7E6,2.182E6,2.16E6,1.00,0.98,1.26,1.25,28,3,3,iTRAQ 4plex (K  N-term),13332,Mth938 domain-containing protein OS=Homo sapiens OX=9606 GN=AAMDC PE=1 SV=1
1729,11137,sp|Q92908-2|GATA6_HUMAN,22.77,84.21,7.514E5,6.062E5,1.36E6,1.372E6,1.00,0.81,1.81,1.83,7.514E5,6.062E5,1.36E6,1.372E6,1.00,0.81,1.81,1.83,15,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),45387,Isoform 2 of Transcription factor GATA-6 OS=Homo sapiens OX=9606 GN=GATA6
2002,39829,sp|Q6KC79-2|NIPBL_HUMAN,13.29,84.21,4.219E5,3.945E5,6.57E5,6.034E5,1.00,0.93,1.56,1.43,4.219E5,3.945E5,6.57E5,6.034E5,1.00,0.93,1.56,1.43,2,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),304343,Isoform 2 of Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL
1387,14791,I3L1K6|I3L1K6_HUMAN,1.01,84.07,2.597E5,2.701E5,3.44E5,3.701E5,1.00,1.04,1.32,1.42,2.597E5,2.701E5,3.44E5,3.701E5,1.00,1.04,1.32,1.42,8,5,1,iTRAQ 4plex (K  N-term),18874,Myosin light chain 4 (Fragment) OS=Homo sapiens OX=9606 GN=MYL4 PE=1 SV=1
1749,1150,sp|O95714|HERC2_HUMAN,5.84,84.05,1.837E6,1.837E6,2.539E6,2.489E6,1.00,1.00,1.38,1.35,1.837E6,1.837E6,2.539E6,2.489E6,1.00,1.00,1.38,1.35,1,5,5,iTRAQ 4plex (K  N-term),527234,E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2
678,8434,sp|A0A0C4DH68|KV224_HUMAN,5.20,84.02,2.419E5,3.191E5,9.081E5,9.782E5,1.00,1.32,3.75,4.04,2.419E5,3.191E5,9.081E5,9.782E5,1.00,1.32,3.75,4.04,11,5,1,iTRAQ 4plex (K  N-term),13079,Immunoglobulin kappa variable 2-24 OS=Homo sapiens OX=9606 GN=IGKV2-24 PE=3 SV=1
1981,12766,B8ZZQ4|B8ZZQ4_HUMAN,6.49,83.91,2.083E5,2.02E5,1.053E6,1.018E6,1.00,0.97,5.06,4.89,2.083E5,2.02E5,1.053E6,1.018E6,1.00,0.97,5.06,4.89,5,3,1,iTRAQ 4plex (K  N-term),21076,Pentatricopeptide repeat domain-containing protein 3  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=PTCD3 PE=1 SV=3
873,39525,sp|P01762|HV311_HUMAN,3.01,83.82,2.277E5,2.369E5,5.691E5,5.118E5,1.00,1.04,2.50,2.25,2.277E5,2.369E5,5.691E5,5.118E5,1.00,1.04,2.50,2.25,11,5,1,iTRAQ 4plex (K  N-term); Acetylation (Protein N-term); Deamidation (NQ),12909,Immunoglobulin heavy variable 3-11 OS=Homo sapiens OX=9606 GN=IGHV3-11 PE=1 SV=2
1368,8613,sp|Q8NBS9-2|TXND5_HUMAN,17.48,83.78,3.746E6,3.768E6,6.483E6,6.276E6,1.00,1.01,1.73,1.68,3.746E6,3.768E6,6.483E6,6.276E6,1.00,1.01,1.73,1.68,9,3,3,iTRAQ 4plex (K  N-term),36178,Isoform 2 of Thioredoxin domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TXNDC5
1649,8890,sp|Q9NYK5|RM39_HUMAN,15.59,83.51,1.151E6,1.213E6,2.25E6,2.149E6,1.00,1.05,1.96,1.87,1.151E6,1.213E6,2.25E6,2.149E6,1.00,1.05,1.96,1.87,14,5,5,iTRAQ 4plex (K  N-term),38712,39S ribosomal protein L39  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL39 PE=1 SV=3
1000,20263,sp|P83881|RL36A_HUMAN,3.52,83.50,3.438E6,3.5E6,5.007E6,5.211E6,1.00,1.02,1.46,1.52,3.438E6,3.5E6,5.007E6,5.211E6,1.00,1.02,1.46,1.52,9,5,2,iTRAQ 4plex (K  N-term),12441,60S ribosomal protein L36a OS=Homo sapiens OX=9606 GN=RPL36A PE=1 SV=2
2001,21568,K7EJ44|K7EJ44_HUMAN,8.65,83.40,7.089E5,6.453E5,8.085E5,9.561E5,1.00,0.91,1.14,1.35,7.089E5,6.453E5,8.085E5,9.561E5,1.00,0.91,1.14,1.35,35,3,3,iTRAQ 4plex (K  N-term),11390,Profilin OS=Homo sapiens OX=9606 GN=PFN1 PE=1 SV=1
1782,3780,D6RCP5|D6RCP5_HUMAN,18.51,83.38,3.985E5,4.043E5,8.54E5,8.164E5,1.00,1.01,2.14,2.05,3.985E5,4.043E5,8.54E5,8.164E5,1.00,1.01,2.14,2.05,9,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),69481,Rho GTPase-activating protein 24 (Fragment) OS=Homo sapiens OX=9606 GN=ARHGAP24 PE=1 SV=1
1825,19893,sp|Q9NSC5-5|HOME3_HUMAN,13.51,83.26,9.022E5,9.232E5,1.599E6,1.609E6,1.00,1.02,1.77,1.78,9.022E5,9.232E5,1.599E6,1.609E6,1.00,1.02,1.77,1.78,14,4,4,iTRAQ 4plex (K  N-term),35954,Isoform 5 of Homer protein homolog 3 OS=Homo sapiens OX=9606 GN=HOMER3
1605,39624,sp|Q92522|H1X_HUMAN,6.75,83.23,1.05E6,1.032E6,1.399E6,1.453E6,1.00,0.98,1.33,1.38,1.05E6,1.032E6,1.399E6,1.453E6,1.00,0.98,1.33,1.38,18,4,4,iTRAQ 4plex (K  N-term); Phosphorylation (STY),22487,Histone H1x OS=Homo sapiens OX=9606 GN=H1FX PE=1 SV=1
2068,39640,sp|Q96GA3|LTV1_HUMAN,17.47,83.22,4.993E5,4.576E5,7.989E5,7.697E5,1.00,0.92,1.60,1.54,4.993E5,4.576E5,7.989E5,7.697E5,1.00,0.92,1.60,1.54,10,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),54855,Protein LTV1 homolog OS=Homo sapiens OX=9606 GN=LTV1 PE=1 SV=1
1665,39560,sp|Q8WU79-2|SMAP2_HUMAN,22.83,83.20,8.504E5,8.947E5,1.766E6,1.728E6,1.00,1.05,2.08,2.03,8.504E5,8.947E5,1.766E6,1.728E6,1.00,1.05,2.08,2.03,11,4,4,iTRAQ 4plex (K  N-term),43490,Isoform 2 of Stromal membrane-associated protein 2 OS=Homo sapiens OX=9606 GN=SMAP2
1543,39468,sp|Q92572|AP3S1_HUMAN,9.84,83.20,1.868E6,1.919E6,2.989E6,3.01E6,1.00,1.03,1.60,1.61,1.868E6,1.919E6,2.989E6,3.01E6,1.00,1.03,1.60,1.61,21,4,4,iTRAQ 4plex (K  N-term),21732,AP-3 complex subunit sigma-1 OS=Homo sapiens OX=9606 GN=AP3S1 PE=1 SV=1
1917,14820,sp|Q9H3U1-2|UN45A_HUMAN,6.57,83.20,8.294E5,8.406E5,1.124E6,1.156E6,1.00,1.01,1.36,1.39,8.294E5,8.406E5,1.124E6,1.156E6,1.00,1.01,1.36,1.39,5,4,4,iTRAQ 4plex (K  N-term),101675,Isoform 2 of Protein unc-45 homolog A OS=Homo sapiens OX=9606 GN=UNC45A
2082,40020,sp|P35249-2|RFC4_HUMAN,19.32,83.19,1.124E6,1.041E6,1.789E6,1.663E6,1.00,0.93,1.59,1.48,1.124E6,1.041E6,1.789E6,1.663E6,1.00,0.93,1.59,1.48,13,3,3,iTRAQ 4plex (K  N-term),33675,Isoform 2 of Replication factor C subunit 4 OS=Homo sapiens OX=9606 GN=RFC4
1706,39395,sp|P35250|RFC2_HUMAN,12.80,83.15,1.619E6,1.684E6,2.642E6,2.704E6,1.00,1.04,1.63,1.67,1.619E6,1.684E6,2.642E6,2.704E6,1.00,1.04,1.63,1.67,15,5,5,iTRAQ 4plex (K  N-term),39157,Replication factor C subunit 2 OS=Homo sapiens OX=9606 GN=RFC2 PE=1 SV=3
1632,39344,sp|P49406|RM19_HUMAN,24.51,83.06,2.221E6,2.024E6,4.562E6,4.402E6,1.00,0.91,2.05,1.98,2.221E6,2.024E6,4.562E6,4.402E6,1.00,0.91,2.05,1.98,14,5,5,iTRAQ 4plex (K  N-term),33535,39S ribosomal protein L19  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL19 PE=1 SV=2
2204,10014,sp|P50452|SPB8_HUMAN,8.22,82.95,1.467E6,1.43E6,2.069E6,1.951E6,1.00,0.98,1.41,1.33,1.467E6,1.43E6,2.069E6,1.951E6,1.00,0.98,1.41,1.33,9,3,3,iTRAQ 4plex (K  N-term),42767,Serpin B8 OS=Homo sapiens OX=9606 GN=SERPINB8 PE=1 SV=2
1751,39347,sp|Q8NEZ4-2|KMT2C_HUMAN,6.28,82.92,3.527E5,3.362E5,5.165E5,5.074E5,1.00,0.95,1.46,1.44,3.527E5,3.362E5,5.165E5,5.074E5,1.00,0.95,1.46,1.44,2,5,4,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),443542,Isoform 2 of Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C
551,5456,sp|P08729|K2C7_HUMAN,1.62,82.91,1.814E5,1.68E5,2.689E5,2.896E5,1.00,0.93,1.48,1.60,1.814E5,1.68E5,2.689E5,2.896E5,1.00,0.93,1.48,1.60,2,5,1,iTRAQ 4plex (K  N-term),51386,Keratin  type II cytoskeletal 7 OS=Homo sapiens OX=9606 GN=KRT7 PE=1 SV=5
1657,18731,sp|Q6IMN6-2|CAPR2_HUMAN,7.01,82.91,1.372E6,1.361E6,2.021E6,1.96E6,1.00,0.99,1.47,1.43,1.372E6,1.361E6,2.021E6,1.96E6,1.00,0.99,1.47,1.43,5,5,5,iTRAQ 4plex (K  N-term),120974,Isoform 2 of Caprin-2 OS=Homo sapiens OX=9606 GN=CAPRIN2
2023,18959,H7C0N4|H7C0N4_HUMAN,0.88,82.90,7.713E4,8.586E4,1.056E5,9.768E4,1.00,1.11,1.37,1.27,7.713E4,8.586E4,1.056E5,9.768E4,1.00,1.11,1.37,1.27,12,2,1,iTRAQ 4plex (K  N-term),18758,Splicing factor 1 (Fragment) OS=Homo sapiens OX=9606 GN=SF1 PE=1 SV=1
2482,7991,sp|Q12778|FOXO1_HUMAN,10.52,82.88,2.138E5,2.093E5,4.797E5,4.56E5,1.00,0.98,2.24,2.13,2.138E5,2.093E5,4.797E5,4.56E5,1.00,0.98,2.24,2.13,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),69662,Forkhead box protein O1 OS=Homo sapiens OX=9606 GN=FOXO1 PE=1 SV=2
1704,39310,sp|Q13496-2|MTM1_HUMAN,6.92,82.87,2.517E5,2.234E5,3.686E5,3.839E5,1.00,0.89,1.46,1.53,2.517E5,2.234E5,3.686E5,3.839E5,1.00,0.89,1.46,1.53,5,5,3,iTRAQ 4plex (K  N-term),66053,Isoform 2 of Myotubularin OS=Homo sapiens OX=9606 GN=MTM1
1862,21883,sp|Q6ICB4|SESQ2_HUMAN,15.27,82.79,1.038E6,1.083E6,1.778E6,1.797E6,1.00,1.04,1.71,1.73,1.038E6,1.083E6,1.778E6,1.797E6,1.00,1.04,1.71,1.73,15,3,3,iTRAQ 4plex (K  N-term),28338,Sesquipedalian-2 OS=Homo sapiens OX=9606 GN=PHETA2 PE=1 SV=1
1950,39840,sp|Q96GP6-2|SREC2_HUMAN,17.44,82.76,4.509E5,4.631E5,8.269E5,8.057E5,1.00,1.03,1.83,1.79,4.509E5,4.631E5,8.269E5,8.057E5,1.00,1.03,1.83,1.79,4,3,3,iTRAQ 4plex (K  N-term),91721,Isoform 2 of Scavenger receptor class F member 2 OS=Homo sapiens OX=9606 GN=SCARF2
1738,39866,sp|Q9UBQ0|VPS29_HUMAN,9.13,82.75,7.738E5,7.481E5,1.104E6,1.135E6,1.00,0.97,1.43,1.47,7.738E5,7.481E5,1.104E6,1.135E6,1.00,0.97,1.43,1.47,16,3,3,iTRAQ 4plex (K  N-term),20506,Vacuolar protein sorting-associated protein 29 OS=Homo sapiens OX=9606 GN=VPS29 PE=1 SV=1
1849,11822,sp|Q5SSJ5-2|HP1B3_HUMAN,9.01,82.70,1.649E6,1.463E6,2.312E6,2.258E6,1.00,0.89,1.40,1.37,1.649E6,1.463E6,2.312E6,2.258E6,1.00,0.89,1.40,1.37,10,5,5,iTRAQ 4plex (K  N-term),57212,Isoform 2 of Heterochromatin protein 1-binding protein 3 OS=Homo sapiens OX=9606 GN=HP1BP3
1799,10506,sp|Q15599|NHRF2_HUMAN,13.28,82.67,8.191E5,8.132E5,1.47E6,1.451E6,1.00,0.99,1.79,1.77,8.191E5,8.132E5,1.47E6,1.451E6,1.00,0.99,1.79,1.77,16,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),37414,Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens OX=9606 GN=SLC9A3R2 PE=1 SV=2
2217,40068,K7ES96|K7ES96_HUMAN,25.68,82.65,5.693E5,6.018E5,1.085E6,1.054E6,1.00,1.06,1.91,1.85,5.693E5,6.018E5,1.085E6,1.054E6,1.00,1.06,1.91,1.85,13,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),35145,Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1
1853,39516,Q5TG80|Q5TG80_HUMAN,6.40,82.49,7.539E5,7.73E5,1.081E6,9.988E5,1.00,1.03,1.43,1.32,7.539E5,7.73E5,1.081E6,9.988E5,1.00,1.03,1.43,1.32,17,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),28296,Voltage-gated potassium channel subunit beta-2 (Fragment) OS=Homo sapiens OX=9606 GN=KCNAB2 PE=1 SV=1
1905,39608,A0A0A0MSK5|A0A0A0MSK5_HUMAN,21.77,82.42,1.456E5,1.624E5,3.327E5,3.24E5,1.00,1.12,2.29,2.23,1.456E5,1.624E5,3.327E5,3.24E5,1.00,1.12,2.29,2.23,9,3,3,iTRAQ 4plex (K  N-term),52406,Torsin-1A-interacting protein 1 OS=Homo sapiens OX=9606 GN=TOR1AIP1 PE=1 SV=1
1926,14627,sp|Q13951|PEBB_HUMAN,8.38,82.37,1.248E6,1.237E6,2.534E6,2.531E6,1.00,0.99,2.03,2.03,1.248E6,1.237E6,2.534E6,2.531E6,1.00,0.99,2.03,2.03,14,2,2,iTRAQ 4plex (K  N-term),21508,Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2
1835,20962,sp|Q96HR3|MED30_HUMAN,9.40,82.32,3.229E6,3.136E6,4.355E6,4.111E6,1.00,0.97,1.35,1.27,3.229E6,3.136E6,4.355E6,4.111E6,1.00,0.97,1.35,1.27,15,3,3,iTRAQ 4plex (K  N-term),20277,Mediator of RNA polymerase II transcription subunit 30 OS=Homo sapiens OX=9606 GN=MED30 PE=1 SV=1
999,39596,sp|P61927|RL37_HUMAN,6.42,82.28,1.407E7,1.413E7,2.024E7,2.09E7,1.00,1.00,1.44,1.49,1.407E7,1.413E7,2.024E7,2.09E7,1.00,1.00,1.44,1.49,35,6,6,iTRAQ 4plex (K  N-term),11078,60S ribosomal protein L37 OS=Homo sapiens OX=9606 GN=RPL37 PE=1 SV=2
1612,39262,sp|O43663-2|PRC1_HUMAN,13.39,82.27,1.111E6,1.079E6,2.034E6,1.983E6,1.00,0.97,1.83,1.78,1.111E6,1.079E6,2.034E6,1.983E6,1.00,0.97,1.83,1.78,10,6,5,iTRAQ 4plex (K  N-term),66596,Isoform 2 of Protein regulator of cytokinesis 1 OS=Homo sapiens OX=9606 GN=PRC1
1548,20819,H7C1L7|H7C1L7_HUMAN,4.01,82.22,1.868E6,1.9E6,2.882E6,2.839E6,1.00,1.02,1.54,1.52,1.868E6,1.9E6,2.882E6,2.839E6,1.00,1.02,1.54,1.52,17,3,2,iTRAQ 4plex (K  N-term),16516,N-acetyl-D-glucosamine kinase OS=Homo sapiens OX=9606 GN=NAGK PE=1 SV=2
1320,10245,sp|P28347|TEAD1_HUMAN,2.96,82.19,1.812E5,2.049E5,4.467E5,3.942E5,1.00,1.13,2.46,2.18,1.812E5,2.049E5,4.467E5,3.942E5,1.00,1.13,2.46,2.18,2,6,1,iTRAQ 4plex (K  N-term),47946,Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2
1932,21245,sp|P46459-2|NSF_HUMAN,8.26,82.10,3.361E5,2.671E5,4.003E5,4.123E5,1.00,0.79,1.19,1.23,3.361E5,2.671E5,4.003E5,4.123E5,1.00,0.79,1.19,1.23,5,4,3,iTRAQ 4plex (K  N-term),71584,Isoform 2 of Vesicle-fusing ATPase OS=Homo sapiens OX=9606 GN=NSF
1892,5553,sp|Q9HCJ0|TNR6C_HUMAN,2.85,82.09,3.983E5,3.979E5,5.753E5,5.724E5,1.00,1.00,1.44,1.44,3.983E5,3.979E5,5.753E5,5.724E5,1.00,1.00,1.44,1.44,1,3,2,iTRAQ 4plex (K  N-term),175964,Trinucleotide repeat-containing gene 6C protein OS=Homo sapiens OX=9606 GN=TNRC6C PE=1 SV=3
1883,39722,sp|Q9UPN4-2|CP131_HUMAN,9.42,81.96,3.901E5,3.577E5,5.11E5,5.468E5,1.00,0.92,1.31,1.40,3.901E5,3.577E5,5.11E5,5.468E5,1.00,0.92,1.31,1.40,6,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),121847,Isoform 2 of Centrosomal protein of 131 kDa OS=Homo sapiens OX=9606 GN=CEP131
1822,5741,sp|Q92609|TBCD5_HUMAN,16.68,81.84,5.141E5,5.428E5,1.028E6,1.007E6,1.00,1.06,2.00,1.96,5.141E5,5.428E5,1.028E6,1.007E6,1.00,1.06,2.00,1.96,5,4,4,iTRAQ 4plex (K  N-term),89004,TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1
1709,14761,sp|P62195|PRS8_HUMAN,3.72,81.78,4.185E5,3.759E5,4.878E5,4.801E5,1.00,0.90,1.17,1.15,4.185E5,3.759E5,4.878E5,4.801E5,1.00,0.90,1.17,1.15,10,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),45626,26S proteasome regulatory subunit 8 OS=Homo sapiens OX=9606 GN=PSMC5 PE=1 SV=1
1893,2840,sp|P46013|KI67_HUMAN,3.68,81.51,8.147E5,8.743E5,7.217E5,6.895E5,1.00,1.07,0.89,0.85,8.147E5,8.743E5,7.217E5,6.895E5,1.00,1.07,0.89,0.85,1,4,4,iTRAQ 4plex (K  N-term),358695,Proliferation marker protein Ki-67 OS=Homo sapiens OX=9606 GN=MKI67 PE=1 SV=2
2151,39744,sp|Q9BRX2|PELO_HUMAN,8.42,81.47,1.229E6,1.25E6,1.817E6,1.744E6,1.00,1.02,1.48,1.42,1.229E6,1.25E6,1.817E6,1.744E6,1.00,1.02,1.48,1.42,8,3,3,iTRAQ 4plex (K  N-term),43359,Protein pelota homolog OS=Homo sapiens OX=9606 GN=PELO PE=1 SV=2
1675,39261,sp|Q96AY3|FKB10_HUMAN,7.80,81.45,3.002E6,3.013E6,4.356E6,4.464E6,1.00,1.00,1.45,1.49,3.002E6,3.013E6,4.356E6,4.464E6,1.00,1.00,1.45,1.49,7,5,5,iTRAQ 4plex (K  N-term),64245,Peptidyl-prolyl cis-trans isomerase FKBP10 OS=Homo sapiens OX=9606 GN=FKBP10 PE=1 SV=1
1712,19214,sp|Q4VC05|BCL7A_HUMAN,4.56,81.40,6.595E5,4.783E5,5.168E5,4.962E5,1.00,0.73,0.78,0.75,6.595E5,4.783E5,5.168E5,4.962E5,1.00,0.73,0.78,0.75,22,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),22810,B-cell CLL/lymphoma 7 protein family member A OS=Homo sapiens OX=9606 GN=BCL7A PE=1 SV=1
2081,20979,sp|Q96BH1|RNF25_HUMAN,23.71,81.37,8.851E5,9.321E5,1.712E6,1.581E6,1.00,1.05,1.93,1.79,8.851E5,9.321E5,1.712E6,1.581E6,1.00,1.05,1.93,1.79,9,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),51219,E3 ubiquitin-protein ligase RNF25 OS=Homo sapiens OX=9606 GN=RNF25 PE=1 SV=1
1734,23311,sp|Q13405|RM49_HUMAN,9.38,81.33,1.318E6,1.446E6,2.032E6,1.942E6,1.00,1.10,1.54,1.47,1.318E6,1.446E6,2.032E6,1.942E6,1.00,1.10,1.54,1.47,23,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),19198,39S ribosomal protein L49  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL49 PE=1 SV=1
1557,21140,sp|Q9NR09|BIRC6_HUMAN,10.76,81.26,6.508E5,6.838E5,1.011E6,1.012E6,1.00,1.05,1.55,1.56,6.508E5,6.838E5,1.011E6,1.012E6,1.00,1.05,1.55,1.56,1,4,3,iTRAQ 4plex (K  N-term),530260,Baculoviral IAP repeat-containing protein 6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=2
1692,39570,E9PBS1|E9PBS1_HUMAN,13.21,81.22,9.814E5,8.96E5,1.682E6,1.727E6,1.00,0.91,1.71,1.76,9.814E5,8.96E5,1.682E6,1.727E6,1.00,0.91,1.71,1.76,12,4,4,iTRAQ 4plex (K  N-term),45652,Multifunctional protein ADE2 (Fragment) OS=Homo sapiens OX=9606 GN=PAICS PE=1 SV=1
1737,39859,sp|Q9NYL4-2|FKB11_HUMAN,11.76,81.12,1.899E6,1.855E6,3.112E6,3.092E6,1.00,0.98,1.64,1.63,1.899E6,1.855E6,3.112E6,3.092E6,1.00,0.98,1.64,1.63,22,4,4,iTRAQ 4plex (K  N-term),15769,Isoform 2 of Peptidyl-prolyl cis-trans isomerase FKBP11 OS=Homo sapiens OX=9606 GN=FKBP11
2153,39811,J3KRI4|J3KRI4_HUMAN,7.22,81.09,4.538E5,4.412E5,6.507E5,6.321E5,1.00,0.97,1.43,1.39,4.538E5,4.412E5,6.507E5,6.321E5,1.00,0.97,1.43,1.39,25,3,3,iTRAQ 4plex (K  N-term),17778,Cytoplasmic dynein 1 light intermediate chain 2 (Fragment) OS=Homo sapiens OX=9606 GN=DYNC1LI2 PE=1 SV=1
1979,23747,sp|P49841|GSK3B_HUMAN,14.63,81.09,7.215E5,7.046E5,1.193E6,1.191E6,1.00,0.98,1.65,1.65,7.215E5,7.046E5,1.193E6,1.191E6,1.00,0.98,1.65,1.65,13,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),46744,Glycogen synthase kinase-3 beta OS=Homo sapiens OX=9606 GN=GSK3B PE=1 SV=2
1458,6775,sp|Q8N1W1-4|ARG28_HUMAN,9.48,80.99,3.03E6,3.098E6,5.063E6,5.101E6,1.00,1.02,1.67,1.68,3.03E6,3.098E6,5.063E6,5.101E6,1.00,1.02,1.67,1.68,4,8,6,iTRAQ 4plex (K  N-term),185843,Isoform 4 of Rho guanine nucleotide exchange factor 28 OS=Homo sapiens OX=9606 GN=ARHGEF28
1852,39456,sp|P46934-4|NEDD4_HUMAN,7.99,80.95,8.18E5,8.35E5,1.252E6,1.189E6,1.00,1.02,1.53,1.45,8.18E5,8.35E5,1.252E6,1.189E6,1.00,1.02,1.53,1.45,7,5,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),104217,Isoform 4 of E3 ubiquitin-protein ligase NEDD4 OS=Homo sapiens OX=9606 GN=NEDD4
1081,5111,sp|Q5JVS0-2|HABP4_HUMAN,16.24,80.93,6.31E5,6.359E5,1.317E6,1.334E6,1.00,1.01,2.09,2.11,6.31E5,6.359E5,1.317E6,1.334E6,1.00,1.01,2.09,2.11,12,4,3,iTRAQ 4plex (K  N-term),34365,Isoform 2 of Intracellular hyaluronan-binding protein 4 OS=Homo sapiens OX=9606 GN=HABP4
2070,39710,sp|O15111|IKKA_HUMAN,31.85,80.83,6.727E5,6.589E5,1.751E6,1.695E6,1.00,0.98,2.60,2.52,6.727E5,6.589E5,1.751E6,1.695E6,1.00,0.98,2.60,2.52,6,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),84640,Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens OX=9606 GN=CHUK PE=1 SV=2
2119,39657,H3BPZ1|H3BPZ1_HUMAN,8.47,80.60,8.771E5,6.757E5,1.026E6,1.003E6,1.00,0.77,1.17,1.14,8.771E5,6.757E5,1.026E6,1.003E6,1.00,0.77,1.17,1.14,9,3,3,iTRAQ 4plex (K  N-term),40069,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase OS=Homo sapiens OX=9606 GN=HACD3 PE=1 SV=1
1088,20810,sp|Q969Q0|RL36L_HUMAN,3.04,80.40,9.969E5,1.086E6,1.477E6,1.465E6,1.00,1.09,1.48,1.47,9.969E5,1.086E6,1.477E6,1.465E6,1.00,1.09,1.48,1.47,9,5,2,iTRAQ 4plex (K  N-term),12469,60S ribosomal protein L36a-like OS=Homo sapiens OX=9606 GN=RPL36AL PE=1 SV=3
1869,40116,sp|Q9UI30-2|TR112_HUMAN,9.34,80.37,9.053E5,9.273E5,1.338E6,1.299E6,1.00,1.02,1.48,1.44,9.053E5,9.273E5,1.338E6,1.299E6,1.00,1.02,1.48,1.44,33,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),13576,Isoform 2 of Multifunctional methyltransferase subunit TRM112-like protein OS=Homo sapiens OX=9606 GN=TRMT112
1703,20346,sp|Q0JRZ9|FCHO2_HUMAN,3.89,80.33,1.51E6,1.407E6,1.764E6,1.83E6,1.00,0.93,1.17,1.21,1.51E6,1.407E6,1.764E6,1.83E6,1.00,0.93,1.17,1.21,6,5,5,iTRAQ 4plex (K  N-term); Phosphorylation (STY),88924,F-BAR domain only protein 2 OS=Homo sapiens OX=9606 GN=FCHO2 PE=1 SV=2
1121,11523,H0YAR1|H0YAR1_HUMAN,1.55,80.25,8.186E5,7.366E5,1.235E6,1.173E6,1.00,0.90,1.51,1.43,8.186E5,7.366E5,1.235E6,1.173E6,1.00,0.90,1.51,1.43,4,4,1,iTRAQ 4plex (K  N-term),22398,Lysyl oxidase homolog 2 (Fragment) OS=Homo sapiens OX=9606 GN=LOXL2 PE=1 SV=1
1870,20936,E5RIE8|E5RIE8_HUMAN,5.23,80.20,2.88E6,2.97E6,3.569E6,3.549E6,1.00,1.03,1.24,1.23,2.88E6,2.97E6,3.569E6,3.549E6,1.00,1.03,1.24,1.23,18,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),22842,Mediator of RNA polymerase II transcription subunit 7 (Fragment) OS=Homo sapiens OX=9606 GN=MED7 PE=1 SV=1
1961,39555,A0A0B4J220|A0A0B4J220_HUMAN,5.83,80.06,7.27E5,6.927E5,9.296E5,9.747E5,1.00,0.95,1.28,1.34,7.27E5,6.927E5,9.296E5,9.747E5,1.00,0.95,1.28,1.34,23,4,3,iTRAQ 4plex (K  N-term),14234,Chromosome 11 open reading frame 48  isoform CRA_c OS=Homo sapiens OX=9606 GN=C11orf98 PE=1 SV=1
1521,39686,sp|Q969M3|YIPF5_HUMAN,25.89,79.89,1.505E6,1.551E6,3.39E6,3.276E6,1.00,1.03,2.25,2.18,1.505E6,1.551E6,3.39E6,3.276E6,1.00,1.03,2.25,2.18,16,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),27989,Protein YIPF5 OS=Homo sapiens OX=9606 GN=YIPF5 PE=1 SV=1
1364,39204,sp|O15226|NKRF_HUMAN,7.30,79.89,2.282E6,2.363E6,3.409E6,3.496E6,1.00,1.04,1.49,1.53,2.282E6,2.363E6,3.409E6,3.496E6,1.00,1.04,1.49,1.53,8,6,6,iTRAQ 4plex (K  N-term),77673,NF-kappa-B-repressing factor OS=Homo sapiens OX=9606 GN=NKRF PE=1 SV=2
1584,2626,sp|Q9UPR3|SMG5_HUMAN,28.20,79.88,7.83E5,7.752E5,1.969E6,1.965E6,1.00,0.99,2.51,2.51,7.83E5,7.752E5,1.969E6,1.965E6,1.00,0.99,2.51,2.51,5,5,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),113928,Protein SMG5 OS=Homo sapiens OX=9606 GN=SMG5 PE=1 SV=3
1319,10243,sp|P28347-2|TEAD1_HUMAN,3.23,79.85,1.213E5,1.338E5,3.206E5,2.965E5,1.00,1.10,2.64,2.44,1.213E5,1.338E5,3.206E5,2.965E5,1.00,1.10,2.64,2.44,3,6,1,iTRAQ 4plex (K  N-term),40000,Isoform 2 of Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1
1816,21680,H7C2Y0|H7C2Y0_HUMAN,7.27,79.83,8.624E5,8.861E5,1.299E6,1.273E6,1.00,1.03,1.51,1.48,8.624E5,8.861E5,1.299E6,1.273E6,1.00,1.03,1.51,1.48,21,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),21650,Septin-2 (Fragment) OS=Homo sapiens OX=9606 GN=SEPT2 PE=1 SV=1
1501,22181,C9J2C4|C9J2C4_HUMAN,9.42,79.77,1.692E6,1.637E6,2.432E6,2.357E6,1.00,0.97,1.44,1.39,1.692E6,1.637E6,2.432E6,2.357E6,1.00,0.97,1.44,1.39,13,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),25377,DnaJ homolog subfamily B member 6 (Fragment) OS=Homo sapiens OX=9606 GN=DNAJB6 PE=1 SV=1
2003,14978,sp|Q9C037-2|TRIM4_HUMAN,22.53,79.74,1.335E6,1.326E6,2.653E6,2.612E6,1.00,0.99,1.99,1.96,1.335E6,1.326E6,2.653E6,2.612E6,1.00,0.99,1.99,1.96,7,3,3,iTRAQ 4plex (K  N-term),54151,Isoform Beta of E3 ubiquitin-protein ligase TRIM4 OS=Homo sapiens OX=9606 GN=TRIM4
1817,39446,sp|Q9H089|LSG1_HUMAN,5.67,79.69,1.789E6,1.808E6,2.522E6,2.342E6,1.00,1.01,1.41,1.31,1.789E6,1.808E6,2.522E6,2.342E6,1.00,1.01,1.41,1.31,6,4,4,iTRAQ 4plex (K  N-term),75225,Large subunit GTPase 1 homolog OS=Homo sapiens OX=9606 GN=LSG1 PE=1 SV=2
2429,23842,C9JQV0|C9JQV0_HUMAN,2.74,79.63,5.083E5,4.455E5,6.018E5,6.217E5,1.00,0.88,1.18,1.22,5.083E5,4.455E5,6.018E5,6.217E5,1.00,0.88,1.18,1.22,22,2,2,iTRAQ 4plex (K  N-term),21883,Uncharacterized protein C7orf50 (Fragment) OS=Homo sapiens OX=9606 GN=C7orf50 PE=1 SV=1
1788,28248,sp|Q9BPZ7-3|SIN1_HUMAN,15.35,79.55,5.536E5,5.558E5,1.018E6,9.703E5,1.00,1.00,1.84,1.75,5.536E5,5.558E5,1.018E6,9.703E5,1.00,1.00,1.84,1.75,10,5,5,iTRAQ 4plex (K  N-term),53744,Isoform 3 of Target of rapamycin complex 2 subunit MAPKAP1 OS=Homo sapiens OX=9606 GN=MAPKAP1
1783,39588,sp|Q2V2M9-2|FHOD3_HUMAN,6.89,79.51,2.852E5,2.918E5,4.064E5,4.31E5,1.00,1.02,1.42,1.51,2.852E5,2.918E5,4.064E5,4.31E5,1.00,1.02,1.42,1.51,3,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),156752,Isoform 2 of FH1/FH2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FHOD3
1821,39547,sp|O75746-2|CMC1_HUMAN,1.46,79.49,4.139E5,3.999E5,6.505E5,6.581E5,1.00,0.97,1.57,1.59,4.139E5,3.999E5,6.505E5,6.581E5,1.00,0.97,1.57,1.59,2,4,1,iTRAQ 4plex (K  N-term),62720,Isoform 2 of Calcium-binding mitochondrial carrier protein Aralar1 OS=Homo sapiens OX=9606 GN=SLC25A12
2198,39833,sp|O95900-2|TRUB2_HUMAN,9.95,79.48,4.6E5,4.676E5,7.454E5,7.274E5,1.00,1.02,1.62,1.58,4.6E5,4.676E5,7.454E5,7.274E5,1.00,1.02,1.62,1.58,12,3,3,iTRAQ 4plex (K  N-term),30454,Isoform 2 of Mitochondrial mRNA pseudouridine synthase TRUB2 OS=Homo sapiens OX=9606 GN=TRUB2
2158,20262,sp|P15407|FOSL1_HUMAN,9.90,79.40,4.639E5,3.575E5,5.86E5,5.856E5,1.00,0.77,1.26,1.26,4.639E5,3.575E5,5.86E5,5.856E5,1.00,0.77,1.26,1.26,20,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),29413,Fos-related antigen 1 OS=Homo sapiens OX=9606 GN=FOSL1 PE=1 SV=1
2121,21504,sp|Q13546-2|RIPK1_HUMAN,16.73,79.39,6.218E5,5.678E5,1.037E6,1.053E6,1.00,0.91,1.67,1.69,6.218E5,5.678E5,1.037E6,1.053E6,1.00,0.91,1.67,1.69,6,3,3,iTRAQ 4plex (K  N-term),70733,Isoform 2 of Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=RIPK1
1833,10476,sp|Q5JWF2-2|GNAS1_HUMAN,1.22,79.37,5.25E4,6.074E4,8.032E4,7.939E4,1.00,1.16,1.53,1.51,5.25E4,6.074E4,8.032E4,7.939E4,1.00,1.16,1.53,1.51,2,3,1,iTRAQ 4plex (K  N-term),109626,Isoform XLas-2 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas OS=Homo sapiens OX=9606 GN=GNAS
1465,10123,sp|P25054-2|APC_HUMAN,23.15,79.30,4.537E5,4.608E5,1.346E6,1.232E6,1.00,1.02,2.97,2.72,4.537E5,4.608E5,1.346E6,1.232E6,1.00,1.02,2.97,2.72,3,7,7,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),300438,Isoform 2 of Adenomatous polyposis coli protein OS=Homo sapiens OX=9606 GN=APC
1646,13570,sp|Q5H9U9|DDX6L_HUMAN,44.65,79.26,3.01E5,2.935E5,2.225E6,1.597E6,1.00,0.98,7.39,5.31,3.01E5,2.935E5,2.225E6,1.597E6,1.00,0.98,7.39,5.31,3,4,4,iTRAQ 4plex (K  N-term),197672,Probable ATP-dependent RNA helicase DDX60-like OS=Homo sapiens OX=9606 GN=DDX60L PE=2 SV=2
1754,39542,H7C5R8|H7C5R8_HUMAN,18.38,79.23,7.068E5,6.997E5,1.367E6,1.387E6,1.00,0.99,1.93,1.96,7.068E5,6.997E5,1.367E6,1.387E6,1.00,0.99,1.93,1.96,2,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),171146,Poly [ADP-ribose] polymerase 14 (Fragment) OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=1
1559,7659,A0A2R8Y4Z0|A0A2R8Y4Z0_HUMAN,5.85,79.19,3.387E5,3.115E5,4.605E5,4.558E5,1.00,0.92,1.36,1.35,3.387E5,3.115E5,4.605E5,4.558E5,1.00,0.92,1.36,1.35,3,4,3,iTRAQ 4plex (K  N-term); Phosphorylation (STY),143901,Cyclin-dependent kinase 13 (Fragment) OS=Homo sapiens OX=9606 GN=CDK13 PE=1 SV=1
1583,39465,sp|Q8TCJ2|STT3B_HUMAN,8.18,79.08,1.319E6,1.258E6,1.886E6,1.878E6,1.00,0.95,1.43,1.42,1.319E6,1.258E6,1.886E6,1.878E6,1.00,0.95,1.43,1.42,4,4,4,iTRAQ 4plex (K  N-term),93674,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B OS=Homo sapiens OX=9606 GN=STT3B PE=1 SV=1
1637,39563,sp|P30041|PRDX6_HUMAN,6.29,79.03,1.877E6,1.764E6,2.409E6,2.476E6,1.00,0.94,1.28,1.32,1.877E6,1.764E6,2.409E6,2.476E6,1.00,0.94,1.28,1.32,20,4,4,iTRAQ 4plex (K  N-term),25035,Peroxiredoxin-6 OS=Homo sapiens OX=9606 GN=PRDX6 PE=1 SV=3
1970,39718,F5H018|F5H018_HUMAN,18.05,78.97,2.513E6,2.589E6,4.752E6,4.738E6,1.00,1.03,1.89,1.89,2.513E6,2.589E6,4.752E6,4.738E6,1.00,1.03,1.89,1.89,16,3,3,iTRAQ 4plex (K  N-term),22436,GTP-binding nuclear protein Ran (Fragment) OS=Homo sapiens OX=9606 GN=RAN PE=1 SV=8
2076,39741,sp|Q15283-2|RASA2_HUMAN,9.52,78.96,1.031E6,1.024E6,1.52E6,1.506E6,1.00,0.99,1.47,1.46,1.031E6,1.024E6,1.52E6,1.506E6,1.00,0.99,1.47,1.46,4,3,3,iTRAQ 4plex (K  N-term),96527,Isoform 2 of Ras GTPase-activating protein 2 OS=Homo sapiens OX=9606 GN=RASA2
2075,39695,sp|Q99459|CDC5L_HUMAN,5.52,78.82,2.684E5,2.732E5,3.697E5,3.715E5,1.00,1.02,1.38,1.38,2.684E5,2.732E5,3.697E5,3.715E5,1.00,1.02,1.38,1.38,4,3,3,iTRAQ 4plex (K  N-term),92251,Cell division cycle 5-like protein OS=Homo sapiens OX=9606 GN=CDC5L PE=1 SV=2
2370,3922,A0A087WW06|A0A087WW06_HUMAN,6.10,78.68,1.182E5,1.152E5,2.128E5,2E5,1.00,0.97,1.80,1.69,1.182E5,1.152E5,2.128E5,2E5,1.00,0.97,1.80,1.69,1,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),256865,Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=1
1267,18465,sp|P78362-2|SRPK2_HUMAN,4.58,78.54,1.081E6,1.061E6,1.775E6,1.872E6,1.00,0.98,1.64,1.73,1.081E6,1.061E6,1.775E6,1.872E6,1.00,0.98,1.64,1.73,1,6,2,iTRAQ 4plex (K  N-term),79029,Isoform 2 of SRSF protein kinase 2 OS=Homo sapiens OX=9606 GN=SRPK2
2211,23948,sp|P51858-2|HDGF_HUMAN,12.60,78.48,3.207E5,3.187E5,5.182E5,5.39E5,1.00,0.99,1.62,1.68,3.207E5,3.187E5,5.182E5,5.39E5,1.00,0.99,1.62,1.68,15,3,3,iTRAQ 4plex (K  N-term),25538,Isoform 2 of Hepatoma-derived growth factor OS=Homo sapiens OX=9606 GN=HDGF
1823,8814,sp|Q96S55-2|WRIP1_HUMAN,9.42,78.48,1.053E6,1.062E6,1.684E6,1.657E6,1.00,1.01,1.60,1.57,1.053E6,1.062E6,1.684E6,1.657E6,1.00,1.01,1.60,1.57,7,4,4,iTRAQ 4plex (K  N-term),69459,Isoform 2 of ATPase WRNIP1 OS=Homo sapiens OX=9606 GN=WRNIP1
1355,3289,sp|P41250|GARS_HUMAN,17.33,78.36,1.811E6,1.629E6,3.166E6,3.104E6,1.00,0.90,1.75,1.71,1.811E6,1.629E6,3.166E6,3.104E6,1.00,0.90,1.75,1.71,6,5,5,iTRAQ 4plex (K  N-term),83166,Glycine--tRNA ligase OS=Homo sapiens OX=9606 GN=GARS PE=1 SV=3
1602,23594,A0A3B3IRP5|A0A3B3IRP5_HUMAN,10.63,78.34,9.691E5,9.321E5,1.57E6,1.615E6,1.00,0.96,1.62,1.67,9.691E5,9.321E5,1.57E6,1.615E6,1.00,0.96,1.62,1.67,9,5,5,iTRAQ 4plex (K  N-term),54156,Parafibromin OS=Homo sapiens OX=9606 GN=CDC73 PE=1 SV=1
1693,11809,sp|Q9BX40|LS14B_HUMAN,12.26,78.26,4.62E5,4.315E5,7.278E5,6.925E5,1.00,0.93,1.58,1.50,4.62E5,4.315E5,7.278E5,6.925E5,1.00,0.93,1.58,1.50,15,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),42071,Protein LSM14 homolog B OS=Homo sapiens OX=9606 GN=LSM14B PE=1 SV=1
1894,18485,sp|Q15024|EXOS7_HUMAN,9.80,78.25,6.077E5,6.077E5,9.545E5,9.202E5,1.00,1.00,1.57,1.51,6.077E5,6.077E5,9.545E5,9.202E5,1.00,1.00,1.57,1.51,12,3,3,iTRAQ 4plex (K  N-term),31821,Exosome complex component RRP42 OS=Homo sapiens OX=9606 GN=EXOSC7 PE=1 SV=3
1963,9591,sp|Q9Y5B8-2|NDK7_HUMAN,19.02,78.22,1.038E6,1.051E6,1.997E6,1.914E6,1.00,1.01,1.92,1.84,1.038E6,1.051E6,1.997E6,1.914E6,1.00,1.01,1.92,1.84,12,4,4,iTRAQ 4plex (K  N-term),38187,Isoform 2 of Nucleoside diphosphate kinase 7 OS=Homo sapiens OX=9606 GN=NME7
2474,40705,sp|P13861-2|KAP2_HUMAN,4.18,78.06,3.392E5,3.385E5,5.142E5,5.361E5,1.00,1.00,1.52,1.58,3.392E5,3.385E5,5.142E5,5.361E5,1.00,1.00,1.52,1.58,8,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),43067,Isoform 2 of cAMP-dependent protein kinase type II-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR2A
2118,18502,sp|Q96EN8|MOCOS_HUMAN,8.94,77.99,2.407E5,2.351E5,3.716E5,3.624E5,1.00,0.98,1.54,1.51,2.407E5,2.351E5,3.716E5,3.624E5,1.00,0.98,1.54,1.51,5,3,3,iTRAQ 4plex (K  N-term),98120,Molybdenum cofactor sulfurase OS=Homo sapiens OX=9606 GN=MOCOS PE=1 SV=2
1369,9070,sp|Q71UI9|H2AV_HUMAN,1.31,77.97,5.783E5,5.696E5,8.579E5,8.906E5,1.00,0.98,1.48,1.54,5.783E5,5.696E5,8.579E5,8.906E5,1.00,0.98,1.48,1.54,11,3,1,iTRAQ 4plex (K  N-term),13509,Histone H2A.V OS=Homo sapiens OX=9606 GN=H2AFV PE=1 SV=3
1803,39636,A0A075B7B5|A0A075B7B5_HUMAN,2.72,77.97,3.534E5,3.83E5,5.121E5,5.121E5,1.00,1.08,1.45,1.45,3.534E5,3.83E5,5.121E5,5.121E5,1.00,1.08,1.45,1.45,3,3,2,iTRAQ 4plex (K  N-term),90909,SLIT-ROBO Rho GTPase-activating protein 2 OS=Homo sapiens OX=9606 GN=SRGAP2 PE=1 SV=1
1808,40094,sp|O60488-2|ACSL4_HUMAN,2.71,77.92,6.333E5,5.306E5,6.972E5,7.837E5,1.00,0.84,1.10,1.24,6.333E5,5.306E5,6.972E5,7.837E5,1.00,0.84,1.10,1.24,3,3,2,iTRAQ 4plex (K  N-term),74436,Isoform Short of Long-chain-fatty-acid--CoA ligase 4 OS=Homo sapiens OX=9606 GN=ACSL4
1936,39863,sp|Q96J84|KIRR1_HUMAN,13.86,77.91,4.756E5,5.014E5,8.437E5,8.79E5,1.00,1.05,1.77,1.85,4.756E5,5.014E5,8.437E5,8.79E5,1.00,1.05,1.77,1.85,10,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),83536,Kin of IRRE-like protein 1 OS=Homo sapiens OX=9606 GN=KIRREL1 PE=1 SV=2
2152,39809,sp|Q9NRX1|PNO1_HUMAN,9.58,77.88,1.16E6,1.223E6,1.861E6,1.762E6,1.00,1.05,1.60,1.52,1.16E6,1.223E6,1.861E6,1.762E6,1.00,1.05,1.60,1.52,15,3,3,iTRAQ 4plex (K  N-term),27924,RNA-binding protein PNO1 OS=Homo sapiens OX=9606 GN=PNO1 PE=1 SV=1
1644,39589,sp|Q15058|KIF14_HUMAN,15.38,77.69,1.002E6,8.885E5,1.74E6,1.748E6,1.00,0.89,1.74,1.74,1.002E6,8.885E5,1.74E6,1.748E6,1.00,0.89,1.74,1.74,2,5,4,iTRAQ 4plex (K  N-term),186490,Kinesin-like protein KIF14 OS=Homo sapiens OX=9606 GN=KIF14 PE=1 SV=1
1857,16096,sp|Q5VUA4|ZN318_HUMAN,4.99,77.64,1.105E6,1.068E6,1.445E6,1.372E6,1.00,0.97,1.31,1.24,1.105E6,1.068E6,1.445E6,1.372E6,1.00,0.97,1.31,1.24,3,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),251110,Zinc finger protein 318 OS=Homo sapiens OX=9606 GN=ZNF318 PE=1 SV=2
1971,6963,E7EQA9|E7EQA9_HUMAN,13.13,77.62,4.981E5,4.813E5,8.718E5,8.658E5,1.00,0.97,1.75,1.74,4.981E5,4.813E5,8.718E5,8.658E5,1.00,0.97,1.75,1.74,8,3,3,iTRAQ 4plex (K  N-term),46152,TRAF family member-associated NF-kappa-B activator OS=Homo sapiens OX=9606 GN=TANK PE=1 SV=1
2115,40463,sp|P45880-2|VDAC2_HUMAN,27.31,77.55,5.704E5,5.132E5,1.084E6,9.963E5,1.00,0.90,1.90,1.75,5.704E5,5.132E5,1.084E6,9.963E5,1.00,0.90,1.90,1.75,10,3,3,iTRAQ 4plex (K  N-term); Phosphorylation (STY),30412,Isoform 2 of Voltage-dependent anion-selective channel protein 2 OS=Homo sapiens OX=9606 GN=VDAC2
1930,21858,sp|Q9H0B6-2|KLC2_HUMAN,6.41,77.49,9.524E4,9.003E4,1.878E5,1.9E5,1.00,0.95,1.97,2.00,9.524E4,9.003E4,1.878E5,1.9E5,1.00,0.95,1.97,2.00,5,4,2,iTRAQ 4plex (K  N-term),60047,Isoform 2 of Kinesin light chain 2 OS=Homo sapiens OX=9606 GN=KLC2
1475,23025,sp|O60563|CCNT1_HUMAN,15.53,77.49,1.13E6,1.142E6,2.223E6,2.161E6,1.00,1.01,1.97,1.91,1.13E6,1.142E6,2.223E6,2.161E6,1.00,1.01,1.97,1.91,6,4,4,iTRAQ 4plex (K  N-term),80685,Cyclin-T1 OS=Homo sapiens OX=9606 GN=CCNT1 PE=1 SV=1
1109,10164,sp|A0A0C4DH25|KVD20_HUMAN,0.60,77.46,1.101E6,1.118E6,8.955E5,9.515E5,1.00,1.02,0.81,0.86,1.101E6,1.118E6,8.955E5,9.515E5,1.00,1.02,0.81,0.86,8,5,1,iTRAQ 4plex (K  N-term),12515,Immunoglobulin kappa variable 3D-20 OS=Homo sapiens OX=9606 GN=IGKV3D-20 PE=3 SV=1
2095,11849,sp|Q9NPI6|DCP1A_HUMAN,22.42,77.43,1.454E6,1.409E6,2.746E6,2.636E6,1.00,0.97,1.89,1.81,1.454E6,1.409E6,2.746E6,2.636E6,1.00,0.97,1.89,1.81,5,3,3,iTRAQ 4plex (K  N-term),63279,mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3
1966,20816,sp|Q8WXX5|DNJC9_HUMAN,7.02,77.34,8.041E5,7.693E5,1.121E6,1.131E6,1.00,0.96,1.39,1.41,8.041E5,7.693E5,1.121E6,1.131E6,1.00,0.96,1.39,1.41,13,3,3,iTRAQ 4plex (K  N-term),29910,DnaJ homolog subfamily C member 9 OS=Homo sapiens OX=9606 GN=DNAJC9 PE=1 SV=1
1957,20396,sp|Q9GZT9|EGLN1_HUMAN,22.15,77.13,3.165E5,3.436E5,6.167E5,5.841E5,1.00,1.09,1.95,1.85,3.165E5,3.436E5,6.167E5,5.841E5,1.00,1.09,1.95,1.85,8,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),46021,Egl nine homolog 1 OS=Homo sapiens OX=9606 GN=EGLN1 PE=1 SV=1
1997,39549,sp|Q9H9B4|SFXN1_HUMAN,3.61,77.12,7.203E5,7.105E5,9.098E5,9.06E5,1.00,0.99,1.26,1.26,7.203E5,7.105E5,9.098E5,9.06E5,1.00,0.99,1.26,1.26,12,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),35619,Sideroflexin-1 OS=Homo sapiens OX=9606 GN=SFXN1 PE=1 SV=4
1705,39365,A0A2R8Y6X0|A0A2R8Y6X0_HUMAN,13.86,77.05,8.793E5,8.644E5,1.601E6,1.58E6,1.00,0.98,1.82,1.80,8.793E5,8.644E5,1.601E6,1.58E6,1.00,0.98,1.82,1.80,6,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),97226,Activity-dependent neuroprotector homeobox protein OS=Homo sapiens OX=9606 GN=ADNP PE=1 SV=1
1920,7288,A0A140T947|A0A140T947_HUMAN,2.97,77.03,2.306E5,2.16E5,3.27E5,3.251E5,1.00,0.94,1.42,1.41,2.306E5,2.16E5,3.27E5,3.251E5,1.00,0.94,1.42,1.41,4,3,2,iTRAQ 4plex (K  N-term),76933,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (Fragment) OS=Homo sapiens OX=9606 GN=DHX16 PE=1 SV=1
1158,20125,sp|P09234|RU1C_HUMAN,4.49,76.97,6.52E6,5.6E6,8.681E6,8.442E6,1.00,0.86,1.33,1.29,6.52E6,5.6E6,8.681E6,8.442E6,1.00,0.86,1.33,1.29,13,2,2,iTRAQ 4plex (K  N-term),17394,U1 small nuclear ribonucleoprotein C OS=Homo sapiens OX=9606 GN=SNRPC PE=1 SV=1
2363,31174,sp|Q5T7V8-2|GORAB_HUMAN,8.93,76.92,5.659E5,6.58E5,1.25E6,1.199E6,1.00,1.16,2.21,2.12,5.659E5,6.58E5,1.25E6,1.199E6,1.00,1.16,2.21,2.12,13,2,2,iTRAQ 4plex (K  N-term),27992,Isoform 2 of RAB6-interacting golgin OS=Homo sapiens OX=9606 GN=GORAB
1545,39577,F5GX62|F5GX62_HUMAN,5.76,76.71,2.016E6,1.945E6,2.474E6,2.704E6,1.00,0.96,1.23,1.34,2.016E6,1.945E6,2.474E6,2.704E6,1.00,0.96,1.23,1.34,27,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),15747,Ras-related protein Rap-1b (Fragment) OS=Homo sapiens OX=9606 GN=RAP1B PE=1 SV=1
1187,14362,sp|Q9NWB6|ARGL1_HUMAN,0.84,76.58,5.414E6,5.45E6,5.827E6,5.828E6,1.00,1.01,1.08,1.08,5.414E6,5.45E6,5.827E6,5.828E6,1.00,1.01,1.08,1.08,22,7,7,iTRAQ 4plex (K  N-term); Phosphorylation (STY),33216,Arginine and glutamate-rich protein 1 OS=Homo sapiens OX=9606 GN=ARGLU1 PE=1 SV=1
1713,39504,sp|Q9H0W8|SMG9_HUMAN,10.34,76.58,5.972E5,6.04E5,1.045E6,1.025E6,1.00,1.01,1.75,1.72,5.972E5,6.04E5,1.045E6,1.025E6,1.00,1.01,1.75,1.72,10,4,4,iTRAQ 4plex (K  N-term),57651,Protein SMG9 OS=Homo sapiens OX=9606 GN=SMG9 PE=1 SV=1
2187,40874,sp|Q75N03-2|HAKAI_HUMAN,1.28,76.56,6.902E4,6.983E4,1.073E5,9.913E4,1.00,1.01,1.55,1.44,6.902E4,6.983E4,1.073E5,9.913E4,1.00,1.01,1.55,1.44,4,3,1,iTRAQ 4plex (K  N-term),54390,Isoform 2 of E3 ubiquitin-protein ligase Hakai OS=Homo sapiens OX=9606 GN=CBLL1
1854,39535,sp|Q8IUH3-3|RBM45_HUMAN,9.66,76.55,1.673E6,1.642E6,2.613E6,2.618E6,1.00,0.98,1.56,1.56,1.673E6,1.642E6,2.613E6,2.618E6,1.00,0.98,1.56,1.56,9,5,5,iTRAQ 4plex (K  N-term),53346,Isoform 3 of RNA-binding protein 45 OS=Homo sapiens OX=9606 GN=RBM45
1938,39980,sp|Q9BYC5|FUT8_HUMAN,10.29,76.53,1.935E6,2.053E6,3.028E6,2.849E6,1.00,1.06,1.56,1.47,1.935E6,2.053E6,3.028E6,2.849E6,1.00,1.06,1.56,1.47,6,3,3,iTRAQ 4plex (K  N-term),66516,Alpha-(1 6)-fucosyltransferase OS=Homo sapiens OX=9606 GN=FUT8 PE=1 SV=2
1864,39933,sp|Q9UMX1-2|SUFU_HUMAN,11.24,76.27,6.836E5,6.514E5,1.09E6,1.05E6,1.00,0.95,1.59,1.54,6.836E5,6.514E5,1.09E6,1.05E6,1.00,0.95,1.59,1.54,8,3,3,iTRAQ 4plex (K  N-term),47932,Isoform 2 of Suppressor of fused homolog OS=Homo sapiens OX=9606 GN=SUFU
1626,11524,sp|Q9Y3C6|PPIL1_HUMAN,48.64,76.26,2.005E6,2.111E6,5.333E6,5.206E6,1.00,1.05,2.66,2.60,2.005E6,2.111E6,5.333E6,5.206E6,1.00,1.05,2.66,2.60,19,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),18237,Peptidyl-prolyl cis-trans isomerase-like 1 OS=Homo sapiens OX=9606 GN=PPIL1 PE=1 SV=1
2017,40115,sp|Q9BYD6|RM01_HUMAN,18.07,76.24,1.954E6,1.971E6,3.597E6,3.548E6,1.00,1.01,1.84,1.82,1.954E6,1.971E6,3.597E6,3.548E6,1.00,1.01,1.84,1.82,9,3,3,iTRAQ 4plex (K  N-term),36909,39S ribosomal protein L1  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL1 PE=1 SV=2
2191,41075,C9JZL8|C9JZL8_HUMAN,4.33,76.13,6.047E5,6.005E5,9.257E5,8.947E5,1.00,0.99,1.53,1.48,6.047E5,6.005E5,9.257E5,8.947E5,1.00,0.99,1.53,1.48,17,2,2,iTRAQ 4plex (K  N-term),20379,Myeloid-associated differentiation marker (Fragment) OS=Homo sapiens OX=9606 GN=MYADM PE=1 SV=1
1716,39631,sp|A2A3N6|PIPSL_HUMAN,4.13,75.82,4.467E5,3.957E5,6.516E5,6.475E5,1.00,0.89,1.46,1.45,4.467E5,3.957E5,6.516E5,6.475E5,1.00,0.89,1.46,1.45,3,4,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),95048,Putative PIP5K1A and PSMD4-like protein OS=Homo sapiens OX=9606 GN=PIPSL PE=5 SV=1
1946,5570,sp|Q15788-2|NCOA1_HUMAN,6.09,75.66,1.005E6,1.07E6,1.412E6,1.386E6,1.00,1.06,1.40,1.38,1.005E6,1.07E6,1.412E6,1.386E6,1.00,1.06,1.40,1.38,4,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),152384,Isoform 2 of Nuclear receptor coactivator 1 OS=Homo sapiens OX=9606 GN=NCOA1
1622,39566,sp|Q9HD33-2|RM47_HUMAN,16.36,75.62,1.138E6,1.177E6,2.274E6,2.204E6,1.00,1.03,2.00,1.94,1.138E6,1.177E6,2.274E6,2.204E6,1.00,1.03,2.00,1.94,17,4,4,iTRAQ 4plex (K  N-term),27086,Isoform 2 of 39S ribosomal protein L47  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL47
1568,3838,sp|Q9BX69|CARD6_HUMAN,26.17,75.60,5.301E5,5.374E5,1.175E6,1.12E6,1.00,1.01,2.22,2.11,5.301E5,5.374E5,1.175E6,1.12E6,1.00,1.01,2.22,2.11,4,3,3,iTRAQ 4plex (K  N-term),116468,Caspase recruitment domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CARD6 PE=1 SV=2
1974,13588,sp|P26572|MGAT1_HUMAN,5.07,75.60,1.646E6,1.667E6,2.157E6,2.187E6,1.00,1.01,1.31,1.33,1.646E6,1.667E6,2.157E6,2.187E6,1.00,1.01,1.31,1.33,7,3,3,iTRAQ 4plex (K  N-term),50878,Alpha-1 3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT1 PE=1 SV=2
1519,20802,sp|Q9BYN8|RT26_HUMAN,10.84,75.58,2.129E6,2.177E6,3.633E6,3.552E6,1.00,1.02,1.71,1.67,2.129E6,2.177E6,3.633E6,3.552E6,1.00,1.02,1.71,1.67,19,4,4,iTRAQ 4plex (K  N-term),24212,28S ribosomal protein S26  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS26 PE=1 SV=1
2123,7908,sp|Q9Y240|CLC11_HUMAN,12.11,75.50,1.745E6,1.714E6,2.868E6,2.798E6,1.00,0.98,1.64,1.60,1.745E6,1.714E6,2.868E6,2.798E6,1.00,0.98,1.64,1.60,10,3,3,iTRAQ 4plex (K  N-term),35695,C-type lectin domain family 11 member A OS=Homo sapiens OX=9606 GN=CLEC11A PE=1 SV=1
2182,18125,sp|Q8N5N7|RM50_HUMAN,12.14,75.39,3.788E5,4.023E5,1.026E6,9.865E5,1.00,1.06,2.71,2.60,3.788E5,4.023E5,1.026E6,9.865E5,1.00,1.06,2.71,2.60,20,2,2,iTRAQ 4plex (K  N-term),18325,39S ribosomal protein L50  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL50 PE=1 SV=2
1982,20960,sp|Q13753-2|LAMC2_HUMAN,12.67,75.37,3.383E5,2.897E5,5.124E5,5.113E5,1.00,0.86,1.51,1.51,3.383E5,2.897E5,5.124E5,5.113E5,1.00,0.86,1.51,1.51,3,3,3,iTRAQ 4plex (K  N-term),121604,Isoform Short of Laminin subunit gamma-2 OS=Homo sapiens OX=9606 GN=LAMC2
2109,20388,G5E9D4|G5E9D4_HUMAN,11.49,75.22,5.178E5,4.818E5,7.219E5,7.559E5,1.00,0.93,1.39,1.46,5.178E5,4.818E5,7.219E5,7.559E5,1.00,0.93,1.39,1.46,7,3,3,iTRAQ 4plex (K  N-term),58833,Elongation protein 4 homolog (S. cerevisiae)  isoform CRA_b OS=Homo sapiens OX=9606 GN=ELP4 PE=1 SV=1
2006,39942,sp|P60174-4|TPIS_HUMAN,6.06,75.18,1.064E6,9.493E5,1.234E6,1.331E6,1.00,0.89,1.16,1.25,1.064E6,9.493E5,1.234E6,1.331E6,1.00,0.89,1.16,1.25,19,3,3,iTRAQ 4plex (K  N-term),17958,Isoform 4 of Triosephosphate isomerase OS=Homo sapiens OX=9606 GN=TPI1
1459,16758,sp|P12107-4|COBA1_HUMAN,0.61,75.17,1.514E6,1.417E6,1.5E6,1.567E6,1.00,0.94,0.99,1.03,1.514E6,1.417E6,1.5E6,1.567E6,1.00,0.94,0.99,1.03,1,4,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),167752,Isoform 4 of Collagen alpha-1(XI) chain OS=Homo sapiens OX=9606 GN=COL11A1
2215,2502,sp|Q13409-3|DC1I2_HUMAN,8.10,75.00,1.124E5,1.204E5,1.725E5,1.794E5,1.00,1.07,1.54,1.60,1.124E5,1.204E5,1.725E5,1.794E5,1.00,1.07,1.54,1.60,13,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),68426,Isoform 2C of Cytoplasmic dynein 1 intermediate chain 2 OS=Homo sapiens OX=9606 GN=DYNC1I2
1841,40057,sp|Q9Y6A4|CFA20_HUMAN,11.43,74.99,3.015E6,3.074E6,4.604E6,4.372E6,1.00,1.02,1.53,1.45,3.015E6,3.074E6,4.604E6,4.372E6,1.00,1.02,1.53,1.45,15,3,3,iTRAQ 4plex (K  N-term),22774,Cilia- and flagella-associated protein 20 OS=Homo sapiens OX=9606 GN=CFAP20 PE=1 SV=1
1768,27017,sp|P11388-4|TOP2A_HUMAN,2.49,74.93,1.289E5,1.324E5,1.693E5,1.878E5,1.00,1.03,1.31,1.46,1.289E5,1.324E5,1.693E5,1.878E5,1.00,1.03,1.31,1.46,1,4,2,iTRAQ 4plex (K  N-term),182680,Isoform 4 of DNA topoisomerase 2-alpha OS=Homo sapiens OX=9606 GN=TOP2A
2315,23908,sp|Q66PJ3-4|AR6P4_HUMAN,3.41,74.84,3.832E5,3.573E5,4.759E5,5.337E5,1.00,0.93,1.24,1.39,3.832E5,3.573E5,4.759E5,5.337E5,1.00,0.93,1.24,1.39,8,2,2,iTRAQ 4plex (K  N-term),42731,Isoform 4 of ADP-ribosylation factor-like protein 6-interacting protein 4 OS=Homo sapiens OX=9606 GN=ARL6IP4
1306,41350,sp|A0A087WSY4|HV432_HUMAN,103.99,74.84,2.167E6,2.284E6,1.029E7,8.683E6,1.00,1.05,4.75,4.01,2.167E6,2.284E6,1.029E7,8.683E6,1.00,1.05,4.75,4.01,9,3,3,iTRAQ 4plex (K  N-term),13025,Immunoglobulin heavy variable 4-30-2 OS=Homo sapiens OX=9606 GN=IGHV4-30-2 PE=3 SV=1
1848,21166,sp|Q13114-2|TRAF3_HUMAN,10.89,74.74,9.33E5,9.412E5,1.716E6,1.644E6,1.00,1.01,1.84,1.76,9.33E5,9.412E5,1.716E6,1.644E6,1.00,1.01,1.84,1.76,10,5,5,iTRAQ 4plex (K  N-term),55306,Isoform 2 of TNF receptor-associated factor 3 OS=Homo sapiens OX=9606 GN=TRAF3
1731,39569,sp|Q8N983-4|RM43_HUMAN,14.66,74.69,1.32E6,1.324E6,2.529E6,2.473E6,1.00,1.00,1.92,1.87,1.32E6,1.324E6,2.529E6,2.473E6,1.00,1.00,1.92,1.87,24,4,4,iTRAQ 4plex (K  N-term),17853,Isoform 4 of 39S ribosomal protein L43  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL43
1523,20361,Q49AN9|Q49AN9_HUMAN,7.16,74.66,1.592E6,1.472E6,2.097E6,1.974E6,1.00,0.92,1.32,1.24,1.592E6,1.472E6,2.097E6,1.974E6,1.00,0.92,1.32,1.24,31,3,3,iTRAQ 4plex (K  N-term),7101,Small nuclear ribonucleoprotein G OS=Homo sapiens OX=9606 GN=SNRPG PE=1 SV=1
1824,17810,A0A1W2PQS1|A0A1W2PQS1_HUMAN,7.50,74.57,5.808E5,5.545E5,8.503E5,8.06E5,1.00,0.95,1.46,1.39,5.808E5,5.545E5,8.503E5,8.06E5,1.00,0.95,1.46,1.39,8,4,3,iTRAQ 4plex (K  N-term),44861,26S proteasome regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMC2 PE=1 SV=1
2378,22727,sp|Q96S59-2|RANB9_HUMAN,3.26,74.48,7.471E5,7.604E5,1.058E6,1.085E6,1.00,1.02,1.42,1.45,7.471E5,7.604E5,1.058E6,1.085E6,1.00,1.02,1.42,1.45,6,2,2,iTRAQ 4plex (K  N-term),43064,Isoform 2 of Ran-binding protein 9 OS=Homo sapiens OX=9606 GN=RANBP9
2133,40180,sp|O43184|ADA12_HUMAN,34.98,74.46,5.832E5,5.855E5,1.239E6,1.366E6,1.00,1.00,2.12,2.34,5.832E5,5.855E5,1.239E6,1.366E6,1.00,1.00,2.12,2.34,3,3,3,iTRAQ 4plex (K  N-term),99542,Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ADAM12 PE=1 SV=3
2113,40226,E7EVX8|E7EVX8_HUMAN,3.46,74.38,5.935E5,6.282E5,8.796E5,8.035E5,1.00,1.06,1.48,1.35,5.935E5,6.282E5,8.796E5,8.035E5,1.00,1.06,1.48,1.35,6,2,2,iTRAQ 4plex (K  N-term),54766,U4/U6 small nuclear ribonucleoprotein Prp31 OS=Homo sapiens OX=9606 GN=PRPF31 PE=1 SV=1
2479,6740,sp|Q9H3K6|BOLA2_HUMAN,6.25,74.36,8.667E5,8.649E5,1.57E6,1.497E6,1.00,1.00,1.81,1.73,8.667E5,8.649E5,1.57E6,1.497E6,1.00,1.00,1.81,1.73,29,2,2,iTRAQ 4plex (K  N-term),10117,BolA-like protein 2 OS=Homo sapiens OX=9606 GN=BOLA2 PE=1 SV=1
1633,19987,sp|P26641|EF1G_HUMAN,4.22,74.34,2.417E6,2.324E6,2.942E6,3.06E6,1.00,0.96,1.22,1.27,2.417E6,2.324E6,2.942E6,3.06E6,1.00,0.96,1.22,1.27,10,5,5,iTRAQ 4plex (K  N-term),50119,Elongation factor 1-gamma OS=Homo sapiens OX=9606 GN=EEF1G PE=1 SV=3
1901,23424,sp|Q13107-2|UBP4_HUMAN,2.36,74.33,5.436E5,5.533E5,1.142E6,1.061E6,1.00,1.02,2.10,1.95,5.436E5,5.533E5,1.142E6,1.061E6,1.00,1.02,2.10,1.95,1,3,1,iTRAQ 4plex (K  N-term),103958,Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 4 OS=Homo sapiens OX=9606 GN=USP4
1934,39623,sp|P40222|TXLNA_HUMAN,6.75,74.19,8.281E5,7.867E5,1.133E6,1.132E6,1.00,0.95,1.37,1.37,8.281E5,7.867E5,1.133E6,1.132E6,1.00,0.95,1.37,1.37,7,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),61891,Alpha-taxilin OS=Homo sapiens OX=9606 GN=TXLNA PE=1 SV=3
1504,9583,sp|P62318-2|SMD3_HUMAN,11.70,74.11,1.318E7,1.25E7,1.851E7,1.712E7,1.00,0.95,1.40,1.30,1.318E7,1.25E7,1.851E7,1.712E7,1.00,0.95,1.40,1.30,16,3,3,iTRAQ 4plex (K  N-term); Oxidation (M),13292,Isoform 2 of Small nuclear ribonucleoprotein Sm D3 OS=Homo sapiens OX=9606 GN=SNRPD3
2209,6469,sp|Q96D15|RCN3_HUMAN,7.36,74.11,2.305E5,2.242E5,3.351E5,2.96E5,1.00,0.97,1.45,1.28,2.305E5,2.242E5,3.351E5,2.96E5,1.00,0.97,1.45,1.28,12,3,3,iTRAQ 4plex (K  N-term),37493,Reticulocalbin-3 OS=Homo sapiens OX=9606 GN=RCN3 PE=1 SV=1
2024,23859,H0YH88|H0YH88_HUMAN,2.78,74.05,9.35E5,8.999E5,1.231E6,1.252E6,1.00,0.96,1.32,1.34,9.35E5,8.999E5,1.231E6,1.252E6,1.00,0.96,1.32,1.34,16,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),21086,Nucleosome assembly protein 1-like 1 (Fragment) OS=Homo sapiens OX=9606 GN=NAP1L1 PE=1 SV=1
2154,39895,sp|Q15389-2|ANGP1_HUMAN,9.56,73.98,5.793E5,6.073E5,9.447E5,9.347E5,1.00,1.05,1.63,1.61,5.793E5,6.073E5,9.447E5,9.347E5,1.00,1.05,1.63,1.61,7,3,3,iTRAQ 4plex (K  N-term),57456,Isoform 2 of Angiopoietin-1 OS=Homo sapiens OX=9606 GN=ANGPT1
2010,24830,sp|Q9BSJ8|ESYT1_HUMAN,6.77,73.98,1.031E6,1.031E6,1.478E6,1.461E6,1.00,1.00,1.43,1.42,1.031E6,1.031E6,1.478E6,1.461E6,1.00,1.00,1.43,1.42,3,3,3,iTRAQ 4plex (K  N-term),122856,Extended synaptotagmin-1 OS=Homo sapiens OX=9606 GN=ESYT1 PE=1 SV=1
1604,20425,A0A087WUF6|A0A087WUF6_HUMAN,3.50,73.98,4.175E6,3.379E6,4.244E6,3.999E6,1.00,0.81,1.02,0.96,4.175E6,3.379E6,4.244E6,3.999E6,1.00,0.81,1.02,0.96,12,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),30770,Fibroblast growth factor OS=Homo sapiens OX=9606 GN=FGF2 PE=1 SV=2
1948,22137,sp|O43813|LANC1_HUMAN,19.31,73.91,3.515E6,3.211E6,6.293E6,6.102E6,1.00,0.91,1.79,1.74,3.515E6,3.211E6,6.293E6,6.102E6,1.00,0.91,1.79,1.74,7,3,3,iTRAQ 4plex (K  N-term),45283,Glutathione S-transferase LANCL1 OS=Homo sapiens OX=9606 GN=LANCL1 PE=1 SV=1
1354,20754,sp|P20839-2|IMDH1_HUMAN,1.34,73.80,9.252E5,8.966E5,1.099E6,1.093E6,1.00,0.97,1.19,1.18,9.252E5,8.966E5,1.099E6,1.093E6,1.00,0.97,1.19,1.18,4,5,2,iTRAQ 4plex (K  N-term),52598,Isoform 2 of Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens OX=9606 GN=IMPDH1
1696,21942,I3L397|I3L397_HUMAN,9.73,73.75,6.559E6,6.372E6,8.829E6,9.707E6,1.00,0.97,1.35,1.48,6.559E6,6.372E6,8.829E6,9.707E6,1.00,0.97,1.35,1.48,14,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),16019,Eukaryotic translation initiation factor 5A (Fragment) OS=Homo sapiens OX=9606 GN=EIF5A PE=1 SV=8
1447,39877,A0A2R8Y7C0|A0A2R8Y7C0_HUMAN,14.06,73.72,4.839E6,4.674E6,7.53E6,8.247E6,1.00,0.97,1.56,1.70,4.839E6,4.674E6,7.53E6,8.247E6,1.00,0.97,1.56,1.70,23,3,3,iTRAQ 4plex (K  N-term),13962,Hemoglobin subunit alpha (Fragment) OS=Homo sapiens OX=9606 GN=HBA2 PE=1 SV=1
1624,39617,sp|Q08AF3|SLFN5_HUMAN,11.40,73.64,1.618E6,1.506E6,2.621E6,2.513E6,1.00,0.93,1.62,1.55,1.618E6,1.506E6,2.621E6,2.513E6,1.00,0.93,1.62,1.55,4,5,4,iTRAQ 4plex (K  N-term),101055,Schlafen family member 5 OS=Homo sapiens OX=9606 GN=SLFN5 PE=1 SV=1
2180,11987,sp|Q9NZ09-2|UBAP1_HUMAN,4.21,73.56,2.054E5,2.244E5,3.351E5,3.34E5,1.00,1.09,1.63,1.63,2.054E5,2.244E5,3.351E5,3.34E5,1.00,1.09,1.63,1.63,7,2,2,iTRAQ 4plex (K  N-term),48247,Isoform 2 of Ubiquitin-associated protein 1 OS=Homo sapiens OX=9606 GN=UBAP1
2092,6514,sp|P51610-2|HCFC1_HUMAN,18.02,73.56,1.148E6,1.147E6,2.286E6,2.131E6,1.00,1.00,1.99,1.86,1.148E6,1.147E6,2.286E6,2.131E6,1.00,1.00,1.99,1.86,2,3,3,iTRAQ 4plex (K  N-term),201848,Isoform 2 of Host cell factor 1 OS=Homo sapiens OX=9606 GN=HCFC1
1787,20350,sp|Q15056-2|IF4H_HUMAN,17.71,73.55,1.158E6,1.059E6,2.114E6,2.044E6,1.00,0.91,1.83,1.77,1.158E6,1.059E6,2.114E6,2.044E6,1.00,0.91,1.83,1.77,21,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),25200,Isoform Short of Eukaryotic translation initiation factor 4H OS=Homo sapiens OX=9606 GN=EIF4H
1931,16075,sp|P15170-2|ERF3A_HUMAN,8.89,73.51,1.336E6,1.219E6,1.861E6,2.003E6,1.00,0.91,1.39,1.50,1.336E6,1.219E6,1.861E6,2.003E6,1.00,0.91,1.39,1.50,6,4,4,iTRAQ 4plex (K  N-term),68601,Isoform 2 of Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens OX=9606 GN=GSPT1
1061,16765,sp|A0A087WSY6|KVD15_HUMAN,6.86,73.46,4.895E5,4.774E5,2.594E6,2.61E6,1.00,0.98,5.30,5.33,4.895E5,4.774E5,2.594E6,2.61E6,1.00,0.98,5.30,5.33,8,4,1,iTRAQ 4plex (K  N-term),12534,Immunoglobulin kappa variable 3D-15 OS=Homo sapiens OX=9606 GN=IGKV3D-15 PE=3 SV=6
970,22884,A0A075B6H7|A0A075B6H7_HUMAN,19.96,73.29,1.36E6,1.395E6,6.682E6,6.471E6,1.00,1.03,4.91,4.76,1.36E6,1.395E6,6.682E6,6.471E6,1.00,1.03,4.91,4.76,7,5,2,iTRAQ 4plex (K  N-term); Phosphorylation (STY),12783,Immunoglobulin kappa variable 3-7 (non-functional) (Fragment) OS=Homo sapiens OX=9606 GN=IGKV3-7 PE=1 SV=1
1683,39703,sp|P35240-6|MERL_HUMAN,4.10,73.24,6.842E5,6.912E5,1.097E6,1.117E6,1.00,1.01,1.60,1.63,6.842E5,6.912E5,1.097E6,1.117E6,1.00,1.01,1.60,1.63,4,3,2,iTRAQ 4plex (K  N-term),63997,Isoform 6 of Merlin OS=Homo sapiens OX=9606 GN=NF2
2473,40703,sp|P82912-2|RT11_HUMAN,4.51,73.19,5.182E5,5.542E5,8.589E5,8.372E5,1.00,1.07,1.66,1.62,5.182E5,5.542E5,8.589E5,8.372E5,1.00,1.07,1.66,1.62,15,2,2,iTRAQ 4plex (K  N-term),20460,Isoform 2 of 28S ribosomal protein S11  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS11
2202,21313,sp|P25685|DNJB1_HUMAN,16.50,73.08,1.248E6,1.112E6,2.19E6,2.094E6,1.00,0.89,1.75,1.68,1.248E6,1.112E6,2.19E6,2.094E6,1.00,0.89,1.75,1.68,9,3,3,iTRAQ 4plex (K  N-term),38044,DnaJ homolog subfamily B member 1 OS=Homo sapiens OX=9606 GN=DNAJB1 PE=1 SV=4
1972,39738,sp|Q9H2W6|RM46_HUMAN,15.57,72.74,6.974E5,6.769E5,1.261E6,1.25E6,1.00,0.97,1.81,1.79,6.974E5,6.769E5,1.261E6,1.25E6,1.00,0.97,1.81,1.79,12,3,3,iTRAQ 4plex (K  N-term),31705,39S ribosomal protein L46  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL46 PE=1 SV=1
2173,20316,A0A0B4J2F8|A0A0B4J2F8_HUMAN,20.71,72.71,5.983E5,4.938E5,1.169E6,1.06E6,1.00,0.83,1.95,1.77,5.983E5,4.938E5,1.169E6,1.06E6,1.00,0.83,1.95,1.77,21,3,3,iTRAQ 4plex (K  N-term),13074,DNA-directed RNA polymerase II subunit RPB11-b2 OS=Homo sapiens OX=9606 GN=POLR2J3 PE=4 SV=1
1424,39455,sp|Q9H4B6|SAV1_HUMAN,15.17,72.70,1.415E6,1.433E6,2.892E6,2.735E6,1.00,1.01,2.04,1.93,1.415E6,1.433E6,2.892E6,2.735E6,1.00,1.01,2.04,1.93,13,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),44634,Protein salvador homolog 1 OS=Homo sapiens OX=9606 GN=SAV1 PE=1 SV=2
1410,17389,sp|P59998|ARPC4_HUMAN,0.75,72.64,1.091E7,1.008E7,1.042E7,1.316E7,1.00,0.92,0.96,1.21,1.091E7,1.008E7,1.042E7,1.316E7,1.00,0.92,0.96,1.21,5,4,1,iTRAQ 4plex (K  N-term),19667,Actin-related protein 2/3 complex subunit 4 OS=Homo sapiens OX=9606 GN=ARPC4 PE=1 SV=3
1802,17736,sp|Q9P2J5-2|SYLC_HUMAN,2.85,72.56,1.202E6,1.176E6,1.371E6,1.436E6,1.00,0.98,1.14,1.19,1.202E6,1.176E6,1.371E6,1.436E6,1.00,0.98,1.14,1.19,3,4,4,iTRAQ 4plex (K  N-term),128038,Isoform 2 of Leucine--tRNA ligase  cytoplasmic OS=Homo sapiens OX=9606 GN=LARS
1759,11794,sp|O00291-3|HIP1_HUMAN,4.99,72.51,1.448E6,1.271E6,1.617E6,1.698E6,1.00,0.88,1.12,1.17,1.448E6,1.271E6,1.617E6,1.698E6,1.00,0.88,1.12,1.17,3,3,3,iTRAQ 4plex (K  N-term),110663,Isoform 3 of Huntingtin-interacting protein 1 OS=Homo sapiens OX=9606 GN=HIP1
1377,39904,F6RFD5|F6RFD5_HUMAN,2.84,72.34,2.893E6,2.741E6,3.753E6,3.865E6,1.00,0.95,1.30,1.34,2.893E6,2.741E6,3.753E6,3.865E6,1.00,0.95,1.30,1.34,15,3,2,iTRAQ 4plex (K  N-term),15397,Destrin OS=Homo sapiens OX=9606 GN=DSTN PE=1 SV=1
1163,5839,sp|P11055|MYH3_HUMAN,1.84,72.28,1.947E6,1.845E6,1.89E6,2.472E6,1.00,0.95,0.97,1.27,1.947E6,1.845E6,1.89E6,2.472E6,1.00,0.95,0.97,1.27,2,5,2,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),223903,Myosin-3 OS=Homo sapiens OX=9606 GN=MYH3 PE=1 SV=3
1733,21411,sp|Q13200-2|PSMD2_HUMAN,7.16,72.12,1.238E6,1.152E6,1.684E6,1.693E6,1.00,0.93,1.36,1.37,1.238E6,1.152E6,1.684E6,1.693E6,1.00,0.93,1.36,1.37,4,4,4,iTRAQ 4plex (K  N-term),82194,Isoform 2 of 26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens OX=9606 GN=PSMD2
1638,23099,sp|Q96HN2-4|SAHH3_HUMAN,1.80,72.01,2.786E4,3.381E4,5.108E4,4.701E4,1.00,1.21,1.83,1.69,2.786E4,3.381E4,5.108E4,4.701E4,1.00,1.21,1.83,1.69,3,4,1,iTRAQ 4plex (K  N-term),56944,Isoform 4 of Adenosylhomocysteinase 3 OS=Homo sapiens OX=9606 GN=AHCYL2
1790,39978,sp|Q8N6Y2-2|LRC17_HUMAN,6.82,71.94,1.679E6,1.637E6,2.199E6,2.336E6,1.00,0.98,1.31,1.39,1.679E6,1.637E6,2.199E6,2.336E6,1.00,0.98,1.31,1.39,8,3,3,iTRAQ 4plex (K  N-term),36273,Isoform 2 of Leucine-rich repeat-containing protein 17 OS=Homo sapiens OX=9606 GN=LRRC17
1871,20958,H3BSA1|H3BSA1_HUMAN,4.54,71.81,3.521E6,3.549E6,5.503E6,5.621E6,1.00,1.01,1.56,1.60,3.521E6,3.549E6,5.503E6,5.621E6,1.00,1.01,1.56,1.60,10,3,2,iTRAQ 4plex (K  N-term),27025,Casein kinase II subunit alpha' (Fragment) OS=Homo sapiens OX=9606 GN=CSNK2A2 PE=1 SV=2
1840,40033,H0YCU9|H0YCU9_HUMAN,3.64,71.75,8.69E5,8.296E5,1.067E6,1.056E6,1.00,0.95,1.23,1.22,8.69E5,8.296E5,1.067E6,1.056E6,1.00,0.95,1.23,1.22,25,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),16852,Transgelin (Fragment) OS=Homo sapiens OX=9606 GN=TAGLN PE=1 SV=1
2478,40808,sp|O15446|RPA34_HUMAN,4.51,71.75,9.737E4,1.116E5,1.654E5,1.624E5,1.00,1.15,1.70,1.67,9.737E4,1.116E5,1.654E5,1.624E5,1.00,1.15,1.70,1.67,9,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),54986,DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens OX=9606 GN=CD3EAP PE=1 SV=1
2214,40044,sp|Q99460-2|PSMD1_HUMAN,2.85,71.71,6.488E5,6.25E5,7.619E5,7.661E5,1.00,0.96,1.17,1.18,6.488E5,6.25E5,7.619E5,7.661E5,1.00,0.96,1.17,1.18,4,3,3,iTRAQ 4plex (K  N-term),102258,Isoform 2 of 26S proteasome non-ATPase regulatory subunit 1 OS=Homo sapiens OX=9606 GN=PSMD1
1832,39706,E9PM17|E9PM17_HUMAN,19.26,71.68,7.914E5,8.091E5,1.633E6,1.623E6,1.00,1.02,2.06,2.05,7.914E5,8.091E5,1.633E6,1.623E6,1.00,1.02,2.06,2.05,7,3,3,iTRAQ 4plex (K  N-term),50877,Serine/threonine-protein kinase PAK 1 OS=Homo sapiens OX=9606 GN=PAK1 PE=1 SV=1
2142,40560,sp|A1KXE4|F168B_HUMAN,32.81,71.65,3.974E5,3.708E5,7.862E5,6.977E5,1.00,0.93,1.98,1.76,3.974E5,3.708E5,7.862E5,6.977E5,1.00,0.93,1.98,1.76,19,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),20324,Myelin-associated neurite-outgrowth inhibitor OS=Homo sapiens OX=9606 GN=FAM168B PE=1 SV=1
1785,8066,sp|Q15811-4|ITSN1_HUMAN,17.72,71.61,6.233E5,6.489E5,1.271E6,1.218E6,1.00,1.04,2.04,1.95,6.233E5,6.489E5,1.271E6,1.218E6,1.00,1.04,2.04,1.95,2,4,4,iTRAQ 4plex (K  N-term),187787,Isoform 4 of Intersectin-1 OS=Homo sapiens OX=9606 GN=ITSN1
2207,10541,sp|Q53F19|NCBP3_HUMAN,3.36,71.40,4.158E5,4.208E5,5.298E5,5.243E5,1.00,1.01,1.27,1.26,4.158E5,4.208E5,5.298E5,5.243E5,1.00,1.01,1.27,1.26,5,3,3,iTRAQ 4plex (K  N-term),70593,Nuclear cap-binding protein subunit 3 OS=Homo sapiens OX=9606 GN=NCBP3 PE=1 SV=2
2359,40177,sp|O95402|MED26_HUMAN,5.73,71.23,5.981E5,6.503E5,1.015E6,1.062E6,1.00,1.09,1.70,1.78,5.981E5,6.503E5,1.015E6,1.062E6,1.00,1.09,1.70,1.78,5,2,2,iTRAQ 4plex (K  N-term),65447,Mediator of RNA polymerase II transcription subunit 26 OS=Homo sapiens OX=9606 GN=MED26 PE=1 SV=2
2364,40215,sp|O00459|P85B_HUMAN,2.24,71.09,1.659E5,1.704E5,2.252E5,2.216E5,1.00,1.03,1.36,1.34,1.659E5,1.704E5,2.252E5,2.216E5,1.00,1.03,1.36,1.34,4,2,2,iTRAQ 4plex (K  N-term),81545,Phosphatidylinositol 3-kinase regulatory subunit beta OS=Homo sapiens OX=9606 GN=PIK3R2 PE=1 SV=2
2179,18902,sp|Q9H204|MED28_HUMAN,1.25,70.95,3.947E6,3.763E6,4.387E6,4.165E6,1.00,0.95,1.11,1.06,3.947E6,3.763E6,4.387E6,4.165E6,1.00,0.95,1.11,1.06,15,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),19520,Mediator of RNA polymerase II transcription subunit 28 OS=Homo sapiens OX=9606 GN=MED28 PE=1 SV=1
2349,22735,sp|Q9BU76-4|MMTA2_HUMAN,2.14,70.86,2.591E5,2.593E5,3.449E5,3.251E5,1.00,1.00,1.33,1.25,2.591E5,2.593E5,3.449E5,3.251E5,1.00,1.00,1.33,1.25,14,2,2,iTRAQ 4plex (K  N-term),20536,Isoform 4 of Multiple myeloma tumor-associated protein 2 OS=Homo sapiens OX=9606 GN=MMTAG2
2414,23731,sp|Q8NDN9|RCBT1_HUMAN,2.79,70.84,4.375E5,4.952E5,6.242E5,5.679E5,1.00,1.13,1.43,1.30,4.375E5,4.952E5,6.242E5,5.679E5,1.00,1.13,1.43,1.30,5,2,2,iTRAQ 4plex (K  N-term),58252,RCC1 and BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCBTB1 PE=1 SV=1
2008,8129,sp|Q13561|DCTN2_HUMAN,8.38,70.67,3.754E5,3.724E5,5.626E5,5.851E5,1.00,0.99,1.50,1.56,3.754E5,3.724E5,5.626E5,5.851E5,1.00,0.99,1.50,1.56,8,3,3,iTRAQ 4plex (K  N-term),44231,Dynactin subunit 2 OS=Homo sapiens OX=9606 GN=DCTN2 PE=1 SV=4
1978,39853,sp|P62495-2|ERF1_HUMAN,10.71,70.66,4.687E5,4.537E5,8.079E5,7.473E5,1.00,0.97,1.72,1.59,4.687E5,4.537E5,8.079E5,7.473E5,1.00,0.97,1.72,1.59,8,3,3,iTRAQ 4plex (K  N-term),45463,Isoform 2 of Eukaryotic peptide chain release factor subunit 1 OS=Homo sapiens OX=9606 GN=ETF1
2476,40770,sp|P51148|RAB5C_HUMAN,2.92,70.60,1.422E5,1.356E5,1.961E5,1.975E5,1.00,0.95,1.38,1.39,1.422E5,1.356E5,1.961E5,1.975E5,1.00,0.95,1.38,1.39,17,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),23483,Ras-related protein Rab-5C OS=Homo sapiens OX=9606 GN=RAB5C PE=1 SV=2
1792,40505,A0A075B7D8|A0A075B7D8_HUMAN,6.44,70.55,1.572E5,1.864E5,7.671E5,8.162E5,1.00,1.19,4.88,5.19,1.572E5,1.864E5,7.671E5,8.162E5,1.00,1.19,4.88,5.19,9,3,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),13080,Immunoglobulin heavy variable 3/OR15-7 (pseudogene) (Fragment) OS=Homo sapiens OX=9606 GN=IGHV3OR15-7 PE=1 SV=1
2005,39932,sp|Q9Y696|CLIC4_HUMAN,6.14,70.52,1.41E6,1.344E6,1.659E6,1.894E6,1.00,0.95,1.18,1.34,1.41E6,1.344E6,1.659E6,1.894E6,1.00,0.95,1.18,1.34,16,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),28772,Chloride intracellular channel protein 4 OS=Homo sapiens OX=9606 GN=CLIC4 PE=1 SV=4
2163,5073,sp|Q6UVK1|CSPG4_HUMAN,6.82,70.50,2.126E5,2.194E5,3.085E5,3E5,1.00,1.03,1.45,1.41,2.126E5,2.194E5,3.085E5,3E5,1.00,1.03,1.45,1.41,2,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),250534,Chondroitin sulfate proteoglycan 4 OS=Homo sapiens OX=9606 GN=CSPG4 PE=1 SV=2
2098,40263,sp|O00442|RTCA_HUMAN,5.13,70.40,8.989E5,8.874E5,1.546E6,1.507E6,1.00,0.99,1.72,1.68,8.989E5,8.874E5,1.546E6,1.507E6,1.00,0.99,1.72,1.68,7,2,2,iTRAQ 4plex (K  N-term),39337,RNA 3'-terminal phosphate cyclase OS=Homo sapiens OX=9606 GN=RTCA PE=1 SV=1
2181,40522,sp|Q9H0U3|MAGT1_HUMAN,14.79,70.36,7.694E5,7.547E5,1.468E6,1.414E6,1.00,0.98,1.91,1.84,7.694E5,7.547E5,1.468E6,1.414E6,1.00,0.98,1.91,1.84,6,3,3,iTRAQ 4plex (K  N-term),38037,Magnesium transporter protein 1 OS=Homo sapiens OX=9606 GN=MAGT1 PE=1 SV=1
2012,21467,sp|P00338|LDHA_HUMAN,8.99,70.21,1.008E6,8.448E5,1.316E6,1.358E6,1.00,0.84,1.30,1.35,1.008E6,8.448E5,1.316E6,1.358E6,1.00,0.84,1.30,1.35,9,3,3,iTRAQ 4plex (K  N-term),36689,L-lactate dehydrogenase A chain OS=Homo sapiens OX=9606 GN=LDHA PE=1 SV=2
1923,20048,J3KRN4|J3KRN4_HUMAN,5.55,70.19,1.067E5,1.068E5,2.079E5,1.938E5,1.00,1.00,1.95,1.82,1.067E5,1.068E5,2.079E5,1.938E5,1.00,1.00,1.95,1.82,4,3,2,iTRAQ 4plex (K  N-term),70468,Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP3K3 PE=1 SV=1
1881,40187,sp|O14617-4|AP3D1_HUMAN,26.91,70.19,1.127E6,1.127E6,2.245E6,2.15E6,1.00,1.00,1.99,1.91,1.127E6,1.127E6,2.245E6,2.15E6,1.00,1.00,1.99,1.91,4,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),114707,Isoform 4 of AP-3 complex subunit delta-1 OS=Homo sapiens OX=9606 GN=AP3D1
1345,22126,sp|A0A0A0MT36|KVD21_HUMAN,2.88,70.11,4.879E5,4.776E5,1.147E6,9.979E5,1.00,0.98,2.35,2.05,4.879E5,4.776E5,1.147E6,9.979E5,1.00,0.98,2.35,2.05,13,4,1,iTRAQ 4plex (K  N-term),12340,Immunoglobulin kappa variable 6D-21 OS=Homo sapiens OX=9606 GN=IGKV6D-21 PE=3 SV=1
2125,29308,sp|Q96L34-2|MARK4_HUMAN,7.05,70.09,9.779E4,1.009E5,2.231E5,2.034E5,1.00,1.03,2.28,2.08,9.779E4,1.009E5,2.231E5,2.034E5,1.00,1.03,2.28,2.08,6,3,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),75321,Isoform 2 of MAP/microtubule affinity-regulating kinase 4 OS=Homo sapiens OX=9606 GN=MARK4
2093,2915,sp|O15164-2|TIF1A_HUMAN,19.54,70.07,2.632E5,2.91E5,5.582E5,5.882E5,1.00,1.11,2.12,2.23,2.632E5,2.91E5,5.582E5,5.882E5,1.00,1.11,2.12,2.23,3,3,3,iTRAQ 4plex (K  N-term),113018,Isoform Short of Transcription intermediary factor 1-alpha OS=Homo sapiens OX=9606 GN=TRIM24
2174,40414,sp|P78357|CNTP1_HUMAN,7.01,70.03,6.469E5,6.046E5,1.223E6,1.169E6,1.00,0.93,1.89,1.81,6.469E5,6.046E5,1.223E6,1.169E6,1.00,0.93,1.89,1.81,2,2,2,iTRAQ 4plex (K  N-term),156266,Contactin-associated protein 1 OS=Homo sapiens OX=9606 GN=CNTNAP1 PE=1 SV=1
2134,40207,I3L1P8|I3L1P8_HUMAN,0.28,70.01,1.131E6,1.115E6,1.118E6,1.084E6,1.00,0.99,0.99,0.96,1.131E6,1.115E6,1.118E6,1.084E6,1.00,0.99,0.99,0.96,8,2,2,iTRAQ 4plex (K  N-term),32182,Mitochondrial 2-oxoglutarate/malate carrier protein (Fragment) OS=Homo sapiens OX=9606 GN=SLC25A11 PE=1 SV=1
2083,40130,sp|Q9ULH0-2|KDIS_HUMAN,15.40,69.65,2.799E5,2.58E5,4.973E5,4.935E5,1.00,0.92,1.78,1.76,2.799E5,2.58E5,4.973E5,4.935E5,1.00,0.92,1.78,1.76,2,3,3,iTRAQ 4plex (K  N-term),185545,Isoform 2 of Kinase D-interacting substrate of 220 kDa OS=Homo sapiens OX=9606 GN=KIDINS220
2026,24034,sp|Q9Y5S9|RBM8A_HUMAN,1.91,69.56,5.628E5,5.658E5,6.981E5,7.24E5,1.00,1.01,1.24,1.29,5.628E5,5.658E5,6.981E5,7.24E5,1.00,1.01,1.24,1.29,16,2,2,iTRAQ 4plex (K  N-term),19889,RNA-binding protein 8A OS=Homo sapiens OX=9606 GN=RBM8A PE=1 SV=1
1216,7425,H7C3T4|H7C3T4_HUMAN,1.35,69.43,5.5E5,5.482E5,8.402E5,8.683E5,1.00,1.00,1.53,1.58,5.5E5,5.482E5,8.402E5,8.683E5,1.00,1.00,1.53,1.58,6,3,1,iTRAQ 4plex (K  N-term),18334,Peroxiredoxin-4 (Fragment) OS=Homo sapiens OX=9606 GN=PRDX4 PE=1 SV=1
1900,39632,sp|Q6PGP7|TTC37_HUMAN,5.99,69.40,6.179E5,5.762E5,8.274E5,8.317E5,1.00,0.93,1.34,1.35,6.179E5,5.762E5,8.274E5,8.317E5,1.00,0.93,1.34,1.35,2,4,4,iTRAQ 4plex (K  N-term),175485,Tetratricopeptide repeat protein 37 OS=Homo sapiens OX=9606 GN=TTC37 PE=1 SV=1
2373,17584,sp|P13489|RINI_HUMAN,7.84,69.39,3.937E5,3.653E5,7.991E5,7.299E5,1.00,0.93,2.03,1.85,3.937E5,3.653E5,7.991E5,7.299E5,1.00,0.93,2.03,1.85,7,2,2,iTRAQ 4plex (K  N-term),49974,Ribonuclease inhibitor OS=Homo sapiens OX=9606 GN=RNH1 PE=1 SV=2
2477,40776,H0YD13|H0YD13_HUMAN,5.21,69.25,3.404E5,3.282E5,5.839E5,5.687E5,1.00,0.96,1.72,1.67,3.404E5,3.282E5,5.839E5,5.687E5,1.00,0.96,1.72,1.67,10,2,2,iTRAQ 4plex (K  N-term),22683,CD44 antigen OS=Homo sapiens OX=9606 GN=CD44 PE=1 SV=2
2323,40302,sp|Q8IWZ8|SUGP1_HUMAN,3.48,69.22,2.135E5,1.907E5,2.913E5,2.852E5,1.00,0.89,1.36,1.34,2.135E5,1.907E5,2.913E5,2.852E5,1.00,0.89,1.36,1.34,6,2,2,iTRAQ 4plex (K  N-term),72471,SURP and G-patch domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUGP1 PE=1 SV=2
2167,40186,sp|Q99988|GDF15_HUMAN,9.92,69.22,1.02E6,1.051E6,1.567E6,1.649E6,1.00,1.03,1.54,1.62,1.02E6,1.051E6,1.567E6,1.649E6,1.00,1.03,1.54,1.62,9,3,3,iTRAQ 4plex (K  N-term),34140,Growth/differentiation factor 15 OS=Homo sapiens OX=9606 GN=GDF15 PE=1 SV=3
1828,39635,sp|P39748-2|FEN1_HUMAN,5.69,69.17,9.736E5,9.667E5,1.344E6,1.406E6,1.00,0.99,1.38,1.44,9.736E5,9.667E5,1.344E6,1.406E6,1.00,0.99,1.38,1.44,9,4,3,iTRAQ 4plex (K  N-term),35673,Isoform FENMIT of Flap endonuclease 1 OS=Homo sapiens OX=9606 GN=FEN1
2011,40027,E7EPI0|E7EPI0_HUMAN,8.74,69.07,6.229E5,5.805E5,9.319E5,9.387E5,1.00,0.93,1.50,1.51,6.229E5,5.805E5,9.319E5,9.387E5,1.00,0.93,1.50,1.51,2,3,3,iTRAQ 4plex (K  N-term),149016,Inhibitor of Bruton tyrosine kinase OS=Homo sapiens OX=9606 GN=IBTK PE=1 SV=1
2200,6929,A0A286YF22|A0A286YF22_HUMAN,3.34,69.03,1.536E6,1.283E6,1.63E6,1.622E6,1.00,0.84,1.06,1.06,1.536E6,1.283E6,1.63E6,1.622E6,1.00,0.84,1.06,1.06,6,3,3,iTRAQ 4plex (K  N-term),55939,D-3-phosphoglycerate dehydrogenase OS=Homo sapiens OX=9606 GN=PHGDH PE=1 SV=1
1763,39678,sp|Q9UQE7|SMC3_HUMAN,9.01,68.98,8.677E5,7.614E5,1.233E6,1.124E6,1.00,0.88,1.42,1.30,8.677E5,7.614E5,1.233E6,1.124E6,1.00,0.88,1.42,1.30,5,5,5,iTRAQ 4plex (K  N-term),141541,Structural maintenance of chromosomes protein 3 OS=Homo sapiens OX=9606 GN=SMC3 PE=1 SV=2
2210,40003,sp|Q96TA2-3|YMEL1_HUMAN,8.75,68.98,5.48E5,5.75E5,8.623E5,8.588E5,1.00,1.05,1.57,1.57,5.48E5,5.75E5,8.623E5,8.588E5,1.00,1.05,1.57,1.57,6,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),75982,Isoform 3 of ATP-dependent zinc metalloprotease YME1L1 OS=Homo sapiens OX=9606 GN=YME1L1
1924,3194,sp|Q96B70|LENG9_HUMAN,6.09,68.97,6.142E5,6.404E5,8.598E5,8.816E5,1.00,1.04,1.40,1.44,6.142E5,6.404E5,8.598E5,8.816E5,1.00,1.04,1.40,1.44,11,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),53167,Leukocyte receptor cluster member 9 OS=Homo sapiens OX=9606 GN=LENG9 PE=2 SV=2
1973,12017,sp|O14818|PSA7_HUMAN,11.21,68.83,1.736E6,1.581E6,2.62E6,2.698E6,1.00,0.91,1.51,1.55,1.736E6,1.581E6,2.62E6,2.698E6,1.00,0.91,1.51,1.55,12,3,3,iTRAQ 4plex (K  N-term),27887,Proteasome subunit alpha type-7 OS=Homo sapiens OX=9606 GN=PSMA7 PE=1 SV=1
2496,11750,G3V158|G3V158_HUMAN,2.12,68.74,8.671E5,8.734E5,6.727E5,6.747E5,1.00,1.01,0.78,0.78,8.671E5,8.734E5,6.727E5,6.747E5,1.00,1.01,0.78,0.78,11,2,2,iTRAQ 4plex (K  N-term),25113,2-deoxyribose-5-phosphate aldolase homolog (C. elegans)  isoform CRA_a OS=Homo sapiens OX=9606 GN=DERA PE=1 SV=1
1671,4123,X6RAY8|X6RAY8_HUMAN,6.68,68.71,6.273E5,6.056E5,1.139E6,1.155E6,1.00,0.97,1.82,1.84,6.273E5,6.056E5,1.139E6,1.155E6,1.00,0.97,1.82,1.84,8,2,2,iTRAQ 4plex (K  N-term),39588,39S ribosomal protein L4  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL4 PE=1 SV=1
1949,17405,F2Z2E2|F2Z2E2_HUMAN,1.44,68.71,1.798E5,1.919E5,2.805E5,2.944E5,1.00,1.07,1.56,1.64,1.798E5,1.919E5,2.805E5,2.944E5,1.00,1.07,1.56,1.64,1,3,1,iTRAQ 4plex (K  N-term),179483,Ras GTPase-activating-like protein IQGAP3 OS=Homo sapiens OX=9606 GN=IQGAP3 PE=1 SV=1
1224,18806,sp|O75525-2|KHDR3_HUMAN,0.72,68.68,4.634E5,4.499E5,5.647E5,5.853E5,1.00,0.97,1.22,1.26,4.634E5,4.499E5,5.647E5,5.853E5,1.00,0.97,1.22,1.26,3,3,1,iTRAQ 4plex (K  N-term),30250,Isoform 2 of KH domain-containing  RNA-binding  signal transduction-associated protein 3 OS=Homo sapiens OX=9606 GN=KHDRBS3
2492,40993,A0A024R216|A0A024R216_HUMAN,5.08,68.66,6.818E5,6.567E5,1.075E6,1.115E6,1.00,0.96,1.58,1.64,6.818E5,6.567E5,1.075E6,1.115E6,1.00,0.96,1.58,1.64,12,2,2,iTRAQ 4plex (K  N-term),22620,Hepatoma-derived growth factor  related protein 3  isoform CRA_a OS=Homo sapiens OX=9606 GN=HDGFRP3 PE=1 SV=1
1868,22082,sp|P56537|IF6_HUMAN,8.22,68.66,6.208E5,6.585E5,9.624E5,9.151E5,1.00,1.06,1.55,1.47,6.208E5,6.585E5,9.624E5,9.151E5,1.00,1.06,1.55,1.47,13,3,3,iTRAQ 4plex (K  N-term),26599,Eukaryotic translation initiation factor 6 OS=Homo sapiens OX=9606 GN=EIF6 PE=1 SV=1
2451,22719,sp|Q96DE0-3|NUD16_HUMAN,1.19,68.65,2.803E5,2.827E5,4.257E5,4.182E5,1.00,1.01,1.52,1.49,2.803E5,2.827E5,4.257E5,4.182E5,1.00,1.01,1.52,1.49,6,2,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),17676,Isoform 3 of U8 snoRNA-decapping enzyme OS=Homo sapiens OX=9606 GN=NUDT16
1770,39746,sp|Q9UHD8|SEPT9_HUMAN,12.05,68.64,5.218E5,5.435E5,9.106E5,9.357E5,1.00,1.04,1.75,1.79,5.218E5,5.435E5,9.106E5,9.357E5,1.00,1.04,1.75,1.79,6,3,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),65402,Septin-9 OS=Homo sapiens OX=9606 GN=SEPT9 PE=1 SV=2
799,19668,sp|P25398|RS12_HUMAN,17.62,68.48,3.141E7,3.088E7,5.561E7,5.482E7,1.00,0.98,1.77,1.75,3.141E7,3.088E7,5.561E7,5.482E7,1.00,0.98,1.77,1.75,20,3,3,iTRAQ 4plex (K  N-term),14515,40S ribosomal protein S12 OS=Homo sapiens OX=9606 GN=RPS12 PE=1 SV=3
2212,4124,sp|Q9BUQ8|DDX23_HUMAN,10.03,68.27,1.712E5,1.744E5,2.974E5,2.987E5,1.00,1.02,1.74,1.74,1.712E5,1.744E5,2.974E5,2.987E5,1.00,1.02,1.74,1.74,4,3,3,iTRAQ 4plex (K  N-term),95583,Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3
1801,7919,sp|P48553|TPC10_HUMAN,10.22,68.27,5.941E5,6.077E5,1.013E6,9.865E5,1.00,1.02,1.71,1.66,5.941E5,6.077E5,1.013E6,9.865E5,1.00,1.02,1.71,1.66,3,4,4,iTRAQ 4plex (K  N-term),142189,Trafficking protein particle complex subunit 10 OS=Homo sapiens OX=9606 GN=TRAPPC10 PE=1 SV=2
1907,1177,sp|Q9P2D1|CHD7_HUMAN,0.83,68.16,3.704E4,3.596E4,4.876E4,4.505E4,1.00,0.97,1.32,1.22,3.704E4,3.596E4,4.876E4,4.505E4,1.00,0.97,1.32,1.22,0,4,1,iTRAQ 4plex (K  N-term),335928,Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens OX=9606 GN=CHD7 PE=1 SV=3
1921,39752,sp|Q01780|EXOSX_HUMAN,7.55,68.12,4.432E5,4.341E5,6.594E5,6.663E5,1.00,0.98,1.49,1.50,4.432E5,4.341E5,6.594E5,6.663E5,1.00,0.98,1.49,1.50,3,3,3,iTRAQ 4plex (K  N-term),100831,Exosome component 10 OS=Homo sapiens OX=9606 GN=EXOSC10 PE=1 SV=2
2360,22390,sp|Q05519-2|SRS11_HUMAN,4.53,68.05,1.959E5,2.141E5,3.18E5,3.3E5,1.00,1.09,1.62,1.69,1.959E5,2.141E5,3.18E5,3.3E5,1.00,1.09,1.62,1.69,5,2,2,iTRAQ 4plex (K  N-term),53414,Isoform 2 of Serine/arginine-rich splicing factor 11 OS=Homo sapiens OX=9606 GN=SRSF11
1937,13787,sp|Q5T1M5-2|FKB15_HUMAN,18.16,68.05,3.033E5,2.972E5,6.355E5,6.883E5,1.00,0.98,2.10,2.27,3.033E5,2.972E5,6.355E5,6.883E5,1.00,0.98,2.10,2.27,3,4,3,iTRAQ 4plex (K  N-term); Phosphorylation (STY),132467,Isoform 2 of FK506-binding protein 15 OS=Homo sapiens OX=9606 GN=FKBP15
1805,39856,sp|Q96QK1|VPS35_HUMAN,13.73,67.98,5.26E5,4.904E5,9.124E5,9.765E5,1.00,0.93,1.73,1.86,5.26E5,4.904E5,9.124E5,9.765E5,1.00,0.93,1.73,1.86,5,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),91707,Vacuolar protein sorting-associated protein 35 OS=Homo sapiens OX=9606 GN=VPS35 PE=1 SV=2
1758,22298,sp|O96013|PAK4_HUMAN,11.65,67.95,3.709E6,2.821E6,4.878E6,5.063E6,1.00,0.76,1.32,1.37,3.709E6,2.821E6,4.878E6,5.063E6,1.00,0.76,1.32,1.37,10,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),64072,Serine/threonine-protein kinase PAK 4 OS=Homo sapiens OX=9606 GN=PAK4 PE=1 SV=1
1636,5734,sp|Q6ZVM7-2|TM1L2_HUMAN,3.33,67.93,1.688E6,1.626E6,2.036E6,2.093E6,1.00,0.96,1.21,1.24,1.688E6,1.626E6,2.036E6,2.093E6,1.00,0.96,1.21,1.24,13,5,5,iTRAQ 4plex (K  N-term); Deamidation (NQ),49964,Isoform 2 of TOM1-like protein 2 OS=Homo sapiens OX=9606 GN=TOM1L2
1522,20850,sp|P62879|GBB2_HUMAN,8.57,67.81,1.669E6,1.747E6,2.593E6,2.595E6,1.00,1.05,1.55,1.55,1.669E6,1.747E6,2.593E6,2.595E6,1.00,1.05,1.55,1.55,8,3,3,iTRAQ 4plex (K  N-term),37331,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 OS=Homo sapiens OX=9606 GN=GNB2 PE=1 SV=3
1544,39519,sp|Q99755-2|PI51A_HUMAN,9.81,67.77,3.476E5,3.559E5,6.444E5,6.183E5,1.00,1.02,1.85,1.78,3.476E5,3.559E5,6.444E5,6.183E5,1.00,1.02,1.85,1.78,9,5,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),56053,Isoform 2 of Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Homo sapiens OX=9606 GN=PIP5K1A
1256,20924,sp|P0DN76|U2AF5_HUMAN,12.79,67.66,5.156E6,5.107E6,7.989E6,7.639E6,1.00,0.99,1.55,1.48,5.156E6,5.107E6,7.989E6,7.639E6,1.00,0.99,1.55,1.48,9,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),27872,Splicing factor U2AF 35 kDa subunit-like protein OS=Homo sapiens OX=9606 GN=U2AF1L5 PE=1 SV=1
1255,18335,sp|A0A0B4J2D9|KVD13_HUMAN,3.64,67.66,2.363E5,2.1E5,6.128E5,5.779E5,1.00,0.89,2.59,2.45,2.363E5,2.1E5,6.128E5,5.779E5,1.00,0.89,2.59,2.45,8,4,1,iTRAQ 4plex (K  N-term),12569,Immunoglobulin kappa variable 1D-13 OS=Homo sapiens OX=9606 GN=IGKV1D-13 PE=3 SV=1
1218,20585,sp|P62857|RS28_HUMAN,14.47,67.56,9.645E6,9.586E6,1.566E7,1.567E7,1.00,0.99,1.62,1.62,9.645E6,9.586E6,1.566E7,1.567E7,1.00,0.99,1.62,1.62,30,2,2,iTRAQ 4plex (K  N-term); Oxidation (M),7841,40S ribosomal protein S28 OS=Homo sapiens OX=9606 GN=RPS28 PE=1 SV=1
2007,39944,H0Y9S7|H0Y9S7_HUMAN,3.34,67.51,4.77E5,4.39E5,5.687E5,5.023E5,1.00,0.92,1.19,1.05,4.77E5,4.39E5,5.687E5,5.023E5,1.00,0.92,1.19,1.05,13,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),34884,Calcium-transporting ATPase type 2C member 1 (Fragment) OS=Homo sapiens OX=9606 GN=ATP2C1 PE=1 SV=1
2049,40411,sp|Q6GYQ0-6|RGPA1_HUMAN,3.50,67.44,6.414E5,6.602E5,7.332E5,9.399E5,1.00,1.03,1.14,1.47,6.414E5,6.602E5,7.332E5,9.399E5,1.00,1.03,1.14,1.47,2,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),234852,Isoform 6 of Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1
1585,40386,sp|Q14689-6|DIP2A_HUMAN,2.13,67.38,2.309E4,2.518E4,4.598E4,3.77E4,1.00,1.09,1.99,1.63,2.309E4,2.518E4,4.598E4,3.77E4,1.00,1.09,1.99,1.63,1,2,1,iTRAQ 4plex (K  N-term),169916,Isoform 6 of Disco-interacting protein 2 homolog A OS=Homo sapiens OX=9606 GN=DIP2A
2120,6394,sp|Q96SU4-7|OSBL9_HUMAN,21.17,67.35,5.261E5,5.456E5,1.344E6,1.311E6,1.00,1.04,2.55,2.49,5.261E5,5.456E5,1.344E6,1.311E6,1.00,1.04,2.55,2.49,5,3,3,iTRAQ 4plex (K  N-term),81166,Isoform 7 of Oxysterol-binding protein-related protein 9 OS=Homo sapiens OX=9606 GN=OSBPL9
1952,39930,sp|O75475|PSIP1_HUMAN,6.99,67.35,7.986E5,7.957E5,1.18E6,1.174E6,1.00,1.00,1.48,1.47,7.986E5,7.957E5,1.18E6,1.174E6,1.00,1.00,1.48,1.47,5,3,3,iTRAQ 4plex (K  N-term),60103,PC4 and SFRS1-interacting protein OS=Homo sapiens OX=9606 GN=PSIP1 PE=1 SV=1
2074,2793,sp|O60264|SMCA5_HUMAN,3.69,67.27,5.405E4,4.093E4,6.876E4,6.251E4,1.00,0.76,1.27,1.16,5.405E4,4.093E4,6.876E4,6.251E4,1.00,0.76,1.27,1.16,4,3,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),121905,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Homo sapiens OX=9606 GN=SMARCA5 PE=1 SV=1
1489,4127,sp|P59998-2|ARPC4_HUMAN,1.42,67.25,3.652E5,3.063E5,4.925E5,4.994E5,1.00,0.84,1.35,1.37,3.652E5,3.063E5,4.925E5,4.994E5,1.00,0.84,1.35,1.37,2,4,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),71719,Isoform 2 of Actin-related protein 2/3 complex subunit 4 OS=Homo sapiens OX=9606 GN=ARPC4
1909,7375,sp|O75396|SC22B_HUMAN,12.53,67.25,4.748E5,5.001E5,8.961E5,8.572E5,1.00,1.05,1.89,1.81,4.748E5,5.001E5,8.961E5,8.572E5,1.00,1.05,1.89,1.81,14,3,3,iTRAQ 4plex (K  N-term),24593,Vesicle-trafficking protein SEC22b OS=Homo sapiens OX=9606 GN=SEC22B PE=1 SV=4
2124,39685,sp|Q8IXM3|RM41_HUMAN,13.80,67.19,5.196E5,5.297E5,1.004E6,9.845E5,1.00,1.02,1.93,1.89,5.196E5,5.297E5,1.004E6,9.845E5,1.00,1.02,1.93,1.89,20,3,3,iTRAQ 4plex (K  N-term),15383,39S ribosomal protein L41  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL41 PE=1 SV=1
2230,40888,G3V2N3|G3V2N3_HUMAN,4.45,67.15,8.409E5,8.249E5,1.289E6,1.341E6,1.00,0.98,1.53,1.59,8.409E5,8.249E5,1.289E6,1.341E6,1.00,0.98,1.53,1.59,20,2,2,iTRAQ 4plex (K  N-term),22557,Paired mesoderm homeobox protein 1 OS=Homo sapiens OX=9606 GN=PRRX1 PE=1 SV=1
2071,40166,A0A087WYF1|A0A087WYF1_HUMAN,5.73,66.88,4.472E5,3.765E5,5.053E5,5.172E5,1.00,0.84,1.13,1.16,4.472E5,3.765E5,5.053E5,5.172E5,1.00,0.84,1.13,1.16,1,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),343418,Laminin subunit alpha-2 OS=Homo sapiens OX=9606 GN=LAMA2 PE=1 SV=1
1898,2024,S4R3H4|S4R3H4_HUMAN,4.83,66.82,2.602E5,2.734E5,3.682E5,3.469E5,1.00,1.05,1.42,1.33,2.602E5,2.734E5,3.682E5,3.469E5,1.00,1.05,1.42,1.33,4,3,3,iTRAQ 4plex (K  N-term),145442,Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens OX=9606 GN=ACIN1 PE=1 SV=1
1872,21644,sp|Q9NS86|LANC2_HUMAN,4.55,66.81,1.028E6,1.039E6,1.724E6,1.634E6,1.00,1.01,1.68,1.59,1.028E6,1.039E6,1.724E6,1.634E6,1.00,1.01,1.68,1.59,6,2,2,iTRAQ 4plex (K  N-term),50854,LanC-like protein 2 OS=Homo sapiens OX=9606 GN=LANCL2 PE=1 SV=1
2480,19851,sp|Q9UHV9|PFD2_HUMAN,5.50,66.77,1.438E6,1.42E6,2.437E6,2.512E6,1.00,0.99,1.69,1.75,1.438E6,1.42E6,2.437E6,2.512E6,1.00,0.99,1.69,1.75,15,2,2,iTRAQ 4plex (K  N-term),16648,Prefoldin subunit 2 OS=Homo sapiens OX=9606 GN=PFDN2 PE=1 SV=1
1988,17771,F6SDV2|F6SDV2_HUMAN,2.28,66.53,7.389E5,7.774E5,9.91E5,9.673E5,1.00,1.05,1.34,1.31,7.389E5,7.774E5,9.91E5,9.673E5,1.00,1.05,1.34,1.31,7,2,2,iTRAQ 4plex (K  N-term),40867,Tubulointerstitial nephritis antigen-like 1  isoform CRA_a OS=Homo sapiens OX=9606 GN=TINAGL1 PE=1 SV=1
2185,40591,sp|Q9H0U6|RM18_HUMAN,18.62,66.47,7.306E5,7.539E5,1.264E6,1.145E6,1.00,1.03,1.73,1.57,7.306E5,7.539E5,1.264E6,1.145E6,1.00,1.03,1.73,1.57,22,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),20577,39S ribosomal protein L18  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL18 PE=1 SV=1
2303,6950,F5H5V6|F5H5V6_HUMAN,1.34,66.42,4.933E5,3.747E5,5.917E5,5.56E5,1.00,0.76,1.20,1.13,4.933E5,3.747E5,5.917E5,5.56E5,1.00,0.76,1.20,1.13,1,2,1,iTRAQ 4plex (K  N-term),139147,Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2
1836,30035,sp|Q13177|PAK2_HUMAN,23.43,66.36,8.969E5,9.266E5,2.197E6,2.113E6,1.00,1.03,2.45,2.36,8.969E5,9.266E5,2.197E6,2.113E6,1.00,1.03,2.45,2.36,11,4,4,iTRAQ 4plex (K  N-term),58043,Serine/threonine-protein kinase PAK 2 OS=Homo sapiens OX=9606 GN=PAK2 PE=1 SV=3
2020,19774,A0A087X1G7|A0A087X1G7_HUMAN,6.11,66.32,8.555E5,8.177E5,1.122E6,1.126E6,1.00,0.96,1.31,1.32,8.555E5,8.177E5,1.122E6,1.126E6,1.00,0.96,1.31,1.32,16,3,3,iTRAQ 4plex (K  N-term),17942,Selenoprotein F OS=Homo sapiens OX=9606 GN=SELENOF PE=1 SV=1
1838,40002,sp|Q9UBW7|ZMYM2_HUMAN,30.76,66.28,5.767E5,6.072E5,1.643E6,1.639E6,1.00,1.05,2.85,2.84,5.767E5,6.072E5,1.643E6,1.639E6,1.00,1.05,2.85,2.84,3,4,4,iTRAQ 4plex (K  N-term),154910,Zinc finger MYM-type protein 2 OS=Homo sapiens OX=9606 GN=ZMYM2 PE=1 SV=1
2165,16155,sp|Q9H3M7-2|TXNIP_HUMAN,10.30,66.17,3.839E5,3.66E5,5.803E5,5.506E5,1.00,0.95,1.51,1.43,3.839E5,3.66E5,5.803E5,5.506E5,1.00,0.95,1.51,1.43,11,3,3,iTRAQ 4plex (K  N-term),37319,Isoform 2 of Thioredoxin-interacting protein OS=Homo sapiens OX=9606 GN=TXNIP
2015,22766,sp|O75940|SPF30_HUMAN,12.43,66.16,6.183E5,6.704E5,1.159E6,1.125E6,1.00,1.08,1.87,1.82,6.183E5,6.704E5,1.159E6,1.125E6,1.00,1.08,1.87,1.82,17,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),26711,Survival of motor neuron-related-splicing factor 30 OS=Homo sapiens OX=9606 GN=SMNDC1 PE=1 SV=1
2101,40297,sp|Q9Y3Y2-4|CHTOP_HUMAN,3.84,66.16,1.538E5,1.526E5,2.3E5,2.421E5,1.00,0.99,1.50,1.57,1.538E5,1.526E5,2.3E5,2.421E5,1.00,0.99,1.50,1.57,16,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),21918,Isoform 3 of Chromatin target of PRMT1 protein OS=Homo sapiens OX=9606 GN=CHTOP
2221,21322,sp|O00483|NDUA4_HUMAN,12.86,66.13,1.812E6,1.82E6,3.038E6,2.9E6,1.00,1.00,1.68,1.60,1.812E6,1.82E6,3.038E6,2.9E6,1.00,1.00,1.68,1.60,31,3,3,iTRAQ 4plex (K  N-term),9370,Cytochrome c oxidase subunit NDUFA4 OS=Homo sapiens OX=9606 GN=NDUFA4 PE=1 SV=1
2190,7429,sp|Q9Y3D9|RT23_HUMAN,22.18,66.03,3.428E5,3.466E5,6.77E5,6.92E5,1.00,1.01,1.98,2.02,3.428E5,3.466E5,6.77E5,6.92E5,1.00,1.01,1.98,2.02,13,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),21771,28S ribosomal protein S23  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS23 PE=1 SV=2
2475,40760,B7Z4U3|B7Z4U3_HUMAN,2.28,66.02,3.021E5,3.137E5,4.171E5,3.773E5,1.00,1.04,1.38,1.25,3.021E5,3.137E5,4.171E5,3.773E5,1.00,1.04,1.38,1.25,6,2,2,iTRAQ 4plex (K  N-term),60699,Suppressor of tumorigenicity 7 protein OS=Homo sapiens OX=9606 GN=ST7 PE=1 SV=1
2189,40958,A0A087WW77|A0A087WW77_HUMAN,4.44,65.92,6.971E5,6.996E5,1.144E6,1.096E6,1.00,1.00,1.64,1.57,6.971E5,6.996E5,1.144E6,1.096E6,1.00,1.00,1.64,1.57,2,2,2,iTRAQ 4plex (K  N-term),114427,Lethal(2) giant larvae protein homolog 1 OS=Homo sapiens OX=9606 GN=LLGL1 PE=1 SV=1
2459,15207,B9A025|B9A025_HUMAN,1.72,65.88,1.525E6,1.424E6,1.769E6,1.766E6,1.00,0.93,1.16,1.16,1.525E6,1.424E6,1.769E6,1.766E6,1.00,0.93,1.16,1.16,3,2,2,iTRAQ 4plex (K  N-term),64847,Lysyl oxidase homolog 3 OS=Homo sapiens OX=9606 GN=LOXL3 PE=1 SV=1
1858,39733,sp|Q96AC1-2|FERM2_HUMAN,12.10,65.82,6.48E5,6.61E5,1.211E6,1.205E6,1.00,1.02,1.87,1.86,6.48E5,6.61E5,1.211E6,1.205E6,1.00,1.02,1.87,1.86,5,4,4,iTRAQ 4plex (K  N-term),72397,Isoform 2 of Fermitin family homolog 2 OS=Homo sapiens OX=9606 GN=FERMT2
1873,23677,E5RIU6|E5RIU6_HUMAN,1.31,65.73,1.088E5,9.506E4,1.377E5,1.492E5,1.00,0.87,1.26,1.37,1.088E5,9.506E4,1.377E5,1.492E5,1.00,0.87,1.26,1.37,7,2,1,iTRAQ 4plex (K  N-term),21738,Cyclin-dependent kinase 1 (Fragment) OS=Homo sapiens OX=9606 GN=CDK1 PE=1 SV=2
1299,23892,sp|P01597|KV139_HUMAN,9.03,65.72,1.336E5,1.541E5,1.187E6,1.2E6,1.00,1.15,8.88,8.98,1.336E5,1.541E5,1.187E6,1.2E6,1.00,1.15,8.88,8.98,13,5,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),12737,Immunoglobulin kappa variable 1-39 OS=Homo sapiens OX=9606 GN=IGKV1-39 PE=1 SV=2
1291,9623,gi|999627|pdb|1EPT|B,7.03,65.70,3.799E6,3.594E6,5.533E6,4.354E6,1.00,0.95,1.46,1.15,3.799E6,3.594E6,5.533E6,4.354E6,1.00,0.95,1.46,1.15,21,5,3,Carbamidomethylation; iTRAQ 4plex (K  N-term); Phosphorylation (STY),8819,Chain B  Porcine E-Trypsin (E.C.3.4.21.4)
1962,39565,sp|Q5T5Y3-2|CAMP1_HUMAN,8.47,65.56,3.352E5,3.418E5,5.871E5,5.767E5,1.00,1.02,1.75,1.72,3.352E5,3.418E5,5.871E5,5.767E5,1.00,1.02,1.75,1.72,5,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),146545,Isoform 2 of Calmodulin-regulated spectrin-associated protein 1 OS=Homo sapiens OX=9606 GN=CAMSAP1
2332,40406,A0A087WXC5|A0A087WXC5_HUMAN,4.97,65.53,1.711E6,1.555E6,2.387E6,2.671E6,1.00,0.91,1.40,1.56,1.711E6,1.555E6,2.387E6,2.671E6,1.00,0.91,1.40,1.56,6,2,2,iTRAQ 4plex (K  N-term),40837,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10  mitochondrial OS=Homo sapiens OX=9606 GN=NDUFA10 PE=1 SV=1
2063,5702,sp|Q08378-2|GOGA3_HUMAN,6.57,65.50,2.953E5,2.945E5,4.267E5,4.253E5,1.00,1.00,1.44,1.44,2.953E5,2.945E5,4.267E5,4.253E5,1.00,1.00,1.44,1.44,3,3,3,iTRAQ 4plex (K  N-term),155682,Isoform 2 of Golgin subfamily A member 3 OS=Homo sapiens OX=9606 GN=GOLGA3
1964,19952,sp|P17655-2|CAN2_HUMAN,5.11,65.45,2.074E6,1.943E6,2.735E6,2.602E6,1.00,0.94,1.32,1.25,2.074E6,1.943E6,2.735E6,2.602E6,1.00,0.94,1.32,1.25,7,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ),71476,Isoform 2 of Calpain-2 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN2
2517,20166,sp|Q9BUE0|MED18_HUMAN,1.63,65.44,7.428E5,7.202E5,8.864E5,8.262E5,1.00,0.97,1.19,1.11,7.428E5,7.202E5,8.864E5,8.262E5,1.00,0.97,1.19,1.11,10,2,2,iTRAQ 4plex (K  N-term),23663,Mediator of RNA polymerase II transcription subunit 18 OS=Homo sapiens OX=9606 GN=MED18 PE=1 SV=1
2025,40741,B4DP61|B4DP61_HUMAN,14.43,65.32,2.126E5,2.363E5,4.149E5,4.02E5,1.00,1.11,1.95,1.89,2.126E5,2.363E5,4.149E5,4.02E5,1.00,1.11,1.95,1.89,16,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),24380,cDNA FLJ60754  moderately similar to Survival motor neuron protein OS=Homo sapiens OX=9606 GN=SMN1 PE=1 SV=1
1718,39737,sp|Q9NXS2|QPCTL_HUMAN,9.03,65.30,1.515E6,1.473E6,2.421E6,2.366E6,1.00,0.97,1.60,1.56,1.515E6,1.473E6,2.421E6,2.366E6,1.00,0.97,1.60,1.56,8,3,3,iTRAQ 4plex (K  N-term),42924,Glutaminyl-peptide cyclotransferase-like protein OS=Homo sapiens OX=9606 GN=QPCTL PE=1 SV=2
1837,39974,sp|Q13190-3|STX5_HUMAN,8.38,65.21,1.993E6,1.999E6,3.177E6,2.904E6,1.00,1.00,1.59,1.46,1.993E6,1.999E6,3.177E6,2.904E6,1.00,1.00,1.59,1.46,10,3,3,iTRAQ 4plex (K  N-term),29887,Isoform 3 of Syntaxin-5 OS=Homo sapiens OX=9606 GN=STX5
2225,40783,sp|Q96A35|RM24_HUMAN,3.82,65.11,3.209E5,3.246E5,5.011E5,5.173E5,1.00,1.01,1.56,1.61,3.209E5,3.246E5,5.011E5,5.173E5,1.00,1.01,1.56,1.61,11,2,2,iTRAQ 4plex (K  N-term),24915,39S ribosomal protein L24  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL24 PE=1 SV=1
2103,40528,sp|P61163|ACTZ_HUMAN,0.30,65.08,7.404E5,7.739E5,7.681E5,7.725E5,1.00,1.05,1.04,1.04,7.404E5,7.739E5,7.681E5,7.725E5,1.00,1.05,1.04,1.04,6,2,2,iTRAQ 4plex (K  N-term),42614,Alpha-centractin OS=Homo sapiens OX=9606 GN=ACTR1A PE=1 SV=1
1356,40107,E9PEW5|E9PEW5_HUMAN,1.56,65.04,3.147E5,3.441E5,5.315E5,4.865E5,1.00,1.09,1.69,1.55,3.147E5,3.441E5,5.315E5,4.865E5,1.00,1.09,1.69,1.55,1,4,1,iTRAQ 4plex (K  N-term),161489,Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=1
2188,24380,E5RIY4|E5RIY4_HUMAN,3.90,65.01,3.824E5,3.632E5,5.775E5,5.735E5,1.00,0.95,1.51,1.50,3.824E5,3.632E5,5.775E5,5.735E5,1.00,0.95,1.51,1.50,13,2,2,iTRAQ 4plex (K  N-term),20098,Transcription termination factor 3  mitochondrial OS=Homo sapiens OX=9606 GN=MTERF3 PE=1 SV=1
2226,40794,sp|Q86SZ2|TPC6B_HUMAN,3.78,65.01,1.29E6,1.175E6,1.836E6,1.788E6,1.00,0.91,1.42,1.39,1.29E6,1.175E6,1.836E6,1.788E6,1.00,0.91,1.42,1.39,14,2,2,iTRAQ 4plex (K  N-term),17983,Trafficking protein particle complex subunit 6B OS=Homo sapiens OX=9606 GN=TRAPPC6B PE=1 SV=1
1953,22322,sp|Q92791|SC65_HUMAN,4.69,64.95,1.05E6,1.007E6,1.329E6,1.335E6,1.00,0.96,1.27,1.27,1.05E6,1.007E6,1.329E6,1.335E6,1.00,0.96,1.27,1.27,7,3,3,iTRAQ 4plex (K  N-term),50381,Endoplasmic reticulum protein SC65 OS=Homo sapiens OX=9606 GN=P3H4 PE=1 SV=1
2069,12567,H0Y7H7|H0Y7H7_HUMAN,9.62,64.84,9.35E4,7.878E4,2.112E5,2.051E5,1.00,0.84,2.26,2.19,9.35E4,7.878E4,2.112E5,2.051E5,1.00,0.84,2.26,2.19,2,3,2,iTRAQ 4plex (K  N-term),159053,Dedicator of cytokinesis protein 4 (Fragment) OS=Homo sapiens OX=9606 GN=DOCK4 PE=1 SV=1
1794,41521,sp|Q9NRW3|ABC3C_HUMAN,1.00,64.67,6.174E5,6.162E5,8.713E5,7.917E5,1.00,1.00,1.41,1.28,6.174E5,6.162E5,8.713E5,7.917E5,1.00,1.00,1.41,1.28,9,1,1,iTRAQ 4plex (K  N-term),22826,DNA dC->dU-editing enzyme APOBEC-3C OS=Homo sapiens OX=9606 GN=APOBEC3C PE=1 SV=2
2218,22824,sp|Q53EZ4|CEP55_HUMAN,2.14,64.63,1.526E6,1.532E6,1.984E6,2.054E6,1.00,1.00,1.30,1.35,1.526E6,1.532E6,1.984E6,2.054E6,1.00,1.00,1.30,1.35,4,3,2,iTRAQ 4plex (K  N-term),54178,Centrosomal protein of 55 kDa OS=Homo sapiens OX=9606 GN=CEP55 PE=1 SV=3
1791,31231,A0A0U1RQT7|A0A0U1RQT7_HUMAN,1.04,64.62,2.142E5,2.218E5,3.091E5,2.933E5,1.00,1.04,1.44,1.37,2.142E5,2.218E5,3.091E5,2.933E5,1.00,1.04,1.44,1.37,2,2,1,iTRAQ 4plex (K  N-term),49500,Casein kinase I isoform gamma-1 OS=Homo sapiens OX=9606 GN=CSNK1G1 PE=1 SV=1
2325,10035,sp|Q9NRM7|LATS2_HUMAN,2.76,64.59,4.125E4,4.867E4,9.7E4,9.194E4,1.00,1.18,2.35,2.23,4.125E4,4.867E4,9.7E4,9.194E4,1.00,1.18,2.35,2.23,1,2,1,iTRAQ 4plex (K  N-term),120136,Serine/threonine-protein kinase LATS2 OS=Homo sapiens OX=9606 GN=LATS2 PE=1 SV=2
2157,8587,sp|Q8IZD4|DCP1B_HUMAN,16.94,64.58,5.65E5,5.692E5,1.212E6,1.179E6,1.00,1.01,2.14,2.09,5.65E5,5.692E5,1.212E6,1.179E6,1.00,1.01,2.14,2.09,4,3,3,iTRAQ 4plex (K  N-term),67723,mRNA-decapping enzyme 1B OS=Homo sapiens OX=9606 GN=DCP1B PE=1 SV=2
2155,16698,sp|Q15746-4|MYLK_HUMAN,5.89,64.53,4.503E5,4.292E5,6.033E5,6.324E5,1.00,0.95,1.34,1.40,4.503E5,4.292E5,6.033E5,6.324E5,1.00,0.95,1.34,1.40,2,3,3,iTRAQ 4plex (K  N-term),197398,Isoform 3B of Myosin light chain kinase  smooth muscle OS=Homo sapiens OX=9606 GN=MYLK
2487,22730,sp|P17535|JUND_HUMAN,1.29,64.41,2.106E5,1.768E5,2.708E5,2.754E5,1.00,0.84,1.29,1.31,2.106E5,1.768E5,2.708E5,2.754E5,1.00,0.84,1.29,1.31,4,2,1,iTRAQ 4plex (K  N-term),35174,Transcription factor jun-D OS=Homo sapiens OX=9606 GN=JUND PE=1 SV=3
2126,2327,sp|Q16531|DDB1_HUMAN,12.43,64.26,1.388E6,1.418E6,2.445E6,2.41E6,1.00,1.02,1.76,1.74,1.388E6,1.418E6,2.445E6,2.41E6,1.00,1.02,1.76,1.74,2,3,3,iTRAQ 4plex (K  N-term),126968,DNA damage-binding protein 1 OS=Homo sapiens OX=9606 GN=DDB1 PE=1 SV=1
2046,40298,sp|Q14999-2|CUL7_HUMAN,12.63,64.18,1.006E6,9.641E5,1.503E6,1.431E6,1.00,0.96,1.49,1.42,1.006E6,9.641E5,1.503E6,1.431E6,1.00,0.96,1.49,1.42,2,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),199748,Isoform 2 of Cullin-7 OS=Homo sapiens OX=9606 GN=CUL7
1591,14155,A0A087WYV8|A0A087WYV8_HUMAN,4.86,64.13,3.186E5,3.131E5,5.811E5,5.606E5,1.00,0.98,1.82,1.76,3.186E5,3.131E5,5.811E5,5.606E5,1.00,0.98,1.82,1.76,1,3,2,iTRAQ 4plex (K  N-term),314676,Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=1
2393,5783,sp|Q9H6R7-2|WDCP_HUMAN,8.38,64.08,9.418E4,1.186E5,2.173E5,2.113E5,1.00,1.26,2.31,2.24,9.418E4,1.186E5,2.173E5,2.113E5,1.00,1.26,2.31,2.24,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),68456,Isoform 2 of WD repeat and coiled-coil-containing protein OS=Homo sapiens OX=9606 GN=WDCP
2483,40918,sp|P08574|CY1_HUMAN,2.24,64.06,3.197E5,3.391E5,4.313E5,4.325E5,1.00,1.06,1.35,1.35,3.197E5,3.391E5,4.313E5,4.325E5,1.00,1.06,1.35,1.35,12,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),35422,Cytochrome c1  heme protein  mitochondrial OS=Homo sapiens OX=9606 GN=CYC1 PE=1 SV=3
2169,40205,sp|Q8IUX4|ABC3F_HUMAN,4.47,64.03,5.089E5,5.027E5,6.611E5,5.894E5,1.00,0.99,1.30,1.16,5.089E5,5.027E5,6.611E5,5.894E5,1.00,0.99,1.30,1.16,7,3,3,iTRAQ 4plex (K  N-term),45020,DNA dC->dU-editing enzyme APOBEC-3F OS=Homo sapiens OX=9606 GN=APOBEC3F PE=1 SV=3
2127,40043,sp|Q13131|AAPK1_HUMAN,12.67,64.02,6.477E5,6.72E5,1.151E6,1.175E6,1.00,1.04,1.78,1.81,6.477E5,6.72E5,1.151E6,1.175E6,1.00,1.04,1.78,1.81,4,3,3,iTRAQ 4plex (K  N-term),64009,5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens OX=9606 GN=PRKAA1 PE=1 SV=4
1876,23307,sp|A6NHT5|HMX3_HUMAN,1.17,63.92,5.292E6,4.991E6,6.603E6,7.425E6,1.00,0.94,1.25,1.40,5.292E6,4.991E6,6.603E6,7.425E6,1.00,0.94,1.25,1.40,4,2,1,iTRAQ 4plex (K  N-term),37825,Homeobox protein HMX3 OS=Homo sapiens OX=9606 GN=HMX3 PE=1 SV=1
2413,40431,sp|Q8TAE8|G45IP_HUMAN,6.58,63.88,2.934E5,3.171E5,5.498E5,5.886E5,1.00,1.08,1.87,2.01,2.934E5,3.171E5,5.498E5,5.886E5,1.00,1.08,1.87,2.01,13,2,2,iTRAQ 4plex (K  N-term),25384,Growth arrest and DNA damage-inducible proteins-interacting protein 1 OS=Homo sapiens OX=9606 GN=GADD45GIP1 PE=1 SV=1
2206,21746,sp|Q9Y580|RBM7_HUMAN,2.69,63.80,1.586E6,1.52E6,1.883E6,1.814E6,1.00,0.96,1.19,1.14,1.586E6,1.52E6,1.883E6,1.814E6,1.00,0.96,1.19,1.14,12,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),30504,RNA-binding protein 7 OS=Homo sapiens OX=9606 GN=RBM7 PE=1 SV=1
2140,40444,sp|Q9Y2X9-2|ZN281_HUMAN,3.09,63.63,7.638E5,7.213E5,1.052E6,1.051E6,1.00,0.94,1.38,1.38,7.638E5,7.213E5,1.052E6,1.051E6,1.00,0.94,1.38,1.38,3,2,2,iTRAQ 4plex (K  N-term),93233,Isoform 2 of Zinc finger protein 281 OS=Homo sapiens OX=9606 GN=ZNF281
2033,41154,sp|Q7Z7L1|SLN11_HUMAN,0.89,63.49,8.847E4,7.686E4,1.049E5,1.058E5,1.00,0.87,1.19,1.20,8.847E4,7.686E4,1.049E5,1.058E5,1.00,0.87,1.19,1.20,3,2,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),102836,Schlafen family member 11 OS=Homo sapiens OX=9606 GN=SLFN11 PE=1 SV=2
2382,40586,sp|Q96I51-2|RCC1L_HUMAN,3.99,63.46,3.421E5,3.287E5,5.052E5,5.174E5,1.00,0.96,1.48,1.51,3.421E5,3.287E5,5.052E5,5.174E5,1.00,0.96,1.48,1.51,8,2,2,iTRAQ 4plex (K  N-term),38441,Isoform 2 of RCC1-like G exchanging factor-like protein OS=Homo sapiens OX=9606 GN=RCC1L
1810,1461,sp|Q9BR76|COR1B_HUMAN,0.86,63.23,3.586E5,3.537E5,4.504E5,4.803E5,1.00,0.99,1.26,1.34,3.586E5,3.537E5,4.504E5,4.803E5,1.00,0.99,1.26,1.34,2,3,1,iTRAQ 4plex (K  N-term),54235,Coronin-1B OS=Homo sapiens OX=9606 GN=CORO1B PE=1 SV=1
1739,11365,C9K0U8|C9K0U8_HUMAN,6.46,63.19,2.123E6,2.045E6,2.899E6,3.051E6,1.00,0.96,1.37,1.44,2.123E6,2.045E6,2.899E6,3.051E6,1.00,0.96,1.37,1.44,24,3,3,iTRAQ 4plex (K  N-term),14131,Single-stranded DNA-binding protein  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=SSBP1 PE=1 SV=1
1118,19715,sp|Q7RTV0|PHF5A_HUMAN,10.07,63.19,9.309E6,9.678E6,1.553E7,1.511E7,1.00,1.04,1.67,1.62,9.309E6,9.678E6,1.553E7,1.511E7,1.00,1.04,1.67,1.62,22,4,4,iTRAQ 4plex (K  N-term),12405,PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1
2495,29746,sp|O95747|OXSR1_HUMAN,2.74,63.18,4.244E5,4.328E5,5.902E5,6.013E5,1.00,1.02,1.39,1.42,4.244E5,4.328E5,5.902E5,6.013E5,1.00,1.02,1.39,1.42,5,2,2,iTRAQ 4plex (K  N-term),58022,Serine/threonine-protein kinase OSR1 OS=Homo sapiens OX=9606 GN=OXSR1 PE=1 SV=1
2021,40173,sp|Q2TAY7|SMU1_HUMAN,11.59,63.17,7.056E5,7.136E5,1.253E6,1.213E6,1.00,1.01,1.78,1.72,7.056E5,7.136E5,1.253E6,1.213E6,1.00,1.01,1.78,1.72,7,3,3,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),57544,WD40 repeat-containing protein SMU1 OS=Homo sapiens OX=9606 GN=SMU1 PE=1 SV=2
1800,39629,sp|Q8N5G2|MACOI_HUMAN,9.06,63.13,5.471E5,5.177E5,9.075E5,8.806E5,1.00,0.95,1.66,1.61,5.471E5,5.177E5,9.075E5,8.806E5,1.00,0.95,1.66,1.61,6,4,4,iTRAQ 4plex (K  N-term),76178,Macoilin OS=Homo sapiens OX=9606 GN=MACO1 PE=1 SV=1
860,20996,sp|B9A064|IGLL5_HUMAN,9.61,63.07,2.578E8,2.622E8,3.685E7,2.895E7,1.00,1.02,0.14,0.11,2.578E8,2.622E8,3.685E7,2.895E7,1.00,1.02,0.14,0.11,4,4,1,iTRAQ 4plex (K  N-term),23063,Immunoglobulin lambda-like polypeptide 5 OS=Homo sapiens OX=9606 GN=IGLL5 PE=2 SV=2
1005,24577,A0A0G2JRQ6|A0A0G2JRQ6_HUMAN,3.59,63.03,2.179E6,2.193E6,3.626E6,3.205E6,1.00,1.01,1.66,1.47,2.179E6,2.193E6,3.626E6,3.205E6,1.00,1.01,1.66,1.47,13,4,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),12748,Uncharacterized protein (Fragment) OS=Homo sapiens OX=9606 PE=1 SV=4
2184,40579,A0A087WZ32|A0A087WZ32_HUMAN,7.19,63.02,3.807E5,3.954E5,8.029E5,7.511E5,1.00,1.04,2.11,1.97,3.807E5,3.954E5,8.029E5,7.511E5,1.00,1.04,2.11,1.97,5,2,2,iTRAQ 4plex (K  N-term),41210,Pleckstrin homology domain-containing family A member 2 OS=Homo sapiens OX=9606 GN=PLEKHA2 PE=1 SV=1
2508,5585,sp|Q96PZ2|F111A_HUMAN,1.66,63.00,1.088E5,1.063E5,1.316E5,1.344E5,1.00,0.98,1.21,1.24,1.088E5,1.063E5,1.316E5,1.344E5,1.00,0.98,1.21,1.24,5,2,2,iTRAQ 4plex (K  N-term),70196,Protein FAM111A OS=Homo sapiens OX=9606 GN=FAM111A PE=1 SV=2
2156,40032,sp|Q8WV41|SNX33_HUMAN,14.19,62.92,4.643E5,4.375E5,8.488E5,7.822E5,1.00,0.94,1.83,1.68,4.643E5,4.375E5,8.488E5,7.822E5,1.00,0.94,1.83,1.68,6,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),65265,Sorting nexin-33 OS=Homo sapiens OX=9606 GN=SNX33 PE=1 SV=1
2220,16166,sp|Q9BTV4|TMM43_HUMAN,7.57,62.84,4.236E5,4.38E5,6.578E5,6.187E5,1.00,1.03,1.55,1.46,4.236E5,4.38E5,6.578E5,6.187E5,1.00,1.03,1.55,1.46,7,3,3,iTRAQ 4plex (K  N-term),44876,Transmembrane protein 43 OS=Homo sapiens OX=9606 GN=TMEM43 PE=1 SV=1
2027,40862,D6R974|D6R974_HUMAN,0.89,62.84,1.133E6,1.149E6,1.208E6,1.29E6,1.00,1.01,1.07,1.14,1.133E6,1.149E6,1.208E6,1.29E6,1.00,1.01,1.07,1.14,12,2,2,iTRAQ 4plex (K  N-term),17361,Ubiquitin carboxyl-terminal hydrolase OS=Homo sapiens OX=9606 GN=UCHL1 PE=1 SV=1
1922,39897,I3L1L3|I3L1L3_HUMAN,8.39,62.74,6.045E5,5.616E5,9.178E5,8.954E5,1.00,0.93,1.52,1.48,6.045E5,5.616E5,9.178E5,8.954E5,1.00,0.93,1.52,1.48,2,3,3,iTRAQ 4plex (K  N-term),140250,Myb-binding protein 1A (Fragment) OS=Homo sapiens OX=9606 GN=MYBBP1A PE=1 SV=1
2170,40281,sp|O15258|RER1_HUMAN,4.88,62.72,9.426E5,1.014E6,1.641E6,1.56E6,1.00,1.08,1.74,1.65,9.426E5,1.014E6,1.641E6,1.56E6,1.00,1.08,1.74,1.65,13,2,2,iTRAQ 4plex (K  N-term),22958,Protein RER1 OS=Homo sapiens OX=9606 GN=RER1 PE=1 SV=1
2438,17053,sp|Q9BT40-2|INP5K_HUMAN,4.88,62.67,8.232E5,8.698E5,1.39E6,1.324E6,1.00,1.06,1.69,1.61,8.232E5,8.698E5,1.39E6,1.324E6,1.00,1.06,1.69,1.61,6,2,2,iTRAQ 4plex (K  N-term),42784,Isoform 2 of Inositol polyphosphate 5-phosphatase K OS=Homo sapiens OX=9606 GN=INPP5K
2410,40419,sp|Q9BW19|KIFC1_HUMAN,1.81,62.65,1.447E5,1.633E5,2.638E5,2.429E5,1.00,1.13,1.82,1.68,1.447E5,1.633E5,2.638E5,2.429E5,1.00,1.13,1.82,1.68,1,2,1,iTRAQ 4plex (K  N-term),73748,Kinesin-like protein KIFC1 OS=Homo sapiens OX=9606 GN=KIFC1 PE=1 SV=2
1806,39882,sp|Q8IY17-5|PLPL6_HUMAN,5.17,62.58,1.091E6,1.15E6,1.54E6,1.568E6,1.00,1.05,1.41,1.44,1.091E6,1.15E6,1.54E6,1.568E6,1.00,1.05,1.41,1.44,3,4,4,iTRAQ 4plex (K  N-term),143351,Isoform 5 of Neuropathy target esterase OS=Homo sapiens OX=9606 GN=PNPLA6
2208,39984,A0A0A0MR09|A0A0A0MR09_HUMAN,4.71,62.58,7.164E5,6.949E5,9.687E5,9.756E5,1.00,0.97,1.35,1.36,7.164E5,6.949E5,9.687E5,9.756E5,1.00,0.97,1.35,1.36,6,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),66954,Tyrosine-protein phosphatase non-receptor type 9 OS=Homo sapiens OX=9606 GN=PTPN9 PE=1 SV=1
1280,23894,sp|A0A0C4DH72|KV106_HUMAN,5.38,62.52,2.917E5,3.212E5,1.236E6,1.195E6,1.00,1.10,4.24,4.10,2.917E5,3.212E5,1.236E6,1.195E6,1.00,1.10,4.24,4.10,12,5,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),12697,Immunoglobulin kappa variable 1-6 OS=Homo sapiens OX=9606 GN=IGKV1-6 PE=3 SV=1
1478,41649,sp|P01825|HV459_HUMAN,33.25,62.47,6.059E5,6.603E5,2.372E6,2.036E6,1.00,1.09,3.92,3.36,6.059E5,6.603E5,2.372E6,2.036E6,1.00,1.09,3.92,3.36,9,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),12936,Immunoglobulin heavy variable 4-59 OS=Homo sapiens OX=9606 GN=IGHV4-59 PE=1 SV=2
3097,10053,H0Y9C1|H0Y9C1_HUMAN,2.00,62.45,1.556E5,1.675E5,2.958E5,2.694E5,1.00,1.08,1.90,1.73,1.556E5,1.675E5,2.958E5,2.694E5,1.00,1.08,1.90,1.73,5,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),49320,CCR4-NOT transcription complex subunit 6-like OS=Homo sapiens OX=9606 GN=CNOT6L PE=1 SV=2
2419,40485,sp|Q9BWM7|SFXN3_HUMAN,2.33,62.36,2.408E5,2.527E5,5.03E5,4.876E5,1.00,1.05,2.09,2.03,2.408E5,2.527E5,5.03E5,4.876E5,1.00,1.05,2.09,2.03,5,2,1,iTRAQ 4plex (K  N-term),35503,Sideroflexin-3 OS=Homo sapiens OX=9606 GN=SFXN3 PE=1 SV=3
2227,40821,sp|P17936|IBP3_HUMAN,2.48,62.24,5.362E5,5.439E5,7.517E5,7.508E5,1.00,1.01,1.40,1.40,5.362E5,5.439E5,7.517E5,7.508E5,1.00,1.01,1.40,1.40,8,2,2,iTRAQ 4plex (K  N-term),31674,Insulin-like growth factor-binding protein 3 OS=Homo sapiens OX=9606 GN=IGFBP3 PE=1 SV=2
2357,41777,sp|Q86X95|CIR1_HUMAN,4.69,62.17,1.208E5,1.126E5,1.758E5,1.857E5,1.00,0.93,1.46,1.54,1.208E5,1.126E5,1.758E5,1.857E5,1.00,0.93,1.46,1.54,6,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),52313,Corepressor interacting with RBPJ 1 OS=Homo sapiens OX=9606 GN=CIR1 PE=1 SV=1
1940,40334,sp|Q9UHC7-3|MKRN1_HUMAN,3.26,62.14,3.613E5,2.947E5,4.461E5,4.132E5,1.00,0.82,1.23,1.14,3.613E5,2.947E5,4.461E5,4.132E5,1.00,0.82,1.23,1.14,10,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),45020,Isoform 3 of E3 ubiquitin-protein ligase makorin-1 OS=Homo sapiens OX=9606 GN=MKRN1
2223,40158,sp|Q9Y4K4|M4K5_HUMAN,2.06,62.11,4.46E5,4.264E5,8.275E5,7.285E5,1.00,0.96,1.86,1.63,4.46E5,4.264E5,8.275E5,7.285E5,1.00,0.96,1.86,1.63,1,3,1,iTRAQ 4plex (K  N-term),95024,Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens OX=9606 GN=MAP4K5 PE=1 SV=2
2486,40939,sp|P10301|RRAS_HUMAN,1.67,62.10,4.533E5,4.792E5,5.699E5,5.726E5,1.00,1.06,1.26,1.26,4.533E5,4.792E5,5.699E5,5.726E5,1.00,1.06,1.26,1.26,11,2,2,iTRAQ 4plex (K  N-term),23480,Ras-related protein R-Ras OS=Homo sapiens OX=9606 GN=RRAS PE=1 SV=1
2450,41088,sp|Q9Y2G8-2|DJC16_HUMAN,4.02,62.10,2.322E5,2.383E5,3.769E5,3.758E5,1.00,1.03,1.62,1.62,2.322E5,2.383E5,3.769E5,3.758E5,1.00,1.03,1.62,1.62,6,2,2,iTRAQ 4plex (K  N-term),53987,Isoform 2 of DnaJ homolog subfamily C member 16 OS=Homo sapiens OX=9606 GN=DNAJC16
2077,17824,sp|Q9Y2H6-2|FND3A_HUMAN,11.36,62.01,2.579E5,2.738E5,4.658E5,4.503E5,1.00,1.06,1.81,1.75,2.579E5,2.738E5,4.658E5,4.503E5,1.00,1.06,1.81,1.75,3,3,3,iTRAQ 4plex (K  N-term),125822,Isoform 2 of Fibronectin type-III domain-containing protein 3A OS=Homo sapiens OX=9606 GN=FNDC3A
2229,40881,sp|Q9UNQ2|DIM1_HUMAN,4.66,62.00,3.819E5,3.859E5,6.338E5,6.607E5,1.00,1.01,1.66,1.73,3.819E5,3.859E5,6.338E5,6.607E5,1.00,1.01,1.66,1.73,6,2,2,iTRAQ 4plex (K  N-term),35236,Probable dimethyladenosine transferase OS=Homo sapiens OX=9606 GN=DIMT1 PE=1 SV=1
1874,21278,F8W6P5|F8W6P5_HUMAN,1.95,61.97,2.575E6,2.488E6,2.198E6,2.392E6,1.00,0.97,0.85,0.93,2.575E6,2.488E6,2.198E6,2.392E6,1.00,0.97,0.85,0.93,26,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),9670,Hemoglobin subunit beta (Fragment) OS=Homo sapiens OX=9606 GN=HBB PE=1 SV=1
2205,39946,sp|P10398|ARAF_HUMAN,10.87,61.89,1.057E6,1.038E6,1.894E6,1.878E6,1.00,0.98,1.79,1.78,1.057E6,1.038E6,1.894E6,1.878E6,1.00,0.98,1.79,1.78,5,3,3,iTRAQ 4plex (K  N-term),67585,Serine/threonine-protein kinase A-Raf OS=Homo sapiens OX=9606 GN=ARAF PE=1 SV=2
2028,20832,sp|Q9BWG4-2|SSBP4_HUMAN,2.36,61.87,3.327E5,3.334E5,4.609E5,4.598E5,1.00,1.00,1.39,1.38,3.327E5,3.334E5,4.609E5,4.598E5,1.00,1.00,1.39,1.38,8,2,2,iTRAQ 4plex (K  N-term),37214,Isoform 2 of Single-stranded DNA-binding protein 4 OS=Homo sapiens OX=9606 GN=SSBP4
1305,22014,A0A075B6S9|A0A075B6S9_HUMAN,2.82,61.80,1.206E5,1.038E5,2.487E5,2.4E5,1.00,0.86,2.06,1.99,1.206E5,1.038E5,2.487E5,2.4E5,1.00,0.86,2.06,1.99,9,4,1,iTRAQ 4plex (K  N-term),12688,Immunoglobulin kappa variable 1-37 (non-functional) (Fragment) OS=Homo sapiens OX=9606 GN=IGKV1-37 PE=1 SV=7
2368,4234,sp|P31040-2|SDHA_HUMAN,5.98,61.75,4.292E5,4.499E5,8.316E5,8.293E5,1.00,1.05,1.94,1.93,4.292E5,4.499E5,8.316E5,8.293E5,1.00,1.05,1.94,1.93,3,2,2,iTRAQ 4plex (K  N-term),67300,Isoform 2 of Succinate dehydrogenase [ubiquinone] flavoprotein subunit  mitochondrial OS=Homo sapiens OX=9606 GN=SDHA
1925,40344,sp|P22695|QCR2_HUMAN,11.96,61.68,5.285E5,5.762E5,8.897E5,8.582E5,1.00,1.09,1.68,1.62,5.285E5,5.762E5,8.897E5,8.582E5,1.00,1.09,1.68,1.62,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),48443,Cytochrome b-c1 complex subunit 2  mitochondrial OS=Homo sapiens OX=9606 GN=UQCRC2 PE=1 SV=3
1935,3589,A0A0G2JPW5|A0A0G2JPW5_HUMAN,9.45,61.65,4.188E5,3.831E5,6.654E5,6.443E5,1.00,0.91,1.59,1.54,4.188E5,3.831E5,6.654E5,6.443E5,1.00,0.91,1.59,1.54,4,3,3,iTRAQ 4plex (K  N-term),118330,Gamma-tubulin complex component OS=Homo sapiens OX=9606 GN=TUBGCP5 PE=1 SV=1
1951,30259,sp|Q99543|DNJC2_HUMAN,3.32,61.63,2.573E5,2.312E5,3.662E5,3.326E5,1.00,0.90,1.42,1.29,2.573E5,2.312E5,3.662E5,3.326E5,1.00,0.90,1.42,1.29,3,3,2,iTRAQ 4plex (K  N-term),71996,DnaJ homolog subfamily C member 2 OS=Homo sapiens OX=9606 GN=DNAJC2 PE=1 SV=4
2143,40599,F8W696|F8W696_HUMAN,7.67,61.52,2.874E5,2.91E5,6.478E5,5.793E5,1.00,1.01,2.25,2.02,2.874E5,2.91E5,6.478E5,5.793E5,1.00,1.01,2.25,2.02,9,2,2,iTRAQ 4plex (K  N-term),27909,Apolipoprotein A-I OS=Homo sapiens OX=9606 GN=APOA1 PE=1 SV=1
2423,40501,sp|Q9UHI8|ATS1_HUMAN,5.78,61.48,3.897E5,4.011E5,6.582E5,7.433E5,1.00,1.03,1.69,1.91,3.897E5,4.011E5,6.582E5,7.433E5,1.00,1.03,1.69,1.91,2,2,2,iTRAQ 4plex (K  N-term),105358,A disintegrin and metalloproteinase with thrombospondin motifs 1 OS=Homo sapiens OX=9606 GN=ADAMTS1 PE=1 SV=4
2019,40146,E5RJI7|E5RJI7_HUMAN,8.62,61.43,7.507E5,7.895E5,1.275E6,1.203E6,1.00,1.05,1.70,1.60,7.507E5,7.895E5,1.275E6,1.203E6,1.00,1.05,1.70,1.60,22,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),16979,39S ribosomal protein L13  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPL13 PE=1 SV=8
1682,18899,sp|Q9NQY0|BIN3_HUMAN,18.81,61.37,1.222E6,1.226E6,2.871E6,2.723E6,1.00,1.00,2.35,2.23,1.222E6,1.226E6,2.871E6,2.723E6,1.00,1.00,2.35,2.23,13,4,4,iTRAQ 4plex (K  N-term),29665,Bridging integrator 3 OS=Homo sapiens OX=9606 GN=BIN3 PE=1 SV=1
2342,40272,sp|Q9H6F5|CCD86_HUMAN,3.05,61.37,1.035E5,1.031E5,1.569E5,1.544E5,1.00,1.00,1.51,1.49,1.035E5,1.031E5,1.569E5,1.544E5,1.00,1.00,1.51,1.49,9,2,2,iTRAQ 4plex (K  N-term); Phosphorylation (STY),40236,Coiled-coil domain-containing protein 86 OS=Homo sapiens OX=9606 GN=CCDC86 PE=1 SV=1
2053,4407,sp|Q14571|ITPR2_HUMAN,1.36,61.23,2.121E5,1.939E5,3.087E5,3.068E5,1.00,0.91,1.46,1.45,2.121E5,1.939E5,3.087E5,3.068E5,1.00,0.91,1.46,1.45,0,3,1,iTRAQ 4plex (K  N-term),308062,Inositol 1 4 5-trisphosphate receptor type 2 OS=Homo sapiens OX=9606 GN=ITPR2 PE=1 SV=2
1908,39691,sp|Q9H2X6-3|HIPK2_HUMAN,2.20,61.13,4.913E4,4.649E4,9.539E4,9.111E4,1.00,0.95,1.94,1.85,4.913E4,4.649E4,9.539E4,9.111E4,1.00,0.95,1.94,1.85,1,4,1,iTRAQ 4plex (K  N-term),128158,Isoform 3 of Homeodomain-interacting protein kinase 2 OS=Homo sapiens OX=9606 GN=HIPK2
2481,40839,sp|Q9HCN4-3|GPN1_HUMAN,6.58,61.11,1.534E5,1.489E5,3.124E5,2.951E5,1.00,0.97,2.04,1.92,1.534E5,1.489E5,3.124E5,2.951E5,1.00,0.97,2.04,1.92,9,2,2,iTRAQ 4plex (K  N-term),31832,Isoform 3 of GPN-loop GTPase 1 OS=Homo sapiens OX=9606 GN=GPN1
2087,733,sp|P14923|PLAK_HUMAN,2.15,61.01,4.406E5,3.49E5,4.337E5,4.712E5,1.00,0.79,0.98,1.07,4.406E5,3.49E5,4.337E5,4.712E5,1.00,0.79,0.98,1.07,3,2,2,iTRAQ 4plex (K  N-term),81745,Junction plakoglobin OS=Homo sapiens OX=9606 GN=JUP PE=1 SV=3
1867,14588,A0A0J9YW64|A0A0J9YW64_HUMAN,10.64,60.98,3.795E5,3.887E5,7.261E5,7.083E5,1.00,1.02,1.91,1.87,3.795E5,3.887E5,7.261E5,7.083E5,1.00,1.02,1.91,1.87,2,4,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),218186,Dedicator of cytokinesis protein 11 (Fragment) OS=Homo sapiens OX=9606 GN=DOCK11 PE=1 SV=1
2348,40388,B1ALS0|B1ALS0_HUMAN,5.20,60.90,6.782E5,6.825E5,1.236E6,1.174E6,1.00,1.01,1.82,1.73,6.782E5,6.825E5,1.236E6,1.174E6,1.00,1.01,1.82,1.73,7,2,2,iTRAQ 4plex (K  N-term),35487,cGMP-dependent protein kinase 1 OS=Homo sapiens OX=9606 GN=PRKG1 PE=1 SV=2
1999,9833,sp|P15144|AMPN_HUMAN,4.94,60.90,5.093E5,4.343E5,6.129E5,6.313E5,1.00,0.85,1.20,1.24,5.093E5,4.343E5,6.129E5,6.313E5,1.00,0.85,1.20,1.24,6,4,4,iTRAQ 4plex (K  N-term),109539,Aminopeptidase N OS=Homo sapiens OX=9606 GN=ANPEP PE=1 SV=4
1986,20572,sp|P30626-3|SORCN_HUMAN,17.45,60.83,5.203E5,5.485E5,1.087E6,1.062E6,1.00,1.05,2.09,2.04,5.203E5,5.485E5,1.087E6,1.062E6,1.00,1.05,2.09,2.04,12,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),20006,Isoform 3 of Sorcin OS=Homo sapiens OX=9606 GN=SRI
2160,6176,sp|P49247|RPIA_HUMAN,14.83,60.71,7.424E5,7.661E5,1.44E6,1.41E6,1.00,1.03,1.94,1.90,7.424E5,7.661E5,1.44E6,1.41E6,1.00,1.03,1.94,1.90,8,3,3,iTRAQ 4plex (K  N-term),33269,Ribose-5-phosphate isomerase OS=Homo sapiens OX=9606 GN=RPIA PE=1 SV=3
2387,40635,sp|Q6ZNB6|NFXL1_HUMAN,4.12,60.71,2.232E5,2.207E5,3.583E5,3.495E5,1.00,0.99,1.61,1.57,2.232E5,2.207E5,3.583E5,3.495E5,1.00,0.99,1.61,1.57,3,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),101339,NF-X1-type zinc finger protein NFXL1 OS=Homo sapiens OX=9606 GN=NFXL1 PE=1 SV=2
2347,40328,sp|Q9NVH0|EXD2_HUMAN,2.34,60.70,3.949E5,3.519E5,4.784E5,4.872E5,1.00,0.89,1.21,1.23,3.949E5,3.519E5,4.784E5,4.872E5,1.00,0.89,1.21,1.23,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),70353,Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2
2141,40549,sp|Q96N66-2|MBOA7_HUMAN,2.51,60.64,4.406E5,4.186E5,5.847E5,5.186E5,1.00,0.95,1.33,1.18,4.406E5,4.186E5,5.847E5,5.186E5,1.00,0.95,1.33,1.18,6,2,2,iTRAQ 4plex (K  N-term),44733,Isoform 2 of Lysophospholipid acyltransferase 7 OS=Homo sapiens OX=9606 GN=MBOAT7
2059,40151,B7Z896|B7Z896_HUMAN,10.77,60.62,1.832E6,1.968E6,3.05E6,3.026E6,1.00,1.07,1.66,1.65,1.832E6,1.968E6,3.05E6,3.026E6,1.00,1.07,1.66,1.65,4,3,3,iTRAQ 4plex (K  N-term),76715,Kinesin-like protein OS=Homo sapiens OX=9606 GN=KIFC3 PE=1 SV=1
2434,40574,sp|Q9UEU0|VTI1B_HUMAN,5.51,60.58,1.81E5,1.536E5,2.901E5,2.718E5,1.00,0.85,1.60,1.50,1.81E5,1.536E5,2.901E5,2.718E5,1.00,0.85,1.60,1.50,13,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),26688,Vesicle transport through interaction with t-SNAREs homolog 1B OS=Homo sapiens OX=9606 GN=VTI1B PE=1 SV=3
2436,40624,G3V529|G3V529_HUMAN,1.59,60.44,3.523E5,3.362E5,4.245E5,4.237E5,1.00,0.95,1.21,1.20,3.523E5,3.362E5,4.245E5,4.237E5,1.00,0.95,1.21,1.20,4,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),91481,ATP-dependent RNA helicase DDX24 OS=Homo sapiens OX=9606 GN=DDX24 PE=1 SV=1
2085,8958,sp|O95785|WIZ_HUMAN,1.87,60.37,1.708E5,1.642E5,2.928E5,3.027E5,1.00,0.96,1.71,1.77,1.708E5,1.642E5,2.928E5,3.027E5,1.00,0.96,1.71,1.77,1,2,1,iTRAQ 4plex (K  N-term),178673,Protein Wiz OS=Homo sapiens OX=9606 GN=WIZ PE=1 SV=2
1994,23665,sp|Q9BZI7-2|REN3B_HUMAN,0.76,60.31,7.59E4,7.172E4,9.369E4,9.437E4,1.00,0.94,1.23,1.24,7.59E4,7.172E4,9.369E4,9.437E4,1.00,0.94,1.23,1.24,3,2,1,iTRAQ 4plex (K  N-term),56213,Isoform 2 of Regulator of nonsense transcripts 3B OS=Homo sapiens OX=9606 GN=UPF3B
2228,13847,sp|Q14106-2|TOB2_HUMAN,15.78,60.28,1.796E5,1.902E5,3.771E5,3.297E5,1.00,1.06,2.10,1.84,1.796E5,1.902E5,3.771E5,3.297E5,1.00,1.06,2.10,1.84,14,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),27192,Isoform 2 of Protein Tob2 OS=Homo sapiens OX=9606 GN=TOB2
2402,40197,sp|Q8NBK3-5|SUMF1_HUMAN,4.08,60.21,2.143E5,2.193E5,3.553E5,3.361E5,1.00,1.02,1.66,1.57,2.143E5,2.193E5,3.553E5,3.361E5,1.00,1.02,1.66,1.57,8,2,2,iTRAQ 4plex (K  N-term),38386,Isoform 5 of Formylglycine-generating enzyme OS=Homo sapiens OX=9606 GN=SUMF1
1606,22847,A0A2Q2TTZ9|A0A2Q2TTZ9_HUMAN,22.08,60.21,7.228E5,7.068E5,1.932E6,1.942E6,1.00,0.98,2.67,2.69,7.228E5,7.068E5,1.932E6,1.942E6,1.00,0.98,2.67,2.69,18,4,3,iTRAQ 4plex (K  N-term),11842,Immunoglobulin kappa variable 1-33 OS=Homo sapiens OX=9606 GN=IGKV1D-33 PE=1 SV=1
2222,21320,sp|P61006-2|RAB8A_HUMAN,1.24,60.14,3.097E6,2.823E6,3.794E6,4.33E6,1.00,0.91,1.22,1.40,3.097E6,2.823E6,3.794E6,4.33E6,1.00,0.91,1.22,1.40,3,3,1,iTRAQ 4plex (K  N-term),23564,Isoform 2 of Ras-related protein Rab-8A OS=Homo sapiens OX=9606 GN=RAB8A
2022,23553,F5H1F6|F5H1F6_HUMAN,13.65,60.14,1.359E6,1.37E6,2.373E6,2.283E6,1.00,1.01,1.75,1.68,1.359E6,1.37E6,2.373E6,2.283E6,1.00,1.01,1.75,1.68,15,3,3,iTRAQ 4plex (K  N-term),20654,Vacuolar protein sorting-associated protein 37B (Fragment) OS=Homo sapiens OX=9606 GN=VPS37B PE=1 SV=1
1965,1976,A0A0A0MSM0|A0A0A0MSM0_HUMAN,7.80,60.12,5.121E5,4.758E5,7.656E5,7.925E5,1.00,0.93,1.49,1.55,5.121E5,4.758E5,7.656E5,7.925E5,1.00,0.93,1.49,1.55,4,3,3,iTRAQ 4plex (K  N-term),88842,Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1
2314,2731,sp|Q9NQT8|KI13B_HUMAN,2.63,60.08,2.698E4,3.468E4,5.316E4,6.205E4,1.00,1.29,1.97,2.30,2.698E4,3.468E4,5.316E4,6.205E4,1.00,1.29,1.97,2.30,1,2,1,iTRAQ 4plex (K  N-term),202787,Kinesin-like protein KIF13B OS=Homo sapiens OX=9606 GN=KIF13B PE=1 SV=2
2866,41418,sp|Q86WP2-4|GPBP1_HUMAN,3.31,60.08,4.931E4,6.053E4,1.313E5,1.229E5,1.00,1.23,2.66,2.49,4.931E4,6.053E4,1.313E5,1.229E5,1.00,1.23,2.66,2.49,8,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),33830,Isoform 4 of Vasculin OS=Homo sapiens OX=9606 GN=GPBP1
2425,40526,sp|Q709F0|ACD11_HUMAN,0.93,60.03,8.435E5,8.627E5,9.672E5,9.739E5,1.00,1.02,1.15,1.15,8.435E5,8.627E5,9.672E5,9.739E5,1.00,1.02,1.15,1.15,3,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),87264,Acyl-CoA dehydrogenase family member 11 OS=Homo sapiens OX=9606 GN=ACAD11 PE=1 SV=3
2417,40466,A6NJD9|A6NJD9_HUMAN,4.57,59.96,3.795E5,3.983E5,6.078E5,6.427E5,1.00,1.05,1.60,1.69,3.795E5,3.983E5,6.078E5,6.427E5,1.00,1.05,1.60,1.69,13,2,2,iTRAQ 4plex (K  N-term),18530,39S ribosomal protein L23  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL23 PE=1 SV=1
2409,7710,sp|Q9BZG1-4|RAB34_HUMAN,1.62,59.90,9.072E4,1.044E5,1.568E5,1.469E5,1.00,1.15,1.73,1.62,9.072E4,1.044E5,1.568E5,1.469E5,1.00,1.15,1.73,1.62,4,2,1,iTRAQ 4plex (K  N-term),26673,Isoform 4 of Ras-related protein Rab-34 OS=Homo sapiens OX=9606 GN=RAB34
1983,40110,sp|Q53GQ0|DHB12_HUMAN,6.06,59.80,9.719E5,9.44E5,1.414E6,1.361E6,1.00,0.97,1.45,1.40,9.719E5,9.44E5,1.414E6,1.361E6,1.00,0.97,1.45,1.40,9,3,3,iTRAQ 4plex (K  N-term),34324,Very-long-chain 3-oxoacyl-CoA reductase OS=Homo sapiens OX=9606 GN=HSD17B12 PE=1 SV=2
1844,40854,A6NL93|A6NL93_HUMAN,3.12,59.69,1.174E6,1.074E6,1.531E6,1.602E6,1.00,0.91,1.30,1.36,1.174E6,1.074E6,1.531E6,1.602E6,1.00,0.91,1.30,1.36,21,2,2,iTRAQ 4plex (K  N-term),9536,Non-histone chromosomal protein HMG-14 OS=Homo sapiens OX=9606 GN=HMGN1 PE=1 SV=1
1993,13830,sp|Q9UL42|PNMA2_HUMAN,3.65,59.63,7.647E5,7.739E5,1.156E6,1.171E6,1.00,1.01,1.51,1.53,7.647E5,7.739E5,1.156E6,1.171E6,1.00,1.01,1.51,1.53,5,2,2,iTRAQ 4plex (K  N-term),41509,Paraneoplastic antigen Ma2 OS=Homo sapiens OX=9606 GN=PNMA2 PE=1 SV=2
2401,23760,A0A087WX10|A0A087WX10_HUMAN,6.11,59.61,1.323E6,1.384E6,2.547E6,2.4E6,1.00,1.05,1.93,1.81,1.323E6,1.384E6,2.547E6,2.4E6,1.00,1.05,1.93,1.81,5,2,2,iTRAQ 4plex (K  N-term),45336,Galactocerebrosidase (Fragment) OS=Homo sapiens OX=9606 GN=GALC PE=1 SV=1
2346,18647,sp|Q13490|BIRC2_HUMAN,6.21,59.61,3.624E5,3.324E5,6.428E5,6.034E5,1.00,0.92,1.77,1.66,3.624E5,3.324E5,6.428E5,6.034E5,1.00,0.92,1.77,1.66,4,2,2,iTRAQ 4plex (K  N-term),69900,Baculoviral IAP repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=BIRC2 PE=1 SV=2
1789,7695,sp|O14646-2|CHD1_HUMAN,4.58,59.52,2.707E5,2.73E5,4.868E5,4.973E5,1.00,1.01,1.80,1.84,2.707E5,2.73E5,4.868E5,4.973E5,1.00,1.01,1.80,1.84,1,4,2,iTRAQ 4plex (K  N-term),196589,Isoform 2 of Chromodomain-helicase-DNA-binding protein 1 OS=Homo sapiens OX=9606 GN=CHD1
1592,20446,sp|P62304|RUXE_HUMAN,9.19,59.42,2.351E6,3.022E6,3.653E6,3.205E6,1.00,1.29,1.55,1.36,2.351E6,3.022E6,3.653E6,3.205E6,1.00,1.29,1.55,1.36,25,2,2,iTRAQ 4plex (K  N-term); Oxidation (M),10804,Small nuclear ribonucleoprotein E OS=Homo sapiens OX=9606 GN=SNRPE PE=1 SV=1
2233,21525,sp|Q01518-2|CAP1_HUMAN,0.44,59.25,3.745E5,3.812E5,4.024E5,3.909E5,1.00,1.02,1.07,1.04,3.745E5,3.812E5,4.024E5,3.909E5,1.00,1.02,1.07,1.04,6,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),51830,Isoform 2 of Adenylyl cyclase-associated protein 1 OS=Homo sapiens OX=9606 GN=CAP1
2488,20799,sp|P05109|S10A8_HUMAN,31.72,58.95,2.905E6,4.305E5,8.825E5,9.032E5,1.00,0.15,0.30,0.31,2.905E6,4.305E5,8.825E5,9.032E5,1.00,0.15,0.30,0.31,19,2,2,iTRAQ 4plex (K  N-term),10835,Protein S100-A8 OS=Homo sapiens OX=9606 GN=S100A8 PE=1 SV=1
2420,40489,sp|O95347-2|SMC2_HUMAN,4.09,58.94,1.995E5,1.948E5,3.238E5,3.268E5,1.00,0.98,1.62,1.64,1.995E5,1.948E5,3.238E5,3.268E5,1.00,0.98,1.62,1.64,2,2,2,iTRAQ 4plex (K  N-term),124926,Isoform 2 of Structural maintenance of chromosomes protein 2 OS=Homo sapiens OX=9606 GN=SMC2
2377,40475,B4DQT1|B4DQT1_HUMAN,3.76,58.90,2.124E5,1.823E5,2.901E5,2.867E5,1.00,0.86,1.37,1.35,2.124E5,1.823E5,2.901E5,2.867E5,1.00,0.86,1.37,1.35,6,2,2,iTRAQ 4plex (K  N-term),39782,Macrophage erythroblast attacher OS=Homo sapiens OX=9606 GN=MAEA PE=1 SV=1
2216,40060,sp|Q96KC8|DNJC1_HUMAN,7.23,58.61,6.036E5,5.433E5,7.835E5,8.587E5,1.00,0.90,1.30,1.42,6.036E5,5.433E5,7.835E5,8.587E5,1.00,0.90,1.30,1.42,6,3,3,iTRAQ 4plex (K  N-term),63883,DnaJ homolog subfamily C member 1 OS=Homo sapiens OX=9606 GN=DNAJC1 PE=1 SV=1
2100,40285,sp|Q9Y5T5-3|UBP16_HUMAN,2.13,58.59,1.935E5,1.89E5,2.488E5,2.57E5,1.00,0.98,1.29,1.33,1.935E5,1.89E5,2.488E5,2.57E5,1.00,0.98,1.29,1.33,2,2,2,iTRAQ 4plex (K  N-term),91870,Isoform 3 of Ubiquitin carboxyl-terminal hydrolase 16 OS=Homo sapiens OX=9606 GN=USP16
2097,40233,sp|Q9UBP9|GULP1_HUMAN,2.60,58.58,5.025E5,4.955E5,6.914E5,7.012E5,1.00,0.99,1.38,1.40,5.025E5,4.955E5,6.914E5,7.012E5,1.00,0.99,1.38,1.40,7,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),34490,PTB domain-containing engulfment adapter protein 1 OS=Homo sapiens OX=9606 GN=GULP1 PE=1 SV=1
2657,15038,J3KNZ9|J3KNZ9_HUMAN,3.10,58.58,1.913E5,2.094E5,4.809E5,4.68E5,1.00,1.09,2.51,2.45,1.913E5,2.094E5,4.809E5,4.68E5,1.00,1.09,2.51,2.45,2,1,1,iTRAQ 4plex (K  N-term),103769,Probable fibrosin-1 OS=Homo sapiens OX=9606 GN=FBRS PE=1 SV=1
1435,24030,A0A0C4DH26|A0A0C4DH26_HUMAN,4.87,58.45,3.564E5,3.546E5,1.287E6,1.336E6,1.00,0.99,3.61,3.75,3.564E5,3.546E5,1.287E6,1.336E6,1.00,0.99,3.61,3.75,7,3,1,iTRAQ 4plex (K  N-term),12570,Immunoglobulin kappa variable 6D-41 (non-functional) (Fragment) OS=Homo sapiens OX=9606 GN=IGKV6D-41 PE=4 SV=1
2317,6362,sp|Q06033-2|ITIH3_HUMAN,2.62,58.35,1.15E6,1.205E6,8.857E5,8.552E5,1.00,1.05,0.77,0.74,1.15E6,1.205E6,8.857E5,8.552E5,1.00,1.05,0.77,0.74,2,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),99328,Isoform 2 of Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens OX=9606 GN=ITIH3
1695,11418,sp|Q9Y6W5|WASF2_HUMAN,11.69,58.35,1.478E6,1.4E6,2.409E6,2.3E6,1.00,0.95,1.63,1.56,1.478E6,1.4E6,2.409E6,2.3E6,1.00,0.95,1.63,1.56,5,3,3,iTRAQ 4plex (K  N-term),54284,Wiskott-Aldrich syndrome protein family member 2 OS=Homo sapiens OX=9606 GN=WASF2 PE=1 SV=3
2102,40401,G3V582|G3V582_HUMAN,1.71,58.35,1.668E5,1.856E5,2.154E5,2.025E5,1.00,1.11,1.29,1.21,1.668E5,1.856E5,2.154E5,2.025E5,1.00,1.11,1.29,1.21,6,2,2,iTRAQ 4plex (K  N-term),41356,Gephyrin OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1
2183,40537,sp|Q13325|IFIT5_HUMAN,4.68,58.33,5.094E5,5.392E5,8.659E5,7.94E5,1.00,1.06,1.70,1.56,5.094E5,5.392E5,8.659E5,7.94E5,1.00,1.06,1.70,1.56,6,2,2,iTRAQ 4plex (K  N-term),55847,Interferon-induced protein with tetratricopeptide repeats 5 OS=Homo sapiens OX=9606 GN=IFIT5 PE=1 SV=1
2162,40131,A0A087WTV6|A0A087WTV6_HUMAN,0.73,58.26,6.471E4,5.867E4,7.689E4,7.257E4,1.00,0.91,1.19,1.12,6.471E4,5.867E4,7.689E4,7.257E4,1.00,0.91,1.19,1.12,4,3,1,iTRAQ 4plex (K  N-term),25868,Pyrroline-5-carboxylate reductase 2 OS=Homo sapiens OX=9606 GN=PYCR2 PE=1 SV=1
2404,40275,sp|Q9H8K7|CJ088_HUMAN,1.90,58.25,1.197E6,1.169E6,1.519E6,1.449E6,1.00,0.98,1.27,1.21,1.197E6,1.169E6,1.519E6,1.449E6,1.00,0.98,1.27,1.21,4,2,2,iTRAQ 4plex (K  N-term),49249,Uncharacterized protein C10orf88 OS=Homo sapiens OX=9606 GN=C10orf88 PE=1 SV=2
2908,9486,sp|Q15554|TERF2_HUMAN,1.38,58.20,3.357E4,3.567E4,4.013E4,5.381E4,1.00,1.06,1.20,1.60,3.357E4,3.567E4,4.013E4,5.381E4,1.00,1.06,1.20,1.60,5,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),59594,Telomeric repeat-binding factor 2 OS=Homo sapiens OX=9606 GN=TERF2 PE=1 SV=3
1697,18082,sp|A0A0C4DH31|HV118_HUMAN,13.89,58.19,9.528E5,9.064E5,3.064E6,2.91E6,1.00,0.95,3.22,3.05,9.528E5,9.064E5,3.064E6,2.91E6,1.00,0.95,3.22,3.05,9,3,2,iTRAQ 4plex (K  N-term),12820,Immunoglobulin heavy variable 1-18 OS=Homo sapiens OX=9606 GN=IGHV1-18 PE=3 SV=1
2345,23409,sp|P78539-4|SRPX_HUMAN,4.60,57.91,3.277E5,2.801E5,4.838E5,4.669E5,1.00,0.85,1.48,1.42,3.277E5,2.801E5,4.838E5,4.669E5,1.00,0.85,1.48,1.42,6,2,2,iTRAQ 4plex (K  N-term),41750,Isoform 4 of Sushi repeat-containing protein SRPX OS=Homo sapiens OX=9606 GN=SRPX
2326,40338,sp|Q8WVS4|WDR60_HUMAN,5.84,57.79,2.291E5,2.174E5,4.316E5,4.254E5,1.00,0.95,1.88,1.86,2.291E5,2.174E5,4.316E5,4.254E5,1.00,0.95,1.88,1.86,3,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),122571,WD repeat-containing protein 60 OS=Homo sapiens OX=9606 GN=WDR60 PE=1 SV=3
2236,2670,sp|Q9NUD5|ZCHC3_HUMAN,2.58,57.67,3.133E5,2.184E5,2.929E5,2.96E5,1.00,0.70,0.93,0.94,3.133E5,2.184E5,2.929E5,2.96E5,1.00,0.70,0.93,0.94,6,2,2,iTRAQ 4plex (K  N-term),43547,Zinc finger CCHC domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ZCCHC3 PE=1 SV=2
2406,40304,sp|O15063|K0355_HUMAN,5.39,57.65,2.427E5,2.449E5,4.603E5,4.135E5,1.00,1.01,1.90,1.70,2.427E5,2.449E5,4.603E5,4.135E5,1.00,1.01,1.90,1.70,2,2,2,iTRAQ 4plex (K  N-term),116020,Uncharacterized protein KIAA0355 OS=Homo sapiens OX=9606 GN=KIAA0355 PE=1 SV=2
3098,20551,B5MC59|B5MC59_HUMAN,4.69,57.61,4.517E5,4.485E5,1.589E6,1.566E6,1.00,0.99,3.52,3.47,4.517E5,4.485E5,1.589E6,1.566E6,1.00,0.99,3.52,3.47,20,1,1,iTRAQ 4plex (K  N-term),9170,Replication protein A 14 kDa subunit OS=Homo sapiens OX=9606 GN=RPA3 PE=1 SV=1
1843,2907,E9PBF6|E9PBF6_HUMAN,1.16,57.53,8.418E4,6.535E4,9.857E4,9.459E4,1.00,0.78,1.17,1.12,8.418E4,6.535E4,9.857E4,9.459E4,1.00,0.78,1.17,1.12,4,3,1,iTRAQ 4plex (K  N-term),44643,Lamin-B1 OS=Homo sapiens OX=9606 GN=LMNB1 PE=1 SV=1
2316,1876,sp|Q9BZ29-3|DOCK9_HUMAN,4.37,57.50,1.369E5,1.342E5,2.217E5,2.314E5,1.00,0.98,1.62,1.69,1.369E5,1.342E5,2.217E5,2.314E5,1.00,0.98,1.62,1.69,2,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),235360,Isoform 3 of Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9
1980,29064,sp|Q86VW0|SESD1_HUMAN,8.29,57.48,7.042E5,7.156E5,1.173E6,1.19E6,1.00,1.02,1.67,1.69,7.042E5,7.156E5,1.173E6,1.19E6,1.00,1.02,1.67,1.69,5,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),79348,SEC14 domain and spectrin repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=SESTD1 PE=1 SV=2
2030,19580,Q5JXI2|Q5JXI2_HUMAN,9.67,57.48,5.207E5,5.414E5,1.301E6,1.29E6,1.00,1.04,2.50,2.48,5.207E5,5.414E5,1.301E6,1.29E6,1.00,1.04,2.50,2.48,9,2,2,iTRAQ 4plex (K  N-term),23701,Four and a half LIM domains protein 1 OS=Homo sapiens OX=9606 GN=FHL1 PE=1 SV=1
1939,7471,G3V325|G3V325_HUMAN,4.07,57.38,5.606E5,5.831E5,9.269E5,8.669E5,1.00,1.04,1.65,1.55,5.606E5,5.831E5,9.269E5,8.669E5,1.00,1.04,1.65,1.55,3,2,2,iTRAQ 4plex (K  N-term),84110,ATP5MF-PTCD1 readthrough OS=Homo sapiens OX=9606 GN=ATP5MF-PTCD1 PE=4 SV=1
2242,41070,K7ESE5|K7ESE5_HUMAN,2.31,57.33,2.89E5,3.128E5,6.001E5,5.982E5,1.00,1.08,2.08,2.07,2.89E5,3.128E5,6.001E5,5.982E5,1.00,1.08,2.08,2.07,16,2,1,iTRAQ 4plex (K  N-term),5827,Leydig cell tumor 10 kDa protein homolog OS=Homo sapiens OX=9606 GN=C19orf53 PE=1 SV=1
2485,18927,sp|Q9H0S4-2|DDX47_HUMAN,1.29,57.19,1.674E5,1.631E5,2.405E5,2.55E5,1.00,0.97,1.44,1.52,1.674E5,1.631E5,2.405E5,2.55E5,1.00,0.97,1.44,1.52,2,2,1,iTRAQ 4plex (K  N-term),45169,Isoform 2 of Probable ATP-dependent RNA helicase DDX47 OS=Homo sapiens OX=9606 GN=DDX47
2516,23205,sp|O14907|TX1B3_HUMAN,0.84,57.02,6.959E5,6.419E5,6.109E5,6.294E5,1.00,0.92,0.88,0.90,6.959E5,6.419E5,6.109E5,6.294E5,1.00,0.92,0.88,0.90,21,2,2,iTRAQ 4plex (K  N-term),13735,Tax1-binding protein 3 OS=Homo sapiens OX=9606 GN=TAX1BP3 PE=1 SV=2
2361,40200,sp|Q9NV70-2|EXOC1_HUMAN,2.48,56.98,2.638E5,2.641E5,3.755E5,3.751E5,1.00,1.00,1.42,1.42,2.638E5,2.641E5,3.755E5,3.751E5,1.00,1.00,1.42,1.42,2,2,2,iTRAQ 4plex (K  N-term),100283,Isoform 2 of Exocyst complex component 1 OS=Homo sapiens OX=9606 GN=EXOC1
2099,22595,A0A0U1RRM1|A0A0U1RRM1_HUMAN,7.36,56.93,2.282E5,2.457E5,4.885E5,5.14E5,1.00,1.08,2.14,2.25,2.282E5,2.457E5,4.885E5,5.14E5,1.00,1.08,2.14,2.25,4,2,2,iTRAQ 4plex (K  N-term),63462,Transcriptional repressor p66-beta OS=Homo sapiens OX=9606 GN=GATAD2B PE=1 SV=1
2350,40393,D3YTG3|D3YTG3_HUMAN,6.11,56.89,1.801E5,1.765E5,3.687E5,2.766E5,1.00,0.98,2.05,1.54,1.801E5,1.765E5,3.687E5,2.766E5,1.00,0.98,2.05,1.54,1,2,2,iTRAQ 4plex (K  N-term),195322,Target of Nesh-SH3 OS=Homo sapiens OX=9606 GN=ABI3BP PE=1 SV=1
2096,11039,sp|O43312-2|MTSS1_HUMAN,13.67,56.80,6.392E5,6.467E5,1.231E6,1.217E6,1.00,1.01,1.93,1.90,6.392E5,6.467E5,1.231E6,1.217E6,1.00,1.01,1.93,1.90,5,3,3,iTRAQ 4plex (K  N-term),50650,Isoform 2 of Metastasis suppressor protein 1 OS=Homo sapiens OX=9606 GN=MTSS1
2424,40525,sp|P47974|TISD_HUMAN,4.10,56.77,1.631E5,1.677E5,2.758E5,2.585E5,1.00,1.03,1.69,1.59,1.631E5,1.677E5,2.758E5,2.585E5,1.00,1.03,1.69,1.59,11,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),51063,mRNA decay activator protein ZFP36L2 OS=Homo sapiens OX=9606 GN=ZFP36L2 PE=1 SV=3
2333,6809,sp|Q9P227|RHG23_HUMAN,3.82,56.72,1.963E5,1.827E5,2.947E5,2.984E5,1.00,0.93,1.50,1.52,1.963E5,1.827E5,2.947E5,2.984E5,1.00,0.93,1.50,1.52,2,2,2,iTRAQ 4plex (K  N-term),162191,Rho GTPase-activating protein 23 OS=Homo sapiens OX=9606 GN=ARHGAP23 PE=1 SV=2
1812,41878,X6RLJ0|X6RLJ0_HUMAN,41.20,56.71,1.089E6,1.298E6,1.509E7,1.375E7,1.00,1.19,13.86,12.62,1.089E6,1.298E6,1.509E7,1.375E7,1.00,1.19,13.86,12.62,5,2,2,iTRAQ 4plex (K  N-term),23352,Complement C1q subcomponent subunit A (Fragment) OS=Homo sapiens OX=9606 GN=C1QA PE=1 SV=7
2112,40144,sp|Q8N1F7|NUP93_HUMAN,6.84,56.70,4.597E5,5.085E5,7.349E5,7.253E5,1.00,1.11,1.60,1.58,4.597E5,5.085E5,7.349E5,7.253E5,1.00,1.11,1.60,1.58,4,3,3,iTRAQ 4plex (K  N-term),93488,Nuclear pore complex protein Nup93 OS=Homo sapiens OX=9606 GN=NUP93 PE=1 SV=2
2164,5614,sp|Q13263|TIF1B_HUMAN,11.58,56.69,3.71E5,4.065E5,6.851E5,6.802E5,1.00,1.10,1.85,1.83,3.71E5,4.065E5,6.851E5,6.802E5,1.00,1.10,1.85,1.83,3,3,3,iTRAQ 4plex (K  N-term),88550,Transcription intermediary factor 1-beta OS=Homo sapiens OX=9606 GN=TRIM28 PE=1 SV=5
2448,40991,A0A087WU62|A0A087WU62_HUMAN,9.37,56.66,5.96E5,6.732E5,1.48E6,1.423E6,1.00,1.13,2.48,2.39,5.96E5,6.732E5,1.48E6,1.423E6,1.00,1.13,2.48,2.39,7,2,2,iTRAQ 4plex (K  N-term),29348,39S ribosomal protein L45  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL45 PE=1 SV=1
2440,40645,H0YGV7|H0YGV7_HUMAN,6.08,56.61,1.181E6,1.175E6,2.205E6,1.991E6,1.00,1.00,1.87,1.69,1.181E6,1.175E6,2.205E6,1.991E6,1.00,1.00,1.87,1.69,4,2,2,iTRAQ 4plex (K  N-term),62399,alpha-1 2-Mannosidase OS=Homo sapiens OX=9606 GN=MAN1B1 PE=1 SV=2
2484,40919,sp|O43837-3|IDH3B_HUMAN,4.19,56.58,1.247E6,1.267E6,1.975E6,2.059E6,1.00,1.02,1.58,1.65,1.247E6,1.267E6,1.975E6,2.059E6,1.00,1.02,1.58,1.65,9,2,2,iTRAQ 4plex (K  N-term),25555,Isoform C of Isocitrate dehydrogenase [NAD] subunit beta  mitochondrial OS=Homo sapiens OX=9606 GN=IDH3B
1902,10151,sp|Q9BT92|TCHP_HUMAN,4.15,56.38,2.41E5,2.402E5,3.979E5,4.157E5,1.00,1.00,1.65,1.72,2.41E5,2.402E5,3.979E5,4.157E5,1.00,1.00,1.65,1.72,3,3,2,iTRAQ 4plex (K  N-term),61072,Trichoplein keratin filament-binding protein OS=Homo sapiens OX=9606 GN=TCHP PE=1 SV=1
2238,41014,I3L0H8|I3L0H8_HUMAN,5.79,56.32,5.605E5,5.267E5,1.008E6,9.891E5,1.00,0.94,1.80,1.76,5.605E5,5.267E5,1.008E6,9.891E5,1.00,0.94,1.80,1.76,4,2,2,iTRAQ 4plex (K  N-term),50520,ATP-dependent RNA helicase DDX19A OS=Homo sapiens OX=9606 GN=DDX19A PE=1 SV=1
2105,8668,sp|Q15311|RBP1_HUMAN,6.99,56.32,1.296E6,1.201E6,1.932E6,1.96E6,1.00,0.93,1.49,1.51,1.296E6,1.201E6,1.932E6,1.96E6,1.00,0.93,1.49,1.51,5,3,3,iTRAQ 4plex (K  N-term),76064,RalA-binding protein 1 OS=Homo sapiens OX=9606 GN=RALBP1 PE=1 SV=3
1910,14,sp|Q4LDE5|SVEP1_HUMAN,6.38,56.32,3.914E5,4.028E5,6.288E5,5.805E5,1.00,1.03,1.61,1.48,3.914E5,4.028E5,6.288E5,5.805E5,1.00,1.03,1.61,1.48,2,4,4,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),390171,Sushi  von Willebrand factor type A  EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3
2013,40058,sp|P35354|PGH2_HUMAN,20.84,56.26,7.522E5,7.994E5,1.943E6,2.037E6,1.00,1.06,2.58,2.71,7.522E5,7.994E5,1.943E6,2.037E6,1.00,1.06,2.58,2.71,6,3,3,iTRAQ 4plex (K  N-term),68996,Prostaglandin G/H synthase 2 OS=Homo sapiens OX=9606 GN=PTGS2 PE=1 SV=2
2321,14684,sp|Q9Y4F3-3|MARF1_HUMAN,7.59,56.24,1.428E5,1.417E5,3.191E5,3.226E5,1.00,0.99,2.23,2.26,1.428E5,1.417E5,3.191E5,3.226E5,1.00,0.99,2.23,2.26,1,2,2,iTRAQ 4plex (K  N-term),186446,Isoform 2 of Meiosis regulator and mRNA stability factor 1 OS=Homo sapiens OX=9606 GN=MARF1
2381,5518,sp|Q9H9J2|RM44_HUMAN,5.09,56.21,4.766E5,4.614E5,7.88E5,8.223E5,1.00,0.97,1.65,1.73,4.766E5,4.614E5,7.88E5,8.223E5,1.00,0.97,1.65,1.73,8,2,2,iTRAQ 4plex (K  N-term),37535,39S ribosomal protein L44  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL44 PE=1 SV=1
1984,20902,sp|Q9Y266|NUDC_HUMAN,5.47,56.18,6.836E5,6.591E5,9.706E5,9.551E5,1.00,0.96,1.42,1.40,6.836E5,6.591E5,9.706E5,9.551E5,1.00,0.96,1.42,1.40,11,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),38243,Nuclear migration protein nudC OS=Homo sapiens OX=9606 GN=NUDC PE=1 SV=1
2408,14190,sp|Q13625-2|ASPP2_HUMAN,8.22,55.96,1.171E5,1.02E5,2.43E5,2.097E5,1.00,0.87,2.08,1.79,1.171E5,1.02E5,2.43E5,2.097E5,1.00,0.87,2.08,1.79,2,2,2,iTRAQ 4plex (K  N-term),111431,Isoform 2 of Apoptosis-stimulating of p53 protein 2 OS=Homo sapiens OX=9606 GN=TP53BP2
2224,40163,sp|P08133-2|ANXA6_HUMAN,8.74,55.95,8.124E5,7.048E5,1.178E6,1.182E6,1.00,0.87,1.45,1.46,8.124E5,7.048E5,1.178E6,1.182E6,1.00,0.87,1.45,1.46,4,3,3,iTRAQ 4plex (K  N-term),72424,Isoform 2 of Annexin A6 OS=Homo sapiens OX=9606 GN=ANXA6
2307,40243,sp|O14607-5|UTY_HUMAN,2.66,55.89,2.172E4,2.825E4,5.058E4,4.338E4,1.00,1.30,2.33,2.00,2.172E4,2.825E4,5.058E4,4.338E4,1.00,1.30,2.33,2.00,2,2,1,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),134762,Isoform 5 of Histone demethylase UTY OS=Homo sapiens OX=9606 GN=UTY
2196,21671,I3L2J1|I3L2J1_HUMAN,0.56,55.87,2.946E5,3.054E5,3.583E5,3.616E5,1.00,1.04,1.22,1.23,2.946E5,3.054E5,3.583E5,3.616E5,1.00,1.04,1.22,1.23,30,1,1,iTRAQ 4plex (K  N-term),6986,Mediator of RNA polymerase II transcription subunit 31 OS=Homo sapiens OX=9606 GN=MED31 PE=1 SV=1
2213,40036,B5MCF9|B5MCF9_HUMAN,6.04,55.85,3.488E5,3.206E5,4.995E5,4.911E5,1.00,0.92,1.43,1.41,3.488E5,3.206E5,4.995E5,4.911E5,1.00,0.92,1.43,1.41,6,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),66078,Pescadillo homolog OS=Homo sapiens OX=9606 GN=PES1 PE=1 SV=1
1989,40544,G3XAN4|G3XAN4_HUMAN,11.45,55.80,2.993E5,2.704E5,4.793E5,4.796E5,1.00,0.90,1.60,1.60,2.993E5,2.704E5,4.793E5,4.796E5,1.00,0.90,1.60,1.60,9,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),33435,Translocating chain-associated membrane protein 1 OS=Homo sapiens OX=9606 GN=TRAM1 PE=1 SV=1
1887,4056,sp|P19447|ERCC3_HUMAN,5.51,55.74,6.995E5,6.889E5,1.005E6,1E6,1.00,0.98,1.44,1.43,6.995E5,6.889E5,1.005E6,1E6,1.00,0.98,1.44,1.43,4,3,3,iTRAQ 4plex (K  N-term),89278,General transcription and DNA repair factor IIH helicase subunit XPB OS=Homo sapiens OX=9606 GN=ERCC3 PE=1 SV=1
2159,20495,sp|P54727|RD23B_HUMAN,6.62,55.61,9.34E5,8.516E5,1.309E6,1.321E6,1.00,0.91,1.40,1.41,9.34E5,8.516E5,1.309E6,1.321E6,1.00,0.91,1.40,1.41,7,3,3,iTRAQ 4plex (K  N-term),43171,UV excision repair protein RAD23 homolog B OS=Homo sapiens OX=9606 GN=RAD23B PE=1 SV=1
1958,40348,sp|P0C2W1|FBSP1_HUMAN,4.58,55.58,8.034E5,8.792E5,1.386E6,1.332E6,1.00,1.09,1.73,1.66,8.034E5,8.792E5,1.386E6,1.332E6,1.00,1.09,1.73,1.66,7,2,2,iTRAQ 4plex (K  N-term),30633,F-box/SPRY domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FBXO45 PE=1 SV=1
2433,40572,sp|O00410-2|IPO5_HUMAN,3.51,55.49,2.672E5,2.84E5,4.239E5,3.991E5,1.00,1.06,1.59,1.49,2.672E5,2.84E5,4.239E5,3.991E5,1.00,1.06,1.59,1.49,2,2,2,iTRAQ 4plex (K  N-term),116982,Isoform 2 of Importin-5 OS=Homo sapiens OX=9606 GN=IPO5
2014,19471,sp|Q13643|FHL3_HUMAN,11.22,55.40,1.952E6,2.08E6,3.611E6,3.646E6,1.00,1.07,1.85,1.87,1.952E6,2.08E6,3.611E6,3.646E6,1.00,1.07,1.85,1.87,9,3,3,iTRAQ 4plex (K  N-term),31192,Four and a half LIM domains protein 3 OS=Homo sapiens OX=9606 GN=FHL3 PE=1 SV=4
2369,40339,sp|Q96KP1|EXOC2_HUMAN,0.53,55.36,3.589E5,3.608E5,3.922E5,3.862E5,1.00,1.01,1.09,1.08,3.589E5,3.608E5,3.922E5,3.862E5,1.00,1.01,1.09,1.08,2,2,2,iTRAQ 4plex (K  N-term),104066,Exocyst complex component 2 OS=Homo sapiens OX=9606 GN=EXOC2 PE=1 SV=1
2131,4607,sp|Q9Y6K5|OAS3_HUMAN,3.01,55.29,1.978E5,1.98E5,3.058E5,2.996E5,1.00,1.00,1.55,1.51,1.978E5,1.98E5,3.058E5,2.996E5,1.00,1.00,1.55,1.51,2,3,2,iTRAQ 4plex (K  N-term),121170,2'-5'-oligoadenylate synthase 3 OS=Homo sapiens OX=9606 GN=OAS3 PE=1 SV=3
2239,41016,sp|Q9NZJ7-2|MTCH1_HUMAN,1.98,55.24,9.311E5,9.375E5,1.227E6,1.243E6,1.00,1.01,1.32,1.33,9.311E5,9.375E5,1.227E6,1.243E6,1.00,1.01,1.32,1.33,5,2,2,iTRAQ 4plex (K  N-term),39920,Isoform 2 of Mitochondrial carrier homolog 1 OS=Homo sapiens OX=9606 GN=MTCH1
2491,20241,K7EM11|K7EM11_HUMAN,4.04,55.21,2.415E5,2.197E5,3.561E5,3.74E5,1.00,0.91,1.47,1.55,2.415E5,2.197E5,3.561E5,3.74E5,1.00,0.91,1.47,1.55,22,2,2,iTRAQ 4plex (K  N-term),13989,PDZ domain-containing protein GIPC1 (Fragment) OS=Homo sapiens OX=9606 GN=GIPC1 PE=1 SV=1
2396,41247,sp|Q9BYH8-3|IKBZ_HUMAN,1.82,55.09,3.414E5,3.966E5,5.802E5,6.166E5,1.00,1.16,1.70,1.81,3.414E5,3.966E5,5.802E5,6.166E5,1.00,1.16,1.70,1.81,4,1,1,iTRAQ 4plex (K  N-term),64299,Isoform 3 of NF-kappa-B inhibitor zeta OS=Homo sapiens OX=9606 GN=NFKBIZ
2235,7099,D6RAA6|D6RAA6_HUMAN,5.27,54.96,4.131E5,4.016E5,7.478E5,7.315E5,1.00,0.97,1.81,1.77,4.131E5,4.016E5,7.478E5,7.315E5,1.00,0.97,1.81,1.77,10,2,2,iTRAQ 4plex (K  N-term),25224,Transmembrane protein 33 (Fragment) OS=Homo sapiens OX=9606 GN=TMEM33 PE=1 SV=1
2351,24123,sp|O43524|FOXO3_HUMAN,4.43,54.93,1.373E5,1.258E5,2.147E5,2.184E5,1.00,0.92,1.56,1.59,1.373E5,1.258E5,2.147E5,2.184E5,1.00,0.92,1.56,1.59,3,2,2,iTRAQ 4plex (K  N-term),71277,Forkhead box protein O3 OS=Homo sapiens OX=9606 GN=FOXO3 PE=1 SV=1
2490,13155,sp|P38935|SMBP2_HUMAN,4.84,54.87,3.96E5,4.052E5,7.148E5,7.022E5,1.00,1.02,1.81,1.77,3.96E5,4.052E5,7.148E5,7.022E5,1.00,1.02,1.81,1.77,2,2,2,iTRAQ 4plex (K  N-term),109149,DNA-binding protein SMUBP-2 OS=Homo sapiens OX=9606 GN=IGHMBP2 PE=1 SV=3
2195,41956,sp|Q9BXJ1|C1QT1_HUMAN,6.00,54.85,2.983E5,3.049E5,5.088E5,5.494E5,1.00,1.02,1.71,1.84,2.983E5,3.049E5,5.088E5,5.494E5,1.00,1.02,1.71,1.84,10,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),31743,Complement C1q tumor necrosis factor-related protein 1 OS=Homo sapiens OX=9606 GN=C1QTNF1 PE=1 SV=1
2086,22657,F8WEF8|F8WEF8_HUMAN,7.77,54.80,3.077E5,3.103E5,7.009E5,7.129E5,1.00,1.01,2.28,2.32,3.077E5,3.103E5,7.009E5,7.129E5,1.00,1.01,2.28,2.32,6,2,2,iTRAQ 4plex (K  N-term),32814,Splicing factor ESS-2 homolog OS=Homo sapiens OX=9606 GN=ESS2 PE=1 SV=1
2529,42257,sp|P17275|JUNB_HUMAN,2.09,54.80,3.779E5,3.951E5,4.93E5,4.706E5,1.00,1.05,1.30,1.25,3.779E5,3.951E5,4.93E5,4.706E5,1.00,1.05,1.30,1.25,7,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),35879,Transcription factor jun-B OS=Homo sapiens OX=9606 GN=JUNB PE=1 SV=1
2431,40559,sp|Q16513-4|PKN2_HUMAN,2.13,54.65,1.179E5,1.228E5,1.616E5,1.611E5,1.00,1.04,1.37,1.37,1.179E5,1.228E5,1.616E5,1.611E5,1.00,1.04,1.37,1.37,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),94136,Isoform 4 of Serine/threonine-protein kinase N2 OS=Homo sapiens OX=9606 GN=PKN2
2166,40182,sp|O60784-3|TOM1_HUMAN,4.15,54.65,9.847E5,1.06E6,1.279E6,1.303E6,1.00,1.08,1.30,1.32,9.847E5,1.06E6,1.279E6,1.303E6,1.00,1.08,1.30,1.32,8,3,3,iTRAQ 4plex (K  N-term),48673,Isoform 3 of Target of Myb protein 1 OS=Homo sapiens OX=9606 GN=TOM1
2489,14888,sp|Q9C073|F117A_HUMAN,1.60,54.65,4.753E5,5.108E5,6.051E5,6.018E5,1.00,1.07,1.27,1.27,4.753E5,5.108E5,6.051E5,6.018E5,1.00,1.07,1.27,1.27,6,2,2,iTRAQ 4plex (K  N-term),48319,Protein FAM117A OS=Homo sapiens OX=9606 GN=FAM117A PE=1 SV=1
2231,40927,sp|Q13495-4|MAMD1_HUMAN,6.70,54.64,4.639E5,4.506E5,9.474E5,9.565E5,1.00,0.97,2.04,2.06,4.639E5,4.506E5,9.474E5,9.565E5,1.00,0.97,2.04,2.06,3,2,2,iTRAQ 4plex (K  N-term),80284,Isoform 3 of Mastermind-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MAMLD1
3030,41869,H7C5U8|H7C5U8_HUMAN,2.31,54.39,4.841E5,5.159E5,9.968E5,9.238E5,1.00,1.07,2.06,1.91,4.841E5,5.159E5,9.968E5,9.238E5,1.00,1.07,2.06,1.91,11,1,1,iTRAQ 4plex (K  N-term),14850,39S ribosomal protein L27  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPL27 PE=1 SV=1
2421,9224,sp|Q9UPY6-2|WASF3_HUMAN,2.21,54.36,2.207E5,2.142E5,2.957E5,2.663E5,1.00,0.97,1.34,1.21,2.207E5,2.142E5,2.957E5,2.663E5,1.00,0.97,1.34,1.21,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),55007,Isoform 2 of Wiskott-Aldrich syndrome protein family member 3 OS=Homo sapiens OX=9606 GN=WASF3
2032,3427,sp|P46060|RAGP1_HUMAN,8.51,54.28,6.994E5,6.612E5,1.537E6,1.538E6,1.00,0.95,2.20,2.20,6.994E5,6.612E5,1.537E6,1.538E6,1.00,0.95,2.20,2.20,3,2,2,iTRAQ 4plex (K  N-term),63542,Ran GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RANGAP1 PE=1 SV=1
2232,40935,E9PRR7|E9PRR7_HUMAN,3.96,54.24,5.968E5,9.633E5,9.914E5,7.667E5,1.00,1.61,1.66,1.28,5.968E5,9.633E5,9.914E5,7.667E5,1.00,1.61,1.66,1.28,17,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),12516,Protein FRG1 (Fragment) OS=Homo sapiens OX=9606 GN=FRG1 PE=1 SV=1
1839,11574,sp|Q7Z3B4-3|NUP54_HUMAN,14.31,54.05,4.079E5,3.748E5,8.562E5,8.573E5,1.00,0.92,2.10,2.10,4.079E5,3.748E5,8.562E5,8.573E5,1.00,0.92,2.10,2.10,5,3,3,iTRAQ 4plex (K  N-term),50776,Isoform 3 of Nucleoporin p54 OS=Homo sapiens OX=9606 GN=NUP54
2454,41273,sp|Q00688|FKBP3_HUMAN,2.97,53.98,3.973E5,4.785E5,5.869E5,5.644E5,1.00,1.20,1.48,1.42,3.973E5,4.785E5,5.869E5,5.644E5,1.00,1.20,1.48,1.42,8,2,2,iTRAQ 4plex (K  N-term),25177,Peptidyl-prolyl cis-trans isomerase FKBP3 OS=Homo sapiens OX=9606 GN=FKBP3 PE=1 SV=1
2172,8342,sp|Q12899|TRI26_HUMAN,3.57,53.97,3.474E5,3.407E5,5.162E5,5.44E5,1.00,0.98,1.49,1.57,3.474E5,3.407E5,5.162E5,5.44E5,1.00,0.98,1.49,1.57,4,2,2,iTRAQ 4plex (K  N-term),62166,Tripartite motif-containing protein 26 OS=Homo sapiens OX=9606 GN=TRIM26 PE=1 SV=1
1741,22377,sp|P15814|IGLL1_HUMAN,4.50,53.95,7.48E5,7.952E5,1.395E6,1.36E6,1.00,1.06,1.87,1.82,7.48E5,7.952E5,1.395E6,1.36E6,1.00,1.06,1.87,1.82,12,4,2,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ),22963,Immunoglobulin lambda-like polypeptide 1 OS=Homo sapiens OX=9606 GN=IGLL1 PE=1 SV=1
1903,3411,A0A0C4DG33|A0A0C4DG33_HUMAN,9.23,53.75,3.773E5,7.552E5,3.694E7,3.652E7,1.00,2.00,97.90,96.77,3.773E5,7.552E5,3.694E7,3.652E7,1.00,2.00,97.90,96.77,1,2,1,iTRAQ 4plex (K  N-term),136585,Peroxisome biogenesis factor 1  isoform CRA_c OS=Homo sapiens OX=9606 GN=PEX1 PE=1 SV=1
2110,244,sp|Q96A19|C102A_HUMAN,9.47,53.64,6.139E5,5.788E5,1.02E6,1.052E6,1.00,0.94,1.66,1.71,6.139E5,5.788E5,1.02E6,1.052E6,1.00,0.94,1.66,1.71,7,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),62596,Coiled-coil domain-containing protein 102A OS=Homo sapiens OX=9606 GN=CCDC102A PE=1 SV=2
2171,21927,sp|Q14624-4|ITIH4_HUMAN,1.07,53.61,1.091E6,1.23E6,1.212E6,1.29E6,1.00,1.13,1.11,1.18,1.091E6,1.23E6,1.212E6,1.29E6,1.00,1.13,1.11,1.18,2,2,2,iTRAQ 4plex (K  N-term),93852,Isoform 4 of Inter-alpha-trypsin inhibitor heavy chain H4 OS=Homo sapiens OX=9606 GN=ITIH4
1954,40154,E9PG73|E9PG73_HUMAN,5.47,53.53,3.464E5,3.184E5,4.855E5,4.772E5,1.00,0.92,1.40,1.38,3.464E5,3.184E5,4.855E5,4.772E5,1.00,0.92,1.40,1.38,3,3,3,iTRAQ 4plex (K  N-term); Phosphorylation (STY),87089,Peptidyl-prolyl cis-trans isomerase G OS=Homo sapiens OX=9606 GN=PPIG PE=1 SV=1
2432,40570,sp|O76021-2|RL1D1_HUMAN,2.09,53.49,1.227E5,1.116E5,1.473E5,1.535E5,1.00,0.91,1.20,1.25,1.227E5,1.116E5,1.473E5,1.535E5,1.00,0.91,1.20,1.25,11,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),30354,Isoform 2 of Ribosomal L1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RSL1D1
2016,11915,sp|Q8NHQ8-2|RASF8_HUMAN,8.42,53.20,4.018E5,3.858E5,6.813E5,6.897E5,1.00,0.96,1.70,1.72,4.018E5,3.858E5,6.813E5,6.897E5,1.00,0.96,1.70,1.72,7,3,3,iTRAQ 4plex (K  N-term),45446,Isoform 2 of Ras association domain-containing protein 8 OS=Homo sapiens OX=9606 GN=RASSF8
2467,21985,sp|Q9BXK1|KLF16_HUMAN,0.66,53.05,6.624E4,6.492E4,7.665E4,8.265E4,1.00,0.98,1.16,1.25,6.624E4,6.492E4,7.665E4,8.265E4,1.00,0.98,1.16,1.25,10,1,1,iTRAQ 4plex (K  N-term),25431,Krueppel-like factor 16 OS=Homo sapiens OX=9606 GN=KLF16 PE=1 SV=1
2353,40595,sp|Q13472-3|TOP3A_HUMAN,2.77,53.05,1.277E5,1.377E5,3.038E5,2.912E5,1.00,1.08,2.38,2.28,1.277E5,1.377E5,3.038E5,2.912E5,1.00,1.08,2.38,2.28,1,2,1,iTRAQ 4plex (K  N-term),101209,Isoform 3 of DNA topoisomerase 3-alpha OS=Homo sapiens OX=9606 GN=TOP3A
2380,40503,sp|Q8IWC1-2|MA7D3_HUMAN,4.55,53.02,1.688E5,1.751E5,2.921E5,3.013E5,1.00,1.04,1.73,1.79,1.688E5,1.751E5,2.921E5,3.013E5,1.00,1.04,1.73,1.79,2,2,2,iTRAQ 4plex (K  N-term),93785,Isoform 2 of MAP7 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=MAP7D3
2161,40078,Q5SQL3|Q5SQL3_HUMAN,5.04,52.92,3.682E4,4.136E4,1.465E5,1.317E5,1.00,1.12,3.98,3.58,3.682E4,4.136E4,1.465E5,1.317E5,1.00,1.12,3.98,3.58,2,3,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),126264,Homeodomain-interacting protein kinase 1 OS=Homo sapiens OX=9606 GN=HIPK1 PE=1 SV=1
2250,41235,sp|Q7Z4I7-4|LIMS2_HUMAN,1.51,52.89,9.714E4,9.163E4,1.394E5,1.543E5,1.00,0.94,1.44,1.59,9.714E4,9.163E4,1.394E5,1.543E5,1.00,0.94,1.44,1.59,4,2,1,iTRAQ 4plex (K  N-term),21615,Isoform 4 of LIM and senescent cell antigen-like-containing domain protein 2 OS=Homo sapiens OX=9606 GN=LIMS2
2029,20089,K7EIJ0|K7EIJ0_HUMAN,5.86,52.89,1.027E6,1.611E6,2.002E6,1.918E6,1.00,1.57,1.95,1.87,1.027E6,1.611E6,2.002E6,1.918E6,1.00,1.57,1.95,1.87,11,2,2,iTRAQ 4plex (K  N-term),18224,WW domain-binding protein 2 (Fragment) OS=Homo sapiens OX=9606 GN=WBP2 PE=1 SV=1
2446,22797,sp|Q9BXB5-2|OSB10_HUMAN,5.64,52.85,7.232E4,7.673E4,1.476E5,1.418E5,1.00,1.06,2.04,1.96,7.232E4,7.673E4,1.476E5,1.418E5,1.00,1.06,2.04,1.96,4,2,2,iTRAQ 4plex (K  N-term),77235,Isoform 2 of Oxysterol-binding protein-related protein 10 OS=Homo sapiens OX=9606 GN=OSBPL10
2437,40626,sp|P40938-2|RFC3_HUMAN,1.99,52.84,3.206E5,3.092E5,4.112E5,3.977E5,1.00,0.96,1.28,1.24,3.206E5,3.092E5,4.112E5,3.977E5,1.00,0.96,1.28,1.24,7,2,2,iTRAQ 4plex (K  N-term),34756,Isoform 2 of Replication factor C subunit 3 OS=Homo sapiens OX=9606 GN=RFC3
2244,23174,sp|P28066|PSA5_HUMAN,6.35,52.76,1.311E6,1.311E6,2.565E6,2.402E6,1.00,1.00,1.96,1.83,1.311E6,1.311E6,2.565E6,2.402E6,1.00,1.00,1.96,1.83,7,2,2,iTRAQ 4plex (K  N-term),26411,Proteasome subunit alpha type-5 OS=Homo sapiens OX=9606 GN=PSMA5 PE=1 SV=3
2504,41182,sp|Q9NZI7-4|UBIP1_HUMAN,4.27,52.72,7.771E5,6.903E5,1.154E6,1.102E6,1.00,0.89,1.49,1.42,7.771E5,6.903E5,1.154E6,1.102E6,1.00,0.89,1.49,1.42,4,2,2,iTRAQ 4plex (K  N-term),56453,Isoform 2 of Upstream-binding protein 1 OS=Homo sapiens OX=9606 GN=UBP1
2522,41319,sp|Q02535|ID3_HUMAN,5.68,52.72,5.332E5,5.084E5,9.348E5,9.551E5,1.00,0.95,1.75,1.79,5.332E5,5.084E5,9.348E5,9.551E5,1.00,0.95,1.75,1.79,17,2,2,iTRAQ 4plex (K  N-term),12999,DNA-binding protein inhibitor ID-3 OS=Homo sapiens OX=9606 GN=ID3 PE=1 SV=2
2494,41035,sp|Q13123|RED_HUMAN,4.65,52.71,4.225E5,4.462E5,7.352E5,7.525E5,1.00,1.06,1.74,1.78,4.225E5,4.462E5,7.352E5,7.525E5,1.00,1.06,1.74,1.78,3,2,2,iTRAQ 4plex (K  N-term),65602,Protein Red OS=Homo sapiens OX=9606 GN=IK PE=1 SV=3
2139,40394,B9A018|B9A018_HUMAN,2.29,52.66,4.252E5,4.395E5,5.859E5,5.812E5,1.00,1.03,1.38,1.37,4.252E5,4.395E5,5.859E5,5.812E5,1.00,1.03,1.38,1.37,4,2,2,iTRAQ 4plex (K  N-term),62044,U4/U6.U5 tri-snRNP-associated protein 2 OS=Homo sapiens OX=9606 GN=USP39 PE=1 SV=1
2298,980,sp|Q14160-2|SCRIB_HUMAN,3.89,52.64,4.825E5,4.807E5,7.352E5,7.753E5,1.00,1.00,1.52,1.61,4.825E5,4.807E5,7.352E5,7.753E5,1.00,1.00,1.52,1.61,1,2,2,iTRAQ 4plex (K  N-term),165242,Isoform 2 of Protein scribble homolog OS=Homo sapiens OX=9606 GN=SCRIB
2865,41150,A0A087X0F1|A0A087X0F1_HUMAN,2.56,52.62,2.741E5,3.043E5,6.044E5,5.904E5,1.00,1.11,2.20,2.15,2.741E5,3.043E5,6.044E5,5.904E5,1.00,1.11,2.20,2.15,1,1,1,iTRAQ 4plex (K  N-term),117309,Protein TASOR OS=Homo sapiens OX=9606 GN=FAM208A PE=1 SV=1
1807,40084,I3L4X7|I3L4X7_HUMAN,18.28,52.51,5.776E6,5.424E6,1.209E7,1.191E7,1.00,0.94,2.09,2.06,5.776E6,5.424E6,1.209E7,1.191E7,1.00,0.94,2.09,2.06,8,3,3,iTRAQ 4plex (K  N-term),29334,G protein pathway suppressor 2 (Fragment) OS=Homo sapiens OX=9606 GN=GPS2 PE=1 SV=2
2507,41188,B1AN62|B1AN62_HUMAN,5.69,52.50,6.399E5,6.586E5,1.136E6,1.218E6,1.00,1.03,1.78,1.90,6.399E5,6.586E5,1.136E6,1.218E6,1.00,1.03,1.78,1.90,12,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),18311,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 OS=Homo sapiens OX=9606 GN=NMNAT1 PE=1 SV=1
2234,13218,A0A1B0GW05|A0A1B0GW05_HUMAN,1.64,52.35,1.512E5,1.431E5,1.799E5,1.863E5,1.00,0.95,1.19,1.23,1.512E5,1.431E5,1.799E5,1.863E5,1.00,0.95,1.19,1.23,4,2,2,iTRAQ 4plex (K  N-term),84534,Probable C-mannosyltransferase DPY19L1 OS=Homo sapiens OX=9606 GN=DPY19L1 PE=1 SV=1
2430,40553,sp|Q9P2R3|ANFY1_HUMAN,2.46,52.31,1.814E5,1.961E5,2.576E5,2.438E5,1.00,1.08,1.42,1.34,1.814E5,1.961E5,2.576E5,2.438E5,1.00,1.08,1.42,1.34,2,2,2,iTRAQ 4plex (K  N-term),128399,Rabankyrin-5 OS=Homo sapiens OX=9606 GN=ANKFY1 PE=1 SV=2
2428,20305,sp|Q8NG27-3|PJA1_HUMAN,5.46,52.30,3.993E5,3.978E5,7.542E5,7.282E5,1.00,1.00,1.89,1.82,3.993E5,3.978E5,7.542E5,7.282E5,1.00,1.00,1.89,1.82,4,2,2,iTRAQ 4plex (K  N-term),64729,Isoform 3 of E3 ubiquitin-protein ligase Praja-1 OS=Homo sapiens OX=9606 GN=PJA1
2512,20107,sp|Q08AG7|MZT1_HUMAN,3.60,52.15,1.232E6,1.249E6,7.898E5,7.553E5,1.00,1.01,0.64,0.61,1.232E6,1.249E6,7.898E5,7.553E5,1.00,1.01,0.64,0.61,22,2,2,iTRAQ 4plex (K  N-term),8479,Mitotic-spindle organizing protein 1 OS=Homo sapiens OX=9606 GN=MZT1 PE=1 SV=2
3099,42278,sp|Q9BVS4-2|RIOK2_HUMAN,1.30,51.98,8.597E4,9.311E4,1.345E5,1.256E5,1.00,1.08,1.56,1.46,8.597E4,9.311E4,1.345E5,1.256E5,1.00,1.08,1.56,1.46,4,1,1,iTRAQ 4plex (K  N-term),54508,Isoform 2 of Serine/threonine-protein kinase RIO2 OS=Homo sapiens OX=9606 GN=RIOK2
2422,40499,sp|Q5SQI0-2|ATAT_HUMAN,1.83,51.95,1.832E5,1.896E5,2.447E5,2.237E5,1.00,1.04,1.34,1.22,1.832E5,1.896E5,2.447E5,2.237E5,1.00,1.04,1.34,1.22,6,2,2,iTRAQ 4plex (K  N-term),45574,Isoform 2 of Alpha-tubulin N-acetyltransferase 1 OS=Homo sapiens OX=9606 GN=ATAT1
2441,40650,sp|Q9BZE4-3|NOG1_HUMAN,4.80,51.88,2.665E5,2.327E5,3.789E5,4.173E5,1.00,0.87,1.42,1.57,2.665E5,2.327E5,3.789E5,4.173E5,1.00,0.87,1.42,1.57,4,2,2,iTRAQ 4plex (K  N-term),60051,Isoform 3 of Nucleolar GTP-binding protein 1 OS=Homo sapiens OX=9606 GN=GTPBP4
2237,41001,F5H3U9|F5H3U9_HUMAN,3.95,51.87,6.038E5,7.023E5,1.008E6,9.328E5,1.00,1.16,1.67,1.54,6.038E5,7.023E5,1.008E6,9.328E5,1.00,1.16,1.67,1.54,64,2,2,iTRAQ 4plex (K  N-term),5238,Protein mago nashi homolog 2 OS=Homo sapiens OX=9606 GN=MAGOHB PE=4 SV=1
2343,22283,sp|Q9NX58|LYAR_HUMAN,3.21,51.87,2.61E5,2.552E5,3.668E5,3.949E5,1.00,0.98,1.41,1.51,2.61E5,2.552E5,3.668E5,3.949E5,1.00,0.98,1.41,1.51,5,2,2,iTRAQ 4plex (K  N-term),43615,Cell growth-regulating nucleolar protein OS=Homo sapiens OX=9606 GN=LYAR PE=1 SV=2
2048,1137,sp|Q14980-2|NUMA1_HUMAN,5.04,51.86,1.151E5,1.222E5,2.217E5,1.979E5,1.00,1.06,1.93,1.72,1.151E5,1.222E5,2.217E5,1.979E5,1.00,1.06,1.93,1.72,1,3,2,iTRAQ 4plex (K  N-term),236513,Isoform 2 of Nuclear mitotic apparatus protein 1 OS=Homo sapiens OX=9606 GN=NUMA1
2130,20007,sp|Q99622|C10_HUMAN,4.38,51.86,6.185E4,5.331E4,9.931E4,8.763E4,1.00,0.86,1.61,1.42,6.185E4,5.331E4,9.931E4,8.763E4,1.00,0.86,1.61,1.42,26,3,2,iTRAQ 4plex (K  N-term),13178,Protein C10 OS=Homo sapiens OX=9606 GN=C12orf57 PE=1 SV=1
2344,40301,sp|Q96CT2|KLH29_HUMAN,3.99,51.83,1.257E5,1.375E5,2.112E5,2.049E5,1.00,1.09,1.68,1.63,1.257E5,1.375E5,2.112E5,2.049E5,1.00,1.09,1.68,1.63,3,2,2,iTRAQ 4plex (K  N-term),94228,Kelch-like protein 29 OS=Homo sapiens OX=9606 GN=KLHL29 PE=2 SV=3
2833,41232,C9JB63|C9JB63_HUMAN,2.14,51.72,1.391E5,1.565E5,2.761E5,2.572E5,1.00,1.13,1.99,1.85,1.391E5,1.565E5,2.761E5,2.572E5,1.00,1.13,1.99,1.85,8,1,1,iTRAQ 4plex (K  N-term),23988,Enoyl-CoA delta isomerase 2  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=ECI2 PE=1 SV=1
2520,41291,sp|Q86VS8|HOOK3_HUMAN,6.65,51.61,3.163E5,3.236E5,6.269E5,6.55E5,1.00,1.02,1.98,2.07,3.163E5,3.236E5,6.269E5,6.55E5,1.00,1.02,1.98,2.07,4,2,2,iTRAQ 4plex (K  N-term),83126,Protein Hook homolog 3 OS=Homo sapiens OX=9606 GN=HOOK3 PE=1 SV=2
2084,40140,sp|Q8WVT3|TPC12_HUMAN,9.49,51.53,5E5,4.819E5,9.065E5,8.636E5,1.00,0.96,1.81,1.73,5E5,4.819E5,9.065E5,8.636E5,1.00,0.96,1.81,1.73,5,3,3,iTRAQ 4plex (K  N-term),79375,Trafficking protein particle complex subunit 12 OS=Homo sapiens OX=9606 GN=TRAPPC12 PE=1 SV=3
2447,40988,sp|Q9UL33-2|TPC2L_HUMAN,4.40,51.41,4.425E5,4.59E5,7.744E5,7.689E5,1.00,1.04,1.75,1.74,4.425E5,4.59E5,7.744E5,7.689E5,1.00,1.04,1.75,1.74,16,2,2,iTRAQ 4plex (K  N-term),16059,Isoform 2 of Trafficking protein particle complex subunit 2-like protein OS=Homo sapiens OX=9606 GN=TRAPPC2L
2367,13267,sp|Q13618-2|CUL3_HUMAN,3.03,51.35,7.907E5,7.85E5,5.178E5,5.118E5,1.00,0.99,0.65,0.65,7.907E5,7.85E5,5.178E5,5.118E5,1.00,0.99,0.65,0.65,3,2,2,iTRAQ 4plex (K  N-term),86234,Isoform 2 of Cullin-3 OS=Homo sapiens OX=9606 GN=CUL3
2129,40137,M0QXL5|M0QXL5_HUMAN,6.74,51.35,1.123E6,1.124E6,1.672E6,1.769E6,1.00,1.00,1.49,1.57,1.123E6,1.124E6,1.672E6,1.769E6,1.00,1.00,1.49,1.57,16,3,3,iTRAQ 4plex (K  N-term); Deamidation (NQ),26639,rRNA 2'-O-methyltransferase fibrillarin (Fragment) OS=Homo sapiens OX=9606 GN=FBL PE=1 SV=1
2411,40423,A0A0A0MQV8|A0A0A0MQV8_HUMAN,5.48,51.34,3.515E5,3.201E5,6.266E5,6.198E5,1.00,0.91,1.78,1.76,3.515E5,3.201E5,6.266E5,6.198E5,1.00,0.91,1.78,1.76,3,2,2,iTRAQ 4plex (K  N-term),69443,GTPase-activating protein and VPS9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GAPVD1 PE=1 SV=1
2741,41308,sp|Q9NQC3-4|RTN4_HUMAN,0.53,51.32,1.217E5,1.194E5,1.39E5,1.452E5,1.00,0.98,1.14,1.19,1.217E5,1.194E5,1.39E5,1.452E5,1.00,0.98,1.14,1.19,2,1,1,iTRAQ 4plex (K  N-term),106360,Isoform 4 of Reticulon-4 OS=Homo sapiens OX=9606 GN=RTN4
2145,41054,sp|P48426-2|PI42A_HUMAN,5.73,51.30,2.034E5,2.039E5,4.109E5,3.938E5,1.00,1.00,2.02,1.94,2.034E5,2.039E5,4.109E5,3.938E5,1.00,1.00,2.02,1.94,6,2,2,iTRAQ 4plex (K  N-term),39802,Isoform 2 of Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Homo sapiens OX=9606 GN=PIP4K2A
2371,40355,sp|Q96PN7-4|TREF1_HUMAN,1.77,51.19,2.763E5,3.069E5,3.603E5,3.539E5,1.00,1.11,1.30,1.28,2.763E5,3.069E5,3.603E5,3.539E5,1.00,1.11,1.30,1.28,2,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),123601,Isoform 4 of Transcriptional-regulating factor 1 OS=Homo sapiens OX=9606 GN=TRERF1
1956,40254,sp|Q9BS26|ERP44_HUMAN,2.22,51.15,8.538E5,8.501E5,1.171E6,1.13E6,1.00,1.00,1.37,1.32,8.538E5,8.501E5,1.171E6,1.13E6,1.00,1.00,1.37,1.32,4,2,2,iTRAQ 4plex (K  N-term),46971,Endoplasmic reticulum resident protein 44 OS=Homo sapiens OX=9606 GN=ERP44 PE=1 SV=1
2493,41033,sp|Q8WXA9-2|SREK1_HUMAN,6.05,50.98,1.917E5,1.972E5,3.996E5,3.778E5,1.00,1.03,2.08,1.97,1.917E5,1.972E5,3.996E5,3.778E5,1.00,1.03,2.08,1.97,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),71650,Isoform 2 of Splicing regulatory glutamine/lysine-rich protein 1 OS=Homo sapiens OX=9606 GN=SREK1
1468,41303,sp|P01709|LV208_HUMAN,28.35,50.97,6.373E7,6.339E7,5.012E6,3.561E6,1.00,0.99,0.08,0.06,6.373E7,6.339E7,5.012E6,3.561E6,1.00,0.99,0.08,0.06,12,3,3,iTRAQ 4plex (K  N-term),12382,Immunoglobulin lambda variable 2-8 OS=Homo sapiens OX=9606 GN=IGLV2-8 PE=1 SV=2
2389,40649,sp|Q96DV4|RM38_HUMAN,4.15,50.92,5.594E5,5.502E5,8.852E5,9.156E5,1.00,0.98,1.58,1.64,5.594E5,5.502E5,8.852E5,9.156E5,1.00,0.98,1.58,1.64,5,2,2,iTRAQ 4plex (K  N-term),44597,39S ribosomal protein L38  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL38 PE=1 SV=2
2383,7442,sp|Q9UBR2|CATZ_HUMAN,2.18,50.88,5.23E5,4.892E5,6.645E5,6.405E5,1.00,0.94,1.27,1.22,5.23E5,4.892E5,6.645E5,6.405E5,1.00,0.94,1.27,1.22,6,2,2,iTRAQ 4plex (K  N-term),33868,Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1
2132,6873,sp|P33993|MCM7_HUMAN,9.07,50.87,6.273E5,6.115E5,1.031E6,1.053E6,1.00,0.97,1.64,1.68,6.273E5,6.115E5,1.031E6,1.053E6,1.00,0.97,1.64,1.68,3,3,3,iTRAQ 4plex (K  N-term),81308,DNA replication licensing factor MCM7 OS=Homo sapiens OX=9606 GN=MCM7 PE=1 SV=4
2031,23154,J3KSL8|J3KSL8_HUMAN,1.79,50.87,1.018E5,9.677E4,1.708E5,1.755E5,1.00,0.95,1.68,1.72,1.018E5,9.677E4,1.708E5,1.755E5,1.00,0.95,1.68,1.72,1,2,1,iTRAQ 4plex (K  N-term),104244,Trafficking protein particle complex subunit 8 OS=Homo sapiens OX=9606 GN=TRAPPC8 PE=1 SV=1
3046,41978,sp|O00221|IKBE_HUMAN,2.26,50.74,6.741E4,7.731E4,1.387E5,1.326E5,1.00,1.15,2.06,1.97,6.741E4,7.731E4,1.387E5,1.326E5,1.00,1.15,2.06,1.97,4,1,1,iTRAQ 4plex (K  N-term),52864,NF-kappa-B inhibitor epsilon OS=Homo sapiens OX=9606 GN=NFKBIE PE=1 SV=3
2449,15498,sp|Q86YV9|HPS6_HUMAN,4.75,50.72,3.152E5,3.24E5,5.737E5,5.649E5,1.00,1.03,1.82,1.79,3.152E5,3.24E5,5.737E5,5.649E5,1.00,1.03,1.82,1.79,2,2,2,iTRAQ 4plex (K  N-term),82975,Hermansky-Pudlak syndrome 6 protein OS=Homo sapiens OX=9606 GN=HPS6 PE=1 SV=1
2412,40430,sp|Q4KMP7|TB10B_HUMAN,5.53,50.64,2.479E5,2.411E5,4.363E5,4.67E5,1.00,0.97,1.76,1.88,2.479E5,2.411E5,4.363E5,4.67E5,1.00,0.97,1.76,1.88,2,2,2,iTRAQ 4plex (K  N-term),87199,TBC1 domain family member 10B OS=Homo sapiens OX=9606 GN=TBC1D10B PE=1 SV=3
1313,13601,sp|O14640-2|DVL1_HUMAN,9.37,50.56,1.307E6,1.936E6,4.219E7,3.053E7,1.00,1.48,32.27,23.35,1.307E6,1.936E6,4.219E7,3.053E7,1.00,1.48,32.27,23.35,1,2,1,iTRAQ 4plex (K  N-term),72881,Isoform 2 of Segment polarity protein dishevelled homolog DVL-1 OS=Homo sapiens OX=9606 GN=DVL1
1941,41217,sp|A0A075B6I1|LV460_HUMAN,29.57,50.50,6.176E5,7.06E5,4.833E6,4.81E6,1.00,1.14,7.83,7.79,6.176E5,7.06E5,4.833E6,4.81E6,1.00,1.14,7.83,7.79,14,2,2,iTRAQ 4plex (K  N-term),12987,Immunoglobulin lambda variable 4-60 OS=Homo sapiens OX=9606 GN=IGLV4-60 PE=3 SV=1
2392,25275,sp|Q92620|PRP16_HUMAN,17.43,50.48,6.797E5,7.114E5,2.718E6,2.473E6,1.00,1.05,4.00,3.64,6.797E5,7.114E5,2.718E6,2.473E6,1.00,1.05,4.00,3.64,2,2,2,iTRAQ 4plex (K  N-term),140502,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens OX=9606 GN=DHX38 PE=1 SV=2
3100,42296,sp|Q5VY43|PEAR1_HUMAN,0.98,50.39,8.652E4,9.259E4,1.223E5,1.184E5,1.00,1.07,1.41,1.37,8.652E4,9.259E4,1.223E5,1.184E5,1.00,1.07,1.41,1.37,1,1,1,iTRAQ 4plex (K  N-term),110666,Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1
2435,22080,sp|Q9Y2R5|RT17_HUMAN,4.80,50.33,3.655E5,3.668E5,6.716E5,6.205E5,1.00,1.00,1.84,1.70,3.655E5,3.668E5,6.716E5,6.205E5,1.00,1.00,1.84,1.70,15,2,2,iTRAQ 4plex (K  N-term),14502,28S ribosomal protein S17  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS17 PE=1 SV=1
2510,41204,sp|Q13637|RAB32_HUMAN,4.39,50.32,3.722E5,3.812E5,6.442E5,6.35E5,1.00,1.02,1.73,1.71,3.722E5,3.812E5,6.442E5,6.35E5,1.00,1.02,1.73,1.71,8,2,2,iTRAQ 4plex (K  N-term),24997,Ras-related protein Rab-32 OS=Homo sapiens OX=9606 GN=RAB32 PE=1 SV=3
1955,21369,sp|Q92989|CLP1_HUMAN,11.98,50.29,1.513E6,1.416E6,2.742E6,2.705E6,1.00,0.94,1.81,1.79,1.513E6,1.416E6,2.742E6,2.705E6,1.00,0.94,1.81,1.79,5,3,3,iTRAQ 4plex (K  N-term),47646,Polyribonucleotide 5'-hydroxyl-kinase Clp1 OS=Homo sapiens OX=9606 GN=CLP1 PE=1 SV=1
3018,41677,sp|P81877-2|SSBP2_HUMAN,1.28,50.26,7.371E4,6.123E4,9.519E4,8.791E4,1.00,0.83,1.29,1.19,7.371E4,6.123E4,9.519E4,8.791E4,1.00,0.83,1.29,1.19,4,1,1,iTRAQ 4plex (K  N-term),31479,Isoform 2 of Single-stranded DNA-binding protein 2 OS=Homo sapiens OX=9606 GN=SSBP2
2247,41173,sp|Q9Y5S1|TRPV2_HUMAN,2.23,50.25,2.09E5,2.135E5,2.51E5,2.543E5,1.00,1.02,1.20,1.22,2.09E5,2.135E5,2.51E5,2.543E5,1.00,1.02,1.20,1.22,6,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),85981,Transient receptor potential cation channel subfamily V member 2 OS=Homo sapiens OX=9606 GN=TRPV2 PE=1 SV=1
3101,42298,sp|Q06587-2|RING1_HUMAN,2.05,50.18,6.438E5,6.506E5,1.237E6,1.231E6,1.00,1.01,1.92,1.91,6.438E5,6.506E5,1.237E6,1.231E6,1.00,1.01,1.92,1.91,4,1,1,iTRAQ 4plex (K  N-term),39146,Isoform 2 of E3 ubiquitin-protein ligase RING1 OS=Homo sapiens OX=9606 GN=RING1
2241,41041,sp|Q7L804|RFIP2_HUMAN,3.55,50.09,3.931E5,3.861E5,6.072E5,6.234E5,1.00,0.98,1.54,1.59,3.931E5,3.861E5,6.072E5,6.234E5,1.00,0.98,1.54,1.59,4,2,2,iTRAQ 4plex (K  N-term),58279,Rab11 family-interacting protein 2 OS=Homo sapiens OX=9606 GN=RAB11FIP2 PE=1 SV=1
2375,40449,sp|Q9NW64-2|RBM22_HUMAN,3.60,50.08,1.615E6,1.619E6,2.409E6,2.521E6,1.00,1.00,1.49,1.56,1.615E6,1.619E6,2.409E6,2.521E6,1.00,1.00,1.49,1.56,6,2,2,iTRAQ 4plex (K  N-term),41152,Isoform 2 of Pre-mRNA-splicing factor RBM22 OS=Homo sapiens OX=9606 GN=RBM22
2240,41022,H7C2H4|H7C2H4_HUMAN,3.64,50.06,1.312E5,1.305E5,2.171E5,2.04E5,1.00,0.99,1.66,1.56,1.312E5,1.305E5,2.171E5,2.04E5,1.00,0.99,1.66,1.56,8,2,2,iTRAQ 4plex (K  N-term),24763,Cystathionine beta-synthase (Fragment) OS=Homo sapiens OX=9606 GN=CBS PE=1 SV=1
2835,23111,sp|O60763|USO1_HUMAN,1.19,49.88,3.825E4,3.35E4,4.333E4,5.083E4,1.00,0.88,1.13,1.33,3.825E4,3.35E4,4.333E4,5.083E4,1.00,0.88,1.13,1.33,2,1,1,iTRAQ 4plex (K  N-term),107895,General vesicular transport factor p115 OS=Homo sapiens OX=9606 GN=USO1 PE=1 SV=2
1580,20839,sp|P35030-5|TRY3_HUMAN,0.60,49.85,9.873E4,1.129E5,1.236E5,1.139E5,1.00,1.14,1.25,1.15,9.873E4,1.129E5,1.236E5,1.139E5,1.00,1.14,1.25,1.15,3,3,1,iTRAQ 4plex (K  N-term),25924,Isoform 5 of Trypsin-3 OS=Homo sapiens OX=9606 GN=PRSS3
2388,22863,sp|P49915|GUAA_HUMAN,5.09,49.84,9.215E5,5.638E5,9.833E5,1.027E6,1.00,0.61,1.07,1.11,9.215E5,5.638E5,9.833E5,1.027E6,1.00,0.61,1.07,1.11,3,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),76716,GMP synthase [glutamine-hydrolyzing] OS=Homo sapiens OX=9606 GN=GMPS PE=1 SV=1
2418,40473,E9PM19|E9PM19_HUMAN,1.95,49.71,3.229E5,3.296E5,6.097E5,5.927E5,1.00,1.02,1.89,1.84,3.229E5,3.296E5,6.097E5,5.927E5,1.00,1.02,1.89,1.84,1,2,1,iTRAQ 4plex (K  N-term),112963,Tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=TYK2 PE=1 SV=1
2331,40223,sp|P04004|VTNC_HUMAN,8.59,49.61,3.038E5,3.013E5,7.898E5,7.758E5,1.00,0.99,2.60,2.55,3.038E5,3.013E5,7.898E5,7.758E5,1.00,0.99,2.60,2.55,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),54306,Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1
2376,40456,sp|Q92599-3|SEPT8_HUMAN,1.14,49.55,1.39E5,1.28E5,1.915E5,1.88E5,1.00,0.92,1.38,1.35,1.39E5,1.28E5,1.915E5,1.88E5,1.00,0.92,1.38,1.35,3,2,1,iTRAQ 4plex (K  N-term),43519,Isoform 3 of Septin-8 OS=Homo sapiens OX=9606 GN=SEPT8
2324,40324,sp|Q7Z6E9-2|RBBP6_HUMAN,4.35,49.49,2.674E5,2.616E5,3.959E5,4.532E5,1.00,0.98,1.48,1.69,2.674E5,2.616E5,3.959E5,4.532E5,1.00,0.98,1.48,1.69,1,2,2,iTRAQ 4plex (K  N-term),197286,Isoform 2 of E3 ubiquitin-protein ligase RBBP6 OS=Homo sapiens OX=9606 GN=RBBP6
3031,5169,sp|Q7Z5L9-2|I2BP2_HUMAN,1.83,49.41,1.041E5,1.289E5,1.902E5,1.882E5,1.00,1.24,1.83,1.81,1.041E5,1.289E5,1.902E5,1.882E5,1.00,1.24,1.83,1.81,4,1,1,iTRAQ 4plex (K  N-term),59481,Isoform 2 of Interferon regulatory factor 2-binding protein 2 OS=Homo sapiens OX=9606 GN=IRF2BP2
2176,40468,Q5RGS4|Q5RGS4_HUMAN,12.01,49.24,6.366E5,7.404E5,1.168E6,1.164E6,1.00,1.16,1.83,1.83,6.366E5,7.404E5,1.168E6,1.164E6,1.00,1.16,1.83,1.83,6,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),43672,Pleckstrin homology domain-containing family A member 1 OS=Homo sapiens OX=9606 GN=PLEKHA1 PE=1 SV=1
2416,40447,sp|A1A4S6|RHG10_HUMAN,4.29,49.22,6.414E5,5.972E5,9.741E5,1.028E6,1.00,0.93,1.52,1.60,6.414E5,5.972E5,9.741E5,1.028E6,1.00,0.93,1.52,1.60,2,2,2,iTRAQ 4plex (K  N-term),89375,Rho GTPase-activating protein 10 OS=Homo sapiens OX=9606 GN=ARHGAP10 PE=1 SV=1
2513,41215,sp|P82914|RT15_HUMAN,2.23,49.22,6.62E5,8.003E5,1.271E6,1.344E6,1.00,1.21,1.92,2.03,6.62E5,8.003E5,1.271E6,1.344E6,1.00,1.21,1.92,2.03,5,2,1,iTRAQ 4plex (K  N-term),29842,28S ribosomal protein S15  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS15 PE=1 SV=1
2533,42358,sp|P82921|RT21_HUMAN,7.88,49.21,2.6E5,2.765E5,5.675E5,5.286E5,1.00,1.06,2.18,2.03,2.6E5,2.765E5,5.675E5,5.286E5,1.00,1.06,2.18,2.03,16,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),10689,28S ribosomal protein S21  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS21 PE=1 SV=3
3102,19972,sp|P07919|QCR6_HUMAN,2.71,49.17,1.062E5,1.167E5,2.419E5,2.447E5,1.00,1.10,2.28,2.30,1.062E5,1.167E5,2.419E5,2.447E5,1.00,1.10,2.28,2.30,23,1,1,iTRAQ 4plex (K  N-term),10739,Cytochrome b-c1 complex subunit 6  mitochondrial OS=Homo sapiens OX=9606 GN=UQCRH PE=1 SV=2
3022,41776,sp|Q9UBV2-2|SE1L1_HUMAN,1.24,49.12,1.718E5,1.868E5,2.308E5,2.631E5,1.00,1.09,1.34,1.53,1.718E5,1.868E5,2.308E5,2.631E5,1.00,1.09,1.34,1.53,7,1,1,iTRAQ 4plex (K  N-term),33530,Isoform 2 of Protein sel-1 homolog 1 OS=Homo sapiens OX=9606 GN=SEL1L
3103,42338,sp|Q14201|BTG3_HUMAN,0.69,49.12,6.642E5,6.638E5,8.5E5,8.431E5,1.00,1.00,1.28,1.27,6.642E5,6.638E5,8.5E5,8.431E5,1.00,1.00,1.28,1.27,8,1,1,iTRAQ 4plex (K  N-term),29116,Protein BTG3 OS=Homo sapiens OX=9606 GN=BTG3 PE=1 SV=3
2426,40539,sp|Q9BZE9-4|ASPC1_HUMAN,3.45,49.10,1.283E6,1.086E6,1.712E6,1.71E6,1.00,0.85,1.33,1.33,1.283E6,1.086E6,1.712E6,1.71E6,1.00,0.85,1.33,1.33,6,2,2,iTRAQ 4plex (K  N-term),37910,Isoform 4 of Tether containing UBX domain for GLUT4 OS=Homo sapiens OX=9606 GN=ASPSCR1
2530,42341,sp|Q99584|S10AD_HUMAN,1.23,48.98,2.194E5,2.167E5,3.019E5,3.306E5,1.00,0.99,1.38,1.51,2.194E5,2.167E5,3.019E5,3.306E5,1.00,0.99,1.38,1.51,11,1,1,iTRAQ 4plex (K  N-term),11471,Protein S100-A13 OS=Homo sapiens OX=9606 GN=S100A13 PE=1 SV=1
2497,20164,sp|P63167|DYL1_HUMAN,1.49,48.88,4.239E5,4.309E5,5.569E5,7.026E5,1.00,1.02,1.31,1.66,4.239E5,4.309E5,5.569E5,7.026E5,1.00,1.02,1.31,1.66,9,2,1,iTRAQ 4plex (K  N-term),10366,Dynein light chain 1  cytoplasmic OS=Homo sapiens OX=9606 GN=DYNLL1 PE=1 SV=1
2243,41074,sp|Q8ND24|RN214_HUMAN,2.63,48.84,2.345E5,1.952E5,2.875E5,2.466E5,1.00,0.83,1.23,1.05,2.345E5,1.952E5,2.875E5,2.466E5,1.00,0.83,1.23,1.05,4,2,2,iTRAQ 4plex (K  N-term),77667,RING finger protein 214 OS=Homo sapiens OX=9606 GN=RNF214 PE=1 SV=2
3028,41855,sp|Q9HA38|ZMAT3_HUMAN,1.53,48.77,6.893E4,5.918E4,9.921E4,9.749E4,1.00,0.86,1.44,1.41,6.893E4,5.918E4,9.921E4,9.749E4,1.00,0.86,1.44,1.41,6,1,1,iTRAQ 4plex (K  N-term),32059,Zinc finger matrin-type protein 3 OS=Homo sapiens OX=9606 GN=ZMAT3 PE=1 SV=1
2531,42349,sp|Q9BRP1|PDD2L_HUMAN,2.23,48.73,4.229E5,4.177E5,8.46E5,7.84E5,1.00,0.99,2.00,1.85,4.229E5,4.177E5,8.46E5,7.84E5,1.00,0.99,2.00,1.85,4,1,1,iTRAQ 4plex (K  N-term),39417,Programmed cell death protein 2-like OS=Homo sapiens OX=9606 GN=PDCD2L PE=1 SV=1
2953,21158,sp|Q14145|KEAP1_HUMAN,1.05,48.69,2.9E5,2.827E5,4.083E5,4.039E5,1.00,0.97,1.41,1.39,2.9E5,2.827E5,4.083E5,4.039E5,1.00,0.97,1.41,1.39,2,1,1,iTRAQ 4plex (K  N-term),69666,Kelch-like ECH-associated protein 1 OS=Homo sapiens OX=9606 GN=KEAP1 PE=1 SV=2
2532,42351,U3KPR7|U3KPR7_HUMAN,0.51,48.69,5.334E5,4.93E5,5.66E5,5.943E5,1.00,0.92,1.06,1.11,5.334E5,4.93E5,5.66E5,5.943E5,1.00,0.92,1.06,1.11,13,1,1,iTRAQ 4plex (K  N-term),11399,Calpain small subunit 1 (Fragment) OS=Homo sapiens OX=9606 GN=CAPNS1 PE=1 SV=1
2498,41062,K7ERP1|K7ERP1_HUMAN,4.59,48.66,3.863E5,4.079E5,6.945E5,6.743E5,1.00,1.06,1.80,1.75,3.863E5,4.079E5,6.945E5,6.743E5,1.00,1.06,1.80,1.75,9,2,2,iTRAQ 4plex (K  N-term),25355,Protein rogdi homolog OS=Homo sapiens OX=9606 GN=ROGDI PE=1 SV=1
2341,40216,sp|O75330-2|HMMR_HUMAN,3.66,48.65,3.824E5,3.862E5,6.276E5,6.23E5,1.00,1.01,1.64,1.63,3.824E5,3.862E5,6.276E5,6.23E5,1.00,1.01,1.64,1.63,3,2,2,iTRAQ 4plex (K  N-term),82302,Isoform 2 of Hyaluronan mediated motility receptor OS=Homo sapiens OX=9606 GN=HMMR
2536,42376,C9JYM0|C9JYM0_HUMAN,1.19,48.60,2.877E5,2.857E5,4.305E5,4.275E5,1.00,0.99,1.50,1.49,2.877E5,2.857E5,4.305E5,4.275E5,1.00,0.99,1.50,1.49,11,1,1,iTRAQ 4plex (K  N-term),15324,Ribonuclease P protein subunit p20 (Fragment) OS=Homo sapiens OX=9606 GN=POP7 PE=1 SV=1
2534,22099,C9JL85|C9JL85_HUMAN,2.30,48.50,6.981E5,6.867E5,9.083E5,9.235E5,1.00,0.98,1.30,1.32,6.981E5,6.867E5,9.083E5,9.235E5,1.00,0.98,1.30,1.32,33,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),5704,Myotrophin OS=Homo sapiens OX=9606 GN=MTPN PE=1 SV=1
3029,14357,C9JCN8|C9JCN8_HUMAN,1.99,48.41,1.506E5,1.452E5,2.704E5,2.766E5,1.00,0.96,1.80,1.84,1.506E5,1.452E5,2.704E5,2.766E5,1.00,0.96,1.80,1.84,6,1,1,iTRAQ 4plex (K  N-term),22254,Fos-related antigen 2 (Fragment) OS=Homo sapiens OX=9606 GN=FOSL2 PE=1 SV=1
2499,21760,E5RFX8|E5RFX8_HUMAN,5.66,48.40,6.212E5,6.715E5,1.255E6,1.005E6,1.00,1.08,2.02,1.62,6.212E5,6.715E5,1.255E6,1.005E6,1.00,1.08,2.02,1.62,13,2,2,iTRAQ 4plex (K  N-term),19131,Cyclin-C (Fragment) OS=Homo sapiens OX=9606 GN=CCNC PE=1 SV=1
3105,42382,E5RIM3|E5RIM3_HUMAN,1.12,48.36,1.11E5,1.069E5,1.563E5,1.582E5,1.00,0.96,1.41,1.42,1.11E5,1.069E5,1.563E5,1.582E5,1.00,0.96,1.41,1.42,2,1,1,iTRAQ 4plex (K  N-term),66734,Phospholipase A-2-activating protein OS=Homo sapiens OX=9606 GN=PLAA PE=1 SV=1
2864,1830,sp|Q7Z5J4-3|RAI1_HUMAN,2.68,48.34,1.417E4,1.363E4,3.149E4,1.994E4,1.00,0.96,2.22,1.41,1.417E4,1.363E4,3.149E4,1.994E4,1.00,0.96,2.22,1.41,1,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),175342,Isoform 3 of Retinoic acid-induced protein 1 OS=Homo sapiens OX=9606 GN=RAI1
2952,22859,sp|Q6ZNA4-2|RN111_HUMAN,3.42,48.29,4.097E4,3.37E4,9.107E4,9.294E4,1.00,0.82,2.22,2.27,4.097E4,3.37E4,9.107E4,9.294E4,1.00,0.82,2.22,2.27,3,1,1,iTRAQ 4plex (K  N-term),107896,Isoform 2 of E3 ubiquitin-protein ligase Arkadia OS=Homo sapiens OX=9606 GN=RNF111
2318,22625,sp|Q9P2K5-2|MYEF2_HUMAN,4.08,48.18,8.152E5,7.222E5,1.229E6,1.159E6,1.00,0.89,1.51,1.42,8.152E5,7.222E5,1.229E6,1.159E6,1.00,0.89,1.51,1.42,5,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),61929,Isoform 2 of Myelin expression factor 2 OS=Homo sapiens OX=9606 GN=MYEF2
3052,42024,sp|P61923-4|COPZ1_HUMAN,0.79,48.16,1.452E5,1.449E5,1.925E5,1.903E5,1.00,1.00,1.33,1.31,1.452E5,1.449E5,1.925E5,1.903E5,1.00,1.00,1.33,1.31,10,1,1,iTRAQ 4plex (K  N-term),21069,Isoform 4 of Coatomer subunit zeta-1 OS=Homo sapiens OX=9606 GN=COPZ1
2537,42385,sp|Q13670|PM2PB_HUMAN,1.95,48.15,1.538E5,1.613E5,2.897E5,2.738E5,1.00,1.05,1.88,1.78,1.538E5,1.613E5,2.897E5,2.738E5,1.00,1.05,1.88,1.78,5,1,1,iTRAQ 4plex (K  N-term),28555,Putative postmeiotic segregation increased 2-like protein 11 OS=Homo sapiens OX=9606 GN=PMS2P11 PE=5 SV=1
3026,12738,B4DJ81|B4DJ81_HUMAN,1.66,48.11,3.731E4,3.836E4,6.506E4,5.784E4,1.00,1.03,1.74,1.55,3.731E4,3.836E4,6.506E4,5.784E4,1.00,1.03,1.74,1.55,3,1,1,iTRAQ 4plex (K  N-term),66922,NADH-ubiquinone oxidoreductase 75 kDa subunit  mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS1 PE=1 SV=1
2535,42368,sp|P12004|PCNA_HUMAN,0.56,48.10,2.798E5,2.571E5,3.156E5,2.948E5,1.00,0.92,1.13,1.05,2.798E5,2.571E5,3.156E5,2.948E5,1.00,0.92,1.13,1.05,7,1,1,iTRAQ 4plex (K  N-term),28769,Proliferating cell nuclear antigen OS=Homo sapiens OX=9606 GN=PCNA PE=1 SV=1
2355,22138,sp|O60678-2|ANM3_HUMAN,3.04,48.01,2.552E5,2.562E5,6.359E5,6.08E5,1.00,1.00,2.49,2.38,2.552E5,2.562E5,6.359E5,6.08E5,1.00,1.00,2.49,2.38,2,1,1,iTRAQ 4plex (K  N-term),52902,Isoform 2 of Protein arginine N-methyltransferase 3 OS=Homo sapiens OX=9606 GN=PRMT3
2175,40415,sp|P24593|IBP5_HUMAN,4.32,47.86,1.397E6,1.477E6,2.36E6,2.405E6,1.00,1.06,1.69,1.72,1.397E6,1.477E6,2.36E6,2.405E6,1.00,1.06,1.69,1.72,7,2,2,iTRAQ 4plex (K  N-term),30570,Insulin-like growth factor-binding protein 5 OS=Homo sapiens OX=9606 GN=IGFBP5 PE=1 SV=1
3104,42373,H7C170|H7C170_HUMAN,1.58,47.81,2.19E5,1.979E5,3.337E5,3.362E5,1.00,0.90,1.52,1.54,2.19E5,1.979E5,3.337E5,3.362E5,1.00,0.90,1.52,1.54,17,1,1,iTRAQ 4plex (K  N-term),13648,Probable 18S rRNA (guanine-N(7))-methyltransferase (Fragment) OS=Homo sapiens OX=9606 GN=BUD23 PE=1 SV=1
3015,41641,H7BZ72|H7BZ72_HUMAN,1.04,47.80,4E4,3.609E4,4.644E4,5.221E4,1.00,0.90,1.16,1.31,4E4,3.609E4,4.644E4,5.221E4,1.00,0.90,1.16,1.31,7,1,1,iTRAQ 4plex (K  N-term),21219,Nucleolar protein 58 (Fragment) OS=Homo sapiens OX=9606 GN=NOP58 PE=1 SV=1
2511,24130,J3QL24|J3QL24_HUMAN,2.48,47.70,8.254E4,7.47E4,1.623E5,1.646E5,1.00,0.91,1.97,1.99,8.254E4,7.47E4,1.623E5,1.646E5,1.00,0.91,1.97,1.99,5,2,1,iTRAQ 4plex (K  N-term),23566,Pyrroline-5-carboxylate reductase 1  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=PYCR1 PE=1 SV=1
2327,40605,sp|P12931|SRC_HUMAN,1.09,47.58,4.587E5,4.173E5,5.749E5,6.135E5,1.00,0.91,1.25,1.34,4.587E5,4.173E5,5.749E5,6.135E5,1.00,0.91,1.25,1.34,3,2,1,Carbamidomethylation; iTRAQ 4plex (K  N-term); Deamidation (NQ),59835,Proto-oncogene tyrosine-protein kinase Src OS=Homo sapiens OX=9606 GN=SRC PE=1 SV=3
2372,40402,G3V2K8|G3V2K8_HUMAN,2.04,47.57,4.02E5,4.226E5,5.059E5,5.502E5,1.00,1.05,1.26,1.37,4.02E5,4.226E5,5.059E5,5.502E5,1.00,1.05,1.26,1.37,11,2,2,iTRAQ 4plex (K  N-term),29889,WD repeat-containing protein 25 OS=Homo sapiens OX=9606 GN=WDR25 PE=1 SV=1
2137,20184,sp|Q96FJ2|DYL2_HUMAN,1.17,47.54,3.934E6,4.305E6,5.592E6,5.883E6,1.00,1.09,1.42,1.50,3.934E6,4.305E6,5.592E6,5.883E6,1.00,1.09,1.42,1.50,8,2,1,iTRAQ 4plex (K  N-term),10350,Dynein light chain 2  cytoplasmic OS=Homo sapiens OX=9606 GN=DYNLL2 PE=1 SV=1
2322,14580,sp|O95671-2|ASML_HUMAN,0.36,47.53,4.322E5,4.46E5,4.396E5,4.187E5,1.00,1.03,1.02,0.97,4.322E5,4.46E5,4.396E5,4.187E5,1.00,1.03,1.02,0.97,3,2,2,iTRAQ 4plex (K  N-term),67193,Isoform 2 of N-acetylserotonin O-methyltransferase-like protein OS=Homo sapiens OX=9606 GN=ASMTL
2146,11154,sp|O60687|SRPX2_HUMAN,2.27,47.25,2.8E5,3.017E5,5.738E5,5.318E5,1.00,1.08,2.05,1.90,2.8E5,3.017E5,5.738E5,5.318E5,1.00,1.08,2.05,1.90,3,1,1,iTRAQ 4plex (K  N-term),52972,Sushi repeat-containing protein SRPX2 OS=Homo sapiens OX=9606 GN=SRPX2 PE=1 SV=1
2078,40255,G5EA36|G5EA36_HUMAN,7.14,47.22,8.918E5,8.612E5,1.287E6,1.326E6,1.00,0.97,1.44,1.49,8.918E5,8.612E5,1.287E6,1.326E6,1.00,0.97,1.44,1.49,2,2,2,iTRAQ 4plex (K  N-term); Phosphorylation (STY),91738,Cell division cycle 27  isoform CRA_c OS=Homo sapiens OX=9606 GN=CDC27 PE=1 SV=1
2442,3391,sp|Q6PJT7-4|ZC3HE_HUMAN,5.55,47.18,3.003E5,3.02E5,5.628E5,5.82E5,1.00,1.01,1.87,1.94,3.003E5,3.02E5,5.628E5,5.82E5,1.00,1.01,1.87,1.94,4,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),64502,Isoform 4 of Zinc finger CCCH domain-containing protein 14 OS=Homo sapiens OX=9606 GN=ZC3H14
2136,40310,sp|Q9P253|VPS18_HUMAN,2.37,47.17,3.031E5,2.954E5,3.918E5,4.171E5,1.00,0.97,1.29,1.38,3.031E5,2.954E5,3.918E5,4.171E5,1.00,0.97,1.29,1.38,2,2,2,iTRAQ 4plex (K  N-term),110186,Vacuolar protein sorting-associated protein 18 homolog OS=Homo sapiens OX=9606 GN=VPS18 PE=1 SV=2
2709,41357,sp|Q9P1Z2-2|CACO1_HUMAN,0.22,47.16,1.083E5,1.089E5,1E5,1.026E5,1.00,1.01,0.92,0.95,1.083E5,1.089E5,1E5,1.026E5,1.00,1.01,0.92,0.95,2,1,1,iTRAQ 4plex (K  N-term),70978,Isoform 2 of Calcium-binding and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CALCOCO1
1698,23579,sp|P62891|RL39_HUMAN,1.71,47.14,3.839E6,3.882E6,6.402E6,6.691E6,1.00,1.01,1.67,1.74,3.839E6,3.882E6,6.402E6,6.691E6,1.00,1.01,1.67,1.74,20,1,1,iTRAQ 4plex (K  N-term),6407,60S ribosomal protein L39 OS=Homo sapiens OX=9606 GN=RPL39 PE=1 SV=2
2503,41164,sp|Q8NB16|MLKL_HUMAN,3.02,47.09,2.978E5,3.079E5,4.557E5,4.53E5,1.00,1.03,1.53,1.52,2.978E5,3.079E5,4.557E5,4.53E5,1.00,1.03,1.53,1.52,8,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),54479,Mixed lineage kinase domain-like protein OS=Homo sapiens OX=9606 GN=MLKL PE=1 SV=1
2501,41140,sp|O95453-2|PARN_HUMAN,4.57,47.05,4.17E5,4.234E5,7.466E5,7.274E5,1.00,1.02,1.79,1.74,4.17E5,4.234E5,7.466E5,7.274E5,1.00,1.02,1.79,1.74,4,2,2,iTRAQ 4plex (K  N-term),66574,Isoform 2 of Poly(A)-specific ribonuclease PARN OS=Homo sapiens OX=9606 GN=PARN
2443,9163,sp|Q9Y4E6-2|WDR7_HUMAN,3.18,46.99,2.088E5,2.124E5,3.12E5,3.279E5,1.00,1.02,1.49,1.57,2.088E5,2.124E5,3.12E5,3.279E5,1.00,1.02,1.49,1.57,3,2,2,iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ); Phosphorylation (STY),160509,Isoform 2 of WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=WDR7
2362,40202,sp|P00387-2|NB5R3_HUMAN,4.64,46.93,3.594E5,3.579E5,6.16E5,6.544E5,1.00,1.00,1.71,1.82,3.594E5,3.579E5,6.16E5,6.544E5,1.00,1.00,1.71,1.82,8,2,2,iTRAQ 4plex (K  N-term),31629,Isoform 2 of NADH-cytochrome b5 reductase 3 OS=Homo sapiens OX=9606 GN=CYB5R3
2252,41294,sp|Q86X52|CHSS1_HUMAN,3.75,46.92,5.221E5,5.344E5,8.509E5,7.945E5,1.00,1.02,1.63,1.52,5.221E5,5.344E5,8.509E5,7.945E5,1.00,1.02,1.63,1.52,2,2,2,iTRAQ 4plex (K  N-term),91784,Chondroitin sulfate synthase 1 OS=Homo sapiens OX=9606 GN=CHSY1 PE=1 SV=3
2875,41818,H7C4H8|H7C4H8_HUMAN,1.01,46.76,4.365E4,4.231E4,6.065E4,5.846E4,1.00,0.97,1.39,1.34,4.365E4,4.231E4,6.065E4,5.846E4,1.00,0.97,1.39,1.34,10,1,1,iTRAQ 4plex (K  N-term),21350,Histone RNA hairpin-binding protein (Fragment) OS=Homo sapiens OX=9606 GN=SLBP PE=1 SV=1
2768,40669,sp|P61129|ZC3H6_HUMAN,1.48,46.73,2.451E5,2.252E5,3.711E5,3.647E5,1.00,0.92,1.51,1.49,2.451E5,2.252E5,3.711E5,3.647E5,1.00,0.92,1.51,1.49,1,1,1,iTRAQ 4plex (K  N-term),131670,Zinc finger CCCH domain-containing protein 6 OS=Homo sapiens OX=9606 GN=ZC3H6 PE=1 SV=2
2523,41330,B0QZ43|B0QZ43_HUMAN,2.27,46.69,6.297E5,6.082E5,8.194E5,8.384E5,1.00,0.97,1.30,1.33,6.297E5,6.082E5,8.194E5,8.384E5,1.00,0.97,1.30,1.33,7,2,2,iTRAQ 4plex (K  N-term),31077,Erlin-1 (Fragment) OS=Homo sapiens OX=9606 GN=ERLIN1 PE=1 SV=1
2415,40434,sp|Q13619-2|CUL4A_HUMAN,3.73,46.64,3.37E5,3.463E5,5.61E5,5.046E5,1.00,1.03,1.66,1.50,3.37E5,3.463E5,5.61E5,5.046E5,1.00,1.03,1.66,1.50,3,2,2,iTRAQ 4plex (K  N-term),76821,Isoform 2 of Cullin-4A OS=Homo sapiens OX=9606 GN=CUL4A
2521,41314,K7EQG9|K7EQG9_HUMAN,3.52,46.61,1.94E5,1.784E5,2.76E5,2.88E5,1.00,0.92,1.42,1.48,1.94E5,1.784E5,2.76E5,2.88E5,1.00,0.92,1.42,1.48,5,2,2,iTRAQ 4plex (K  N-term),44562,Tyrosine-protein phosphatase non-receptor type OS=Homo sapiens OX=9606 GN=PTPN2 PE=1 SV=1
2538,42405,H0YA26|H0YA26_HUMAN,0.88,46.55,1.355E5,1.232E5,1.689E5,1.677E5,1.00,0.91,1.25,1.24,1.355E5,1.232E5,1.689E5,1.677E5,1.00,0.91,1.25,1.24,3,1,1,iTRAQ 4plex (K  N-term),53083,Pantothenate kinase 4 (Fragment) OS=Homo sapiens OX=9606 GN=PANK4 PE=1 SV=1
2374,40446,sp|Q8TBM8|DJB14_HUMAN,2.43,46.51,3.734E5,3.401E5,4.328E5,4.899E5,1.00,0.91,1.16,1.31,3.734E5,3.401E5,4.328E5,4.899E5,1.00,0.91,1.16,1.31,5,2,2,iTRAQ 4plex (K  N-term),42516,DnaJ homolog subfamily B member 14 OS=Homo sapiens OX=9606 GN=DNAJB14 PE=1 SV=1
2384,11951,sp|Q9Y2I7|FYV1_HUMAN,4.05,46.40,2.534E5,2.311E5,7.073E5,7.323E5,1.00,0.91,2.79,2.89,2.534E5,2.311E5,7.073E5,7.323E5,1.00,0.91,2.79,2.89,1,2,1,iTRAQ 4plex (K  N-term),237134,1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3
2445,40671,sp|Q9NTI5-2|PDS5B_HUMAN,3.94,46.38,2.062E5,1.858E5,2.961E5,3.143E5,1.00,0.90,1.44,1.52,2.062E5,1.858E5,2.961E5,3.143E5,1.00,0.90,1.44,1.52,1,2,2,iTRAQ 4plex (K  N-term),158280,Isoform 2 of Sister chromatid cohesion protein PDS5 homolog B OS=Homo sapiens OX=9606 GN=PDS5B
2135,6438,sp|Q9H3S7|PTN23_HUMAN,4.13,46.35,9.281E5,9.727E5,1.555E6,1.535E6,1.00,1.05,1.68,1.65,9.281E5,9.727E5,1.555E6,1.535E6,1.00,1.05,1.68,1.65,1,2,2,iTRAQ 4plex (K  N-term),178972,Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens OX=9606 GN=PTPN23 PE=1 SV=1
2427,22307,sp|Q06124-2|PTN11_HUMAN,0.92,46.31,5.272E5,5.229E5,6.089E5,5.653E5,1.00,0.99,1.15,1.07,5.272E5,5.229E5,6.089E5,5.653E5,1.00,0.99,1.15,1.07,3,2,2,iTRAQ 4plex (K  N-term),68011,Isoform 2 of Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens OX=9606 GN=PTPN11
2500,41133,D6RDV0|D6RDV0_HUMAN,2.54,46.26,3.204E5,3.352E5,4.678E5,4.624E5,1.00,1.05,1.46,1.44,3.204E5,3.352E5,4.678E5,4.624E5,1.00,1.05,1.46,1.44,7,2,2,iTRAQ 4plex (K  N-term),31869,Tumor suppressor candidate 3 OS=Homo sapiens OX=9606 GN=TUSC3 PE=1 SV=1
2961,41731,C9JB30|C9JB30_HUMAN,0.54,46.21,8.565E4,7.458E4,9.107E4,8.94E4,1.00,0.87,1.06,1.04,8.565E4,7.458E4,9.107E4,8.94E4,1.00,0.87,1.06,1.04,10,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),24582,Microtubule-associated protein RP/EB family member 3 (Fragment) OS=Homo sapiens OX=9606 GN=MAPRE3 PE=1 SV=1
2539,16144,sp|Q6DD87|ZN787_HUMAN,2.25,45.97,1.539E5,1.395E5,2.855E5,2.705E5,1.00,0.91,1.86,1.76,1.539E5,1.395E5,2.855E5,2.705E5,1.00,0.91,1.86,1.76,3,1,1,iTRAQ 4plex (K  N-term),40428,Zinc finger protein 787 OS=Homo sapiens OX=9606 GN=ZNF787 PE=1 SV=4
2290,22597,sp|O14531|DPYL4_HUMAN,4.15,45.95,2.966E5,2.724E5,4.142E5,4.66E5,1.00,0.92,1.40,1.57,2.966E5,2.724E5,4.142E5,4.66E5,1.00,0.92,1.40,1.57,4,2,2,iTRAQ 4plex (K  N-term),61878,Dihydropyrimidinase-related protein 4 OS=Homo sapiens OX=9606 GN=DPYSL4 PE=1 SV=2
2407,40322,sp|P26358-3|DNMT1_HUMAN,3.36,45.94,4.507E5,4.76E5,7.083E5,6.485E5,1.00,1.06,1.57,1.44,4.507E5,4.76E5,7.083E5,6.485E5,1.00,1.06,1.57,1.44,1,2,2,iTRAQ 4plex (K  N-term),144465,Isoform 3 of DNA (cytosine-5)-methyltransferase 1 OS=Homo sapiens OX=9606 GN=DNMT1
2356,11038,sp|Q00587-2|BORG5_HUMAN,2.24,45.79,1.115E5,1.06E5,2.039E5,2.168E5,1.00,0.95,1.83,1.95,1.115E5,1.06E5,2.039E5,2.168E5,1.00,0.95,1.83,1.95,7,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),39686,Isoform 2 of Cdc42 effector protein 1 OS=Homo sapiens OX=9606 GN=CDC42EP1
3106,42433,A0A0A0MTD5|A0A0A0MTD5_HUMAN,1.75,45.68,1.284E5,1.542E5,2.141E5,2.294E5,1.00,1.20,1.67,1.79,1.284E5,1.542E5,2.141E5,2.294E5,1.00,1.20,1.67,1.79,5,1,1,iTRAQ 4plex (K  N-term),26081,Calcium uptake protein 2  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MICU2 PE=1 SV=1
3051,15956,E9PJC3|E9PJC3_HUMAN,0.82,45.65,4.074E4,3.689E4,4.96E4,4.313E4,1.00,0.91,1.22,1.06,4.074E4,3.689E4,4.96E4,4.313E4,1.00,0.91,1.22,1.06,5,1,1,iTRAQ 4plex (K  N-term),40574,Suppression of tumorigenicity 5 protein OS=Homo sapiens OX=9606 GN=ST5 PE=1 SV=1
3107,42450,sp|P46977-2|STT3A_HUMAN,1.59,45.62,7.727E4,7.745E4,1.32E5,1.205E5,1.00,1.00,1.71,1.56,7.727E4,7.745E4,1.32E5,1.205E5,1.00,1.00,1.71,1.56,2,1,1,iTRAQ 4plex (K  N-term),69589,Isoform 2 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A OS=Homo sapiens OX=9606 GN=STT3A
3049,41995,G3V5Q1|G3V5Q1_HUMAN,2.23,45.59,1.38E5,1.359E5,2.19E5,2.766E5,1.00,0.98,1.59,2.00,1.38E5,1.359E5,2.19E5,2.766E5,1.00,0.98,1.59,2.00,7,1,1,iTRAQ 4plex (K  N-term),27125,DNA-(apurinic or apyrimidinic site) lyase (Fragment) OS=Homo sapiens OX=9606 GN=APEX1 PE=1 SV=1
2254,14297,C9JA28|C9JA28_HUMAN,1.89,45.52,3.071E5,3.254E5,5.688E5,5.555E5,1.00,1.06,1.85,1.81,3.071E5,3.254E5,5.688E5,5.555E5,1.00,1.06,1.85,1.81,8,1,1,iTRAQ 4plex (K  N-term),20161,Translocon-associated protein subunit gamma OS=Homo sapiens OX=9606 GN=SSR3 PE=1 SV=1
3108,42490,H0YEN2|H0YEN2_HUMAN,0.47,45.49,2.433E5,2.388E5,2.842E5,2.605E5,1.00,0.98,1.17,1.07,2.433E5,2.388E5,2.842E5,2.605E5,1.00,0.98,1.17,1.07,2,1,1,iTRAQ 4plex (K  N-term),63780,Serine/threonine-protein phosphatase 6 regulatory subunit 3 (Fragment) OS=Homo sapiens OX=9606 GN=PPP6R3 PE=1 SV=1
2519,41285,E9PN50|E9PN50_HUMAN,3.17,45.43,2.728E5,2.582E5,4.027E5,3.982E5,1.00,0.95,1.48,1.46,2.728E5,2.582E5,4.027E5,3.982E5,1.00,0.95,1.48,1.46,15,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),28586,26S proteasome regulatory subunit 6A (Fragment) OS=Homo sapiens OX=9606 GN=PSMC3 PE=1 SV=9
2518,41277,sp|Q9BVP2-2|GNL3_HUMAN,5.50,45.34,3.888E5,3.987E5,7.123E5,7.54E5,1.00,1.03,1.83,1.94,3.888E5,3.987E5,7.123E5,7.54E5,1.00,1.03,1.83,1.94,5,2,2,iTRAQ 4plex (K  N-term),60540,Isoform 2 of Guanine nucleotide-binding protein-like 3 OS=Homo sapiens OX=9606 GN=GNL3
3047,41980,sp|Q8WVJ9|TWST2_HUMAN,2.24,45.27,2.925E5,2.903E5,5.915E5,5.823E5,1.00,0.99,2.02,1.99,2.925E5,2.903E5,5.915E5,5.823E5,1.00,0.99,2.02,1.99,8,1,1,iTRAQ 4plex (K  N-term),18124,Twist-related protein 2 OS=Homo sapiens OX=9606 GN=TWIST2 PE=1 SV=1
2251,8591,F5H7X1|F5H7X1_HUMAN,4.34,45.20,8.025E5,7.79E5,1.25E6,1.348E6,1.00,0.97,1.56,1.68,8.025E5,7.79E5,1.25E6,1.348E6,1.00,0.97,1.56,1.68,22,2,2,iTRAQ 4plex (K  N-term),9430,26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens OX=9606 GN=PSMD9 PE=1 SV=1
2515,41222,C9J2I1|C9J2I1_HUMAN,3.77,45.16,8.419E5,8.922E5,1.371E6,1.281E6,1.00,1.06,1.63,1.52,8.419E5,8.922E5,1.371E6,1.281E6,1.00,1.06,1.63,1.52,7,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),39974,Armadillo repeat-containing protein 8 (Fragment) OS=Homo sapiens OX=9606 GN=ARMC8 PE=1 SV=1
2034,11886,F5H4Q5|F5H4Q5_HUMAN,2.73,45.06,9.045E5,9.317E5,2.076E6,2.069E6,1.00,1.03,2.30,2.29,9.045E5,9.317E5,2.076E6,2.069E6,1.00,1.03,2.30,2.29,7,1,1,iTRAQ 4plex (K  N-term),17143,Vacuolar protein sorting-associated protein 37C (Fragment) OS=Homo sapiens OX=9606 GN=VPS37C PE=1 SV=1
2248,41190,D6RC14|D6RC14_HUMAN,3.78,44.86,4.044E5,4.024E5,6.72E5,6.562E5,1.00,0.99,1.66,1.62,4.044E5,4.024E5,6.72E5,6.562E5,1.00,0.99,1.66,1.62,11,2,2,iTRAQ 4plex (K  N-term),17095,39S ribosomal protein L3  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPL3 PE=1 SV=1
2192,41192,sp|Q13443|ADAM9_HUMAN,4.19,44.86,8.573E5,7.807E5,1.343E6,1.279E6,1.00,0.91,1.57,1.49,8.573E5,7.807E5,1.343E6,1.279E6,1.00,0.91,1.57,1.49,2,2,2,iTRAQ 4plex (K  N-term),90556,Disintegrin and metalloproteinase domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ADAM9 PE=1 SV=1
2352,18962,sp|Q9P2E5-2|CHPF2_HUMAN,3.72,44.85,5.098E5,5.167E5,8.41E5,8.395E5,1.00,1.01,1.65,1.65,5.098E5,5.167E5,8.41E5,8.395E5,1.00,1.01,1.65,1.65,2,2,2,iTRAQ 4plex (K  N-term),74528,Isoform 2 of Chondroitin sulfate glucuronyltransferase OS=Homo sapiens OX=9606 GN=CHPF2
3115,23742,X6RGY1|X6RGY1_HUMAN,1.76,44.75,1.554E5,1.517E5,2.691E5,2.712E5,1.00,0.98,1.73,1.75,1.554E5,1.517E5,2.691E5,2.712E5,1.00,0.98,1.73,1.75,14,1,1,iTRAQ 4plex (K  N-term),10633,Zinc finger CCCH-type with G patch domain-containing protein (Fragment) OS=Homo sapiens OX=9606 GN=ZGPAT PE=1 SV=1
2502,7392,sp|Q96PE3-2|INP4A_HUMAN,3.14,44.71,8.541E5,8.188E5,1.26E6,1.273E6,1.00,0.96,1.47,1.49,8.541E5,8.188E5,1.26E6,1.273E6,1.00,0.96,1.47,1.49,3,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),105699,Isoform 2 of Type I inositol 3 4-bisphosphate 4-phosphatase OS=Homo sapiens OX=9606 GN=INPP4A
2946,5164,sp|Q68D10|SPT2_HUMAN,1.64,44.71,3.727E5,3.625E5,6.149E5,6.255E5,1.00,0.97,1.65,1.68,3.727E5,3.625E5,6.149E5,6.255E5,1.00,0.97,1.65,1.68,2,1,1,iTRAQ 4plex (K  N-term),75599,Protein SPT2 homolog OS=Homo sapiens OX=9606 GN=SPTY2D1 PE=1 SV=3
3112,42523,sp|Q96IX5|USMG5_HUMAN,0.96,44.65,1.424E5,1.511E5,2.006E5,1.897E5,1.00,1.06,1.41,1.33,1.424E5,1.511E5,2.006E5,1.897E5,1.00,1.06,1.41,1.33,26,1,1,iTRAQ 4plex (K  N-term),6458,Up-regulated during skeletal muscle growth protein 5 OS=Homo sapiens OX=9606 GN=ATP5MD PE=1 SV=1
3109,42503,K7EKZ6|K7EKZ6_HUMAN,1.65,44.60,2.227E4,2.241E4,3.891E4,3.2E4,1.00,1.01,1.75,1.44,2.227E4,2.241E4,3.891E4,3.2E4,1.00,1.01,1.75,1.44,6,1,1,iTRAQ 4plex (K  N-term),28852,CXXC-type zinc finger protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=CXXC1 PE=1 SV=1
2506,18234,sp|P62491-2|RB11A_HUMAN,0.52,44.46,5.964E5,5.941E5,6.494E5,6.308E5,1.00,1.00,1.09,1.06,5.964E5,5.941E5,6.494E5,6.308E5,1.00,1.00,1.09,1.06,12,2,2,iTRAQ 4plex (K  N-term),17659,Isoform 2 of Ras-related protein Rab-11A OS=Homo sapiens OX=9606 GN=RAB11A
3110,42508,H3BV02|H3BV02_HUMAN,1.03,44.45,4.521E5,4.541E5,6.494E5,5.913E5,1.00,1.00,1.44,1.31,4.521E5,4.541E5,6.494E5,5.913E5,1.00,1.00,1.44,1.31,25,1,1,iTRAQ 4plex (K  N-term),5952,Rho family-interacting cell polarization regulator 1 (Fragment) OS=Homo sapiens OX=9606 GN=RIPOR1 PE=1 SV=8
3114,42530,B7Z4K4|B7Z4K4_HUMAN,2.20,44.39,1.427E5,1.763E5,2.886E5,2.873E5,1.00,1.24,2.02,2.01,1.427E5,1.763E5,2.886E5,2.873E5,1.00,1.24,2.02,2.01,7,1,1,iTRAQ 4plex (K  N-term),21231,Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase OS=Homo sapiens OX=9606 GN=FTSJ1 PE=1 SV=1
3111,20990,B7Z9U0|B7Z9U0_HUMAN,2.84,44.36,3.977E4,3.068E4,7.374E4,6.449E4,1.00,0.77,1.85,1.62,3.977E4,3.068E4,7.374E4,6.449E4,1.00,0.77,1.85,1.62,11,1,1,iTRAQ 4plex (K  N-term),14656,cDNA  FLJ78954  highly similar to CCR4-NOT transcription complex subunit 8 OS=Homo sapiens OX=9606 GN=CNOT8 PE=1 SV=1
3118,42557,sp|O15260-2|SURF4_HUMAN,1.54,44.29,7.092E5,6.867E5,1.116E6,1.15E6,1.00,0.97,1.57,1.62,7.092E5,6.867E5,1.116E6,1.15E6,1.00,0.97,1.57,1.62,6,1,1,iTRAQ 4plex (K  N-term),17970,Isoform 2 of Surfeit locus protein 4 OS=Homo sapiens OX=9606 GN=SURF4
3025,29381,sp|O75306-2|NDUS2_HUMAN,3.09,44.25,5.535E4,4.498E4,1.113E5,1.147E5,1.00,0.81,2.01,2.07,5.535E4,4.498E4,1.113E5,1.147E5,1.00,0.81,2.01,2.07,2,1,1,iTRAQ 4plex (K  N-term),51852,Isoform 2 of NADH dehydrogenase [ubiquinone] iron-sulfur protein 2  mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS2
2245,41165,G3XAI9|G3XAI9_HUMAN,2.87,44.23,5.904E5,5.429E5,7.901E5,8.212E5,1.00,0.92,1.34,1.39,5.904E5,5.429E5,7.901E5,8.212E5,1.00,0.92,1.34,1.39,17,2,2,iTRAQ 4plex (K  N-term),12410,Protein FAM133B OS=Homo sapiens OX=9606 GN=FAM133B PE=1 SV=1
2906,41379,A0A1B0GVV8|A0A1B0GVV8_HUMAN,2.19,44.16,9.073E4,1.003E5,1.835E5,1.657E5,1.00,1.11,2.02,1.83,9.073E4,1.003E5,1.835E5,1.657E5,1.00,1.11,2.02,1.83,1,1,1,iTRAQ 4plex (K  N-term),123894,Zinc finger E-box-binding homeobox 2 OS=Homo sapiens OX=9606 GN=ZEB2 PE=1 SV=1
3035,41894,J3KRE2|J3KRE2_HUMAN,0.24,44.13,3.945E5,3.601E5,3.857E5,3.93E5,1.00,0.91,0.98,1.00,3.945E5,3.601E5,3.857E5,3.93E5,1.00,0.91,0.98,1.00,12,1,1,iTRAQ 4plex (K  N-term),14814,Rho GDP-dissociation inhibitor 1 OS=Homo sapiens OX=9606 GN=ARHGDIA PE=1 SV=1
2902,7322,sp|Q9BVR0|HRC23_HUMAN,1.05,44.11,4.53E4,5.7E4,6.577E4,6.194E4,1.00,1.26,1.45,1.37,4.53E4,5.7E4,6.577E4,6.194E4,1.00,1.26,1.45,1.37,3,1,1,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Deamidation (NQ),128943,Putative HERC2-like protein 3 OS=Homo sapiens OX=9606 GN=HERC2P3 PE=5 SV=2
2193,11673,sp|Q92743|HTRA1_HUMAN,2.71,44.10,2.415E5,2.362E5,3.495E5,3.439E5,1.00,0.98,1.45,1.42,2.415E5,2.362E5,3.495E5,3.439E5,1.00,0.98,1.45,1.42,4,2,2,iTRAQ 4plex (K  N-term),51287,Serine protease HTRA1 OS=Homo sapiens OX=9606 GN=HTRA1 PE=1 SV=1
2177,40483,sp|P82932|RT06_HUMAN,1.75,44.07,1.627E6,1.617E6,2.011E6,2.099E6,1.00,0.99,1.24,1.29,1.627E6,1.617E6,2.011E6,2.099E6,1.00,0.99,1.24,1.29,13,2,2,iTRAQ 4plex (K  N-term),14227,28S ribosomal protein S6  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS6 PE=1 SV=3
3113,42524,sp|O95400|CD2B2_HUMAN,0.92,44.05,6.237E4,5.385E4,7.483E4,7.494E4,1.00,0.86,1.20,1.20,6.237E4,5.385E4,7.483E4,7.494E4,1.00,0.86,1.20,1.20,7,1,1,iTRAQ 4plex (K  N-term),37646,CD2 antigen cytoplasmic tail-binding protein 2 OS=Homo sapiens OX=9606 GN=CD2BP2 PE=1 SV=1
3117,42554,sp|Q01167-2|FOXK2_HUMAN,0.49,43.95,2.069E5,1.891E5,2.067E5,2.273E5,1.00,0.91,1.00,1.10,2.069E5,1.891E5,2.067E5,2.273E5,1.00,0.91,1.00,1.10,3,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),64256,Isoform 2 of Forkhead box protein K2 OS=Homo sapiens OX=9606 GN=FOXK2
2246,41170,H7C4H2|H7C4H2_HUMAN,4.98,43.86,1.169E6,1.133E6,2.059E6,2.109E6,1.00,0.97,1.76,1.80,1.169E6,1.133E6,2.059E6,2.109E6,1.00,0.97,1.76,1.80,17,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),17621,Signal recognition particle receptor subunit beta (Fragment) OS=Homo sapiens OX=9606 GN=SRPRB PE=1 SV=1
3027,41849,D6R967|D6R967_HUMAN,1.75,43.86,2.156E5,2.155E5,3.743E5,3.843E5,1.00,1.00,1.74,1.78,2.156E5,2.155E5,3.743E5,3.843E5,1.00,1.00,1.74,1.78,7,1,1,iTRAQ 4plex (K  N-term),21390,Inorganic pyrophosphatase 2  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=PPA2 PE=1 SV=1
3037,41897,E9PN17|E9PN17_HUMAN,2.65,43.86,8.544E4,8.723E4,1.946E5,1.81E5,1.00,1.02,2.28,2.12,8.544E4,8.723E4,1.946E5,1.81E5,1.00,1.02,2.28,2.12,14,1,1,iTRAQ 4plex (K  N-term),8452,ATP synthase subunit g  mitochondrial OS=Homo sapiens OX=9606 GN=ATP5MG PE=1 SV=1
2168,40194,Q5VUC6|Q5VUC6_HUMAN,3.22,43.84,1.019E6,1.045E6,1.597E6,1.592E6,1.00,1.02,1.57,1.56,1.019E6,1.045E6,1.597E6,1.592E6,1.00,1.02,1.57,1.56,3,3,2,iTRAQ 4plex (K  N-term),56717,Glycylpeptide N-tetradecanoyltransferase OS=Homo sapiens OX=9606 GN=NMT2 PE=1 SV=1
2540,23821,sp|P53999|TCP4_HUMAN,1.27,43.66,9.367E5,8.75E5,1.319E6,1.352E6,1.00,0.93,1.41,1.44,9.367E5,8.75E5,1.319E6,1.352E6,1.00,0.93,1.41,1.44,9,1,1,iTRAQ 4plex (K  N-term),14395,Activated RNA polymerase II transcriptional coactivator p15 OS=Homo sapiens OX=9606 GN=SUB1 PE=1 SV=3
2395,41230,sp|Q9UBI6|GBG12_HUMAN,5.86,43.62,2.822E5,2.784E5,5.706E5,5.361E5,1.00,0.99,2.02,1.90,2.822E5,2.784E5,5.706E5,5.361E5,1.00,0.99,2.02,1.90,25,2,2,iTRAQ 4plex (K  N-term),8006,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 OS=Homo sapiens OX=9606 GN=GNG12 PE=1 SV=3
3043,41972,sp|Q8NEF9|SRFB1_HUMAN,2.01,43.60,2.156E5,1.878E5,3.511E5,3.605E5,1.00,0.87,1.63,1.67,2.156E5,1.878E5,3.511E5,3.605E5,1.00,0.87,1.63,1.67,3,1,1,iTRAQ 4plex (K  N-term),48634,Serum response factor-binding protein 1 OS=Homo sapiens OX=9606 GN=SRFBP1 PE=1 SV=1
2541,42590,D6RB59|D6RB59_HUMAN,1.50,43.51,6.354E5,6.371E5,1.05E6,1.012E6,1.00,1.00,1.65,1.59,6.354E5,6.371E5,1.05E6,1.012E6,1.00,1.00,1.65,1.59,2,1,1,iTRAQ 4plex (K  N-term),53241,Exocyst complex component 3 OS=Homo sapiens OX=9606 GN=EXOC3 PE=1 SV=1
1647,1382,sp|O15078|CE290_HUMAN,5.41,43.49,4.865E5,5.244E5,9.911E5,9.986E5,1.00,1.08,2.04,2.05,4.865E5,5.244E5,9.911E5,9.986E5,1.00,1.08,2.04,2.05,1,3,2,iTRAQ 4plex (K  N-term); Deamidation (NQ); Phosphorylation (STY),290384,Centrosomal protein of 290 kDa OS=Homo sapiens OX=9606 GN=CEP290 PE=1 SV=2
3120,42570,B4DZG7|B4DZG7_HUMAN,1.21,43.41,5.328E4,4.566E4,6.351E4,6.976E4,1.00,0.86,1.19,1.31,5.328E4,4.566E4,6.351E4,6.976E4,1.00,0.86,1.19,1.31,10,1,1,iTRAQ 4plex (K  N-term),15443,cDNA FLJ50309  highly similar to ADP-ribosylation factor-like protein 1 OS=Homo sapiens OX=9606 GN=ARL1 PE=1 SV=1
2365,40273,sp|Q6ZW31-2|SYDE1_HUMAN,3.72,43.35,3.695E5,3.72E5,6.155E5,6.085E5,1.00,1.01,1.67,1.65,3.695E5,3.72E5,6.155E5,6.085E5,1.00,1.01,1.67,1.65,4,2,2,iTRAQ 4plex (K  N-term),72911,Isoform 2 of Rho GTPase-activating protein SYDE1 OS=Homo sapiens OX=9606 GN=SYDE1
2405,14325,sp|Q5JTH9-2|RRP12_HUMAN,3.09,43.31,6.156E5,6.071E5,9.156E5,9.279E5,1.00,0.99,1.49,1.51,6.156E5,6.071E5,9.156E5,9.279E5,1.00,0.99,1.49,1.51,2,2,2,iTRAQ 4plex (K  N-term),132709,Isoform 2 of RRP12-like protein OS=Homo sapiens OX=9606 GN=RRP12
2725,41259,F8WF02|F8WF02_HUMAN,2.39,43.25,2.972E5,3.258E5,6.298E5,6.229E5,1.00,1.10,2.12,2.10,2.972E5,3.258E5,6.298E5,6.229E5,1.00,1.10,2.12,2.10,6,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),27651,Pyruvate dehydrogenase E1 component subunit beta  mitochondrial OS=Homo sapiens OX=9606 GN=PDHB PE=1 SV=1
3119,21022,sp|O15212|PFD6_HUMAN,0.50,43.06,9.676E4,9.378E4,1.131E5,9.626E4,1.00,0.97,1.17,0.99,9.676E4,9.378E4,1.131E5,9.626E4,1.00,0.97,1.17,0.99,9,1,1,iTRAQ 4plex (K  N-term),14583,Prefoldin subunit 6 OS=Homo sapiens OX=9606 GN=PFDN6 PE=1 SV=1
2088,20378,A0A2R8YDI2|A0A2R8YDI2_HUMAN,0.96,43.03,9.025E4,9.212E4,1.276E5,1.194E5,1.00,1.02,1.41,1.32,9.025E4,9.212E4,1.276E5,1.194E5,1.00,1.02,1.41,1.32,6,2,1,iTRAQ 4plex (K  N-term),19049,Myosin regulatory light chain 10 OS=Homo sapiens OX=9606 GN=MYL10 PE=1 SV=2
3121,42577,sp|P02656|APOC3_HUMAN,0.75,42.97,7.627E4,7.858E4,9.895E4,1.003E5,1.00,1.03,1.30,1.31,7.627E4,7.858E4,9.895E4,1.003E5,1.00,1.03,1.30,1.31,16,1,1,iTRAQ 4plex (K  N-term),10852,Apolipoprotein C-III OS=Homo sapiens OX=9606 GN=APOC3 PE=1 SV=1
2509,41196,sp|Q15691|MARE1_HUMAN,3.70,42.95,7.885E5,7.262E5,1.194E6,1.204E6,1.00,0.92,1.51,1.53,7.885E5,7.262E5,1.194E6,1.204E6,1.00,0.92,1.51,1.53,10,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),29999,Microtubule-associated protein RP/EB family member 1 OS=Homo sapiens OX=9606 GN=MAPRE1 PE=1 SV=3
2811,41826,sp|P0DI81-3|TPC2A_HUMAN,1.51,42.52,2.406E5,2.378E5,3.954E5,3.837E5,1.00,0.99,1.64,1.59,2.406E5,2.378E5,3.954E5,3.837E5,1.00,0.99,1.64,1.59,8,1,1,iTRAQ 4plex (K  N-term),20374,Isoform 3 of Trafficking protein particle complex subunit 2 OS=Homo sapiens OX=9606 GN=TRAPPC2
2947,41415,sp|O76094-2|SRP72_HUMAN,0.77,42.50,4.552E5,4.382E5,5.581E5,5.779E5,1.00,0.96,1.23,1.27,4.552E5,4.382E5,5.581E5,5.779E5,1.00,0.96,1.23,1.27,2,1,1,iTRAQ 4plex (K  N-term),67880,Isoform 2 of Signal recognition particle subunit SRP72 OS=Homo sapiens OX=9606 GN=SRP72
3126,42625,sp|Q6A1A2|PDPK2_HUMAN,0.80,42.49,1.033E5,1.079E5,1.378E5,1.301E5,1.00,1.04,1.33,1.26,1.033E5,1.079E5,1.378E5,1.301E5,1.00,1.04,1.33,1.26,5,1,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),44765,Putative 3-phosphoinositide-dependent protein kinase 2 OS=Homo sapiens OX=9606 GN=PDPK2P PE=5 SV=1
3125,42622,Q5H928|Q5H928_HUMAN,1.66,42.48,9.656E5,7.206E5,1.246E6,1.063E6,1.00,0.75,1.29,1.10,9.656E5,7.206E5,1.246E6,1.063E6,1.00,0.75,1.29,1.10,6,1,1,iTRAQ 4plex (K  N-term),17224,3-hydroxyacyl-CoA dehydrogenase type-2 OS=Homo sapiens OX=9606 GN=HSD17B10 PE=1 SV=1
3116,42546,H0Y653|H0Y653_HUMAN,1.23,42.42,1.142E5,1.203E5,1.683E5,1.748E5,1.00,1.05,1.47,1.53,1.142E5,1.203E5,1.683E5,1.748E5,1.00,1.05,1.47,1.53,7,1,1,iTRAQ 4plex (K  N-term),24264,Nucleolar protein 56 (Fragment) OS=Homo sapiens OX=9606 GN=NOP56 PE=1 SV=1
2439,40643,E9PJ60|E9PJ60_HUMAN,1.74,42.38,3.494E5,3.52E5,4.589E5,4.052E5,1.00,1.01,1.31,1.16,3.494E5,3.52E5,4.589E5,4.052E5,1.00,1.01,1.31,1.16,5,2,2,iTRAQ 4plex (K  N-term),49375,Probable ATP-dependent RNA helicase DDX20 OS=Homo sapiens OX=9606 GN=DDX20 PE=1 SV=1
2769,41288,sp|P58397-3|ATS12_HUMAN,1.39,42.28,1.029E5,9.955E4,1.572E5,1.602E5,1.00,0.97,1.53,1.56,1.029E5,9.955E4,1.572E5,1.602E5,1.00,0.97,1.53,1.56,1,1,1,iTRAQ 4plex (K  N-term),168460,Isoform 3 of A disintegrin and metalloproteinase with thrombospondin motifs 12 OS=Homo sapiens OX=9606 GN=ADAMTS12
2949,41478,sp|Q8IWV7-2|UBR1_HUMAN,1.34,42.20,2.066E5,2.205E5,2.869E5,3.273E5,1.00,1.07,1.39,1.58,2.066E5,2.205E5,2.869E5,3.273E5,1.00,1.07,1.39,1.58,2,1,1,iTRAQ 4plex (K  N-term),93184,Isoform 2 of E3 ubiquitin-protein ligase UBR1 OS=Homo sapiens OX=9606 GN=UBR1
2186,40607,sp|Q9BYJ4-2|TRI34_HUMAN,1.40,42.20,5.937E4,5.975E4,9.644E4,9.268E4,1.00,1.01,1.62,1.56,5.937E4,5.975E4,9.644E4,9.268E4,1.00,1.01,1.62,1.56,3,2,1,iTRAQ 4plex (K  N-term),31338,Isoform 2 of Tripartite motif-containing protein 34 OS=Homo sapiens OX=9606 GN=TRIM34
2178,21055,Q5TEC6|Q5TEC6_HUMAN,1.26,42.19,5.997E5,5.505E5,6.635E5,8.494E5,1.00,0.92,1.11,1.42,5.997E5,5.505E5,6.635E5,8.494E5,1.00,0.92,1.11,1.42,7,2,1,iTRAQ 4plex (K  N-term),15430,Histone H3 OS=Homo sapiens OX=9606 GN=HIST2H3PS2 PE=1 SV=1
3124,42618,X6RA30|X6RA30_HUMAN,1.64,42.16,1.892E5,1.091E5,1.835E5,1.884E5,1.00,0.58,0.97,1.00,1.892E5,1.091E5,1.835E5,1.884E5,1.00,0.58,0.97,1.00,4,1,1,iTRAQ 4plex (K  N-term),33891,Cell division cycle protein 123 homolog OS=Homo sapiens OX=9606 GN=CDC123 PE=1 SV=1
2542,42645,H0YNE0|H0YNE0_HUMAN,1.05,42.15,8.861E4,8.359E4,1.211E5,1.104E5,1.00,0.94,1.37,1.25,8.861E4,8.359E4,1.211E5,1.104E5,1.00,0.94,1.37,1.25,5,1,1,iTRAQ 4plex (K  N-term),24541,Mortality factor 4-like protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=MORF4L1 PE=1 SV=1
3122,42615,sp|P16455|MGMT_HUMAN,1.87,42.02,4.89E4,3.84E4,7.14E4,6.877E4,1.00,0.79,1.46,1.41,4.89E4,3.84E4,7.14E4,6.877E4,1.00,0.79,1.46,1.41,6,1,1,iTRAQ 4plex (K  N-term),21646,Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens OX=9606 GN=MGMT PE=1 SV=1
3020,41754,I3L495|I3L495_HUMAN,2.62,42.00,1.526E5,1.42E5,2.986E5,3.206E5,1.00,0.93,1.96,2.10,1.526E5,1.42E5,2.986E5,3.206E5,1.00,0.93,1.96,2.10,16,1,1,iTRAQ 4plex (K  N-term),9632,Platelet-activating factor acetylhydrolase IB subunit alpha (Fragment) OS=Homo sapiens OX=9606 GN=PAFAH1B1 PE=1 SV=1
3128,42633,sp|Q5F1R6|DJC21_HUMAN,2.25,41.87,7.166E4,6.759E4,1.391E5,1.072E5,1.00,0.94,1.94,1.50,7.166E4,6.759E4,1.391E5,1.072E5,1.00,0.94,1.94,1.50,2,1,1,iTRAQ 4plex (K  N-term),62028,DnaJ homolog subfamily C member 21 OS=Homo sapiens OX=9606 GN=DNAJC21 PE=1 SV=2
3042,41958,sp|O00186|STXB3_HUMAN,0.88,41.83,3.652E5,3.634E5,4.939E5,4.98E5,1.00,0.99,1.35,1.36,3.652E5,3.634E5,4.939E5,4.98E5,1.00,0.99,1.35,1.36,2,1,1,iTRAQ 4plex (K  N-term),67764,Syntaxin-binding protein 3 OS=Homo sapiens OX=9606 GN=STXBP3 PE=1 SV=2
3130,11727,A0A1B0GVI7|A0A1B0GVI7_HUMAN,2.57,41.83,1.012E6,9.917E5,2.188E6,2.171E6,1.00,0.98,2.16,2.14,1.012E6,9.917E5,2.188E6,2.171E6,1.00,0.98,2.16,2.14,1,1,1,iTRAQ 4plex (K  N-term),90582,Uncharacterized protein (Fragment) OS=Homo sapiens OX=9606 PE=4 SV=1
3039,41912,M0R1I2|M0R1I2_HUMAN,1.04,41.78,5.171E4,4.988E4,7.211E4,6.691E4,1.00,0.96,1.39,1.29,5.171E4,4.988E4,7.211E4,6.691E4,1.00,0.96,1.39,1.29,5,1,1,iTRAQ 4plex (K  N-term),31638,Urokinase plasminogen activator surface receptor OS=Homo sapiens OX=9606 GN=PLAUR PE=1 SV=1
3132,19148,sp|O00151|PDLI1_HUMAN,1.45,41.74,3.924E5,3.77E5,6.132E5,6.149E5,1.00,0.96,1.56,1.57,3.924E5,3.77E5,6.132E5,6.149E5,1.00,0.96,1.56,1.57,3,1,1,iTRAQ 4plex (K  N-term),36072,PDZ and LIM domain protein 1 OS=Homo sapiens OX=9606 GN=PDLIM1 PE=1 SV=4
3133,42670,sp|P14174|MIF_HUMAN,1.43,41.72,3.669E5,3.351E5,5.013E5,5.449E5,1.00,0.91,1.37,1.49,3.669E5,3.351E5,5.013E5,5.449E5,1.00,0.91,1.37,1.49,10,1,1,iTRAQ 4plex (K  N-term),12476,Macrophage migration inhibitory factor OS=Homo sapiens OX=9606 GN=MIF PE=1 SV=4
3021,41762,C9JZW3|C9JZW3_HUMAN,1.33,41.63,1.054E5,9.906E4,1.566E5,1.45E5,1.00,0.94,1.49,1.38,1.054E5,9.906E4,1.566E5,1.45E5,1.00,0.94,1.49,1.38,12,1,1,iTRAQ 4plex (K  N-term),13443,Elongation factor 1-beta (Fragment) OS=Homo sapiens OX=9606 GN=EEF1B2 PE=1 SV=1
3024,41796,sp|Q9HCS4|TF7L1_HUMAN,1.15,41.58,1.087E5,1.052E5,1.452E5,1.576E5,1.00,0.97,1.34,1.45,1.087E5,1.052E5,1.452E5,1.576E5,1.00,0.97,1.34,1.45,4,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),62631,Transcription factor 7-like 1 OS=Homo sapiens OX=9606 GN=TCF7L1 PE=2 SV=1
2543,42647,H0YDV5|H0YDV5_HUMAN,0.28,41.58,4.022E5,4.146E5,4.486E5,4.326E5,1.00,1.03,1.12,1.08,4.022E5,4.146E5,4.486E5,4.326E5,1.00,1.03,1.12,1.08,6,1,1,iTRAQ 4plex (K  N-term),24366,Myc target protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=MYCT1 PE=1 SV=1
2391,23739,Q86SW4|Q86SW4_HUMAN,2.48,41.54,3.511E5,3.758E5,4.576E5,5.069E5,1.00,1.07,1.30,1.44,3.511E5,3.758E5,4.576E5,5.069E5,1.00,1.07,1.30,1.44,7,2,2,iTRAQ 4plex (K  N-term),29625,Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex (Fragment) OS=Homo sapiens OX=9606 GN=DLST PE=1 SV=1
3129,42646,sp|O95159|ZFPL1_HUMAN,1.18,41.53,3.762E5,3.42E5,4.97E5,5.149E5,1.00,0.91,1.32,1.37,3.762E5,3.42E5,4.97E5,5.149E5,1.00,0.91,1.32,1.37,6,1,1,iTRAQ 4plex (K  N-term),34114,Zinc finger protein-like 1 OS=Homo sapiens OX=9606 GN=ZFPL1 PE=1 SV=2
3011,7590,sp|O00231|PSD11_HUMAN,1.22,41.42,1.148E5,1.186E5,1.755E5,1.702E5,1.00,1.03,1.53,1.48,1.148E5,1.186E5,1.755E5,1.702E5,1.00,1.03,1.53,1.48,3,1,1,iTRAQ 4plex (K  N-term),47464,26S proteasome non-ATPase regulatory subunit 11 OS=Homo sapiens OX=9606 GN=PSMD11 PE=1 SV=3
2904,41338,sp|Q8N122-3|RPTOR_HUMAN,2.83,41.41,1.152E5,1.145E5,2.733E5,2.62E5,1.00,0.99,2.37,2.27,1.152E5,1.145E5,2.733E5,2.62E5,1.00,0.99,2.37,2.27,1,1,1,iTRAQ 4plex (K  N-term),131514,Isoform 3 of Regulatory-associated protein of mTOR OS=Homo sapiens OX=9606 GN=RPTOR
3131,21718,sp|P62875|RPAB5_HUMAN,2.90,41.37,2.522E6,2.712E6,6.018E6,5.471E6,1.00,1.08,2.39,2.17,2.522E6,2.712E6,6.018E6,5.471E6,1.00,1.08,2.39,2.17,13,1,1,iTRAQ 4plex (K  N-term),7645,DNA-directed RNA polymerases I  II  and III subunit RPABC5 OS=Homo sapiens OX=9606 GN=POLR2L PE=1 SV=1
3137,42692,A0A0U1RR85|A0A0U1RR85_HUMAN,1.12,41.27,3.265E5,3.387E5,4.825E5,4.831E5,1.00,1.04,1.48,1.48,3.265E5,3.387E5,4.825E5,4.831E5,1.00,1.04,1.48,1.48,12,1,1,iTRAQ 4plex (K  N-term),9446,Receptor expression-enhancing protein (Fragment) OS=Homo sapiens OX=9606 GN=REEP3 PE=1 SV=1
2740,40583,sp|Q05209|PTN12_HUMAN,1.57,41.26,1.574E5,1.541E5,2.618E5,2.305E5,1.00,0.98,1.66,1.46,1.574E5,1.541E5,2.618E5,2.305E5,1.00,0.98,1.66,1.46,2,1,1,iTRAQ 4plex (K  N-term),88106,Tyrosine-protein phosphatase non-receptor type 12 OS=Homo sapiens OX=9606 GN=PTPN12 PE=1 SV=3
2867,16777,sp|P49916-4|DNLI3_HUMAN,1.02,41.25,1.409E5,1.206E5,1.709E5,1.729E5,1.00,0.86,1.21,1.23,1.409E5,1.206E5,1.709E5,1.729E5,1.00,0.86,1.21,1.23,1,1,1,iTRAQ 4plex (K  N-term),95802,Isoform 4 of DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3
3135,42677,X6RI37|X6RI37_HUMAN,1.86,41.22,1.631E5,1.497E5,2.764E5,2.607E5,1.00,0.92,1.69,1.60,1.631E5,1.497E5,2.764E5,2.607E5,1.00,0.92,1.69,1.60,3,1,1,iTRAQ 4plex (K  N-term),41899,Leucine-rich repeat protein SHOC-2 (Fragment) OS=Homo sapiens OX=9606 GN=SHOC2 PE=1 SV=1
2544,23581,G3V3U4|G3V3U4_HUMAN,1.59,41.22,5.369E5,5.386E5,8.887E5,9.112E5,1.00,1.00,1.66,1.70,5.369E5,5.386E5,8.887E5,9.112E5,1.00,1.00,1.66,1.70,12,1,1,iTRAQ 4plex (K  N-term),11570,Proteasome subunit alpha type OS=Homo sapiens OX=9606 GN=PSMA6 PE=1 SV=1
3136,42681,E9PNR6|E9PNR6_HUMAN,0.78,41.19,3.019E5,3.193E5,3.997E5,3.912E5,1.00,1.06,1.32,1.30,3.019E5,3.193E5,3.997E5,3.912E5,1.00,1.06,1.32,1.30,5,1,1,iTRAQ 4plex (K  N-term),22492,Rho GTPase-activating protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=ARHGAP1 PE=1 SV=1
2514,8836,A0A087WTZ5|A0A087WTZ5_HUMAN,1.50,41.12,2.535E5,1.991E5,2.338E5,2.559E5,1.00,0.79,0.92,1.01,2.535E5,1.991E5,2.338E5,2.559E5,1.00,0.79,0.92,1.01,7,2,2,iTRAQ 4plex (K  N-term),27016,UBX domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBXN1 PE=1 SV=1
2466,42063,sp|Q9UKD2|MRT4_HUMAN,0.97,40.96,2.628E5,2.478E5,3.202E5,3.499E5,1.00,0.94,1.22,1.33,2.628E5,2.478E5,3.202E5,3.499E5,1.00,0.94,1.22,1.33,5,1,1,iTRAQ 4plex (K  N-term),27560,mRNA turnover protein 4 homolog OS=Homo sapiens OX=9606 GN=MRTO4 PE=1 SV=2
3139,42705,D6RJI5|D6RJI5_HUMAN,1.61,40.96,3.207E5,3.329E5,5.297E5,5.485E5,1.00,1.04,1.65,1.71,3.207E5,3.329E5,5.297E5,5.485E5,1.00,1.04,1.65,1.71,6,1,1,iTRAQ 4plex (K  N-term),19283,Beta-1 4-galactosyltransferase 7 OS=Homo sapiens OX=9606 GN=B4GALT7 PE=1 SV=1
2403,40258,sp|O75947|ATP5H_HUMAN,4.62,40.89,6.419E5,6.232E5,1.124E6,1.108E6,1.00,0.97,1.75,1.73,6.419E5,6.232E5,1.124E6,1.108E6,1.00,0.97,1.75,1.73,11,2,2,iTRAQ 4plex (K  N-term),18491,ATP synthase subunit d  mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PD PE=1 SV=3
3123,42617,sp|P52823|STC1_HUMAN,1.83,40.88,9.914E4,1.009E5,1.815E5,1.63E5,1.00,1.02,1.83,1.64,9.914E4,1.009E5,1.815E5,1.63E5,1.00,1.02,1.83,1.64,4,1,1,iTRAQ 4plex (K  N-term),27621,Stanniocalcin-1 OS=Homo sapiens OX=9606 GN=STC1 PE=1 SV=1
2397,41441,sp|O43181|NDUS4_HUMAN,1.34,40.82,2.391E5,2.082E5,3.082E5,3.296E5,1.00,0.87,1.29,1.38,2.391E5,2.082E5,3.082E5,3.296E5,1.00,0.87,1.29,1.38,9,1,1,iTRAQ 4plex (K  N-term),20108,NADH dehydrogenase [ubiquinone] iron-sulfur protein 4  mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS4 PE=1 SV=1
2545,23668,sp|Q9NWU5-2|RM22_HUMAN,1.93,40.77,4.808E5,4.663E5,8.739E5,7.785E5,1.00,0.97,1.82,1.62,4.808E5,4.663E5,8.739E5,7.785E5,1.00,0.97,1.82,1.62,10,1,1,iTRAQ 4plex (K  N-term),13734,Isoform 2 of 39S ribosomal protein L22  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL22
3134,42672,sp|Q9H8M2-2|BRD9_HUMAN,2.06,40.71,2.083E5,2.383E5,4.055E5,3.918E5,1.00,1.14,1.95,1.88,2.083E5,2.383E5,4.055E5,3.918E5,1.00,1.14,1.95,1.88,8,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),22534,Isoform 2 of Bromodomain-containing protein 9 OS=Homo sapiens OX=9606 GN=BRD9
3127,23339,C9JUJ0|C9JUJ0_HUMAN,2.30,40.65,1.988E5,2.013E5,4.125E5,3.858E5,1.00,1.01,2.07,1.94,1.988E5,2.013E5,4.125E5,3.858E5,1.00,1.01,2.07,1.94,13,1,1,iTRAQ 4plex (K  N-term),11940,CGG triplet repeat-binding protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=CGGBP1 PE=1 SV=1
2674,651,sp|O60343-2|TBCD4_HUMAN,1.81,40.60,1.362E5,1.456E5,2.476E5,2.283E5,1.00,1.07,1.82,1.68,1.362E5,1.456E5,2.476E5,2.283E5,1.00,1.07,1.82,1.68,1,1,1,iTRAQ 4plex (K  N-term),139556,Isoform 2 of TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4
2394,41202,sp|Q15477|SKIV2_HUMAN,0.43,40.54,3.996E5,4.026E5,4.7E5,4.432E5,1.00,1.01,1.18,1.11,3.996E5,4.026E5,4.7E5,4.432E5,1.00,1.01,1.18,1.11,1,1,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),137755,Helicase SKI2W OS=Homo sapiens OX=9606 GN=SKIV2L PE=1 SV=3
2956,41617,K7EKH5|K7EKH5_HUMAN,0.95,40.53,2.604E5,2.219E5,3.108E5,2.908E5,1.00,0.85,1.19,1.12,2.604E5,2.219E5,3.108E5,2.908E5,1.00,0.85,1.19,1.12,17,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),15035,Fructose-bisphosphate aldolase C (Fragment) OS=Homo sapiens OX=9606 GN=ALDOC PE=1 SV=1
3142,42734,sp|Q9NVJ2|ARL8B_HUMAN,1.30,40.41,6.129E5,5.588E5,8.711E5,8.509E5,1.00,0.91,1.42,1.39,6.129E5,5.588E5,8.711E5,8.509E5,1.00,0.91,1.42,1.39,5,1,1,iTRAQ 4plex (K  N-term),21539,ADP-ribosylation factor-like protein 8B OS=Homo sapiens OX=9606 GN=ARL8B PE=1 SV=1
3138,3724,sp|Q9BQ67|GRWD1_HUMAN,1.90,40.33,3.645E5,3.38E5,6.28E5,6.121E5,1.00,0.93,1.72,1.68,3.645E5,3.38E5,6.28E5,6.121E5,1.00,0.93,1.72,1.68,2,1,1,iTRAQ 4plex (K  N-term),49419,Glutamate-rich WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=GRWD1 PE=1 SV=1
3048,41990,sp|Q8TAF3-3|WDR48_HUMAN,2.30,40.31,1.528E5,1.251E5,2.517E5,2.603E5,1.00,0.82,1.65,1.70,1.528E5,1.251E5,2.517E5,2.603E5,1.00,0.82,1.65,1.70,2,1,1,iTRAQ 4plex (K  N-term),75349,Isoform 3 of WD repeat-containing protein 48 OS=Homo sapiens OX=9606 GN=WDR48
2366,10791,sp|Q9UM82|SPAT2_HUMAN,7.09,40.13,2.94E5,2.796E5,6.349E5,6.495E5,1.00,0.95,2.16,2.21,2.94E5,2.796E5,6.349E5,6.495E5,1.00,0.95,2.16,2.21,3,2,2,iTRAQ 4plex (K  N-term),58427,Spermatogenesis-associated protein 2 OS=Homo sapiens OX=9606 GN=SPATA2 PE=1 SV=2
3140,42710,sp|Q9UH62|ARMX3_HUMAN,1.16,40.10,3.944E5,4.074E5,5.88E5,5.899E5,1.00,1.03,1.49,1.50,3.944E5,4.074E5,5.88E5,5.899E5,1.00,1.03,1.49,1.50,3,1,1,iTRAQ 4plex (K  N-term),42501,Armadillo repeat-containing X-linked protein 3 OS=Homo sapiens OX=9606 GN=ARMCX3 PE=1 SV=1
2547,42784,sp|O43854-2|EDIL3_HUMAN,1.98,40.07,4.186E5,4.383E5,7.947E5,7.231E5,1.00,1.05,1.90,1.73,4.186E5,4.383E5,7.947E5,7.231E5,1.00,1.05,1.90,1.73,2,1,1,iTRAQ 4plex (K  N-term),52748,Isoform 2 of EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EDIL3
2249,20950,sp|Q8IUR0|TPPC5_HUMAN,5.77,40.04,7.707E5,7.321E5,1.495E6,1.461E6,1.00,0.95,1.94,1.90,7.707E5,7.321E5,1.495E6,1.461E6,1.00,0.95,1.94,1.90,9,2,2,iTRAQ 4plex (K  N-term),20783,Trafficking protein particle complex subunit 5 OS=Homo sapiens OX=9606 GN=TRAPPC5 PE=1 SV=1
2255,24041,sp|Q6P161|RM54_HUMAN,1.48,40.02,6.914E5,6.796E5,1.045E6,1.117E6,1.00,0.98,1.51,1.62,6.914E5,6.796E5,1.045E6,1.117E6,1.00,0.98,1.51,1.62,7,1,1,iTRAQ 4plex (K  N-term),15819,39S ribosomal protein L54  mitochondrial OS=Homo sapiens OX=9606 GN=MRPL54 PE=1 SV=1
2916,41981,H3BQ67|H3BQ67_HUMAN,1.19,39.89,2.913E5,2.665E5,4.029E5,3.819E5,1.00,0.91,1.38,1.31,2.913E5,2.665E5,4.029E5,3.819E5,1.00,0.91,1.38,1.31,7,1,1,iTRAQ 4plex (K  N-term),18931,Lon protease homolog 2  peroxisomal (Fragment) OS=Homo sapiens OX=9606 GN=LONP2 PE=1 SV=1
1987,40529,K7EK07|K7EK07_HUMAN,1.24,39.87,5.2E5,4.982E5,7.136E5,7.666E5,1.00,0.96,1.37,1.47,5.2E5,4.982E5,7.136E5,7.666E5,1.00,0.96,1.37,1.47,7,2,1,iTRAQ 4plex (K  N-term),14914,Histone H3 (Fragment) OS=Homo sapiens OX=9606 GN=H3F3B PE=1 SV=1
3145,42746,Q5JXX1|Q5JXX1_HUMAN,1.07,39.81,6.681E4,6.557E4,9.586E4,8.641E4,1.00,0.98,1.43,1.29,6.681E4,6.557E4,9.586E4,8.641E4,1.00,0.98,1.43,1.29,7,1,1,iTRAQ 4plex (K  N-term),17617,Mortality factor 4-like protein 2 (Fragment) OS=Homo sapiens OX=9606 GN=MORF4L2 PE=1 SV=1
3141,42730,E9PM51|E9PM51_HUMAN,0.69,39.78,1.316E5,1.269E5,1.635E5,1.602E5,1.00,0.96,1.24,1.22,1.316E5,1.269E5,1.635E5,1.602E5,1.00,0.96,1.24,1.22,5,1,1,iTRAQ 4plex (K  N-term),26705,General transcription factor IIH subunit 1 OS=Homo sapiens OX=9606 GN=GTF2H1 PE=1 SV=1
3144,23596,sp|Q99436-2|PSB7_HUMAN,2.11,39.74,1.811E5,1.505E5,2.972E5,2.933E5,1.00,0.83,1.64,1.62,1.811E5,1.505E5,2.972E5,2.933E5,1.00,0.83,1.64,1.62,7,1,1,iTRAQ 4plex (K  N-term),15323,Isoform 2 of Proteasome subunit beta type-7 OS=Homo sapiens OX=9606 GN=PSMB7
2742,41385,sp|Q6N021-2|TET2_HUMAN,0.96,39.74,9.99E4,1.078E5,1.362E5,1.408E5,1.00,1.08,1.36,1.41,9.99E4,1.078E5,1.362E5,1.408E5,1.00,1.08,1.36,1.41,1,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),130254,Isoform 2 of Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2
2464,42014,A0A087WU08|A0A087WU08_HUMAN,3.61,39.64,6.619E5,6.824E5,1.88E6,1.873E6,1.00,1.03,2.84,2.83,6.619E5,6.824E5,1.88E6,1.873E6,1.00,1.03,2.84,2.83,3,1,1,iTRAQ 4plex (K  N-term),31408,Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1
2966,24803,sp|Q8IXK0-4|PHC2_HUMAN,1.00,39.63,5.734E4,5.816E4,8.127E4,8.186E4,1.00,1.01,1.42,1.43,5.734E4,5.816E4,8.127E4,8.186E4,1.00,1.01,1.42,1.43,1,1,1,iTRAQ 4plex (K  N-term),87812,Isoform 4 of Polyhomeotic-like protein 2 OS=Homo sapiens OX=9606 GN=PHC2
3149,20461,F5H875|F5H875_HUMAN,1.21,39.62,4.646E5,4.629E5,7.036E5,6.788E5,1.00,1.00,1.51,1.46,4.646E5,4.629E5,7.036E5,6.788E5,1.00,1.00,1.51,1.46,7,1,1,iTRAQ 4plex (K  N-term),14313,Charged multivesicular body protein 1a OS=Homo sapiens OX=9606 GN=CHMP1A PE=1 SV=2
3041,41920,sp|Q08426-2|ECHP_HUMAN,1.49,39.57,3.657E5,3.839E5,5.439E5,6.043E5,1.00,1.05,1.49,1.65,3.657E5,3.839E5,5.439E5,6.043E5,1.00,1.05,1.49,1.65,2,1,1,iTRAQ 4plex (K  N-term),69154,Isoform 2 of Peroxisomal bifunctional enzyme OS=Homo sapiens OX=9606 GN=EHHADH
3146,42749,Q9HB66|Q9HB66_HUMAN,1.07,39.44,1.418E5,1.256E5,1.696E5,1.834E5,1.00,0.89,1.20,1.29,1.418E5,1.256E5,1.696E5,1.834E5,1.00,0.89,1.20,1.29,27,1,1,iTRAQ 4plex (K  N-term),7264,Alternative protein MKKS OS=Homo sapiens OX=9606 GN=MKKS PE=1 SV=1
2546,42712,sp|Q96T60-2|PNKP_HUMAN,0.85,39.35,1.708E5,1.618E5,2.197E5,2.012E5,1.00,0.95,1.29,1.18,1.708E5,1.618E5,2.197E5,2.012E5,1.00,0.95,1.29,1.18,3,1,1,iTRAQ 4plex (K  N-term),53004,Isoform 2 of Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens OX=9606 GN=PNKP
2905,7473,sp|Q14203-2|DCTN1_HUMAN,1.32,39.30,2.976E4,2.733E4,4.06E4,4.32E4,1.00,0.92,1.36,1.45,2.976E4,2.733E4,4.06E4,4.32E4,1.00,0.92,1.36,1.45,1,1,1,iTRAQ 4plex (K  N-term),127404,Isoform p135 of Dynactin subunit 1 OS=Homo sapiens OX=9606 GN=DCTN1
2444,22086,sp|P07384|CAN1_HUMAN,3.50,39.25,8.628E5,6.567E5,1.072E6,9.975E5,1.00,0.76,1.24,1.16,8.628E5,6.567E5,1.072E6,9.975E5,1.00,0.76,1.24,1.16,2,2,2,iTRAQ 4plex (K  N-term),81890,Calpain-1 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN1 PE=1 SV=1
1842,40228,sp|P09543-2|CN37_HUMAN,0.95,39.11,2.88E5,2.841E5,3.994E5,3.882E5,1.00,0.99,1.39,1.35,2.88E5,2.841E5,3.994E5,3.882E5,1.00,0.99,1.39,1.35,2,2,1,iTRAQ 4plex (K  N-term),45099,Isoform CNPI of 2' 3'-cyclic-nucleotide 3'-phosphodiesterase OS=Homo sapiens OX=9606 GN=CNP
2903,41325,sp|Q9H8Y5|ANKZ1_HUMAN,0.83,39.09,2.541E5,2.621E5,2.552E5,3.428E5,1.00,1.03,1.00,1.35,2.541E5,2.621E5,2.552E5,3.428E5,1.00,1.03,1.00,1.35,2,1,1,iTRAQ 4plex (K  N-term),80927,Ankyrin repeat and zinc finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKZF1 PE=1 SV=1
3023,41787,sp|Q9NZ01|TECR_HUMAN,1.38,39.05,5.774E5,5.02E5,8.04E5,7.768E5,1.00,0.87,1.39,1.35,5.774E5,5.02E5,8.04E5,7.768E5,1.00,0.87,1.39,1.35,3,1,1,iTRAQ 4plex (K  N-term),36034,Very-long-chain enoyl-CoA reductase OS=Homo sapiens OX=9606 GN=TECR PE=1 SV=1
3147,14704,H3BUH7|H3BUH7_HUMAN,1.68,39.04,3.535E5,3.017E5,5.281E5,5.173E5,1.00,0.85,1.49,1.46,3.535E5,3.017E5,5.281E5,5.173E5,1.00,0.85,1.49,1.46,9,1,1,iTRAQ 4plex (K  N-term),16917,Fructose-bisphosphate aldolase A (Fragment) OS=Homo sapiens OX=9606 GN=ALDOA PE=1 SV=1
2965,22311,sp|O60711|LPXN_HUMAN,1.58,38.99,3.331E5,3.15E5,5.35E5,5.239E5,1.00,0.95,1.61,1.57,3.331E5,3.15E5,5.35E5,5.239E5,1.00,0.95,1.61,1.57,3,1,1,iTRAQ 4plex (K  N-term),43332,Leupaxin OS=Homo sapiens OX=9606 GN=LPXN PE=1 SV=1
2460,41922,C9JVK8|C9JVK8_HUMAN,1.67,38.95,1.774E5,1.649E5,2.82E5,2.879E5,1.00,0.93,1.59,1.62,1.774E5,1.649E5,2.82E5,2.879E5,1.00,0.93,1.59,1.62,5,1,1,iTRAQ 4plex (K  N-term),25064,5-azacytidine-induced protein 2 (Fragment) OS=Homo sapiens OX=9606 GN=AZI2 PE=1 SV=1
3060,3375,sp|Q8WXE0-2|CSKI2_HUMAN,3.43,38.84,1.976E4,2.46E4,5.505E4,5.247E4,1.00,1.25,2.79,2.66,1.976E4,2.46E4,5.505E4,5.247E4,1.00,1.25,2.79,2.66,1,1,1,iTRAQ 4plex (K  N-term),118157,Isoform 2 of Caskin-2 OS=Homo sapiens OX=9606 GN=CASKIN2
1560,3582,A0A087X0T3|A0A087X0T3_HUMAN,1.64,38.81,4.514E4,4.534E4,7.911E4,7.217E4,1.00,1.00,1.75,1.60,4.514E4,4.534E4,7.911E4,7.217E4,1.00,1.00,1.75,1.60,1,3,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),225711,Myosin-7B OS=Homo sapiens OX=9606 GN=MYH7B PE=1 SV=1
2461,41938,C9JV50|C9JV50_HUMAN,1.84,38.67,1.898E5,1.655E5,2.814E5,3.035E5,1.00,0.87,1.48,1.60,1.898E5,1.655E5,2.814E5,3.035E5,1.00,0.87,1.48,1.60,5,1,1,iTRAQ 4plex (K  N-term),21430,Phosphatidylinositide phosphatase SAC1 (Fragment) OS=Homo sapiens OX=9606 GN=SACM1L PE=1 SV=1
2379,40498,sp|P11717|MPRI_HUMAN,1.74,38.66,6.954E5,7.244E5,5.681E5,5.414E5,1.00,1.04,0.82,0.78,6.954E5,7.244E5,5.681E5,5.414E5,1.00,1.04,0.82,0.78,1,2,2,iTRAQ 4plex (K  N-term),274373,Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3
2550,42826,sp|A0FGR8-4|ESYT2_HUMAN,2.24,38.59,4.84E5,4.606E5,9.379E5,9.352E5,1.00,0.95,1.94,1.93,4.84E5,4.606E5,9.379E5,9.352E5,1.00,0.95,1.94,1.93,2,1,1,iTRAQ 4plex (K  N-term),59403,Isoform 4 of Extended synaptotagmin-2 OS=Homo sapiens OX=9606 GN=ESYT2
2767,3493,sp|O75150-4|BRE1B_HUMAN,0.32,38.52,6.968E4,6.985E4,7.893E4,7.41E4,1.00,1.00,1.13,1.06,6.968E4,6.985E4,7.893E4,7.41E4,1.00,1.00,1.13,1.06,2,1,1,iTRAQ 4plex (K  N-term),102074,Isoform 4 of E3 ubiquitin-protein ligase BRE1B OS=Homo sapiens OX=9606 GN=RNF40
2390,24395,sp|P61221|ABCE1_HUMAN,2.59,38.48,5.91E5,5.81E5,8.241E5,8.534E5,1.00,0.98,1.39,1.44,5.91E5,5.81E5,8.241E5,8.534E5,1.00,0.98,1.39,1.44,3,2,2,iTRAQ 4plex (K  N-term),67314,ATP-binding cassette sub-family E member 1 OS=Homo sapiens OX=9606 GN=ABCE1 PE=1 SV=1
3143,42738,A0A087WT96|A0A087WT96_HUMAN,1.68,38.44,1.384E5,1.574E5,2.261E5,2.427E5,1.00,1.14,1.63,1.75,1.384E5,1.574E5,2.261E5,2.427E5,1.00,1.14,1.63,1.75,10,1,1,iTRAQ 4plex (K  N-term),14111,E3 ubiquitin-protein ligase ARIH1 (Fragment) OS=Homo sapiens OX=9606 GN=ARIH1 PE=1 SV=1
3152,42807,sp|P41743|KPCI_HUMAN,1.43,38.38,9.047E4,9.018E4,1.471E5,1.388E5,1.00,1.00,1.63,1.53,9.047E4,9.018E4,1.471E5,1.388E5,1.00,1.00,1.63,1.53,2,1,1,iTRAQ 4plex (K  N-term),68262,Protein kinase C iota type OS=Homo sapiens OX=9606 GN=PRKCI PE=1 SV=2
1942,41366,sp|O00479|HMGN4_HUMAN,1.32,38.34,4.586E5,5.231E5,7.049E5,7.207E5,1.00,1.14,1.54,1.57,4.586E5,5.231E5,7.049E5,7.207E5,1.00,1.14,1.54,1.57,10,1,1,iTRAQ 4plex (K  N-term),9539,High mobility group nucleosome-binding domain-containing protein 4 OS=Homo sapiens OX=9606 GN=HMGN4 PE=1 SV=3
3151,42798,sp|Q9Y6G9|DC1L1_HUMAN,3.32,38.29,1.082E5,1.184E5,2.674E5,2.91E5,1.00,1.09,2.47,2.69,1.082E5,1.184E5,2.674E5,2.91E5,1.00,1.09,2.47,2.69,2,1,1,iTRAQ 4plex (K  N-term),56579,Cytoplasmic dynein 1 light intermediate chain 1 OS=Homo sapiens OX=9606 GN=DYNC1LI1 PE=1 SV=3
3036,41895,E9PFK5|E9PFK5_HUMAN,1.28,38.21,1.191E5,1.099E5,1.709E5,1.711E5,1.00,0.92,1.44,1.44,1.191E5,1.099E5,1.709E5,1.711E5,1.00,0.92,1.44,1.44,1,1,1,iTRAQ 4plex (K  N-term),88866,Nucleolar protein 14 OS=Homo sapiens OX=9606 GN=NOP14 PE=1 SV=1
2385,40616,A0A1B0GWA2|A0A1B0GWA2_HUMAN,1.58,38.07,1.832E5,2.173E5,2.391E5,2.36E5,1.00,1.19,1.31,1.29,1.832E5,2.173E5,2.391E5,2.36E5,1.00,1.19,1.31,1.29,6,2,2,iTRAQ 4plex (K  N-term),60927,Alkylglycerone-phosphate synthase (Fragment) OS=Homo sapiens OX=9606 GN=AGPS PE=1 SV=1
3150,42790,E7ET40|E7ET40_HUMAN,1.63,38.07,5.898E5,5.466E5,8.702E5,9.418E5,1.00,0.93,1.48,1.60,5.898E5,5.466E5,8.702E5,9.418E5,1.00,0.93,1.48,1.60,2,1,1,iTRAQ 4plex (K  N-term),46925,Urokinase-type plasminogen activator OS=Homo sapiens OX=9606 GN=PLAU PE=1 SV=1
2386,40631,sp|Q9UBI9|HDC_HUMAN,2.21,38.04,2.702E5,2.709E5,3.816E5,3.482E5,1.00,1.00,1.41,1.29,2.702E5,2.709E5,3.816E5,3.482E5,1.00,1.00,1.41,1.29,4,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),58837,Headcase protein homolog OS=Homo sapiens OX=9606 GN=HECA PE=1 SV=1
3148,42770,sp|Q9H6W3-2|RIOX1_HUMAN,1.19,38.03,8.414E4,8.349E4,1.265E5,1.266E5,1.00,0.99,1.50,1.50,8.414E4,8.349E4,1.265E5,1.266E5,1.00,0.99,1.50,1.50,3,1,1,iTRAQ 4plex (K  N-term),48687,Isoform 2 of Ribosomal oxygenase 1 OS=Homo sapiens OX=9606 GN=RIOX1
2901,41216,sp|P57772|SELB_HUMAN,1.31,37.88,6.303E5,6.312E5,9.59E5,9.876E5,1.00,1.00,1.52,1.57,6.303E5,6.312E5,9.59E5,9.876E5,1.00,1.00,1.52,1.57,2,1,1,iTRAQ 4plex (K  N-term),65305,Selenocysteine-specific elongation factor OS=Homo sapiens OX=9606 GN=EEFSEC PE=1 SV=4
3153,42813,sp|Q02447-4|SP3_HUMAN,0.96,37.87,2.273E5,2.533E5,3.198E5,3.196E5,1.00,1.11,1.41,1.41,2.273E5,2.533E5,3.198E5,3.196E5,1.00,1.11,1.41,1.41,5,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),52050,Isoform 4 of Transcription factor Sp3 OS=Homo sapiens OX=9606 GN=SP3
2950,41490,sp|Q5SRE5-2|NU188_HUMAN,1.63,37.76,5.014E4,4.442E4,7.701E4,6.505E4,1.00,0.89,1.54,1.30,5.014E4,4.442E4,7.701E4,6.505E4,1.00,0.89,1.54,1.30,1,1,1,iTRAQ 4plex (K  N-term),182292,Isoform 2 of Nucleoporin NUP188 homolog OS=Homo sapiens OX=9606 GN=NUP188
2549,42821,F8VQQ8|F8VQQ8_HUMAN,0.73,37.75,3.392E5,2.75E5,2.605E5,2.616E5,1.00,0.81,0.77,0.77,3.392E5,2.75E5,2.605E5,2.616E5,1.00,0.81,0.77,0.77,12,1,1,iTRAQ 4plex (K  N-term),10089,Ubiquitin-conjugating enzyme E2 N OS=Homo sapiens OX=9606 GN=UBE2N PE=1 SV=1
2463,41988,V9GYN7|V9GYN7_HUMAN,2.85,37.67,3.589E5,3.926E5,8.572E5,7.618E5,1.00,1.09,2.39,2.12,3.589E5,3.926E5,8.572E5,7.618E5,1.00,1.09,2.39,2.12,4,1,1,iTRAQ 4plex (K  N-term),31239,DnaJ homolog subfamily B member 12 (Fragment) OS=Homo sapiens OX=9606 GN=DNAJB12 PE=1 SV=1
1659,24212,A0A0B4J2B8|A0A0B4J2B8_HUMAN,6.82,37.62,3.582E6,3.926E6,8.079E6,6.949E6,1.00,1.10,2.26,1.94,3.582E6,3.926E6,8.079E6,6.949E6,1.00,1.10,2.26,1.94,7,2,1,iTRAQ 4plex (K  N-term); Oxidation (M),12954,Immunoglobulin heavy variable 1/OR15-9 (non-functional) (Fragment) OS=Homo sapiens OX=9606 GN=IGHV1OR15-9 PE=4 SV=1
2035,21971,sp|Q8NDC0|MISSL_HUMAN,5.00,37.54,6.024E5,5.798E5,2.22E6,2.014E6,1.00,0.96,3.69,3.34,6.024E5,5.798E5,2.22E6,2.014E6,1.00,0.96,3.69,3.34,3,1,1,iTRAQ 4plex (K  N-term),24269,MAPK-interacting and spindle-stabilizing protein-like OS=Homo sapiens OX=9606 GN=MAPK1IP1L PE=1 SV=4
2457,41816,sp|Q96KS9|F167A_HUMAN,0.88,37.54,3.154E5,2.999E5,4.093E5,4.111E5,1.00,0.95,1.30,1.30,3.154E5,2.999E5,4.093E5,4.111E5,1.00,0.95,1.30,1.30,6,1,1,iTRAQ 4plex (K  N-term),24182,Protein FAM167A OS=Homo sapiens OX=9606 GN=FAM167A PE=1 SV=1
3016,20694,sp|P27824|CALX_HUMAN,1.65,37.47,2.502E5,2.33E5,3.802E5,4.041E5,1.00,0.93,1.52,1.62,2.502E5,2.33E5,3.802E5,4.041E5,1.00,0.93,1.52,1.62,2,1,1,iTRAQ 4plex (K  N-term),67568,Calnexin OS=Homo sapiens OX=9606 GN=CANX PE=1 SV=2
2963,41801,sp|Q06265-3|EXOS9_HUMAN,0.84,37.43,1.069E5,1.051E5,1.399E5,1.426E5,1.00,0.98,1.31,1.33,1.069E5,1.051E5,1.399E5,1.426E5,1.00,0.98,1.31,1.33,5,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),39235,Isoform 3 of Exosome complex component RRP45 OS=Homo sapiens OX=9606 GN=EXOSC9
3156,42846,sp|O43818|U3IP2_HUMAN,1.34,37.38,1.113E5,9.543E4,1.516E5,1.465E5,1.00,0.86,1.36,1.32,1.113E5,9.543E4,1.516E5,1.465E5,1.00,0.86,1.36,1.32,2,1,1,iTRAQ 4plex (K  N-term),51841,U3 small nucleolar RNA-interacting protein 2 OS=Homo sapiens OX=9606 GN=RRP9 PE=1 SV=1
3017,24839,sp|Q9UMZ2-6|SYNRG_HUMAN,2.63,37.32,2.192E4,2.065E4,4.33E4,4.73E4,1.00,0.94,1.98,2.16,2.192E4,2.065E4,4.33E4,4.73E4,1.00,0.94,1.98,2.16,1,1,1,iTRAQ 4plex (K  N-term),119509,Isoform 5 of Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG
2256,42851,sp|P00747|PLMN_HUMAN,5.12,37.19,4.174E5,4.431E5,1.642E6,1.615E6,1.00,1.06,3.93,3.87,4.174E5,4.431E5,1.642E6,1.615E6,1.00,1.06,3.93,3.87,1,1,1,iTRAQ 4plex (K  N-term),90569,Plasminogen OS=Homo sapiens OX=9606 GN=PLG PE=1 SV=2
2552,42833,sp|Q15773|MLF2_HUMAN,1.65,37.19,3.883E5,3.908E5,6.74E5,6.608E5,1.00,1.01,1.74,1.70,3.883E5,3.908E5,6.74E5,6.608E5,1.00,1.01,1.74,1.70,5,1,1,iTRAQ 4plex (K  N-term),28147,Myeloid leukemia factor 2 OS=Homo sapiens OX=9606 GN=MLF2 PE=1 SV=1
3154,42843,sp|Q14061|COX17_HUMAN,1.25,37.12,1.245E5,1.277E5,1.921E5,1.869E5,1.00,1.03,1.54,1.50,1.245E5,1.277E5,1.921E5,1.869E5,1.00,1.03,1.54,1.50,25,1,1,iTRAQ 4plex (K  N-term),6915,Cytochrome c oxidase copper chaperone OS=Homo sapiens OX=9606 GN=COX17 PE=1 SV=2
2548,42801,D6RCQ0|D6RCQ0_HUMAN,0.28,37.10,4.458E5,4.751E5,4.945E5,4.971E5,1.00,1.07,1.11,1.12,4.458E5,4.751E5,4.945E5,4.971E5,1.00,1.07,1.11,1.12,12,1,1,iTRAQ 4plex (K  N-term),10424,Eukaryotic translation elongation factor 1 epsilon-1 (Fragment) OS=Homo sapiens OX=9606 GN=EEF1E1 PE=4 SV=1
3040,41915,A0A096LPA3|A0A096LPA3_HUMAN,1.45,37.05,8.18E4,9.025E4,1.239E5,1.344E5,1.00,1.10,1.51,1.64,8.18E4,9.025E4,1.239E5,1.344E5,1.00,1.10,1.51,1.64,9,1,1,iTRAQ 4plex (K  N-term),17351,Probable peptidyl-tRNA hydrolase (Fragment) OS=Homo sapiens OX=9606 GN=PTRH1 PE=1 SV=1
3155,42845,B4DEP1|B4DEP1_HUMAN,1.03,37.04,3.726E5,3.591E5,5.169E5,5.041E5,1.00,0.96,1.39,1.35,3.726E5,3.591E5,5.169E5,5.041E5,1.00,0.96,1.39,1.35,7,1,1,iTRAQ 4plex (K  N-term),14285,Adenylosuccinate lyase OS=Homo sapiens OX=9606 GN=ADSL PE=1 SV=1
2524,12155,sp|Q6P6C2|ALKB5_HUMAN,3.63,36.97,3.177E5,3.177E5,5.329E5,5.226E5,1.00,1.00,1.68,1.64,3.177E5,3.177E5,5.329E5,5.226E5,1.00,1.00,1.68,1.64,4,2,2,iTRAQ 4plex (K  N-term),44256,RNA demethylase ALKBH5 OS=Homo sapiens OX=9606 GN=ALKBH5 PE=1 SV=2
3010,41466,sp|Q9Y2W2|WBP11_HUMAN,0.94,36.81,3.86E5,3.776E5,4.452E5,5.266E5,1.00,0.98,1.15,1.36,3.86E5,3.776E5,4.452E5,5.266E5,1.00,0.98,1.15,1.36,1,1,1,iTRAQ 4plex (K  N-term),69998,WW domain-binding protein 11 OS=Homo sapiens OX=9606 GN=WBP11 PE=1 SV=1
3061,31073,sp|P45974-2|UBP5_HUMAN,0.62,36.74,4.315E5,5.01E5,5.334E5,5.426E5,1.00,1.16,1.24,1.26,4.315E5,5.01E5,5.334E5,5.426E5,1.00,1.16,1.24,1.26,1,1,1,iTRAQ 4plex (K  N-term),93308,Isoform Short of Ubiquitin carboxyl-terminal hydrolase 5 OS=Homo sapiens OX=9606 GN=USP5
2915,14345,I3L2C7|I3L2C7_HUMAN,2.16,36.65,1.117E5,1.314E5,2.065E5,2.245E5,1.00,1.18,1.85,2.01,1.117E5,1.314E5,2.065E5,2.245E5,1.00,1.18,1.85,2.01,1,1,1,iTRAQ 4plex (K  N-term),118822,Gem-associated protein 4 OS=Homo sapiens OX=9606 GN=GEMIN4 PE=1 SV=1
3160,42880,F8VRL4|F8VRL4_HUMAN,1.43,36.55,7.329E4,7.177E4,1.172E5,1.144E5,1.00,0.98,1.60,1.56,7.329E4,7.177E4,1.172E5,1.144E5,1.00,0.98,1.60,1.56,9,1,1,iTRAQ 4plex (K  N-term),11015,Diphosphoinositol polyphosphate phosphohydrolase 2 (Fragment) OS=Homo sapiens OX=9606 GN=NUDT4 PE=1 SV=1
2967,42035,sp|Q14978|NOLC1_HUMAN,1.19,36.54,2.25E5,2.196E5,3.003E5,3.327E5,1.00,0.98,1.33,1.48,2.25E5,2.196E5,3.003E5,3.327E5,1.00,0.98,1.33,1.48,1,1,1,iTRAQ 4plex (K  N-term),73603,Nucleolar and coiled-body phosphoprotein 1 OS=Homo sapiens OX=9606 GN=NOLC1 PE=1 SV=2
2554,42873,C9JAB9|C9JAB9_HUMAN,1.41,36.54,9.567E4,9.332E4,1.483E5,1.513E5,1.00,0.98,1.55,1.58,9.567E4,9.332E4,1.483E5,1.513E5,1.00,0.98,1.55,1.58,5,1,1,iTRAQ 4plex (K  N-term),20069,Cytoplasmic protein NCK1 (Fragment) OS=Homo sapiens OX=9606 GN=NCK1 PE=1 SV=1
2834,7118,A0A0A0MRE9|A0A0A0MRE9_HUMAN,1.65,36.54,9.947E4,1.101E5,1.692E5,1.735E5,1.00,1.11,1.70,1.74,9.947E4,1.101E5,1.692E5,1.735E5,1.00,1.11,1.70,1.74,0,1,1,iTRAQ 4plex (K  N-term),362578,A-kinase anchor protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=1
3159,42878,J3KS15|J3KS15_HUMAN,1.62,36.52,2.523E5,2.084E5,3.545E5,3.591E5,1.00,0.83,1.40,1.42,2.523E5,2.084E5,3.545E5,3.591E5,1.00,0.83,1.40,1.42,5,1,1,iTRAQ 4plex (K  N-term),21905,Peptidyl-tRNA hydrolase ICT1  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPL58 PE=1 SV=1
2837,41534,sp|P43246-2|MSH2_HUMAN,1.45,36.52,1.614E5,1.799E5,2.614E5,2.645E5,1.00,1.11,1.62,1.64,1.614E5,1.799E5,2.614E5,2.645E5,1.00,1.11,1.62,1.64,1,1,1,iTRAQ 4plex (K  N-term),97323,Isoform 2 of DNA mismatch repair protein Msh2 OS=Homo sapiens OX=9606 GN=MSH2
2551,10972,H0YDF6|H0YDF6_HUMAN,2.28,36.46,4.224E5,4.159E5,8.583E5,7.956E5,1.00,0.98,2.03,1.88,4.224E5,4.159E5,8.583E5,7.956E5,1.00,0.98,2.03,1.88,7,1,1,iTRAQ 4plex (K  N-term),19368,NHS-like protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=NHSL1 PE=1 SV=1
2553,23661,sp|Q9NX24|NHP2_HUMAN,1.05,36.42,3.572E5,3.401E5,4.89E5,4.92E5,1.00,0.95,1.37,1.38,3.572E5,3.401E5,4.89E5,4.92E5,1.00,0.95,1.37,1.38,7,1,1,iTRAQ 4plex (K  N-term),17201,H/ACA ribonucleoprotein complex subunit 2 OS=Homo sapiens OX=9606 GN=NHP2 PE=1 SV=1
3157,42853,sp|Q08AM6|VAC14_HUMAN,2.15,36.33,2.151E5,2.231E5,4.067E5,4.299E5,1.00,1.04,1.89,2.00,2.151E5,2.231E5,4.067E5,4.299E5,1.00,1.04,1.89,2.00,2,1,1,iTRAQ 4plex (K  N-term),87973,Protein VAC14 homolog OS=Homo sapiens OX=9606 GN=VAC14 PE=1 SV=1
2842,41934,A0A087WTA5|A0A087WTA5_HUMAN,2.70,36.24,3.585E5,4.063E5,7.336E5,8.253E5,1.00,1.13,2.05,2.30,3.585E5,4.063E5,7.336E5,8.253E5,1.00,1.13,2.05,2.30,2,1,1,iTRAQ 4plex (K  N-term),57496,Translation initiation factor eIF-2B subunit delta OS=Homo sapiens OX=9606 GN=EIF2B4 PE=1 SV=1
3163,42920,sp|P04181|OAT_HUMAN,2.02,36.14,1.503E5,1.334E5,2.554E5,2.577E5,1.00,0.89,1.70,1.71,1.503E5,1.334E5,2.554E5,2.577E5,1.00,0.89,1.70,1.71,3,1,1,iTRAQ 4plex (K  N-term),48535,Ornithine aminotransferase  mitochondrial OS=Homo sapiens OX=9606 GN=OAT PE=1 SV=1
3050,42004,sp|O43172|PRP4_HUMAN,2.04,36.03,1.461E5,1.54E5,2.842E5,2.839E5,1.00,1.05,1.94,1.94,1.461E5,1.54E5,2.842E5,2.839E5,1.00,1.05,1.94,1.94,2,1,1,iTRAQ 4plex (K  N-term),58449,U4/U6 small nuclear ribonucleoprotein Prp4 OS=Homo sapiens OX=9606 GN=PRPF4 PE=1 SV=2
1992,22009,sp|P25490|TYY1_HUMAN,3.49,36.00,3.606E5,3.645E5,5.835E5,5.981E5,1.00,1.01,1.62,1.66,3.606E5,3.645E5,5.835E5,5.981E5,1.00,1.01,1.62,1.66,4,2,2,iTRAQ 4plex (K  N-term),44713,Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2
2257,9895,sp|Q12933-4|TRAF2_HUMAN,1.93,35.98,4.505E5,4.524E5,8.355E5,8.455E5,1.00,1.00,1.85,1.88,4.505E5,4.524E5,8.355E5,8.455E5,1.00,1.00,1.85,1.88,2,1,1,iTRAQ 4plex (K  N-term),53055,Isoform 4 of TNF receptor-associated factor 2 OS=Homo sapiens OX=9606 GN=TRAF2
3158,42871,sp|Q92968|PEX13_HUMAN,3.97,35.73,1.235E5,1.321E5,3.857E5,3.286E5,1.00,1.07,3.12,2.66,1.235E5,1.321E5,3.857E5,3.286E5,1.00,1.07,3.12,2.66,2,1,1,iTRAQ 4plex (K  N-term),44130,Peroxisomal membrane protein PEX13 OS=Homo sapiens OX=9606 GN=PEX13 PE=1 SV=2
3045,41977,M0QXD6|M0QXD6_HUMAN,1.43,35.72,1.487E5,1.695E5,2.424E5,2.235E5,1.00,1.14,1.63,1.50,1.487E5,1.695E5,2.424E5,2.235E5,1.00,1.14,1.63,1.50,3,1,1,iTRAQ 4plex (K  N-term),48596,General transcription factor IIF subunit 1 (Fragment) OS=Homo sapiens OX=9606 GN=GTF2F1 PE=1 SV=1
2465,42051,sp|P31431-2|SDC4_HUMAN,0.86,35.71,2.064E5,2.101E5,2.815E5,2.773E5,1.00,1.02,1.36,1.34,2.064E5,2.101E5,2.815E5,2.773E5,1.00,1.02,1.36,1.34,9,1,1,iTRAQ 4plex (K  N-term),16545,Isoform 2 of Syndecan-4 OS=Homo sapiens OX=9606 GN=SDC4
3167,42954,J3QRY6|J3QRY6_HUMAN,1.73,35.60,7.902E4,8.416E4,1.411E5,1.259E5,1.00,1.07,1.79,1.59,7.902E4,8.416E4,1.411E5,1.259E5,1.00,1.07,1.79,1.59,3,1,1,iTRAQ 4plex (K  N-term),38464,Cleavage and polyadenylation specific factor 3-like  isoform CRA_g OS=Homo sapiens OX=9606 GN=INTS11 PE=1 SV=1
2555,42874,sp|P11166|GTR1_HUMAN,0.87,35.56,7.166E5,6.11E5,8.339E5,7.782E5,1.00,0.85,1.16,1.09,7.166E5,6.11E5,8.339E5,7.782E5,1.00,0.85,1.16,1.09,3,1,1,iTRAQ 4plex (K  N-term),54084,Solute carrier family 2  facilitated glucose transporter member 1 OS=Homo sapiens OX=9606 GN=SLC2A1 PE=1 SV=2
2556,19998,sp|Q5JVF3-3|PCID2_HUMAN,3.95,35.56,2.521E5,2.649E5,7.815E5,7.561E5,1.00,1.05,3.10,3.00,2.521E5,2.649E5,7.815E5,7.561E5,1.00,1.05,3.10,3.00,2,1,1,iTRAQ 4plex (K  N-term),43375,Isoform 3 of PCI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PCID2
3165,42939,H7C4V0|H7C4V0_HUMAN,1.53,35.40,1.064E5,1.002E5,1.674E5,1.685E5,1.00,0.94,1.57,1.58,1.064E5,1.002E5,1.674E5,1.685E5,1.00,0.94,1.57,1.58,4,1,1,iTRAQ 4plex (K  N-term),34820,PX domain-containing protein kinase-like protein (Fragment) OS=Homo sapiens OX=9606 GN=PXK PE=1 SV=1
2462,29576,sp|Q5M9Q1|NKAPL_HUMAN,1.11,35.36,6.114E5,6.932E5,9.01E5,8.52E5,1.00,1.13,1.47,1.39,6.114E5,6.932E5,9.01E5,8.52E5,1.00,1.13,1.47,1.39,2,1,1,iTRAQ 4plex (K  N-term),46312,NKAP-like protein OS=Homo sapiens OX=9606 GN=NKAPL PE=2 SV=3
2557,42995,H0Y613|H0Y613_HUMAN,1.45,35.22,1.156E5,1.108E5,1.822E5,1.751E5,1.00,0.96,1.58,1.51,1.156E5,1.108E5,1.822E5,1.751E5,1.00,0.96,1.58,1.51,1,1,1,iTRAQ 4plex (K  N-term),112648,Genetic suppressor element 1 (Fragment) OS=Homo sapiens OX=9606 GN=GSE1 PE=1 SV=1
3019,100,sp|P36954|RPB9_HUMAN,1.49,35.15,6.377E4,6.082E4,1.011E5,9.627E4,1.00,0.95,1.59,1.51,6.377E4,6.082E4,1.011E5,9.627E4,1.00,0.95,1.59,1.51,9,1,1,iTRAQ 4plex (K  N-term),14523,DNA-directed RNA polymerase II subunit RPB9 OS=Homo sapiens OX=9606 GN=POLR2I PE=1 SV=1
3034,41884,A0A0A0MQU1|A0A0A0MQU1_HUMAN,1.59,35.14,2.802E5,2.372E5,3.349E5,4.056E5,1.00,0.85,1.20,1.45,2.802E5,2.372E5,3.349E5,4.056E5,1.00,0.85,1.20,1.45,1,1,1,iTRAQ 4plex (K  N-term),78826,Inverted formin-2 (Fragment) OS=Homo sapiens OX=9606 GN=INF2 PE=1 SV=1
2948,41444,B9A062|B9A062_HUMAN,1.20,35.12,2.138E5,2.378E5,2.962E5,3.246E5,1.00,1.11,1.39,1.52,2.138E5,2.378E5,2.962E5,3.246E5,1.00,1.11,1.39,1.52,5,1,1,iTRAQ 4plex (K  N-term),23867,Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase  mitochondrial OS=Homo sapiens OX=9606 GN=MTHFD2 PE=1 SV=1
3169,42989,H0YE28|H0YE28_HUMAN,1.35,35.11,6.26E5,6.486E5,9.645E5,9.939E5,1.00,1.04,1.54,1.59,6.26E5,6.486E5,9.645E5,9.939E5,1.00,1.04,1.54,1.59,10,1,1,iTRAQ 4plex (K  N-term),10450,Selenoprotein H (Fragment) OS=Homo sapiens OX=9606 GN=SELENOH PE=1 SV=1
3168,17083,sp|Q9BQA1-2|MEP50_HUMAN,1.12,35.03,3.33E5,3.253E5,4.653E5,4.809E5,1.00,0.98,1.40,1.44,3.33E5,3.253E5,4.653E5,4.809E5,1.00,0.98,1.40,1.44,4,1,1,iTRAQ 4plex (K  N-term),29651,Isoform 2 of Methylosome protein 50 OS=Homo sapiens OX=9606 GN=WDR77
3161,42901,H0YKH0|H0YKH0_HUMAN,2.41,34.98,6.276E4,5.414E4,1.131E5,1.167E5,1.00,0.86,1.80,1.86,6.276E4,5.414E4,1.131E5,1.167E5,1.00,0.86,1.80,1.86,3,1,1,iTRAQ 4plex (K  N-term),47761,Transducin-like enhancer protein 3 OS=Homo sapiens OX=9606 GN=TLE3 PE=1 SV=1
3162,42918,sp|Q9BW61|DDA1_HUMAN,1.02,34.90,1.166E5,1.247E5,1.627E5,1.676E5,1.00,1.07,1.40,1.44,1.166E5,1.247E5,1.627E5,1.676E5,1.00,1.07,1.40,1.44,12,1,1,iTRAQ 4plex (K  N-term),11835,DET1- and DDB1-associated protein 1 OS=Homo sapiens OX=9606 GN=DDA1 PE=1 SV=1
2558,21596,J3QS68|J3QS68_HUMAN,2.00,34.82,2.655E5,2.484E5,4.762E5,4.465E5,1.00,0.94,1.79,1.68,2.655E5,2.484E5,4.762E5,4.465E5,1.00,0.94,1.79,1.68,6,1,1,iTRAQ 4plex (K  N-term),17448,E3 ubiquitin-protein ligase RNF135 (Fragment) OS=Homo sapiens OX=9606 GN=RNF135 PE=1 SV=8
2458,7156,sp|Q14191|WRN_HUMAN,1.00,34.65,4.66E5,4.622E5,6.588E5,6.557E5,1.00,0.99,1.41,1.41,4.66E5,4.622E5,6.588E5,6.557E5,1.00,0.99,1.41,1.41,1,1,1,iTRAQ 4plex (K  N-term),162460,Werner syndrome ATP-dependent helicase OS=Homo sapiens OX=9606 GN=WRN PE=1 SV=2
3164,42929,A0A182DWI4|A0A182DWI4_HUMAN,1.40,34.63,9.861E4,8.332E4,1.349E5,1.225E5,1.00,0.85,1.37,1.24,9.861E4,8.332E4,1.349E5,1.225E5,1.00,0.85,1.37,1.24,7,1,1,iTRAQ 4plex (K  N-term),18494,Selenoprotein S OS=Homo sapiens OX=9606 GN=SELENOS PE=1 SV=1
2469,43404,sp|Q9Y6H1|CHCH2_HUMAN,3.95,34.59,1.516E5,1.591E5,2.692E5,2.64E5,1.00,1.05,1.78,1.74,1.516E5,1.591E5,2.692E5,2.64E5,1.00,1.05,1.78,1.74,16,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),15513,Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CHCHD2 PE=1 SV=1
3038,41905,sp|Q9BW62|KATL1_HUMAN,1.52,34.56,2.972E5,2.093E5,1.876E5,1.772E5,1.00,0.70,0.63,0.60,2.972E5,2.093E5,1.876E5,1.772E5,1.00,0.70,0.63,0.60,2,1,1,iTRAQ 4plex (K  N-term),55392,Katanin p60 ATPase-containing subunit A-like 1 OS=Homo sapiens OX=9606 GN=KATNAL1 PE=1 SV=1
2525,41457,sp|Q9H4L5-8|OSBL3_HUMAN,5.81,34.46,4.359E5,4.388E5,9.213E5,9.008E5,1.00,1.01,2.11,2.07,4.359E5,4.388E5,9.213E5,9.008E5,1.00,1.01,2.11,2.07,4,2,2,iTRAQ 4plex (K  N-term),64776,Isoform 2d of Oxysterol-binding protein-related protein 3 OS=Homo sapiens OX=9606 GN=OSBPL3
2452,28014,sp|Q9UM47|NOTC3_HUMAN,1.58,34.34,1.006E5,1.021E5,1.652E5,1.722E5,1.00,1.02,1.64,1.71,1.006E5,1.021E5,1.652E5,1.722E5,1.00,1.02,1.64,1.71,0,2,1,iTRAQ 4plex (K  N-term),243629,Neurogenic locus notch homolog protein 3 OS=Homo sapiens OX=9606 GN=NOTCH3 PE=1 SV=2
3166,42951,H0Y459|H0Y459_HUMAN,2.00,34.32,6.514E4,7.215E4,1.229E5,1.256E5,1.00,1.11,1.89,1.93,6.514E4,7.215E4,1.229E5,1.256E5,1.00,1.11,1.89,1.93,12,1,1,iTRAQ 4plex (K  N-term),10037,Nuclear receptor corepressor 1 (Fragment) OS=Homo sapiens OX=9606 GN=NCOR1 PE=1 SV=1
2527,2516,sp|Q9BTE3-2|MCMBP_HUMAN,3.46,34.20,3.137E5,3.224E5,5.201E5,5.211E5,1.00,1.03,1.66,1.66,3.137E5,3.224E5,5.201E5,5.211E5,1.00,1.03,1.66,1.66,4,2,2,iTRAQ 4plex (K  N-term),72749,Isoform 2 of Mini-chromosome maintenance complex-binding protein OS=Homo sapiens OX=9606 GN=MCMBP
2354,5704,sp|B2RTY4-2|MYO9A_HUMAN,2.10,34.13,4.632E4,5.325E4,9.252E4,9.053E4,1.00,1.15,2.00,1.95,4.632E4,5.325E4,9.252E4,9.053E4,1.00,1.15,2.00,1.95,0,2,1,iTRAQ 4plex (K  N-term),290378,Isoform 2 of Unconventional myosin-IXa OS=Homo sapiens OX=9606 GN=MYO9A
3175,17984,sp|Q9ULC8-2|ZDHC8_HUMAN,2.32,34.00,9.544E4,8.526E4,1.759E5,1.792E5,1.00,0.89,1.84,1.88,9.544E4,8.526E4,1.759E5,1.792E5,1.00,0.89,1.84,1.88,1,1,1,iTRAQ 4plex (K  N-term),71235,Isoform 2 of Probable palmitoyltransferase ZDHHC8 OS=Homo sapiens OX=9606 GN=ZDHHC8
3171,43010,sp|Q9Y5P6|GMPPB_HUMAN,0.49,33.84,1.487E6,1.399E6,1.68E6,1.64E6,1.00,0.94,1.13,1.10,1.487E6,1.399E6,1.68E6,1.64E6,1.00,0.94,1.13,1.10,3,1,1,iTRAQ 4plex (K  N-term),39834,Mannose-1-phosphate guanyltransferase beta OS=Homo sapiens OX=9606 GN=GMPPB PE=1 SV=2
3177,43036,sp|Q9NXX6|NSE4A_HUMAN,2.28,33.74,1.452E5,1.601E5,2.836E5,3.013E5,1.00,1.10,1.95,2.07,1.452E5,1.601E5,2.836E5,3.013E5,1.00,1.10,1.95,2.07,4,1,1,iTRAQ 4plex (K  N-term),44301,Non-structural maintenance of chromosomes element 4 homolog A OS=Homo sapiens OX=9606 GN=NSMCE4A PE=1 SV=2
3181,43052,B3KQH5|B3KQH5_HUMAN,2.86,33.73,2.414E5,2.388E5,5.509E5,5.74E5,1.00,0.99,2.28,2.38,2.414E5,2.388E5,5.509E5,5.74E5,1.00,0.99,2.28,2.38,1,1,1,iTRAQ 4plex (K  N-term),80512,Integrator complex subunit 6  isoform CRA_b OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1
3176,43035,C9IYP1|C9IYP1_HUMAN,2.24,33.70,1.318E5,1.455E5,2.708E5,2.469E5,1.00,1.10,2.05,1.87,1.318E5,1.455E5,2.708E5,2.469E5,1.00,1.10,2.05,1.87,10,1,1,iTRAQ 4plex (K  N-term),13283,Disks large homolog 1 (Fragment) OS=Homo sapiens OX=9606 GN=DLG1 PE=1 SV=1
2559,43032,sp|Q9NR50-3|EI2BG_HUMAN,0.92,33.65,3.884E5,3.673E5,4.822E5,5.096E5,1.00,0.95,1.24,1.31,3.884E5,3.673E5,4.822E5,5.096E5,1.00,0.95,1.24,1.31,2,1,1,iTRAQ 4plex (K  N-term),44803,Isoform 3 of Translation initiation factor eIF-2B subunit gamma OS=Homo sapiens OX=9606 GN=EIF2B3
3170,43005,sp|P32189-1|GLPK_HUMAN,1.35,33.58,1.147E5,1.232E5,1.602E5,1.828E5,1.00,1.07,1.40,1.59,1.147E5,1.232E5,1.602E5,1.828E5,1.00,1.07,1.40,1.59,2,1,1,iTRAQ 4plex (K  N-term),57489,Isoform 1 of Glycerol kinase OS=Homo sapiens OX=9606 GN=GK
2562,43055,sp|P01042-3|KNG1_HUMAN,3.67,33.58,1.38E5,1.301E5,3.807E5,2.581E5,1.00,0.94,2.76,1.87,1.38E5,1.301E5,3.807E5,2.581E5,1.00,0.94,2.76,1.87,2,1,1,iTRAQ 4plex (K  N-term),43822,Isoform 3 of Kininogen-1 OS=Homo sapiens OX=9606 GN=KNG1
3173,43016,H7C2A1|H7C2A1_HUMAN,1.58,33.55,6.616E4,5.605E4,9.17E4,9.605E4,1.00,0.85,1.39,1.45,6.616E4,5.605E4,9.17E4,9.605E4,1.00,0.85,1.39,1.45,7,1,1,iTRAQ 4plex (K  N-term),13976,Heat shock 70 kDa protein 14 (Fragment) OS=Homo sapiens OX=9606 GN=HSPA14 PE=1 SV=1
3055,42065,sp|P56181-2|NDUV3_HUMAN,1.63,33.30,1.789E5,1.643E5,2.843E5,2.538E5,1.00,0.92,1.59,1.42,1.789E5,1.643E5,2.843E5,2.538E5,1.00,0.92,1.59,1.42,2,1,1,iTRAQ 4plex (K  N-term),50984,Isoform 2 of NADH dehydrogenase [ubiquinone] flavoprotein 3  mitochondrial OS=Homo sapiens OX=9606 GN=NDUFV3
2914,41859,sp|Q8TEH3|DEN1A_HUMAN,0.57,33.24,2.508E5,2.284E5,2.777E5,2.823E5,1.00,0.91,1.11,1.13,2.508E5,2.284E5,2.777E5,2.823E5,1.00,0.91,1.11,1.13,1,1,1,iTRAQ 4plex (K  N-term),110577,DENN domain-containing protein 1A OS=Homo sapiens OX=9606 GN=DENND1A PE=1 SV=2
2560,21427,sp|P62306|RUXF_HUMAN,1.50,33.22,7.311E4,6.947E4,1.16E5,8.868E4,1.00,0.95,1.59,1.21,7.311E4,6.947E4,1.16E5,8.868E4,1.00,0.95,1.59,1.21,15,1,1,iTRAQ 4plex (K  N-term),9725,Small nuclear ribonucleoprotein F OS=Homo sapiens OX=9606 GN=SNRPF PE=1 SV=1
3172,43015,M0R3H8|M0R3H8_HUMAN,1.46,33.19,1.375E5,1.29E5,2.043E5,2.125E5,1.00,0.94,1.49,1.55,1.375E5,1.29E5,2.043E5,2.125E5,1.00,0.94,1.49,1.55,3,1,1,iTRAQ 4plex (K  N-term),44214,Uncharacterized protein (Fragment) OS=Homo sapiens OX=9606 PE=3 SV=1
3184,22169,sp|P07858|CATB_HUMAN,1.03,33.00,2.811E5,2.766E5,3.983E5,3.671E5,1.00,0.98,1.42,1.31,2.811E5,2.766E5,3.983E5,3.671E5,1.00,0.98,1.42,1.31,2,1,1,iTRAQ 4plex (K  N-term),37822,Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=3
3063,43069,Q5T123|Q5T123_HUMAN,1.84,32.99,8.581E4,7.004E4,9.396E4,1.293E5,1.00,0.82,1.09,1.51,8.581E4,7.004E4,9.396E4,1.293E5,1.00,0.82,1.09,1.51,11,1,1,iTRAQ 4plex (K  N-term),9381,SH3 domain-binding glutamic acid-rich-like protein 3 OS=Homo sapiens OX=9606 GN=SH3BGRL3 PE=1 SV=1
3182,43062,A6NDF3|A6NDF3_HUMAN,1.74,32.91,1.158E5,1.142E5,2.021E5,2.043E5,1.00,0.99,1.74,1.76,1.158E5,1.142E5,2.021E5,2.043E5,1.00,0.99,1.74,1.76,4,1,1,iTRAQ 4plex (K  N-term),26644,Protein PBDC1 OS=Homo sapiens OX=9606 GN=PBDC1 PE=1 SV=2
3179,29641,sp|P18440|ARY1_HUMAN,0.75,32.90,1.468E5,1.424E5,1.87E5,1.844E5,1.00,0.97,1.27,1.26,1.468E5,1.424E5,1.87E5,1.844E5,1.00,0.97,1.27,1.26,3,1,1,iTRAQ 4plex (K  N-term),33899,Arylamine N-acetyltransferase 1 OS=Homo sapiens OX=9606 GN=NAT1 PE=1 SV=2
3186,43075,H7C3J3|H7C3J3_HUMAN,1.66,32.77,2.065E5,2.176E5,3.594E5,3.602E5,1.00,1.05,1.74,1.74,2.065E5,2.176E5,3.594E5,3.602E5,1.00,1.05,1.74,1.74,3,1,1,iTRAQ 4plex (K  N-term),30354,THUMP domain-containing protein 3 (Fragment) OS=Homo sapiens OX=9606 GN=THUMPD3 PE=1 SV=1
2526,8407,sp|Q01543-3|FLI1_HUMAN,7.09,32.73,3.941E5,3.677E5,8.125E5,8.859E5,1.00,0.93,2.06,2.25,3.941E5,3.677E5,8.125E5,8.859E5,1.00,0.93,2.06,2.25,6,2,2,iTRAQ 4plex (K  N-term); Deamidation (NQ),47576,Isoform 3 of Friend leukemia integration 1 transcription factor OS=Homo sapiens OX=9606 GN=FLI1
3197,43187,sp|P10155|RO60_HUMAN,2.28,32.66,1.985E4,2.235E4,4.159E4,4.097E4,1.00,1.13,2.10,2.06,1.985E4,2.235E4,4.159E4,4.097E4,1.00,1.13,2.10,2.06,1,1,1,iTRAQ 4plex (K  N-term),60671,60 kDa SS-A/Ro ribonucleoprotein OS=Homo sapiens OX=9606 GN=TROVE2 PE=1 SV=2
3178,43045,sp|Q99549|MPP8_HUMAN,2.29,32.65,2.68E4,2.334E4,4.228E4,4.895E4,1.00,0.87,1.58,1.83,2.68E4,2.334E4,4.228E4,4.895E4,1.00,0.87,1.58,1.83,4,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),97182,M-phase phosphoprotein 8 OS=Homo sapiens OX=9606 GN=MPHOSPH8 PE=1 SV=2
2970,20225,sp|Q6NZ67|MZT2B_HUMAN,2.50,32.47,3.973E4,4.015E4,8.792E4,8.802E4,1.00,1.01,2.21,2.22,3.973E4,4.015E4,8.792E4,8.802E4,1.00,1.01,2.21,2.22,6,1,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),16226,Mitotic-spindle organizing protein 2B OS=Homo sapiens OX=9606 GN=MZT2B PE=1 SV=1
3044,41973,sp|Q6ZSC3|RBM43_HUMAN,0.83,32.31,2.258E5,2.177E5,2.91E5,2.941E5,1.00,0.96,1.29,1.30,2.258E5,2.177E5,2.91E5,2.941E5,1.00,0.96,1.29,1.30,3,1,1,iTRAQ 4plex (K  N-term),40666,RNA-binding protein 43 OS=Homo sapiens OX=9606 GN=RBM43 PE=2 SV=1
3180,43049,Q5T4U8|Q5T4U8_HUMAN,0.79,32.24,1.646E5,1.494E5,1.829E5,1.989E5,1.00,0.91,1.11,1.21,1.646E5,1.494E5,1.829E5,1.989E5,1.00,0.91,1.11,1.21,7,1,1,iTRAQ 4plex (K  N-term),17318,Geranylgeranyl transferase type-2 subunit beta OS=Homo sapiens OX=9606 GN=RABGGTB PE=1 SV=1
2561,22833,sp|P41240|CSK_HUMAN,2.05,32.22,1.813E5,1.589E5,2.972E5,3.1E5,1.00,0.88,1.64,1.71,1.813E5,1.589E5,2.972E5,3.1E5,1.00,0.88,1.64,1.71,2,1,1,iTRAQ 4plex (K  N-term),50704,Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1
3187,43079,sp|O94874-3|UFL1_HUMAN,1.14,32.04,1.97E5,1.905E5,2.519E5,2.848E5,1.00,0.97,1.28,1.45,1.97E5,1.905E5,2.519E5,2.848E5,1.00,0.97,1.28,1.45,2,1,1,iTRAQ 4plex (K  N-term),57584,Isoform 3 of E3 UFM1-protein ligase 1 OS=Homo sapiens OX=9606 GN=UFL1
3053,11650,sp|Q9H4F8-2|SMOC1_HUMAN,1.10,31.92,1.121E5,9.743E4,1.427E5,1.437E5,1.00,0.87,1.27,1.28,1.121E5,9.743E4,1.427E5,1.437E5,1.00,0.87,1.27,1.28,3,1,1,iTRAQ 4plex (K  N-term),48262,Isoform 2 of SPARC-related modular calcium-binding protein 1 OS=Homo sapiens OX=9606 GN=SMOC1
2968,20938,sp|Q9BRF8-2|CPPED_HUMAN,0.95,31.92,5.603E5,5.484E5,7.477E5,7.697E5,1.00,0.98,1.33,1.37,5.603E5,5.484E5,7.477E5,7.697E5,1.00,0.98,1.33,1.37,5,1,1,iTRAQ 4plex (K  N-term),19036,Isoform 2 of Serine/threonine-protein phosphatase CPPED1 OS=Homo sapiens OX=9606 GN=CPPED1
3183,43065,sp|P78345|RPP38_HUMAN,1.11,31.91,1.919E5,1.897E5,2.677E5,2.806E5,1.00,0.99,1.40,1.46,1.919E5,1.897E5,2.677E5,2.806E5,1.00,0.99,1.40,1.46,4,1,1,iTRAQ 4plex (K  N-term),31834,Ribonuclease P protein subunit p38 OS=Homo sapiens OX=9606 GN=RPP38 PE=1 SV=2
2954,41555,A0A1W2PNW1|A0A1W2PNW1_HUMAN,1.29,31.90,1.393E5,1.45E5,2.182E5,1.933E5,1.00,1.04,1.57,1.39,1.393E5,1.45E5,2.182E5,1.933E5,1.00,1.04,1.57,1.39,2,1,1,iTRAQ 4plex (K  N-term),76078,Signal transducer and activator of transcription OS=Homo sapiens OX=9606 GN=STAT6 PE=1 SV=1
3188,43091,H0YD73|H0YD73_HUMAN,0.56,31.53,1.108E5,1.063E5,1.291E5,1.311E5,1.00,0.96,1.17,1.18,1.108E5,1.063E5,1.291E5,1.311E5,1.00,0.96,1.17,1.18,5,1,1,iTRAQ 4plex (K  N-term),25095,26S proteasome non-ATPase regulatory subunit 13 (Fragment) OS=Homo sapiens OX=9606 GN=PSMD13 PE=1 SV=1
3191,43129,sp|Q99798|ACON_HUMAN,1.12,31.50,1.502E5,1.479E5,2.183E5,2.197E5,1.00,0.98,1.45,1.46,1.502E5,1.479E5,2.183E5,2.197E5,1.00,0.98,1.45,1.46,2,1,1,iTRAQ 4plex (K  N-term),85425,Aconitate hydratase  mitochondrial OS=Homo sapiens OX=9606 GN=ACO2 PE=1 SV=2
3013,41638,sp|Q96JE7|SC16B_HUMAN,3.24,31.45,8.982E4,9.088E4,2.387E5,1.8E5,1.00,1.01,2.66,2.00,8.982E4,9.088E4,2.387E5,1.8E5,1.00,1.01,2.66,2.00,1,1,1,iTRAQ 4plex (K  N-term),116604,Protein transport protein Sec16B OS=Homo sapiens OX=9606 GN=SEC16B PE=1 SV=2
3190,22516,sp|Q9NPD3|EXOS4_HUMAN,1.12,31.41,4.171E5,4.144E5,6.135E5,5.784E5,1.00,0.99,1.47,1.39,4.171E5,4.144E5,6.135E5,5.784E5,1.00,0.99,1.47,1.39,4,1,1,iTRAQ 4plex (K  N-term),26383,Exosome complex component RRP41 OS=Homo sapiens OX=9606 GN=EXOSC4 PE=1 SV=3
3189,43109,H0YLM3|H0YLM3_HUMAN,1.17,31.39,1.777E5,1.674E5,2.524E5,2.354E5,1.00,0.94,1.42,1.33,1.777E5,1.674E5,2.524E5,2.354E5,1.00,0.94,1.42,1.33,15,1,1,iTRAQ 4plex (K  N-term),10478,Pre-B-cell leukemia transcription factor 1 (Fragment) OS=Homo sapiens OX=9606 GN=PBX1 PE=1 SV=1
3185,43071,B4DWR3|B4DWR3_HUMAN,0.73,31.36,1.131E5,1.16E5,1.48E5,1.379E5,1.00,1.03,1.31,1.22,1.131E5,1.16E5,1.48E5,1.379E5,1.00,1.03,1.31,1.22,6,1,1,iTRAQ 4plex (K  N-term),22254,Prefoldin subunit 3 OS=Homo sapiens OX=9606 GN=VBP1 PE=1 SV=1
3032,41874,sp|Q5TAP6|UT14C_HUMAN,1.58,31.22,1.461E5,1.373E5,2.341E5,2.345E5,1.00,0.94,1.60,1.60,1.461E5,1.373E5,2.341E5,2.345E5,1.00,0.94,1.60,1.60,1,1,1,iTRAQ 4plex (K  N-term),87188,U3 small nucleolar RNA-associated protein 14 homolog C OS=Homo sapiens OX=9606 GN=UTP14C PE=1 SV=1
3033,41877,sp|O43516-4|WIPF1_HUMAN,1.73,31.08,5.801E5,5.874E5,9.173E5,1.03E6,1.00,1.01,1.58,1.78,5.801E5,5.874E5,9.173E5,1.03E6,1.00,1.01,1.58,1.78,3,1,1,iTRAQ 4plex (K  N-term),36426,Isoform 4 of WAS/WASL-interacting protein family member 1 OS=Homo sapiens OX=9606 GN=WIPF1
3056,42071,sp|Q16832|DDR2_HUMAN,1.23,31.04,2.306E5,2.266E5,3.482E5,3.385E5,1.00,0.98,1.51,1.47,2.306E5,2.266E5,3.482E5,3.385E5,1.00,0.98,1.51,1.47,1,1,1,iTRAQ 4plex (K  N-term),96736,Discoidin domain-containing receptor 2 OS=Homo sapiens OX=9606 GN=DDR2 PE=1 SV=2
3054,13893,E9PEZ7|E9PEZ7_HUMAN,1.82,30.97,1.779E5,1.839E5,3.254E5,3.213E5,1.00,1.03,1.83,1.81,1.779E5,1.839E5,3.254E5,3.213E5,1.00,1.03,1.83,1.81,2,1,1,iTRAQ 4plex (K  N-term),49251,Abl interactor 2 OS=Homo sapiens OX=9606 GN=ABI2 PE=1 SV=1
2959,41702,sp|Q14190|SIM2_HUMAN,2.17,30.93,7.95E4,9.898E4,1.539E5,1.607E5,1.00,1.25,1.94,2.02,7.95E4,9.898E4,1.539E5,1.607E5,1.00,1.25,1.94,2.02,1,1,1,iTRAQ 4plex (K  N-term),73219,Single-minded homolog 2 OS=Homo sapiens OX=9606 GN=SIM2 PE=1 SV=2
3057,20640,sp|Q9NX70-2|MED29_HUMAN,0.93,30.57,2.999E5,3.065E5,4.185E5,4.165E5,1.00,1.02,1.40,1.39,2.999E5,3.065E5,4.185E5,4.165E5,1.00,1.02,1.40,1.39,4,1,1,iTRAQ 4plex (K  N-term),21362,Isoform 2 of Mediator of RNA polymerase II transcription subunit 29 OS=Homo sapiens OX=9606 GN=MED29
3192,43150,A2IDC7|A2IDC7_HUMAN,0.81,30.38,1.932E5,1.915E5,2.492E5,2.571E5,1.00,0.99,1.29,1.33,1.932E5,1.915E5,2.492E5,2.571E5,1.00,0.99,1.29,1.33,5,1,1,iTRAQ 4plex (K  N-term),23146,39S ribosomal protein L28  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPL28 PE=1 SV=1
3193,43163,sp|Q9UL01|DSE_HUMAN,0.70,30.22,7.311E4,7.858E4,9.468E4,9.11E4,1.00,1.07,1.29,1.25,7.311E4,7.858E4,9.468E4,9.11E4,1.00,1.07,1.29,1.25,1,1,1,iTRAQ 4plex (K  N-term),109773,Dermatan-sulfate epimerase OS=Homo sapiens OX=9606 GN=DSE PE=1 SV=1
3194,43169,Q9NSS8|Q9NSS8_HUMAN,1.81,30.10,2.094E5,2.177E5,3.615E5,3.819E5,1.00,1.04,1.73,1.82,2.094E5,2.177E5,3.615E5,3.819E5,1.00,1.04,1.73,1.82,8,1,1,iTRAQ 4plex (K  N-term),14263,U5 small nuclear ribonucleoprotein 40 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP40 PE=1 SV=1
2563,23509,E9PI14|E9PI14_HUMAN,2.67,29.84,4.945E5,4.418E5,1.009E6,1.013E6,1.00,0.89,2.04,2.05,4.945E5,4.418E5,1.009E6,1.013E6,1.00,0.89,2.04,2.05,12,1,1,iTRAQ 4plex (K  N-term),9582,39S ribosomal protein L16  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPL16 PE=1 SV=1
2528,41716,sp|Q96JC1-2|VPS39_HUMAN,2.28,29.54,3.409E5,2.919E5,4.25E5,4.045E5,1.00,0.86,1.25,1.19,3.409E5,2.919E5,4.25E5,4.045E5,1.00,0.86,1.25,1.19,2,2,2,iTRAQ 4plex (K  N-term),100769,Isoform 2 of Vam6/Vps39-like protein OS=Homo sapiens OX=9606 GN=VPS39
3195,43176,H3BNE2|H3BNE2_HUMAN,1.21,29.34,4.27E4,3.83E4,5.865E4,5.473E4,1.00,0.90,1.37,1.28,4.27E4,3.83E4,5.865E4,5.473E4,1.00,0.90,1.37,1.28,5,1,1,iTRAQ 4plex (K  N-term),26785,Cell cycle progression protein 1 (Fragment) OS=Homo sapiens OX=9606 GN=CCPG1 PE=1 SV=8
3196,43182,R4GMX5|R4GMX5_HUMAN,1.75,29.26,1.513E5,1.666E5,2.718E5,2.539E5,1.00,1.10,1.80,1.68,1.513E5,1.666E5,2.718E5,2.539E5,1.00,1.10,1.80,1.68,11,1,1,iTRAQ 4plex (K  N-term),9335,Basigin (Fragment) OS=Homo sapiens OX=9606 GN=BSG PE=1 SV=1
3202,111,sp|Q9C005|DPY30_HUMAN,1.40,29.22,2.562E5,2.509E5,4.051E5,4.024E5,1.00,0.98,1.58,1.57,2.562E5,2.509E5,4.051E5,4.024E5,1.00,0.98,1.58,1.57,7,1,1,iTRAQ 4plex (K  N-term),11250,Protein dpy-30 homolog OS=Homo sapiens OX=9606 GN=DPY30 PE=1 SV=1
2945,11145,sp|Q9Y2Q9|RT28_HUMAN,0.98,29.09,2.541E5,2.521E5,3.519E5,3.574E5,1.00,0.99,1.38,1.41,2.541E5,2.521E5,3.519E5,3.574E5,1.00,0.99,1.38,1.41,5,1,1,iTRAQ 4plex (K  N-term),20843,28S ribosomal protein S28  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS28 PE=1 SV=1
3207,43244,sp|Q15042-4|RB3GP_HUMAN,1.45,28.92,2.106E5,1.84E5,3.024E5,2.658E5,1.00,0.87,1.44,1.26,2.106E5,1.84E5,3.024E5,2.658E5,1.00,0.87,1.44,1.26,1,1,1,iTRAQ 4plex (K  N-term),105296,Isoform 3 of Rab3 GTPase-activating protein catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP1
3198,43197,sp|Q7Z2T5|TRM1L_HUMAN,0.65,28.90,1.338E5,1.422E5,1.177E5,1.116E5,1.00,1.06,0.88,0.83,1.338E5,1.422E5,1.177E5,1.116E5,1.00,1.06,0.88,0.83,2,1,1,iTRAQ 4plex (K  N-term),81747,TRMT1-like protein OS=Homo sapiens OX=9606 GN=TRMT1L PE=1 SV=2
3203,10846,sp|A6NKD9|CC85C_HUMAN,0.76,28.74,8.12E4,9.034E4,7.997E4,6.832E4,1.00,1.11,0.98,0.84,8.12E4,9.034E4,7.997E4,6.832E4,1.00,1.11,0.98,0.84,2,1,1,iTRAQ 4plex (K  N-term),45210,Coiled-coil domain-containing protein 85C OS=Homo sapiens OX=9606 GN=CCDC85C PE=1 SV=1
3199,43198,Q5JYX0|Q5JYX0_HUMAN,0.47,28.72,4.793E5,4.607E5,5.318E5,5.489E5,1.00,0.96,1.11,1.15,4.793E5,4.607E5,5.318E5,5.489E5,1.00,0.96,1.11,1.15,6,1,1,iTRAQ 4plex (K  N-term),15180,Cell division control protein 42 homolog (Fragment) OS=Homo sapiens OX=9606 GN=CDC42 PE=1 SV=1
3205,43238,F8VYR5|F8VYR5_HUMAN,0.67,28.71,9.396E5,8.915E5,7.658E5,7.362E5,1.00,0.95,0.82,0.78,9.396E5,8.915E5,7.658E5,7.362E5,1.00,0.95,0.82,0.78,12,1,1,iTRAQ 4plex (K  N-term),8443,28S ribosomal protein S24  mitochondrial OS=Homo sapiens OX=9606 GN=MRPS24 PE=1 SV=1
2564,6510,sp|O60237|MYPT2_HUMAN,0.67,28.65,5.458E4,5.556E4,6.488E4,6.995E4,1.00,1.02,1.19,1.28,5.458E4,5.556E4,6.488E4,6.995E4,1.00,1.02,1.19,1.28,2,1,1,iTRAQ 4plex (K  N-term),110404,Protein phosphatase 1 regulatory subunit 12B OS=Homo sapiens OX=9606 GN=PPP1R12B PE=1 SV=2
3204,20922,sp|Q9Y2Z0-2|SGT1_HUMAN,1.04,28.61,6.254E5,5.764E5,7.885E5,8.324E5,1.00,0.92,1.26,1.33,6.254E5,5.764E5,7.885E5,8.324E5,1.00,0.92,1.26,1.33,3,1,1,iTRAQ 4plex (K  N-term),37805,Isoform 2 of Protein SGT1 homolog OS=Homo sapiens OX=9606 GN=SUGT1
3200,43204,H7C571|H7C571_HUMAN,4.59,28.58,8.913E4,1.077E5,3.213E5,3.084E5,1.00,1.21,3.60,3.46,8.913E4,1.077E5,3.213E5,3.084E5,1.00,1.21,3.60,3.46,4,1,1,iTRAQ 4plex (K  N-term),22626,Transcription cofactor vestigial-like protein 3 (Fragment) OS=Homo sapiens OX=9606 GN=VGLL3 PE=1 SV=8
2951,41500,sp|Q8N5C6|SRBD1_HUMAN,2.12,28.55,1.946E5,2.037E5,3.77E5,3.869E5,1.00,1.05,1.94,1.99,1.946E5,2.037E5,3.77E5,3.869E5,1.00,1.05,1.94,1.99,1,1,1,iTRAQ 4plex (K  N-term),111776,S1 RNA-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SRBD1 PE=1 SV=2
3201,43212,sp|Q02750-2|MP2K1_HUMAN,1.09,28.43,1.665E5,1.444E5,2.019E5,2.122E5,1.00,0.87,1.21,1.27,1.665E5,1.444E5,2.019E5,2.122E5,1.00,0.87,1.21,1.27,3,1,1,iTRAQ 4plex (K  N-term),40764,Isoform 2 of Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens OX=9606 GN=MAP2K1
3012,41605,B5MCR8|B5MCR8_HUMAN,1.56,28.23,2.039E5,2.167E5,3.463E5,3.383E5,1.00,1.06,1.70,1.66,2.039E5,2.167E5,3.463E5,3.383E5,1.00,1.06,1.70,1.66,3,1,1,iTRAQ 4plex (K  N-term),42509,Solute carrier family 30 (Zinc transporter)  member 6  isoform CRA_b OS=Homo sapiens OX=9606 GN=SLC30A6 PE=1 SV=1
2943,40601,sp|Q01196-7|RUNX1_HUMAN,1.83,28.20,1.275E5,1.212E5,2.19E5,2.226E5,1.00,0.95,1.72,1.75,1.275E5,1.212E5,2.19E5,2.226E5,1.00,0.95,1.72,1.75,3,1,1,iTRAQ 4plex (K  N-term),26509,Isoform AML-1FC of Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1
3208,43250,sp|Q9HC35-2|EMAL4_HUMAN,1.01,28.00,2.169E5,2.212E5,2.957E5,3.109E5,1.00,1.02,1.36,1.43,2.169E5,2.212E5,2.957E5,3.109E5,1.00,1.02,1.36,1.43,1,1,1,iTRAQ 4plex (K  N-term),102444,Isoform 2 of Echinoderm microtubule-associated protein-like 4 OS=Homo sapiens OX=9606 GN=EML4
3058,8619,sp|Q5T011-5|SZT2_HUMAN,0.72,27.67,2.074E5,2.029E5,2.644E5,2.329E5,1.00,0.98,1.27,1.12,2.074E5,2.029E5,2.644E5,2.329E5,1.00,0.98,1.27,1.12,0,1,1,iTRAQ 4plex (K  N-term),371856,Isoform 3 of KICSTOR complex protein SZT2 OS=Homo sapiens OX=9606 GN=SZT2
3209,11696,sp|P20618|PSB1_HUMAN,1.93,27.50,1.23E5,1.094E5,2.038E5,2.071E5,1.00,0.89,1.66,1.68,1.23E5,1.094E5,2.038E5,2.071E5,1.00,0.89,1.66,1.68,5,1,1,iTRAQ 4plex (K  N-term),26489,Proteasome subunit beta type-1 OS=Homo sapiens OX=9606 GN=PSMB1 PE=1 SV=2
2907,41404,sp|Q9UHB9-4|SRP68_HUMAN,1.66,27.47,5.783E5,5.836E5,9.862E5,1.008E6,1.00,1.01,1.71,1.74,5.783E5,5.836E5,9.862E5,1.008E6,1.00,1.01,1.71,1.74,2,1,1,iTRAQ 4plex (K  N-term),66108,Isoform 4 of Signal recognition particle subunit SRP68 OS=Homo sapiens OX=9606 GN=SRP68
3211,43272,sp|O43310|CTIF_HUMAN,2.61,27.45,1.503E5,1.35E5,2.699E5,3.063E5,1.00,0.90,1.80,2.04,1.503E5,1.35E5,2.699E5,3.063E5,1.00,0.90,1.80,2.04,2,1,1,iTRAQ 4plex (K  N-term),67587,CBP80/20-dependent translation initiation factor OS=Homo sapiens OX=9606 GN=CTIF PE=1 SV=1
3206,43240,A0A024R1R8|A0A024R1R8_HUMAN,2.10,27.39,1.808E5,1.845E5,3.58E5,3.583E5,1.00,1.02,1.98,1.98,1.808E5,1.845E5,3.58E5,3.583E5,1.00,1.02,1.98,1.98,14,1,1,iTRAQ 4plex (K  N-term),7091,HCG2014768  isoform CRA_a OS=Homo sapiens OX=9606 GN=hCG_2014768 PE=4 SV=1
3210,43270,sp|P49189-2|AL9A1_HUMAN,1.40,27.35,1.572E5,1.54E5,2.324E5,2.498E5,1.00,0.98,1.48,1.59,1.572E5,1.54E5,2.324E5,2.498E5,1.00,0.98,1.48,1.59,2,1,1,iTRAQ 4plex (K  N-term),46455,Isoform 2 of 4-trimethylaminobutyraldehyde dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH9A1
2818,42150,sp|Q9HC36|MRM3_HUMAN,1.04,27.30,2.974E5,2.881E5,4.129E5,4.169E5,1.00,0.97,1.39,1.40,2.974E5,2.881E5,4.129E5,4.169E5,1.00,0.97,1.39,1.40,3,1,1,iTRAQ 4plex (K  N-term),47020,rRNA methyltransferase 3  mitochondrial OS=Homo sapiens OX=9606 GN=MRM3 PE=1 SV=2
3212,23181,I3L4L8|I3L4L8_HUMAN,1.49,27.30,2.617E5,2.743E5,4.352E5,4.288E5,1.00,1.05,1.66,1.64,2.617E5,2.743E5,4.352E5,4.288E5,1.00,1.05,1.66,1.64,12,1,1,iTRAQ 4plex (K  N-term),9420,WD repeat domain phosphoinositide-interacting protein 3 OS=Homo sapiens OX=9606 GN=WDR45B PE=1 SV=1
2871,12767,K7EQL6|K7EQL6_HUMAN,0.56,26.88,2.415E5,2.269E5,2.799E5,2.734E5,1.00,0.94,1.16,1.13,2.415E5,2.269E5,2.799E5,2.734E5,1.00,0.94,1.16,1.13,1,1,1,iTRAQ 4plex (K  N-term),143937,Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1
3215,43338,E9PPG2|E9PPG2_HUMAN,0.53,26.81,3.185E5,3.353E5,3.854E5,3.886E5,1.00,1.05,1.21,1.22,3.185E5,3.353E5,3.854E5,3.886E5,1.00,1.05,1.21,1.22,10,1,1,iTRAQ 4plex (K  N-term),12580,AMP deaminase 3 (Fragment) OS=Homo sapiens OX=9606 GN=AMPD3 PE=1 SV=1
2869,41526,sp|Q8IZD2-8|KMT2E_HUMAN,3.61,26.79,1.483E5,1.548E5,4.299E5,3.36E5,1.00,1.04,2.90,2.27,1.483E5,1.548E5,4.299E5,3.36E5,1.00,1.04,2.90,2.27,2,1,1,iTRAQ 4plex (K  N-term),131736,Isoform NKp44L of Inactive histone-lysine N-methyltransferase 2E OS=Homo sapiens OX=9606 GN=KMT2E
3214,43324,B3KRF7|B3KRF7_HUMAN,0.49,26.76,1.95E5,1.933E5,2.207E5,2.324E5,1.00,0.99,1.13,1.19,1.95E5,1.933E5,2.207E5,2.324E5,1.00,0.99,1.13,1.19,3,1,1,iTRAQ 4plex (K  N-term),39324,Zinc finger protein with KRAB and SCAN domains 1 OS=Homo sapiens OX=9606 GN=ZKSCAN1 PE=1 SV=1
3216,43349,sp|Q8N5L8|RP25L_HUMAN,2.03,26.20,9.946E4,8.208E4,1.602E5,1.556E5,1.00,0.83,1.61,1.56,9.946E4,8.208E4,1.602E5,1.556E5,1.00,0.83,1.61,1.56,6,1,1,iTRAQ 4plex (K  N-term),17631,Ribonuclease P protein subunit p25-like protein OS=Homo sapiens OX=9606 GN=RPP25L PE=1 SV=1
2944,40976,sp|Q8WVM8-2|SCFD1_HUMAN,0.75,25.95,8.6E4,9.199E4,1.051E5,1.135E5,1.00,1.07,1.22,1.32,8.6E4,9.199E4,1.051E5,1.135E5,1.00,1.07,1.22,1.32,4,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),62260,Isoform 2 of Sec1 family domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SCFD1
3062,43004,sp|Q86Y22-2|CONA1_HUMAN,1.71,25.32,1.387E5,1.274E5,2.134E5,2.267E5,1.00,0.92,1.54,1.63,1.387E5,1.274E5,2.134E5,2.267E5,1.00,0.92,1.54,1.63,3,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),30672,Isoform 2 of Collagen alpha-1(XXIII) chain OS=Homo sapiens OX=9606 GN=COL23A1
2911,204,sp|O94964-2|SOGA1_HUMAN,1.33,25.24,1.511E5,1.432E5,2.274E5,2.176E5,1.00,0.95,1.50,1.44,1.511E5,1.432E5,2.274E5,2.176E5,1.00,0.95,1.50,1.44,0,1,1,iTRAQ 4plex (K  N-term),183857,Isoform 2 of Protein SOGA1 OS=Homo sapiens OX=9606 GN=SOGA1
3059,23587,sp|Q86TI2|DPP9_HUMAN,1.23,24.97,2.704E5,2.539E5,3.901E5,3.593E5,1.00,0.94,1.44,1.33,2.704E5,2.539E5,3.901E5,3.593E5,1.00,0.94,1.44,1.33,1,1,1,iTRAQ 4plex (K  N-term),98263,Dipeptidyl peptidase 9 OS=Homo sapiens OX=9606 GN=DPP9 PE=1 SV=3
2910,41597,sp|Q9NSV4-7|DIAP3_HUMAN,1.80,24.95,1.443E5,1.586E5,2.468E5,2.635E5,1.00,1.10,1.71,1.83,1.443E5,1.586E5,2.468E5,2.635E5,1.00,1.10,1.71,1.83,1,1,1,iTRAQ 4plex (K  N-term),127856,Isoform 7 of Protein diaphanous homolog 3 OS=Homo sapiens OX=9606 GN=DIAPH3
3219,43417,sp|Q5VTE6-2|ANGE2_HUMAN,1.60,24.54,6.27E4,6.313E4,1.082E5,1.039E5,1.00,1.01,1.73,1.66,6.27E4,6.313E4,1.082E5,1.039E5,1.00,1.01,1.73,1.66,2,1,1,iTRAQ 4plex (K  N-term),42106,Isoform 2 of Protein angel homolog 2 OS=Homo sapiens OX=9606 GN=ANGEL2
3064,7001,A0A096LNV3|A0A096LNV3_HUMAN,0.86,24.50,2.538E5,2.598E5,3.461E5,3.158E5,1.00,1.02,1.36,1.24,2.538E5,2.598E5,3.461E5,3.158E5,1.00,1.02,1.36,1.24,4,1,1,iTRAQ 4plex (K  N-term),20885,E3 ubiquitin-protein ligase RNF114 (Fragment) OS=Homo sapiens OX=9606 GN=RNF114 PE=1 SV=1
3218,24143,sp|P68036|UB2L3_HUMAN,0.99,24.48,2.621E5,2.608E5,3.398E5,3.715E5,1.00,0.99,1.30,1.42,2.621E5,2.608E5,3.398E5,3.715E5,1.00,0.99,1.30,1.42,5,1,1,iTRAQ 4plex (K  N-term),17862,Ubiquitin-conjugating enzyme E2 L3 OS=Homo sapiens OX=9606 GN=UBE2L3 PE=1 SV=1
2456,20727,sp|Q9Y333|LSM2_HUMAN,2.73,23.83,5.297E5,5.439E5,1.233E6,1.094E6,1.00,1.03,2.33,2.06,5.297E5,5.439E5,1.233E6,1.094E6,1.00,1.03,2.33,2.06,7,1,1,iTRAQ 4plex (K  N-term),10835,U6 snRNA-associated Sm-like protein LSm2 OS=Homo sapiens OX=9606 GN=LSM2 PE=1 SV=1
3220,43452,D6RH30|D6RH30_HUMAN,4.62,23.71,1.198E5,1.231E5,4.269E5,4.356E5,1.00,1.03,3.56,3.63,1.198E5,1.231E5,4.269E5,4.356E5,1.00,1.03,3.56,3.63,12,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),21870,Nuclear factor NF-kappa-B p105 subunit (Fragment) OS=Homo sapiens OX=9606 GN=NFKB1 PE=1 SV=1
3221,43456,sp|Q9H3H3|CK068_HUMAN,0.42,23.60,1.664E5,1.681E5,1.951E5,1.824E5,1.00,1.01,1.17,1.10,1.664E5,1.681E5,1.951E5,1.824E5,1.00,1.01,1.17,1.10,4,1,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),31430,UPF0696 protein C11orf68 OS=Homo sapiens OX=9606 GN=C11orf68 PE=1 SV=3
2962,41794,H3BNX5|H3BNX5_HUMAN,1.53,23.57,1.03E5,9.642E4,1.489E5,1.628E5,1.00,0.94,1.45,1.58,1.03E5,9.642E4,1.489E5,1.628E5,1.00,0.94,1.45,1.58,2,1,1,iTRAQ 4plex (K  N-term),89833,Zinc finger protein 106 (Fragment) OS=Homo sapiens OX=9606 GN=ZNF106 PE=1 SV=1
3223,10036,B4DJV5|B4DJV5_HUMAN,1.27,23.51,1.523E5,1.473E5,2.245E5,2.294E5,1.00,0.97,1.47,1.51,1.523E5,1.473E5,2.245E5,2.294E5,1.00,0.97,1.47,1.51,3,1,1,iTRAQ 4plex (K  N-term),49038,cDNA FLJ51513  highly similar to Periodic tryptophan protein 1 homolog OS=Homo sapiens OX=9606 GN=PWP1 PE=1 SV=1
3229,43537,sp|Q8N1X5|YF001_HUMAN,8.91,23.38,3.882E5,2.99E4,3.83E4,2.731E4,1.00,0.08,0.10,0.07,3.882E5,2.99E4,3.83E4,2.731E4,1.00,0.08,0.10,0.07,10,1,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),16487,Uncharacterized protein FLJ37310 OS=Homo sapiens OX=9606 PE=2 SV=1
2036,19976,sp|O75531|BAF_HUMAN,2.56,23.37,3.12E6,2.701E6,5.481E6,5.98E6,1.00,0.87,1.76,1.92,3.12E6,2.701E6,5.481E6,5.98E6,1.00,0.87,1.76,1.92,8,1,1,iTRAQ 4plex (K  N-term),10059,Barrier-to-autointegration factor OS=Homo sapiens OX=9606 GN=BANF1 PE=1 SV=1
3224,43491,sp|O43395|PRPF3_HUMAN,0.81,23.26,4.457E4,4.029E4,5.422E4,5.342E4,1.00,0.90,1.22,1.20,4.457E4,4.029E4,5.422E4,5.342E4,1.00,0.90,1.22,1.20,1,1,1,iTRAQ 4plex (K  N-term),77529,U4/U6 small nuclear ribonucleoprotein Prp3 OS=Homo sapiens OX=9606 GN=PRPF3 PE=1 SV=2
3067,3837,sp|Q9UGU0-2|TCF20_HUMAN,1.25,23.13,3.922E4,4.361E4,6.028E4,6.088E4,1.00,1.11,1.54,1.55,3.922E4,4.361E4,6.028E4,6.088E4,1.00,1.11,1.54,1.55,0,1,1,iTRAQ 4plex (K  N-term),209652,Isoform 2 of Transcription factor 20 OS=Homo sapiens OX=9606 GN=TCF20
3226,24477,sp|A0A0B4J1V6|HV373_HUMAN,1.37,22.92,1.409E5,1.506E5,2.263E5,2.233E5,1.00,1.07,1.61,1.59,1.409E5,1.506E5,2.263E5,2.233E5,1.00,1.07,1.61,1.59,16,1,1,iTRAQ 4plex (K  N-term),12858,Immunoglobulin heavy variable 3-73 OS=Homo sapiens OX=9606 GN=IGHV3-73 PE=3 SV=1
3014,22254,sp|P62312|LSM6_HUMAN,1.19,22.80,2.04E5,2.026E5,3.079E5,3.078E5,1.00,0.99,1.51,1.51,2.04E5,2.026E5,3.079E5,3.078E5,1.00,0.99,1.51,1.51,12,1,1,iTRAQ 4plex (K  N-term),9128,U6 snRNA-associated Sm-like protein LSm6 OS=Homo sapiens OX=9606 GN=LSM6 PE=1 SV=1
3227,43504,sp|P00390-5|GSHR_HUMAN,0.87,22.70,2.181E5,2.227E5,2.916E5,2.988E5,1.00,1.02,1.34,1.37,2.181E5,2.227E5,2.916E5,2.988E5,1.00,1.02,1.34,1.37,4,1,1,iTRAQ 4plex (K  N-term),47267,Isoform 4 of Glutathione reductase  mitochondrial OS=Homo sapiens OX=9606 GN=GSR
2929,43520,H3BP86|H3BP86_HUMAN,4.80,22.07,1.401E6,1.46E6,4.192E5,3.903E5,1.00,1.04,0.30,0.28,1.401E6,1.46E6,4.192E5,3.903E5,1.00,1.04,0.30,0.28,9,1,1,Carbamidomethylation; iTRAQ 4plex (K  N-term),15403,Rho family-interacting cell polarization regulator 1 (Fragment) OS=Homo sapiens OX=9606 GN=RIPOR1 PE=1 SV=1
3232,43598,S4R3V1|S4R3V1_HUMAN,1.58,22.05,9.127E4,9.18E4,1.554E5,1.564E5,1.00,1.01,1.70,1.71,9.127E4,9.18E4,1.554E5,1.564E5,1.00,1.01,1.70,1.71,2,1,1,iTRAQ 4plex (K  N-term),45122,Calcium uptake protein 1  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MICU1 PE=1 SV=7
3237,22960,sp|P04424-3|ARLY_HUMAN,0.26,21.89,2.356E5,2.468E5,2.232E5,2.328E5,1.00,1.05,0.95,0.99,2.356E5,2.468E5,2.232E5,2.328E5,1.00,1.05,0.95,0.99,2,1,1,iTRAQ 4plex (K  N-term),48733,Isoform 3 of Argininosuccinate lyase OS=Homo sapiens OX=9606 GN=ASL
1774,22540,sp|Q8IZF6-2|AGRG4_HUMAN,0.35,21.83,8.671E6,8.199E6,8.876E6,9.344E6,1.00,0.95,1.02,1.08,8.671E6,8.199E6,8.876E6,9.344E6,1.00,0.95,1.02,1.08,0,1,1,iTRAQ 4plex (K  N-term),301614,Isoform 2 of Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4
2468,22370,A0A087WWW9|A0A087WWW9_HUMAN,0.82,21.22,1.548E5,1.496E5,1.983E5,2.02E5,1.00,0.97,1.28,1.31,1.548E5,1.496E5,1.983E5,2.02E5,1.00,0.97,1.28,1.31,3,1,1,iTRAQ 4plex (K  N-term),25102,B-cell lymphoma/leukemia 10 OS=Homo sapiens OX=9606 GN=BCL10 PE=1 SV=2
3231,43588,sp|Q15645-2|PCH2_HUMAN,1.33,21.07,1.256E5,1.314E5,1.887E5,1.993E5,1.00,1.05,1.50,1.59,1.256E5,1.314E5,1.887E5,1.993E5,1.00,1.05,1.50,1.59,5,1,1,iTRAQ 4plex (K  N-term),22084,Isoform 2 of Pachytene checkpoint protein 2 homolog OS=Homo sapiens OX=9606 GN=TRIP13
2932,43578,sp|P02788-2|TRFL_HUMAN,2.22,21.03,4.822E5,4.379E5,8.738E5,8.955E5,1.00,0.91,1.81,1.86,4.822E5,4.379E5,8.738E5,8.955E5,1.00,0.91,1.81,1.86,1,1,1,iTRAQ 4plex (K  N-term),73161,Isoform DeltaLf of Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF
1899,43617,sp|Q86Y56-2|DAAF5_HUMAN,9.24,20.93,1.62E6,1.838E6,2.748E7,2.652E7,1.00,1.13,16.96,16.37,1.62E6,1.838E6,2.748E7,2.652E7,1.00,1.13,16.96,16.37,1,1,1,iTRAQ 4plex (K  N-term),92044,Isoform 2 of Dynein assembly factor 5  axonemal OS=Homo sapiens OX=9606 GN=DNAAF5
3235,15016,sp|Q7L014|DDX46_HUMAN,0.88,20.75,4.103E5,4.108E5,5.446E5,5.639E5,1.00,1.00,1.33,1.37,4.103E5,4.108E5,5.446E5,5.639E5,1.00,1.00,1.33,1.37,1,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),117362,Probable ATP-dependent RNA helicase DDX46 OS=Homo sapiens OX=9606 GN=DDX46 PE=1 SV=2
2912,2164,sp|P39880-9|CUX1_HUMAN,1.21,20.70,1.789E5,1.749E5,2.511E5,2.674E5,1.00,0.98,1.40,1.50,1.789E5,1.749E5,2.511E5,2.674E5,1.00,0.98,1.40,1.50,2,1,1,iTRAQ 4plex (K  N-term),72024,Isoform 11 of Homeobox protein cut-like 1 OS=Homo sapiens OX=9606 GN=CUX1
3245,43715,E9PNL9|E9PNL9_HUMAN,0.72,20.59,2.604E5,3.143E5,3.248E5,3.399E5,1.00,1.21,1.25,1.31,2.604E5,3.143E5,3.248E5,3.399E5,1.00,1.21,1.25,1.31,9,1,1,iTRAQ 4plex (K  N-term),13008,Exostosin-2 (Fragment) OS=Homo sapiens OX=9606 GN=EXT2 PE=1 SV=1
3250,43743,sp|Q9Y2T2|AP3M1_HUMAN,1.64,20.50,3.473E5,3.292E5,5.726E5,5.718E5,1.00,0.95,1.65,1.65,3.473E5,3.292E5,5.726E5,5.718E5,1.00,0.95,1.65,1.65,2,1,1,iTRAQ 4plex (K  N-term),46939,AP-3 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP3M1 PE=1 SV=1
3247,43725,H0YG82|H0YG82_HUMAN,1.86,20.37,2.77E5,2.732E5,4.339E5,5.066E5,1.00,0.99,1.57,1.83,2.77E5,2.732E5,4.339E5,5.066E5,1.00,0.99,1.57,1.83,5,1,1,iTRAQ 4plex (K  N-term),18030,28S ribosomal protein S35  mitochondrial (Fragment) OS=Homo sapiens OX=9606 GN=MRPS35 PE=1 SV=1
3238,19538,sp|Q9HA64|KT3K_HUMAN,0.61,20.01,2.32E5,2.305E5,2.89E5,2.722E5,1.00,0.99,1.25,1.17,2.32E5,2.305E5,2.89E5,2.722E5,1.00,0.99,1.25,1.17,2,1,1,iTRAQ 4plex (K  N-term),34412,Ketosamine-3-kinase OS=Homo sapiens OX=9606 GN=FN3KRP PE=1 SV=2
3241,43642,C9JQ75|C9JQ75_HUMAN,1.27,19.76,9.18E4,9.542E4,1.374E5,1.432E5,1.00,1.04,1.50,1.56,9.18E4,9.542E4,1.374E5,1.432E5,1.00,1.04,1.50,1.56,4,1,1,iTRAQ 4plex (K  N-term),21227,B-cell receptor-associated protein 31 (Fragment) OS=Homo sapiens OX=9606 GN=BCAP31 PE=1 SV=1
2918,42076,sp|O95391|SLU7_HUMAN,2.58,19.72,5.717E4,5.284E4,1.198E5,1.06E5,1.00,0.92,2.10,1.85,5.717E4,5.284E4,1.198E5,1.06E5,1.00,0.92,2.10,1.85,2,1,1,iTRAQ 4plex (K  N-term),68387,Pre-mRNA-splicing factor SLU7 OS=Homo sapiens OX=9606 GN=SLU7 PE=1 SV=2
3254,43776,J3QS10|J3QS10_HUMAN,1.10,19.22,1.345E5,1.4E5,1.989E5,1.819E5,1.00,1.04,1.48,1.35,1.345E5,1.4E5,1.989E5,1.819E5,1.00,1.04,1.48,1.35,4,1,1,iTRAQ 4plex (K  N-term),29720,StAR-related lipid transfer protein 3 OS=Homo sapiens OX=9606 GN=STARD3 PE=1 SV=1
3256,29119,sp|Q9H4M7|PKHA4_HUMAN,2.17,19.16,1.647E5,1.849E5,3.226E5,3.334E5,1.00,1.12,1.96,2.02,1.647E5,1.849E5,3.226E5,3.334E5,1.00,1.12,1.96,2.02,2,1,1,iTRAQ 4plex (K  N-term),85401,Pleckstrin homology domain-containing family A member 4 OS=Homo sapiens OX=9606 GN=PLEKHA4 PE=1 SV=2
3243,9787,A0A2U3TZH4|A0A2U3TZH4_HUMAN,1.46,19.07,7.034E4,5.082E4,8.438E4,8.06E4,1.00,0.72,1.20,1.15,7.034E4,5.082E4,8.438E4,8.06E4,1.00,0.72,1.20,1.15,4,1,1,iTRAQ 4plex (K  N-term),21755,PDZ and LIM domain protein 3 OS=Homo sapiens OX=9606 GN=PDLIM3 PE=1 SV=1
2311,43834,sp|Q9UPQ7-3|PZRN3_HUMAN,1.13,18.92,2.26E5,2.296E5,3.372E5,3.347E5,1.00,1.02,1.49,1.48,2.26E5,2.296E5,3.372E5,3.347E5,1.00,1.02,1.49,1.48,1,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),80006,Isoform 3 of E3 ubiquitin-protein ligase PDZRN3 OS=Homo sapiens OX=9606 GN=PDZRN3
3070,43440,sp|Q86Y38|XYLT1_HUMAN,3.63,18.49,5.898E4,5.113E4,1.505E5,1.421E5,1.00,0.87,2.55,2.41,5.898E4,5.113E4,1.505E5,1.421E5,1.00,0.87,2.55,2.41,2,1,1,iTRAQ 4plex (K  N-term),107569,Xylosyltransferase 1 OS=Homo sapiens OX=9606 GN=XYLT1 PE=1 SV=1
3252,17304,sp|O15516|CLOCK_HUMAN,2.48,18.49,8.807E4,9.132E4,1.944E5,1.918E5,1.00,1.04,2.21,2.18,8.807E4,9.132E4,1.944E5,1.918E5,1.00,1.04,2.21,2.18,1,1,1,iTRAQ 4plex (K  N-term),95304,Circadian locomoter output cycles protein kaput OS=Homo sapiens OX=9606 GN=CLOCK PE=1 SV=1
3253,43775,sp|Q6UWE0|LRSM1_HUMAN,0.59,18.33,1.688E5,1.627E5,1.858E5,2.03E5,1.00,0.96,1.10,1.20,1.688E5,1.627E5,1.858E5,2.03E5,1.00,0.96,1.10,1.20,2,1,1,iTRAQ 4plex (K  N-term),83594,E3 ubiquitin-protein ligase LRSAM1 OS=Homo sapiens OX=9606 GN=LRSAM1 PE=1 SV=1
2991,43631,sp|Q969V4|TEKT1_HUMAN,1.08,18.15,2.441E5,2.816E5,1.945E5,2.858E5,1.00,1.15,0.80,1.17,2.441E5,2.816E5,1.945E5,2.858E5,1.00,1.15,0.80,1.17,3,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),48283,Tektin-1 OS=Homo sapiens OX=9606 GN=TEKT1 PE=1 SV=1
2994,6282,sp|Q9P2P1|NYNRI_HUMAN,5.10,17.86,2.775E5,3.229E5,4.649E5,1.11E6,1.00,1.16,1.68,4.00,2.775E5,3.229E5,4.649E5,1.11E6,1.00,1.16,1.68,4.00,0,1,1,iTRAQ 4plex (K  N-term),208365,Protein NYNRIN OS=Homo sapiens OX=9606 GN=NYNRIN PE=2 SV=3
2899,604,sp|Q9H8L6|MMRN2_HUMAN,0.70,17.80,9.968E4,1.077E5,1.291E5,1.093E5,1.00,1.08,1.30,1.10,9.968E4,1.077E5,1.291E5,1.093E5,1.00,1.08,1.30,1.10,1,1,1,iTRAQ 4plex (K  N-term); Phosphorylation (STY),104409,Multimerin-2 OS=Homo sapiens OX=9606 GN=MMRN2 PE=1 SV=2
3089,43751,sp|Q96K37|S35E1_HUMAN,1.78,17.73,5.56E4,5.444E4,9.926E4,9.487E4,1.00,0.98,1.79,1.71,5.56E4,5.444E4,9.926E4,9.487E4,1.00,0.98,1.79,1.71,2,1,1,iTRAQ 4plex (K  N-term),44773,Solute carrier family 35 member E1 OS=Homo sapiens OX=9606 GN=SLC35E1 PE=1 SV=2
3001,43791,E9PIT3|E9PIT3_HUMAN,2.11,17.64,1.934E5,1.905E5,3.793E5,3.489E5,1.00,0.99,1.96,1.80,1.934E5,1.905E5,3.793E5,3.489E5,1.00,0.99,1.96,1.80,1,1,1,iTRAQ 4plex (K  N-term),65409,Prothrombin OS=Homo sapiens OX=9606 GN=F2 PE=1 SV=1
2672,16779,G3V5X7|G3V5X7_HUMAN,1.40,17.19,1.131E4,1.57E4,1.271E4,1.85E4,1.00,1.39,1.12,1.64,1.131E4,1.57E4,1.271E4,1.85E4,1.00,1.39,1.12,1.64,1,1,1,Carbamidomethylation; iTRAQ 4plex (K  N-term); Oxidation (M); Phosphorylation (STY),278021,Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=1
2827,2806,sp|Q9Y2K3|MYH15_HUMAN,0.56,17.00,4.157E5,3.792E5,4.494E5,4.677E5,1.00,0.91,1.08,1.13,4.157E5,3.792E5,4.494E5,4.677E5,1.00,0.91,1.08,1.13,1,1,1,iTRAQ 4plex (K  N-term),224617,Myosin-15 OS=Homo sapiens OX=9606 GN=MYH15 PE=1 SV=5
2603,25711,A0A140T9I7|A0A140T9I7_HUMAN,0.59,16.88,2.612E6,2.431E6,2.427E6,3.02E6,1.00,0.93,0.93,1.16,2.612E6,2.431E6,2.427E6,3.02E6,1.00,0.93,0.93,1.16,0,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),159288,Collagen alpha-2(XI) chain (Fragment) OS=Homo sapiens OX=9606 GN=COL11A2 PE=1 SV=1
3078,43579,sp|Q9HCM4-2|E41L5_HUMAN,0.64,16.86,1.108E5,1.185E5,1.374E5,1.406E5,1.00,1.07,1.24,1.27,1.108E5,1.185E5,1.374E5,1.406E5,1.00,1.07,1.24,1.27,4,1,1,iTRAQ 4plex (K  N-term); Deamidation (NQ),57886,Isoform 2 of Band 4.1-like protein 5 OS=Homo sapiens OX=9606 GN=EPB41L5
